Citrus Sinensis ID: 022732
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 293 | 2.2.26 [Sep-21-2011] | |||||||
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.836 | 0.676 | 0.792 | 1e-108 | |
| Q39193 | 361 | Serine/threonine-protein | yes | no | 0.836 | 0.678 | 0.792 | 1e-108 | |
| Q940H6 | 362 | Serine/threonine-protein | no | no | 0.839 | 0.679 | 0.769 | 1e-107 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.836 | 0.676 | 0.780 | 1e-107 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.836 | 0.678 | 0.764 | 1e-106 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.692 | 0.547 | 0.832 | 1e-100 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.706 | 0.610 | 0.758 | 8e-91 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.706 | 0.610 | 0.753 | 2e-90 | |
| Q75LR7 | 342 | Serine/threonine-protein | no | no | 0.696 | 0.596 | 0.745 | 1e-88 | |
| Q02066 | 332 | Abscisic acid-inducible p | N/A | no | 0.713 | 0.629 | 0.731 | 4e-87 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 390 bits (1002), Expect = e-108, Method: Compositional matrix adjust.
Identities = 195/246 (79%), Positives = 221/246 (89%), Gaps = 1/246 (0%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKS
Sbjct: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPK+FRKTIQRIL
Sbjct: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRILG 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD IS ECRDLI+RIFVA+PA RI+IPEI H WFLKNLPADL+D+ MSSQY
Sbjct: 238 VQYSIPDYVHISPECRDLIARIFVANPATRISIPEIRNHPWFLKNLPADLMDDSKMSSQY 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
EEP+QPMQS+D IMQI+AEA+IPA G+ G+N ++ + DDDM+DLDS+ +LD++SSG
Sbjct: 298 EEPEQPMQSMDEIMQILAEATIPAAGSGGINQFLN-DGLDLDDDMEDLDSDPDLDVESSG 356
Query: 288 EIIYAL 293
EI+YA+
Sbjct: 357 EIVYAM 362
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1001), Expect = e-108, Method: Compositional matrix adjust.
Identities = 195/246 (79%), Positives = 218/246 (88%), Gaps = 1/246 (0%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQRILS
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
V+YS+PD IS EC LISRIFVADPA RI+IPEI H WFLKNLPADL++E SQ+
Sbjct: 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQF 296
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
+EP+QPMQS+D IMQII+EA+IPAV L+ +MT + DDDMDD DSESE+DIDSSG
Sbjct: 297 QEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMT-DNLDLDDDMDDFDSESEIDIDSSG 355
Query: 288 EIIYAL 293
EI+YAL
Sbjct: 356 EIVYAL 361
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (996), Expect = e-107, Method: Compositional matrix adjust.
Identities = 190/247 (76%), Positives = 218/247 (88%), Gaps = 1/247 (0%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 175
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+
Sbjct: 176 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQY++PD IS ECR LISRIFVADPA RI+IPEI H+WFLKNLPADL+++ TM++Q+
Sbjct: 236 VQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQF 295
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDD-DMDDLDSESELDIDSS 286
+E DQP QS++ IMQIIAEA++P GT LN Y+T +LD+DDD + D +LDIDSS
Sbjct: 296 DESDQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSS 355
Query: 287 GEIIYAL 293
GEI+YA+
Sbjct: 356 GEIVYAM 362
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 386 bits (992), Expect = e-107, Method: Compositional matrix adjust.
Identities = 192/246 (78%), Positives = 215/246 (87%), Gaps = 1/246 (0%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 118 EARFFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPE+LLR EYDGK+ADVWSCGVTLYVMLVG YPFEDP EP+D+RKTIQRILS
Sbjct: 178 TVGTPAYIAPEILLRQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRILS 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
V YS+P+ +S ECR LISRIFVADPA RITIPEI +WFLKNLP DL+DE M SQ+
Sbjct: 238 VTYSIPEDLHLSPECRHLISRIFVADPATRITIPEITSDKWFLKNLPGDLMDENRMGSQF 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
+EP+QPMQS+D IMQII+EA+IP V L+ +M + DDDMDD DSESE+D+DSSG
Sbjct: 298 QEPEQPMQSLDTIMQIISEATIPTVRNRCLDDFMA-DNLDLDDDMDDFDSESEIDVDSSG 356
Query: 288 EIIYAL 293
EI+YAL
Sbjct: 357 EIVYAL 362
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 385 bits (988), Expect = e-106, Method: Compositional matrix adjust.
Identities = 188/246 (76%), Positives = 222/246 (90%), Gaps = 1/246 (0%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKS
Sbjct: 117 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKS 176
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP++PK+FRKTIQ+IL
Sbjct: 177 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILG 236
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD IS ECRDLI+RIFV +PA+RIT+PEI H WF+KN+PADL+D+ +S+QY
Sbjct: 237 VQYSIPDYVHISPECRDLITRIFVGNPASRITMPEIKNHPWFMKNIPADLMDDGMVSNQY 296
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
EEPDQPMQ+++ IMQI+AEA+IPA GT G+N ++T + DDDM+D+DS+ +LDI+SSG
Sbjct: 297 EEPDQPMQNMNEIMQILAEATIPAAGTSGINQFLT-DSLDLDDDMEDMDSDLDLDIESSG 355
Query: 288 EIIYAL 293
EI+YA+
Sbjct: 356 EIVYAM 361
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (936), Expect = e-100, Method: Compositional matrix adjust.
Identities = 169/203 (83%), Positives = 187/203 (92%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR+FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 128 EARYFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 187
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGK ADVWSCGVTLYVM+VG YPFEDP+EPK+FRKTIQRIL+
Sbjct: 188 TVGTPAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQRILN 247
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+P+ IS ECR LISRIFV DP+ RITIPEI H WFLKNLPADL+D+ +MSSQY
Sbjct: 248 VQYSIPENVDISPECRHLISRIFVGDPSLRITIPEIRSHGWFLKNLPADLMDDDSMSSQY 307
Query: 228 EEPDQPMQSVDVIMQIIAEASIP 250
EEPDQPMQ++D IMQI+ EA+IP
Sbjct: 308 EEPDQPMQTMDQIMQILTEATIP 330
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 333 bits (854), Expect = 8e-91, Method: Compositional matrix adjust.
Identities = 157/207 (75%), Positives = 173/207 (83%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCH+MQ+CHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKS
Sbjct: 99 EARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKS 158
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVL R EYDGK+ADVWSCGVTLYVMLVG YPFEDPDEP++FRKTI RILS
Sbjct: 159 TVGTPAYIAPEVLARKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILS 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQY VPD +S ECR L+SRIFVA+P RITIPEI H WFLKNLP ++ DE MS Q
Sbjct: 219 VQYMVPDYVRVSMECRHLLSRIFVANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQM 278
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGT 254
+ + P Q ++ IM II EA P G+
Sbjct: 279 NDINTPSQGLEEIMAIIQEARKPGDGS 305
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (852), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 156/207 (75%), Positives = 173/207 (83%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCH+MQ+CHRDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKS
Sbjct: 99 EARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKS 158
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVL R EYDGK+ADVWSCGVTLYVMLVG YPFEDPDEP++FRKTI RILS
Sbjct: 159 TVGTPAYIAPEVLARKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILS 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQY VPD +S ECR L+SRIFVA+P RITIPEI H WFLKNLP ++ DE MS Q
Sbjct: 219 VQYMVPDYVRVSMECRHLLSRIFVANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQM 278
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGT 254
+ + P Q ++ IM II EA P G+
Sbjct: 279 NDINTPSQGLEEIMAIIQEARKPGDGS 305
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 152/204 (74%), Positives = 170/204 (83%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS PRLKICDFGYSKSSVLHSQPKS
Sbjct: 99 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKS 158
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVL R EYDGK+ADVWSCGVTLYVMLVG YPFEDPD+P++FRKTI RILS
Sbjct: 159 TVGTPAYIAPEVLSRKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILS 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD +S +CR L+SRIFV +P RITIPEI H WFLKNLP ++ DE S Q
Sbjct: 219 VQYSIPDYVRVSADCRHLLSRIFVGNPEQRITIPEIKNHPWFLKNLPIEMTDEYQRSMQL 278
Query: 228 EEPDQPMQSVDVIMQIIAEASIPA 251
+ + P QS++ +M II EA P
Sbjct: 279 ADMNTPSQSLEEVMAIIQEARKPG 302
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q02066|AAIP_WHEAT Abscisic acid-inducible protein kinase (Fragment) OS=Triticum aestivum PE=2 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (822), Expect = 4e-87, Method: Compositional matrix adjust.
Identities = 155/212 (73%), Positives = 171/212 (80%), Gaps = 3/212 (1%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ RFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKS
Sbjct: 89 EGRFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSVAPRLKICDFGYSKSSVLHSQPKS 148
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVL R EYDGK+ADVWSCGVTLYVMLVG YPFEDPDEP++FRKTI RILS
Sbjct: 149 TVGTPAYIAPEVLSRREYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILS 208
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYSVPD +S +C L+SRIFV +P RITIPEI H WFLK LP ++ DE S Q
Sbjct: 209 VQYSVPDYVRVSMDCIHLLSRIFVGNPQQRITIPEIKNHPWFLKRLPVEMTDEYQRSMQL 268
Query: 228 EEPDQPMQSVDVIMQIIAEASIP---AVGTHG 256
+ + P QS++ M II EA P A+G G
Sbjct: 269 ADMNTPSQSLEEAMAIIQEAQKPGDNALGVAG 300
|
Involved in water-stress responses. Triticum aestivum (taxid: 4565) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 293 | ||||||
| 357518557 | 363 | Serine/threonine protein kinase SAPK3 [M | 0.836 | 0.674 | 0.825 | 1e-117 | |
| 217072176 | 363 | unknown [Medicago truncatula] | 0.836 | 0.674 | 0.821 | 1e-116 | |
| 359475222 | 371 | PREDICTED: serine/threonine-protein kina | 0.863 | 0.681 | 0.782 | 1e-114 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.839 | 0.677 | 0.796 | 1e-114 | |
| 224105505 | 362 | predicted protein [Populus trichocarpa] | 0.836 | 0.676 | 0.804 | 1e-114 | |
| 255561655 | 363 | Serine/threonine-protein kinase SAPK10, | 0.839 | 0.677 | 0.792 | 1e-114 | |
| 147788088 | 363 | hypothetical protein VITISV_025025 [Viti | 0.839 | 0.677 | 0.792 | 1e-113 | |
| 224123434 | 363 | predicted protein [Populus trichocarpa] | 0.839 | 0.677 | 0.792 | 1e-113 | |
| 388491244 | 363 | unknown [Medicago truncatula] | 0.839 | 0.677 | 0.784 | 1e-113 | |
| 255562649 | 362 | Serine/threonine-protein kinase SAPK10, | 0.836 | 0.676 | 0.833 | 1e-112 |
| >gi|357518557|ref|XP_003629567.1| Serine/threonine protein kinase SAPK3 [Medicago truncatula] gi|355523589|gb|AET04043.1| Serine/threonine protein kinase SAPK3 [Medicago truncatula] gi|388521379|gb|AFK48751.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1100), Expect = e-117, Method: Compositional matrix adjust.
Identities = 203/246 (82%), Positives = 223/246 (90%), Gaps = 1/246 (0%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP PRLKICDFGYSKSSVLHSQPKS
Sbjct: 118 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPTPRLKICDFGYSKSSVLHSQPKS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQR+LS
Sbjct: 178 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGSYPFEDPNEPKDFRKTIQRVLS 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD I+ ECR LISRIFV DPA RIT+PEI KH+WFLKNLP DL+DEK M +Q+
Sbjct: 238 VQYSIPDNVQITPECRHLISRIFVFDPAERITMPEIWKHKWFLKNLPMDLMDEKIMGNQF 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
EEP+QPMQS+D IMQII+EA+IPA GT L+ +M DNLDM DD+ DDL+ ESELDIDSSG
Sbjct: 298 EEPEQPMQSIDTIMQIISEATIPAAGTCSLDQFMADNLDM-DDEFDDLEYESELDIDSSG 356
Query: 288 EIIYAL 293
EI+YA+
Sbjct: 357 EIVYAM 362
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217072176|gb|ACJ84448.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1090), Expect = e-116, Method: Compositional matrix adjust.
Identities = 202/246 (82%), Positives = 222/246 (90%), Gaps = 1/246 (0%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP PRLKICDFGYSKSSVLHSQPKS
Sbjct: 118 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPTPRLKICDFGYSKSSVLHSQPKS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQR+LS
Sbjct: 178 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGSYPFEDPNEPKDFRKTIQRVLS 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD I+ E R LISRIFV DPA RIT+PEI KH+WFLKNLP DL+DEK M +Q+
Sbjct: 238 VQYSIPDNVQITPEGRHLISRIFVFDPAERITMPEIWKHKWFLKNLPMDLMDEKIMGNQF 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
EEP+QPMQS+D IMQII+EA+IPA GT L+ +M DNLDM DD+ DDL+ ESELDIDSSG
Sbjct: 298 EEPEQPMQSIDTIMQIISEATIPAAGTCSLDQFMADNLDM-DDEFDDLEYESELDIDSSG 356
Query: 288 EIIYAL 293
EI+YA+
Sbjct: 357 EIVYAM 362
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475222|ref|XP_003631617.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1074), Expect = e-114, Method: Compositional matrix adjust.
Identities = 198/253 (78%), Positives = 222/253 (87%)
Query: 41 LLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 100
+L+ L ARFFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV
Sbjct: 119 VLMQLAHLARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 178
Query: 101 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160
LHSQPKSTVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+F K
Sbjct: 179 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHK 238
Query: 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 220
TIQRIL VQYS+PD IS ECR LISRIFVADPA RITI EI H+WFLKNLPADL+DE
Sbjct: 239 TIQRILKVQYSIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDE 298
Query: 221 KTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESE 280
M +QYEEP+QPMQS+D IM+II EA IPA GT LN Y+T +LD+DD+ +DL+++ +
Sbjct: 299 TKMDNQYEEPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPD 358
Query: 281 LDIDSSGEIIYAL 293
LDIDSSGEI+YA+
Sbjct: 359 LDIDSSGEIVYAM 371
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1071), Expect = e-114, Method: Compositional matrix adjust.
Identities = 196/246 (79%), Positives = 219/246 (89%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 118 EARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+F KTIQRIL
Sbjct: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILK 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD IS ECR LISRIFVADPA RITI EI H+WFLKNLPADL+DE M +QY
Sbjct: 238 VQYSIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDETKMDNQY 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
EEP+QPMQS+D IM+II EA IPA GT LN Y+T +LD+DD+ +DL+++ +LDIDSSG
Sbjct: 298 EEPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSG 357
Query: 288 EIIYAL 293
EI+YA+
Sbjct: 358 EIVYAM 363
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224105505|ref|XP_002313835.1| predicted protein [Populus trichocarpa] gi|222850243|gb|EEE87790.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1070), Expect = e-114, Method: Compositional matrix adjust.
Identities = 198/246 (80%), Positives = 223/246 (90%), Gaps = 1/246 (0%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 118 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDPDEP +FR TI RIL+
Sbjct: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPMNFRNTIHRILN 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD IS EC+ LISRIFVADPA RITIPEI H+WFLKNLPADL+ E TM++++
Sbjct: 238 VQYSIPDYVHISPECQHLISRIFVADPAMRITIPEIRNHEWFLKNLPADLMVENTMNNEF 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
EEPDQPMQS++ IMQII+EA+IPA GT LN Y+T +LD+ DDDM+DL+S+ ELD+DSSG
Sbjct: 298 EEPDQPMQSIEEIMQIISEATIPAAGTPSLNQYLTGSLDI-DDDMEDLESDPELDLDSSG 356
Query: 288 EIIYAL 293
EI+YA+
Sbjct: 357 EIVYAM 362
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1069), Expect = e-114, Method: Compositional matrix adjust.
Identities = 195/246 (79%), Positives = 225/246 (91%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 118 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+
Sbjct: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD IS EC+ LISRIFVADPA RI+IPEI H+WFLKNLPADL+D+KT+++Q+
Sbjct: 238 VQYSIPDYVHISPECQHLISRIFVADPAKRISIPEIKNHEWFLKNLPADLMDDKTINNQF 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
+EP+QP+QS+D IMQII+EA+IPA GT N Y+T +LD+DDD +DL+S+ ELD+DSSG
Sbjct: 298 DEPEQPVQSIDEIMQIISEATIPAAGTGNPNQYLTGSLDIDDDMEEDLESDPELDMDSSG 357
Query: 288 EIIYAL 293
EI+YA+
Sbjct: 358 EIVYAM 363
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147788088|emb|CAN62745.1| hypothetical protein VITISV_025025 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 413 bits (1061), Expect = e-113, Method: Compositional matrix adjust.
Identities = 195/246 (79%), Positives = 217/246 (88%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKS
Sbjct: 118 EARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSSAPRLKICDFGYSKSSVLHSQPKS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+F KTIQRIL
Sbjct: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILK 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD IS ECR LISRIFVADPA RITI EI H WFLKNLPADL+DE M +QY
Sbjct: 238 VQYSIPDYVHISPECRHLISRIFVADPATRITIAEIRNHDWFLKNLPADLMDETKMDNQY 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
EEP+QPMQS+D IM+II EA IPA GT LN Y+T +LD+DD+ +DL+++ +LDIDSSG
Sbjct: 298 EEPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSG 357
Query: 288 EIIYAL 293
EI+YA+
Sbjct: 358 EIVYAM 363
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 413 bits (1061), Expect = e-113, Method: Compositional matrix adjust.
Identities = 195/246 (79%), Positives = 218/246 (88%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP S
Sbjct: 118 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPTS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDPDEP++FR TI RIL+
Sbjct: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPRNFRSTIHRILN 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD IS EC+ LISRIFVADPA RITIPEI H WFLKN PADL+ E M++Q+
Sbjct: 238 VQYSIPDYVHISPECQHLISRIFVADPAKRITIPEIRNHDWFLKNFPADLMVENNMNNQF 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
EEPDQPMQS+D IMQII EA+IPA GT LN Y+T +LD+DD+ +DL+S+ ELD+DSSG
Sbjct: 298 EEPDQPMQSIDEIMQIITEATIPAAGTPSLNHYLTGSLDIDDEMEEDLESDPELDLDSSG 357
Query: 288 EIIYAL 293
EI+YA+
Sbjct: 358 EIVYAM 363
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388491244|gb|AFK33688.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 413 bits (1061), Expect = e-113, Method: Compositional matrix adjust.
Identities = 193/246 (78%), Positives = 220/246 (89%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCHAM+VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 118 EARFFFQQLISGVSYCHAMEVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+
Sbjct: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTINRILN 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
V YS+PD IS EC+ LISRIFVADPA RI+IPEI H+WFLKNLP DL+D+ ++Q+
Sbjct: 238 VHYSIPDYVHISPECQHLISRIFVADPAKRISIPEIRNHEWFLKNLPTDLMDDNGTNNQF 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
EEPDQP QSV+ IMQIIAEA++PA GT LN Y+T +LD+DDD +DLD++ +LDIDSSG
Sbjct: 298 EEPDQPTQSVEEIMQIIAEATVPAAGTQSLNPYLTGSLDIDDDMEEDLDTDPDLDIDSSG 357
Query: 288 EIIYAL 293
EI+YA+
Sbjct: 358 EIVYAM 363
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562649|ref|XP_002522330.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538408|gb|EEF40014.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 410 bits (1055), Expect = e-112, Method: Compositional matrix adjust.
Identities = 205/246 (83%), Positives = 221/246 (89%), Gaps = 1/246 (0%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 118 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPKDFRKTIQRILS
Sbjct: 178 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKDFRKTIQRILS 237
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQYS+PD IS EC DLISRIF+ DPAARITIP+I H+WFLKNLP DL+DE+TM + +
Sbjct: 238 VQYSIPDVVQISPECCDLISRIFIFDPAARITIPQIKTHEWFLKNLPMDLMDERTMGNHF 297
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
EEPDQPMQS+D IMQII+EA+IPA G HGLN +M + DDDM D DSESELD+DSSG
Sbjct: 298 EEPDQPMQSIDTIMQIISEATIPAAGDHGLNRFMA-DNLDMDDDMMDFDSESELDVDSSG 356
Query: 288 EIIYAL 293
EI+YAL
Sbjct: 357 EIVYAL 362
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 293 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.726 | 0.588 | 0.807 | 3.4e-93 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.699 | 0.567 | 0.829 | 6.3e-92 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.713 | 0.580 | 0.698 | 6.2e-78 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.696 | 0.565 | 0.707 | 1.5e-76 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.703 | 0.583 | 0.692 | 3.9e-76 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.699 | 0.597 | 0.690 | 3.1e-74 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.706 | 0.591 | 0.682 | 1.7e-73 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.689 | 0.595 | 0.653 | 1.4e-69 | |
| TAIR|locus:2094672 | 512 | KIN11 "SNF1 kinase homolog 11" | 0.542 | 0.310 | 0.485 | 1.2e-33 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.587 | 0.386 | 0.454 | 1.1e-32 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 928 (331.7 bits), Expect = 3.4e-93, P = 3.4e-93
Identities = 172/213 (80%), Positives = 193/213 (90%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 175
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+
Sbjct: 176 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQY++PD IS ECR LISRIFVADPA RI+IPEI H+WFLKNLPADL+++ TM++Q+
Sbjct: 236 VQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQF 295
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCY 260
+E DQP QS++ IMQIIAEA++P GT LN Y
Sbjct: 296 DESDQPGQSIEEIMQIIAEATVPPAGTQNLNHY 328
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 916 (327.5 bits), Expect = 6.3e-92, P = 6.3e-92
Identities = 170/205 (82%), Positives = 188/205 (91%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQRILS
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
V+YS+PD IS EC LISRIFVADPA RI+IPEI H WFLKNLPADL++E SQ+
Sbjct: 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQF 296
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAV 252
+EP+QPMQS+D IMQII+EA+IPAV
Sbjct: 297 QEPEQPMQSLDTIMQIISEATIPAV 321
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 784 (281.0 bits), Expect = 6.2e-78, P = 6.2e-78
Identities = 148/212 (69%), Positives = 175/212 (82%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR+FFQQLI GV YCH++Q+CHRDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKS
Sbjct: 99 EARYFFQQLICGVDYCHSLQICHRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKS 158
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVL R EYDGK ADVWSCGVTLYVMLVGGYPFEDPD+P++FRKTIQRI++
Sbjct: 159 TVGTPAYIAPEVLSRREYDGKHADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMA 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQY +PD ISQECR L+SRIFV + A RIT+ EI KH W+LKNLP +L E ++ Y
Sbjct: 219 VQYKIPDYVHISQECRHLLSRIFVTNSAKRITLKEIKKHPWYLKNLPKELT-EPAQAAYY 277
Query: 228 --EEPDQPMQSVDVIMQIIAEASIPAVGTHGL 257
E P +QSV+ IM+I+ EA PA ++ +
Sbjct: 278 KRETPSFSLQSVEDIMKIVGEARNPAPSSNAV 309
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 771 (276.5 bits), Expect = 1.5e-76, P = 1.5e-76
Identities = 145/205 (70%), Positives = 171/205 (83%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR+FFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKS
Sbjct: 99 EARYFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKS 158
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVL R EYDGK+ADVWSCGVTLYVMLVG YPFED ++PK+F+KTIQRI++
Sbjct: 159 TVGTPAYIAPEVLSRGEYDGKMADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMA 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD-EKTMSSQ 226
V+Y +PD ISQ+C+ L+SRIFV + RITI +I KH WFLKNLP +L + + +
Sbjct: 219 VKYKIPDYVHISQDCKHLLSRIFVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFR 278
Query: 227 YEEPDQPMQSVDVIMQIIAEASIPA 251
E P +QSV+ IM+I+ EA PA
Sbjct: 279 KENPTFSLQSVEEIMKIVEEAKTPA 303
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 3.9e-76, P = 3.9e-76
Identities = 144/208 (69%), Positives = 171/208 (82%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR+FFQQLI GV YCH++Q+CHRDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKS
Sbjct: 99 EARYFFQQLICGVDYCHSLQICHRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKS 158
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVL R EYDGK ADVWSCGVTLYVMLVG YPFEDP++PK+FRKTIQRI++
Sbjct: 159 TVGTPAYIAPEVLSRREYDGKHADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMA 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
VQY +PD ISQEC+ L+SRIFV + A RIT+ EI H W+LKNLP +L+ E ++ Y
Sbjct: 219 VQYKIPDYVHISQECKHLLSRIFVTNSAKRITLKEIKNHPWYLKNLPKELL-ESAQAAYY 277
Query: 228 EEPDQ-PMQSVDVIMQIIAEASIPAVGT 254
+ +QSV+ IM+I+ EA PA T
Sbjct: 278 KRDTSFSLQSVEDIMKIVGEARNPAPST 305
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 749 (268.7 bits), Expect = 3.1e-74, P = 3.1e-74
Identities = 145/210 (69%), Positives = 165/210 (78%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQLISGV+YCH++Q+CHRDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+
Sbjct: 99 EARFFFQQLISGVNYCHSLQICHRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKT 158
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVL EYDGKIADVWSCGVTLYVMLVG YPFEDP +PKDFRKTI RIL
Sbjct: 159 TVGTPAYIAPEVLSTKEYDGKIADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILK 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
QY++PD +S ECR L+SRIFVA+P RITI EI H WFLKNLP ++ + M +
Sbjct: 219 AQYAIPDYVRVSDECRHLLSRIFVANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMMNG- 277
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGL 257
P Q+V+ I+ II EA P GL
Sbjct: 278 --PST--QTVEEIVWIIEEARKPITVATGL 303
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 742 (266.3 bits), Expect = 1.7e-73, P = 1.7e-73
Identities = 144/211 (68%), Positives = 169/211 (80%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ R++F+QLISGVSYCHAMQ+CHRDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKS
Sbjct: 99 EGRYYFKQLISGVSYCHAMQICHRDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKS 158
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAY+APEVL R EY+GKIADVWSCGVTLYVMLVG YPFEDP++P++ R TIQRILS
Sbjct: 159 TVGTPAYVAPEVLSRKEYNGKIADVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILS 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN-LPADLVDEKT---M 223
V Y++PD IS EC+ L+SRIFVADP RIT+PEI KH WFLK L +EK +
Sbjct: 219 VHYTIPDYVRISSECKHLLSRIFVADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGV 278
Query: 224 SSQYEEPDQPMQSVDVIMQIIAEASIPAVGT 254
+ EE ++ QSV+ I++II EA GT
Sbjct: 279 EEEEEEEEKCRQSVEEIVKIIEEARKGVNGT 309
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 705 (253.2 bits), Expect = 1.4e-69, P = 1.4e-69
Identities = 136/208 (65%), Positives = 161/208 (77%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR+FFQQLI GV Y HA+Q+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKS
Sbjct: 99 EARYFFQQLICGVHYLHALQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKS 158
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEV R EYDGK DVWSCGV LYVMLVG YPFEDP +P++FRKT+Q+I++
Sbjct: 159 TVGTPAYIAPEVFCRSEYDGKSVDVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMA 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
V Y +P IS++CR L+SRIFVA+P R T+ EI H WFLKNLP +L E + Y
Sbjct: 219 VNYKIPGYVHISEDCRKLLSRIFVANPLHRSTLKEIKSHAWFLKNLPREL-KEPAQAIYY 277
Query: 228 EEPDQPM----QSVDVIMQIIAEA-SIP 250
+ + Q V+ IM+I+ EA +IP
Sbjct: 278 QRNVNLINFSPQRVEEIMKIVGEARTIP 305
|
|
| TAIR|locus:2094672 KIN11 "SNF1 kinase homolog 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 366 (133.9 bits), Expect = 1.2e-33, P = 1.2e-33
Identities = 81/167 (48%), Positives = 101/167 (60%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR FFQQ+ISGV YCH V HRDLK EN LLD +KI DFG S K+
Sbjct: 119 EARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSRC--NIKIADFGLSNVMRDGHFLKT 176
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
+ G+P Y APEV+ Y G DVWSCGV LY +L G PF+D + P F+K I
Sbjct: 177 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-- 234
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
Y++P + +S E RDLI R+ + DP RITIPEI +H+WF +LP
Sbjct: 235 --YTLP--SHLSSEARDLIPRMLIVDPVKRITIPEIRQHRWFQTHLP 277
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 357 (130.7 bits), Expect = 1.1e-32, P = 1.1e-32
Identities = 89/196 (45%), Positives = 112/196 (57%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVL 101
AR +FQQLIS V YCH+ V HRDLK EN LLD + LKI DFG S + +L
Sbjct: 112 ARRYFQQLISAVDYCHSRGVSHRDLKPENLLLDENGD--LKISDFGLSALPEQILQDGLL 169
Query: 102 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
H+Q GTPAY+APEVL + YDG AD+WSCGV LYV+L G PF+D + +RK
Sbjct: 170 HTQ----CGTPAYVAPEVLKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRK- 224
Query: 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADL---V 218
I + P S E R LIS++ V DP RI+IP IM+ W KN L +
Sbjct: 225 ---IFRADFEFPPW--FSPEARRLISKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKI 279
Query: 219 DEK--TMSSQYEEPDQ 232
DE + SS+ E ++
Sbjct: 280 DEPICSQSSKNNEEEE 295
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.7311 | 0.7133 | 0.6295 | N/A | no |
| Q39193 | SRK2I_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7926 | 0.8361 | 0.6786 | yes | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.7584 | 0.7064 | 0.6106 | N/A | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7926 | 0.8361 | 0.6767 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 293 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-58 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-52 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-35 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-33 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-28 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-27 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-25 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-24 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-23 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-23 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-23 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-22 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-22 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-21 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-21 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-20 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-19 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-16 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-15 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-14 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-10 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 8e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.001 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.001 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.001 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.002 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.003 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.003 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.003 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 0.003 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.003 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-58
Identities = 61/163 (37%), Positives = 91/163 (55%), Gaps = 7/163 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARF+ +Q++S + Y H+ + HRDLK EN LLD +K+ DFG ++ + +
Sbjct: 98 EARFYLRQILSALEYLHSKGIVHRDLKPENILLDED--GHVKLADFGLARQLDPGEKLTT 155
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
VGTP Y+APEVLL Y + D+WS GV LY +L G PF D+ + ++I
Sbjct: 156 FVGTPEYMAPEVLLGKGYGKAV-DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGK 211
Query: 168 VQYSVP-DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+ P IS E +DLI ++ V DP R+T E ++H +F
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-52
Identities = 67/165 (40%), Positives = 94/165 (56%), Gaps = 6/165 (3%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+A+ Q++ G+ Y H+ + HRDLK EN LLD + +KI DFG +K + S +
Sbjct: 99 EAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENG--VVKIADFGLAKKLLKSSSSLT 156
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T VGTP Y+APEVLL G DVWS GV LY +L G PF + D + I+RIL
Sbjct: 157 TFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENIL-DQLQLIRRIL 215
Query: 167 S--VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+++ P + S+E +DLI + DP+ R T EI++H WF
Sbjct: 216 GPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-37
Identities = 70/206 (33%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 18 VKMKFVF---LSLSFFFSLC----LFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVC 69
VK+ + F L LF +ARF+ +++ + Y H++ +
Sbjct: 56 VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 70 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYD 126
+RDLK EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL Y
Sbjct: 116 YRDLKPENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY- 170
Query: 127 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 186
GK D WS GV LY ML G PF D + ++IL P+ +S E RDLI
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFPEF--LSPEARDLI 224
Query: 187 SRIFVADPAARIT---IPEIMKHQWF 209
S + DP R+ EI H +F
Sbjct: 225 SGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-35
Identities = 53/160 (33%), Positives = 75/160 (46%), Gaps = 39/160 (24%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPK 106
+ Q++ G+ Y H+ + HRDLK EN LLD S ++K+ DFG SK + S K
Sbjct: 93 EILRILLQILEGLEYLHSNGIIHRDLKPENILLD-SDNGKVKLADFGLSKLLTSDKSLLK 151
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ VGTPAY+APEVLL Y + +D+WS GV LY +
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
E +DLI ++ DP R + EI++H
Sbjct: 188 -------------PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 59/186 (31%), Positives = 88/186 (47%), Gaps = 34/186 (18%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----------- 97
RF+ +++ + Y H+ + HRDLK EN LLD +KI DFG +K
Sbjct: 104 TRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESN 161
Query: 98 ----------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 147
+ S VGT Y++PE LL + GK +D+W+ G +Y ML G
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKP 220
Query: 148 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI----PEI 203
PF +E T Q+IL ++YS P P + +DLI ++ V DP R+ + E+
Sbjct: 221 PFRGSNEY----LTFQKILKLEYSFPPNFP--PDAKDLIEKLLVLDPQDRLGVNEGYDEL 274
Query: 204 MKHQWF 209
H +F
Sbjct: 275 KAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-33
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 13/165 (7%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPK 106
R + +Q++ G++Y H+ + HRD+K N L+D +K+ DFG +K
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTG 161
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
S GTP ++APEV +R E G+ AD+WS G T+ M G P+ + P + +I
Sbjct: 162 SVRGTPYWMAPEV-IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA---LYKIG 217
Query: 167 SVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
S +P+ +S+E +D + + DP R T E+++H +
Sbjct: 218 SSGEPPEIPEH--LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 58/169 (34%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
ARF+ Q++ + Y H++ + +RDLK EN LLD G +KI DFG++K + +
Sbjct: 102 VARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRT 155
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
+ GTP Y+APE++L Y GK D W+ G+ +Y ML G PF D D P + ++I
Sbjct: 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFD-DNP---IQIYEKI 210
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
L + P + S + +DLI + D R+ + +I H WF
Sbjct: 211 LEGKVRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 6e-32
Identities = 63/173 (36%), Positives = 89/173 (51%), Gaps = 19/173 (10%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SS 99
AR + +++ + Y H+ + HRDLK +N L+D + LK+ DFG SK +
Sbjct: 95 ARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN--GHLKLTDFGLSKVGLVRRQINLN 152
Query: 100 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159
+ K VGTP YIAPEV+L + K D WS G LY LVG PF + P
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHG-ETP---E 207
Query: 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF 209
+ Q IL+ + P+ +S E DLIS++ V DP R+ +I EI H +F
Sbjct: 208 EIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (284), Expect = 4e-29
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 18 VKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-----------QARFFFQQLISGVSYCHAM 66
VK+ F + + + L LL +A F Q++S + Y H+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEV 119
+ HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+APEV
Sbjct: 121 GIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 120 LL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-------QY 170
LL Y +D+WS G+TLY +L G PFE +T++ IL +
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 171 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
S + IS+ DL+ ++ DP R++ + H
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 53/158 (33%), Positives = 85/158 (53%), Gaps = 13/158 (8%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 107
+F QL + Y H+ ++ HRD+K +N L +K+ DFG SK S+V + K+
Sbjct: 107 DWFVQLCLALKYLHSRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KT 162
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
VGTP Y++PE+ Y+ K +D+WS G LY + +PFE ++ + +IL
Sbjct: 163 VVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILK 217
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
QY P + S E R+L+S + DP R +I +I++
Sbjct: 218 GQYP-PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 66/207 (31%), Positives = 90/207 (43%), Gaps = 45/207 (21%)
Query: 42 LLGLLVQ--------ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 93
L+ LL++ ARF+ +L+ + H + HRD+K +N L+D +K+ DF
Sbjct: 88 LMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG--HIKLADF 145
Query: 94 GYSK--------------------------SSVLHSQPK----STVGTPAYIAPEVLLRH 123
G K H Q + STVGTP YIAPEVL
Sbjct: 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205
Query: 124 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 183
Y + D WS GV LY ML G PF + + K I S+++ P P+S E
Sbjct: 206 PYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRF--PPDPPVSPEAI 262
Query: 184 DLISRIFVADPAARIT-IPEIMKHQWF 209
DLI R + DP R+ EI H +F
Sbjct: 263 DLICR-LLCDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-28
Identities = 57/167 (34%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
ARF+ ++ Y H + +RDLK EN LLD + +K+ DFG++K + +
Sbjct: 94 TARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN--GYVKLVDFGFAKKLKSGQKTWT 151
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GTP Y+APE++L YD D WS G+ LY +L G PF + DE D + IL
Sbjct: 152 FCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDE--DPMEIYNDILK 208
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+ N I + +DLI ++ +P R+ I +I KH+WF
Sbjct: 209 GNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 27/174 (15%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQ 104
R + QL+ G++Y H+ + HRD+K N LD + +K+ DFG + ++ + +
Sbjct: 102 RVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEE 159
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKI--ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
+S GTPAY+APEV+ + G AD+WS G + M G P+ + D
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE------- 212
Query: 163 QRILSVQYSV--------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208
+ + V PD+ +S E +D + R +DP R T E+++H +
Sbjct: 213 ---FQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 64/180 (35%), Positives = 95/180 (52%), Gaps = 15/180 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARF+ +++S + Y H+ V +RDLKLEN +LD +KI DFG K +
Sbjct: 96 RARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMK 153
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP Y+APEVL ++Y G+ D W GV +Y M+ G PF + D K F + IL
Sbjct: 154 TFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELIL 208
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEK 221
+ P T +S E + L++ + DP R+ EIM+H++F D+V +K
Sbjct: 209 MEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKK 266
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 6e-27
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
++L+ G+ Y H+ + HRD+K N LL DG +K+ DFG S + VGT
Sbjct: 105 KELLKGLEYLHSNGIIHRDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGT 160
Query: 112 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 171
P ++APEV+ YD K AD+WS G+T + G P+ + K K +
Sbjct: 161 PYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPG 216
Query: 172 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208
+ + S E +D + + +P R T +++KH +
Sbjct: 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 65/192 (33%), Positives = 95/192 (49%), Gaps = 18/192 (9%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
L +ARF+ +L+ + H V +RDLK EN LLD + +CDFG K ++
Sbjct: 92 LSRARFYTAELLCALENLHKFNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDK 149
Query: 106 KST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+T GTP Y+APE+LL H Y K D W+ GV LY ML G PF D + + +RK +Q
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITI---PEIMKHQWFLKNLPADLVDEK 221
L PD ++ +DL+ + DP R+ EI H +F + L +K
Sbjct: 209 PL----RFPDG--FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF-----SQLSWKK 257
Query: 222 TMSSQYEEPDQP 233
+ + P +P
Sbjct: 258 LLMKGIQPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 64/174 (36%), Positives = 92/174 (52%), Gaps = 18/174 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
ARF+ ++ V H + HRDLK EN L+D S +K+ DFG SK V + S
Sbjct: 102 HARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANS 157
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDEP----KDFRKT 161
VG+P Y+APEVL YD + D WS G LY L G PF P+E K +++T
Sbjct: 158 VVGSPDYMAPEVLRGKGYDFTV-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
Query: 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-TIPEIMKHQWFLKNLP 214
+QR + P N +S E DLI+++ + DP+ R ++ +I H +F K +
Sbjct: 217 LQRPVYDD---PRFN-LSDEAWDLITKL-INDPSRRFGSLEDIKNHPFF-KEVD 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 60/203 (29%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ QL+ G++YCH+ ++ HRDLK +N L++ LK+ DFG +++ P
Sbjct: 99 LIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLR 153
Query: 108 T----VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG----------------- 145
T V T Y APE+LL Y + D+WS G M+ G
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212
Query: 146 ---GYPFED--PD--------------EPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 186
G P E+ P PKD K + R + E DL+
Sbjct: 213 QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPR-------------LDPEGIDLL 259
Query: 187 SRIFVADPAARITIPEIMKHQWF 209
S++ +PA RI+ E +KH +F
Sbjct: 260 SKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-25
Identities = 73/237 (30%), Positives = 116/237 (48%), Gaps = 26/237 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 106
+ RF+ +++S + Y H+ ++ +RDLKLEN +LD +KI DFG K + + K
Sbjct: 96 RTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD--GHIKITDFGLCKEGITDAATMK 153
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ GTP Y+APEVL ++Y G+ D W GV +Y M+ G PF + D K F + IL
Sbjct: 154 TFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELIL 208
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEK 221
P T +S + + L+S + + DP R+ EIM+H +F D+ D+K
Sbjct: 209 MEDIKFPRT--LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKK 266
Query: 222 TMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSE 278
+ P +P + + + E T +T D+D MD +D+E
Sbjct: 267 LVP-----PFKPQVTSETDTRYFDEEFTAQTIT------ITPPEKYDEDGMDCMDNE 312
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 55/167 (32%), Positives = 79/167 (47%), Gaps = 10/167 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+A F+ Q+I G+ + H ++ +RDLK EN LLD R I D G + + K
Sbjct: 96 RAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKG 153
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GTP Y+APEVL YD D ++ G TLY M+ G PF E + + +R L
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+ PD S E +DL + DP R+ + E+ +H F
Sbjct: 213 MAVEYPDKF--SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 62/171 (36%), Positives = 92/171 (53%), Gaps = 21/171 (12%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
+ARF+ ++I G+ + H + +RDLKL+N LLD +KI DFG K ++
Sbjct: 95 EARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD--GHIKIADFGMCKENMNGEGK 152
Query: 106 KST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
ST GTP YIAPE+L +Y+ + D WS GV LY ML+G PF DE + F
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESV-DWWSFGVLLYEMLIGQSPFHGEDEDELF------ 205
Query: 165 ILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARITIP-EIMKHQWF 209
S+ + P IS+E +D +S++F DP R+ + +I +H +F
Sbjct: 206 -----DSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 58/170 (34%), Positives = 91/170 (53%), Gaps = 12/170 (7%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
L +A F+ +++ G+ + H+ + +RDLKL+N +LD +KI DFG K +V
Sbjct: 95 LYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD--GHIKIADFGMCKENVFGDNR 152
Query: 106 KST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
ST GTP YIAPE+L +Y + D WS GV LY ML+G PF DE + F
Sbjct: 153 ASTFCGTPDYIAPEILQGLKYTFSV-DWWSFGVLLYEMLIGQSPFHGDDEDELFE----- 206
Query: 165 ILSVQYSVPD-TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213
S++ P I++E +D++ ++F DP R+ + ++ F K +
Sbjct: 207 --SIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 63/194 (32%), Positives = 104/194 (53%), Gaps = 24/194 (12%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
L +A F+ ++I G+ + H+ + +RDLKL+N LLD +KI DFG K ++L
Sbjct: 95 LPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD--GHIKIADFGMCKENMLGDAK 152
Query: 106 KST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
T GTP YIAPE+LL +Y+ + D WS GV LY ML+G PF DE + F+
Sbjct: 153 TCTFCGTPDYIAPEILLGQKYNTSV-DWWSFGVLLYEMLIGQSPFHGHDEEELFQ----- 206
Query: 165 ILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 219
S+ NP +++E +D++ ++FV +P R+ + ++ F + + ++
Sbjct: 207 ------SIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALE 260
Query: 220 EKTMSSQYEEPDQP 233
E+ + E P +P
Sbjct: 261 ER----EIEPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-24
Identities = 64/193 (33%), Positives = 96/193 (49%), Gaps = 20/193 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARF+ +++ G+ + H + +RDLKL+N LLD +KI DFG K +L S
Sbjct: 97 RARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE--GHIKIADFGMCKEGILGGVTTS 154
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP YIAPE+L Y G D W+ GV LY ML G PFE DE + F Q IL
Sbjct: 155 TFCGTPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELF----QSIL 209
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIP-----EIMKHQWFLKNLPADLVDEK 221
+ P +S+E + ++ +P R+ +I H +F + + D ++ K
Sbjct: 210 EDEVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF-REIDWDKLERK 266
Query: 222 TMSSQYEEPDQPM 234
+ + P +P
Sbjct: 267 EI----KPPFKPK 275
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 9e-24
Identities = 59/168 (35%), Positives = 84/168 (50%), Gaps = 19/168 (11%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
A+ + +++ GV H + HRD+K EN L+D LK+ DFG S++ + K
Sbjct: 99 AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKF 153
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRIL 166
VGTP Y+APE +L D K++D WS G ++ L G PF E PD IL
Sbjct: 154 VGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNIL 206
Query: 167 SVQYSVPD--TNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF 209
S + + P+ S E DLI+R+ DPA R+ EI H +F
Sbjct: 207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-23
Identities = 64/181 (35%), Positives = 98/181 (54%), Gaps = 16/181 (8%)
Query: 48 QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 105
+ARF+ +++S + Y H+ V +RDLKLEN +LD +KI DFG K + +
Sbjct: 96 RARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATM 153
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
K+ GTP Y+APEVL ++Y G+ D W GV +Y M+ G PF + D K F + I
Sbjct: 154 KTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELI 208
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDE 220
L + P T +S E + L+S + DP R+ EIM+H++F + D+ ++
Sbjct: 209 LMEEIRFPRT--LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEK 266
Query: 221 K 221
K
Sbjct: 267 K 267
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 54/164 (32%), Positives = 89/164 (54%), Gaps = 16/164 (9%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVG 110
++++ G+ Y H+ V HRD+K +N LL DGS +K+ DFG++ + + S+ S VG
Sbjct: 123 REVLQGLEYLHSQNVIHRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVG 178
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP--FEDPDEPKDFRKTIQRILSV 168
TP ++APEV+ R +Y K+ D+WS G+ M G P +P F T + I +
Sbjct: 179 TPYWMAPEVIKRKDYGPKV-DIWSLGIMCIEM-AEGEPPYLREPPLRALFLITTKGIPPL 236
Query: 169 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
+ + S E +D +++ V DP R + E+++H FLK
Sbjct: 237 K----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP-FLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 59/193 (30%), Positives = 86/193 (44%), Gaps = 37/193 (19%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-----------------PAPRLKIC 91
ARF+ +++ + Y H + + +RDLK EN LL S P P K
Sbjct: 105 ARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164
Query: 92 DFGYSKSSVLHSQP-----------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 140
G +SSV S VGT YIAPEV+ + + D W+ G+ LY
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLY 223
Query: 141 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-- 198
ML G PF+ + +T IL + + P + P+S RDLI ++ V DP+ R+
Sbjct: 224 EMLYGTTPFKG----SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGS 279
Query: 199 --TIPEIMKHQWF 209
EI +H +F
Sbjct: 280 KRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 62/180 (34%), Positives = 98/180 (54%), Gaps = 15/180 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 106
+ARF+ +++S + Y H+ V +RD+KLEN +LD +KI DFG K + + K
Sbjct: 96 RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMK 153
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ GTP Y+APEVL ++Y G+ D W GV +Y M+ G PF + D + F + IL
Sbjct: 154 TFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELIL 208
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEK 221
+ P T +S E + L++ + DP R+ E+M+H++FL D+V +K
Sbjct: 209 MEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 266
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 8e-23
Identities = 54/163 (33%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 51 FFFQQLISGVSYCHAM-QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ +Q++ G+ Y H + HRD+K N L+ G KI DFG SK +
Sbjct: 103 YIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCN 158
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T VGT Y++PE ++ E AD+WS G+TL +G +PF P +P F + +Q I
Sbjct: 159 TFVGTVTYMSPE-RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAIC 216
Query: 167 SV-QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208
S+P S E RD IS DP R + E+++H +
Sbjct: 217 DGPPPSLPA-EEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 63/208 (30%), Positives = 89/208 (42%), Gaps = 56/208 (26%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------- 97
+ RF+ + I + H + HRD+K +N LLD +K+ DFG
Sbjct: 102 ETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEF 159
Query: 98 -----------SSVLHSQPK------------------STVGTPAYIAPEVLLRHEYDGK 128
S+P STVGTP YIAPEV L+ Y K
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NK 218
Query: 129 IADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRD 184
D WS GV +Y MLVG PF ++P E T ++I++ + ++ PD P+S E +D
Sbjct: 219 ECDWWSLGVIMYEMLVGYPPFCSDNPQE------TYRKIINWKETLQFPDEVPLSPEAKD 272
Query: 185 LISRIFVADPAARITIP---EIMKHQWF 209
LI R + R+ EI H +F
Sbjct: 273 LIKR-LCCEAERRLGNNGVNEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-22
Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 12/166 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
Q +F+ +++ + Y H+ + HRD+K +N LLD + I DF + + S
Sbjct: 101 QVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTS 158
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
T GTP Y+APEVL R Y D WS GVT Y L G P+ R +I +
Sbjct: 159 TSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHS-----RTIRDQIRA 212
Query: 168 VQYSVPDTNPI--SQECRDLISRIFVADPAARI--TIPEIMKHQWF 209
Q + P S E D I+++ DP R+ + ++ H +F
Sbjct: 213 KQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 31/187 (16%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--- 106
+ + QL+ G+++CH+ + HRDLK EN L++ LK+ DFG ++S S +
Sbjct: 101 KSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYT 156
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------ 154
V T Y APE+LL + D+WS G +L F E
Sbjct: 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLG 216
Query: 155 ---PKDFRKTIQRILSVQYSVPDTNPI---------SQECRDLISRIFVADPAARITIPE 202
P+ + K + ++S P + S + DL+S++ DP RIT +
Sbjct: 217 TPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276
Query: 203 IMKHQWF 209
+ H +F
Sbjct: 277 ALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-22
Identities = 60/184 (32%), Positives = 90/184 (48%), Gaps = 31/184 (16%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----- 103
AR +F + + + Y H + HRDLK +N L+ + +K+ DFG SK ++
Sbjct: 103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLY 160
Query: 104 -----------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--E 150
K GTP YIAPEV+LR Y GK D W+ G+ LY LVG PF +
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGD 219
Query: 151 DPDEPKDFRKTIQRILSVQYSVPDTN-PISQECRDLISRIFVADPAARITIP---EIMKH 206
P+E F + I S P+ + + + +DLISR+ +P R+ E+ +H
Sbjct: 220 TPEEL--FGQVI----SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273
Query: 207 QWFL 210
++FL
Sbjct: 274 RFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-22
Identities = 61/180 (33%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 47 VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 106
+ARF+ ++ S + Y H++ + +RDLK EN LLD L DFG K + HS+
Sbjct: 96 PRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLT--DFGLCKEGIEHSKTT 153
Query: 107 ST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
ST GTP Y+APEVL + YD + D W G LY ML G PF D + + + +
Sbjct: 154 STFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP 212
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARI----TIPEIMKHQWFLKNLPADLVDEK 221
L ++ + IS R L+ + D R+ EI H +F DLV++K
Sbjct: 213 LRLKPN------ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKK 266
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 60/171 (35%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ 104
ARF+ +++ + H+M HRD+K +N LLD S LK+ DFG + ++
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMDANGMVRCD 201
Query: 105 PKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
+ VGTP YI+PEVL Y G+ D WS GV LY MLVG PF + K
Sbjct: 202 --TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
Query: 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF 209
+ S+ + PD IS++ +DLI F+ D R+ + EI H +F
Sbjct: 260 MDHKNSLTF--PDDIEISKQAKDLI-CAFLTDREVRLGRNGVDEIKSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 18/167 (10%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
F+ +++ + Y H+ ++ +RDLK EN LLD +K+ DFG++K L + +
Sbjct: 103 GLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTL 158
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
GTP Y+APEV+ + K D W+ G+ +Y MLVG PF D D P ++IL+
Sbjct: 159 CGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFD-DNPFGI---YEKILAG 213
Query: 169 QYSVPDT-NPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+ P + + +DLI ++ V D R+ ++ H+WF
Sbjct: 214 KLEFPRHLDLYA---KDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 57/167 (34%), Positives = 91/167 (54%), Gaps = 15/167 (8%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 107
+F+ +L + + H++ + +RDLK EN LLD +K+ DFG SK S+ H + S
Sbjct: 100 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYS 157
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GT Y+APEV+ R + + AD WS GV ++ ML G PF+ KD ++T+ IL
Sbjct: 158 FCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILK 212
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+ +P +S E + L+ +F +PA R+ + EI +H +F
Sbjct: 213 AKLGMPQF--LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-21
Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 16/165 (9%)
Query: 47 VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 106
R + +Q++ G+ Y H HRD+K N L+D + +K+ DFG +K V S K
Sbjct: 102 PVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAK 159
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
S G+P ++APEV+ + G AD+WS G T+ M G P+ + + +
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVF 212
Query: 167 SVQYS-----VPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
+ S +PD +S E +D I + DP+ R T E+++H
Sbjct: 213 KIGRSKELPPIPDH--LSDEAKDFILKCLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-21
Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 15/167 (8%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ--- 104
R + +Q++ GV Y H+ + HRD+K N L D A +K+ DFG SK + S
Sbjct: 106 TRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICSSGTG 163
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--FRKTI 162
KS GTP +++PEV+ Y G+ ADVWS G T+ ML P+ + E F+
Sbjct: 164 MKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIAT 221
Query: 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
Q +P +S + R+ + R FV + R + E+++H +
Sbjct: 222 Q---PTNPQLPSH--VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 6e-21
Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 39/194 (20%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
Q + + +QL+ G+ Y H+ + HRD+K N L++ LK+ DFG ++ +
Sbjct: 101 QIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADY 158
Query: 108 T--VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG------------------- 145
T V T Y PE+LL Y ++ D+WS G L + +G
Sbjct: 159 TNRVITLWYRPPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL 217
Query: 146 -GYP----FEDPDEPKDF-----RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 195
G P + + F +K +R L + + I DL+ ++ DP
Sbjct: 218 CGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFK----HLIDPSALDLLDKLLTLDPK 273
Query: 196 ARITIPEIMKHQWF 209
RI+ + ++H++F
Sbjct: 274 KRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-21
Identities = 58/181 (32%), Positives = 93/181 (51%), Gaps = 17/181 (9%)
Query: 37 FMWLLLLGLLVQ--ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 94
FM L G+ ++ A F+ ++ + + H + +RDLK EN LLD +K+ DFG
Sbjct: 88 FMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFG 145
Query: 95 YSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153
K S+ T GT Y+APE+L+R + GK D WS G +Y ML G PF +
Sbjct: 146 LCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAEN 204
Query: 154 EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQW 208
+KTI +IL + ++P ++ E RDL+ ++ +P++R+ E+ H +
Sbjct: 205 R----KKTIDKILKGKLNLPPY--LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258
Query: 209 F 209
F
Sbjct: 259 F 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 11/186 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 106
+ R + +++ + + H + + +RD+KLEN LLD + + DFG SK + + +
Sbjct: 106 EVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERA 163
Query: 107 -STVGTPAYIAPEVLLRHEYD-GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
S GT Y+APEV+ K D WS GV + +L G PF E + +R
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR 223
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLKNLPADLVDEK 221
IL + P T +S E RD I ++ DP R+ EI H F + + D + K
Sbjct: 224 ILKSKPPFPKT--MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP-FFQGIDWDDLAAK 280
Query: 222 TMSSQY 227
+ + +
Sbjct: 281 RIPAPF 286
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-20
Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 23/164 (14%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTP 112
++++ + Y H + V HRD+K N L+ + +K+CDFG + +S +ST VGTP
Sbjct: 108 REVLVALKYIHKVGVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTP 165
Query: 113 AYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 171
++APEV+ YD K AD+WS G+T+Y M G P+ D D
Sbjct: 166 YWMAPEVITEGKYYDTK-ADIWSLGITIYEMATGNPPYSDVDA-----------FRAMML 213
Query: 172 VPDTNP-------ISQECRDLISRIFVADPAARITIPEIMKHQW 208
+P + P S+ R+ ++ +P R++ E++K +W
Sbjct: 214 IPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 56/168 (33%), Positives = 85/168 (50%), Gaps = 15/168 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
A F+ ++ G+ + H+ + +RDLKL+N +LD +KI DFG K ++ +
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTTR 159
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP YIAPE++ Y GK D W+ GV LY ML G PF+ DE + F Q I+
Sbjct: 160 TFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----QSIM 214
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITI-----PEIMKHQWF 209
S P + +S+E + + PA R+ +I +H +F
Sbjct: 215 EHNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 5e-20
Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 22/166 (13%)
Query: 52 FFQQLISGVSYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 106
QL+ + CH V HRDLK N LD + +K+ DFG +K S
Sbjct: 110 ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFA 167
Query: 107 ST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
T VGTP Y++PE L YD K +D+WS G +Y + PF ++ + +I
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPF----TARNQLQLASKI 222
Query: 166 LSVQYSVPDTNPI----SQECRDLISRIFVADPAARITIPEIMKHQ 207
++ I S E ++I + DP R + E+++
Sbjct: 223 KEGKFR-----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 6e-20
Identities = 50/156 (32%), Positives = 71/156 (45%), Gaps = 11/156 (7%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVG 110
F QL+ G+ H ++ HRDLK N LL +KI D G SK VL K+ +G
Sbjct: 108 IFIQLLRGLQALHEQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIG 163
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP Y+APEV Y K +D+WS G LY M PF E + + ++ +Y
Sbjct: 164 TPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPF----EARSMQDLRYKVQRGKY 218
Query: 171 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
P SQ+ ++ I + P R +I+
Sbjct: 219 P-PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-20
Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
A+F+ +L+ Y H+ + +RDLK EN LLD +K+ DFG++K + + +
Sbjct: 120 AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTL 175
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
GTP Y+APEV ++ + GK D W+ GV LY + G PF D D P FR ++IL+
Sbjct: 176 CGTPEYLAPEV-IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAG 230
Query: 169 QYSVPDTNPISQECRDLISRIFVADPAARI-TIP----EIMKHQWF 209
+ P N RDL+ + D R+ T+ ++ H +F
Sbjct: 231 RLKFP--NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-20
Identities = 57/167 (34%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHS 103
++++ G+ Y H+ HRD+K N LL DGS +KI DFG S S
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRK 161
Query: 104 QPKSTVGTPAYIAPEVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
K+ VGTP ++APEV+ H YD K AD+WS G+T + G P+ K T+
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220
Query: 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
Q + D S+ R +IS DP+ R T E++KH++F
Sbjct: 221 QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 9e-20
Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 27/168 (16%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT 111
+++ G+ Y H HRD+K N LL +G +K+ DFG S + S+ + VGT
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGT 161
Query: 112 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------PKDFRKTIQR 164
P ++APEV+ + YD K AD+WS G+T + G P D PK+ +++
Sbjct: 162 PFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG 220
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
N S+ +D +S DP R + E++KH+ F+K
Sbjct: 221 -----------NKFSKPFKDFVSLCLNKDPKERPSAKELLKHK-FIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-19
Identities = 51/155 (32%), Positives = 80/155 (51%), Gaps = 7/155 (4%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
FF Q++ + + H + HRDLK +N LLD +KI DFG SK S+ + VGT
Sbjct: 106 FFVQILLALHHVHTKLILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGT 164
Query: 112 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 171
P YI+PE+ Y+ K +D+W+ G LY + FE + P + +I+S ++
Sbjct: 165 PCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLP----ALVLKIMSGTFA 219
Query: 172 VPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
P ++ S + R LI + DP+ R + +IM
Sbjct: 220 -PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPK 106
+A F+ Q+ISG+ + H ++ +RDLK EN LLD ++I D G + + S+ K
Sbjct: 98 RACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTK 155
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
GTP ++APE+L EYD + D ++ GVTLY M+ PF E + ++ QRIL
Sbjct: 156 GYAGTPGFMAPELLQGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL 214
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI 198
+ + PD S + + DP R+
Sbjct: 215 NDSVTYPDK--FSPASKSFCEALLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 54/161 (33%), Positives = 88/161 (54%), Gaps = 11/161 (6%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVG 110
++ +S+ HA V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VG
Sbjct: 122 LAVLKALSFLHAQGVIHRDIKSDSILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVG 177
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP ++APEV+ R Y G D+WS G+ + M+ G P+ + + P K I+ L +
Sbjct: 178 TPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPK- 234
Query: 171 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
+ + + +S R + R+ V DPA R T E++ H + K
Sbjct: 235 -LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 54/166 (32%), Positives = 84/166 (50%), Gaps = 19/166 (11%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLH 102
R F +Q++ G++Y H + HRD+K N L+D +KI DFG SK S+ +
Sbjct: 109 RNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTN 166
Query: 103 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
S G+ ++APEV+ + Y K AD+WS G + ML G +PF D + +
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQ-------L 218
Query: 163 QRILSV-QYSVPD-TNPISQECRDLISRIFVADPAARITIPEIMKH 206
Q I + + + P+ + IS E D + + F D R T E++KH
Sbjct: 219 QAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPK 106
A+F+ +L+ + H M HRD+K EN L+D + +K+ DFG + ++ K
Sbjct: 104 AQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSK 161
Query: 107 STVGTPAYIAPEVLLRHEYDGKIA-----DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
VGTP YIAPEVL DGK D WS GV Y M+ G PF + KT
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE----GTSAKT 217
Query: 162 IQRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF-------LKN 212
I++ Q + P+ +S + DLI + + R+ + H +F ++N
Sbjct: 218 YNNIMNFQRFLKFPEDPKVSSDFLDLIQSL-LCGQKERLGYEGLCCHPFFSKIDWNNIRN 276
Query: 213 LPADLV-----DEKTMSSQYEEPDQ 232
V D+ T S ++EP++
Sbjct: 277 SLPPFVPTLKSDDDT--SNFDEPEK 299
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 62/187 (33%), Positives = 95/187 (50%), Gaps = 13/187 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQ 104
+ F Q++ + H+ ++ HRDLK N L P +K+ DFG+SK SV
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
S GTP Y+APE+ R Y K AD+WS GV LY +L PF+ P + R+ +Q+
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQ----REIMQQ 282
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
+L +Y P P+S + L+ + +PA R T +++ H FLK + A+L +
Sbjct: 283 VLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLL-HTEFLKYV-ANLFQDIVRH 339
Query: 225 SQYEEPD 231
S+ P
Sbjct: 340 SETISPH 346
|
Length = 478 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 55/190 (28%), Positives = 82/190 (43%), Gaps = 32/190 (16%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP 105
Q + + + L+ GV+Y HA + HRDLK N L+ S LKI DFG ++ S
Sbjct: 100 QVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLY 157
Query: 106 KSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
V T Y APE+L +YD + D+W+ G +L G P + + + R
Sbjct: 158 SHQVATRWYRAPELLYGARKYDPGV-DLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFR 215
Query: 165 ILSVQ--------YSVPDTNPI-----------------SQECRDLISRIFVADPAARIT 199
L S+PD N I S E DL+ + V DP+ R++
Sbjct: 216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS 275
Query: 200 IPEIMKHQWF 209
E ++H +F
Sbjct: 276 AAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 11/169 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 106
+ RF+ ++I + + H + + +RD+KLEN LLD + + DFG SK + + +
Sbjct: 106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKERT 163
Query: 107 -STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
S GT Y+APE++ GK D WS G+ ++ +L G PF E + +RI
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI 223
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
L P I E +DL+ ++ DP R+ EI +H +F
Sbjct: 224 LKCDPPFPSF--IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-19
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 34/185 (18%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 110
QL+ ++YCH+ + HRD+K EN L+ S + LK+CDFG++++ L ++P S V
Sbjct: 108 QLLQAIAYCHSHNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVA 163
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF---EDPDEPKDFRKTIQRILS 167
T Y APE+L+ GK DVW+ G + +L G F D D+ +K + +
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223
Query: 168 VQYSVPDTNP-------ISQECRDLISRIFVA----------------DPAARITIPEIM 204
+ +NP + + R + DP R+T E++
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283
Query: 205 KHQWF 209
+H +F
Sbjct: 284 QHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-19
Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 11/185 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+A+F+ +L+ + + H + +RDLK EN LLD + + +CDFG SK+++ ++ +
Sbjct: 97 RAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG--HIALCDFGLSKANLTDNKTTN 154
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GT Y+APEVLL + K D WS GV ++ M G PF D + +R I
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN----IA 210
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITI---PEIMKHQWFLKNLPADLVDEKTM 223
+ P N +S E R + + +P R+ +K F ++ DL+ +K +
Sbjct: 211 FGKVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQI 269
Query: 224 SSQYE 228
+ ++
Sbjct: 270 TPPFK 274
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-19
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 14/162 (8%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 108
+ Q++S VSY H + HRD+K N L + A +K+ DFG SK S ++ +
Sbjct: 106 YLFQIVSAVSYIHKAGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TV 161
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
VGTP Y++PE+ +Y+ K +D+W+ G LY +L F+ + K +Q +
Sbjct: 162 VGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT- 219
Query: 169 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210
P + S E L+ + DP R T E++ Q L
Sbjct: 220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLD-QPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 65/225 (28%)
Query: 42 LLGLLVQ--------ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 93
++ LL++ ARF+ +L + H M HRD+K +N L+D +K+ DF
Sbjct: 88 MMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDF 145
Query: 94 G-------------YSK---------------SSVLHSQPK----------------STV 109
G Y K S + + K S V
Sbjct: 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLV 205
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 169
GTP YIAPEVLLR Y ++ D WS GV LY MLVG PF P + T ++++ +
Sbjct: 206 GTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAD-TPAE---TQLKVINWE 260
Query: 170 YS--VPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF 209
+ +P +S+E DLI R+ R+ EI H +F
Sbjct: 261 TTLHIPSQAKLSREASDLILRL-CCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-19
Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 15/168 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+A F+ ++ G+ Y H ++ +RDLKL+N LLD +KI DFG K + S
Sbjct: 102 RAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTS 159
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP ++APEVL Y + D W GV +Y MLVG PF DE + F I+
Sbjct: 160 TFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF----DSIV 214
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+ + P +S+E ++ R+ +P R+ ++ K +F
Sbjct: 215 NDEVRYPRF--LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 54/174 (31%), Positives = 86/174 (49%), Gaps = 24/174 (13%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP 105
Q R+ +Q++ +++ H+ +V HRDLK N LL DG +K+ DFG S + Q
Sbjct: 104 QIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQK 159
Query: 106 KST-VGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159
+ T +GTP ++APEV+ + YD K AD+WS G+TL + P + +
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELN------ 212
Query: 160 KTIQRILSVQYSVPDT----NPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
++ +L + S P T + S D + V DP R T E++KH +
Sbjct: 213 -PMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 53/152 (34%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
QA F+ ++ G+ + H + +RDLKL+N +LD +KI DFG K ++
Sbjct: 102 QAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMVDGVTTR 159
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP YIAPE++ Y GK D W+ GV LY ML G PF+ DE + F Q I+
Sbjct: 160 TFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF----QSIM 214
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI 198
S P + +S+E + + P+ R+
Sbjct: 215 EHNVSYPKS--LSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 48/162 (29%), Positives = 88/162 (54%), Gaps = 12/162 (7%)
Query: 55 QLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 113
++ G++Y H ++ HRD+K N L++ ++K+CDFG S V +S K+ VGT +
Sbjct: 108 AVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLV-NSLAKTFVGTSS 164
Query: 114 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYS 171
Y+APE + ++Y K +D+WS G++L + G +P+ ++P D I +L V
Sbjct: 165 YMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVNEP 220
Query: 172 VP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
P + S + +D ++ + DP R + E+++H + K
Sbjct: 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-18
Identities = 63/193 (32%), Positives = 96/193 (49%), Gaps = 21/193 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARF+ ++ S + + H + +RDLKL+N LLD K+ DFG K + + + S
Sbjct: 97 RARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTS 154
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP YIAPE+L Y G D W+ GV LY ML G PFE +E F + IL
Sbjct: 155 TFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAIL 209
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITI------PEIMKHQWFLKNLPADLVDE 220
+ + P +SQ+ D++ +P R+ I++H +F K L + ++
Sbjct: 210 NDEVVYPTW--LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF-KELDWEKLNR 266
Query: 221 KTMSSQYEEPDQP 233
+ Q E P +P
Sbjct: 267 R----QIEPPFRP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 57/179 (31%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARF+ ++ S + Y H++ + +RDLK EN LLD + + DFG K ++ H+ S
Sbjct: 97 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNGTTS 154
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP Y+APEVL + YD + D W G LY ML G PF + + + + + L
Sbjct: 155 TFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI----TIPEIMKHQWFLKNLPADLVDEK 221
++ P+ I+ R L+ + D R+ EI H +F DL+++K
Sbjct: 214 QLK---PN---ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKK 266
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 36/193 (18%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ 104
+ F QL+ G+++CH +V HRDLK +N L++ LK+ DFG +++ + +
Sbjct: 99 PNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNT 156
Query: 105 PKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-----GYPFED------- 151
+ V T Y AP+VLL Y I D+WS G + M+ G G ED
Sbjct: 157 FSNEVVTLWYRAPDVLLGSRTYSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215
Query: 152 ----PDE---------PKDFRKTIQRI--LSVQYSVPDTNPISQECRDLISRIFVADPAA 196
P E P+ ++ T R +Q P +P+ DL+ R+ +P
Sbjct: 216 IMGTPTESTWPGISQLPE-YKPTFPRYPPQDLQQLFPHADPLGI---DLLHRLLQLNPEL 271
Query: 197 RITIPEIMKHQWF 209
RI+ + ++H WF
Sbjct: 272 RISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 12/165 (7%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 108
+ +QL+ G+SY H Q+ HRD+K N L+D S RL+I DFG ++ L ++
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEF 164
Query: 109 ----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+GT A++APEV LR E G+ DVWS G + M P+ + ++ + I +
Sbjct: 165 QGQLLGTIAFMAPEV-LRGEQYGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFK 222
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
I S + +S RD+ R P R E++KH F
Sbjct: 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 56/170 (32%), Positives = 82/170 (48%), Gaps = 26/170 (15%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQP 105
A + +Q L G++Y H V HRD+K N L DG +K+ DFG + K + +
Sbjct: 102 AVYVYQVL-QGLAYLHEQGVIHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDD 156
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-PKDFRKTIQR 164
S VGTP ++APEV+ +D+WS G T+ +L G P+ D + FR
Sbjct: 157 ASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFR----- 210
Query: 165 ILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARITIPEIMKHQWF 209
I V D +P IS E +D + + F DP R T +++KH W
Sbjct: 211 I------VQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-18
Identities = 54/193 (27%), Positives = 78/193 (40%), Gaps = 39/193 (20%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
++F Q++ G+ Y H+ V HRDLK N L++ + LKICDFG ++ K
Sbjct: 106 QYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFL 163
Query: 109 ---VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG------------------- 145
V T Y APE+LL Y I D+WS G +L
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222
Query: 146 -GYPFEDPDEPKDFRKTIQRILSVQYS--------VPDTNPISQECRDLISRIFVADPAA 196
G P E+ + K + S+ P +P E DL+ ++ V DP
Sbjct: 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP---EAIDLLEKMLVFDPKK 279
Query: 197 RITIPEIMKHQWF 209
RIT E + H +
Sbjct: 280 RITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-18
Identities = 62/171 (36%), Positives = 89/171 (52%), Gaps = 17/171 (9%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ 104
ARF+ +++ + H+M HRD+K +N LLD S LK+ DFG +K ++
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCD 201
Query: 105 PKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
+ VGTP YI+PEVL Y G+ D WS GV LY MLVG PF + K
Sbjct: 202 --TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
Query: 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF 209
+ S+ + PD N IS+E ++LI F+ D R+ + EI +H +F
Sbjct: 260 MNHKNSLTF--PDDNDISKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-18
Identities = 57/168 (33%), Positives = 85/168 (50%), Gaps = 15/168 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 106
A F+ ++ G+ + H+ + +RDLKL+N +LD +KI DFG K ++ K
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTTK 159
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ GTP YIAPE++ Y GK D W+ GV LY ML G PFE DE + F Q I+
Sbjct: 160 TFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIM 214
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITI-PE----IMKHQWF 209
+ P + +S+E + + P R+ PE I +H +F
Sbjct: 215 EHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 260
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-18
Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PK 106
RFF Q L+ G+++ H+ ++ HRD+K N LD +KI D G +K +L
Sbjct: 105 RFFIQILL-GLAHLHSKKILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFAN 159
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ VGTP Y++PE+ Y+ K +DVW+ GV LY G +PF+ ++ K I+ +
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF 218
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAAR 197
P + SQ+ LI + D R
Sbjct: 219 P-----PVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-18
Identities = 56/169 (33%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTP 112
+Q++SG++Y H + HRD+K N L++ A +KI DFG S+ P S+VGT
Sbjct: 175 RQILSGIAYLHRRHIVHRDIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTI 232
Query: 113 AYIAPEVL---LRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
AY++PE + L H YDG D+WS GV++ +G +PF + D+ + I
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLMCAIC-- 289
Query: 169 QYSVPDTNP--ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215
S P P S+E R IS +PA R + ++++H + L+ P
Sbjct: 290 -MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337
|
Length = 353 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
++F Q++ G+ Y H+ V HRDLK N L++ + LKICDFG ++ + Q
Sbjct: 110 IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGY 165
Query: 109 VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGG--YPFEDP------------D 153
V T Y APE++L +YD ++ D+WS G ML G +P +D
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT 224
Query: 154 EPKDFRKTI--QRILSVQYSVPDTN--PISQ-------ECRDLISRIFVADPAARITIPE 202
P D TI + L S+P P S+ DL+ ++ V DP RI+ E
Sbjct: 225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284
Query: 203 IMKHQWF-LKNLPADL-VDEKTMSSQYEEPDQPMQSVDVIM 241
+ H + + P D V E+ + + D P+ + V+M
Sbjct: 285 ALAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMM 325
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 43/112 (38%), Positives = 62/112 (55%), Gaps = 4/112 (3%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
++RF+ ++ + + H V +RDLKL+N LLD K+ DFG K +L+ +
Sbjct: 97 RSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE--GHCKLADFGMCKEGILNGVTTT 154
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158
T GTP YIAPE+L EY + D W+ GV +Y M+ G PFE +E F
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSV-DWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 11/160 (6%)
Query: 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 126
++ HRD+K N L++ ++K+CDFG S +++S + VGT Y++PE + +Y
Sbjct: 124 RIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYT 180
Query: 127 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-VQYSVPDTNP------IS 179
K +DVWS G+++ + +G +PF + D + IL +Q V + P
Sbjct: 181 VK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239
Query: 180 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 219
++ RD + + DP R T ++ F++ L A VD
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVD 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-17
Identities = 54/199 (27%), Positives = 80/199 (40%), Gaps = 52/199 (26%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
R Q++ G+++ H HRDLK EN L+ S +KI DFG ++ + S+P
Sbjct: 100 VIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPY 155
Query: 108 T--VGTPAYIAPEVLLRH-EYDGKIADVWSCG------VTLYVMLVGGYPFEDPDEPKDF 158
T V T Y APE+LLR Y + D+W+ G TL + G + D+
Sbjct: 156 TDYVSTRWYRAPEILLRSTSYSSPV-DIWALGCIMAELYTLRPLFPGS---SEIDQ---- 207
Query: 159 RKTIQRILSV-------------------QYSVPDTNPI---------SQECRDLISRIF 190
+ +I SV + P P S E DLI +
Sbjct: 208 ---LYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDML 264
Query: 191 VADPAARITIPEIMKHQWF 209
DP R T + ++H +F
Sbjct: 265 RWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-17
Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 14/157 (8%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPK 106
+F QL S + + H+ ++ HRD+K N + + +K+ D G SK++ HS
Sbjct: 111 YFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL-- 166
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
VGTP Y++PE + + Y+ K +D+WS G LY M PF + + ++I
Sbjct: 167 --VGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIE 221
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 203
Y + S+E RDL+SR DP R I +
Sbjct: 222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 22/195 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
ARF+ ++ +++ H + +RDLKL+N LLD +K+ D+G K + S
Sbjct: 97 HARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTS 154
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF------EDPDE-PKDFR 159
T GTP YIAPE+L +Y + D W+ GV ++ M+ G PF ++PD+ +D+
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSV-DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY- 212
Query: 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI------TIPEIMKHQWFLKNL 213
Q IL Q +P + +S + ++ DP R+ +I H +F +N+
Sbjct: 213 -LFQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF-RNI 268
Query: 214 PADLVDEKTMSSQYE 228
DL+++K + Y+
Sbjct: 269 DWDLLEQKQVLPPYK 283
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 52/189 (27%), Positives = 75/189 (39%), Gaps = 34/189 (17%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STV 109
+ G+ Y H+ + HRDLK N L+ LK+ DFG ++S P V
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQV 163
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-- 167
T Y APE+L + G D+WS G ++ L+ PF D D I L
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGC-IFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222
Query: 168 ------VQYSVPDTNPI---------------SQECRDLISRIFVADPAARITIPEIMKH 206
S+PD S + DL+ R+ +P RIT + ++H
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
Query: 207 QWFLKNLPA 215
+F N PA
Sbjct: 283 PYF-SNDPA 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 67/209 (32%), Positives = 91/209 (43%), Gaps = 46/209 (22%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ- 104
R+F QL+ G+ Y H+ V HRDLK N L++ L+I DFG S S H
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYF 167
Query: 105 PKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTI 162
V T Y APE+LL EY I D+WS G ML F P K++ +
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLF-----PGKNYVHQL 221
Query: 163 QRILSV------------------QY--SVPDTNPI---------SQECRDLISRIFVAD 193
+ ILSV +Y ++P P+ S E DL+S++ D
Sbjct: 222 KLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD 281
Query: 194 PAARITIPEIMKHQWFLKNLPADLVDEKT 222
P RIT+ + ++H FL D DE T
Sbjct: 282 PEERITVEQALQHP-FLAQYH-DPDDEPT 308
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 52/163 (31%), Positives = 86/163 (52%), Gaps = 12/163 (7%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP-- 105
R + +Q++ G+SY H+ + HRD+K N L D A +K+ DFG SK ++ S
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGI 166
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
+S GTP +++PEV+ Y G+ ADVWS G T+ ML P+ + + I +I
Sbjct: 167 RSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKI 221
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208
+ + + IS+ RD + IFV + R + E+++H +
Sbjct: 222 ATQPTNPQLPSHISEHARDFLGCIFV-EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 47/127 (37%), Positives = 65/127 (51%), Gaps = 8/127 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARF+ ++ S + Y H++ + +RDLK EN LLD + + DFG K V + S
Sbjct: 97 RARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ--GHVVLTDFGLCKEGVEPEETTS 154
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP Y+APEVL + YD + D W G LY ML G PF +D + IL
Sbjct: 155 TFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYS----RDVSQMYDNIL 209
Query: 167 SVQYSVP 173
+P
Sbjct: 210 HKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 54/164 (32%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQP 105
R + +Q++ GVSY H+ + HRD+K N L D +K+ DFG SK + +
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGM 166
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
KS GTP +++PEV+ Y G+ AD+WS G T+ ML P+ + + K
Sbjct: 167 KSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----- 220
Query: 166 LSVQYSVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKHQW 208
++ Q + P P +S CRD + RIFV + R + E+++H +
Sbjct: 221 IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 55/176 (31%), Positives = 85/176 (48%), Gaps = 8/176 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARF+ ++ S + Y H++ + +RDLK EN LLD + + DFG K + S +
Sbjct: 97 RARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTT 154
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP Y+APEV+ + YD + D W G LY ML G PF D + + + + L
Sbjct: 155 TFCGTPEYLAPEVIRKQPYDNTV-DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213
Query: 167 SVQYSVPDTN-PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEK 221
++ T I +E L+ + A+ EI +H +F DL +K
Sbjct: 214 VLRPGASLTAWSILEE---LLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKK 266
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 40/191 (20%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP 105
+ +QL+ GV + H+ ++ HRDLK +N L+ DG ++KI DFG ++
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMAL 163
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--------------------VG 145
S V T Y APEVLL+ Y + D+WS G + V
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222
Query: 146 GYPFEDPDEPKD-------FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 198
G P E+ + P++ F R S + VP+ I +E DL+ ++ +P RI
Sbjct: 223 GLPSEE-EWPRNVSLPRSSFPSYTPR--SFKSFVPE---ICEEGLDLLKKMLTFNPHKRI 276
Query: 199 TIPEIMKHQWF 209
+ E ++H +F
Sbjct: 277 SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 48/154 (31%), Positives = 85/154 (55%), Gaps = 13/154 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 104
+A F Q++ V + H+ + HRD+K N LL + +K+ DFG+SK ++V
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSDDV 201
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
++ GTP Y+APE+ R Y K AD++S GV LY +L PF+ ++ + + +
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDG----ENMEEVMHK 256
Query: 165 ILSVQYS-VPDTNPISQECRDLISRIFVADPAAR 197
L+ +Y +P + IS E +++++ + +DP R
Sbjct: 257 TLAGRYDPLPPS--ISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 51/164 (31%), Positives = 85/164 (51%), Gaps = 16/164 (9%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 110
F+ Q++ Y ++ + +RDLK EN LLD +K+ DFG++K V+ ++ + G
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCG 190
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP YIAPE+LL + GK AD W+ G+ +Y +LVG PF + ++K ++ I+
Sbjct: 191 TPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK 249
Query: 171 SVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+ D N C+ L+ ++ D R + +H WF
Sbjct: 250 FL-DNN-----CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 55/196 (28%), Positives = 87/196 (44%), Gaps = 42/196 (21%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
L + + QL+ G+++CH+ +V HRDLK +N L++ A +K+ DFG +++ + P
Sbjct: 99 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---P 153
Query: 106 KST----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML------------------ 143
T V T Y APE+LL +Y D+WS G M+
Sbjct: 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213
Query: 144 --VGGYPFED--------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 193
G P E PD F K ++ VP P+ ++ RDL+S++ D
Sbjct: 214 FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQ--DFSKVVP---PLDEDGRDLLSQMLHYD 268
Query: 194 PAARITIPEIMKHQWF 209
P RI+ + H +F
Sbjct: 269 PNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-16
Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 23/173 (13%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 106
Q ++++ G+ Y H+ + HRD+K N LL S +K+ DFG + + +Q K
Sbjct: 102 QIATMLKEILKGLDYLHSEKKIHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKR 158
Query: 107 -STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
+ VGTP ++APEV+ + YD K AD+WS G+T + L G P P
Sbjct: 159 NTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITA-IELAKGEPPNSDMHP---------- 206
Query: 166 LSVQYSVPDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
+ V + +P NP S+ ++ I DP+ R T E++KH++ +KN
Sbjct: 207 MRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 45/201 (22%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--------- 98
+F+ + + + H + HRD+K +N LLD +K+ DFG
Sbjct: 102 ATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEF 159
Query: 99 --SVLHSQPK-------------------------STVGTPAYIAPEVLLRHEYDGKIAD 131
++ H+ P STVGTP YIAPEV ++ Y+ K+ D
Sbjct: 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCD 218
Query: 132 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 191
WS GV +Y ML+G PF + +RK + ++ + P PIS++ +DLI R F
Sbjct: 219 WWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVF--PPEVPISEKAKDLILR-FC 275
Query: 192 ADPAARI---TIPEIMKHQWF 209
D RI + EI H +F
Sbjct: 276 TDSENRIGSNGVEEIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-16
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 12/156 (7%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VG 110
+F QL+ GV Y H ++ HRDLK +N L + LKI DFG S+ + +T G
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTG 167
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP Y++PE L YD K +D+WS G LY M + FE ++F + RI+
Sbjct: 168 TPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPT 222
Query: 171 -SVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
S+P+T ++ ++ + DP+ R + EI++
Sbjct: 223 PSLPETYS--RQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-16
Identities = 50/159 (31%), Positives = 89/159 (55%), Gaps = 10/159 (6%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV 109
F+ +Q++ G+ Y H Q+ HRD+K +N L++ + + +KI DFG SK + ++ ++
Sbjct: 112 FYTKQILEGLKYLHDNQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFT 170
Query: 110 GTPAYIAPEVLLRHEYD-GKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--FRKTIQRIL 166
GT Y+APEV+ + G AD+WS G T+ M G PF + EP+ F+ + +I
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI- 229
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
+P++ +S E ++ I R F DP R + ++++
Sbjct: 230 --HPEIPES--LSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 57/190 (30%), Positives = 83/190 (43%), Gaps = 43/190 (22%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGT 111
QL+SGV++ H + HRDLK N LL + LKICDFG ++ S L + V T
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-T 169
Query: 112 PAYIAPEVLL-RHEYDGKIADVWSCG------VTLYVMLVG--------------GYPFE 150
Y APE+LL EY I D+WS G +T + G G P E
Sbjct: 170 LWYRAPELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE 228
Query: 151 D--PDEPKDFRKTIQRILSVQYSVPDTNPISQECR---------DLISRIFVADPAARIT 199
P F + + ++ N + ++ DL++R+ DPA RI+
Sbjct: 229 KIWP----GFSE-LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283
Query: 200 IPEIMKHQWF 209
+ +KH +F
Sbjct: 284 AEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-16
Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPK 106
RFF +Q++ G++Y H+ + HRDLK +N L+D KI DFG SK S + Q
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNM 168
Query: 107 STVGTPAYIAPEV--LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
S G+ ++APEV Y K+ D+WS G + M G P+ D + I
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKV-DIWSLGCVVLEMFAGRRPWSD-------EEAIAA 220
Query: 165 I--LSVQYSVP----DTNP-ISQECRDLISRIFVADPAARITIPEIMKH 206
+ L + S P D + +S D ++ F +P R T E+++H
Sbjct: 221 MFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-16
Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 23/173 (13%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
Q ++++ G+ Y H+ + HRD+K N LL S +K+ DFG + + +Q K
Sbjct: 102 QIATILREILKGLDYLHSEKKIHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKR 158
Query: 108 T--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
VGTP ++APEV+ + YD K AD+WS G+T + L G P P
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITA-IELAKGEPPHSELHP---------- 206
Query: 166 LSVQYSVPDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
+ V + +P NP S+ ++ + +P+ R T E++KH++ ++
Sbjct: 207 MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-16
Identities = 56/192 (29%), Positives = 87/192 (45%), Gaps = 36/192 (18%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPK 106
++F QL+ G+ Y H+ V HRDLK N LL+ + LKICDFG ++ +S
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMT 166
Query: 107 STVGTPAYIAPEVLLR-HEYDGKIADVWSCG---------------------VTLYVMLV 144
V T Y APE+LL EY I DVWS G + L L+
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225
Query: 145 GG-----YPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAAR 197
G F ++ + + +++ ++ P NP++ DL+ ++ V DP+ R
Sbjct: 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAI---DLLEKMLVFDPSKR 282
Query: 198 ITIPEIMKHQWF 209
IT+ E + H +
Sbjct: 283 ITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 16/184 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 106
+ + + +++ + + H + + +RD+KLEN LLD + + + DFG SK +
Sbjct: 106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDEVERA 163
Query: 107 -STVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
S GT Y+AP+++ + +D K D WS GV +Y +L G PF E + +
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR 222
Query: 164 RILSVQYSVP-DTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADL 217
RIL + P + + ++ +D+I R+ + DP R+ EI KH +F K DL
Sbjct: 223 RILKSEPPYPQEMSALA---KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279
Query: 218 VDEK 221
+K
Sbjct: 280 AAKK 283
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 56/163 (34%), Positives = 89/163 (54%), Gaps = 13/163 (7%)
Query: 56 LISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTP 112
++ +S HA V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTP 180
Query: 113 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTIQRILSVQYS 171
++APE++ R Y G D+WS G+ + M+ G P F +P P K I+ L +
Sbjct: 181 YWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPK-- 235
Query: 172 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
+ + + +S + + R+ V DPA R T E++KH + K P
Sbjct: 236 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 56/174 (32%), Positives = 93/174 (53%), Gaps = 22/174 (12%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVG 110
+ ++ + Y H+ V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VG
Sbjct: 124 ESVLQALCYLHSQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVG 179
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT-IQRILSVQ 169
TP ++APEV+ R Y ++ D+WS G+ + M+ G EP F + +Q + ++
Sbjct: 180 TPYWMAPEVISRTPYGTEV-DIWSLGIMVIEMVDG--------EPPYFSDSPVQAMKRLR 230
Query: 170 YSVP----DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK-NLPADLV 218
S P + + IS RD + R+ +P R T E++ H + L+ LP LV
Sbjct: 231 DSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 65/238 (27%), Positives = 98/238 (41%), Gaps = 56/238 (23%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQ 104
+ F Q++ G+ Y H+ V HRDLK N L D LKICDFG ++ S +
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENA 163
Query: 105 PKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF---ED-------- 151
T V T Y APE++L + K DVWS G L L+G P +D
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPVFKGKDYVDQLNQI 222
Query: 152 ------PDEPKDFRKTIQRILS-----------------VQYSVPDTNPISQECRDLISR 188
PDE +T+ RI S + P+ NP DL+ +
Sbjct: 223 LQVLGTPDE-----ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANP---LALDLLEK 274
Query: 189 IFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAE 246
+ DP RI++ E ++H + + D DE ++ + S++ + +I E
Sbjct: 275 LLAFDPTKRISVEEALEHPYL--AIWHDPDDEPVCQKPFDFSFESEDSMEELRDMIIE 330
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 34/186 (18%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 108
+ QL+ G++YCH+ +V HRDLK +N L+D A LK+ DFG +++ P T
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTH 158
Query: 109 -VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--------------------VGGY 147
V T Y APE+LL D+WS G M+ G
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGT 218
Query: 148 PFED--PD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 203
P ED P D++ T + S N + ++ DL+S++ V DPA RI+
Sbjct: 219 PDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPN-LDEDGLDLLSKMLVYDPAKRISAKAA 277
Query: 204 MKHQWF 209
++H +F
Sbjct: 278 LQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 22/190 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
ARF+ ++ ++Y H + +RDLKL+N LLD +K+ D+G K + S
Sbjct: 97 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTS 154
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF------EDPDE-PKDFR 159
T GTP YIAPE+L +Y G D W+ GV ++ M+ G PF ++PD+ +D+
Sbjct: 155 TFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY- 212
Query: 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-TIPE-----IMKHQWFLKNL 213
Q IL Q +P + +S + ++ DP R+ P+ I H +F +N+
Sbjct: 213 -LFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNV 268
Query: 214 PADLVDEKTM 223
DL+++K +
Sbjct: 269 DWDLMEQKQV 278
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 44/212 (20%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--------- 98
+ +F+ + + + H + HRD+K +N LLD +K+ DFG
Sbjct: 102 ETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEF 159
Query: 99 --SVLHSQPK-------------------------STVGTPAYIAPEVLLRHEYDGKIAD 131
++ HS P STVGTP YIAPEV ++ Y+ K+ D
Sbjct: 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCD 218
Query: 132 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 191
WS GV +Y ML+G PF + ++K + ++ + P PIS++ +DLI R F
Sbjct: 219 WWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIF--PPEVPISEKAKDLILR-FC 275
Query: 192 ADPAARITIP--EIMKHQWFLKNLPADLVDEK 221
+ RI P E +K F + + + + E+
Sbjct: 276 CEWEHRIGAPGVEEIKTNPFFEGVDWEHIRER 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 54/161 (33%), Positives = 83/161 (51%), Gaps = 12/161 (7%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP-- 105
R + +Q++ GVSY H+ + HRD+K N L D A +K+ DFG SK ++ S
Sbjct: 109 RRYTRQILQGVSYLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGI 166
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
KS GTP +++PEV+ Y G+ ADVWS T+ ML P+ + + K +
Sbjct: 167 KSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP 225
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
+PD +S CRD + +IFV + R T +++H
Sbjct: 226 TKPM--LPDG--VSDACRDFLKQIFVEE-KRRPTAEFLLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 55/171 (32%), Positives = 87/171 (50%), Gaps = 17/171 (9%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ 104
A+F+ +++ + H+M + HRD+K +N LLD LK+ DFG ++ ++
Sbjct: 144 AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD 201
Query: 105 PKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
+ VGTP YI+PEVL Y G+ D WS GV L+ MLVG PF + K
Sbjct: 202 --TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
Query: 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF 209
+ S+ + P+ IS+ ++LI F+ D R+ + EI +H +F
Sbjct: 260 MDHKNSLNF--PEDVEISKHAKNLIC-AFLTDREVRLGRNGVEEIKQHPFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 57 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 116
+ G+SY H+ ++ HRD+K N LL +K+CDFG S V S + GT Y+A
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMA 171
Query: 117 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 176
PE + Y +DVWS G+TL + +PF P + + I + Y V N
Sbjct: 172 PERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPF-----PPEGEPPLGPIELLSYIVNMPN 225
Query: 177 PI-----------SQECRDLISRIFVADPAARITIPEIMKHQWFL 210
P S+E +D I + DP R T ++++H W
Sbjct: 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 57/190 (30%), Positives = 78/190 (41%), Gaps = 41/190 (21%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 108
+F Q++ G+ Y H+ V HRDLK N LL+ LKICDFG ++ +
Sbjct: 110 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLT 167
Query: 109 --VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRI 165
V T Y APE++L + K D+WS G L ML F P KD+ + I
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF-----PGKDYLHQLNLI 222
Query: 166 LSV--QYSVPDTNPI-SQECR--------------------------DLISRIFVADPAA 196
L V S D N I S R DL+ ++ +P
Sbjct: 223 LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHK 282
Query: 197 RITIPEIMKH 206
RIT+ E + H
Sbjct: 283 RITVEEALAH 292
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-15
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTP 112
Q + G+ Y H+ + HRD+K N LL+ K+ DFG S + + ++ + +GTP
Sbjct: 106 YQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTP 163
Query: 113 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 172
++APEV+ Y+ K AD+WS G+T M G P+ D ++ I +
Sbjct: 164 FWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSD-------IHPMRAIFMIPNKP 215
Query: 173 PDT--NP--ISQECRDLISRIFVADPAARITIPEIMKH 206
P T +P S E D + + V DP R + ++++H
Sbjct: 216 PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 7e-15
Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 17/163 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
QL+ ++ H + H D+KLEN L D + R+ +CD+G K P GT Y
Sbjct: 117 QLVEALNDLHKHNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDY 172
Query: 115 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE-DPDE---PKDFRKTIQRILSVQY 170
+PE + H YD D W+ GV Y +L G +PF+ D DE + K Q+
Sbjct: 173 FSPEKIKGHNYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------ 225
Query: 171 SVPDTNPISQECRDLISRIFVADPAAR-ITIPEIMKHQWFLKN 212
+P +S+ D + + + R EI+KH FLK
Sbjct: 226 KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP-FLKI 267
|
Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 52/189 (27%), Positives = 79/189 (41%), Gaps = 42/189 (22%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--V 109
+ QL+ + + H + HRD+K EN L+ LK+ DFG + ++S+P T +
Sbjct: 105 YMYQLLKSLDHMHRNGIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYI 159
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--------------------VGGYPF 149
T Y APE LL Y G D+W+ G + +L V G P
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP- 218
Query: 150 EDPDEPKDFRKTIQRILSVQYSVPDTNPI---------SQECRDLISRIFVADPAARITI 200
D + K FRK+ Y+ P S E DL+ ++ DP RIT
Sbjct: 219 -DAEVLKKFRKSRHM----NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273
Query: 201 PEIMKHQWF 209
+ ++H +F
Sbjct: 274 KQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL----L 121
V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE +
Sbjct: 135 GVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 122 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN-PISQ 180
+YD + ADVWS G++L + G +P+++ +F + + +IL + N S
Sbjct: 192 NPKYDIR-ADVWSLGISLVELATGQFPYKNCK--TEF-EVLTKILQEEPPSLPPNEGFSP 247
Query: 181 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216
+ + D R E+++H + + A+
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 29/187 (15%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKS 107
+ F QL+ G+++CH+ V HRDLK +N L++ + LK+ DFG +++ + +
Sbjct: 101 VKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYSA 158
Query: 108 TVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
V T Y P+VL + Y I D+WS G + G P ++ D K I R+L
Sbjct: 159 EVVTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 217
Query: 167 SVQ--------YSVPDTNP----------------ISQECRDLISRIFVADPAARITIPE 202
+PD P ++ RDL+ + V +P RI+ E
Sbjct: 218 GTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277
Query: 203 IMKHQWF 209
++H +F
Sbjct: 278 ALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 54/163 (33%), Positives = 91/163 (55%), Gaps = 20/163 (12%)
Query: 56 LISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTP 112
++ +SY H V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTP 182
Query: 113 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 172
++APEV+ R Y G D+WS G+ + M+ G P+ +EP +Q + ++ ++
Sbjct: 183 YWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYF--NEPP-----LQAMRRIRDNL 234
Query: 173 P----DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
P D++ +S R + + V +P+ R T E+++H FLK
Sbjct: 235 PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP-FLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 45/159 (28%), Positives = 87/159 (54%), Gaps = 17/159 (10%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PK 106
+F Q+ + + H ++ HRD+K +N L DG+ +K+ DFG ++ VL+S +
Sbjct: 106 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVELAR 159
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ +GTP Y++PE+ Y+ K +D+W+ G LY M + F E + + + +I+
Sbjct: 160 TCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAF----EAGNMKNLVLKII 214
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
Y P ++ S + R+L+S++F +P R ++ I++
Sbjct: 215 RGSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 33/186 (17%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 108
+ Q++ G++YCH+ +V HRDLK +N L+D LK+ DFG +++ + P T
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTH 162
Query: 109 -VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
V T Y APE+LL + D+WS G ++ +V P D D I RIL
Sbjct: 163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFKIFRILG 221
Query: 168 VQY--------SVPD---TNP-------------ISQECRDLISRIFVADPAARITIPEI 203
S+PD P + DL+S++ DP+ RIT
Sbjct: 222 TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281
Query: 204 MKHQWF 209
++H++F
Sbjct: 282 LEHEYF 287
|
Length = 294 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 62/193 (32%), Positives = 89/193 (46%), Gaps = 30/193 (15%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
ARF+ +++ + H + HRD+K +N LLD + RL DFG S L T
Sbjct: 104 ARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGT 157
Query: 109 ------VGTPAYIAPEVLLRHEYDGK-----IADVWSCGVTLYVMLVGGYPFEDPDEPKD 157
VGTP YI+PE+L E DGK D WS GV +Y ML G PF +
Sbjct: 158 VQSNVAVGTPDYISPEILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
Query: 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF----- 209
+ K + Q+ PD +S+E +DLI R+ + P R+ + + H +F
Sbjct: 217 YGKIMNHKEHFQFP-PDVTDVSEEAKDLIRRL-ICSPETRLGRNGLQDFKDHPFFEGIDW 274
Query: 210 --LKNLPADLVDE 220
++N A V E
Sbjct: 275 DNIRNSTAPYVPE 287
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 53/191 (27%), Positives = 76/191 (39%), Gaps = 44/191 (23%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 110
F QL+ GV++CH V HRDLK +N L+D LKI D G ++ S+ +
Sbjct: 115 FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-- 168
T Y APEVLL + D+WS G M F E +Q++L +
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-------LQQLLHIFK 226
Query: 169 ------------------------------QYSVPDTNPISQECRDLISRIFVADPAARI 198
+VPD +S E DL+ ++ DPA RI
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRI 283
Query: 199 TIPEIMKHQWF 209
+ + H +F
Sbjct: 284 SAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
ARF+ ++ +++ H + +RDLKL+N LLD +K+ D+G K + S
Sbjct: 97 HARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTS 154
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF----EDPD-EPKDFRKT 161
T GTP YIAPE+L EY G D W+ GV ++ M+ G PF ++PD +D+
Sbjct: 155 TFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY--L 211
Query: 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI------TIPEIMKHQWFLKNLPA 215
Q IL +P +S + ++ DP R+ +I H +F +++
Sbjct: 212 FQVILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF-RSIDW 268
Query: 216 DLVDEKTMSSQYEEPDQPMQSVD 238
DL+++K Q P +P + D
Sbjct: 269 DLLEKK----QVTPPFKPQITDD 287
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 16/163 (9%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VG 110
++ + + + H+ QV HRD+K +N LL DGS +K+ DFG+ +ST VG
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVG 177
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRILSV 168
TP ++APEV+ R Y K+ D+WS G+ M+ G P+ E+P R +
Sbjct: 178 TPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNG 231
Query: 169 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
+ + +S RD ++R D R + E+++H FLK
Sbjct: 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 56 LISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
++ + Y H+ + V HRD+K N L++ ++K+CDFG S V G Y
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLVDSVAKTIDAGCKPY 169
Query: 115 IAPE----VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
+APE L + YD K +DVWS G+T+ + G +P++ P F++ Q +
Sbjct: 170 MAPERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSP 226
Query: 171 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+P S E +D +++ + R PE+++H +F
Sbjct: 227 QLPA-EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-14
Identities = 43/154 (27%), Positives = 80/154 (51%), Gaps = 7/154 (4%)
Query: 56 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 115
++ G++Y ++++ HRD+K N L++ ++K+CDFG S V +S K+ VGT AY+
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYM 160
Query: 116 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 175
APE + +Y G +DVWS G++ + +G +P+ + + +Q + + P
Sbjct: 161 APERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219
Query: 176 NPI---SQECRDLISRIFVADPAARITIPEIMKH 206
P+ S++ I++ P R +M H
Sbjct: 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-14
Identities = 52/164 (31%), Positives = 87/164 (53%), Gaps = 18/164 (10%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVG 110
++ + + + H+ QV HRD+K +N LL DGS +K+ DFG+ ++ + S+ + VG
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVG 178
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP ++APEV+ R Y K+ D+WS G+ M+ G P+ + + + L
Sbjct: 179 TPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATN 231
Query: 171 SVPD-TNP--ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
P+ NP +S RD ++R D R + E+++HQ FLK
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ-FLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 61/221 (27%), Positives = 86/221 (38%), Gaps = 53/221 (23%)
Query: 31 FSLCLFFMWLLLLGLLV---------QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81
F L +M L+GLL + F +QL+ G++YCH HRD+K N LL+
Sbjct: 91 FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN 150
Query: 82 GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 139
++K+ DFG ++ T V T Y PE+LL E G DVWSCG L
Sbjct: 151 NK--GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
Query: 140 YVML--------------------VGGYPFED--PD----------EPKDFRKTIQRILS 167
+ + G P PD +PK K +R L
Sbjct: 209 GELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPK---KQYRRRLR 265
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208
++S I DL+ + DP+ R T E + W
Sbjct: 266 EEFSF-----IPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-14
Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 53 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGT 111
++++ G+ Y H+ + HRD+K N LL S +K+ DFG + ++T VGT
Sbjct: 107 LREILKGLDYLHSERKIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 112 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 171
P ++APEV+ + YD K AD+WS G+T + G P D + V +
Sbjct: 165 PFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHP-----------MRVLFL 212
Query: 172 VPDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
+P +P S+ ++ + DP R T E++KH++ +
Sbjct: 213 IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-14
Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 14/157 (8%)
Query: 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 126
+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE + +
Sbjct: 123 NIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 127 GKI-----ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--IS 179
+DVWS G+++ M +G YP+ P+ + ++ ++ P T P S
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYP----PETYANIFAQLSAIVDGDPPTLPSGYS 235
Query: 180 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216
+ +D +++ P R T ++++H W +K AD
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-14
Identities = 41/111 (36%), Positives = 61/111 (54%), Gaps = 8/111 (7%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
+ QA +Q++ G+ Y HA ++ HRD+K EN ++ ++ I D G ++ V+
Sbjct: 156 IDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAF 213
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP---FEDPD 153
GT APEVL R +Y+ K AD+WS G+ L+ ML YP FEDP
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEML--AYPSTIFEDPP 261
|
Length = 357 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-14
Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 40/178 (22%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST 108
+ ++ + G++Y H +V HRD+K +N LL + +K+ DFG S +Q ST
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDST 166
Query: 109 -------VGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFED--PDE 154
+GTP ++APEV+ YD + +DVWS G+T + G P D P
Sbjct: 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPM- 224
Query: 155 PKDFRKTIQRILSVQYSVPDT----NPISQECRDLISRIFVADPAARITIPEIMKHQW 208
+ + +I + P T S++ D IS + + R + E+++H +
Sbjct: 225 -----RALFKIPR---NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 63/213 (29%), Positives = 87/213 (40%), Gaps = 59/213 (27%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTL--LDGSPAPRLKICDFG------------ 94
ARF+ +L + H M HRD+K +N L LDG +K+ DFG
Sbjct: 103 ARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSK 158
Query: 95 -YSKSSVLHS---QPK--------------------------------STVGTPAYIAPE 118
Y K S + +P S VGTP YIAPE
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218
Query: 119 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 178
VLLR Y ++ D WS GV L+ MLVG PF P + K I ++ +P +
Sbjct: 219 VLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH--IPPQVKL 275
Query: 179 SQECRDLISRIFVA--DPAARITIPEIMKHQWF 209
S E DLI+++ + + R +I H +F
Sbjct: 276 SPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 12/177 (6%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 110
+ Q+ G+ + H+M + +RD+K EN LLD RL D G + G
Sbjct: 99 HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAG 156
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
T Y+APE+L Y + D ++ G ++Y M+ G PF+D E + +R L +
Sbjct: 157 TNGYMAPEILKEEPYSYPV-DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
Query: 171 SVPDTNPISQECRDLISRIFVADPAARITIPEI----MKHQWF----LKNLPADLVD 219
N ++E +D+ P R+ E KH++F L A L+
Sbjct: 216 KFEHQN-FTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIP 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 16/159 (10%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PK 106
+F Q+ G+ + H ++ HRD+K +N L +G A K+ DFG ++ L+
Sbjct: 106 WFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAY 160
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ VGTP Y++PE+ Y+ K D+WS G LY + +PFE + + + +I
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKIC 215
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
++ P + S++ R LIS++F P R +I I+K
Sbjct: 216 QGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 57/190 (30%), Positives = 80/190 (42%), Gaps = 32/190 (16%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
R F QL+ G++YCH +V HRDLK +N L+ S LK+ DFG +++ + S+ S
Sbjct: 105 VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSN 162
Query: 109 -VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
V T Y P+VLL EY + D+W G Y M G F + +D I R+L
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221
Query: 167 S----------------VQYSVPDTNP-----------ISQECRDLISRIFVADPAARIT 199
YS P P +L + +P RI+
Sbjct: 222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281
Query: 200 IPEIMKHQWF 209
E MKH +F
Sbjct: 282 AAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 13/170 (7%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
ARF+ +++ + H + HRD+K +N L+D + RL DFG + +S+
Sbjct: 104 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSS 161
Query: 109 --VGTPAYIAPEVLLRHEYDGK-----IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
VGTP YI+PE+L E DGK D WS GV +Y ML G PF + + K
Sbjct: 162 VAVGTPDYISPEILQAME-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
Query: 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADP--AARITIPEIMKHQWF 209
+ Q+ T+ +S++ +DLI R+ + + I + +H +F
Sbjct: 221 MNHKERFQFPAQVTD-VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 45/123 (36%), Positives = 62/123 (50%), Gaps = 31/123 (25%)
Query: 54 QQLISGVSYCHAMQ-------VCHRDLKLENTLL-----------------DGSPAPRLK 89
+QL+ ++YCH ++ V HRDLK +N L +G P K
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA--K 182
Query: 90 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGG 146
I DFG SK+ + S S VGTP Y +PE+LL HE YD K +D+W+ G +Y + G
Sbjct: 183 IGDFGLSKNIGIESMAHSCVGTPYYWSPELLL-HETKSYDDK-SDMWALGCIIYELCSGK 240
Query: 147 YPF 149
PF
Sbjct: 241 TPF 243
|
Length = 1021 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQP 105
RF+ ++I G+ + H V +RDLK N LLD R+ CDF K P
Sbjct: 100 RFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------P 152
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
++VGT Y+APEVL + AD +S G L+ +L G PF + KD + +
Sbjct: 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMT 211
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITI-----PEIMKHQWF 209
L+V +PD+ S E + L+ + D + R+ E+ +H +F
Sbjct: 212 LTVNVELPDS--FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 58/191 (30%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ R + QLI + +CH + HRD+K EN L+ S LK+CDFG++++ S
Sbjct: 101 KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANY 158
Query: 108 T--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
T V T Y +PE+LL Y GK D+WS G L L G P + D TIQ++
Sbjct: 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILG-ELSDGQPLFPGESEIDQLFTIQKV 216
Query: 166 L--------SVQYSVPD---------TNPISQECR----------DLISRIFVADPAARI 198
L + YS P +P S E R DL+ + +P R
Sbjct: 217 LGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY 276
Query: 199 TIPEIMKHQWF 209
+ + H F
Sbjct: 277 LTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVL 101
ARF+ +++ + H + HRD+K +N LLD + R LK+ G +SSV
Sbjct: 104 ARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV- 162
Query: 102 HSQPKSTVGTPAYIAPEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157
VGTP YI+PE+L E G D WS GV +Y ML G PF +
Sbjct: 163 ------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
Query: 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA--ARITIPEIMKHQWF------ 209
+ K + Q+ T+ +S+E +DLI R+ + + I + KH +F
Sbjct: 217 YGKIMNHEERFQFPSHITD-VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275
Query: 210 -LKNLPADL---VDEKTMSSQYEEPDQPMQSVDVI 240
++NL A V + +S ++ D +++ ++
Sbjct: 276 NIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNPEIA 310
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 38/156 (24%), Positives = 64/156 (41%), Gaps = 15/156 (9%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTV 109
Q+ G+ Y + HRDL N L+ + +KI DFG Y K +
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI 168
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 169
++APE L ++ K +DVWS GV L+ + G + + +++
Sbjct: 169 ---RWMAPESLKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG---- 220
Query: 170 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
Y +P E L+ + + DP R T E+++
Sbjct: 221 YRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-13
Identities = 50/163 (30%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VG 110
++ + + + H+ QV HRD+K +N LL DGS +K+ DFG+ +ST VG
Sbjct: 122 RECLQALDFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVG 177
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP ++APEV+ R Y K+ D+WS G+ M+ G P+ + + + +++
Sbjct: 178 TPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNG 231
Query: 171 SVPDTNP--ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
+ NP +S RD ++R D R + E+++H FLK
Sbjct: 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 57/211 (27%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YS 96
RF+ + + + H + HRD+K +N L+D +K+ DFG Y
Sbjct: 104 RFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 97 K----------------------SSVLHSQPK-------------STVGTPAYIAPEVLL 121
K + + S+ + STVGTP YIAPE+ L
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221
Query: 122 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 181
+ Y G+ D WS G ++ L+G PF + + +RK I ++ + PD +S E
Sbjct: 222 QQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF--PDDIHLSVE 278
Query: 182 CRDLISRIFVADPAARI---TIPEIMKHQWF 209
DLI R+ + + R+ EI H +F
Sbjct: 279 AEDLIRRL-ITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 51/154 (33%), Positives = 75/154 (48%), Gaps = 16/154 (10%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQP 105
RF+ ++I G+ + H V +RDLK N LLD R+ CDF K P
Sbjct: 100 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------P 152
Query: 106 KSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
++VGT Y+APEVL + YD AD +S G L+ +L G PF + KD + +
Sbjct: 153 HASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRM 210
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARI 198
L++ +PD+ S E R L+ + D R+
Sbjct: 211 TLTMAVELPDS--FSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-13
Identities = 51/163 (31%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VG 110
++ + + + HA QV HRD+K +N LL DGS +K+ DFG+ +ST VG
Sbjct: 122 RECLQALEFLHANQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVG 177
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP ++APEV+ R Y K+ D+WS G+ M+ G P+ + + + +++
Sbjct: 178 TPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNG 231
Query: 171 SVPDTNP--ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
+ NP +S RD ++R D R + E+++H FLK
Sbjct: 232 TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 53/171 (30%), Positives = 84/171 (49%), Gaps = 24/171 (14%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP 105
Q + +Q++ + Y H+M++ HRDLK N LL DG +K+ DFG S +V Q
Sbjct: 111 QIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQR 166
Query: 106 K-STVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159
+ S +GTP ++APEV++ YD K AD+WS G+TL M + P
Sbjct: 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEM-------AQIEPPHHEL 218
Query: 160 KTIQRILSVQYSVPDT----NPISQECRDLISRIFVADPAARITIPEIMKH 206
++ +L + S P T + S E RD + P R + ++++H
Sbjct: 219 NPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-13
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPK 106
+F QL S V + H+ +V HRD+K N + + +K+ D G SK++ H
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH---- 164
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
S VGTP Y++PE + + Y+ K +D+WS G LY M PF + + Q+I
Sbjct: 165 SLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLFSLCQKIE 221
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITI 200
Y T S++ R+L+S DP R I
Sbjct: 222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-13
Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 20/184 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 106
+A F+ ++ G+ H ++ +RDLK EN LLD ++I D G + + + +
Sbjct: 103 RAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIR 159
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
VGT Y+APEV+ Y D W G +Y M+ G PF E + +R+
Sbjct: 160 GRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK 218
Query: 167 SVQ--YSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF----LKNLPA 215
Q YS S+ R + ++ DP R+ E+ H +F K L A
Sbjct: 219 EDQEEYS----EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA 274
Query: 216 DLVD 219
+++
Sbjct: 275 GMLE 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-13
Identities = 39/111 (35%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHS 103
+ +Q++ GV+Y H V HRD+K N +L P +K+ DFG ++ HS
Sbjct: 105 CKYTKQILDGVAYLHNNCVVHRDIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHS 162
Query: 104 QP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153
KS GTP ++APEV+ Y G+ +D+WS G T++ M G P D
Sbjct: 163 NMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-13
Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---- 107
+F Q+ GV + H +V HRD+K +N L + ++K+ DFG S+ L + P +
Sbjct: 105 WFVQMCLGVQHIHEKRVLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACT 159
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
VGTP Y+ PE+ Y+ K +D+WS G LY + +PF + ++ I ++
Sbjct: 160 YVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQ 214
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 204
Y P + S E R LI ++F +P +R + I+
Sbjct: 215 GSYK-PLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 55/205 (26%), Positives = 81/205 (39%), Gaps = 54/205 (26%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS----- 107
Q+++GV Y H+ V HRDLK N L+ +G +KI D G ++ + ++ K
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLD 173
Query: 108 -TVGTPAYIAPEVLL--RHEYDGKIADVWSCG------VTLY------------------ 140
V T Y APE+LL RH Y I D+W+ G +TL
Sbjct: 174 PVVVTIWYRAPELLLGARH-YTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 141 -----VMLVGGYPFED--PD-----EPKDFRKTIQRILSVQYSVPD----TNPISQECRD 184
+ V G P E PD E K + S+ + D
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 185 LISRIFVADPAARITIPEIMKHQWF 209
L+ ++ DP RIT E ++H +F
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 51/190 (26%), Positives = 81/190 (42%), Gaps = 30/190 (15%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTP 112
QL+ G+ Y H + HRDLK+ N LL LKI DFG +++ L ++P + V T
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTL 172
Query: 113 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ-------RI 165
Y APE+LL D+W+ G L +L E + IQ I
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232
Query: 166 --------LSVQYSVPDTNP----------ISQECRDLISRIFVADPAARITIPEIMKHQ 207
L ++++P P +S+ L++ + + DP R T E ++
Sbjct: 233 WPGFSDLPLVGKFTLPK-QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291
Query: 208 WFLKN-LPAD 216
+F + LP +
Sbjct: 292 YFKEKPLPCE 301
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 57 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 116
+ G++Y H+ + HRD+K N LL + ++K+ DFG S+ + S S VGTP ++A
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMA 189
Query: 117 PEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 173
PEV+L +YDGK+ DVWS G+T + L P P + + I +
Sbjct: 190 PEVILAMDEGQYDGKV-DVWSLGITC-IELAERKP---PLFNMNAMSALYHIAQNESPTL 244
Query: 174 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
+N S R+ + P R T E++KH + L+ P
Sbjct: 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 22/160 (13%)
Query: 59 GVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPA 113
G++Y H HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP
Sbjct: 113 GLAYLHETGKIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPY 166
Query: 114 YIAPEVL---LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
++APEV + YDGK D+W+ G+T + P D P + + I +
Sbjct: 167 WMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPMFDLH-P---MRALFLISKSNF 221
Query: 171 SVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQ 207
P D S D I + DP R T ++++H
Sbjct: 222 PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 1e-12
Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTV 109
Q+ G+ Y + HRDL N L+ + +KI DFG Y K +
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 169
++APE L ++ K +DVWS GV L+ + G ++ + ++
Sbjct: 168 ---RWMAPESLKEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---- 219
Query: 170 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
Y +P E DL+ + + DP R T E+++
Sbjct: 220 YRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 18/183 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+A F+ ++ G+ H ++ +RDLK EN LLD ++I D G + K
Sbjct: 103 RAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKG 160
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
VGT Y+APEV+ Y D W+ G LY M+ G PF+ + K R+ ++R++
Sbjct: 161 RVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVK 218
Query: 168 VQYSVPD--TNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF----LKNLPAD 216
V + + S + R L + DP R+ E+ +H F K L A
Sbjct: 219 ---EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAG 275
Query: 217 LVD 219
+++
Sbjct: 276 MLE 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 31/194 (15%)
Query: 43 LGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 102
L ++ FQ ++ G+ +CH+ + HRD+K EN L+ S + +K+CDFG+++ ++
Sbjct: 97 LDESRVRKYLFQ-ILRGIEFCHSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAA 152
Query: 103 SQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF---EDPDEPKD 157
T V T Y APE+L+ G+ D+W+ G + ML G F D D+
Sbjct: 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212
Query: 158 FRKTIQRILSVQYSVPDTNPISQECR----------------------DLISRIFVADPA 195
K + ++ + NP+ R DL + DP
Sbjct: 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPD 272
Query: 196 ARITIPEIMKHQWF 209
R + +++ H++F
Sbjct: 273 DRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 37/181 (20%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
+ G++Y H+ + HRD+K N LL + +K+ DFG S+ L S S VGTP +
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYW 177
Query: 115 IAPEVLL---RHEYDGKIADVWSCGVT----------LYVM--LVGGYPFEDPDEPKDFR 159
+APEV+L +YDGK DVWS G+T L+ M + Y D P
Sbjct: 178 MAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP---- 232
Query: 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 219
T+ +N S R+ + P R + E++KH++ L+ P ++
Sbjct: 233 -TLS-----------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVII 280
Query: 220 E 220
+
Sbjct: 281 D 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 36/188 (19%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+ F Q++ G+ Y H+ + HRD+K N L++ + LKICDFG ++ T
Sbjct: 106 KVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQ 163
Query: 109 -VGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFE--------------- 150
V T Y APE+L+ RH Y + D+WS G +L F+
Sbjct: 164 EVVTQYYRAPEILMGSRH-YTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL 221
Query: 151 -DPDEPKDFRK----TIQRILSVQYSVPDTN-------PISQECRDLISRIFVADPAARI 198
P + R IL + P + E L+ R+ V DP RI
Sbjct: 222 GTPSL-EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280
Query: 199 TIPEIMKH 206
+ + + H
Sbjct: 281 SAADALAH 288
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 55/196 (28%), Positives = 82/196 (41%), Gaps = 35/196 (17%)
Query: 44 GLL--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 101
+L V R+ QL+ + Y H+ V HRDLK N LL+ R+K+ DFG ++S
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSE 159
Query: 102 HSQPKST------VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE----- 150
+ V T Y APE+LL K D+WS G L ML+G F
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
Query: 151 ----------DPDEPKD-------FRKTIQRILSV--QYSVPDTNP-ISQECRDLISRIF 190
P +D F T+ L + + + P S + DL+ ++
Sbjct: 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279
Query: 191 VADPAARITIPEIMKH 206
V +P R+T E ++H
Sbjct: 280 VFNPNKRLTAEEALEH 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 29/187 (15%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+ F QL+ G++YCH +V HRDLK +N L++ LK+ DFG +++ + ++ S
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER--GELKLADFGLARAKSIPTKTYSNE 164
Query: 109 VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGG--YPFEDPDEPKDF------- 158
V T Y P++LL +Y +I D+W G Y M G +P +E F
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT 223
Query: 159 --RKTIQRILS----VQYSVPDTNP---------ISQECRDLISRIFVADPAARITIPEI 203
+T ILS Y+ P + + +L+S++ + RI+ E
Sbjct: 224 PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283
Query: 204 MKHQWFL 210
MKH +F
Sbjct: 284 MKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 54/182 (29%), Positives = 86/182 (47%), Gaps = 32/182 (17%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPA 113
Q++ G+ +CH+ +V HRDLK +N L+D +K+ DFG +++ + + + V T
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLW 166
Query: 114 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--FRKTIQRILSVQ-- 169
Y APEVLL D+WS G T++ + P D D FR I RIL
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTE 223
Query: 170 ------YSVPD---TNP-------------ISQECRDLISRIFVADPAARITIPEIMKHQ 207
S+PD T P + ++ DL+ ++ + DPA RI+ + + H
Sbjct: 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283
Query: 208 WF 209
+F
Sbjct: 284 YF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-12
Identities = 38/101 (37%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 45 LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 104
LL Q R +QL+ V Y H ++ HRD+KLEN L+ L DFG + +
Sbjct: 265 LLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLG--DFGTAMPFEKERE 322
Query: 105 PKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 143
VGT A +PE+L Y +I D+WSCG+ L ML
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 53 FQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F Q++ + Y H ++ HRDL N +L ++ I DFG +K S+ S VGT
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGT 176
Query: 112 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 171
Y PE++ Y G+ ADVW+ G LY M PF + +I+ Y
Sbjct: 177 ILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYS----TNMLSLATKIVEAVYE 231
Query: 172 VPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
S++ D+I+ D AR P+I++
Sbjct: 232 PLPEGMYSEDVTDVITSCLTPDAEAR---PDIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 46/205 (22%)
Query: 56 LISGVSYC-HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
+I G++Y ++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSY 168
Query: 115 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--------------------- 153
++PE L Y + +D+WS G++L M +G YP PD
Sbjct: 169 MSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227
Query: 154 EPK-------------DFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADP 194
P+ D R + + Y V + P E +D +++ + +P
Sbjct: 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNP 287
Query: 195 AARITIPEIMKHQWFLKNLPADLVD 219
A R + ++M H F+K A+ VD
Sbjct: 288 AERADLKQLMVHA-FIKRSEAEEVD 311
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
+F Q++ G+ Y HA + HRDLK N L + LKI DFG ++ + S+ V
Sbjct: 121 QFLVYQMLKGLKYIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYV 176
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------P 155
T Y APEV+L + + D+WS G + ML G F+ D
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236
Query: 156 KDFRKTIQRILSVQYS--------------VPDTNPISQECRDLISRIFVADPAARITIP 201
K+F + +Q + Y +P+ NP++ +++ ++ V D +RIT
Sbjct: 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAV---NVLEKMLVLDAESRITAA 293
Query: 202 EIMKHQWFLK-NLPADLVDEKTMSSQYEEPDQPMQ 235
E + H +F + + P D + ++E DQ ++
Sbjct: 294 EALAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLE 328
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-12
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 9/170 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+A F+ +++ G+ H +RDLK EN LLD ++I D G + +
Sbjct: 103 RALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRG 160
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
VGT Y+APEVL Y D W G +Y M+ G PF E + +R+L
Sbjct: 161 RVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE 219
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPE----IMKHQWFLKNL 213
+ + S+E + + + DP R+ E +K F +N+
Sbjct: 220 TEEVY--SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-12
Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 31/187 (16%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+ F Q++ G++YCH +V HRDLK +N L++ LK+ DFG +++ + ++ S
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNE 164
Query: 109 VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
V T Y P+VLL EY +I D+W G + M G P +D I R+L
Sbjct: 165 VVTLWYRPPDVLLGSSEYSTQI-DMWGVGCIFFEM-ASGRPLFPGSTVEDELHLIFRLLG 222
Query: 168 V----------------QYSVPDTNP---------ISQECRDLISRIFVADPAARITIPE 202
Y+ P P + E +L+++ + RI+ E
Sbjct: 223 TPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282
Query: 203 IMKHQWF 209
MKH +F
Sbjct: 283 AMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 47/194 (24%), Positives = 84/194 (43%), Gaps = 39/194 (20%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 110
+ Q++ G+ + H+ + HRDLK N ++ LKI DFG ++++ + V
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVV 184
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI----- 165
T Y APEV+L Y + D+WS G + ++ G F+ D + K I+++
Sbjct: 185 TRYYRAPEVILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243
Query: 166 ----------------------LSVQYSVPD---------TNPISQECRDLISRIFVADP 194
+S + PD + + RDL+S++ V DP
Sbjct: 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDP 303
Query: 195 AARITIPEIMKHQW 208
RI++ E ++H +
Sbjct: 304 DKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPK 106
+F QL S + + H+ +V HRD+K N + + +K+ D G SK++ H
Sbjct: 111 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH---- 164
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
S VGTP Y++PE + + Y+ K +D+WS G LY M PF + + ++I
Sbjct: 165 SLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIE 221
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAAR 197
Y ++ S+E R L++ DP R
Sbjct: 222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 34/184 (18%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGT 111
Q + V++CH HRD+K EN L+ + ++K+CDFG+++ +L V T
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVAT 163
Query: 112 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF----EDPDEPKDFRKTI----- 162
Y APE+L+ G DVW+ G ++ L+ G P D D+ RKT+
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGC-VFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP 222
Query: 163 --QRILSVQ-----YSVP---DTNPISQECRDLISR-------IFVADPAARITIPEIMK 205
Q+I S S+P P+ + ++ S DP R++ E+++
Sbjct: 223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282
Query: 206 HQWF 209
H +F
Sbjct: 283 HPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 108
+F Q+ + Y H + HRDLK +N L + +K+ D G ++ VL +Q +
Sbjct: 107 WFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTL 162
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
+GTP Y++PE+ Y+ K +DVW+ G +Y M + F KD + RI+
Sbjct: 163 IGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRIIEG 217
Query: 169 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208
+ P S E +LI+ + P R ++ I++ +
Sbjct: 218 KLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 62/213 (29%), Positives = 84/213 (39%), Gaps = 59/213 (27%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--------------------------G 82
ARF+ +L V H M HRD+K +N L+D
Sbjct: 103 ARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 83 SPAPRLKICDFGYS------------------KSSVLHSQ--PKSTVGTPAYIAPEVLLR 122
R DF +++ H + S VGTP YIAPEVLLR
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 123 HEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRILSVQYS--VPDTNPI 178
Y ++ D WS GV LY MLVG PF + P E T ++++ Q S +P +
Sbjct: 223 TGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLE------TQMKVINWQTSLHIPPQAKL 275
Query: 179 SQECRDLISRIFVA--DPAARITIPEIMKHQWF 209
S E DLI ++ D + EI H +F
Sbjct: 276 SPEASDLIIKLCRGPEDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 53/171 (30%), Positives = 83/171 (48%), Gaps = 24/171 (14%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQP 105
Q R +Q + ++Y H ++ HRDLK N L LDG +K+ DFG S + Q
Sbjct: 104 QIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQR 159
Query: 106 K-STVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159
+ S +GTP ++APEV++ YD K ADVWS G+TL M + P
Sbjct: 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEM-------AQIEPPHHEL 211
Query: 160 KTIQRILSVQYSVPDT----NPISQECRDLISRIFVADPAARITIPEIMKH 206
++ +L + S P T + S E +D + + + AR T ++++H
Sbjct: 212 NPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 29/186 (15%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+ F QL+ G+SYCH ++ HRDLK +N L++ LK+ DFG +++ + ++ S
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK--GELKLADFGLARAKSVPTKTYSNE 163
Query: 109 VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG--------------------GY 147
V T Y P+VLL EY I D+W G LY M G G
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPI-DMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGT 222
Query: 148 PFEDP----DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 203
P E+ ++FR + Q + + + DL+S + + + +RI+
Sbjct: 223 PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282
Query: 204 MKHQWF 209
++H +F
Sbjct: 283 LRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 46/182 (25%)
Query: 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 126
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 120 KIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYT 176
Query: 127 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------YSV 172
+ +D+WS G++L M +G YP PD K ++ +
Sbjct: 177 VQ-SDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMFGRPVSEGEAKESHRPVSGHP 230
Query: 173 PDTNP-----------------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 209
PD+ S E +D + + +P R + E+ KH +
Sbjct: 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
Query: 210 LK 211
+
Sbjct: 291 KR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 36/85 (42%), Positives = 53/85 (62%), Gaps = 9/85 (10%)
Query: 57 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 116
+ G++Y H+ + HRD+K N LL + ++K+ DFG S+ S S VGTP ++A
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMA 185
Query: 117 PEVLL---RHEYDGKIADVWSCGVT 138
PEV+L +YDGK+ DVWS G+T
Sbjct: 186 PEVILAMDEGQYDGKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 32/189 (16%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
R F QL+ G++Y H + HRDLK +N L+ S LK+ DFG +++ + SQ S+
Sbjct: 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSE 163
Query: 109 VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
V T Y P+VLL +Y + D+W G ML G F + + + I +L
Sbjct: 164 VVTLWYRPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG 222
Query: 168 VQYS--------VPDTNP-----------------ISQ--ECRDLISRIFVADPAARITI 200
V +P+ P +S+ + DL S++ + P RI+
Sbjct: 223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA 282
Query: 201 PEIMKHQWF 209
+ + H +F
Sbjct: 283 QDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 13/167 (7%)
Query: 57 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 116
+ G++Y H+ + HRD+K N LL S +K+ DFG S+ + + VGTP ++A
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMA 179
Query: 117 PEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 173
PEV+L +YDGK+ DVWS G+T + P + + + I +
Sbjct: 180 PEVILAMDEGQYDGKV-DVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPAL 234
Query: 174 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 220
+ S+ R+ + P R T ++KH++ L+ P ++ +
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 3e-11
Identities = 40/153 (26%), Positives = 63/153 (41%), Gaps = 12/153 (7%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
Q+ G+ Y + + HRDL N L+ +KI DFG S+ + G
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLP 170
Query: 115 I---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
I APE L + K +DVWS GV L+ + +G P+ + ++ + Y
Sbjct: 171 IRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPG----LSNEEVLEYLRK-GY 224
Query: 171 SVPDTNPISQECRDLISRIFVADPAARITIPEI 203
+P E +L+ + DP R T E+
Sbjct: 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 50/213 (23%)
Query: 53 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------YS 96
F ++ + + Y H+ V HRDLK +N LL + I D+G
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 97 KSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153
+ ++ +S P VGTP Y+APE LL D+++ GV LY ML +P+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR-- 233
Query: 154 EPKDFRKTIQRILSVQYSVPDTNPIS--QECRDLISRI----FVADPAARIT-----IPE 202
K RK +S + + ++ +E +S+I DPA R + +
Sbjct: 234 --KKGRK-----ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286
Query: 203 IMKH-----QWFLKNLPADLVDEKTMSSQYEEP 230
+ H +W +K A L+ +K ++ EP
Sbjct: 287 LEPHLQGSPEWTVK---ATLMTKKKSCWKFYEP 316
|
Length = 932 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 56 LISGVSYC-HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
++ G++Y Q+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSY 168
Query: 115 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153
++PE L Y + +D+WS G++L + +G YP PD
Sbjct: 169 MSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 39/194 (20%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 110
+ Q++ G+ + H+ + HRDLK N ++ LKI DFG ++++ V
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVV 187
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI----- 165
T Y APEV+L Y + D+WS G + M+ GG F D + K I+++
Sbjct: 188 TRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 166 ----------------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADP 194
S + PD N + + + RDL+S++ V D
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 195 AARITIPEIMKHQW 208
+ RI++ E ++H +
Sbjct: 307 SKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 52/202 (25%), Positives = 82/202 (40%), Gaps = 54/202 (26%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLH 102
L + + QL ++Y H+ +CHRDLK +N L+D P LK+CDFG +K+ +
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAG 224
Query: 103 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG----------------- 145
+ S + + Y APE++L D+WS G + M++G
Sbjct: 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284
Query: 146 ---GYPFED--------------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 187
G P ED PD +PKD +K P P + + IS
Sbjct: 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVF----------PKGTP--DDAINFIS 332
Query: 188 RIFVADPAARITIPEIMKHQWF 209
+ +P R+ E + +F
Sbjct: 333 QFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+A F+ +L G+ ++ +RDLK EN LLD ++I D G + +
Sbjct: 103 RAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRG 160
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
VGT Y+APEV+ +Y D W G +Y M+ G PF E + +R+
Sbjct: 161 RVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE 219
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARI 198
Q + S++ + + + +P R+
Sbjct: 220 DQEEY--SEKFSEDAKSICRMLLTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 36/187 (19%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
+ +Q + G+ + HA + HRDLK EN L+ + ++K+ DFG ++ V
Sbjct: 111 KDLMRQFLRGLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVV 168
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--------------------VGGYPF 149
T Y APEVLL+ Y + D+WS G M + G P
Sbjct: 169 VTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227
Query: 150 EDPDEPKD-------FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 202
ED D P+D F R VQ VP+ I + L+ + +P RI+
Sbjct: 228 ED-DWPRDVTLPRGAFSPRGPR--PVQSVVPE---IEESGAQLLLEMLTFNPHKRISAFR 281
Query: 203 IMKHQWF 209
++H +F
Sbjct: 282 ALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 44/200 (22%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 110
+ Q++ G+ + H+ + HRDLK N ++ LKI DFG ++++ V
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVV 179
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR------ 164
T Y APEV+L Y + D+WS G + M+ G F D + K I++
Sbjct: 180 TRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238
Query: 165 --ILSVQYSV-------------------PDTN-PISQE---------CRDLISRIFVAD 193
+ +Q +V PD P E RDL+S++ V D
Sbjct: 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298
Query: 194 PAARITIPEIMKH----QWF 209
P RI++ + ++H W+
Sbjct: 299 PEKRISVDDALQHPYINVWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 9/107 (8%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 109
+ ++++ G+++ HA +V HRD+K +N LL + +K+ DFG S ++T +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 110 GTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFED 151
GTP ++APEV+ E YD + +D+WS G+T M G P D
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 54/217 (24%), Positives = 81/217 (37%), Gaps = 60/217 (27%)
Query: 42 LLGLLVQARFFF---------QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKI 90
L GLL F + L++G+ Y H ++ HRD+K N L+ DG LK+
Sbjct: 105 LAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKL 160
Query: 91 CDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRHEYDGKIADVWSCG--------- 136
DFG +++ L K V T Y PE+LL G D+W G
Sbjct: 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
Query: 137 ------------VTLYVMLVGG-----YP-------FEDPDEPKDFRKTIQRILSVQYSV 172
+TL L G +P F+ + P+ ++ ++ L
Sbjct: 221 SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK- 279
Query: 173 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
DLI ++ V DPA RI + H +F
Sbjct: 280 ------DPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 48/170 (28%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 102
L Q F QQ+ G++Y H+ HRDL N LLD +KI DFG +K+ +
Sbjct: 106 LAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEY 163
Query: 103 SQPKSTVGTPAY-IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
+ + +P + A E L +++ +DVWS GVTLY +L + P PK F +
Sbjct: 164 YRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEM 220
Query: 162 IQ------------RILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 199
I +L +P QE L+ + + R T
Sbjct: 221 IGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPT 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 36/116 (31%), Positives = 53/116 (45%), Gaps = 10/116 (8%)
Query: 41 LLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 100
+ L L+ F Q+ G+ Y + + HRDL N L++ +KI DFG +K
Sbjct: 106 INLKRLLL---FSSQICKGMDYLGSQRYIHRDLAARNILVESE--DLVKISDFGLAKVLP 160
Query: 101 LHSQ---PKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152
K +P + APE L ++ +DVWS GVTLY + G P + P
Sbjct: 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 21/166 (12%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 109
+ ++++ G+S+ H +V HRD+K +N LL + +K+ DFG S ++T +
Sbjct: 115 YICREILRGLSHLHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFI 172
Query: 110 GTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF----RK 160
GTP ++APEV+ E YD K +D+WS G+T M G P D + R
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 231
Query: 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
R+ S ++ S++ + I V + + R T ++MKH
Sbjct: 232 PAPRLKSKKW--------SKKFQSFIESCLVKNHSQRPTTEQLMKH 269
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 47/189 (24%), Positives = 72/189 (38%), Gaps = 29/189 (15%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS- 107
AR F QL+ G+ Y H+ V HRDLK N ++ + LKI DFG ++ H K
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 108 ---TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF------ 158
+ T Y +P +LL K D+W+ G ML G F E +
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234
Query: 159 --------RKTIQRILSVQYSVPDTNP----------ISQECRDLISRIFVADPAARITI 200
R + ++ P ++ E D + +I +P R+T
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
Query: 201 PEIMKHQWF 209
E + H +
Sbjct: 295 EEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 50/212 (23%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+F Q++ G+ Y H+ + HRDLK N L + LKI DFG ++ H+ +
Sbjct: 121 HVQFLIYQILRGLKYIHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEM 174
Query: 108 T--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
T V T Y APE++L + + D+WS G + +L G F D D K I R+
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRL 233
Query: 166 LSVQYSVPDTNPISQECR--------------------------DLISRIFVADPAARIT 199
+ + S+ R DL+ ++ V D RIT
Sbjct: 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 293
Query: 200 IPEIMKHQWFLKNLPADLVDEKTMSSQYEEPD 231
+ + H +F +QY +PD
Sbjct: 294 AAQALAHAYF---------------AQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 39/194 (20%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 110
+ Q++ G+ + H+ + HRDLK N ++ LKI DFG ++++ V
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVV 180
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI----- 165
T Y APEV+L Y + D+WS G + M+ F D + K I+++
Sbjct: 181 TRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 166 ----------------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADP 194
L+ PD+ N + + + RDL+S++ V DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 195 AARITIPEIMKHQW 208
A RI++ E ++H +
Sbjct: 300 AKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 37/199 (18%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+ F QL+ G+SY H + HRDLK +N L+ S LK+ DFG +++ + S S
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNE 163
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
V T Y P+VLL D+W G M+ G F KD + ++RI V
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM---KDIQDQLERIFLV 220
Query: 169 Q-----------YSVPDTNP------ISQECR-------------DLISRIFVADPAARI 198
+S+P P + R DL S++ P R+
Sbjct: 221 LGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL 280
Query: 199 TIPEIMKHQWFLKNLPADL 217
+ + H++F +LP L
Sbjct: 281 SAQAALSHEYF-SDLPPRL 298
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 47/188 (25%), Positives = 80/188 (42%), Gaps = 35/188 (18%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
++ Q++ G+ Y H+ + HRDLK N L + LKI DFG ++ + ++ V
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYV 175
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD---------------- 153
T Y APEV+L + + D+WS G + ML G F+ D
Sbjct: 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235
Query: 154 ----------EPKDFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIP 201
K + K++ + +S P +P + DL+ ++ D R+T
Sbjct: 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAV---DLLEKMLELDVDKRLTAT 292
Query: 202 EIMKHQWF 209
E ++H +F
Sbjct: 293 EALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 52/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+F Q++ G+ Y H+ + HRDLK N ++ LKI DFG ++ H+ +
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEM 172
Query: 108 T--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG--YPFED------------ 151
T V T Y APE++L + + D+WS G + +L G +P D
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232
Query: 152 --PDEPKDFRKTIQ--RILSVQYSVPDT------------NPISQECRDLISRIFVADPA 195
PDE + + I + S+P NP++ DL+ ++ V DP
Sbjct: 233 GTPDE--ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAI---DLLEKMLVLDPD 287
Query: 196 ARITIPEIMKHQWF 209
RIT E + H +
Sbjct: 288 KRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 6e-10
Identities = 29/117 (24%), Positives = 50/117 (42%), Gaps = 12/117 (10%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 113
Q+ G+ Y + HRDL N L+ + +KI DFG S+ ++
Sbjct: 109 LQIAKGMEYLESKNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGG 164
Query: 114 YI-----APEVLLRHEYDGKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRKTIQR 164
+ APE L ++ K +DVWS GV L+ + G P+ ++ + ++
Sbjct: 165 KLPIKWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 41/199 (20%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--- 106
+FF QL+ + Y H V HRDLK +N L + +LKICDFG ++ + +
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFW 163
Query: 107 -STVGTPAYIAPEVL--LRHEYDGKIADVWSCGVTLYVMLVG------------------ 145
V T Y APE+ +Y I D+WS G +L G
Sbjct: 164 TDYVATRWYRAPELCGSFFSKYTPAI-DIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD 222
Query: 146 --GYPFEDP------DEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPA 195
G P + ++ + + ++++ V +S P+ +P++ L+ R+ DP
Sbjct: 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLAL---RLLERLLAFDPK 279
Query: 196 ARITIPEIMKHQWFLKNLP 214
R T E + +F K L
Sbjct: 280 DRPTAEEALADPYF-KGLA 297
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQP 105
F Q+ G+ Y M++ HRDL N L+ + ++KI DFG S+ S V S+
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVKRSKG 189
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQR 164
+ V ++A E L H Y + +DVWS GV L+ ++ +GG P+ P + +
Sbjct: 190 RIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY-----PGIAPERLFN 240
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
+L Y + S+E +L+ + +P R T +I K
Sbjct: 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 58/214 (27%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
+F QL+ G+ Y H+ + HRDLK N ++ L+I DFG ++ + + V
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYV 176
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV- 168
T Y APE++L + + D+WS G + +L G F D+ ++RI+ V
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG----NDYIDQLKRIMEVV 232
Query: 169 -----------------QY--SVP------------DTNPISQECRDLISRIFVADPAAR 197
+Y S+P NP++ DL+ ++ V D R
Sbjct: 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAI---DLLEKMLVLDSDKR 289
Query: 198 ITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPD 231
I+ E + H +F SQY +P+
Sbjct: 290 ISASEALAHPYF---------------SQYHDPE 308
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 48/205 (23%), Positives = 73/205 (35%), Gaps = 52/205 (25%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 106
Q + + QL+ G++Y H + HRD+K N L+D LKI DFG ++ P
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPN 171
Query: 107 -------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-------- 145
+ V T Y PE+LL D+W G M
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231
Query: 146 ------------GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRD 184
G P E+ P E R L ++ + E D
Sbjct: 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG-----KLGPEGLD 286
Query: 185 LISRIFVADPAARITIPEIMKHQWF 209
L+S++ DP R+T + ++H +F
Sbjct: 287 LLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKST 108
+ + + G+ + H + HRD+K N LL + +K+ DFG S +S + ++
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTS 184
Query: 109 VGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
VGTP ++APEV+ L YD + DVWS G+T + G P D + K I
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFK-IP 242
Query: 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208
R P+ S E D I + D R T+ ++++H +
Sbjct: 243 RNPPPTLHQPEL--WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 35/88 (39%), Positives = 51/88 (57%), Gaps = 8/88 (9%)
Query: 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL--- 121
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 127 LKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSA 183
Query: 122 RHEYDGKIADVWSCGVTLYVMLVGGYPF 149
R YD + +DVWS G+TLY + G +P+
Sbjct: 184 RDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 30/185 (16%)
Query: 41 LLLGLLVQARFFFQQLIS--------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 92
L+ GLL+ + + +IS G+ + H ++ HRD+K N LL +K+ D
Sbjct: 114 LVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVD 171
Query: 93 FGYSKS-SVLHSQPKSTVGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGG 146
FG S + + ++VGTP ++APEV+ + YD + DVWS G+T
Sbjct: 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDAR-CDVWSLGIT-------A 223
Query: 147 YPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRD---LISRIFVADPAARITIP 201
D D P ++ + + + P T +P + CR IS+ + D AR ++
Sbjct: 224 IELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP-EKWCRSFNHFISQCLIKDFEARPSVT 282
Query: 202 EIMKH 206
+++H
Sbjct: 283 HLLEH 287
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 3/89 (3%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
QL+ G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ S V T Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWY 175
Query: 115 IAPEVLLRHEYDGKIADVWSCGVTLYVML 143
APEVLL+ Y + D+WS G M
Sbjct: 176 RAPEVLLQSSYATPV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 50/213 (23%), Positives = 75/213 (35%), Gaps = 66/213 (30%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------HS 103
Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 104 QPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-------------- 145
Q + S V T Y APE+L+ E D+WS G +L G
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244
Query: 146 ------GYPFED---------------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 184
G P ED P +PKD + S + D
Sbjct: 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPN-------------ASDDAID 291
Query: 185 LISRIFVADPAARITIPEIMKHQWFLKN-LPAD 216
L+ + +P RI+ E +KH++F + LP D
Sbjct: 292 LLQSLLKLNPLERISAKEALKHEYFKSDPLPCD 324
|
Length = 335 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 24/162 (14%)
Query: 15 GVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLL--VQARFFFQQLIS-------GVSYCHA 65
GV K + +++ + + CL L L RF QL+ G++Y +
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCL-------LNYLREHGKRFQPSQLLEMCKDVCEGMAYLES 118
Query: 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLR 122
Q HRDL N L+D +K+ DFG S+ VL + S+VG+ + PEVLL
Sbjct: 119 KQFIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLY 175
Query: 123 HEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ 163
++ K +DVW+ GV ++ V +G P+E + + K Q
Sbjct: 176 SKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 6e-08
Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 53/205 (25%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP------- 105
Q++ G+ Y HA V HRDLK N L+ +G R+KI D G+++ L + P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADL 172
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML---------------------- 143
V T Y APE+LL + K D+W+ G +L
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
Query: 144 -------VGGYP----FED----PDEP---KDFRKTIQRILS-VQYSVPDTNPISQECRD 184
V G+P +ED P+ P KDFR+T S ++Y +
Sbjct: 233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292
Query: 185 LISRIFVADPAARITIPEIMKHQWF 209
L+ ++ DP RIT + ++ +F
Sbjct: 293 LLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 30/95 (31%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 47 VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQP 105
+Q + ++ + G++Y H+ HRD+K N LL + +K+ DFG +K + ++
Sbjct: 106 LQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL--TDNGDVKLADFGVAAKITATIAKR 163
Query: 106 KSTVGTPAYIAPEVLLRHEYDG--KIADVWSCGVT 138
KS +GTP ++APEV + G ++ D+W+ G+T
Sbjct: 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPK 106
Q + ++ + G+ Y H+ HRD+K N LL + +K+ DFG S + ++ K
Sbjct: 107 QIAYVSRETLQGLYYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRK 164
Query: 107 STVGTPAYIAPEVLLRHEYDG--KIADVWSCGVT 138
S +GTP ++APEV G ++ D+W+ G+T
Sbjct: 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT 111
Q+ G+ Y + Q HRDL N L++ ++KI DFG +K+ + K + +
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 112 PAY-IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ------- 163
P + APE L++ ++ +DVWS GVTLY +L Y + F K I
Sbjct: 175 PVFWYAPECLIQSKF-YIASDVWSFGVTLYELLT--YCDSESSPMTLFLKMIGPTHGQMT 231
Query: 164 -----RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
R+L +P +E L+ + + P+ R T +++
Sbjct: 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 53/205 (25%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP------- 105
Q++ G+ Y HA V HRDLK N L+ +G R+KI D G+++ L + P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADL 172
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML---------------------- 143
V T Y APE+LL + K D+W+ G +L
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
Query: 144 -------VGGYP----FED----PDEP---KDFRKTIQRILS-VQYSVPDTNPISQECRD 184
V G+P +ED P+ KDFR+ S ++Y +
Sbjct: 233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 292
Query: 185 LISRIFVADPAARITIPEIMKHQWF 209
L+ ++ DP RIT + M+ +F
Sbjct: 293 LLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 110
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 111 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 165
P ++APE + Y + +DVWS GV L+ + +G P+ ++F + ++ R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
+ + + P+ I C + DP R T +++
Sbjct: 297 RAPENATPEIYRIMLAC-------WQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 44/146 (30%), Positives = 62/146 (42%), Gaps = 20/146 (13%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 105
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK--DFRKTI 162
TV T APEVL Y + D+WS G+ ++ V F + + I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378
Query: 163 QRILSVQYSVPDTNPISQECRDLISR 188
RI+ D P R L+S+
Sbjct: 379 LRIIRQAQVHVDEFPQHAGSR-LVSQ 403
|
Length = 461 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 7/103 (6%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGT 111
Q+ G+SY H V H+D+ N ++D ++KI D S+ H +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 112 PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPD 153
++A E L+ EY +DVWS GV L+ +M +G P+ + D
Sbjct: 183 VKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEID 224
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 8/101 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 113
+ + Y + HRDL N L+ +K+ DFG ++ VL Q S+ GT
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKF 163
Query: 114 YI---APEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFE 150
+ PEV + K +DVWS GV ++ + G P+E
Sbjct: 164 PVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 110
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 111 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 165
P ++APE + Y + +DVWS GV L+ + +G P+ ++F + ++ R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
+ Y+ P+ +C + +P+ R T E+++H
Sbjct: 302 RAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 7/101 (6%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP 112
Q+ G+SY ++ HRDL N L+ +P +KI DFG +K V + + G P
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 113 -AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
++A E +L Y K +DVWS GVT++ +M G P+E
Sbjct: 175 IKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 109
F Q+ G+S+ + HRDL N LL + KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 110 GTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKD--FRKTIQ-- 163
P ++APE + Y + +DVWS G+ L+ + +G P+ P P D F K I+
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPY--PGMPVDSKFYKMIKEG 333
Query: 164 -RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
R+LS + + + I + C D ADP R T +I++
Sbjct: 334 YRMLSPECAPSEMYDIMKSCWD-------ADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 31/101 (30%), Positives = 43/101 (42%), Gaps = 11/101 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVG 110
Q+ G++Y HRDL N L+ K+ DFG + K V L S K
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY- 168
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 150
+ APE + K +DVWS G+ LY + G P+
Sbjct: 169 --KWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 110
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 111 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 165
P ++APE + Y + +DVWS GV L+ + +G P+ ++F + ++ R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
+ +Y+ P+ I +C +P R T E+++
Sbjct: 296 RAPEYATPEIYSIMLDCWH-------NNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F Q+ G+ + + HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 112 P----AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRIL 166
++APE + + Y ++DVWS G+ L+ + +GG P+ F I+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-- 355
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAAR 197
+ + PD QE D++ + + ++P R
Sbjct: 356 GYRMAKPDHAT--QEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
+GTP Y+APE+LL + G D W+ GV L+ L G PF D + F Q IL+
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVF----QNILNR 595
Query: 169 QYSVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF 209
P+ +S ++ I + DP R + E+ +H F
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 59 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYI 115
G++Y + V HRDL N L+ + +K+ DFG ++ VL Q S+ GT +
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWS 168
Query: 116 APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
+PEV +Y K +DVWS GV ++ V G P+E+
Sbjct: 169 SPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 109
F Q+ G+++ + HRDL N LL + +KICDFG ++ + S K
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 110 GTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKD--FRKTIQRI 165
P ++APE + Y + +DVWS G+ L+ + +G P+ P P D F K I+
Sbjct: 204 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPY--PGMPVDSKFYKLIKE- 259
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 203
+ + P+ P E D++ + ADP R T +I
Sbjct: 260 -GYRMAQPEHAP--AEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 34/107 (31%), Positives = 51/107 (47%), Gaps = 14/107 (13%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPK 106
+ Q+ +G+ Y + + HRDL N LL + ++KI DFG ++ + +
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEH 159
Query: 107 STVGTP-AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152
V P A+ APE LR +DVW GVTL+ M G E+P
Sbjct: 160 LKV--PFAWCAPES-LRTRTFSHASDVWMFGVTLWEMFTYG---EEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 108
F Q+ +G+ + + HRDL N L+ +KICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQR 164
++APE + + Y ++DVWS G+ L+ + +GG P+ + + F I+R
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 52/176 (29%), Positives = 78/176 (44%), Gaps = 26/176 (14%)
Query: 38 MWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYS 96
W L L L++ F Q+ G+ + + HRD+ N LL DG A KICDFG +
Sbjct: 206 SWPLDLDDLLR---FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLA 259
Query: 97 KSSVLHSQ--PKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDP 152
+ + S K P ++APE + Y + +DVWS G+ L+ + +G P+
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGI 318
Query: 153 DEPKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARITIPEI 203
F K ++R Q S PD P I + C +L +P R T +I
Sbjct: 319 LVNSKFYKMVKR--GYQMSRPDFAPPEIYSIMKMCWNL-------EPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 31/97 (31%), Positives = 43/97 (44%), Gaps = 6/97 (6%)
Query: 56 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST--VGTP 112
L+ ++Y H + HRD+K EN LD L DFG + H P+ GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTL 251
Query: 113 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 149
+PE+L Y K D+WS G+ L+ M V
Sbjct: 252 ETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 8/101 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP- 112
Q + G+ Y HRDL N L+ S +K+ DFG ++ VL + S+ G
Sbjct: 107 QDVCEGMEYLERNSFIHRDLAARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKF 163
Query: 113 --AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 150
+ PEV +Y K +DVWS GV ++ V G PFE
Sbjct: 164 PVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 12/101 (11%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---- 113
+G+ Y M HRDL N L++ + K+ DFG S+ VL P+ T T
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIP 173
Query: 114 --YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
+ APE + ++ +DVWS G+ ++ VM G P+ D
Sbjct: 174 IRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSKSSVLHSQPK--STV 109
+ ++ + Y H ++ HRD+K EN ++ P +C DFG + V + K
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DVCLGDFGAACFPVDINANKYYGWA 244
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 145
GT A APE+L R Y G D+WS G+ L+ M
Sbjct: 245 GTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 38/158 (24%), Positives = 62/158 (39%), Gaps = 22/158 (13%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P 112
++ G++Y A + HRDL N ++ +KI DFG ++ + P
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 113 A-YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDF---RKTIQRI 165
++APE L + K +DVWS GV L+ M Y +E F +
Sbjct: 185 VRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL- 242
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 203
P+ P + +L+ + +P R T EI
Sbjct: 243 -------PENCP--DKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVL 101
F + +++ + Y H+ HR +K + LL G ++ + YS + V+
Sbjct: 104 AFILKDVLNALDYIHSKGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVV 161
Query: 102 HSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK--- 156
H PKS+V +++PEVL + Y+ K D++S G+T + G PF+D +
Sbjct: 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKDMPATQMLL 220
Query: 157 -DFRKTIQRIL-----------SVQYSVPDTNPISQECRDLIS-RIFVA----------- 192
R T+ +L Q + +P +++ D R F
Sbjct: 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280
Query: 193 -DPAARITIPEIMKHQWF--LKNLPADLVD 219
DP +R + +++ H +F K L+D
Sbjct: 281 RDPESRPSASQLLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 27/172 (15%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG--TP 112
Q+ SG+ Y ++ HRDL N L+ +KI DFG S++ L+S V P
Sbjct: 138 QIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSSDYYRVQGRAP 193
Query: 113 AYI---APEVLLRHEYDGKIADVWSCGVTLY--VMLVGGYPFED-PDEP------KDFRK 160
I A E +L ++ K +DVW+ GVTL+ + L P+E D+ FR
Sbjct: 194 LPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRD 252
Query: 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
++I +P ++ +L+ + D R T EI H FL+
Sbjct: 253 DGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HL-FLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 29/99 (29%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTP 112
Q+ G+ Y + + HRDL N L+ + +KI DFG ++ +++ + + + P
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKKTTNGRLP 202
Query: 113 A-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
++APE L Y + +DVWS GV ++ + +GG P+
Sbjct: 203 VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGT 111
Q+ G++Y + HRDL N L+ + KI DFG ++ ++ +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKF 166
Query: 112 P-AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 148
P + APE + K +DVWS G+ L ++ G YP
Sbjct: 167 PIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 28/100 (28%), Positives = 45/100 (45%), Gaps = 10/100 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK-----SSVLHSQPKST 108
Q++ ++ H + HRDLK +N ++ + P K+ DFG + T
Sbjct: 87 QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146
Query: 109 ---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 145
+GTP Y APE LR E +D+++ G+ L G
Sbjct: 147 TEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 113
Q+ G+SY +++ HRDL N L+ SP +KI DFG ++ + G
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVP 174
Query: 114 --YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 150
++A E +L + + +DVWS GVT++ +M G P++
Sbjct: 175 IKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F + G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGR 172
Query: 112 -PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
P ++A E L Y +DVWS GV L+ ++ +GG P+
Sbjct: 173 LPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 12/101 (11%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---- 113
SG+ Y M HRDL N L++ + K+ DFG S+ VL P++ T
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIP 172
Query: 114 --YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
+ APE + ++ +DVWS G+ ++ VM G P+ +
Sbjct: 173 IRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 38/154 (24%), Positives = 64/154 (41%), Gaps = 17/154 (11%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPK 106
F Q+ G+++ HRDL+ N L+ S + KI DFG ++ K
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAK 164
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRI 165
+ + APE + + K +DVWS G+ L ++ G P+ P+ + R
Sbjct: 165 FPI---KWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRA 215
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARIT 199
L Y +P +E +++ R + P R T
Sbjct: 216 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 9e-05
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F + +G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T+G
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGR 179
Query: 112 -PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
P ++A E L Y K +DVWS GV L+ ++ +GG P+
Sbjct: 180 LPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 8/102 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVG 110
Q+ G+ Y HRDL N LL KI DFG SK+ + + +S
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGK 159
Query: 111 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFE 150
P + APE + ++ + +DVWS G+T++ G P++
Sbjct: 160 WPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 39/144 (27%), Positives = 63/144 (43%), Gaps = 12/144 (8%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-Y 114
+G+ Y + HRDL N L+ LKI DFG S+ +++ P +
Sbjct: 105 AGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKW 162
Query: 115 IAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 173
APE L Y + +DVWS G+ L+ +G P+ + + R+ I++ V+ P
Sbjct: 163 TAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQ--GVRLPCP 218
Query: 174 DTNPISQECRDLISRIFVADPAAR 197
+ P L+ R + DP R
Sbjct: 219 ELCP--DAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 20/122 (16%)
Query: 37 FMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 96
F L+G+L + + SG+ Y M HRDL N L++ + K+ DFG S
Sbjct: 103 FTVGQLVGML-------RGIASGMKYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLS 153
Query: 97 KSSVLHSQPKSTVGT-----PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
+ L ++T T P + APE + + +DVWS G+ ++ VM G P+
Sbjct: 154 R--RLED-SEATYTTKGGKIPIRWTAPEA-IAYRKFTSASDVWSFGIVMWEVMSYGERPY 209
Query: 150 ED 151
D
Sbjct: 210 WD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 13/96 (13%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TV 109
+ Q+ G+ Y + + HRDL N L++ R+KI DFG +K + Q K V
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTK---VLPQDKEYYKV 167
Query: 110 GTPA-----YIAPEVLLRHEYDGKIADVWSCGVTLY 140
P + APE L ++ +DVWS GV LY
Sbjct: 168 REPGESPIFWYAPESLTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG- 110
Q+ G+ + + + HRDL N L+ + +KI DFG ++ +H K+T G
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--IHHIDYYRKTTNGR 195
Query: 111 TPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
P ++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 196 LPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 11/102 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 113
Q+ G++Y ++ HRDL N L+ +KI DFG +K +L + K
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGK 172
Query: 114 ----YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 150
++A E +L Y + +DVWS GVT++ +M G P++
Sbjct: 173 VPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT-P 112
Q+ G+ Y + + HRDL N L+ +KI DFG ++ + K+T G P
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 113 A-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 206 VKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG--T 111
Q+ G+ Y + + HRDL N L+ +KI DFG ++ + K+T G
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKKTTNGRLP 199
Query: 112 PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 200 VKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT 111
Q+ SG+ Y ++ HRDL N L+ +KI DFG S+ S + V
Sbjct: 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDYYRIQGRAVLP 194
Query: 112 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144
++A E +L ++ +DVW+ GVTL+ M
Sbjct: 195 IRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
Q+ SG++Y A HRDL N L+ + K+ DFG ++ + ++ G
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFP 167
Query: 115 I---APEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 148
I APE L + + K +DVWS G+ L ++ G YP
Sbjct: 168 IKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYP 206
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 8/102 (7%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT-- 111
Q+ G++Y + HRDL N LL + KI DFG S++ ++T
Sbjct: 103 QVAMGMAYLESKHFVHRDLAARNVLLVNRH--QAKISDFGMSRALGAGSDYYRATTAGRW 160
Query: 112 P-AYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFED 151
P + APE + ++ K +DVWS GVTL+ G P+ +
Sbjct: 161 PLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 20/163 (12%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 106
F + G+ Y HRDL N +L + +C DFG SK S + Q +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGR 173
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQ 163
+IA E L Y K +DVW+ GVT++ + G YP + E D+ +
Sbjct: 174 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232
Query: 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
R+ P+ E DL+ + ADP R T ++ +
Sbjct: 233 RL-----KQPEDCL--DELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 7/91 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 110
Q+ G+ Y HRDL N LL KI DFG SK + + + K+
Sbjct: 102 HQVSMGMKYLEETNFVHRDLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGK 159
Query: 111 TPA-YIAPEVLLRHEYDGKIADVWSCGVTLY 140
P + APE + +++ K +DVWS GV ++
Sbjct: 160 WPVKWYAPECMNYYKFSSK-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT 111
Q+ +G+ Y + HRDL N L+ +KI DFG S+ S+ + ++
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 112 PAYIAPEVLLRHEYDGKIADVWSCGVTLY 140
++ PE +L ++ + +D+WS GV L+
Sbjct: 190 VRWMPPEAILYGKFTTE-SDIWSFGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 21/115 (18%)
Query: 51 FFFQQLISGVSYCHAMQVCHRDLKLENTL--LDGSPAPRLKICDFGY----------SKS 98
+ Q ++ + Y H M HR +K + L +DG K+ G +
Sbjct: 105 YILQGVLKALDYIHHMGYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRL 158
Query: 99 SVLHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFED 151
V+H PK +V +++PEVL ++ YD K +D++S G+T + G PF+D
Sbjct: 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 13/122 (10%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 106
F + SG+ Y + HRDL N +L+ + + +C DFG SK + + Q +
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGR 172
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQ 163
+IA E L Y K +DVWS GVT++ + G YP + E D+ +
Sbjct: 173 IAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
Query: 164 RI 165
R+
Sbjct: 232 RL 233
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 45/153 (29%), Positives = 66/153 (43%), Gaps = 23/153 (15%)
Query: 59 GVSYCHAMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTP 112
G Y M HRDL N L+ G A R +KI DFG ++ S + + +
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 113 AYIAPEVLLRHEYDGKI---ADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRIL 166
++APE LL DGK +DVWS GV ++ +L G YP + E R+
Sbjct: 178 RWMAPESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARIT 199
P+ P + L++ + DP+ R T
Sbjct: 234 K-----PENCP--DKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 15/150 (10%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIA 116
G+ Y HRDL N L+ K+ DFG +K + SQ + + P + A
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVA--KVSDFGLAKEA---SQGQDSGKLPVKWTA 167
Query: 117 PEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEP-KDFRKTIQRILSVQYSVPD 174
PE L ++ K +DVWS G+ L+ + G P+ P P KD +++ + P+
Sbjct: 168 PEALREKKFSTK-SDVWSFGILLWEIYSFGRVPY--PRIPLKDVVPHVEK--GYRMEAPE 222
Query: 175 TNPISQECRDLISRIFVADPAARITIPEIM 204
P E ++ + DPA R T ++
Sbjct: 223 GCP--PEVYKVMKDCWELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 39/138 (28%), Positives = 57/138 (41%), Gaps = 20/138 (14%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTV 109
+G++Y + HRDL N L+ + LKI DFG S+ SS L P
Sbjct: 104 AGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK-- 159
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRIL 166
+ APE L Y + +DVWS G+ L+ G YP + ++ + R+
Sbjct: 160 ----WTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMS 214
Query: 167 SVQYSVPDTNPISQECRD 184
Q D + Q C D
Sbjct: 215 CPQKCPDDVYKVMQRCWD 232
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F + G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGR 184
Query: 112 -PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
P ++A E L Y +DVWS GV L+ ++ +GG P+
Sbjct: 185 LPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTP 112
Q+ G+ Y + + HRDL N L+ +KI DFG ++ + + + S P
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKKTSNGRLP 199
Query: 113 A-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
++APE L Y + +DVWS G+ ++ + +GG P+
Sbjct: 200 VKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 7e-04
Identities = 27/91 (29%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTV 109
Q+ S + Y HRDL N L+ +K+ DFG S+ + H+ K +
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 169
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 140
+ APE L +++ K +DVW+ GV L+
Sbjct: 170 ---KWTAPESLAYNKFSIK-SDVWAFGVLLW 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 8e-04
Identities = 29/92 (31%), Positives = 41/92 (44%), Gaps = 13/92 (14%)
Query: 63 CHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 120
A++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 121 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152
Y K AD++S G+TLY L P+ +
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEALDYELPYNEE 107
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 8e-04
Identities = 44/161 (27%), Positives = 65/161 (40%), Gaps = 30/161 (18%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KS 107
+G+ Y + HRDL N L+ + LKI DFG Y+ S L P K
Sbjct: 104 AGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKW 161
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQR 164
T APE L Y + +DVWS G+ L+ G YP + ++ ++ R
Sbjct: 162 T-------APEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR 213
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
+ P P +E L+ + + DP R + EI
Sbjct: 214 M-----PAPQLCP--EEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 8e-04
Identities = 42/135 (31%), Positives = 63/135 (46%), Gaps = 18/135 (13%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHS 103
F Q+ G+ Y + + HRDL N +LD S +K+ DFG Y K S H+
Sbjct: 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHT 160
Query: 104 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRK 160
K V ++A E L ++ K +DVWS GV L+ ++ G YP D + +
Sbjct: 161 GAKLPV---KWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL 216
Query: 161 TIQRILSVQYSVPDT 175
+R+L +Y PD
Sbjct: 217 QGRRLLQPEY-CPDP 230
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 9e-04
Identities = 29/90 (32%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F + + Y A HRDL N L+ S K+ DFG +K + S + T
Sbjct: 107 FSLDVCEAMEYLEANNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKL 161
Query: 112 PA-YIAPEVLLRHEYDGKIADVWSCGVTLY 140
P + APE L ++ K +DVWS G+ L+
Sbjct: 162 PVKWTAPEALREKKFSTK-SDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 110
QQ+ +G+ Y + HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146
++ PE ++ ++ + +DVWS GV L+ + G
Sbjct: 185 PIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYG 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 14/165 (8%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH 102
L Q Q+ SG+ Y + HRDL N L+ + +KI DFG S+ S+ +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYY 179
Query: 103 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKT 161
T+ ++ PE ++ ++ + +DVWS GV L+ + G P+ +
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238
Query: 162 IQ-RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
Q R+L P +E D++ + +P R+ I EI K
Sbjct: 239 TQGRVLERPRVCP------KEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 16/158 (10%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 113
Q+ SG+ Y + HRDL N L+ +KI DFG S+ +++ VG
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHT 184
Query: 114 -----YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILS 167
++ PE ++ ++ + +DVWS GV L+ + G P+ + Q L
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
+ P T P E D++ + DP RI I +I +
Sbjct: 244 QR---PRTCP--SEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 113
Q+ SG+ Y ++ HRDL N L+ + +KI DFG S++ L++ + A
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAV 201
Query: 114 ----YIAPEVLLRHEYDGKIADVWSCGVTLYVML 143
++A E +L ++ +DVW+ GVTL+ +L
Sbjct: 202 LPIRWMAWECILMGKFT-TASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 39/154 (25%), Positives = 66/154 (42%), Gaps = 13/154 (8%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
++Q F + G+ Y + ++ HRDL N L+ S K+ DFG ++ + S
Sbjct: 99 VIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV--SEDGVAKVSDFGLAR---VGSMG 153
Query: 106 KSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ 163
P + APE L ++ K +DVWS GV L+ V G P+ PK K ++
Sbjct: 154 VDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPY-----PKMSLKEVK 207
Query: 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAAR 197
+ Y + + L++ + +P R
Sbjct: 208 ECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 113
Q+ SG+ Y ++ HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTM 185
Query: 114 ----YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146
++ PE +L ++ + +D+WS GV L+ + G
Sbjct: 186 LPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYG 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 32/105 (30%), Positives = 47/105 (44%), Gaps = 14/105 (13%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
Q+ SG++Y M HRDL+ N L+ + K+ DFG ++ L + T
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQ 161
Query: 112 PA-----YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 148
A + APE L + K +DVWS G+ L + G YP
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 35/153 (22%), Positives = 63/153 (41%), Gaps = 21/153 (13%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL-----DGSPAPRLKICDFGYSKSSVLHSQPKST 108
+QL S + Y ++ H ++ +N L+ + P +K+ D G + + +
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER 167
Query: 109 VGTPAYIAPEVLLRHEYDGKIA-DVWSCGVTLYVMLVGG-YPFE--DPDEPKDFRKTIQR 164
+ +IAPE + + IA D WS G TL + G P E + F + R
Sbjct: 168 I---PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAAR 197
+ +PD ++ LI++ + DP R
Sbjct: 225 L-----PMPDCAELAN----LINQCWTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 13/152 (8%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F Q+ G++Y HRDL+ N L+ S + KI DFG ++ + ++ + G
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGA 164
Query: 112 P---AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILS 167
+ APE + + K +DVWS G+ LY ++ G P+ P + L
Sbjct: 165 KFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPY-----PGMSNSDVMSALQ 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARIT 199
Y +P E D++ + R T
Sbjct: 219 RGYRMPRMENCPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 35/160 (21%), Positives = 64/160 (40%), Gaps = 22/160 (13%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTV 109
Q+ G+ + + HRDL N L+ L Y+ +
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL 182
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED-PDEPKDFRKTIQRILS 167
++APE + ++ K +DVWS GV ++ V G PF DE + + R+ +
Sbjct: 183 ---RWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLNRLQA 233
Query: 168 --VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
++ VP+ P L++R + +P R + E++
Sbjct: 234 GKLELPVPEGCPSR--LYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP-- 112
Q+ G+ Y ++ HRDL N L+ SP +KI DFG ++ + + G
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVK-SPN-HVKITDFGLARLLEGDEKEYNADGGKMP 174
Query: 113 -AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 150
++A E + ++ + +DVWS GVT++ +M GG P++
Sbjct: 175 IKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 293 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.91 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.64 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.57 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.52 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.51 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.51 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.47 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.33 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.26 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.26 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.23 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.05 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.0 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.83 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.76 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.74 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.63 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.6 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.35 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.34 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.24 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.12 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.88 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.86 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.31 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.74 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.66 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.5 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.12 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 95.66 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 95.54 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.34 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.44 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.28 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.22 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.26 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.13 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 92.61 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.31 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.27 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 92.19 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.15 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 91.82 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.76 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 91.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 91.29 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.26 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 90.94 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 90.77 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 90.76 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 90.49 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 89.48 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 89.08 | |
| PLN02236 | 344 | choline kinase | 88.69 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 87.79 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 86.66 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 86.36 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 85.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 85.81 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 85.16 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 85.14 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 84.71 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 83.24 | |
| PF10446 | 458 | DUF2457: Protein of unknown function (DUF2457); In | 81.09 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=348.10 Aligned_cols=203 Identities=32% Similarity=0.453 Sum_probs=178.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
+|||+|+++++|+.....|||| ||+.||+|++.+..++.+. ..+.+++|++.|+.|||++||+||||||+|||+..+
T Consensus 234 ~HP~IV~~~d~f~~~ds~YmVl-E~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~ 312 (475)
T KOG0615|consen 234 SHPNIVRIKDFFEVPDSSYMVL-EYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND 312 (475)
T ss_pred CCCCEEEEeeeeecCCceEEEE-EEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC
Confidence 6999999999999999999999 7999999999999999888 889999999999999999999999999999999766
Q ss_pred -CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccC--CCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 -PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
....+||+|||+|+..+......+.||||.|.|||++.+.++ +..++|+||+||++|-+++|.+||.+......
T Consensus 313 ~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--- 389 (475)
T KOG0615|consen 313 AEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--- 389 (475)
T ss_pred CcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---
Confidence 334689999999998888888899999999999999976543 34458999999999999999999988665432
Q ss_pred HHHHHhccccC--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 161 TIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
..+.+..+.+. .+.|..+|.++++||.+||..||++|||+.|+|+||||+..
T Consensus 390 l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 390 LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 33344445443 35678899999999999999999999999999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-49 Score=352.31 Aligned_cols=204 Identities=30% Similarity=0.525 Sum_probs=183.8
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.-=+|+|+|++|++|++.+++|+|+ |+|..++|..+++..+.+. +|+++++||+.||.|||+++|+|||||..|+|+
T Consensus 73 r~L~HpnIV~f~~~FEDs~nVYivL-ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL 151 (592)
T KOG0575|consen 73 RSLKHPNIVQFYHFFEDSNNVYIVL-ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL 151 (592)
T ss_pred HhcCCCcEEeeeeEeecCCceEEEE-EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee
Confidence 3347999999999999999999999 7999999999999888877 999999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+.+-+ |||+|||+|...... ....+.||||+|.|||++.+.++... +||||+||++|-|+.|++||...+ +.
T Consensus 152 ~~~~~--VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~----vk 224 (592)
T KOG0575|consen 152 NENMN--VKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKT----VK 224 (592)
T ss_pred cCcCc--EEecccceeeeecCcccccceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccch----HH
Confidence 77654 999999999877644 67788999999999999998887655 999999999999999999998754 47
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~ 216 (293)
+++.++....+.+|. .+|.++++||.++|.+||.+|||+.++|.|+||++...+.
T Consensus 225 ety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 225 ETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred HHHHHHHhcCccccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence 777888888888877 4999999999999999999999999999999997665444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=330.16 Aligned_cols=204 Identities=25% Similarity=0.406 Sum_probs=176.7
Q ss_pred CCcchhhhhceeeece-eEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMK-FVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~-~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~ 81 (293)
-++++|++||.|.... .++++| ||+.||+|..+++..++++ ....++.++++||.|||. .+||||||||+|||++
T Consensus 135 ~spyIV~~ygaF~~~~~~isI~m-EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN 213 (364)
T KOG0581|consen 135 QSPYIVGFYGAFYSNGEEISICM-EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN 213 (364)
T ss_pred CCCCeeeEeEEEEeCCceEEeeh-hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec
Confidence 6899999999999999 599999 7999999999999888877 889999999999999995 9999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC-CchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-DEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~-~~~~~~~~ 160 (293)
..+ .|||||||.++..... ..++.+||..|||||.+.+..|..+ +||||||+.++|+++|+.||... .....+..
T Consensus 214 skG--eVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~ 289 (364)
T KOG0581|consen 214 SKG--EVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE 289 (364)
T ss_pred cCC--CEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHH
Confidence 655 5999999999876444 7788999999999999999999877 99999999999999999999875 22334456
Q ss_pred HHHHHhcccc-CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 161 TIQRILSVQY-SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 161 ~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
.+..++.... ..|. ..+|+++++||..||++||.+|||+.++++|||+++....
T Consensus 290 Ll~~Iv~~ppP~lP~-~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 290 LLCAIVDEPPPRLPE-GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred HHHHHhcCCCCCCCc-ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 6666666433 2232 2489999999999999999999999999999999865443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=338.77 Aligned_cols=202 Identities=41% Similarity=0.673 Sum_probs=183.3
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.+-.|+|++++++++....++|+|| |||.||+|++++.+.+++. +++.+++||+.|++|||++||+||||||+|||+
T Consensus 75 ~~~~HpnI~~l~ev~~t~~~~~ivm-Ey~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill 153 (370)
T KOG0583|consen 75 RLRSHPNIIRLLEVFATPTKIYIVM-EYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL 153 (370)
T ss_pred HhccCCCEeEEEEEEecCCeEEEEE-EecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe
Confidence 3446899999999999999999999 7999999999999988887 999999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCc-CCCCCCCCCcCCCCccchhhhcccc-CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 81 DGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+.+. +.+||+|||++... .......+.+||+.|+|||++.+.. |.++++||||+|+++|.|++|+.||...+.
T Consensus 154 d~~~-~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---- 228 (370)
T KOG0583|consen 154 DGNE-GNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---- 228 (370)
T ss_pred cCCC-CCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH----
Confidence 8773 45999999999977 5667788999999999999999988 999999999999999999999999998655
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
..+..++....+.+|.+.. |.++++|+.+||.+||.+|+|+.+++.||||+.
T Consensus 229 ~~l~~ki~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 229 PNLYRKIRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 4455557777787877733 999999999999999999999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=314.70 Aligned_cols=195 Identities=29% Similarity=0.536 Sum_probs=178.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.++.++++++.|.+..++|||| ||+.||.|++++++.++++ .+++|++||+.||+|||+++|++|||||+|||++++
T Consensus 102 ~~PFlv~l~~t~~d~~~lymvm-eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~ 180 (355)
T KOG0616|consen 102 SHPFLVKLYGTFKDNSNLYMVM-EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN 180 (355)
T ss_pred cCceeEEEEEeeccCCeEEEEE-eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC
Confidence 3899999999999999999999 7999999999999999998 999999999999999999999999999999999876
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ ++||+|||+|+... ....+.||||.|+|||++.+.+|+.. +|+||||+++|||+.|.+||...+. ..+.+
T Consensus 181 G--~iKitDFGFAK~v~--~rT~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~----~~iY~ 251 (355)
T KOG0616|consen 181 G--HIKITDFGFAKRVS--GRTWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNP----IQIYE 251 (355)
T ss_pred C--cEEEEeccceEEec--CcEEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCCh----HHHHH
Confidence 6 59999999998653 34678899999999999999888654 9999999999999999999998877 67788
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
+++.....+|.. +|+++++||+++|+.|-.+|. ...++..||||+..
T Consensus 252 KI~~~~v~fP~~--fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 252 KILEGKVKFPSY--FSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHhCcccCCcc--cCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 888888888776 899999999999999999995 56799999999854
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=321.61 Aligned_cols=199 Identities=32% Similarity=0.524 Sum_probs=173.7
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..||.+|+++-.|++..++|+|+ ||+.||.|+..|++.+.+. .++.|+++|+.||.|||++|||||||||+|||++.
T Consensus 82 v~hPFiv~l~ysFQt~~kLylVl-d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~ 160 (357)
T KOG0598|consen 82 IKHPFIVKLIYSFQTEEKLYLVL-DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDE 160 (357)
T ss_pred CCCCcEeeeEEecccCCeEEEEE-eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecC
Confidence 46899999999999999999999 7999999999999999998 79999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCc-CCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.+ +++|+|||+++.. .......+.+||+.|||||++.+.+|+.. +|+||||+++|+|++|.+||.+.+. .++
T Consensus 161 ~G--Hi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~----~~~ 233 (357)
T KOG0598|consen 161 QG--HIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDV----KKM 233 (357)
T ss_pred CC--cEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccH----HHH
Confidence 65 5999999999853 34455667799999999999999988666 9999999999999999999999876 445
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC----CHHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----TIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp----t~~ell~h~~~~~~ 212 (293)
++++.......+ +.-+|.+++++|+++|.+||++|. ++.++.+||||+..
T Consensus 234 ~~~I~~~k~~~~-p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 234 YDKILKGKLPLP-PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHhcCcCCCC-CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 555555542211 223899999999999999999996 68899999999754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=334.93 Aligned_cols=203 Identities=29% Similarity=0.485 Sum_probs=177.8
Q ss_pred CCCCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 1 MHPVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 1 ~~~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
|+-+.+|+.++++|-.|+++..+|+|+ ||+.+|+|.++|.+.|.+. -+++|++||+.||+|||++|||||||||+||
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvL-e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENI 205 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVL-EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENI 205 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEE-EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence 445779999999999999999999999 7999999999999999998 8899999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCC--------------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHS--------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 144 (293)
|++.++ ++||+|||.|+.+.... ...+.+||..|.+||++..... ++.+|+|+||||+|+|+.
T Consensus 206 LLd~dm--hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmla 282 (604)
T KOG0592|consen 206 LLDKDG--HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLA 282 (604)
T ss_pred eEcCCC--cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhc
Confidence 997655 69999999998543221 1245789999999999977665 455999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 145 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 145 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
|.+||.+.++ ..+.++++...+.+|.. +++.+++||+++|..||++|+|+.+|.+||||..-.
T Consensus 283 G~PPFra~Ne----yliFqkI~~l~y~fp~~--fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 283 GQPPFRAANE----YLIFQKIQALDYEFPEG--FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred CCCCCccccH----HHHHHHHHHhcccCCCC--CCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 9999999888 44556666677766654 789999999999999999999999999999997643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=341.34 Aligned_cols=200 Identities=37% Similarity=0.687 Sum_probs=187.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|.+++|+.++...++|+|+ ||+.||.||+++..+|+++ ++.++++||+.|+.|+|..+|||||+||+|+|++..
T Consensus 70 ~HpnVl~LydVwe~~~~lylvl-Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~ 148 (786)
T KOG0588|consen 70 EHPNVLRLYDVWENKQHLYLVL-EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK 148 (786)
T ss_pred cCCCeeeeeeeeccCceEEEEE-EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc
Confidence 5899999999999999999999 7999999999999999988 999999999999999999999999999999999877
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
++ |||+|||+|.....+....+.||+|+|.|||++.|.+|.+.++||||+|||+|.|+||+.||.+.+ +..++.
T Consensus 149 ~n--IKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir~LLl 222 (786)
T KOG0588|consen 149 NN--IKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IRVLLL 222 (786)
T ss_pred cC--EeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HHHHHH
Confidence 65 999999999988888888999999999999999999999999999999999999999999998644 477778
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
++..+.+.+|.. +|.++++||++||..||.+|+|.+++++|||+.+...
T Consensus 223 KV~~G~f~MPs~--Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 223 KVQRGVFEMPSN--ISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHcCcccCCCc--CCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 888888888865 9999999999999999999999999999999986543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=324.89 Aligned_cols=202 Identities=31% Similarity=0.488 Sum_probs=175.2
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+.++.+||+|..|++..++|||| ||+.||++..+|.+.+.+. .+++|+++++.|+..||+.|+|||||||+|+||+.
T Consensus 198 ~ds~~vVKLyYsFQD~~~LYLiM-EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~ 276 (550)
T KOG0605|consen 198 VDSPWVVKLYYSFQDKEYLYLIM-EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDA 276 (550)
T ss_pred cCCCcEEEEEEEecCCCeeEEEE-EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecC
Confidence 67899999999999999999999 7999999999999999998 99999999999999999999999999999999977
Q ss_pred CCCCCEEEecCCCCcCcCC----------------------C--C------------------------CCCCCcCCCCc
Q 022732 83 SPAPRLKICDFGYSKSSVL----------------------H--S------------------------QPKSTVGTPAY 114 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~----------------------~--~------------------------~~~~~~gt~~y 114 (293)
.| ++||+|||+++.... . . ...+.+|||.|
T Consensus 277 ~G--HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDY 354 (550)
T KOG0605|consen 277 KG--HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDY 354 (550)
T ss_pred CC--CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccc
Confidence 65 599999999852110 0 0 01246799999
Q ss_pred cchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCC
Q 022732 115 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 194 (293)
Q Consensus 115 ~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 194 (293)
||||++.+.+|.-. +|+||||||+|||+.|.+||.+.+....+.+++.-. ..+.+|....++.+++|||.+||. ||
T Consensus 355 iAPEVll~kgY~~~-cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr--~~l~fP~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 355 IAPEVLLGKGYGKE-CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR--ETLKFPEEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred cchHHHhcCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--hhccCCCcCcccHHHHHHHHHHhc-CH
Confidence 99999999998655 999999999999999999999999877666665432 235566677799999999999999 99
Q ss_pred CCCC---CHHHHHcCcccccCC
Q 022732 195 AARI---TIPEIMKHQWFLKNL 213 (293)
Q Consensus 195 ~~Rp---t~~ell~h~~~~~~~ 213 (293)
.+|. +++||.+||||+...
T Consensus 431 ~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHhcCcccHHHHhcCCccccCC
Confidence 9999 589999999998643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=315.73 Aligned_cols=207 Identities=24% Similarity=0.377 Sum_probs=178.9
Q ss_pred CCCCCcchhhhhceeeece-eEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 3 PVGSSSSEYAMLGVSVKMK-FVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~-~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
-+..|+|+|++.+++.+.+ ++|+|| ||+. .+|+++++.+++ ++ .++.|+.||++||+|+|.+|+.|||+||+||
T Consensus 64 kln~hpniikL~Evi~d~~~~L~fVf-E~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENi 141 (538)
T KOG0661|consen 64 KLNPHPNIIKLKEVIRDNDRILYFVF-EFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENI 141 (538)
T ss_pred hcCCCCcchhhHHHhhccCceEeeeH-Hhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhhe
Confidence 3567999999999999998 999999 5776 599999988754 33 9999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
|+..+. .|||+|||+|+........+.++.|.||+|||++++..+++.++|+||+|||++|+.+-++.|.|.++.+++
T Consensus 142 Li~~~~--~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi 219 (538)
T KOG0661|consen 142 LISGND--VIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI 219 (538)
T ss_pred Eecccc--eeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH
Confidence 997433 499999999999888888888999999999999998888777799999999999999999999999999988
Q ss_pred HHHHHHHhccc---------------cCCCCC---------CCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 159 RKTIQRILSVQ---------------YSVPDT---------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 159 ~~~~~~~~~~~---------------~~~~~~---------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.++..-+.... +.+|.. ...+.++.++|.+||.+||++|||++++|+||||+-..
T Consensus 220 ~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 220 YKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 87776432221 222221 23689999999999999999999999999999997543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=291.94 Aligned_cols=201 Identities=30% Similarity=0.544 Sum_probs=174.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
-|||++++.+.+....+.|+|+ |++.|++|+.-|.++...+ .+..+++||++||.|+|.+||||||+||+|+++...
T Consensus 68 qHP~IvrL~~ti~~~~~~ylvF-e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK 146 (355)
T KOG0033|consen 68 QHPNIVRLHDSIQEESFHYLVF-DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK 146 (355)
T ss_pred CCCcEeehhhhhcccceeEEEE-ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec
Confidence 4899999999999999999999 7999999999988875555 789999999999999999999999999999999654
Q ss_pred CC-CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~-~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
.+ .-+||+|||+|............+|||.|||||++...+|..+ +|||+.|+|+|-|+.|++||.+.+..+. +
T Consensus 147 ~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rl----y 221 (355)
T KOG0033|consen 147 AKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRL----Y 221 (355)
T ss_pred cCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHH----H
Confidence 32 3589999999998776666677889999999999988888555 9999999999999999999999776444 4
Q ss_pred HHHhccccCC--CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+++....+.+ |.+..+++++++|+++||..||.+|+|+.|+|+|||+.+.
T Consensus 222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 4455555544 4577899999999999999999999999999999999753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=298.59 Aligned_cols=201 Identities=34% Similarity=0.553 Sum_probs=178.4
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
-+.||+++|++.++|+...++++|+ |.+..|.|+++|.+.-.++ .++.+++|++.|+.|||.++||||||||+|||+
T Consensus 78 qv~GHP~II~l~D~yes~sF~FlVF-dl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl 156 (411)
T KOG0599|consen 78 QVMGHPYIIDLQDVYESDAFVFLVF-DLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL 156 (411)
T ss_pred HhcCCCcEEEeeeeccCcchhhhhh-hhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee
Confidence 4689999999999999999999999 7999999999998887776 899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc------ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
+.+-+ +||+|||+|+....+......||||.|.|||.+.. .+| ++.+|+||+|+|+|-|+.|.+||.....
T Consensus 157 ddn~~--i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 157 DDNMN--IKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred ccccc--eEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 87665 99999999999988888999999999999999864 334 4559999999999999999999986443
Q ss_pred hHHHHHHHHHHhcccc--CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 155 PKDFRKTIQRILSVQY--SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
+-+...+..+.+ ..|.|..+|...++||.+||+.||.+|+|++|+|+||||.+
T Consensus 234 ----mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 234 ----MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred ----HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 334444555544 45778889999999999999999999999999999999953
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=309.61 Aligned_cols=205 Identities=26% Similarity=0.386 Sum_probs=163.7
Q ss_pred CCCCCcchhhhhceeeece--eEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 3 PVGSSSSEYAMLGVSVKMK--FVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~--~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.+. |+|+|+++|...... .++++| ||+.||+|.+++...+ .++ .++.|.+||++||.|||++|++||||||+|
T Consensus 70 ~l~-~p~IV~~~G~~~~~~~~~~~i~m-Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~N 147 (313)
T KOG0198|consen 70 RLN-HPNIVQYYGSSSSRENDEYNIFM-EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPAN 147 (313)
T ss_pred hCC-CCCEEeeCCccccccCeeeEeee-eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccce
Confidence 344 899999999855444 577777 8999999999999987 555 999999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCC----CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC-
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVL----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP- 152 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~- 152 (293)
||++.. ++.+||+|||+++.... ........||+.|||||++.......+.+||||+||++.||+||+.||...
T Consensus 148 iLl~~~-~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~ 226 (313)
T KOG0198|consen 148 ILLDPS-NGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF 226 (313)
T ss_pred EEEeCC-CCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc
Confidence 999873 23499999999986542 223345789999999999986333444699999999999999999999873
Q ss_pred CchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 153 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
... ..+-.+.......+.+..+|.++++||.+||..+|.+|||+.++|.|||.+....
T Consensus 227 ~~~----~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 227 EEA----EALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred chH----HHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 221 2222222222222344559999999999999999999999999999999976544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=306.36 Aligned_cols=201 Identities=30% Similarity=0.501 Sum_probs=176.1
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC-
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS- 83 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~- 83 (293)
|+|+|++++++++.+++|+|| |||.||+|..||++.+.+. .++.++.||+.||++||+++||||||||.|||++..
T Consensus 68 H~nIV~l~d~~~~~~~i~lVM-EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~ 146 (429)
T KOG0595|consen 68 HPNIVRLLDCIEDDDFIYLVM-EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTA 146 (429)
T ss_pred CcceeeEEEEEecCCeEEEEE-EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCC
Confidence 999999999999999999999 7999999999999998877 899999999999999999999999999999999875
Q ss_pred CC---CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 PA---PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~~---~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.. ..+||+|||+|+.........+.+|+|.|||||++....|+.+ +|+||+|+|+|++++|+.||...+..+.+.
T Consensus 147 ~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~- 224 (429)
T KOG0595|consen 147 RNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL- 224 (429)
T ss_pred CCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH-
Confidence 22 5689999999998887777888999999999999988899887 899999999999999999999887755544
Q ss_pred HHHHHhccccCCC-CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 161 TIQRILSVQYSVP-DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 161 ~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.+.......| .+..++..+.+++...|..+|.+|.+..+-+.|+++..+.
T Consensus 225 ---~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 225 ---YIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ---HHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 2222332222 2334678888999999999999999999999999986554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=319.08 Aligned_cols=197 Identities=28% Similarity=0.503 Sum_probs=173.1
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+.||..+.+++.|++..++|+|| ||+.||+ ...++..+.++ .++.|++.|+.||+|||++||||||||.+|||++.
T Consensus 426 ~~HPFL~~L~~~fQT~~~l~fvm-ey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~ 503 (694)
T KOG0694|consen 426 NRHPFLVNLFSCFQTKEHLFFVM-EYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT 503 (694)
T ss_pred ccCCeEeecccccccCCeEEEEE-EecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc
Confidence 36999999999999999999999 7999999 44555556666 99999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.| ++||+|||+++... ......+.+|||.|||||++.+..|+.. +|+|||||++|||+.|..||.+.++.+.
T Consensus 504 eG--h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~---- 576 (694)
T KOG0694|consen 504 EG--HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEV---- 576 (694)
T ss_pred cC--cEEecccccccccCCCCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHH----
Confidence 65 59999999999644 6677788999999999999999998655 9999999999999999999999888554
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~ 212 (293)
...|+......|.+ +|.++.++++++|.++|.+|.. +.++.+||||+.-
T Consensus 577 FdsI~~d~~~yP~~--ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 577 FDSIVNDEVRYPRF--LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHhcCCCCCCCc--ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 44555666666666 9999999999999999999995 5789999999754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=310.63 Aligned_cols=200 Identities=22% Similarity=0.373 Sum_probs=173.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
-|+|+|.+++.|...+.+-+|| ||++||+|-+.+....--. ++..+++++++||+|||.+||+|||||.+|||++.++
T Consensus 328 ~H~NiVnfl~Sylv~deLWVVM-Eym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g 406 (550)
T KOG0578|consen 328 HHPNIVNFLDSYLVGDELWVVM-EYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG 406 (550)
T ss_pred cchHHHHHHHHhcccceeEEEE-eecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC
Confidence 5899999999999999999999 7999999999887765333 9999999999999999999999999999999998776
Q ss_pred CCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
. +||+|||++....... ...+.+|||.|||||++.+..|..+ +||||||++++||+-|++||...+....+..+.
T Consensus 407 ~--vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa- 482 (550)
T KOG0578|consen 407 S--VKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA- 482 (550)
T ss_pred c--EEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-
Confidence 5 9999999987655443 6678899999999999999888666 999999999999999999998766544333322
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.++...+..+..+|+.+++||.+||+.|+.+|+++.+||+||||+..
T Consensus 483 --~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 483 --TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred --hcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 34455666677799999999999999999999999999999999543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=288.48 Aligned_cols=200 Identities=22% Similarity=0.378 Sum_probs=167.3
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
|+|.|.+++.|.....+|+|+ |||... +...|.... -++ .++.|++|++.|+.|+|++++|||||||+||||+.+
T Consensus 60 H~NLVnLiEVFrrkrklhLVF-E~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~ 137 (396)
T KOG0593|consen 60 HENLVNLIEVFRRKRKLHLVF-EYCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN 137 (396)
T ss_pred cchHHHHHHHHHhcceeEEEe-eecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC
Confidence 789999999999999999999 799984 444444432 222 899999999999999999999999999999999776
Q ss_pred CCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||||||+|+... +....+.++.|.||+|||.+.|...+++++||||+||++.||++|.+.|.+.++.+++..+.
T Consensus 138 g--vvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ 215 (396)
T KOG0593|consen 138 G--VVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR 215 (396)
T ss_pred C--cEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH
Confidence 5 59999999999765 55666778899999999999995555677999999999999999999999999988887766
Q ss_pred HHHhccc---------------cCCCCC----------CCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 163 QRILSVQ---------------YSVPDT----------NPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 163 ~~~~~~~---------------~~~~~~----------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
..+.+.. ..+|.+ +.++.-+.+|+++||..||.+|++.++++.|+||.
T Consensus 216 ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 216 KTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred HHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 5432211 112221 34678899999999999999999999999999993
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=287.50 Aligned_cols=205 Identities=27% Similarity=0.382 Sum_probs=169.0
Q ss_pred Ccchhhhhceeee-----ceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 7 SSSEYAMLGVSVK-----MKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 7 ~~~~v~~~~~~~~-----~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
|+|+|.+++++.- .+-+|+|+ |++ +.+|...+++++.+. .++.++.||+.||+|+|+.+++||||||.|+|
T Consensus 80 HeNIi~l~di~~p~~~~~f~DvYiV~-elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll 157 (359)
T KOG0660|consen 80 HENIIGLLDIFRPPSRDKFNDVYLVF-ELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLL 157 (359)
T ss_pred CCCcceEEeecccccccccceeEEeh-hHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhhee
Confidence 8999999999865 68899999 577 669999998888676 99999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCC---CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++.+.. +||+|||+|+.... ....+..+.|.||+|||++......++.+||||+|||+.||++|++.|.|.+...
T Consensus 158 ~n~~c~--lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~ 235 (359)
T KOG0660|consen 158 LNADCD--LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH 235 (359)
T ss_pred eccCCC--EEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH
Confidence 976654 99999999997643 3344667899999999998776555667999999999999999999999988777
Q ss_pred HHHHHHHHHhccc-------------------cCCC------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 157 DFRKTIQRILSVQ-------------------YSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 157 ~~~~~~~~~~~~~-------------------~~~~------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
++..+..-+.... ...| .....++.+.+|+.+||..||.+|+|++++|+|||+..
T Consensus 236 Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 236 QLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 6655543221111 0111 12357899999999999999999999999999999986
Q ss_pred CCCC
Q 022732 212 NLPA 215 (293)
Q Consensus 212 ~~~~ 215 (293)
-..+
T Consensus 316 ~hdp 319 (359)
T KOG0660|consen 316 YHDP 319 (359)
T ss_pred hcCC
Confidence 5443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=285.72 Aligned_cols=207 Identities=30% Similarity=0.478 Sum_probs=178.1
Q ss_pred CCCCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 022732 4 VGSSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKL 75 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp 75 (293)
..+|+|+|.++++|+. -+.+.+|| |.++||.|++.++.++. +. +|..+++||..|+.|||+.+|.||||||
T Consensus 111 ~s~h~~iV~IidVyeNs~~~rkcLLiVm-E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKp 189 (400)
T KOG0604|consen 111 ASGHPHIVSIIDVYENSYQGRKCLLIVM-ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKP 189 (400)
T ss_pred hcCCCceEEeehhhhhhccCceeeEeee-ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCCh
Confidence 3689999999998863 36677777 89999999999999987 44 9999999999999999999999999999
Q ss_pred CcEEEcCCC-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 76 ENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 76 ~NIl~~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
+|+|..... +..+||+|||+|+.........+.+-||.|.|||++...+|+ +.+|+||+||++|-|++|.+||.....
T Consensus 190 ENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 190 ENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred hheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCC
Confidence 999997543 456899999999987667777889999999999999777775 559999999999999999999988765
Q ss_pred hHHHHHHHHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 155 PKDFRKTIQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
...-..+..++..+.+.+| .|..+|++++++|+++|..+|.+|.|..+++.|||+.+.
T Consensus 269 ~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 269 LAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred ccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 4333445556667777666 467799999999999999999999999999999999754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=305.56 Aligned_cols=196 Identities=28% Similarity=0.480 Sum_probs=172.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
-|+|+|+++++|++.+++++|+ ||+.| +|+.+|...+.++ +++.++.+++.||.|||+++|+|||+||.|||+..+
T Consensus 59 kHpniv~m~esfEt~~~~~vVt-e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~ 136 (808)
T KOG0597|consen 59 KHPNIVEMLESFETSAHLWVVT-EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG 136 (808)
T ss_pred CCcchhhHHHhhcccceEEEEe-hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC
Confidence 3899999999999999999999 79999 9999999999998 999999999999999999999999999999999665
Q ss_pred CCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+|+||||+|+.+..... .++..|||.|||||+..+..|+.. +|+||||||+||+.+|++||.... +...+
T Consensus 137 ~--~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~s----i~~Lv 209 (808)
T KOG0597|consen 137 G--TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARS----ITQLV 209 (808)
T ss_pred C--ceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHH----HHHHH
Confidence 4 599999999997665433 345579999999999998888766 999999999999999999998644 35556
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+.|......+|. ..|..+..||+.+|.+||.+|.|+.+++.|||+++.
T Consensus 210 ~~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 210 KSILKDPVKPPS--TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHhcCCCCCcc--cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 666665555544 589999999999999999999999999999999754
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=291.26 Aligned_cols=203 Identities=25% Similarity=0.398 Sum_probs=173.5
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
+-+|+..+.+|..|+..++.|+|| |||.||+|..+++++. .++ .+++|+++++.||+|||-.|||+|||||+|||
T Consensus 133 ~lDHPFlPTLYa~fet~~~~cl~m-eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENIL 211 (459)
T KOG0610|consen 133 LLDHPFLPTLYASFETDKYSCLVM-EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENIL 211 (459)
T ss_pred hcCCCccchhhheeeccceeEEEE-ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeE
Confidence 357899999999999999999999 7999999999998764 344 89999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCC-----------------------------------C----------------------
Q 022732 80 LDGSPAPRLKICDFGYSKSSVL-----------------------------------H---------------------- 102 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~-----------------------------------~---------------------- 102 (293)
|..++ +|.|+||.++..... .
T Consensus 212 vredG--HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~ 289 (459)
T KOG0610|consen 212 VREDG--HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTG 289 (459)
T ss_pred EecCC--cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCC
Confidence 96655 699999998642100 0
Q ss_pred CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHH
Q 022732 103 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 182 (293)
Q Consensus 103 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 182 (293)
....+.+||-.|.|||++.|.+.... +|+|+||+++|||+.|..||.+.+.... ..+++.....+|....+|..+
T Consensus 290 ~RSnSFVGThEYlAPEvI~G~GHgsA-VDWWtfGIflYEmLyG~TPFKG~~~~~T----l~NIv~~~l~Fp~~~~vs~~a 364 (459)
T KOG0610|consen 290 ARSNSFVGTHEYLAPEVIRGEGHGSA-VDWWTFGIFLYEMLYGTTPFKGSNNKET----LRNIVGQPLKFPEEPEVSSAA 364 (459)
T ss_pred ccccccccccccccceeeecCCCCch-hhHHHHHHHHHHHHhCCCCcCCCCchhh----HHHHhcCCCcCCCCCcchhHH
Confidence 01124578999999999999988655 9999999999999999999999998554 455666677778777899999
Q ss_pred HHHHHHccccCCCCCCC----HHHHHcCcccccCCC
Q 022732 183 RDLISRIFVADPAARIT----IPEIMKHQWFLKNLP 214 (293)
Q Consensus 183 ~~li~~~L~~dp~~Rpt----~~ell~h~~~~~~~~ 214 (293)
+|||+++|.+||.+|.. +.|+.+||||+.-..
T Consensus 365 kDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 365 KDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred HHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 99999999999999997 999999999976533
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=273.63 Aligned_cols=197 Identities=34% Similarity=0.537 Sum_probs=175.1
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHH--HcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLL--LLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~--~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
=-|+|++++|++|.+..++|+++ ||..+|+|+..|+ ...++. .+..|+.|++.||.|+|.++++||||||+|+|+
T Consensus 79 L~hpnilrlY~~fhd~~riyLil-Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl 157 (281)
T KOG0580|consen 79 LRHPNILRLYGYFHDSKRIYLIL-EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL 157 (281)
T ss_pred cCCccHHhhhhheeccceeEEEE-EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc
Confidence 35899999999999999999999 7999999999999 445555 899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+..+ .+|++|||.+.... .....+.+||..|.+||+..+..++.. +|+|++|++.||++.|.+||..... .+
T Consensus 158 g~~~--~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~----~e 229 (281)
T KOG0580|consen 158 GSAG--ELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSH----SE 229 (281)
T ss_pred CCCC--CeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhh----HH
Confidence 7665 49999999998754 667788999999999999999888777 9999999999999999999998764 45
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.++++......+|. .+|..++++|.+||.++|.+|.+..+++.|||+..+
T Consensus 230 tYkrI~k~~~~~p~--~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 230 TYKRIRKVDLKFPS--TISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHccccCCc--ccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 55666666666664 499999999999999999999999999999998653
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=300.44 Aligned_cols=207 Identities=29% Similarity=0.454 Sum_probs=180.4
Q ss_pred CCCCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 1 MHPVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 1 ~~~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
|+.+.+|+|+|.+++.|++...+|+|| |+|.||.|++.+.+.. +. .+..++.|++.|++|||+.|++||||||+|+
T Consensus 89 l~~l~~hpniv~l~~~~e~~~~~~lvm-EL~~GGeLfd~i~~~~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~ 166 (382)
T KOG0032|consen 89 LQQLSGHPNIVQLKDAFEDPDSVYLVM-ELCEGGELFDRIVKKH-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENL 166 (382)
T ss_pred HHhccCCCCEEEEEEEEEcCCeEEEEE-EecCCchHHHHHHHcc-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHe
Confidence 455677999999999999999999999 7999999999998873 43 9999999999999999999999999999999
Q ss_pred EEcCCCC--CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 79 LLDGSPA--PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 79 l~~~~~~--~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
|+..... +.+|++|||+|............+||+.|+|||++.+.+|... +|+||+|+++|.|++|..||.+.+...
T Consensus 167 L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~ 245 (382)
T KOG0032|consen 167 LLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFE 245 (382)
T ss_pred eeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhH
Confidence 9976543 4799999999998776667778899999999999988888666 999999999999999999999988755
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.+..+...- ..+..+.+..+|..+++||++||..||.+|+|+.++|+|||++..
T Consensus 246 ~~~~i~~~~--~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 246 IFLAILRGD--FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHcCC--CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 554333321 233445677799999999999999999999999999999998765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=296.59 Aligned_cols=197 Identities=31% Similarity=0.503 Sum_probs=166.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.|...+++|+|| ||+.||+|..++...+.+. +++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 53 ~hp~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~ 131 (323)
T cd05571 53 RHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD 131 (323)
T ss_pred CCCCCCCEEEEEEcCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC
Confidence 5899999999999999999999 7999999999998877665 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+++... ........+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||...+.... .
T Consensus 132 ~--~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~----~ 204 (323)
T cd05571 132 G--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKL----F 204 (323)
T ss_pred C--CEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHH----H
Confidence 5 59999999987532 2233345679999999999988777655 9999999999999999999987654332 2
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
..+......+| ..++.++.+||.+||.+||++|| ++.++++||||...
T Consensus 205 ~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 205 ELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHHcCCCCCC--CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 33333333333 45899999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=296.79 Aligned_cols=208 Identities=32% Similarity=0.492 Sum_probs=173.3
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+|+++++..+. +.+|||+ |||..|.+..-=-....+. +|+.|++.++.||+|||.+|||||||||+|+|++
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVl-ey~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVL-EYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS 244 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEE-EeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc
Confidence 589999999999754 8999999 7999987754332222144 9999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcC------CCCCCCCCcCCCCccchhhhcc---ccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 82 GSPAPRLKICDFGYSKSSV------LHSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~------~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
.+ +++||+|||.+.... ........+|||.|+|||.+.+ ..+.+++.||||+||++|.|+.|+.||.+.
T Consensus 245 ~~--g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 245 SD--GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred CC--CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 66 469999999987542 2222344789999999999877 557788899999999999999999999986
Q ss_pred CchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCCccch
Q 022732 153 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 220 (293)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~ 220 (293)
.. ..+..+|.+....+|....+...+++||.+||.+||.+|+++.++..|||..+........+
T Consensus 323 ~~----~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~ 386 (576)
T KOG0585|consen 323 FE----LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSE 386 (576)
T ss_pred hH----HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCC
Confidence 65 55666777788888888788999999999999999999999999999999987755444333
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=285.68 Aligned_cols=214 Identities=26% Similarity=0.365 Sum_probs=172.0
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
=.|+|+++++..|.....+++|| .|+.+|++.++++..-+ +. .+..+++++++||.|||.+|-||||||+.||||
T Consensus 81 ~~HPNIv~~~~sFvv~~~LWvVm-pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi 159 (516)
T KOG0582|consen 81 IDHPNIVTYHCSFVVDSELWVVM-PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI 159 (516)
T ss_pred cCCCCcceEEEEEEecceeEEee-hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE
Confidence 47999999999999999999999 79999999999987532 22 789999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCC----C-CCCcCCCCccchhhhc--cccCCCchhhhhhhhhHHHHHHhCCCCCCCCC
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQ----P-KSTVGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~----~-~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 153 (293)
+.++. |||+|||.+..+..... . ++.+||++|||||++. ..+|+.+ +||||||++..||++|..||....
T Consensus 160 ~~dG~--VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 160 DSDGT--VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred cCCCc--EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCC
Confidence 77765 99999998753322211 1 5668999999999943 3567666 999999999999999999999888
Q ss_pred chHHHHHHHHHHhcc----ccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCCccchhc
Q 022732 154 EPKDFRKTIQRILSV----QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKT 222 (293)
Q Consensus 154 ~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~~~ 222 (293)
+.+.+...+++-... .........++..++.+|..||++||.+|||++++|+|+||++.........+.
T Consensus 237 PmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~ 309 (516)
T KOG0582|consen 237 PMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKL 309 (516)
T ss_pred hHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhh
Confidence 765554444332110 001112244778999999999999999999999999999999877666544433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=269.70 Aligned_cols=203 Identities=23% Similarity=0.337 Sum_probs=172.0
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH---HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV---QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~---~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
|+|+|+++++|.....+.+|+ ||+.. +|...|+.+...- +++.|+.++++||+|||++.|+||||||.|+|++.+
T Consensus 60 h~nIi~LiD~F~~~~~l~lVf-Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~ 137 (318)
T KOG0659|consen 60 HPNIIELIDVFPHKSNLSLVF-EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD 137 (318)
T ss_pred CcchhhhhhhccCCCceEEEE-Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC
Confidence 899999999999999999999 68875 8998887765432 999999999999999999999999999999999655
Q ss_pred CCCCEEEecCCCCcCcCCCCCC-CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+|+........ ...+-|.||+|||.+.|.+.++..+|+||+|||+.||+.|.+.|.+.++.+++..++
T Consensus 138 g--~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If 215 (318)
T KOG0659|consen 138 G--QLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF 215 (318)
T ss_pred C--cEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH
Confidence 4 6999999999976544433 334789999999999987766777999999999999999999999999999988887
Q ss_pred HHHhccccC-CC---------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYS-VP---------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~-~~---------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..+...... +| .....+.++.+|+.+||..||.+|+|+.++++|+||+...
T Consensus 216 ~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 216 RALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 654333211 11 1123678899999999999999999999999999998643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=291.54 Aligned_cols=202 Identities=25% Similarity=0.382 Sum_probs=171.8
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|+|++.++.... ..+|||+ ||+.. +|..++...+ .|. +++.|++||+.||+|||++||+|||||.+||||
T Consensus 174 ~HpNIikL~eivt~~~~~siYlVF-eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi 251 (560)
T KOG0600|consen 174 DHPNIIKLEEIVTSKLSGSIYLVF-EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI 251 (560)
T ss_pred CCCcccceeeEEEecCCceEEEEE-ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE
Confidence 589999999999887 7999999 79997 8888887754 233 999999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+.++ .+||+|||+|+...... ..++.+-|.||+|||.++|...++..+|+||+|||+.||++|++.|.+.++..++
T Consensus 252 dn~G--~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl 329 (560)
T KOG0600|consen 252 DNNG--VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL 329 (560)
T ss_pred cCCC--CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence 7665 49999999999544433 4567789999999999999777777799999999999999999999999999998
Q ss_pred HHHHHHHhcccc------CCCC-----------------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 159 RKTIQRILSVQY------SVPD-----------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 159 ~~~~~~~~~~~~------~~~~-----------------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
..|++-...... .+|. ...++..+.+|+..||..||.+|.|+.++|+++||..
T Consensus 330 ~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 330 HKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred HHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 888864332211 1110 1236789999999999999999999999999999943
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=291.44 Aligned_cols=197 Identities=31% Similarity=0.506 Sum_probs=166.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.+...+.+|+|| ||+.||+|.+++...+.+. .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 51 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~ 129 (312)
T cd05585 51 NCPFIVPLKFSFQSPEKLYLVL-AFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ 129 (312)
T ss_pred CCCcEeceeeEEecCCeEEEEE-cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC
Confidence 6899999999999999999999 7999999999998877666 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+++.... .......+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+... ..
T Consensus 130 ~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~----~~ 202 (312)
T cd05585 130 G--HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNE----MY 202 (312)
T ss_pred C--cEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHH----HH
Confidence 5 599999999875322 222344579999999999988777655 999999999999999999998766533 33
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC---CHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~ell~h~~~~~~ 212 (293)
+.+......++ ..+++++++||.+||.+||.+|| ++.+++.||||.+.
T Consensus 203 ~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 203 RKILQEPLRFP--DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHcCCCCCC--CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 34444433333 34889999999999999999997 57999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=294.05 Aligned_cols=195 Identities=28% Similarity=0.463 Sum_probs=165.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.+...+++|+|| ||+.||+|.+++...+.++ .++.++.||+.||+|||++|++||||||+|||++.+
T Consensus 76 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~ 154 (329)
T PTZ00263 76 SHPFIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK 154 (329)
T ss_pred CCCCCCcEEEEEEcCCEEEEEE-cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC
Confidence 5899999999999999999999 7999999999998887666 888999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||+++... .......||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+..... ...
T Consensus 155 ~--~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~----~~~ 225 (329)
T PTZ00263 155 G--HVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFR----IYE 225 (329)
T ss_pred C--CEEEeeccCceEcC--CCcceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHH----HHH
Confidence 5 59999999997542 22335679999999999988777554 999999999999999999998766533 333
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~ 212 (293)
.+......+|. .++..+++||.+||++||.+|++ +.+++.||||...
T Consensus 226 ~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 226 KILAGRLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHhcCCcCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 44444443333 38899999999999999999996 7999999999763
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=291.73 Aligned_cols=198 Identities=28% Similarity=0.454 Sum_probs=166.8
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|++++++++...+++|+|| ||+.||+|..++.+.+.+. .++.++.|++.||.|||++|++||||||+|||++.
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~-Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~ 131 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVM-EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH 131 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEE-cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC
Confidence 46999999999999999999999 7999999999998877666 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++.... ........||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+....
T Consensus 132 ~~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~---- 204 (320)
T cd05590 132 EG--HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDL---- 204 (320)
T ss_pred CC--cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHH----
Confidence 65 499999999875322 223344579999999999987777655 9999999999999999999988765333
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH------HHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI------PEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~h~~~~~~ 212 (293)
...+.......+ ..++.++++||++||++||.+||++ .++++||||...
T Consensus 205 ~~~i~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 205 FEAILNDEVVYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHHHhcCCCCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 333333333333 3489999999999999999999998 899999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=287.91 Aligned_cols=194 Identities=27% Similarity=0.503 Sum_probs=164.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.+.+++|+|| ||+.+|+|.+++...+.+. .++.++.||+.||+|||++|++||||||+|||++.+
T Consensus 59 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~ 137 (291)
T cd05612 59 SHPFIIRLFWTEHDQRFLYMLM-EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE 137 (291)
T ss_pred CCCcHhhhHhhhccCCeEEEEE-eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC
Confidence 5899999999999999999999 7999999999998887766 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||+++.... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... .+
T Consensus 138 ~--~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~----~~ 208 (291)
T cd05612 138 G--HIKLTDFGFAKKLRD--RTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGI----YE 208 (291)
T ss_pred C--CEEEEecCcchhccC--CcccccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH----HH
Confidence 4 599999999875432 2334579999999999988777554 9999999999999999999988765333 33
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCccccc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLK 211 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~ 211 (293)
.+......++ ..++..+++||++||+.||.+||+ +.++++||||..
T Consensus 209 ~i~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 209 KILAGKLEFP--RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHhCCcCCC--ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 3333333333 347899999999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=276.82 Aligned_cols=187 Identities=24% Similarity=0.348 Sum_probs=156.8
Q ss_pred CCcchhhhhc-eeeecee-EEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHH--cC--CeecCC
Q 022732 6 SSSSEYAMLG-VSVKMKF-VFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHA--MQ--VCHRDL 73 (293)
Q Consensus 6 ~~~~~v~~~~-~~~~~~~-~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~--~~--iiHrdl 73 (293)
-|+|+|++|+ .|...+. +++|| |||.+|+|...++.- ..++ .++.++.|++.||..+|+ .. |+||||
T Consensus 76 ~HpNIVqYy~~~f~~~~evlnivm-E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDI 154 (375)
T KOG0591|consen 76 NHPNIVQYYAHSFIEDNEVLNIVM-ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDI 154 (375)
T ss_pred CCchHHHHHHHhhhccchhhHHHH-HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccC
Confidence 3899999999 7777777 99999 799999999988543 3344 899999999999999998 44 999999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
||.||+++.++ .+||+|||+++..... ....+.+|||.||+||.+.+.+|+.+ +||||+||++|||+.-..||.+.
T Consensus 155 KPaNIFl~~~g--vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 155 KPANIFLTANG--VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred cchheEEcCCC--ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc
Confidence 99999997665 4999999999865433 23457899999999999999999877 99999999999999999999987
Q ss_pred CchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH
Q 022732 153 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 200 (293)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 200 (293)
+ +....+++....++.-....+|.++..+|..|+..||.+||+.
T Consensus 232 n----~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 232 N----LLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred c----HHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 3 4556666666655422224589999999999999999999984
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=286.97 Aligned_cols=202 Identities=31% Similarity=0.542 Sum_probs=183.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
-|+++|.+|++|+..+.+.+|| ||..+|.|++|+...+.++ +++.+++||+.|+.|+|+++++|||||.+|||++.+
T Consensus 111 NHPhII~IyEVFENkdKIvivM-EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N 189 (668)
T KOG0611|consen 111 NHPHIIQIYEVFENKDKIVIVM-EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN 189 (668)
T ss_pred CCCceeehhhhhcCCceEEEEE-EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC
Confidence 4899999999999999999999 7999999999999999998 999999999999999999999999999999999988
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
++ +||+|||++..+.......+.||+|.|.+||+++|.+|.++.+|.||||+++|-|..|..||.+.+. ..+++
T Consensus 190 ~N--iKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvr 263 (668)
T KOG0611|consen 190 NN--IKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVR 263 (668)
T ss_pred CC--eeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHH
Confidence 76 9999999998877777788999999999999999999999999999999999999999999998765 56667
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCCc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADL 217 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~ 217 (293)
.+..+.+..|. -+.++.-||+.||..||.+|.|..++-.|=|+.-......
T Consensus 264 QIs~GaYrEP~---~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V 314 (668)
T KOG0611|consen 264 QISRGAYREPE---TPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMPV 314 (668)
T ss_pred HhhcccccCCC---CCchHHHHHHHHHhcCcccchhHHHHhhhheeeccccccc
Confidence 77777777665 4678999999999999999999999999977765444433
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=275.78 Aligned_cols=204 Identities=24% Similarity=0.328 Sum_probs=171.0
Q ss_pred CCCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 5 GSSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
+.|+|+|.+-++.... +.+|+|| |||+- +|.+++.+-+ ++. +++.++.|++.|++|||.+.|+||||||+|+|
T Consensus 132 ~~H~NIV~vkEVVvG~~~d~iy~VM-e~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLL 209 (419)
T KOG0663|consen 132 ARHPNIVEVKEVVVGSNMDKIYIVM-EYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLL 209 (419)
T ss_pred cCCCCeeeeEEEEeccccceeeeeH-HHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhee
Confidence 4599999988887654 7799999 79986 8888887654 444 99999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+...+. +||+|||+|+.++... ..+..+-|.||+|||.+++.+.++.++|+||+|||+.|++++++.|.+..+.+++
T Consensus 210 m~~~G~--lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl 287 (419)
T KOG0663|consen 210 LSHKGI--LKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL 287 (419)
T ss_pred eccCCc--EEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence 976654 9999999999765543 3455678999999999999877777799999999999999999999999999998
Q ss_pred HHHHHHHhcccc-------CCCCC-------------------CCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 159 RKTIQRILSVQY-------SVPDT-------------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 159 ~~~~~~~~~~~~-------~~~~~-------------------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
..+++.+....- ..|.. ..+|....+|+..+|.+||.+|.|+.++|+|.||...
T Consensus 288 ~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 288 DKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred HHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 888875432221 01100 1156899999999999999999999999999999874
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=291.92 Aligned_cols=202 Identities=31% Similarity=0.569 Sum_probs=181.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
-|+|+|++|++..+...+|+|+ |+..+|+|++||.+... .. .++.|++||+.|+.|+|+..+|||||||+|+.+-.
T Consensus 75 QHpNiVRLYEViDTQTKlyLiL-ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE 153 (864)
T KOG4717|consen 75 QHPNIVRLYEVIDTQTKLYLIL-ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE 153 (864)
T ss_pred cCcCeeeeeehhcccceEEEEE-EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee
Confidence 4899999999999999999999 79999999999987643 23 89999999999999999999999999999987754
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
. -|-|||+|||++..+.+.....+.||+..|.|||+++|..|+.+++||||||||+|-|.+|++||...++.+.+..
T Consensus 154 K-lGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm-- 230 (864)
T KOG4717|consen 154 K-LGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM-- 230 (864)
T ss_pred e-cCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh--
Confidence 3 3569999999999998999999999999999999999999999999999999999999999999999888665544
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
++...+.+|.. +|.+|++||.+||+.||++|.+++++..++|++...+.
T Consensus 231 --ImDCKYtvPsh--vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 231 --IMDCKYTVPSH--VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred --hhcccccCchh--hhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 45566666654 89999999999999999999999999999999865433
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=284.99 Aligned_cols=209 Identities=22% Similarity=0.357 Sum_probs=176.4
Q ss_pred CCCCcchhhhhceeeec-----eeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 4 VGSSSSEYAMLGVSVKM-----KFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~-----~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
.-+|+|+|++.-+|... -+..+|| ||+.. +|...++. +..++ .++-|++||++||.|||+.||+|||
T Consensus 73 ~l~HpNIV~L~~~f~~~~~~d~~~lnlVl-eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRD 150 (364)
T KOG0658|consen 73 KLDHPNIVRLLYFFSSSTESDEVYLNLVL-EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRD 150 (364)
T ss_pred hcCCcCeeeEEEEEEecCCCchhHHHHHH-HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCC
Confidence 45899999999988644 2567899 78885 89988874 45666 9999999999999999999999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
|||.|+|++... +.+||||||.|+....+....+.+.|..|+|||.+.|....+.+.||||.|||+.||+-|++.|.|.
T Consensus 151 IKPqNlLvD~~t-g~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 151 IKPQNLLVDPDT-GVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred CChheEEEcCCC-CeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 999999998763 5799999999998888888888999999999999999776666699999999999999999999999
Q ss_pred CchHHHHHHHHHHhccc-------------cCCC----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 153 DEPKDFRKTIQRILSVQ-------------YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 153 ~~~~~~~~~~~~~~~~~-------------~~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+..+++..+++-+.... ..+| .....++++.+|+.++|..+|.+|.++.++|.||||
T Consensus 230 s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fF 309 (364)
T KOG0658|consen 230 SSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFF 309 (364)
T ss_pred CHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhh
Confidence 98888888776432221 0111 123478999999999999999999999999999999
Q ss_pred ccCCCC
Q 022732 210 LKNLPA 215 (293)
Q Consensus 210 ~~~~~~ 215 (293)
.....+
T Consensus 310 delr~~ 315 (364)
T KOG0658|consen 310 DELRDP 315 (364)
T ss_pred HHhhCc
Confidence 765443
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=293.28 Aligned_cols=194 Identities=28% Similarity=0.472 Sum_probs=165.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.+.++.|+|| ||+.||+|.+++...+.+. .+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 89 ~hp~Iv~~~~~~~~~~~~~lv~-Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~ 167 (340)
T PTZ00426 89 NHPFCVNLYGSFKDESYLYLVL-EFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD 167 (340)
T ss_pred CCCCCcceEEEEEeCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC
Confidence 5899999999999999999999 7999999999998887766 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||+++... .......||+.|+|||++.+..++.+ +|+||+||++|+|++|..||.+.+... ..+
T Consensus 168 ~--~ikL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~ 238 (340)
T PTZ00426 168 G--FIKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLL----IYQ 238 (340)
T ss_pred C--CEEEecCCCCeecC--CCcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHH----HHH
Confidence 4 59999999997543 22345679999999999987776544 999999999999999999998876533 333
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCccccc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLK 211 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~ 211 (293)
.+......+| ..++..+.++|++||..+|.+|+ +++++++||||..
T Consensus 239 ~i~~~~~~~p--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 239 KILEGIIYFP--KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHhcCCCCCC--CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 3444433333 34789999999999999999995 8999999999975
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=292.40 Aligned_cols=204 Identities=28% Similarity=0.396 Sum_probs=166.8
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..|++++++++++...+.+|+|| ||+.||+|.+++...+.+. +++.++.||+.||.|||++|++||||||+|||++
T Consensus 61 l~~~~~i~~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~ 139 (332)
T cd05614 61 VRQSPFLVTLHYAFQTEAKLHLIL-DYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139 (332)
T ss_pred ccCCCCcccEEEEEecCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC
Confidence 457899999999999999999999 7999999999998877665 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
.++ .+||+|||+++...... ......||+.|+|||++.+....+.++|||||||++|+|++|+.||..........
T Consensus 140 ~~~--~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 217 (332)
T cd05614 140 SEG--HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217 (332)
T ss_pred CCC--CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH
Confidence 655 59999999987543222 22345799999999998765544555999999999999999999997544322223
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
.+...+...... .+..++..+.++|.+||..||++|| +++++++||||+..
T Consensus 218 ~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 218 EVSRRILKCDPP--FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHhcCCCC--CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 333344333333 3345899999999999999999999 88899999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=288.74 Aligned_cols=198 Identities=30% Similarity=0.512 Sum_probs=165.1
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
-.|+|+++++++|...+++|+|| ||+.||+|..++...+.+. ++..++.||+.||+|||++|++||||||+|||++.
T Consensus 53 ~~~~~i~~~~~~~~~~~~~~lv~-E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~ 131 (316)
T cd05620 53 WENPFLTHLYCTFQTKEHLFFVM-EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131 (316)
T ss_pred cCCCCccCeeEEEEeCCEEEEEE-CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC
Confidence 47899999999999999999999 7999999999998877665 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++.... .......+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+....+
T Consensus 132 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~~--- 205 (316)
T cd05620 132 DG--HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELF--- 205 (316)
T ss_pred CC--CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 55 599999999874322 223345679999999999988777655 99999999999999999999876653332
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH-HHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI-PEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-~ell~h~~~~~~ 212 (293)
..+.......+. .++.+++++|.+||..||.+||++ +++++||||...
T Consensus 206 -~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 206 -ESIRVDTPHYPR--WITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -HHHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 222223333333 488999999999999999999997 588999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=290.34 Aligned_cols=197 Identities=29% Similarity=0.502 Sum_probs=165.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.+...+++|+|| ||+.+|+|..++...+.+. +++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 53 ~hp~iv~~~~~~~~~~~~~lv~-Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~ 131 (328)
T cd05593 53 RHPFLTSLKYSFQTKDRLCFVM-EYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD 131 (328)
T ss_pred CCCCCcceEEEEEcCCEEEEEE-eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC
Confidence 5899999999999999999999 7999999999998877665 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+++.... .......+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||...+... ..
T Consensus 132 ~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~----~~ 204 (328)
T cd05593 132 G--HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEK----LF 204 (328)
T ss_pred C--cEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHH----HH
Confidence 5 599999999875322 222344579999999999987777555 999999999999999999998765433 22
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
..+......+ +..++.++.+||++||.+||.+|+ ++.++++||||...
T Consensus 205 ~~~~~~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 205 ELILMEDIKF--PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HHhccCCccC--CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 3333333333 345899999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.66 Aligned_cols=199 Identities=27% Similarity=0.427 Sum_probs=167.4
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
...|+|+++++++|...+++|+|| ||+.+|+|..++.+.+.+. .++.++.||+.||.|||++|++||||||+||+++
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~-E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~ 130 (321)
T cd05591 52 AAKHPFLTALHCCFQTKDRLFFVM-EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130 (321)
T ss_pred ccCCCCccceeeEEEcCCeEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence 347899999999999999999999 7999999999998877665 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .+||+|||+++.... ........||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||...+....+
T Consensus 131 ~~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~-- 205 (321)
T cd05591 131 AEG--HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLF-- 205 (321)
T ss_pred CCC--CEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHH--
Confidence 655 599999999874322 223345579999999999987777655 99999999999999999999887654333
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-------CHHHHHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-------TIPEIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-------t~~ell~h~~~~~~ 212 (293)
..+.......|. .++.++.++|.+||.+||++|+ ++.++++||||...
T Consensus 206 --~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 206 --ESILHDDVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred --HHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 334444333333 3789999999999999999999 89999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.74 Aligned_cols=200 Identities=28% Similarity=0.431 Sum_probs=162.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|++++++++.+.+..++|+|| ||+.||+|.+++.+.+.+. +++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 59 ~~~~iv~~~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~ 137 (363)
T cd05628 59 DSLWVVKMFYSFQDKLNLYLIM-EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK 137 (363)
T ss_pred CCCCcceEEEEEecCCeEEEEE-cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC
Confidence 6889999999999999999999 7999999999998877766 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC------------------------------------CCCCCcCCCCccchhhhccccCCC
Q 022732 84 PAPRLKICDFGYSKSSVLHS------------------------------------QPKSTVGTPAYIAPEVLLRHEYDG 127 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ 127 (293)
+ ++||+|||+++...... .....+||+.|+|||++.+..++.
T Consensus 138 ~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~ 215 (363)
T cd05628 138 G--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK 215 (363)
T ss_pred C--CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC
Confidence 4 59999999987432110 012457999999999998877765
Q ss_pred chhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCC---CCCCHHHHH
Q 022732 128 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA---ARITIPEIM 204 (293)
Q Consensus 128 ~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~---~Rpt~~ell 204 (293)
+ +|+||+||++|+|++|+.||.+.+.......+... .....+|...+++.+++++|.+|+. +|. .||++.+++
T Consensus 216 ~-~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 216 L-CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW--KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred c-hhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 5 99999999999999999999887654433333221 1223345445689999999999765 444 468999999
Q ss_pred cCcccccC
Q 022732 205 KHQWFLKN 212 (293)
Q Consensus 205 ~h~~~~~~ 212 (293)
+||||+..
T Consensus 292 ~hp~f~~~ 299 (363)
T cd05628 292 TNPFFEGV 299 (363)
T ss_pred CCCCCCCC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=288.45 Aligned_cols=193 Identities=26% Similarity=0.379 Sum_probs=162.3
Q ss_pred CCcchhhhhceeeece-eEEEeehhhccCchhHHHHHH--cCCHH--HHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMK-FVFLSLSFFFSLCLFFMWLLL--LGLLV--QARFFFQQLISGVSYCHAMQ-VCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~-~~~lv~~ey~~gg~L~~~l~~--~~~~~--~~~~~~~qil~~l~~LH~~~-iiHrdlkp~NIl 79 (293)
.|+|+|+|+|++.+.. ..++|| ||+.+|+|..++.. +..+. .+..++.+|++|+.|||+++ ||||||||+|||
T Consensus 97 ~HpNIV~f~G~~~~~~~~~~iVt-Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiL 175 (362)
T KOG0192|consen 97 RHPNIVQFYGACTSPPGSLCIVT-EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNIL 175 (362)
T ss_pred CCCCeeeEEEEEcCCCCceEEEE-EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEE
Confidence 5999999999999998 799999 79999999999988 45555 88999999999999999999 999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhc--cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++... .++||+|||+++..... .......||+.|||||++. ...|+.+ +||||+|+++|||+||+.||.+.....
T Consensus 176 v~~~~-~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~ 253 (362)
T KOG0192|consen 176 VDLKG-KTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQ 253 (362)
T ss_pred EcCCC-CEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence 97764 25999999999865443 3344478999999999998 4577666 999999999999999999999987633
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. ..+.....+.+.+..+++.+..++.+||..||.+||++.+++.
T Consensus 254 ~~----~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 254 VA----SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HH----HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 22 2333333344444458899999999999999999999998776
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.87 Aligned_cols=197 Identities=30% Similarity=0.512 Sum_probs=165.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|...+++|+|| ||+.+|+|..++...+.+. .++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 53 ~hp~i~~~~~~~~~~~~~~lv~-E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 131 (323)
T cd05595 53 RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD 131 (323)
T ss_pred CCCCCcceeeEEecCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC
Confidence 6899999999999999999999 7999999999998877665 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+++.... ........||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||...+.... .
T Consensus 132 ~--~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~----~ 204 (323)
T cd05595 132 G--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERL----F 204 (323)
T ss_pred C--CEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHH----H
Confidence 5 599999999875322 222344579999999999987777555 9999999999999999999987665332 2
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
..+......+| ..+++++.++|.+||.+||.+|+ ++.++++|+||...
T Consensus 205 ~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 205 ELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred HHHhcCCCCCC--CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 23333333333 34899999999999999999998 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.60 Aligned_cols=202 Identities=25% Similarity=0.418 Sum_probs=165.1
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..|+|+++++++|...+++|+|| ||+.||+|..++.+.+.++ .++.++.||+.||.|||++|++||||||+||+++
T Consensus 52 ~~~hp~Iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~ 130 (329)
T cd05588 52 ASNHPFLVGLHSCFQTESRLFFVI-EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD 130 (329)
T ss_pred ccCCCCCCceEEEEEcCCEEEEEE-eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC
Confidence 347999999999999999999999 7999999999998877666 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCc-CCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch-----
Q 022732 82 GSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----- 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----- 155 (293)
.++ .+||+|||+++.. .........+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||......
T Consensus 131 ~~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05588 131 AEG--HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207 (329)
T ss_pred CCC--CEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccc
Confidence 655 5999999998742 22233345679999999999988777655 99999999999999999999642211
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC------HHHHHcCccccc
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT------IPEIMKHQWFLK 211 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~ell~h~~~~~ 211 (293)
.......+.+.......| ..++..+.++|++||.+||.+|+| +.++++||||..
T Consensus 208 ~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 208 NTEDYLFQVILEKQIRIP--RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred cchHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 111122333333433333 348899999999999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=291.33 Aligned_cols=201 Identities=28% Similarity=0.427 Sum_probs=166.9
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
++.|++++++++.|...++.|+|| ||+.+|+|..++...+.+. .++.++.||+.||+|||++||+||||||+|||++
T Consensus 52 ~~~~p~i~~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~ 130 (330)
T cd05586 52 LDESPFIVGLKFSFQTDSDLYLVT-DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130 (330)
T ss_pred cCCCCcCcceEEEEecCCeEEEEE-cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence 357999999999999999999999 7999999999998887766 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .+||+|||+++... ........+||+.|+|||++.+......++||||+||++|+|++|+.||.+.+...
T Consensus 131 ~~~--~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---- 204 (330)
T cd05586 131 ATG--HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---- 204 (330)
T ss_pred CCC--CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----
Confidence 655 59999999987532 22333456799999999998765433455999999999999999999998766533
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC----CHHHHHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----TIPEIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp----t~~ell~h~~~~~~ 212 (293)
....+......++. ..++.++++||++||.+||.+|| ++.++++||||...
T Consensus 205 ~~~~i~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 205 MYRNIAFGKVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHHHHHcCCCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 33333333333332 23789999999999999999998 78999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=283.05 Aligned_cols=201 Identities=22% Similarity=0.328 Sum_probs=164.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|++++++++.+.+.++.|+|+ ||+.+|+|..++...+ .+. .+..++.|++.||.|||++|++||||||+|||++
T Consensus 58 ~~~~iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~ 136 (285)
T cd05631 58 NSRFVVSLAYAYETKDALCLVL-TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD 136 (285)
T ss_pred CCCcEEEEEEEEccCCeEEEEE-EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC
Confidence 5789999999999999999999 7999999998886533 233 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ .+||+|||++.............||+.|+|||++.+..++.+ +||||+||++|+|++|+.||............
T Consensus 137 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05631 137 DRG--HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213 (285)
T ss_pred CCC--CEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence 654 599999999976543334445679999999999988777655 89999999999999999999876653333333
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~ 212 (293)
...+..... ..+..++.++.+||++||.+||.+||+ ++++++||||...
T Consensus 214 ~~~~~~~~~--~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 214 DRRVKEDQE--EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHhhcccc--cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 333332222 233458999999999999999999997 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=286.86 Aligned_cols=197 Identities=29% Similarity=0.483 Sum_probs=165.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.|...+.+|+|| ||+.|++|.+++...+.+. .+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 58 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 136 (323)
T cd05584 58 KHPFIVDLIYAFQTGGKLYLIL-EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ 136 (323)
T ss_pred CCCchhceeeEEecCCeEEEEE-eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 5899999999999999999999 7999999999998887655 888899999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+++.... ........||+.|+|||++.+..+..+ +|||||||++|+|++|+.||...+.... .
T Consensus 137 ~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~~----~ 209 (323)
T cd05584 137 G--HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKT----I 209 (323)
T ss_pred C--CEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHHH----H
Confidence 4 599999999874322 222344579999999999987776544 9999999999999999999988765333 3
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
..+.......+ ..+++++.+||.+||.++|.+|| ++.+++.||||...
T Consensus 210 ~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 210 DKILKGKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHHcCCCCCC--CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 33434433333 34889999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=286.52 Aligned_cols=198 Identities=28% Similarity=0.432 Sum_probs=165.5
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
-.|+|++++++.+...+..|+|| ||+.||+|..+++..+.+. .++.++.||+.||.|||++|++||||||+|||++.
T Consensus 53 l~hp~iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~ 131 (323)
T cd05575 53 VKHPFLVGLHYSFQTADKLYFVL-DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS 131 (323)
T ss_pred CCCCCCCCeeEEEEeCCEEEEEE-cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC
Confidence 36899999999999999999999 7999999999998877666 88899999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++.... .......+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+... .
T Consensus 132 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~----~ 204 (323)
T cd05575 132 QG--HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAE----M 204 (323)
T ss_pred CC--cEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHH----H
Confidence 55 599999999875322 223344579999999999988777655 999999999999999999998766533 3
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH----HHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI----PEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~h~~~~~~ 212 (293)
...+....... ...++..+.++|.+||++||.+||++ .+++.||||...
T Consensus 205 ~~~i~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 205 YDNILNKPLRL--KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred HHHHHcCCCCC--CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 33333333333 23478999999999999999999987 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=285.75 Aligned_cols=199 Identities=32% Similarity=0.545 Sum_probs=165.6
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
...|+|++++++++....+.|+|| ||+.||+|..++...+.+. +++.++.||+.||.|||++||+||||||+||+++
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~-e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~ 130 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVM-EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD 130 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEE-cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC
Confidence 347999999999999999999999 7999999999998877666 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .+||+|||+++.... .......+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+.....
T Consensus 131 ~~~--~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~-- 205 (316)
T cd05592 131 KDG--HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELF-- 205 (316)
T ss_pred CCC--CEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 655 599999999875322 223345579999999999988777655 99999999999999999999887653332
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH-HHHHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI-PEIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-~ell~h~~~~~~ 212 (293)
..+.......+ ..++.++.+||.+||..+|.+||++ .++++||||...
T Consensus 206 --~~i~~~~~~~~--~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 206 --DSILNDRPHFP--RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred --HHHHcCCCCCC--CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 23333322233 3478999999999999999999986 588899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.81 Aligned_cols=203 Identities=24% Similarity=0.321 Sum_probs=168.7
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCH----HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLL----VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~----~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
...-|.|++|++|...+|.|||+| +.+.+|+++|+.+... ..++.++.||+.||.+||+.||||+||||+|||+
T Consensus 245 ~~~~n~Vrm~d~F~fr~HlciVfE--LL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL 322 (586)
T KOG0667|consen 245 DDKYNIVRMLDYFYFRNHLCIVFE--LLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILL 322 (586)
T ss_pred CCCeeEEEeeeccccccceeeeeh--hhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheee
Confidence 456789999999999999999995 4556999999987643 3999999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.......||++|||.|..... ...+.+.+..|+|||+++|.+|+.+ .||||||||++||++|.+.|.+.++.+++..
T Consensus 323 ~~~~r~~vKVIDFGSSc~~~q--~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~ 399 (586)
T KOG0667|consen 323 KDPKRSRIKVIDFGSSCFESQ--RVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLAR 399 (586)
T ss_pred ccCCcCceeEEecccccccCC--cceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHH
Confidence 877666899999999986433 3347889999999999999999887 9999999999999999999999998888776
Q ss_pred HHHHHhccc------------------------------------------------cCCC-CCC--------CCCHHHH
Q 022732 161 TIQRILSVQ------------------------------------------------YSVP-DTN--------PISQECR 183 (293)
Q Consensus 161 ~~~~~~~~~------------------------------------------------~~~~-~~~--------~~s~~~~ 183 (293)
+++-+.... ...| ... .-...+.
T Consensus 400 I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~ 479 (586)
T KOG0667|consen 400 IIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFI 479 (586)
T ss_pred HHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHH
Confidence 664221000 0011 000 0125679
Q ss_pred HHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 184 DLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 184 ~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+||.+||.+||.+|+|+.++|+|||+...
T Consensus 480 dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 480 DFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred HHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 99999999999999999999999999854
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=286.75 Aligned_cols=198 Identities=30% Similarity=0.508 Sum_probs=166.7
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|++++++++...+++|+|| ||+.||+|..++.+.+.++ ++..++.||+.||.|||++|++||||||+||+++.
T Consensus 53 ~~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~ 131 (318)
T cd05570 53 GKHPFLTQLHSCFQTKDRLFFVM-EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS 131 (318)
T ss_pred cCCCCccceeeEEEcCCEEEEEE-cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC
Confidence 47999999999999999999999 7999999999998887666 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++.... .......+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+....
T Consensus 132 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~---- 204 (318)
T cd05570 132 EG--HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDEL---- 204 (318)
T ss_pred CC--cEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHH----
Confidence 65 599999999874322 222344579999999999988777655 9999999999999999999987664332
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH-----HHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI-----PEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~h~~~~~~ 212 (293)
...+.......+ ..++..+.+||++||.+||.+|||+ .+++.||||+..
T Consensus 205 ~~~i~~~~~~~~--~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 205 FQSILEDEVRYP--RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HHHHHcCCCCCC--CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 233333333333 3488999999999999999999999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=288.65 Aligned_cols=198 Identities=31% Similarity=0.500 Sum_probs=164.9
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~ 81 (293)
..|+|++++++.|...+++|+|| ||+.||+|..++...+.+. .++.++.||+.||.|||+ +|++||||||+|||++
T Consensus 52 ~~hp~i~~~~~~~~~~~~~~lv~-E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~ 130 (325)
T cd05594 52 SRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD 130 (325)
T ss_pred CCCCCCCceEEEEEcCCEEEEEE-eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC
Confidence 35899999999999999999999 7999999999998877665 889999999999999997 7999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .+||+|||+++... .........||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+....
T Consensus 131 ~~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~--- 204 (325)
T cd05594 131 KDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKL--- 204 (325)
T ss_pred CCC--CEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHH---
Confidence 655 59999999987432 2223345579999999999988777555 9999999999999999999987665332
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
...+......+| ..+++++.+||.+||.+||++|+ ++.++++||||...
T Consensus 205 -~~~i~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 205 -FELILMEEIRFP--RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred -HHHHhcCCCCCC--CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 223333333333 34889999999999999999997 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=286.74 Aligned_cols=202 Identities=25% Similarity=0.427 Sum_probs=164.8
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..|+|++++++++...+.+|+|| ||+.+|+|..++...+.++ .++.++.||+.||.|||++|++||||||+||+++
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~-E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~ 130 (329)
T cd05618 52 ASNHPFLVGLHSCFQTESRLFFVI-EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 130 (329)
T ss_pred cCCCCcCCceeeEEEeCCEEEEEE-eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC
Confidence 347999999999999999999999 7999999999998877666 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc-----h
Q 022732 82 GSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----P 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-----~ 155 (293)
.++ .+||+|||+++... .........||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||..... .
T Consensus 131 ~~~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05618 131 SEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207 (329)
T ss_pred CCC--CEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCccc
Confidence 665 59999999987432 2223345679999999999988777655 9999999999999999999953211 1
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC------HHHHHcCccccc
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT------IPEIMKHQWFLK 211 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~ell~h~~~~~ 211 (293)
.......+.+......+| ..++..+.++|++||..||.+||+ +.++++||||+.
T Consensus 208 ~~~~~~~~~i~~~~~~~p--~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 208 NTEDYLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred ccHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 111222333344444444 348899999999999999999998 579999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=285.27 Aligned_cols=199 Identities=30% Similarity=0.530 Sum_probs=165.3
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
...|+|++++++++.+.++.|+|| ||+.||+|..++.....+. ++..++.|++.||.|||++|++||||||+|||++
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~-ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~ 130 (316)
T cd05619 52 AWEHPFLTHLYCTFQTKENLFFVM-EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD 130 (316)
T ss_pred ccCCCcCcceEEEEEeCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC
Confidence 357999999999999999999999 7999999999998766554 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .+||+|||+++.... ........||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+....+
T Consensus 131 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~-- 205 (316)
T cd05619 131 TDG--HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELF-- 205 (316)
T ss_pred CCC--CEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 655 599999999874322 222345579999999999988777655 99999999999999999999876653322
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHH-HHHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP-EIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~-ell~h~~~~~~ 212 (293)
+.+.......+ ..++.+++++|.+||.+||.+||++. ++++||||+..
T Consensus 206 --~~i~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 206 --QSIRMDNPCYP--RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred --HHHHhCCCCCC--ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 22222222233 34889999999999999999999996 89999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=274.82 Aligned_cols=203 Identities=25% Similarity=0.352 Sum_probs=169.1
Q ss_pred CCcc-hhhhhceeeece------eEEEeehhhccCchhHHHHHHcCC----HH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 6 SSSS-EYAMLGVSVKMK------FVFLSLSFFFSLCLFFMWLLLLGL----LV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 6 ~~~~-~v~~~~~~~~~~------~~~lv~~ey~~gg~L~~~l~~~~~----~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
+|+| ++++++++.+.+ .+|+|+ ||+.. +|..++...+. ++ .++.+++||+.||+|||++||+|||
T Consensus 68 ~~~~~iv~L~dv~~~~~~~~~~~~l~lvf-e~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRD 145 (323)
T KOG0594|consen 68 SHANHIVRLHDVIHTSNNHRGIGKLYLVF-EFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRD 145 (323)
T ss_pred CCCcceEEEEeeeeecccccccceEEEEE-Eeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 4667 999999999998 899999 67775 89999987653 22 7999999999999999999999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
|||.||||+.++ .+||+|||+|+..... ......++|.||+|||++.+....+..+||||+|||++||+++++.|.+
T Consensus 146 LKPQNlLi~~~G--~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG 223 (323)
T KOG0594|consen 146 LKPQNLLISSSG--VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPG 223 (323)
T ss_pred CCcceEEECCCC--cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCC
Confidence 999999997754 5999999999966533 3456678999999999999986556669999999999999999999999
Q ss_pred CCchHHHHHHHHHHhcccc--------------CCCCC----------CCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q 022732 152 PDEPKDFRKTIQRILSVQY--------------SVPDT----------NPISQECRDLISRIFVADPAARITIPEIMKHQ 207 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~--------------~~~~~----------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~ 207 (293)
..+.+++..+.+.+..... .++.+ ...+.+..+++.+||+.+|.+|.|+..++.||
T Consensus 224 ~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 224 DSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred CcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 9998888888775433321 11111 11335899999999999999999999999999
Q ss_pred ccccC
Q 022732 208 WFLKN 212 (293)
Q Consensus 208 ~~~~~ 212 (293)
||...
T Consensus 304 yf~~~ 308 (323)
T KOG0594|consen 304 YFSEL 308 (323)
T ss_pred hhccc
Confidence 99765
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=289.14 Aligned_cols=199 Identities=32% Similarity=0.500 Sum_probs=166.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.+.+.++.|+|| ||+.|++|.+++.+.+.+. .++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~ 137 (350)
T cd05573 59 DSPWIVKLYYSFQDEEHLYLVM-EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD 137 (350)
T ss_pred CCCCccchhhheecCCeEEEEE-cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC
Confidence 4899999999999999999999 7999999999998876665 899999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCCCC------------------------------CCCCCcCCCCccchhhhccccCCCchhhhh
Q 022732 84 PAPRLKICDFGYSKSSVLHS------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVW 133 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvw 133 (293)
+ .+||+|||+++...... ......||+.|+|||++.+..++.+ +|||
T Consensus 138 ~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Diw 214 (350)
T cd05573 138 G--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWW 214 (350)
T ss_pred C--CEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeE
Confidence 5 59999999987543322 2334579999999999988877655 9999
Q ss_pred hhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-HHHHHcCccccc
Q 022732 134 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-IPEIMKHQWFLK 211 (293)
Q Consensus 134 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~ell~h~~~~~ 211 (293)
||||++|+|++|+.||...........+... ......|....+++++.+||.+||. +|.+|++ +.++++||||+.
T Consensus 215 SlG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 215 SLGVILYEMLYGFPPFYSDTLQETYNKIINW--KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred ecchhhhhhccCCCCCCCCCHHHHHHHHhcc--CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 9999999999999999887754333332221 1233445455579999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=284.60 Aligned_cols=196 Identities=28% Similarity=0.457 Sum_probs=163.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...++.|+|| ||+.|++|..++.... +. +++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 60 ~hp~i~~~~~~~~~~~~~~lv~-E~~~~~~L~~~~~~~~-l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~ 137 (324)
T cd05589 60 RHPFLVNLFACFQTEDHVCFVM-EYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE 137 (324)
T ss_pred CCCChhceeeEEEcCCEEEEEE-cCCCCCcHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC
Confidence 5899999999999999999999 7999999999886543 33 899999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+++.... .......+|++.|+|||++.+..+..+ +|+|||||++|+|++|+.||.+.+.....
T Consensus 138 ~--~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~---- 210 (324)
T cd05589 138 G--FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVF---- 210 (324)
T ss_pred C--cEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHH----
Confidence 5 599999999874322 233345679999999999988777555 99999999999999999999887654333
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
..+.......| ..++..+.++|.+||..||.+|| ++.++++||||+..
T Consensus 211 ~~i~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 211 DSIVNDEVRYP--RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHhCCCCCC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 33333333333 34889999999999999999999 69999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=290.66 Aligned_cols=200 Identities=31% Similarity=0.515 Sum_probs=164.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.+.+++|+|| ||+.||+|.+++...+.+. .++.++.||+.||+|||++|++||||||+|||++.+
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~-E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~ 137 (364)
T cd05599 59 DNPWVVKLYYSFQDENYLYLIM-EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK 137 (364)
T ss_pred CCCCCcceEEEEEcCCeEEEEE-CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 4899999999999999999999 7999999999998887766 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC---------------------------------------CCCCCcCCCCccchhhhcccc
Q 022732 84 PAPRLKICDFGYSKSSVLHS---------------------------------------QPKSTVGTPAYIAPEVLLRHE 124 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~ 124 (293)
+ .+||+|||+++...... ...+.+||+.|+|||++.+..
T Consensus 138 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (364)
T cd05599 138 G--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215 (364)
T ss_pred C--CEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC
Confidence 5 59999999986432111 112346999999999998877
Q ss_pred CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC---HH
Q 022732 125 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT---IP 201 (293)
Q Consensus 125 ~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ 201 (293)
++.+ +|+|||||++|+|++|..||.+.+.......+... ......+....+++++++||.+||. +|.+|++ +.
T Consensus 216 ~~~~-~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 216 YNKE-CDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCe-eeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 7655 99999999999999999999887654433332211 1122334444689999999999996 9999998 99
Q ss_pred HHHcCcccccC
Q 022732 202 EIMKHQWFLKN 212 (293)
Q Consensus 202 ell~h~~~~~~ 212 (293)
+++.||||+..
T Consensus 292 ~ll~h~~~~~~ 302 (364)
T cd05599 292 EIKSHPFFKGV 302 (364)
T ss_pred HHhcCCCcCCC
Confidence 99999999754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=289.42 Aligned_cols=196 Identities=24% Similarity=0.341 Sum_probs=173.6
Q ss_pred Ccchhhhhceeeecee-EEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 7 SSSEYAMLGVSVKMKF-VFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~-~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
|||+|.++++|+..+. .|+|| +||+||++.+.|.+.. .++ .+..|+.|++.|+.|||+++|+|||||+.|||++
T Consensus 62 hP~iv~y~ds~~~~~~~l~Ivm-~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt 140 (426)
T KOG0589|consen 62 HPNIVEYKDSFEEDGQLLCIVM-EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT 140 (426)
T ss_pred CCCeeeeccchhcCCceEEEEE-eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc
Confidence 8999999999999999 88888 7999999999997665 333 8999999999999999999999999999999998
Q ss_pred CCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++. |||+|||+|+...... ...+.+|||.||+||++.+.+|+.+ +|+|||||++|||++-+.+|...+-.....+
T Consensus 141 k~~~--VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k 217 (426)
T KOG0589|consen 141 KDKK--VKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILK 217 (426)
T ss_pred ccCc--eeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHH
Confidence 7765 8999999999877766 6778899999999999999999877 9999999999999999999998876555555
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
+.+.. ..|.+..+|.+++.+|+.||.++|..||++.++|.+|....
T Consensus 218 i~~~~-----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 218 INRGL-----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred Hhhcc-----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 44433 34556679999999999999999999999999999998763
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=280.32 Aligned_cols=200 Identities=24% Similarity=0.421 Sum_probs=159.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+ +|.+++...+. ++ .++.++.||+.||+|||++||+||||||+|||++.
T Consensus 61 ~h~niv~~~~~~~~~~~~~lv~-e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~ 138 (288)
T cd07871 61 KHANIVTLHDIIHTERCLTLVF-EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE 138 (288)
T ss_pred CCCCEeeEEEEEcCCCeEEEEE-eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 5899999999999999999999 79986 89998876553 23 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++..... .......+++.|+|||++.+....+.++|+||+||++|+|++|+.||.+.+....+..+
T Consensus 139 ~~--~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 139 KG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred CC--CEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 55 5999999998753322 22334578999999999876443445599999999999999999999887765544443
Q ss_pred HHHHhccc---------------cCCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 162 IQRILSVQ---------------YSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 162 ~~~~~~~~---------------~~~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
........ ...+. ...++.++++||++||++||.+|||+.++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 33211100 00111 12468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=286.04 Aligned_cols=199 Identities=31% Similarity=0.446 Sum_probs=166.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...++.|+|| ||+.||+|.+++...+.+. +++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 137 (333)
T cd05600 59 KSEWLVKLLYAFQDDEYLYLAM-EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS 137 (333)
T ss_pred CCCCCccEEEEEEcCCEEEEEE-eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC
Confidence 4899999999999999999999 7999999999998877665 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||+++.... ......||+.|+|||++.+..++.+ +||||+||++|+|++|..||...+....+..+..
T Consensus 138 ~--~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 212 (333)
T cd05600 138 G--HIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212 (333)
T ss_pred C--CEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh
Confidence 4 599999999975432 3455679999999999988877655 9999999999999999999988765444333322
Q ss_pred HHhccccCCCCC----CCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDT----NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.. .....+.. ..++.++.+||.+||..+|.+||++.++++||||...
T Consensus 213 ~~--~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 213 WK--ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred cc--ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 11 11111211 2468999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=284.94 Aligned_cols=198 Identities=28% Similarity=0.518 Sum_probs=164.2
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..++++++++++|...+++|+|| ||+.||+|..++...+.+. +++.++.||+.||.|||++|++||||||+|||++.
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~-E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 136 (324)
T cd05587 58 GKPPFLTQLHSCFQTMDRLYFVM-EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136 (324)
T ss_pred CCCCceeeeEEEEEcCCEEEEEE-cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence 34567889999999999999999 7999999999998877655 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++.... .......+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+.....
T Consensus 137 ~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~--- 210 (324)
T cd05587 137 EG--HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELF--- 210 (324)
T ss_pred CC--CEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 55 599999999874322 223345579999999999988777555 99999999999999999999887654333
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH-----HHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI-----PEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~h~~~~~~ 212 (293)
..+.......| ..++.++.+++.+||.+||.+|++. .++++||||+..
T Consensus 211 -~~i~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 211 -QSIMEHNVSYP--KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred -HHHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 33333333333 4589999999999999999999976 899999999763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=279.51 Aligned_cols=203 Identities=22% Similarity=0.367 Sum_probs=156.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.+....|+|| ||+. ++|.+++... +.+. .++.++.||+.||+|||++|++||||||+|||++.
T Consensus 61 ~h~niv~~~~~~~~~~~~~lv~-e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 138 (303)
T cd07869 61 KHANIVLLHDIIHTKETLTLVF-EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD 138 (303)
T ss_pred CCCCcCeEEEEEecCCeEEEEE-ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 5899999999999999999999 7986 5777777654 3333 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH-HHH
Q 022732 83 SPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRK 160 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~ 160 (293)
++ .+||+|||+++.... ........||+.|+|||++.+......++|+||+||++|+|++|..||.+...... +..
T Consensus 139 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 216 (303)
T cd07869 139 TG--ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER 216 (303)
T ss_pred CC--CEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 55 599999999874322 22234467899999999987655445559999999999999999999987654322 222
Q ss_pred HHHHHhccc-----------------cC--CC-------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 161 TIQRILSVQ-----------------YS--VP-------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~-----------------~~--~~-------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+........ .. .+ .....+.++++||.+||++||++|||+.++++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 217 IFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred HHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 211110000 00 00 001245789999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=288.36 Aligned_cols=198 Identities=24% Similarity=0.357 Sum_probs=168.2
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
++|+.++|+.|.....+-++| |||.||++.++++....+. .+..++++++.||.|||.++.+|||||+.|||+...+
T Consensus 70 ~~~it~yygsyl~g~~LwiiM-ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g 148 (467)
T KOG0201|consen 70 SPNITEYYGSYLKGTKLWIIM-EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG 148 (467)
T ss_pred cchHHhhhhheeecccHHHHH-HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC
Confidence 477889999999999999999 7999999999999888755 8888999999999999999999999999999997764
Q ss_pred CCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.+||+|||++...... ....+.+|||.|||||++.+..|+.+ +||||||++.+||++|.+||....+...+ .
T Consensus 149 --~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvl----f 221 (467)
T KOG0201|consen 149 --DVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVL----F 221 (467)
T ss_pred --cEEEEecceeeeeechhhccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEE----E
Confidence 4999999999765443 33478899999999999998899888 89999999999999999999987763221 1
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
-+....+ ......+|+.+++|+..||.+||+.||++.++|+|+|+++..
T Consensus 222 lIpk~~P-P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 222 LIPKSAP-PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred eccCCCC-CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 1111111 112236899999999999999999999999999999998643
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=285.28 Aligned_cols=203 Identities=25% Similarity=0.407 Sum_probs=165.2
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..|++++++++++...+++|+|| ||+.||+|..++...+.+. .++.++.||+.||+|||++|++||||||+|||++
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~ 130 (327)
T cd05617 52 ASSNPFLVGLHSCFQTTSRLFLVI-EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130 (327)
T ss_pred hcCCCCEeeEEEEEEeCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe
Confidence 457899999999999999999999 7999999999998877666 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch---HH
Q 022732 82 GSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KD 157 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~ 157 (293)
.++ .+||+|||+++... ........+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||...... ..
T Consensus 131 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~ 207 (327)
T cd05617 131 ADG--HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207 (327)
T ss_pred CCC--CEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCccccc
Confidence 665 49999999987422 2233345679999999999988777555 99999999999999999999643211 11
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC------HHHHHcCcccccC
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT------IPEIMKHQWFLKN 212 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt------~~ell~h~~~~~~ 212 (293)
.....+.+....... +..++..+.++|.+||.+||.+|++ +.+++.||||...
T Consensus 208 ~~~~~~~~~~~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 208 EDYLFQVILEKPIRI--PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHHHHHhCCCCC--CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 122223333333333 3348899999999999999999997 5799999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=284.21 Aligned_cols=198 Identities=28% Similarity=0.494 Sum_probs=166.4
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.+.+++++++++++...+.+|+|| ||+.+|+|..++...+.+. ++..++.||+.||.|||++|++||||||+|||++
T Consensus 57 ~~~~~~i~~~~~~~~~~~~~~lv~-E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 135 (323)
T cd05616 57 SGKPPFLTQLHSCFQTMDRLYFVM-EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135 (323)
T ss_pred ccCCCeEeeEEEEEecCCEEEEEE-cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC
Confidence 356788999999999999999999 7999999999998877665 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ ++||+|||+++.... ........||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+.....
T Consensus 136 ~~~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~-- 210 (323)
T cd05616 136 SEG--HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELF-- 210 (323)
T ss_pred CCC--cEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHH--
Confidence 665 599999999875332 223345679999999999988777655 99999999999999999999887654333
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCccccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLK 211 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~ 211 (293)
..+......+| ..++.++.+++.+||+++|.+|++ ..++++||||+.
T Consensus 211 --~~i~~~~~~~p--~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 211 --QSIMEHNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred --HHHHhCCCCCC--CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 33333433333 348999999999999999999997 489999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=289.90 Aligned_cols=200 Identities=31% Similarity=0.480 Sum_probs=163.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.|.+.+++|+|| ||+.||+|.+++.+.+.+. .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~ 137 (382)
T cd05625 59 DNEWVVRLYYSFQDKDNLYFVM-DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137 (382)
T ss_pred CCCcCCeEEEEEEeCCEEEEEE-eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 6899999999999999999999 7999999999998877655 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC------------------------------------------------CCCCCCcCCCCcc
Q 022732 84 PAPRLKICDFGYSKSSVLH------------------------------------------------SQPKSTVGTPAYI 115 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~------------------------------------------------~~~~~~~gt~~y~ 115 (293)
+ ++||+|||+++..... ....+.+||+.|+
T Consensus 138 g--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 215 (382)
T cd05625 138 G--HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYI 215 (382)
T ss_pred C--CEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccC
Confidence 5 5999999997522100 0012346999999
Q ss_pred chhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCC
Q 022732 116 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 195 (293)
Q Consensus 116 aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 195 (293)
|||++.+..++.+ +||||+||++|+|++|+.||.+.+.......+... ......|....+++++.++|.+|+ .+|.
T Consensus 216 aPE~~~~~~~~~~-~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 216 APEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW--QTSLHIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred CHHHhcCCCCCCe-eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHcc--CCCcCCCCcccCCHHHHHHHHHHc-cCHh
Confidence 9999988888655 99999999999999999999887654433332221 122334444568999999999976 6999
Q ss_pred CCCC---HHHHHcCcccccC
Q 022732 196 ARIT---IPEIMKHQWFLKN 212 (293)
Q Consensus 196 ~Rpt---~~ell~h~~~~~~ 212 (293)
+|++ +.++++||||+..
T Consensus 292 ~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 292 DRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HcCCCCCHHHHhcCCCcCCc
Confidence 9997 9999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=290.20 Aligned_cols=199 Identities=28% Similarity=0.470 Sum_probs=161.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.+.+++|+|| ||+.||+|..++...+.+. .++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 59 ~hp~iv~~~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~ 137 (377)
T cd05629 59 DSPWVVSLYYSFQDAQYLYLIM-EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG 137 (377)
T ss_pred CCCCcceEEEEEEcCCeeEEEE-eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC
Confidence 6899999999999999999999 7999999999998877665 888999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC------------------------------------------------CCCCCcCCCCcc
Q 022732 84 PAPRLKICDFGYSKSSVLHS------------------------------------------------QPKSTVGTPAYI 115 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~------------------------------------------------~~~~~~gt~~y~ 115 (293)
+ .+||+|||+++...... ...+.+||+.|+
T Consensus 138 ~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 215 (377)
T cd05629 138 G--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYI 215 (377)
T ss_pred C--CEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcccc
Confidence 4 59999999986321100 001246999999
Q ss_pred chhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCC
Q 022732 116 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 195 (293)
Q Consensus 116 aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 195 (293)
|||++.+..++.+ +|+||+||++|+|++|..||.+......+..+... .....+|....++.++++||.+||. +|.
T Consensus 216 aPE~~~~~~~~~~-~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 216 APEIFLQQGYGQE-CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred CHHHHccCCCCCc-eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHh
Confidence 9999988777655 99999999999999999999887654433333221 1223344444689999999999997 777
Q ss_pred CC---CCHHHHHcCccccc
Q 022732 196 AR---ITIPEIMKHQWFLK 211 (293)
Q Consensus 196 ~R---pt~~ell~h~~~~~ 211 (293)
+| +|+.+++.||||+.
T Consensus 292 ~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hcCCCCCHHHHhcCCCcCC
Confidence 65 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=283.75 Aligned_cols=198 Identities=27% Similarity=0.414 Sum_probs=165.6
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
-.|+|++++++.|...+..|+|| ||+.||+|..++.+.+.+. +++.++.||+.||.|||++|++||||||+|||++.
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~ 131 (325)
T cd05604 53 VKHPFLVGLHYSFQTTEKLYFVL-DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS 131 (325)
T ss_pred CCCCCCccEEEEEecCCEEEEEE-cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence 46899999999999999999999 7999999999998877766 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++... ........+||+.|+|||++.+..++.+ +|+||+||++|+|++|..||...+....+
T Consensus 132 ~~--~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~--- 205 (325)
T cd05604 132 QG--HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMY--- 205 (325)
T ss_pred CC--CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHH---
Confidence 65 59999999987532 2223345579999999999988777655 99999999999999999999887654333
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH----HHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI----PEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~h~~~~~~ 212 (293)
..+....... ....+..+.++|++||.++|.+||++ .+++.||||...
T Consensus 206 -~~~~~~~~~~--~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 206 -DNILHKPLVL--RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred -HHHHcCCccC--CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 3333333222 23478999999999999999999976 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=288.21 Aligned_cols=202 Identities=29% Similarity=0.444 Sum_probs=162.9
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|++++++.|.+.+++|+|| ||+.||+|.+++.+.+.++ .++.++.||+.||.|||++||+||||||+|||++.
T Consensus 58 l~h~~iv~l~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~ 136 (381)
T cd05626 58 ADNEWVVKLYYSFQDKDNLYFVM-DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL 136 (381)
T ss_pred cCCCCeeeeEEEEecCCEEEEEE-ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC
Confidence 36899999999999999999999 7999999999998877666 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC------------------------------------------------CCCCCCcCCCCc
Q 022732 83 SPAPRLKICDFGYSKSSVLH------------------------------------------------SQPKSTVGTPAY 114 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~------------------------------------------------~~~~~~~gt~~y 114 (293)
++ ++||+|||+++..... ....+.+||+.|
T Consensus 137 ~~--~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (381)
T cd05626 137 DG--HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNY 214 (381)
T ss_pred CC--CEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccc
Confidence 54 5999999997532100 001235799999
Q ss_pred cchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHcc--cc
Q 022732 115 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF--VA 192 (293)
Q Consensus 115 ~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L--~~ 192 (293)
+|||++.+..++.+ +||||+||++|+|++|+.||...+.......+... ......+....+++++.+||.+|+ ..
T Consensus 215 ~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~dli~~ll~~~~ 291 (381)
T cd05626 215 IAPEVLLRKGYTQL-CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW--ENTLHIPPQVKLSPEAVDLITKLCCSAE 291 (381)
T ss_pred cCHHHHcCCCCCCc-cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc--ccccCCCCCCCCCHHHHHHHHHHccCcc
Confidence 99999988777655 99999999999999999999887654333332211 122344555568999999999955 45
Q ss_pred CCCCCCCHHHHHcCcccccC
Q 022732 193 DPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 193 dp~~Rpt~~ell~h~~~~~~ 212 (293)
++..|+++.++++||||...
T Consensus 292 ~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 292 ERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred cccCCCCHHHHhcCcccCCC
Confidence 55569999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=285.14 Aligned_cols=197 Identities=30% Similarity=0.476 Sum_probs=165.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|...+.+|+|| ||+.+|+|.+++.+...+. .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 56 ~h~niv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 134 (318)
T cd05582 56 NHPFIVKLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 134 (318)
T ss_pred CCCCcccEEEEEEcCCEEEEEE-cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC
Confidence 5899999999999999999999 7999999999998877665 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+++..... .......||+.|+|||++.+..+..+ +|+||+||++|+|++|+.||...+.....
T Consensus 135 ~--~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~---- 207 (318)
T cd05582 135 G--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETM---- 207 (318)
T ss_pred C--cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHHH----
Confidence 5 4999999998754333 23345679999999999987777555 99999999999999999999876653333
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~ 212 (293)
..+.......| ..++..+.++|++||++||.+||+ +.+++.||||...
T Consensus 208 ~~i~~~~~~~p--~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 208 TMILKAKLGMP--QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHHHcCCCCCC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 33333333333 347899999999999999999999 7789999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=280.79 Aligned_cols=203 Identities=22% Similarity=0.366 Sum_probs=162.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+.+|+|| ||+.|++|.+++...+.++ .+..++.|++.||.|||++ +++||||||+||+++.
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~ 139 (331)
T cd06649 61 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS 139 (331)
T ss_pred CCCCCCeEEEEEEECCEEEEEe-ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC
Confidence 5899999999999999999999 7999999999998877655 8889999999999999986 6999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
++ .+||+|||++..... .......||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||....... +..+.
T Consensus 140 ~~--~~kl~Dfg~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~ 214 (331)
T cd06649 140 RG--EIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIF 214 (331)
T ss_pred CC--cEEEccCcccccccc-cccccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHh
Confidence 55 599999999875432 23345579999999999988777655 999999999999999999997654322 11111
Q ss_pred H-------------------------------------------HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC
Q 022732 163 Q-------------------------------------------RILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 199 (293)
Q Consensus 163 ~-------------------------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt 199 (293)
. .+............++.++++||.+||.+||++|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt 294 (331)
T cd06649 215 GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD 294 (331)
T ss_pred cccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC
Confidence 0 011110000011236889999999999999999999
Q ss_pred HHHHHcCcccccCCC
Q 022732 200 IPEIMKHQWFLKNLP 214 (293)
Q Consensus 200 ~~ell~h~~~~~~~~ 214 (293)
+.++++||||+....
T Consensus 295 ~~ell~h~~~~~~~~ 309 (331)
T cd06649 295 LKMLMNHTFIKRSEV 309 (331)
T ss_pred HHHHhcChHHhhccc
Confidence 999999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=267.53 Aligned_cols=211 Identities=26% Similarity=0.422 Sum_probs=176.9
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
-||+|+++++++|+++.+.|+|| |-+.||+|.+.|+++..+. +|..+++.|+.||.|||.+||.|||+||+|||...
T Consensus 133 qgh~nilqLiefFEdd~~FYLVf-EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 133 QGHKNILQLIEFFEDDTRFYLVF-EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES 211 (463)
T ss_pred cCCccHHHHHHHhcccceEEEEE-ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC
Confidence 48999999999999999999999 7999999999999998887 99999999999999999999999999999999865
Q ss_pred CC-CCCEEEecCCCCcCcCCCC--------CCCCCcCCCCccchhhhc----cccCCCchhhhhhhhhHHHHHHhCCCCC
Q 022732 83 SP-APRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPF 149 (293)
Q Consensus 83 ~~-~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~el~~g~~pf 149 (293)
.. -..|||+||.+...+.... ...+.+|+..|||||+.. ...++.+++|.||||||+|-|++|++||
T Consensus 212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF 291 (463)
T KOG0607|consen 212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF 291 (463)
T ss_pred CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence 33 2358999999876433221 224568999999999863 2344566799999999999999999999
Q ss_pred CCCCc-----------hHHHHHHHHHHhccccCCCC--CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCC
Q 022732 150 EDPDE-----------PKDFRKTIQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216 (293)
Q Consensus 150 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~ 216 (293)
.+.-. ..--......|..+.+++|. |..+|.+++++|+.+|..++.+|.++.++++|||+....+..
T Consensus 292 vG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 292 VGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred cCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 87432 12234566778888888874 567999999999999999999999999999999998765543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=275.29 Aligned_cols=200 Identities=23% Similarity=0.353 Sum_probs=158.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|......|+|| ||+.++.+..+......+. .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 58 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~ 136 (287)
T cd07848 58 KQENIVELKEAFRRRGKLYLVF-EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN 136 (287)
T ss_pred CCccccchhhhEecCCEEEEEE-ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence 5899999999999999999999 7999988776655444444 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
+ .+||+|||+++...... ......||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+.......+
T Consensus 137 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 137 D--VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred C--cEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5 59999999997643222 2234578999999999988777554 99999999999999999999886654433322
Q ss_pred HHHHhcc---------------ccCCCC-----------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 162 IQRILSV---------------QYSVPD-----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 162 ~~~~~~~---------------~~~~~~-----------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
....... ....+. ...+|.++.+||++||.+||.+|||++++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 2111000 000110 11268889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=286.50 Aligned_cols=203 Identities=29% Similarity=0.452 Sum_probs=165.0
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
..|+|++++++++.+.+++|+|| ||+.||+|..++..... ...+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 100 ~~h~~iv~~~~~~~~~~~~~lv~-Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~ 178 (370)
T cd05596 100 ANSEWIVQLHYAFQDDKYLYMVM-EYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 178 (370)
T ss_pred CCCCCcceEEEEEecCCEEEEEE-cCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC
Confidence 46899999999999999999999 79999999999876542 22888999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhcccc---CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+ .+||+|||++....... .....+||+.|+|||++.+.. ..+.++|+|||||++|+|++|+.||.+.+....+
T Consensus 179 ~--~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 256 (370)
T cd05596 179 G--HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 256 (370)
T ss_pred C--CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH
Confidence 5 59999999987543222 223567999999999986543 2345599999999999999999999987654433
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCC--CCCHHHHHcCcccccC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA--RITIPEIMKHQWFLKN 212 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~ 212 (293)
..+... .....+|....+|.++++||.+||..+|.+ |+|+.++++||||+..
T Consensus 257 ~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 257 SKIMDH--KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHcC--CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 333221 122344555568999999999999999988 9999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=282.89 Aligned_cols=197 Identities=27% Similarity=0.447 Sum_probs=164.4
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
-.|+|++++++.+...+..|+|| ||+.|++|..++...+.+. .++.++.||+.||.|||++|++||||||+|||++.
T Consensus 53 ~~h~~Iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~ 131 (325)
T cd05602 53 VKHPFLVGLHFSFQTADKLYFVL-DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS 131 (325)
T ss_pred CCCCCCCceeEEEEcCCeEEEEE-eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC
Confidence 36899999999999999999999 7999999999998877665 88889999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++... ........+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+....+..
T Consensus 132 ~~--~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~- 207 (325)
T cd05602 132 QG--HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN- 207 (325)
T ss_pred CC--CEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHH-
Confidence 54 59999999987532 2223345679999999999988777655 9999999999999999999987665433333
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHH----HHHcCccccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP----EIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~----ell~h~~~~~ 211 (293)
+...... ....++..+.++|.+||+++|.+|+++. ++++|+||..
T Consensus 208 ---i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 208 ---ILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ---HHhCCcC--CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 3222222 2335889999999999999999999765 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=284.14 Aligned_cols=200 Identities=24% Similarity=0.371 Sum_probs=161.9
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH---HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV---QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~---~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
+-|+.++|++|++=..+.++||||+ |...+|..+|++..... .++.|+.|+++|+.++|..||||.||||.|+|+
T Consensus 416 Lkg~~~IIqL~DYEv~d~~lYmvmE--~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl 493 (677)
T KOG0596|consen 416 LKGHDKIIQLYDYEVTDGYLYMVME--CGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL 493 (677)
T ss_pred hcCCceEEEEeeeeccCceEEEEee--cccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE
Confidence 3478899999999999999999996 56679999998887654 899999999999999999999999999999988
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCC----------CchhhhhhhhhHHHHHHhCCC
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYD----------GKIADVWSCGVTLYVMLVGGY 147 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~----------~~~~DvwslG~il~el~~g~~ 147 (293)
=. |++||+|||+|..+..... ..+.+||+.||+||.+....+. ++++||||||||+|+|+.|+.
T Consensus 494 Vk---G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgkt 570 (677)
T KOG0596|consen 494 VK---GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKT 570 (677)
T ss_pred Ee---eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCC
Confidence 43 4699999999986544332 3567899999999998653332 455999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHhccccCCCCCCCC-CHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 148 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPI-SQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
||..- ......+..+......++.+.-- ..++.++++.||..||++|||..++|+|||+.-
T Consensus 571 Pf~~~---~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 571 PFGQI---INQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred chHHH---HHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 99753 22344455566655533332111 234999999999999999999999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.70 Aligned_cols=204 Identities=22% Similarity=0.335 Sum_probs=159.6
Q ss_pred CCcchhhhhceeeec--------eeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHcCCeec
Q 022732 6 SSSSEYAMLGVSVKM--------KFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAMQVCHR 71 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--------~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~~iiHr 71 (293)
.|+|+|+++++|... .++|+|| ||+.+ +|..++.. ...++ .++.++.||+.||.|||++||+||
T Consensus 117 ~h~niv~l~~~~~~~~~~~~~~~~~l~lvm-E~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHr 194 (440)
T PTZ00036 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVM-EFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHR 194 (440)
T ss_pred CCCCCcceeeeEeecccccCCCceEEEEEE-ecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence 589999999987542 3577899 79986 66666643 33344 889999999999999999999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
||||+|||++.++ +.+||+|||+|+............||+.|+|||++.+....+.++||||+||++|+|++|.+||.+
T Consensus 195 DLKp~NILl~~~~-~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 195 DLKPQNLLIDPNT-HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred CcCHHHEEEcCCC-CceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999997543 259999999998665545555678999999999987754344559999999999999999999998
Q ss_pred CCchHHHHHHHHHHhccc-------------cCCC----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 152 PDEPKDFRKTIQRILSVQ-------------YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~-------------~~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
......+..+++...... ..++ .+...+.++++||.+||++||.+|||+.++++|||
T Consensus 274 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 274 QSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 877666655554321110 0111 11236789999999999999999999999999999
Q ss_pred cccC
Q 022732 209 FLKN 212 (293)
Q Consensus 209 ~~~~ 212 (293)
|...
T Consensus 354 f~~~ 357 (440)
T PTZ00036 354 FDDL 357 (440)
T ss_pred HHhh
Confidence 9754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=276.24 Aligned_cols=199 Identities=25% Similarity=0.348 Sum_probs=160.4
Q ss_pred CCcchhhhhceee-----eceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSV-----KMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~-----~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.|+|++++++++. ....+|+|+ ||+. ++|.+++.... .++ .++.++.||+.||.|||++|++||||||+
T Consensus 62 ~hpniv~~~~~~~~~~~~~~~~~~lv~-e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~ 139 (290)
T cd07862 62 EHPNVVRLFDVCTVSRTDRETKLTLVF-EHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 139 (290)
T ss_pred CCCCcceEEEEEecccCCCCCcEEEEE-ccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH
Confidence 5899999999985 346789999 7987 58999887643 233 88999999999999999999999999999
Q ss_pred cEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 77 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 77 NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
|||++.++ .+||+|||+++............||+.|+|||++.+..+..+ +|+||+||++|+|++|+.||.+.....
T Consensus 140 Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~ 216 (290)
T cd07862 140 NILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVD 216 (290)
T ss_pred HEEEcCCC--CEEEccccceEeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 99997655 599999999986544444456679999999999987777655 999999999999999999999887766
Q ss_pred HHHHHHHHHhcccc-CCC--------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 157 DFRKTIQRILSVQY-SVP--------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 157 ~~~~~~~~~~~~~~-~~~--------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.+..+......... .++ ....++..+++|+.+||+.||++|||+.++++||||
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 66555543211100 000 012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=285.64 Aligned_cols=203 Identities=27% Similarity=0.442 Sum_probs=163.6
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
-.|+|++++++.|...+++|+|| ||+.||+|.+++.....-. +++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 100 ~~hp~iv~~~~~~~~~~~~~lv~-Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~ 178 (370)
T cd05621 100 ANSPWVVQLFCAFQDDKYLYMVM-EYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH 178 (370)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEE-cCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC
Confidence 46899999999999999999999 7999999999997654222 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhcccc---CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+ .+||+|||+|....... ...+.+||+.|+|||++.+.. +.+.++|+||+||++|+|++|+.||.+.+....+
T Consensus 179 ~--~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~ 256 (370)
T cd05621 179 G--HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY 256 (370)
T ss_pred C--CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH
Confidence 5 59999999997543222 224567999999999987643 2345599999999999999999999887654443
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCC--CCCHHHHHcCcccccC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA--RITIPEIMKHQWFLKN 212 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~ 212 (293)
..+... .....+|....++..+++++.+||..++.+ |+|+.++++||||+..
T Consensus 257 ~~i~~~--~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 257 SKIMDH--KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHhC--CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 333321 122344555568999999999999865544 8899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=280.66 Aligned_cols=198 Identities=28% Similarity=0.417 Sum_probs=164.3
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
-.|+|++++++.|...+..|+|| ||+.|++|...+...+.+. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~ 131 (321)
T cd05603 53 LKHPFLVGLHYSFQTAEKLYFVL-DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS 131 (321)
T ss_pred CCCCCccceeeEEEcCCEEEEEE-cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 36899999999999999999999 7999999999998776655 88899999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++... ........+||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+.+... .
T Consensus 132 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~----~ 204 (321)
T cd05603 132 QG--HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQ----M 204 (321)
T ss_pred CC--CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHH----H
Confidence 55 59999999987532 2223344579999999999987777655 999999999999999999998866433 2
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH----HHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI----PEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~h~~~~~~ 212 (293)
...+....... +...+..+.++|.+||+++|.+|+++ .++++|+||...
T Consensus 205 ~~~i~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 205 YDNILHKPLQL--PGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHHHhcCCCCC--CCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 33333333333 33478999999999999999999965 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.64 Aligned_cols=200 Identities=30% Similarity=0.483 Sum_probs=163.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|++++++++.|.+.+++|+|| ||+.||+|.+++.+.+.+. .++.++.|++.||.|||++|++||||||+|||++.+
T Consensus 59 ~~~~iv~~~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~ 137 (360)
T cd05627 59 DGAWVVKMFYSFQDKRNLYLIM-EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK 137 (360)
T ss_pred CCCCEeeEEEEEEcCCEEEEEE-eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC
Confidence 5789999999999999999999 7999999999998877666 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC------------------------------------CCCCCcCCCCccchhhhccccCCC
Q 022732 84 PAPRLKICDFGYSKSSVLHS------------------------------------QPKSTVGTPAYIAPEVLLRHEYDG 127 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ 127 (293)
+ ++||+|||+++...... .....+||+.|+|||++.+..++.
T Consensus 138 ~--~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~ 215 (360)
T cd05627 138 G--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215 (360)
T ss_pred C--CEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC
Confidence 4 59999999986432110 012357999999999998888765
Q ss_pred chhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC---CHHHHH
Q 022732 128 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIM 204 (293)
Q Consensus 128 ~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~ell 204 (293)
+ +|+||+||++|+|++|+.||.+.+....+..+... .....+|....++.++++||.+|+ .+|.+|+ ++.+++
T Consensus 216 ~-~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 216 L-CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW--KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred c-ceeccccceeeecccCCCCCCCCCHHHHHHHHHcC--CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 5 99999999999999999999887664433332211 122334444558999999999976 5999998 589999
Q ss_pred cCcccccC
Q 022732 205 KHQWFLKN 212 (293)
Q Consensus 205 ~h~~~~~~ 212 (293)
+||||...
T Consensus 292 ~hp~f~~~ 299 (360)
T cd05627 292 SHPFFEGV 299 (360)
T ss_pred cCCCCCCC
Confidence 99999763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=286.84 Aligned_cols=200 Identities=25% Similarity=0.380 Sum_probs=167.9
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
-+|+++|++|+.|..++.+.+++ |||.||-....+-.-++ +. ++..+.+|++.||.|||+++|||||||+.|||++
T Consensus 86 CdHP~ivkLl~ayy~enkLwili-EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T 164 (1187)
T KOG0579|consen 86 CDHPVIVKLLSAYYFENKLWILI-EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT 164 (1187)
T ss_pred CCChHHHHHHHHHhccCceEEEE-eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE
Confidence 46999999999999999999999 79999999888876554 33 9999999999999999999999999999999998
Q ss_pred CCCCCCEEEecCCCCcCc-CCCCCCCCCcCCCCccchhhhc-----cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 82 GSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
.+|. |+|+|||++... .......+.+|||+|||||++. ..+|+.+ +||||||+++.+|..+.+|....+..
T Consensus 165 ldGd--irLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpM 241 (1187)
T KOG0579|consen 165 LDGD--IRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPM 241 (1187)
T ss_pred ecCc--EeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchH
Confidence 8776 999999997543 2334456789999999999864 3567666 89999999999999999999887775
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
..+.++.+. ....+-.+..+|..+.+|+.+||.+||..||+++++|+||||..
T Consensus 242 RVllKiaKS---ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 242 RVLLKIAKS---EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHhhc---CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 544433321 12223345668999999999999999999999999999999953
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=287.73 Aligned_cols=200 Identities=31% Similarity=0.481 Sum_probs=162.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.|.+.+++|+|| ||+.||+|.+++.+.+.+. .++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~-E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~ 137 (376)
T cd05598 59 DNEWVVKLYYSFQDKDNLYFVM-DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD 137 (376)
T ss_pred CCCCcceEEEEEEcCCEEEEEE-eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC
Confidence 6899999999999999999999 7999999999998887665 788999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC--------------------------------------------CCCCCCcCCCCccchhh
Q 022732 84 PAPRLKICDFGYSKSSVLH--------------------------------------------SQPKSTVGTPAYIAPEV 119 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~--------------------------------------------~~~~~~~gt~~y~aPE~ 119 (293)
+ .+||+|||+|...... ......+||+.|+|||+
T Consensus 138 ~--~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 215 (376)
T cd05598 138 G--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV 215 (376)
T ss_pred C--CEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHH
Confidence 4 5999999997522100 00123479999999999
Q ss_pred hccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-
Q 022732 120 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI- 198 (293)
Q Consensus 120 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp- 198 (293)
+.+..++.+ +||||+||++|+|++|+.||.+.........+.. .......+....++.++.++|.+|+ .+|.+|+
T Consensus 216 ~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 216 LLRTGYTQL-CDWWSVGVILYEMLVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred HcCCCCCcc-eeeeeccceeeehhhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 988777655 9999999999999999999988765443322221 1122233444568999999999976 6999999
Q ss_pred --CHHHHHcCcccccC
Q 022732 199 --TIPEIMKHQWFLKN 212 (293)
Q Consensus 199 --t~~ell~h~~~~~~ 212 (293)
|+.++++||||+..
T Consensus 292 ~~t~~ell~h~~~~~~ 307 (376)
T cd05598 292 KNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCHHHHhCCCCcCCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=283.01 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=163.7
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
..|+|++++++++...+++|+|| ||+.||+|.+++.+. +.+. .++.++.||+.||.|||++|++||||||+|||++
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~ 136 (330)
T cd05601 58 SNSPWIPQLQYAFQDKDNLYLVM-EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID 136 (330)
T ss_pred CCCCCCcceeeEEecCCeEEEEE-CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC
Confidence 46899999999999999999999 799999999999876 4454 8889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhcc------ccCCCchhhhhhhhhHHHHHHhCCCCCCCCC
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLR------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 153 (293)
.++ .+||+|||++........ .....||+.|+|||++.. ..+ +.++||||+||++|+|++|+.||....
T Consensus 137 ~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 137 RTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY-GVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred CCC--CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCC-CCcceeecccceeeeeccCCCCCCCCC
Confidence 655 599999999975433222 233479999999999863 333 345999999999999999999998876
Q ss_pred chHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 154 EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
....+..+... .....+|....++.++.+||.+||. +|.+|||+.+++.||||...
T Consensus 214 ~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 214 SAKTYNNIMNF--QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 64444333321 1112344445589999999999998 99999999999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=278.72 Aligned_cols=198 Identities=27% Similarity=0.482 Sum_probs=165.0
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..+++++++++++...+.+|+|| ||+.||+|..++...+.+. +++.++.||+.||.|||++|++||||||+|||++.
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~-Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 58 DKPPFLTQLHSCFQTVDRLYFVM-EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred cCCCchhheeeEEecCCEEEEEE-cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 45678889999999999999999 7999999999998877665 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++..... .......||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+......
T Consensus 137 ~~--~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~---- 209 (323)
T cd05615 137 EG--HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDEL---- 209 (323)
T ss_pred CC--CEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHHH----
Confidence 55 5999999998753222 22344569999999999987777555 9999999999999999999988765333
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~ 212 (293)
.+.+.......| ..++.++.+++.+||.++|.+|++ ..++++||||+..
T Consensus 210 ~~~i~~~~~~~p--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 210 FQSIMEHNVSYP--KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHHhCCCCCC--ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 333333333333 348899999999999999999997 5789999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=278.42 Aligned_cols=202 Identities=24% Similarity=0.380 Sum_probs=159.1
Q ss_pred CCcchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++... ..+|+|| ||+.+ +|..++...-....+..++.|++.||.|||++||+||||||+||+
T Consensus 81 ~h~~ii~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl 158 (364)
T cd07875 81 NHKNIIGLLNVFTPQKSLEEFQDVYIVM-ELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158 (364)
T ss_pred CCCCccccceeecccccccccCeEEEEE-eCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 689999999988644 4679999 79876 677777655445588999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ .+||+|||+++............||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+....+.
T Consensus 159 l~~~~--~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 235 (364)
T cd07875 159 VKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235 (364)
T ss_pred ECCCC--cEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 97654 599999999986544444455679999999999988777655 999999999999999999998877655544
Q ss_pred HHHHHHhcc------------------ccC--------------C----CCCCCCCHHHHHHHHHccccCCCCCCCHHHH
Q 022732 160 KTIQRILSV------------------QYS--------------V----PDTNPISQECRDLISRIFVADPAARITIPEI 203 (293)
Q Consensus 160 ~~~~~~~~~------------------~~~--------------~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el 203 (293)
.++..+... ... . ......+.++++||.+||+.||.+|||+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~ 315 (364)
T cd07875 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315 (364)
T ss_pred HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence 443321100 000 0 0011135688999999999999999999999
Q ss_pred HcCcccccC
Q 022732 204 MKHQWFLKN 212 (293)
Q Consensus 204 l~h~~~~~~ 212 (293)
|+||||...
T Consensus 316 L~hp~~~~~ 324 (364)
T cd07875 316 LQHPYINVW 324 (364)
T ss_pred hcCcccccc
Confidence 999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=287.80 Aligned_cols=194 Identities=26% Similarity=0.377 Sum_probs=172.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|.|.|+|.....+|+|| |||..|.|+..|+....+. ....|.++|+.|++|||.++|||||||.-||||..+
T Consensus 170 kH~NII~FkGVCtqsPcyCIiM-EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~ 248 (904)
T KOG4721|consen 170 KHPNIITFKGVCTQSPCYCIIM-EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD 248 (904)
T ss_pred cCcceeeEeeeecCCceeEEee-eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc
Confidence 4899999999999999999999 7999999999999988766 889999999999999999999999999999999876
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.. |||+|||-++....-...-+++||..|||||+|...+.+.+ +||||+|||||||+||..||.+.+. ..|+-
T Consensus 249 d~--VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVds----sAIIw 321 (904)
T KOG4721|consen 249 DV--VKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDS----SAIIW 321 (904)
T ss_pred ce--EEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccch----heeEE
Confidence 54 99999999886555555567889999999999998888777 9999999999999999999998776 34444
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 207 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~ 207 (293)
.+....+.+|.+..+++-++-||+.||...|.+||++.+++.|-
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 55555566677777899999999999999999999999999984
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=272.12 Aligned_cols=201 Identities=22% Similarity=0.327 Sum_probs=162.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++....+.|+|| ||+.|++|..++...+. +. .+..++.|++.||+|||++|++||||||+||+++
T Consensus 51 ~hp~i~~~~~~~~~~~~~~lv~-e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~ 129 (277)
T cd05607 51 NSPFIVNLAYAFESKTHLCLVM-SLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD 129 (277)
T ss_pred CCCcEEEEEEEEecCCeEEEEE-ecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc
Confidence 6899999999999999999999 79999999998866543 22 7788999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ .++|+|||++.............|++.|+|||++.+..++.+ +|+||+||++|+|++|+.||............
T Consensus 130 ~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~ 206 (277)
T cd05607 130 DQG--NCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206 (277)
T ss_pred CCC--CEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Confidence 655 499999999876543333344578999999999987776555 99999999999999999999865432222233
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH----HHHHcCccccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI----PEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~h~~~~~ 211 (293)
...........+ ...++.+++++|.+||++||.+||++ .+++.||||+.
T Consensus 207 ~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 207 KRRTLEDEVKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHhhccccccc-cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 333333222221 23478999999999999999999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=278.32 Aligned_cols=204 Identities=24% Similarity=0.406 Sum_probs=158.1
Q ss_pred CCcchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+++++++|... ..+|+|| ||+.+ +|...+...-....+..++.||+.||.|||++||+||||||+||+
T Consensus 78 ~h~niv~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl 155 (359)
T cd07876 78 NHKNIISLLNVFTPQKSLEEFQDVYLVM-ELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 155 (359)
T ss_pred CCCCEeeeeeeeccCCCccccceeEEEE-eCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 589999999998654 3579999 79876 566666544444488899999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ .+||+|||+++............||+.|+|||++.+..+..+ +|+||+||++|+|++|+.||.+.+....+.
T Consensus 156 ~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 156 VKSDC--TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred ECCCC--CEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 97654 599999999976544444455678999999999988877666 999999999999999999998876544333
Q ss_pred HHHHHH------------------hccccCCC------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHH
Q 022732 160 KTIQRI------------------LSVQYSVP------------------DTNPISQECRDLISRIFVADPAARITIPEI 203 (293)
Q Consensus 160 ~~~~~~------------------~~~~~~~~------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~el 203 (293)
...... .......+ .....++++++||.+||..||++|||+.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 312 (359)
T cd07876 233 KVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312 (359)
T ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence 222211 00000000 011246789999999999999999999999
Q ss_pred HcCcccccCCC
Q 022732 204 MKHQWFLKNLP 214 (293)
Q Consensus 204 l~h~~~~~~~~ 214 (293)
++||||.....
T Consensus 313 l~hp~~~~~~~ 323 (359)
T cd07876 313 LRHPYITVWYD 323 (359)
T ss_pred hcCchhhhhcC
Confidence 99999976443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=272.65 Aligned_cols=200 Identities=26% Similarity=0.352 Sum_probs=162.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+++++++|...++.|+|| ||+.||+|..++... ..+. .+..++.||+.||.|||++|++||||||+||+
T Consensus 51 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 129 (280)
T cd05608 51 HSRFIVSLAYAFQTKTDLCLVM-TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVL 129 (280)
T ss_pred CCCcEeeeeEEEcCCCeEEEEE-eCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 5789999999999999999999 799999999887432 2333 88999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++.++ .+||+|||++....... ......||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.........
T Consensus 130 i~~~~--~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~ 206 (280)
T cd05608 130 LDNDG--NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVEN 206 (280)
T ss_pred ECCCC--CEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhH
Confidence 97654 59999999987543322 2234578999999999988777655 99999999999999999999875543322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCccccc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLK 211 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~ 211 (293)
......+..... ..+..++..+.+++.+||+.||.+|| +++++++||||+.
T Consensus 207 ~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 207 KELKQRILNDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHHHhhcccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 333333333322 22345889999999999999999999 8899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=266.98 Aligned_cols=196 Identities=30% Similarity=0.509 Sum_probs=169.4
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
|+....+--.|+...++|+|| ||..||.|+-.|.....++ .+++|-..|+.||.|||+++||+||||.+|++++.++
T Consensus 227 HPFLt~LKYsFQt~drlCFVM-eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG 305 (516)
T KOG0690|consen 227 HPFLTSLKYSFQTQDRLCFVM-EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG 305 (516)
T ss_pred CcHHHHhhhhhccCceEEEEE-EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC
Confidence 555666777899999999999 7999999999999888887 8999999999999999999999999999999997765
Q ss_pred CCCEEEecCCCCcC-cCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
++||+|||+++. +.......+.||||.|.|||++....|. +++|+|.+||++|||++|+.||...+....+.-+.
T Consensus 306 --HIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl- 381 (516)
T KOG0690|consen 306 --HIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL- 381 (516)
T ss_pred --ceEeeecccchhcccccceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-
Confidence 599999999985 4556677889999999999999888875 45999999999999999999999888755544433
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
.....+| ..+|++++.|+..+|.+||++|. .+.|+.+|+||...
T Consensus 382 ---~ed~kFP--r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 382 ---MEDLKFP--RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred ---hhhccCC--ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 3344444 45999999999999999999998 57899999999753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=272.20 Aligned_cols=200 Identities=24% Similarity=0.361 Sum_probs=165.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++.+...+++|+|| ||+.||+|..++...+ .++ .+..++.|++.||.|||++|++||||||+||+++
T Consensus 58 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 136 (285)
T cd05605 58 NSRFVVSLAYAYETKDALCLVL-TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD 136 (285)
T ss_pred CCCCEeeeeeeecCCCeEEEEE-eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC
Confidence 5889999999999999999999 7999999998886543 344 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ .++|+|||++.............|++.|+|||++.+..++.+ +|+||+||++|++++|+.||.+.........+
T Consensus 137 ~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05605 137 DYG--HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213 (285)
T ss_pred CCC--CEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence 654 599999999876544444445679999999999987776555 89999999999999999999886654433333
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCccccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~ 211 (293)
...+....... +..++..+.+||.+||..||.+|| ++.++++||||..
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 214 ERRVKEDQEEY--SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHhhhccccc--CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 33333322222 334889999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=297.46 Aligned_cols=202 Identities=30% Similarity=0.467 Sum_probs=171.7
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+|.+.=++.+.-.|++++++|+|| ||+.||+|..++.+.++++ .|++|++.|+.||.-||+.|+|||||||+|||++
T Consensus 131 ~~ns~Wiv~LhyAFQD~~~LYlVM-dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld 209 (1317)
T KOG0612|consen 131 FGNSEWIVQLHYAFQDERYLYLVM-DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD 209 (1317)
T ss_pred cCCcHHHHHHHHHhcCccceEEEE-ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec
Confidence 566777899999999999999999 7999999999999999887 9999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhcc----ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
..| +|||+|||.+..+...+ .....+|||.|.+||++.. .+.+++.+|+||+||++|||+.|..||...+-.
T Consensus 210 ~~G--HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv 287 (1317)
T KOG0612|consen 210 KSG--HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV 287 (1317)
T ss_pred ccC--cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH
Confidence 765 59999999987665433 3456789999999999863 244567799999999999999999999976554
Q ss_pred HHHHHHHHHHhcc--ccCCCCCCCCCHHHHHHHHHccccCCCCCCC---HHHHHcCcccccCC
Q 022732 156 KDFRKTIQRILSV--QYSVPDTNPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLKNL 213 (293)
Q Consensus 156 ~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~h~~~~~~~ 213 (293)
.++.+|.+. .+.+|....+|.++++||++++. +|..|.+ ++++..||||....
T Consensus 288 ----eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 288 ----ETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred ----HHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 444444444 45666557799999999999875 7888887 99999999997643
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=291.04 Aligned_cols=197 Identities=26% Similarity=0.384 Sum_probs=162.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+++++++|...++.|+|| ||+.||+|..++... ..+. ++..++.||+.||.|||++||+||||||+|||
T Consensus 123 ~Hpniv~~~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIl 201 (478)
T PTZ00267 123 DHFGIVKHFDDFKSDDKLLLIM-EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201 (478)
T ss_pred CCCCEeEEEEEEEECCEEEEEE-ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEE
Confidence 6899999999999999999999 799999999888542 2343 88899999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++.++ .+||+|||+++...... .....+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.....
T Consensus 202 l~~~~--~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~ 278 (478)
T PTZ00267 202 LMPTG--IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQRE 278 (478)
T ss_pred ECCCC--cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 97655 59999999998543221 2345579999999999987776555 999999999999999999998766533
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
+...+...... +.+..++.++.++|.+||.++|++||++.+++.|+|++.
T Consensus 279 ----~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 279 ----IMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ----HHHHHHhCCCC-CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 33333332221 333458899999999999999999999999999999853
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=276.25 Aligned_cols=202 Identities=24% Similarity=0.387 Sum_probs=160.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~NIl~~~ 82 (293)
.|+|+++++++|...+++|+|| ||+.|++|.+++...+.+. .+..++.|++.||.|||++ +++||||||+|||++.
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~ 139 (333)
T cd06650 61 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 139 (333)
T ss_pred CCCcccceeEEEEECCEEEEEE-ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC
Confidence 5899999999999999999999 7999999999998877655 7889999999999999975 7999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH-
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT- 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~- 161 (293)
++ .+||+|||++..... .......|++.|+|||++.+..++.+ +|+||+||++|++++|+.||........ ...
T Consensus 140 ~~--~~kL~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~ 214 (333)
T cd06650 140 RG--EIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMF 214 (333)
T ss_pred CC--CEEEeeCCcchhhhh-hccccCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHh
Confidence 55 499999999875422 22344578999999999987766555 9999999999999999999976543211 111
Q ss_pred ----------------------------------------HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHH
Q 022732 162 ----------------------------------------IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 201 (293)
Q Consensus 162 ----------------------------------------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 201 (293)
...+............++.++++||.+||++||++|||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ 294 (333)
T cd06650 215 GCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLK 294 (333)
T ss_pred cCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHH
Confidence 0111111100001123678999999999999999999999
Q ss_pred HHHcCcccccCC
Q 022732 202 EIMKHQWFLKNL 213 (293)
Q Consensus 202 ell~h~~~~~~~ 213 (293)
+++.||||+...
T Consensus 295 ell~h~~~~~~~ 306 (333)
T cd06650 295 QLMVHAFIKRSE 306 (333)
T ss_pred HHhhCHHHhcCc
Confidence 999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=280.98 Aligned_cols=203 Identities=29% Similarity=0.468 Sum_probs=162.7
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
..|+|++++++.+...++.|+|| ||+.||+|..++....... .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 100 ~~hp~iv~~~~~~~~~~~~~lv~-Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~ 178 (371)
T cd05622 100 ANSPWVVQLFYAFQDDRYLYMVM-EYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 178 (371)
T ss_pred CCCCCCCeEEEEEEcCCEEEEEE-cCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC
Confidence 46899999999999999999999 7999999999997654322 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhcccc---CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+ ++||+|||+++...... .....+||+.|+|||++.+.. ..+.++|+||+||++|+|++|+.||.+.+....+
T Consensus 179 ~--~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 256 (371)
T cd05622 179 G--HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 256 (371)
T ss_pred C--CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH
Confidence 4 59999999997543222 223567999999999987543 2345599999999999999999999887654333
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCC--CCCHHHHHcCcccccC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA--RITIPEIMKHQWFLKN 212 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~ 212 (293)
..+... .....+|....++..++++|.+||..++.+ |+++.++++|+||+..
T Consensus 257 ~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 257 SKIMNH--KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHcC--CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 333221 112344555568999999999999844443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=283.50 Aligned_cols=194 Identities=31% Similarity=0.424 Sum_probs=167.8
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+++|+|++++.+.+.+..++|+|| |++.|+-+...+.....+. ++..|+++|+.|+.|||++|++||||||+|||++
T Consensus 372 ~~~h~niv~~~~v~~~~~~~~~v~-e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~- 449 (612)
T KOG0603|consen 372 VRDHPNIVKSHDVYEDGKEIYLVM-ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD- 449 (612)
T ss_pred hcCCCcceeecceecCCceeeeee-hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-
Confidence 578999999999999999999999 7999999999998887776 8889999999999999999999999999999996
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+..++++|+|||.++..... ..+.+-|..|.|||++....|+.. |||||||+++|+|++|+.||...... ..+.
T Consensus 450 ~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~ 523 (612)
T KOG0603|consen 450 GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAG---IEIH 523 (612)
T ss_pred CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCch---HHHH
Confidence 23346999999999864333 445677899999999998888766 99999999999999999999887665 3444
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.++....+. ..+|..+++||+.||+.||.+|+++.+++.||||
T Consensus 524 ~~i~~~~~s----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 524 TRIQMPKFS----ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhhcCCccc----cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 444443332 4599999999999999999999999999999999
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=275.71 Aligned_cols=203 Identities=24% Similarity=0.361 Sum_probs=158.8
Q ss_pred CCcchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+++++++|... ...|+|| ||+.+ +|...+...-....++.++.|++.||.|||++|++||||||+|||
T Consensus 74 ~h~niv~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nil 151 (355)
T cd07874 74 NHKNIISLLNVFTPQKSLEEFQDVYLVM-ELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151 (355)
T ss_pred CCCchhceeeeeeccccccccceeEEEh-hhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEE
Confidence 689999999998644 4579999 79976 677777655444588999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ .+||+|||+++............||+.|+|||++.+..+..+ +|+||+||++|+|++|+.||.+.+....+.
T Consensus 152 l~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 152 VKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred ECCCC--CEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 97654 599999999986544444456679999999999988777655 999999999999999999998876544433
Q ss_pred HHHHHHhcc------------------ccC--------------C----CCCCCCCHHHHHHHHHccccCCCCCCCHHHH
Q 022732 160 KTIQRILSV------------------QYS--------------V----PDTNPISQECRDLISRIFVADPAARITIPEI 203 (293)
Q Consensus 160 ~~~~~~~~~------------------~~~--------------~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el 203 (293)
..+..+... ... . ......+.++++||.+||..||.+|||+.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 332221100 000 0 0011245788999999999999999999999
Q ss_pred HcCcccccCC
Q 022732 204 MKHQWFLKNL 213 (293)
Q Consensus 204 l~h~~~~~~~ 213 (293)
++||||....
T Consensus 309 l~hp~~~~~~ 318 (355)
T cd07874 309 LQHPYINVWY 318 (355)
T ss_pred hcCcchhccc
Confidence 9999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=281.81 Aligned_cols=202 Identities=21% Similarity=0.294 Sum_probs=156.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|....+.|+|+ |++. ++|..++.....++ .++.++.||+.||.|||++||+||||||+|||++..
T Consensus 141 ~HpnIv~~~~~~~~~~~~~lv~-e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~ 218 (391)
T PHA03212 141 NHPSIIQLKGTFTYNKFTCLIL-PRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP 218 (391)
T ss_pred CCCCCCCEeEEEEECCeeEEEE-ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC
Confidence 5899999999999999999999 5775 68999987776555 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC--CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCC-------c
Q 022732 84 PAPRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-------E 154 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~-------~ 154 (293)
+ .+||+|||+|+.... ........||+.|+|||++.+..++.+ +|+||+||++|+|++|..||.... .
T Consensus 219 ~--~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~ 295 (391)
T PHA03212 219 G--DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDS 295 (391)
T ss_pred C--CEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCch
Confidence 5 599999999864321 122334579999999999988777544 999999999999999998775432 1
Q ss_pred hHHHHHHHHHHhc----------------------cccCCCC----C---CCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 155 PKDFRKTIQRILS----------------------VQYSVPD----T---NPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 155 ~~~~~~~~~~~~~----------------------~~~~~~~----~---~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
...+..++..... .....+. + ..++.++.+||.+||++||.+|||+.++|+
T Consensus 296 ~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 296 DRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1122222211110 0000010 0 124678999999999999999999999999
Q ss_pred CcccccC
Q 022732 206 HQWFLKN 212 (293)
Q Consensus 206 h~~~~~~ 212 (293)
||||+..
T Consensus 376 hp~f~~~ 382 (391)
T PHA03212 376 FAAFQDI 382 (391)
T ss_pred ChhhccC
Confidence 9999753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=279.26 Aligned_cols=198 Identities=29% Similarity=0.471 Sum_probs=178.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.++.+|++|-.|.+.+++|++| |-|.||.|...|+.++.+. .+++|+..+++|++|||++|||+|||||+|++++.+
T Consensus 478 ~s~fIvrLYrTfrd~kyvYmLm-EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~ 556 (732)
T KOG0614|consen 478 RSDFIVRLYRTFRDSKYVYMLM-EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR 556 (732)
T ss_pred CchHHHHHHHHhccchhhhhhH-HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC
Confidence 3778999999999999999999 7999999999999999998 999999999999999999999999999999999877
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+. +||.|||+|+.........+.+|||.|.|||+++..+.+.. +|.||||+++|||++|.+||.+.+.......+++
T Consensus 557 Gy--~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk 633 (732)
T KOG0614|consen 557 GY--LKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILK 633 (732)
T ss_pred Cc--eEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence 65 99999999999999999999999999999999998888666 9999999999999999999999998665555554
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCccccc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLK 211 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~ 211 (293)
.+ ..+..+..++..+.+||+++-..+|.+|.. ..++.+|.||..
T Consensus 634 Gi----d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 634 GI----DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred hh----hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 44 333344668999999999999999999995 789999999953
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=276.11 Aligned_cols=203 Identities=23% Similarity=0.345 Sum_probs=155.5
Q ss_pred CCcchhhhhceeeec-----eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKM-----KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~-----~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++... ..+|+|| ||+. ++|.+++...+.+. .++.++.||+.||.|||++|++||||||+||
T Consensus 57 ~hpniv~~~~~~~~~~~~~~~~~~lv~-e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 134 (338)
T cd07859 57 RHPDIVEIKHIMLPPSRREFKDIYVVF-ELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNI 134 (338)
T ss_pred CCCCEeeecceEeccCCCCCceEEEEE-ecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 589999999988643 3589999 7995 68999998776665 8999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhcc--ccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
|++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++ .++||||+||++|+|++|+.||.+.
T Consensus 135 ll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 135 LANADC--KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred EECCCC--cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccC-chhHHHHHHHHHHHHHcCCCCCCCC
Confidence 997654 59999999987532211 1234579999999999865 3444 4599999999999999999999876
Q ss_pred CchHHHHHHHHHH----------------------hccccCCC---CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q 022732 153 DEPKDFRKTIQRI----------------------LSVQYSVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQ 207 (293)
Q Consensus 153 ~~~~~~~~~~~~~----------------------~~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~ 207 (293)
+....+..+.... .......+ ....+++.+.++|.+||..||++|||+.++++||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 212 NVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 5433222111100 00000000 1123678899999999999999999999999999
Q ss_pred ccccCC
Q 022732 208 WFLKNL 213 (293)
Q Consensus 208 ~~~~~~ 213 (293)
||+...
T Consensus 292 ~f~~~~ 297 (338)
T cd07859 292 YFKGLA 297 (338)
T ss_pred hhhhcC
Confidence 997543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=287.37 Aligned_cols=204 Identities=21% Similarity=0.311 Sum_probs=155.4
Q ss_pred CCcchhhhhceeeec-eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKM-KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~-~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~ 81 (293)
.+.+.++++++|... .++|+|| +++ |++|..++.+.+.+. +++.++.||+.||.|||+ .||+||||||+|||++
T Consensus 189 ~~~~i~~i~~~~~~~~~~~~iv~-~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~ 266 (467)
T PTZ00284 189 DRFPLMKIQRYFQNETGHMCIVM-PKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILME 266 (467)
T ss_pred cCcceeeeEEEEEcCCceEEEEE-ecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEe
Confidence 345678888888765 5788888 565 778999998877666 899999999999999998 5999999999999997
Q ss_pred CCCC--------------CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCC
Q 022732 82 GSPA--------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 147 (293)
Q Consensus 82 ~~~~--------------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 147 (293)
..+. .++||+|||.+... .......+||+.|+|||++.+..+..+ +|||||||++|||++|+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKL 343 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCC
Confidence 6432 24899999987642 223345689999999999988887655 999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHhccc-------------------cC-CCC----------------CCCCCHHHHHHHHHccc
Q 022732 148 PFEDPDEPKDFRKTIQRILSVQ-------------------YS-VPD----------------TNPISQECRDLISRIFV 191 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~~~-------------------~~-~~~----------------~~~~s~~~~~li~~~L~ 191 (293)
||.+.+....+..+...+.... .. .+. ..-.+..+++||.+||+
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 9988765443332221110000 00 000 00024568899999999
Q ss_pred cCCCCCCCHHHHHcCcccccCCC
Q 022732 192 ADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 192 ~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
+||.+|||+.++|+||||.+..+
T Consensus 424 ~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 424 YDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred cChhhCCCHHHHhcCccccccCC
Confidence 99999999999999999987544
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=268.64 Aligned_cols=199 Identities=24% Similarity=0.323 Sum_probs=158.8
Q ss_pred CCcchhhhhceeee-----ceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVK-----MKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~-----~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.|+|++++++++.. ...+++|+ ||+.+ +|.+++..... ++ +++.++.|++.||.|||++|++||||||+
T Consensus 60 ~h~ni~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~ 137 (288)
T cd07863 60 DHPNIVRLMDVCATSRTDRETKVTLVF-EHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 137 (288)
T ss_pred CCCCeeeeeeeeccccCCCCceEEEEE-ccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 58999999999865 35689999 79885 88888876432 33 89999999999999999999999999999
Q ss_pred cEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 77 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 77 NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
||+++.++ .+||+|||+++............||+.|+|||++.+..++.+ +|+||+||++|+|++|++||.+.....
T Consensus 138 Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~ 214 (288)
T cd07863 138 NILVTSGG--QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEAD 214 (288)
T ss_pred HEEECCCC--CEEECccCccccccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHH
Confidence 99997655 599999999986544444445678999999999987776555 999999999999999999998877655
Q ss_pred HHHHHHHHHhccc-------cC-----C---------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 157 DFRKTIQRILSVQ-------YS-----V---------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 157 ~~~~~~~~~~~~~-------~~-----~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.+.++........ .. . .....++..++++|.+||++||.+|||+.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 215 QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 5544443221100 00 0 0012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=276.02 Aligned_cols=203 Identities=25% Similarity=0.373 Sum_probs=157.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 85 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~ 85 (293)
.|+|++++++++...+.+|+|| ||+.+++|..... .....+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 130 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~- 205 (353)
T PLN00034 130 NHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGTHI--ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK- 205 (353)
T ss_pred CCCCcceeeeEeccCCeEEEEE-ecCCCCccccccc--CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-
Confidence 5899999999999999999999 7999999865321 11227788999999999999999999999999999997654
Q ss_pred CCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhcc----ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 86 PRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 86 ~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.+||+|||+++..... .......||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||...... .+..
T Consensus 206 -~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~ 283 (353)
T PLN00034 206 -NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWAS 283 (353)
T ss_pred -CEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHH
Confidence 5999999998754322 22345679999999998743 233445699999999999999999999743322 1222
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
....+.. .........++.++++||.+||..||.+|||+.++++||||.+....
T Consensus 284 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 284 LMCAICM-SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred HHHHHhc-cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence 2222221 11222334578999999999999999999999999999999876443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=278.27 Aligned_cols=203 Identities=22% Similarity=0.352 Sum_probs=161.2
Q ss_pred CCcchhhhhceeeece-----eEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMK-----FVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~-----~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++...+ .+|+|+ ||+. ++|..++...+.+. .++.++.||+.||.|||++|++||||||+||
T Consensus 57 ~h~niv~~~~~~~~~~~~~~~~~~lv~-e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni 134 (372)
T cd07853 57 KHDNVLSALDILQPPHIDPFEEIYVVT-ELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNL 134 (372)
T ss_pred CCCCcCCHhheecCCCccccceEEEEe-eccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHE
Confidence 5899999999999887 899999 7987 57888887776665 8999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCC--CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
|++.++ .+||+|||+++..... .......+++.|+|||++.+......++||||+||++|+|++|+.||.+.+...
T Consensus 135 li~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 135 LVNSNC--VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred EECCCC--CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 997654 5999999998754322 122344689999999999876544555999999999999999999998876654
Q ss_pred HHHHHHHH-------------------HhccccCC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 157 DFRKTIQR-------------------ILSVQYSV-------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 157 ~~~~~~~~-------------------~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
.+..+... +....... ......+.++.+||.+||+.||.+|||+.++++||||.
T Consensus 213 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 292 (372)
T cd07853 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292 (372)
T ss_pred HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence 44333221 11111111 11234688999999999999999999999999999998
Q ss_pred cC
Q 022732 211 KN 212 (293)
Q Consensus 211 ~~ 212 (293)
..
T Consensus 293 ~~ 294 (372)
T cd07853 293 EG 294 (372)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=270.69 Aligned_cols=203 Identities=23% Similarity=0.393 Sum_probs=160.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...++.|+|| ||+.+ +|.+++...+. +. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 62 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~ 139 (309)
T cd07872 62 KHANIVTLHDIVHTDKSLTLVF-EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE 139 (309)
T ss_pred CCCCcceEEEEEeeCCeEEEEE-eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 5899999999999999999999 79986 78888866543 33 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++..... .......+|+.|+|||++.+......++|+||+||++|+|++|+.||.+.+..+.+..+
T Consensus 140 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 140 RG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217 (309)
T ss_pred CC--CEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 55 5999999998753322 22234568999999999876544455699999999999999999999887655444333
Q ss_pred HHHHhccc---------------cCCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQ---------------YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~---------------~~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
........ ...+ ....++.++++||.+||..||.+|||+.++++||||+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 218 FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred HHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 32211000 0011 112478899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=284.47 Aligned_cols=202 Identities=27% Similarity=0.414 Sum_probs=169.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH----HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV----QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~----~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
-|+|+|+++|.+.+..++-+.| |-+.||+|.++|+++ |++. ...+|.+||++||.|||.+.|||||||.+|+||
T Consensus 630 rHkNIVrYLGs~senGf~kIFM-EqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLv 708 (1226)
T KOG4279|consen 630 RHKNIVRYLGSVSENGFFKIFM-EQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLV 708 (1226)
T ss_pred hhHhHHHHhhccCCCCeEEEEe-ecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEE
Confidence 4899999999999999888888 799999999999876 6664 789999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCc-CCCCCCCCCcCCCCccchhhhcc-ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 81 DGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+.. .|.+||+|||-++.. +......+..||..|||||++.. ..-+++++|||||||++.||.||++||....++...
T Consensus 709 NTy-SGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA 787 (1226)
T KOG4279|consen 709 NTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA 787 (1226)
T ss_pred eec-cceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh
Confidence 764 356999999998753 34455567789999999999854 334577799999999999999999999887766543
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+-.+ +..+ ...|.+..+|.+++.||.+|+.++|..||++.++|..||++.+
T Consensus 788 MFkV-GmyK--vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 788 MFKV-GMYK--VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred hhhh-ccee--cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 3222 1222 2334455589999999999999999999999999999999755
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=283.51 Aligned_cols=201 Identities=33% Similarity=0.587 Sum_probs=184.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+||+|.+.+.+..+|+|| ||+.+|.+++++.+.+++. .++.++.|++.|++|||+++|||||||++|||++.+
T Consensus 113 ~HPnIvkl~~v~~t~~~lylV~-eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~ 191 (596)
T KOG0586|consen 113 NHPNIVKLFSVIETEATLYLVM-EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN 191 (596)
T ss_pred CCcceeeeeeeeeecceeEEEE-EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc
Confidence 5899999999999999999999 7999999999999999988 999999999999999999999999999999999877
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
-+ +||+|||++..........+.+|++.|.|||++.+.+|.++.+|+||+|+++|-|+.|..||.+.+- .....
T Consensus 192 mn--ikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----k~Lr~ 265 (596)
T KOG0586|consen 192 MN--IKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----KELRP 265 (596)
T ss_pred cc--eeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----ccccc
Confidence 65 9999999999888888889999999999999999999999999999999999999999999998664 44455
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
+.+...+.+|.. +|.++.++|+++|.++|.+|++.++++.|.|.......
T Consensus 266 rvl~gk~rIp~~--ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 266 RVLRGKYRIPFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hheeeeecccce--eechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 666777777776 89999999999999999999999999999998655443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=265.86 Aligned_cols=227 Identities=24% Similarity=0.433 Sum_probs=183.6
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
-+..+++...|++-+++|+|| ||+.||+|.-.|++-+++. .|..|++.|+-||-|||++||++||||.+||+++..+
T Consensus 409 ppFL~qlHScFQTmDRLyFVM-EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 409 PPFLVQLHSCFQTMDRLYFVM-EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG 487 (683)
T ss_pred CchHHHHHHHhhhhhheeeEE-EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC
Confidence 356789999999999999999 7999999999999999988 9999999999999999999999999999999997655
Q ss_pred CCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
++||+|||+++... ......+.+|||.|+|||++...+|. +++|+||+||++|||+.|++||.+.++...+..+..
T Consensus 488 --HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 488 --HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred --ceEeeecccccccccCCcceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 69999999998533 34556778999999999999988884 559999999999999999999999998666665554
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH-----HHHHcCcccccCCCCCccchhcccCCCCCCCCCCCCHH
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITI-----PEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVD 238 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
....+|.. +|.++.++++.+|.+.|.+|... .++..||||+.. ..+.......++++.+......+.+
T Consensus 565 ----hnvsyPKs--lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i-DWek~E~~eiqPPfkPk~k~~r~~e 637 (683)
T KOG0696|consen 565 ----HNVSYPKS--LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI-DWEKLERREIQPPFKPKIKCGRDAE 637 (683)
T ss_pred ----ccCcCccc--ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc-cHHHHhhccCCCCCCCccccCCchh
Confidence 34444443 89999999999999999999954 689999999753 3333334444444444433333333
Q ss_pred HHHHHH
Q 022732 239 VIMQII 244 (293)
Q Consensus 239 ~~~~~~ 244 (293)
.....+
T Consensus 638 NFD~~F 643 (683)
T KOG0696|consen 638 NFDKFF 643 (683)
T ss_pred hhhHHH
Confidence 333333
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=262.59 Aligned_cols=196 Identities=26% Similarity=0.389 Sum_probs=161.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++......|+|+ ||+.|++|.+++...+.+. .++.++.|++.||.|||++|++||||+|+||+++.+
T Consensus 62 ~~~~i~~~~~~~~~~~~~~~v~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~ 140 (263)
T cd06625 62 QHERIVQYYGCLRDDETLSIFM-EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA 140 (263)
T ss_pred CCCCeeeeEEEEccCCeEEEEE-EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 5899999999999999999999 7999999999998877665 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCC----CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+ +++|+|||+++........ ....|+..|+|||++.+..+. .++|+||+||++|++++|+.||...+......
T Consensus 141 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 217 (263)
T cd06625 141 G--NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217 (263)
T ss_pred C--CEEEeecccceeccccccccccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHH
Confidence 4 5999999998753322111 234678899999999877654 44999999999999999999998765433222
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.........+.+..++..+.++|.+||..+|.+|||+.++++|+||
T Consensus 218 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 218 ----KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ----HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 2222222333344588999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=277.81 Aligned_cols=202 Identities=23% Similarity=0.334 Sum_probs=159.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|......|+|| ||+. ++|..++...+.+. +++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 144 ~h~~iv~~~~~~~~~~~~~lv~-e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~ 221 (392)
T PHA03207 144 SHRAIINLIHAYRWKSTVCMVM-PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP 221 (392)
T ss_pred CCCCccceeeeEeeCCEEEEEe-hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 5899999999999999999999 6876 58888887666655 999999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc---hHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---PKD 157 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~---~~~ 157 (293)
+ .+||+|||+++....... .....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+... ...
T Consensus 222 ~--~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 298 (392)
T PHA03207 222 E--NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ 298 (392)
T ss_pred C--CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHH
Confidence 5 599999999875433221 234579999999999988777655 9999999999999999999977543 222
Q ss_pred HHHHHHHHhccccC-------------------------CCC---CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 158 FRKTIQRILSVQYS-------------------------VPD---TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 158 ~~~~~~~~~~~~~~-------------------------~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+..++..+...... .+. ...++.++++||.+||..||.+|||+.++|.||||
T Consensus 299 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 299 LRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred HHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 22322221111100 000 01246789999999999999999999999999999
Q ss_pred ccC
Q 022732 210 LKN 212 (293)
Q Consensus 210 ~~~ 212 (293)
.+.
T Consensus 379 ~~~ 381 (392)
T PHA03207 379 TKE 381 (392)
T ss_pred hcc
Confidence 764
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.08 Aligned_cols=200 Identities=28% Similarity=0.380 Sum_probs=173.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+++.+|.+--.|++.+.+|+|+ ..+.||+|.-.|-+.+. +. .+++|+++|+.||++||..+||+||+||+|||+|
T Consensus 243 ~s~FiVslaYAfeTkd~LClVL-tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD 321 (591)
T KOG0986|consen 243 SSPFIVSLAYAFETKDALCLVL-TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD 321 (591)
T ss_pred ccCcEEEEeeeecCCCceEEEE-EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec
Confidence 3456777778899999999999 59999999988877663 33 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
..+ +++|+|+|+|..+.........+||..|||||++....|+.. +|+|||||++|+|+.|..||..........++
T Consensus 322 d~G--hvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv 398 (591)
T KOG0986|consen 322 DHG--HVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV 398 (591)
T ss_pred cCC--CeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHH
Confidence 665 599999999998877777777799999999999998888766 89999999999999999999887665554555
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCccccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~ 211 (293)
-++++......+ ..+|++++++.+.+|++||.+|. +++++.+||||+.
T Consensus 399 drr~~~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 399 DRRTLEDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHhcchhhcc--cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 566665555554 45899999999999999999998 5689999999986
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=274.59 Aligned_cols=201 Identities=27% Similarity=0.395 Sum_probs=153.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|+ ||+. ++|.+++... ..+. +++.++.||+.||.|||++||+||||||+|||++.
T Consensus 115 ~h~~iv~~~~~~~~~~~~~lv~-e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 192 (357)
T PHA03209 115 NHPSVIRMKDTLVSGAITCMVL-PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND 192 (357)
T ss_pred CCCCCcChhheEEeCCeeEEEE-EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 5899999999999999999999 6885 5888888654 3344 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC-CCCCch------
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEP------ 155 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~~~~~------ 155 (293)
.+ .+||+|||+++............||+.|+|||++.+..+..+ +|+||+||++|+|+++..++ ......
T Consensus 193 ~~--~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~ 269 (357)
T PHA03209 193 VD--QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269 (357)
T ss_pred CC--CEEEecCccccccccCcccccccccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHH
Confidence 55 499999999875433333445679999999999988777655 99999999999999865444 332211
Q ss_pred ---HHHHHHHHHHhccccCCC----------------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 022732 156 ---KDFRKTIQRILSVQYSVP----------------------------DTNPISQECRDLISRIFVADPAARITIPEIM 204 (293)
Q Consensus 156 ---~~~~~~~~~~~~~~~~~~----------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 204 (293)
..+..++.........++ ....++.++.+||.+||+.||.+|||+.++|
T Consensus 270 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l 349 (357)
T PHA03209 270 SCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349 (357)
T ss_pred HHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence 111111111110000011 0123567888899999999999999999999
Q ss_pred cCccccc
Q 022732 205 KHQWFLK 211 (293)
Q Consensus 205 ~h~~~~~ 211 (293)
+||||++
T Consensus 350 ~hp~f~~ 356 (357)
T PHA03209 350 NYPMFAQ 356 (357)
T ss_pred cCchhcc
Confidence 9999974
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=271.03 Aligned_cols=203 Identities=26% Similarity=0.447 Sum_probs=158.6
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
..|+|++++++.|...+++|+|| ||+.||+|.+++.+. ..+. .++.++.||+.||+|||++|++||||||+|||++
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 136 (331)
T cd05597 58 GDRRWITNLHYAFQDENNLYLVM-DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136 (331)
T ss_pred CCCCCCCceEEEEecCCeEEEEE-ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC
Confidence 46899999999999999999999 799999999999763 3444 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhcc----ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
.++ .+||+|||++........ .....||+.|+|||++.+ ....+.++|+||+||++|+|++|+.||.+....
T Consensus 137 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 137 KNG--HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred CCC--CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 654 599999999875433222 123469999999999863 223344599999999999999999999876654
Q ss_pred HHHHHHHHHHhccccCCC-CCCCCCHHHHHHHHHccccCCCC--CCCHHHHHcCcccccC
Q 022732 156 KDFRKTIQRILSVQYSVP-DTNPISQECRDLISRIFVADPAA--RITIPEIMKHQWFLKN 212 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~ 212 (293)
.....+.... .....+ ....++.++++||++||..++++ |+++.++++||||...
T Consensus 215 ~~~~~i~~~~--~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 215 ETYGKIMNHK--EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHcCC--CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 4433332211 111122 22347999999999998764443 7899999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=266.28 Aligned_cols=200 Identities=25% Similarity=0.380 Sum_probs=160.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+|++++.+++.+...+++|+|| ||+.|++|..++...+. +. .+..++.|++.||.|||++|++||||||+||+++
T Consensus 58 ~~~~i~~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~ 136 (285)
T cd05630 58 NSRFVVSLAYAYETKDALCLVL-TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD 136 (285)
T ss_pred CCCCeeeeeEEEecCCEEEEEE-EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC
Confidence 5789999999999999999999 79999999999865432 33 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ .++|+|||++.............|++.|+|||++.+..++.+ +|+||+||++|+|++|+.||.......... .
T Consensus 137 ~~~--~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~ 212 (285)
T cd05630 137 DHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKRE-E 212 (285)
T ss_pred CCC--CEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHH-H
Confidence 654 599999999875543334345679999999999987776555 999999999999999999998754321111 1
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCccccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~ 211 (293)
....... ........++.++.+|+.+||+.||.+||| +.++++||||++
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 213 VERLVKE-VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHhhhhh-hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 1111110 111123347899999999999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.14 Aligned_cols=197 Identities=26% Similarity=0.424 Sum_probs=161.8
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|++++++.|...+..|+|| ||+.+++|.+++...+.+. +++.++.|++.||.|||+.|++||||||+||+++.
T Consensus 66 ~~h~~iv~~~~~~~~~~~~~iv~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~ 144 (267)
T PHA03390 66 KDNPNFIKLYYSVTTLKGHVLIM-DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144 (267)
T ss_pred hcCCCEEEEEEEEecCCeeEEEE-EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC
Confidence 36899999999999999999999 7999999999998876555 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH-HHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~ 161 (293)
++ ++++|+|||+++.... .....|+..|+|||++.+..++.+ +|+||+||++|+|++|+.||........ ....
T Consensus 145 ~~-~~~~l~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T PHA03390 145 AK-DRIYLCDYGLCKIIGT---PSCYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219 (267)
T ss_pred CC-CeEEEecCccceecCC---CccCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH
Confidence 65 2599999999875432 234468999999999988777555 9999999999999999999986543221 1122
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-HHHHHcCcccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-IPEIMKHQWFL 210 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~ell~h~~~~ 210 (293)
.... ....+....+++.+++||.+||+++|.+||+ ++++++||||+
T Consensus 220 ~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 220 LKRQ---QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHhh---cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 2221 1122333458999999999999999999996 69999999996
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=271.12 Aligned_cols=202 Identities=24% Similarity=0.440 Sum_probs=158.7
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
..|++++++++.+...++.|+|| ||+.||+|.+++.+. +.+. .++.++.||+.||.|||++|++||||||+|||++
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~-ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~ 136 (332)
T cd05623 58 GDNQWITTLHYAFQDENNLYLVM-DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136 (332)
T ss_pred CCCCCEeeEEEEEecCCEEEEEE-eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC
Confidence 47889999999999999999999 799999999999773 4444 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhcc----ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
.++ ++||+|||++........ ....+||+.|+|||++.+ ....+.++|+||+||++|+|++|+.||...+..
T Consensus 137 ~~~--~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 137 MNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred CCC--CEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 654 599999999875322221 223579999999999863 222344599999999999999999999887654
Q ss_pred HHHHHHHHHHhccccCCCC-CCCCCHHHHHHHHHccccCCCC--CCCHHHHHcCccccc
Q 022732 156 KDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVADPAA--RITIPEIMKHQWFLK 211 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~h~~~~~ 211 (293)
..+..+.... ....+|. ...++.++++||++||..++.+ |+++.++++||||..
T Consensus 215 ~~~~~i~~~~--~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 215 ETYGKIMNHK--ERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHhCCC--ccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 4433332211 1112222 2357999999999999765554 689999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=264.16 Aligned_cols=190 Identities=20% Similarity=0.174 Sum_probs=156.1
Q ss_pred CCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~NI 78 (293)
.|+|++++++++.+ ...+++|| ||+.||+|.+++.+.+.+. .+..++.|++.||.|||+. +++||||||+||
T Consensus 76 ~h~nIv~~~g~~~~~~~~~~~~~lv~-Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~ni 154 (283)
T PHA02988 76 DSNNILKIYGFIIDIVDDLPRLSLIL-EYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSF 154 (283)
T ss_pred CCCCEEEEeeeEEecccCCCceEEEE-EeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhE
Confidence 57899999999987 46789999 7999999999998877665 8899999999999999984 999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc--ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
+++.++ .+||+|||+++.... ......|++.|+|||++.+ ..++.+ +||||+||++|+|++|+.||.+.+...
T Consensus 155 ll~~~~--~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~ 229 (283)
T PHA02988 155 LVTENY--KLKIICHGLEKILSS--PPFKNVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTTKE 229 (283)
T ss_pred EECCCC--cEEEcccchHhhhcc--ccccccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence 997665 599999999875422 2234578999999999876 455444 999999999999999999998776533
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
. ...+.......+.+..++..+++++.+||+.||.+|||+.++++
T Consensus 230 ~----~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 230 I----YDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred H----HHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 3 23333333334444458899999999999999999999999986
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=262.84 Aligned_cols=202 Identities=26% Similarity=0.351 Sum_probs=161.6
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.+.|+|++++++.+...+..|+|| ||+.|++|..++...+.+. .+..++.|++.||.|||++|++||||||+||+++
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~ 131 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFIL-DLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD 131 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEE-ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC
Confidence 356899999999999999999999 7999999999998877666 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ .++|+|||++...... ......|++.|+|||.+.+......++|+||+||++|+|++|..||........ ...
T Consensus 132 ~~~--~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~ 207 (279)
T cd05633 132 EHG--HVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI 207 (279)
T ss_pred CCC--CEEEccCCcceecccc-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHH
Confidence 655 5999999998754322 223457999999999986433334459999999999999999999976543221 111
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
....... ....+..++.+++++|.+||..||.+|+ ++.++++||||+..
T Consensus 208 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 208 DRMTLTV--NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HHHhhcC--CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 1111111 2222344889999999999999999999 69999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=266.76 Aligned_cols=202 Identities=23% Similarity=0.324 Sum_probs=149.2
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHcC---------CHH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLLG---------LLV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~~---------~~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
.|+|+++++++|.. ...+|+|+ ||+.+ +|..++.... .++ .++.++.||+.||.|||++|++|||
T Consensus 56 ~h~niv~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrD 133 (317)
T cd07868 56 KHPNVISLQKVFLSHADRKVWLLF-DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 133 (317)
T ss_pred CCCCCcceeeeEecCCCcEEEEEE-eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 58999999999854 46788898 68765 7888775321 233 7899999999999999999999999
Q ss_pred CCCCcEEEcCC--CCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCC
Q 022732 73 LKLENTLLDGS--PAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 73 lkp~NIl~~~~--~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 146 (293)
|||+|||+... ..+.+||+|||+++...... ......||+.|+|||++.+....+.++|+||+||++|+|++|+
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 213 (317)
T cd07868 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred CCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999532 23469999999997543221 2234578999999999987554455699999999999999999
Q ss_pred CCCCCCCch---------HHHHHHHHHHh------------------------ccccCC--------CCCCCCCHHHHHH
Q 022732 147 YPFEDPDEP---------KDFRKTIQRIL------------------------SVQYSV--------PDTNPISQECRDL 185 (293)
Q Consensus 147 ~pf~~~~~~---------~~~~~~~~~~~------------------------~~~~~~--------~~~~~~s~~~~~l 185 (293)
.||...... ..+..+..... ...... ......+..+.+|
T Consensus 214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 293 (317)
T cd07868 214 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 293 (317)
T ss_pred CCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHH
Confidence 999754321 11111111000 000000 0011235678999
Q ss_pred HHHccccCCCCCCCHHHHHcCccc
Q 022732 186 ISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 186 i~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
|.+||++||.+|||++++|+||||
T Consensus 294 i~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 294 LQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=259.11 Aligned_cols=200 Identities=30% Similarity=0.499 Sum_probs=165.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.+.+.+..|+|+ ||..+++|.+++.+...+. .+..++.||+.||.|||++|++|+||+|.||+++.+
T Consensus 51 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~ 129 (262)
T cd05572 51 NHPFIVKLYRTFKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN 129 (262)
T ss_pred CCCCEeeeeeeEEcCCccEEEE-ecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC
Confidence 6899999999999999999999 7999999999998876655 888999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .++|+|||++.............|++.|+|||.+.+..++.+ +|+||+||++|++++|..||....... .....
T Consensus 130 ~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~ 204 (262)
T cd05572 130 G--YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDP--MEIYN 204 (262)
T ss_pred C--CEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHH
Confidence 5 599999999986544333445578999999999877766555 899999999999999999998766211 22333
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCccccc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLK 211 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~ 211 (293)
.+.......+.+...+.+++++|.+||..+|.+||+ +.++++||||+.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 333222223333346899999999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=258.49 Aligned_cols=200 Identities=30% Similarity=0.458 Sum_probs=162.5
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
...|+|++++++++...+..|+|+ ||+.|++|.++++..+.++ .+..++.|++.||.|||++|++||||+|+||+++
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~ 131 (260)
T cd05611 53 QGESPYVAKLYYSFQSKDYLYLVM-EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131 (260)
T ss_pred cCCCCCeeeeeeeEEcCCeEEEEE-eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 347899999999999999999999 7999999999998876655 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ .+||+|||++..... .....|++.|+|||.+.+..++ .++|+||+|+++|++++|..||...+....+..+
T Consensus 132 ~~~--~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 205 (260)
T cd05611 132 QTG--HLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205 (260)
T ss_pred CCC--cEEEeecccceeccc---cccCCCCcCccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 654 599999999875322 3345688999999998876654 4599999999999999999999876654333222
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC---CHHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~ell~h~~~~~~ 212 (293)
..... .........+++.+.++|.+||+.+|++|| ++++++.||||++.
T Consensus 206 ~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 206 LSRRI--NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred Hhccc--CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 22111 111112234789999999999999999999 55799999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.16 Aligned_cols=199 Identities=31% Similarity=0.526 Sum_probs=159.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++......|+|| ||+.+++|.+++...+.+. .+..++.||+.||.+||++|++|+||||+||+++.+
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~-~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~ 134 (260)
T PF00069_consen 56 RHPNIVQILDVFQDDNYLYIVM-EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN 134 (260)
T ss_dssp TBTTBCHEEEEEEESSEEEEEE-EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT
T ss_pred cccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5899999999999999999999 7999999999998666655 999999999999999999999999999999999755
Q ss_pred CCCCEEEecCCCCcCc-CCCCCCCCCcCCCCccchhhhc-cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 PAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
+ .++|+|||.+... ..........+++.|+|||++. +... ..++|+||+|+++|+|++|..||...........
T Consensus 135 ~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~- 210 (260)
T PF00069_consen 135 G--EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI- 210 (260)
T ss_dssp S--EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH-
T ss_pred c--ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccchhhhhh-
Confidence 4 5999999998742 2233445567899999999987 4444 4559999999999999999999998732222222
Q ss_pred HHHHhcccc--CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 162 IQRILSVQY--SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 162 ~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
......... ........+..+.++|.+||+.||++|||+.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 211 IEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 222111111 111111234899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=268.52 Aligned_cols=201 Identities=23% Similarity=0.357 Sum_probs=154.8
Q ss_pred CCcchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.|+|+++++++|... ...|+++ +++ +++|..++.... +. .++.++.||+.||.|||++||+||||||+|
T Consensus 72 ~h~~iv~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~l~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~N 148 (343)
T cd07878 72 KHENVIGLLDVFTPATSIENFNEVYLVT-NLM-GADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSN 148 (343)
T ss_pred CCCchhhhhhhhcccccccccCcEEEEe-ecC-CCCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCeecccCChhh
Confidence 589999999988643 4578888 566 778988876533 43 899999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
|+++.++ .+||+|||+++.... ......||+.|+|||++.+....+.++|+||+||++|+|++|+.||.+.+....
T Consensus 149 il~~~~~--~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 224 (343)
T cd07878 149 VAVNEDC--ELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ 224 (343)
T ss_pred EEECCCC--CEEEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9997655 599999999985432 334567999999999987744445559999999999999999999987665444
Q ss_pred HHHHHHHHhccc-------------------cCCCC------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 158 FRKTIQRILSVQ-------------------YSVPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 158 ~~~~~~~~~~~~-------------------~~~~~------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+..+........ ...+. ....++.+.+||.+||..||.+|||+.+++.||||.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 225 LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 333322110000 00000 12356788999999999999999999999999999764
Q ss_pred C
Q 022732 213 L 213 (293)
Q Consensus 213 ~ 213 (293)
.
T Consensus 305 ~ 305 (343)
T cd07878 305 H 305 (343)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=263.05 Aligned_cols=203 Identities=24% Similarity=0.395 Sum_probs=159.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|+ ||+. ++|.+++...+ .+. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 62 ~h~nI~~~~~~~~~~~~~~lv~-e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~ 139 (301)
T cd07873 62 KHANIVTLHDIIHTEKSLTLVF-EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE 139 (301)
T ss_pred CCCCcceEEEEEecCCeEEEEE-eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECC
Confidence 5899999999999999999999 7997 48888887643 233 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||++....... ......+++.|+|||++.+....+.++|+||+||++|+|++|+.||...+.......+
T Consensus 140 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 140 RG--ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred CC--cEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 55 59999999987533222 2234467899999999876554455699999999999999999999887654443333
Q ss_pred HHHHhcc---------------ccCCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSV---------------QYSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~---------------~~~~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
....... ....+. ...+++.+++||.+||+.||.+|||++++++||||+.-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 218 FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred HHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 2211100 000111 12478899999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=275.90 Aligned_cols=198 Identities=22% Similarity=0.398 Sum_probs=165.5
Q ss_pred CCcchhhhhceeeecee--EEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKF--VFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQ--VCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~--~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~--iiHrdlkp~NIl 79 (293)
.|+|+|+||.+|.+.+. +.+|+ |.+.+|+|+.|+++.+++. .++.|++||++||.|||++. |||||||-+|||
T Consensus 99 ~H~NIirfy~SW~d~~n~~in~iT-EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIF 177 (632)
T KOG0584|consen 99 KHPNIIRFYDSWVDTDNKTINFIT-ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIF 177 (632)
T ss_pred CCCceeeeeeheecCCCceeeeee-ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEE
Confidence 48999999999998866 88888 7999999999999988766 89999999999999999985 999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
|+.+ .|.|||+|+|+|+... .....+.+|||.|||||+.. ..|+.. +||||||+++.||+|+.+||....+..++.
T Consensus 178 inG~-~G~VKIGDLGLAtl~r-~s~aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY 253 (632)
T KOG0584|consen 178 VNGN-LGEVKIGDLGLATLLR-KSHAKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIY 253 (632)
T ss_pred EcCC-cCceeecchhHHHHhh-ccccceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHH
Confidence 9744 4689999999998653 34445689999999999975 778776 999999999999999999999988876554
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+ ++..+..+-....--.+++++||.+||.. .+.|+|+.|||+||||...
T Consensus 254 K---KV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 254 K---KVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred H---HHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 4 33332211111111258999999999999 9999999999999999764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=268.23 Aligned_cols=201 Identities=26% Similarity=0.472 Sum_probs=158.9
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
..|++++++++++...++.|+|| ||+.||+|..++.+. +.+. .++.++.|++.||+|||++||+||||||+|||++
T Consensus 58 ~~~~~i~~l~~~~~~~~~~~lv~-Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~ 136 (331)
T cd05624 58 GDCQWITTLHYAFQDENYLYLVM-DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136 (331)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEE-eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc
Confidence 57899999999999999999999 799999999999873 4444 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhcc-----ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
.++ .+||+|||+++....... .....||+.|+|||++.+ ..+ +.++|+||+||++|+|++|+.||...+.
T Consensus 137 ~~~--~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 137 MNG--HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY-GPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred CCC--CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCC-CCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 654 599999999875433222 123569999999999865 233 3459999999999999999999987665
Q ss_pred hHHHHHHHHHHhccccCCCC-CCCCCHHHHHHHHHccccCCCC--CCCHHHHHcCccccc
Q 022732 155 PKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVADPAA--RITIPEIMKHQWFLK 211 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~h~~~~~ 211 (293)
...+..+.... ....+|. ...++.+++++|.+||...+++ |++++++++||||..
T Consensus 214 ~~~~~~i~~~~--~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 214 VETYGKIMNHE--ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHcCC--CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 44333322211 1112222 2347899999999999876654 568999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=259.24 Aligned_cols=198 Identities=24% Similarity=0.341 Sum_probs=156.8
Q ss_pred CCCCcchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCC
Q 022732 4 VGSSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDL 73 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdl 73 (293)
+..|+|+++++++|... .++|+|+ ||+.+++|.+++.... .+. .+..++.|++.||+|||+++++||||
T Consensus 59 ~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~-e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl 137 (272)
T cd06637 59 YSHHRNIATYYGAFIKKNPPGMDDQLWLVM-EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 137 (272)
T ss_pred hcCCCCeeeEeeEEeecCCCCCCcEEEEEE-EcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 35699999999999753 5789999 7999999999998643 333 78899999999999999999999999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhcc-----ccCCCchhhhhhhhhHHHHHHhCCC
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGY 147 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~ 147 (293)
||+||+++.++ .+||+|||++...... .......|++.|+|||++.+ ..++. ++|+||+||++|+|++|+.
T Consensus 138 ~~~nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 138 KGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred CHHHEEECCCC--CEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCc-hhhHHHHHHHHHHHHhCCC
Confidence 99999997665 4999999998754322 23345678999999999863 23433 4999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 148 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
||........... .............++.++++|+.+||..+|.+|||+.++++||||
T Consensus 215 p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 215 PLCDMHPMRALFL----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CccccCHHHHHHH----HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 9976544322211 112222222234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=261.00 Aligned_cols=201 Identities=24% Similarity=0.368 Sum_probs=164.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|++++++++.+...+..|+|+ ||+.+++|..++...+ .++ .+..++.|++.||.|||++||+||||||+||+++
T Consensus 58 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~ 136 (285)
T cd05632 58 NSQFVVNLAYAYETKDALCLVL-TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136 (285)
T ss_pred CCcCceeEEEEEecCCEEEEEE-EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC
Confidence 5789999999999999999999 7999999998886543 233 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ .+||+|||++.............|++.|+|||++.+..++.+ +|+||+||++|++++|..||.+.........+
T Consensus 137 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~ 213 (285)
T cd05632 137 DYG--HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213 (285)
T ss_pred CCC--CEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 654 599999999875443333445679999999999987776555 89999999999999999999876554333333
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~ 212 (293)
...+...... ....++.++.+|+.+||+.||.+||+ +.+++.|+||+..
T Consensus 214 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 214 DRRVLETEEV--YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHhhhccccc--cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 3333333222 23347899999999999999999999 8899999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=257.11 Aligned_cols=195 Identities=30% Similarity=0.412 Sum_probs=160.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...++.++|+ ||+.+++|..++...+.+. .+..++.|++.||.|||++|++||||+|+||+++.+
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~ 142 (267)
T cd06628 64 QHENIVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK 142 (267)
T ss_pred CCCCeeeEEEEEEeCCccEEEE-EecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC
Confidence 5899999999999999999999 7999999999998877766 888999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC-------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 84 PAPRLKICDFGYSKSSVLHS-------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
+ .+||+|||.++...... ......|++.|+|||.+.+..+..+ +|+||+||++|+|++|+.||.......
T Consensus 143 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~ 219 (267)
T cd06628 143 G--GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQ 219 (267)
T ss_pred C--CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHH
Confidence 4 59999999987543211 1123458899999999887766545 899999999999999999998765533
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...... .. .....+..++..+.++|++||+++|.+||++.++++||||
T Consensus 220 ~~~~~~----~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 220 AIFKIG----EN-ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHh----cc-CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 322211 11 1112233478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=260.29 Aligned_cols=202 Identities=23% Similarity=0.373 Sum_probs=159.8
Q ss_pred CCCCCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 3 PVGSSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.+.+|+|.+++++++.+. +..|+|+ ||+.+ +|.+.+... +.+. .++.++.|++.||+|||++|++||||||.|
T Consensus 53 ~l~~h~~i~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~n 130 (282)
T cd07831 53 RLSPHPNILRLIEVLFDRKTGRLALVF-ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPEN 130 (282)
T ss_pred hcCCCCCccceEEEEecCCCCcEEEEE-ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHH
Confidence 355799999999999988 8999999 79975 788888664 3334 899999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
|+++. +.+||+|||+++............+++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+....
T Consensus 131 i~l~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 131 ILIKD---DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred EEEcC---CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 99977 469999999998654444444556899999999876555555569999999999999999999988765443
Q ss_pred HHHHHHHHhc--------------cccCCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 158 FRKTIQRILS--------------VQYSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 158 ~~~~~~~~~~--------------~~~~~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+..+...... .....+. ...++..+.++|.+||.++|.+|||+.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 208 IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 3333221100 0011111 12468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=258.96 Aligned_cols=201 Identities=26% Similarity=0.372 Sum_probs=163.3
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+.|++++++++.+...+..|+|+ ||+.|++|..++...+.+. .++.++.|++.||.|||+++++||||||+||+++.
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~~v~-e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~ 132 (278)
T cd05606 54 GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 132 (278)
T ss_pred CCCCcEeeeeeeeecCCEEEEEE-ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC
Confidence 57899999999999999999999 7999999999998777655 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccc-cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||++..... .......|+..|+|||++.+. .++ .++|+||+||++|+|++|+.||........ ...
T Consensus 133 ~~--~~kl~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~-~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~ 207 (278)
T cd05606 133 HG--HVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI 207 (278)
T ss_pred CC--CEEEccCcCccccCc-cCCcCcCCCcCCcCcHHhcCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCCccch-HHH
Confidence 54 599999999875432 223445799999999998754 444 449999999999999999999987633211 112
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccCC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNL 213 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~~ 213 (293)
........... +..+|.++.+++.+||..+|.+|| ++.++++||||+...
T Consensus 208 ~~~~~~~~~~~--~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 208 DRMTLTMAVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHHhhccCCCC--CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 22222222222 334789999999999999999999 999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=260.03 Aligned_cols=200 Identities=24% Similarity=0.390 Sum_probs=156.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC---CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG---LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~---~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
+|+|++++++++...++.|+|| ||+. ++|.+++.... .+. .++.++.||+.||.|||++|++||||||+||++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~-e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~ 134 (285)
T cd07861 57 QHPNIVCLQDVLMQESRLYLIF-EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI 134 (285)
T ss_pred CCCCEeeeEEEEeeCCeEEEEE-ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE
Confidence 4899999999999999999999 7997 58888886532 333 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+.++ .+||+|||++....... ......+++.|+|||++.+......++|+||+||++|+|++|+.||.+........
T Consensus 135 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~ 212 (285)
T cd07861 135 DNKG--VIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212 (285)
T ss_pred cCCC--cEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 7655 59999999987543222 22334678999999998765443455999999999999999999998766544333
Q ss_pred HHHHHHhcc--------------ccCC---------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 160 KTIQRILSV--------------QYSV---------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 160 ~~~~~~~~~--------------~~~~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
......... .... .....++++++++|++||+.||.+|||+.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 213 RIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 322211100 0000 0123478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=267.75 Aligned_cols=194 Identities=22% Similarity=0.364 Sum_probs=152.1
Q ss_pred CCCCcchhhhhceeeece-eEEEeehhhccCchhHHHHHHcCC-------------------------------------
Q 022732 4 VGSSSSEYAMLGVSVKMK-FVFLSLSFFFSLCLFFMWLLLLGL------------------------------------- 45 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~-~~~lv~~ey~~gg~L~~~l~~~~~------------------------------------- 45 (293)
++.|+|++++++++...+ .+|+|| ||+.+|+|.+++.....
T Consensus 67 l~~h~niv~~~~~~~~~~~~~~lv~-ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (338)
T cd05102 67 IGNHLNVVNLLGACTKPNGPLMVIV-EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVL 145 (338)
T ss_pred hccCcceeeEEeEecCCCCceEEEE-ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcc
Confidence 457999999999887654 578888 79999999999976421
Q ss_pred -------------------------HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 46 -------------------------LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 46 -------------------------~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
+. .+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~ 223 (338)
T cd05102 146 FSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARD 223 (338)
T ss_pred ccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccc
Confidence 22 6678999999999999999999999999999997654 599999999975
Q ss_pred cCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 022732 99 SVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD 174 (293)
Q Consensus 99 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (293)
..... ......+++.|+|||++.+..++.+ +||||+||++|+|++ |..||.+......+...+ ... .....
T Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~-~~~~~ 298 (338)
T cd05102 224 IYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL---KDG-TRMRA 298 (338)
T ss_pred cccCcchhcccCCCCCccccCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---hcC-CCCCC
Confidence 42221 1123346788999999987777655 999999999999997 999998765433322222 111 12223
Q ss_pred CCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 175 TNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 175 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+..+++++.+++.+||..||.+|||+.++++
T Consensus 299 ~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 299 PENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=259.03 Aligned_cols=201 Identities=21% Similarity=0.348 Sum_probs=160.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...++.|+|+ ||+.++.|..++.....+. +++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 58 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~ 136 (286)
T cd07847 58 KHPNLVNLIEVFRRKRKLHLVF-EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ 136 (286)
T ss_pred CCCCEeeeeeEEeeCCEEEEEE-eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC
Confidence 4899999999999999999999 7999999988887665555 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ ++||+|||++....... ......++..|+|||++.+....+.++|+||+||++|+|++|+.||.+.........+.
T Consensus 137 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 214 (286)
T cd07847 137 G--QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR 214 (286)
T ss_pred C--cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 5 59999999987543332 22345688999999998764444455999999999999999999998876654443333
Q ss_pred HHHhcc---------------ccCCCC----------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 163 QRILSV---------------QYSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 163 ~~~~~~---------------~~~~~~----------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...... ....+. ...++..+.+||.+||.++|++|||+.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 215 KTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 211100 000010 12367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.52 Aligned_cols=200 Identities=26% Similarity=0.366 Sum_probs=167.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
-|+|+|++||+=.....+|+.| |||+||+|.++++..+... ..+.|..|++.|+.|||+.|||||||||.||+++.+
T Consensus 1292 nHpNlV~YyGVEvHRekv~IFM-EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~ 1370 (1509)
T KOG4645|consen 1292 NHPNLVRYYGVEVHREKVYIFM-EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN 1370 (1509)
T ss_pred cCccccccCceeecHHHHHHHH-HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC
Confidence 4899999999999999999999 7999999999999887776 778999999999999999999999999999999877
Q ss_pred CCCCEEEecCCCCcCcCCCC-----CCCCCcCCCCccchhhhcccc--CCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 84 PAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
+ .+|++|||.|.....+. ..+...||+-|||||++.+.+ -.+.++||||||||+.||+||+.||...++.-
T Consensus 1371 g--~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1371 G--LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred C--cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence 6 59999999998654432 234568999999999998744 23455999999999999999999999877654
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+++- ++..+ ...+.+..+|++.++||.+||..||++|.++.+++.|.|-+..
T Consensus 1449 aIMy---~V~~g-h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1449 AIMY---HVAAG-HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHh---HHhcc-CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 4333 32222 2233445599999999999999999999999999999986544
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=266.70 Aligned_cols=202 Identities=18% Similarity=0.309 Sum_probs=154.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+++++++|...+..|+|+ ||+.+|+|.+++... +.++ .++.++.|++.||.|||++|++||||||+|||++
T Consensus 57 ~hpniv~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~ 135 (327)
T cd08227 57 NHPNIVPYRATFIADNELWVVT-SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 135 (327)
T ss_pred CCCCeeeEEEEEEECCEEEEEE-eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe
Confidence 7999999999999999999999 799999999999753 2233 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--------CCCCCcCCCCccchhhhccc--cCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
.++ .++++||+.+....... ......++..|+|||++.+. .++ .++|+||+||++|+|++|+.||..
T Consensus 136 ~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 136 VDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cCC--cEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCC
Confidence 655 49999998654321111 11223567789999998753 354 459999999999999999999986
Q ss_pred CCchHHHHHHHHHHhccc----------------------------------------cCCCCCCCCCHHHHHHHHHccc
Q 022732 152 PDEPKDFRKTIQRILSVQ----------------------------------------YSVPDTNPISQECRDLISRIFV 191 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~s~~~~~li~~~L~ 191 (293)
.................. ...+....+++.+.+||.+||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 292 (327)
T cd08227 213 MPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQ 292 (327)
T ss_pred cchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHh
Confidence 544332222211100000 0001112357889999999999
Q ss_pred cCCCCCCCHHHHHcCccccc
Q 022732 192 ADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 192 ~dp~~Rpt~~ell~h~~~~~ 211 (293)
.||++|||++++++||||++
T Consensus 293 ~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 293 RNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hCchhcCCHHHHhcChhhhh
Confidence 99999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=260.25 Aligned_cols=195 Identities=30% Similarity=0.507 Sum_probs=163.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
+|+|++++++.+...+..|+|| ||+.+++|.+++.+.+.++ .+..++.||+.||.|||++|++||||+|.||+++.+
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~ 137 (290)
T cd05580 59 RHPFLVNLYGSFQDDSNLYLVM-EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD 137 (290)
T ss_pred CCCCccceeeEEEcCCeEEEEE-ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC
Confidence 4899999999999999999999 7999999999998887766 888999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||+++..... .....|++.|+|||.+.+...+. ++|+||||+++|+|++|+.||....... ..+
T Consensus 138 ~--~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~ 208 (290)
T cd05580 138 G--YIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGK-AVDWWALGILIYEMLAGYPPFFDDNPIQ----IYE 208 (290)
T ss_pred C--CEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCHHH----HHH
Confidence 4 5999999998764332 34456899999999987766544 4999999999999999999998766422 223
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
.+.......+ ..++..++++|.+||..+|.+|+ +++++++||||...
T Consensus 209 ~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 209 KILEGKVRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHhcCCccCC--ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 3333333333 34789999999999999999999 89999999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=262.67 Aligned_cols=199 Identities=30% Similarity=0.488 Sum_probs=163.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+|+|++++++.+...++.|+|| ||+.|++|.+++... ..+. .++.++.|++.||.|||++|++||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~ 137 (316)
T cd05574 59 DHPFLPTLYASFQTETYLCLVM-DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH 137 (316)
T ss_pred CCCCchhheeeeecCCEEEEEE-EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc
Confidence 4889999999999999999999 799999999999764 2334 8888999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC------------------------------CCCCCcCCCCccchhhhccccCCCchhh
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIAD 131 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~D 131 (293)
.++ .++|+|||++....... ......||..|+|||++.+..++. ++|
T Consensus 138 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~D 214 (316)
T cd05574 138 ESG--HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AVD 214 (316)
T ss_pred CCC--CEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc-hHH
Confidence 654 59999999976432111 112346889999999998777654 499
Q ss_pred hhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC----HHHHHcCc
Q 022732 132 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT----IPEIMKHQ 207 (293)
Q Consensus 132 vwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt----~~ell~h~ 207 (293)
+||+||++|+|++|..||.+.+....+..+ .......+....++..+.++|.+||..+|++||| +.+++.||
T Consensus 215 i~slG~ll~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 215 WWTLGILLYEMLYGTTPFKGSNRDETFSNI----LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHHHHHhhCCCCCCCCchHHHHHHH----hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 999999999999999999887764444333 2333344444447899999999999999999999 99999999
Q ss_pred ccccC
Q 022732 208 WFLKN 212 (293)
Q Consensus 208 ~~~~~ 212 (293)
||+..
T Consensus 291 ~~~~~ 295 (316)
T cd05574 291 FFRGV 295 (316)
T ss_pred hhhcC
Confidence 99763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=259.98 Aligned_cols=202 Identities=21% Similarity=0.319 Sum_probs=163.2
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.+|+|++++++.|....+.|+|+ ||+.|++|.+++.... ...++..++.|++.||.|||++|++||||||+||+++.+
T Consensus 74 ~~h~~v~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~ 152 (296)
T cd06654 74 NKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152 (296)
T ss_pred CCCCCEeeEEEEEEeCCEEEEee-cccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC
Confidence 36899999999999999999999 7999999999987643 233899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||++....... ......|++.|+|||.+.+..+..+ +|+||+||++|+|++|+.||........+....
T Consensus 153 ~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~ 229 (296)
T cd06654 153 G--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (296)
T ss_pred C--CEEECccccchhccccccccCcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh
Confidence 5 59999999987543222 2234578999999999877666544 999999999999999999998766533322211
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.......+.+..++..+.+++.+||.++|.+|||+.++++||||....
T Consensus 230 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 230 ---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred ---cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 112222233445789999999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=257.53 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=160.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+++++++|...+..|+|+ ||+.+++|..++.+ .+.+. .+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 60 ~h~~ii~~~~~~~~~~~~~~v~-e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~ 138 (282)
T cd06643 60 DHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL 138 (282)
T ss_pred CCCCeeeEEEEEeeCCEEEEEE-EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcc
Confidence 6899999999999999999999 79999999998865 33344 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhcc-----ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++ ++||+|||++...... .......+++.|+|||++.. ..++ .++|+||+||++|+|++|+.||...+...
T Consensus 139 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~ 215 (282)
T cd06643 139 DG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMR 215 (282)
T ss_pred CC--CEEEccccccccccccccccccccccccccCHhhccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHH
Confidence 55 5999999998653222 22334568999999999742 2333 44999999999999999999998765433
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
....+... .....+.+..++.++.+||.+||.++|.+||++.++++||||+..
T Consensus 216 ~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 216 VLLKIAKS---EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHhhc---CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 33332221 111223344578999999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=267.29 Aligned_cols=191 Identities=25% Similarity=0.377 Sum_probs=161.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH--cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL--LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~--~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+++|++|+++..+..+|||| ||+..|+|.++|+. .+.+. +...++.||++|++||.++++|||||.+.||||+
T Consensus 259 ~H~~lV~l~gV~~~~~piyIVt-E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~ 337 (468)
T KOG0197|consen 259 RHEKLVKLYGVCTKQEPIYIVT-EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD 337 (468)
T ss_pred cccCeEEEEEEEecCCceEEEE-EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec
Confidence 5899999999999999999999 79999999999998 23333 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.+. .+||+|||+|+......- .....-...|.|||.+....++.+ |||||+|++|||++| |+.|+.+.+..+.+
T Consensus 338 ~~~--~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~ 414 (468)
T KOG0197|consen 338 EDL--VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVL 414 (468)
T ss_pred cCc--eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHH
Confidence 665 599999999994322111 111223567999999998888777 999999999999998 89999988875544
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. +...++.|.+..+|.++-+++..||..+|++|||++.+..
T Consensus 415 ~~-----le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 415 EL-----LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HH-----HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 33 3456788888889999999999999999999999986543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=260.46 Aligned_cols=201 Identities=24% Similarity=0.394 Sum_probs=159.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~~ 82 (293)
+|+|++++++.|...+++|+|+ ||+.|++|.+++.+.+.++ .++.++.|++.||.|||+ .+++||||||.||+++.
T Consensus 57 ~h~~iv~~~~~~~~~~~~~lv~-ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~ 135 (308)
T cd06615 57 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS 135 (308)
T ss_pred CCCCCCeEEEEEeeCCEEEEEe-eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec
Confidence 6899999999999999999999 7999999999998877665 889999999999999997 59999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
++ .+||+|||++..... .......|++.|+|||++.+..+..+ +|+||+||++|++++|+.||...+... .....
T Consensus 136 ~~--~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~ 210 (308)
T cd06615 136 RG--EIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMF 210 (308)
T ss_pred CC--cEEEccCCCcccccc-cccccCCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcchhh-HHHhh
Confidence 54 499999999875422 22345678999999999877666544 999999999999999999997544211 11111
Q ss_pred H---------------------------------HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 163 Q---------------------------------RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 163 ~---------------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
. .+............++.++++|+.+||..+|++|||+.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred cCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 1 0000000000011267899999999999999999999999999999
Q ss_pred ccC
Q 022732 210 LKN 212 (293)
Q Consensus 210 ~~~ 212 (293)
.+.
T Consensus 291 ~~~ 293 (308)
T cd06615 291 KRA 293 (308)
T ss_pred hhc
Confidence 764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=272.40 Aligned_cols=201 Identities=29% Similarity=0.456 Sum_probs=166.0
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
|++.=+|++|-.|++.+.+|+|| +|+.||++.++|.+-+.|. .|++|++.+..|+++.|+.|+|||||||+||||+.
T Consensus 686 ADn~WVVrLyySFQDkdnLYFVM-dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr 764 (1034)
T KOG0608|consen 686 ADNEWVVRLYYSFQDKDNLYFVM-DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 764 (1034)
T ss_pred cCCcceEEEEEEeccCCceEEEE-eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc
Confidence 56667899999999999999999 8999999999999999998 99999999999999999999999999999999987
Q ss_pred CCCCCEEEecCCCCcCcCC-----------C--------------------------------CCCCCCcCCCCccchhh
Q 022732 83 SPAPRLKICDFGYSKSSVL-----------H--------------------------------SQPKSTVGTPAYIAPEV 119 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~-----------~--------------------------------~~~~~~~gt~~y~aPE~ 119 (293)
++ +|||+|||+++...- + ....+.+||+.|+|||+
T Consensus 765 dG--HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapev 842 (1034)
T KOG0608|consen 765 DG--HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEV 842 (1034)
T ss_pred CC--ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHH
Confidence 76 599999999863210 0 00123579999999999
Q ss_pred hccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-
Q 022732 120 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI- 198 (293)
Q Consensus 120 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp- 198 (293)
+...+|+.. ||+||.|||||||+.|++||...+....-.+++. ....+.++....+|+++.++|.++ ..+++.|.
T Consensus 843 l~r~g~~q~-cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n--w~~~l~~~~~~~ls~e~~~li~kL-c~sad~RLG 918 (1034)
T KOG0608|consen 843 LARTGYTQL-CDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN--WRNFLHIPYQGNLSKEALDLIQKL-CCSADSRLG 918 (1034)
T ss_pred hcccCcccc-chhhHhhHHHHHHhhCCCCccCCCCCcceeeeee--hhhccccccccccCHHHHHHHHHH-hcChhhhhc
Confidence 999998766 9999999999999999999988776443222221 112234455566999999999986 56888998
Q ss_pred --CHHHHHcCcccccC
Q 022732 199 --TIPEIMKHQWFLKN 212 (293)
Q Consensus 199 --t~~ell~h~~~~~~ 212 (293)
.++++..||||+.-
T Consensus 919 kng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 919 KNGADQVKAHPFFKGI 934 (1034)
T ss_pred ccchhhhhcCcccccc
Confidence 46779999999754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=256.69 Aligned_cols=198 Identities=22% Similarity=0.352 Sum_probs=157.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.+...+..|+|+ ||+.+++|.+++...+.+. +++.++.|++.||.|||++|++|+||||+||+++.+
T Consensus 64 ~h~~ii~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~ 142 (267)
T cd06645 64 KHSNIVAYFGSYLRRDKLWICM-EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN 142 (267)
T ss_pred CCCCeeeEEEEEEeCCEEEEEE-eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 6899999999999999999999 7999999999998877666 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhc---cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+ .+||+|||++...... .......|++.|+|||++. ...+. .++|+||+||++|+|++|..||..........
T Consensus 143 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~ 219 (267)
T cd06645 143 G--HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALF 219 (267)
T ss_pred C--CEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccchhhHH
Confidence 4 5999999998654322 2223457899999999974 23343 45999999999999999999997655433222
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
....... ..........++..+.++|.+||..+|.+|||+.++++|||
T Consensus 220 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 220 LMTKSNF-QPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred hhhccCC-CCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 2111100 01111122347889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=273.45 Aligned_cols=202 Identities=25% Similarity=0.366 Sum_probs=166.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCc--hhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLC--LFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg--~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
-|||+|.+-|+|..+....+|| |||.|. +|.+..++.-.-.++..|..+.+.||+|||+.+.||||||+.|||++..
T Consensus 84 ~HPntieYkgCyLre~TaWLVM-EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~ 162 (948)
T KOG0577|consen 84 RHPNTIEYKGCYLREHTAWLVM-EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP 162 (948)
T ss_pred cCCCcccccceeeccchHHHHH-HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC
Confidence 3899999999999999999999 799984 4444443332233999999999999999999999999999999999655
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc---ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+ .|||+|||.|... ...++++|||.|||||+++. ..|+++ +||||||+++.||...++|+...+....+
T Consensus 163 g--~VKLaDFGSAsi~---~PAnsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSAL-- 234 (948)
T KOG0577|consen 163 G--LVKLADFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSAL-- 234 (948)
T ss_pred C--eeeeccccchhhc---CchhcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHH--
Confidence 4 5999999998754 55678999999999999874 677888 99999999999999999998876664433
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCCcc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLV 218 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~ 218 (293)
..|.....+.-....+|..++.|+..||++-|..|||.+++|+|+|+.+..++..+
T Consensus 235 --YHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 235 --YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred --HHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHH
Confidence 33333333333355689999999999999999999999999999999887776643
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=258.79 Aligned_cols=200 Identities=28% Similarity=0.388 Sum_probs=163.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++.+...+..|+|+ ||+.+++|.+++.+.+ .+. .++.++.|++.||.|||++|++||||+|+||+++
T Consensus 51 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~ 129 (277)
T cd05577 51 SSRFIVSLAYAFETKDDLCLVM-TLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD 129 (277)
T ss_pred CCCCEeeeeeEEecCCeEEEEE-ecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence 3899999999999999999999 7999999999997765 344 8888999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ .+||+|||.+.............++..|+|||++.+..++.+ +|+||+||++|+|++|+.||...........+
T Consensus 130 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 206 (277)
T cd05577 130 DHG--NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL 206 (277)
T ss_pred CCC--CEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHH
Confidence 655 499999999876544334445568889999999877665544 99999999999999999999876542222233
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCccccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~ 211 (293)
......... ..+..+++.+.++|.+||+.+|.+|| ++.+++.||||.+
T Consensus 207 ~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 207 KRRTLEMAV--EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred Hhccccccc--cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 333222222 22334789999999999999999999 8889999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=258.28 Aligned_cols=200 Identities=23% Similarity=0.362 Sum_probs=153.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.+.++.|+|+ ||+.+ +|.+++.+ .+.+. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 57 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~ 134 (284)
T cd07839 57 KHKNIVRLYDVLHSDKKLTLVF-EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK 134 (284)
T ss_pred CCCCeeeHHHHhccCCceEEEE-ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC
Confidence 5899999999999999999999 79975 77777765 34444 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCC-chHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-EPKDFRK 160 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~-~~~~~~~ 160 (293)
++ .+||+|||+++...... ......+++.|+|||++.+....+.++|+||+||++|+|++|..||.... ....+..
T Consensus 135 ~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (284)
T cd07839 135 NG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212 (284)
T ss_pred CC--cEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence 55 59999999987543322 22345678999999998775544555999999999999999988864433 3233322
Q ss_pred HHHHHhccc-------------cCC----------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRILSVQ-------------YSV----------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~~~~-------------~~~----------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+........ ... .....+++++++||.+||..||.+|||+.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 222110000 000 0112378999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=258.87 Aligned_cols=203 Identities=25% Similarity=0.397 Sum_probs=163.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
+|+|++++++.+...++.|+|+ ||+.+++|.+++..... ..++..++.||+.||.|||++|++||||||+||+++.++
T Consensus 77 ~h~~ii~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~ 155 (292)
T cd06658 77 HHENVVDMYNSYLVGDELWVVM-EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG 155 (292)
T ss_pred CCCcHHHHHHheecCCeEEEEE-eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC
Confidence 6899999999999999999999 79999999998865432 238999999999999999999999999999999997654
Q ss_pred CCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.+||+|||++...... .......|++.|+|||.+.+..++.+ +|+||+||++|++++|+.||........+..+.
T Consensus 156 --~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~- 231 (292)
T cd06658 156 --RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR- 231 (292)
T ss_pred --CEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence 5999999998643222 22234568999999999877666554 999999999999999999998766543332221
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
... ....+....++..+.+++.+||..+|.+|||+.++++||||+...++
T Consensus 232 ~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 232 DNL--PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred hcC--CCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 111 12223334578999999999999999999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=273.21 Aligned_cols=201 Identities=24% Similarity=0.303 Sum_probs=153.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|++++++......|+|| ||+. ++|..++.... .+. +++.++.||+.||.|||++||+||||||+|||++.
T Consensus 218 ~HpnIv~l~~~~~~~~~~~lv~-e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~ 295 (461)
T PHA03211 218 SHPAVLALLDVRVVGGLTCLVL-PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG 295 (461)
T ss_pred CCCCCCcEEEEEEECCEEEEEE-EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC
Confidence 5899999999999999999999 6775 68888886643 344 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc-----
Q 022732 83 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----- 154 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----- 154 (293)
++ .+||+|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|||++|..++.....
T Consensus 296 ~~--~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~ 372 (461)
T PHA03211 296 PE--DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERR 372 (461)
T ss_pred CC--CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccC
Confidence 54 59999999987542221 1223569999999999988777655 9999999999999998765433211
Q ss_pred --hHHHHHHHHHHhccccCC--------------------------C---CCCCCCHHHHHHHHHccccCCCCCCCHHHH
Q 022732 155 --PKDFRKTIQRILSVQYSV--------------------------P---DTNPISQECRDLISRIFVADPAARITIPEI 203 (293)
Q Consensus 155 --~~~~~~~~~~~~~~~~~~--------------------------~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~el 203 (293)
...+.++++........+ + ....++.++.+||.+||+.||.+|||+.|+
T Consensus 373 ~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el 452 (461)
T PHA03211 373 PYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL 452 (461)
T ss_pred CcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH
Confidence 122333333211100000 0 011356789999999999999999999999
Q ss_pred HcCccccc
Q 022732 204 MKHQWFLK 211 (293)
Q Consensus 204 l~h~~~~~ 211 (293)
|+||||+.
T Consensus 453 L~hp~f~~ 460 (461)
T PHA03211 453 LRLPLFQS 460 (461)
T ss_pred hhCcccCC
Confidence 99999964
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=258.82 Aligned_cols=206 Identities=23% Similarity=0.298 Sum_probs=162.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.+.+..|+|| ||+ +++|.+++.... .+. .++.++.||++||.|||++|++|+||||+||+++.
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~-e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~ 137 (298)
T cd07841 60 KHPNIIGLLDVFGHKSNINLVF-EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS 137 (298)
T ss_pred CCCCChhhhheeecCCEEEEEE-ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC
Confidence 4899999999999999999999 799 899999998766 444 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++..... .......+++.|+|||.+.+......++|+||+||++|++++|.+||.+......+..+
T Consensus 138 ~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~ 215 (298)
T cd07841 138 DG--VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215 (298)
T ss_pred CC--CEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH
Confidence 54 5999999998754332 22233457889999999866544455699999999999999998888877665544443
Q ss_pred HHHHhcccc-------C----------CC-----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 162 IQRILSVQY-------S----------VP-----DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 162 ~~~~~~~~~-------~----------~~-----~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
......... . .+ .....+..+.+||.+||.++|++|||+.+++.|+||+....+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 216 FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred HHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 322110000 0 00 012357889999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=277.72 Aligned_cols=197 Identities=26% Similarity=0.365 Sum_probs=157.9
Q ss_pred CCcchhhhhceeeece--------eEEEeehhhccCchhHHHHHHcC----CHH--HHHHHHHHHHHHHHHHHHcCCeec
Q 022732 6 SSSSEYAMLGVSVKMK--------FVFLSLSFFFSLCLFFMWLLLLG----LLV--QARFFFQQLISGVSYCHAMQVCHR 71 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~--------~~~lv~~ey~~gg~L~~~l~~~~----~~~--~~~~~~~qil~~l~~LH~~~iiHr 71 (293)
.|.|++++++.+.... .+++|| ||+.+|+|.+++.... .+. .+..++.|++.||.|||++||+||
T Consensus 89 ~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~-Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHr 167 (496)
T PTZ00283 89 DFFSIVKCHEDFAKKDPRNPENVLMIALVL-DYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR 167 (496)
T ss_pred CCCcEEEeecceecccccCcccceEEEEEE-eCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 5678888877765432 478999 7999999999997532 333 889999999999999999999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p 148 (293)
||||+|||++.++ .+||+|||+++..... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.|
T Consensus 168 DLKP~NILl~~~~--~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~P 244 (496)
T PTZ00283 168 DIKSANILLCSNG--LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRP 244 (496)
T ss_pred CCCHHHEEEeCCC--CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCC
Confidence 9999999997655 5999999998754321 22345679999999999988777655 9999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
|.+.+... .+..+..... .+.+..+++++.+++.+||..+|.+||++.++++|||++.
T Consensus 245 f~~~~~~~----~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 245 FDGENMEE----VMHKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCHHH----HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 98765433 3333333222 2334458899999999999999999999999999999864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=254.87 Aligned_cols=197 Identities=24% Similarity=0.341 Sum_probs=160.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|+ ||+.|++|.+++.+.+.++ .+..++.|++.||+|||+.|++|+||+|+||+++.+
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~ 138 (265)
T cd06631 60 KHVNIVQYLGTCLDDNTISIFM-EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN 138 (265)
T ss_pred CCCCEeeEeeEeecCCeEEEEE-ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC
Confidence 4789999999999999999999 7999999999998876655 888999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC-------CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 84 PAPRLKICDFGYSKSSVL-------HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
+ .+||+|||++..... ........|+..|+|||++.+..++.+ +|+||+||++|++++|..||...+...
T Consensus 139 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 139 G--IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred C--eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHH
Confidence 4 599999999864321 112234568999999999887776555 999999999999999999998755433
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
....+.. ......+.+..++.++.+||++||.++|.+||++.+++.||||
T Consensus 216 ~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 216 AMFYIGA---HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHhhh---ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 2222111 1111122334588999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=251.59 Aligned_cols=195 Identities=26% Similarity=0.362 Sum_probs=159.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++.+...+..|+|+ ||+.|++|.+++... ..+. .+..++.|++.||.|||++|++|+||||+||+++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~ 135 (256)
T cd08529 57 DSSYIIRYYESFLDKGKLNIVM-EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135 (256)
T ss_pred CCCCeehheeeeccCCEEEEEE-EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe
Confidence 6899999999999999999999 799999999999775 2333 7889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .+||+|||+++....... .....|++.|+|||++.+..++.+ +|+|||||++++|++|+.||........
T Consensus 136 ~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~--- 209 (256)
T cd08529 136 AYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGAL--- 209 (256)
T ss_pred CCC--CEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 654 599999999875433222 234468899999999987776555 9999999999999999999987664332
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...+..... .+....++.++.+++.+||+.+|++||++.++++|||+
T Consensus 210 -~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 210 -ILKIIRGVF-PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -HHHHHcCCC-CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 222222221 12222578999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=247.03 Aligned_cols=203 Identities=24% Similarity=0.355 Sum_probs=161.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHH-HcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLL-LLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~-~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~ 81 (293)
+.+-+|+.+|+|.....+.+.| |.+.. .+..+++ ..++++ -+-.+..-++.||.||-. +||+|||+||+|||++
T Consensus 149 dcpyIV~c~GyFi~n~dV~IcM-elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD 226 (391)
T KOG0983|consen 149 DCPYIVQCFGYFITNTDVFICM-ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD 226 (391)
T ss_pred CCCeeeeeeeEEeeCchHHHHH-HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc
Confidence 3466899999999999999999 45543 4444443 345666 567788889999999985 5899999999999998
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc---ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
..++ +||||||++.............|-+.|||||.+.- .+|+.+ +||||||++++||.||+.||.+.+.....
T Consensus 227 e~Gn--iKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ 303 (391)
T KOG0983|consen 227 ERGN--IKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEV 303 (391)
T ss_pred cCCC--EEeecccccceeecccccccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHH
Confidence 8775 99999999987766666667789999999998853 456666 89999999999999999999997654433
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
..++.. .....++....+|+++++|+..||.+|+.+||...++|+|||++.....
T Consensus 304 ltkvln--~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 304 LTKVLN--EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred HHHHHh--cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 333322 2233455556699999999999999999999999999999999765443
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=254.15 Aligned_cols=201 Identities=27% Similarity=0.384 Sum_probs=161.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...++.++|+ ||+.|++|.+++...+.+. .+..++.||+.||.|||++|++||||+|+||+++.+
T Consensus 61 ~h~~iv~~~~~~~~~~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~ 139 (268)
T cd06630 61 NHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139 (268)
T ss_pred CCCceehhhceeccCCeEEEEE-eccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 5899999999999999999999 7999999999998877665 889999999999999999999999999999999654
Q ss_pred CCCCEEEecCCCCcCcCCCCC-----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+. .+||+|||.+........ .....|+..|+|||++.+..++.+ +|+||+||++|++++|..||.........
T Consensus 140 ~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 217 (268)
T cd06630 140 GQ-RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHL 217 (268)
T ss_pred CC-EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence 32 489999999875433211 123468889999999877666554 89999999999999999999765433222
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
. ..............+..+++++.+++.+||..+|.+|||+.++++||||+
T Consensus 218 ~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 218 A-LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred H-HHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 2 22222222222223334789999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=255.21 Aligned_cols=202 Identities=26% Similarity=0.358 Sum_probs=163.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|++++++++......|+|+ ||+.+++|.+++.... ....++.++.|++.||.|||+++++||||+|+||+++.++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~ 135 (274)
T cd06609 57 RSPYITKYYGSFLKGSKLWIIM-EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG 135 (274)
T ss_pred CCCCeeeeeEEEEECCeEEEEE-EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC
Confidence 3899999999999999999999 7999999999998752 2239999999999999999999999999999999997755
Q ss_pred CCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.++|+|||+++..... .......+++.|+|||.+.+..++.+ +|+||+||++|++++|+.||...+..... .
T Consensus 136 --~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~----~ 208 (274)
T cd06609 136 --DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVL----F 208 (274)
T ss_pred --CEEEcccccceeecccccccccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHH----H
Confidence 4999999999765433 23344578899999999987776555 99999999999999999999876543222 2
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
.+............++.++.+++.+||..+|++|||++++++||||++....
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 209 LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 2222211111112278999999999999999999999999999999875443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=257.77 Aligned_cols=201 Identities=22% Similarity=0.331 Sum_probs=163.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|++++++++...+.+|+|+ ||+.+++|..++.... ...++..++.|++.||.|||++|++||||||+||+++.++
T Consensus 74 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~ 152 (296)
T cd06655 74 KNPNIVNFLDSFLVGDELFVVM-EYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG 152 (296)
T ss_pred CCCceeeeeeeEecCceEEEEE-EecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 6899999999999999999999 7999999999987654 2339999999999999999999999999999999997654
Q ss_pred CCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.+||+|||++........ .....+++.|+|||.+.+..++.+ +|+||+||++|++++|+.||...+.......+..
T Consensus 153 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~ 229 (296)
T cd06655 153 --SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229 (296)
T ss_pred --CEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 599999999875433222 234568899999999877766555 9999999999999999999988765443322221
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
........+..++..+.++|.+||..+|.+|||+.+++.||||+...
T Consensus 230 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 230 ---NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ---cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 11122233445889999999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=255.45 Aligned_cols=204 Identities=23% Similarity=0.338 Sum_probs=169.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.++..||+||.+-....+.+|| |||..|++.+.++.+. .+. ++..+++..+.||+|||...-+|||||..|||++.
T Consensus 86 ~S~yVVKYYGSYFK~sDLWIVM-EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT 164 (502)
T KOG0574|consen 86 KSKYVVKYYGSYFKHSDLWIVM-EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT 164 (502)
T ss_pred CCchhhhhhhhhccCCceEeeh-hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc
Confidence 4677899999999999999999 7999999999997654 344 89999999999999999999999999999999965
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.+ +.||+|||+|...... ...++.+|||.|||||++..-+|+.. +||||||++..||..|++||.+..+.+. +
T Consensus 165 ~G--~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRA---I 238 (502)
T KOG0574|consen 165 DG--IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRA---I 238 (502)
T ss_pred cc--hhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccce---e
Confidence 54 5899999999754332 34567899999999999999999888 8999999999999999999988665322 1
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~ 216 (293)
..-..+....+..+..+|.++.+|+++||.++|++|.|+-++++|||++.....+
T Consensus 239 FMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 239 FMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred EeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 1111122223334455899999999999999999999999999999987654433
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=254.38 Aligned_cols=198 Identities=27% Similarity=0.342 Sum_probs=160.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC---CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG---LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~---~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++.+...+..|+|+ ||+.|++|.+++.... .+. .++.++.|++.||.|||++|++||||+|+||++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~iv~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~ 135 (267)
T cd06610 57 NHPNVVKYYTSFVVGDELWLVM-PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL 135 (267)
T ss_pred CCCCEEEEEEEEeeCCEEEEEE-eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE
Confidence 6889999999999999999999 7999999999997642 233 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCC-----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
+.++ .+||+|||++........ .....|+..|+|||++......+.++|+||+||++|+|++|+.||......
T Consensus 136 ~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 213 (267)
T cd06610 136 GEDG--SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213 (267)
T ss_pred cCCC--CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence 8654 499999999875433222 133468999999999876633445599999999999999999999876654
Q ss_pred HHHHHHHHHHhccccCCCC---CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 156 KDFRKTIQRILSVQYSVPD---TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
..+...... .....+. ...++..+.+++.+||..||++|||+.++++||||
T Consensus 214 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 214 KVLMLTLQN---DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred hhHHHHhcC---CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 433333322 1111111 13578999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=257.01 Aligned_cols=198 Identities=24% Similarity=0.340 Sum_probs=155.4
Q ss_pred CCCCcchhhhhceeee------ceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCC
Q 022732 4 VGSSSSEYAMLGVSVK------MKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDL 73 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~------~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdl 73 (293)
+..|+|+++++++|.. .+++|+|| ||+.+|+|.+++.... .+. .+..++.||+.||.|||++|++||||
T Consensus 69 ~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl 147 (282)
T cd06636 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVM-EFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDI 147 (282)
T ss_pred hcCCCcEEEEeeehhcccccCCCCEEEEEE-EeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 3468999999999853 56889999 7999999999997643 233 78899999999999999999999999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhcc-----ccCCCchhhhhhhhhHHHHHHhCCC
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGY 147 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~ 147 (293)
||+||+++.++ .++|+|||++...... .......|++.|+|||++.. ..++.+ +|+||+||++|+|++|..
T Consensus 148 ~~~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~el~~g~~ 224 (282)
T cd06636 148 KGQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAP 224 (282)
T ss_pred CHHHEEECCCC--CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHHHHhCCC
Confidence 99999997655 4999999998754321 22344578999999999752 334444 999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 148 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
||........... +............++.++.+||.+||..||.+|||+.++++||||
T Consensus 225 p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 225 PLCDMHPMRALFL----IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CccccCHHhhhhh----HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 9976554322221 111111111223478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=254.30 Aligned_cols=201 Identities=23% Similarity=0.406 Sum_probs=160.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|.+++++.+....+.|+|| ||+.|++|.++++.. .+. .+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~ 137 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIM-EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT 137 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEE-ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC
Confidence 6899999999999999999999 799999999998765 443 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .++|+|||++....... ......|++.|+|||.+.+....+.++|+||+||++|+|++|..||..........
T Consensus 138 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--- 212 (277)
T cd06917 138 G--NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--- 212 (277)
T ss_pred C--CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh---
Confidence 4 59999999987543322 23345689999999998654444455999999999999999999998765432211
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.+............++.++.+++.+||..||++||++.+++.|+||++...
T Consensus 213 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 213 -LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred -ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 111111111111237789999999999999999999999999999976543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=286.30 Aligned_cols=202 Identities=24% Similarity=0.351 Sum_probs=159.9
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHc-------CCee
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAM-------QVCH 70 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~-------~iiH 70 (293)
.|+|+|+++++|.. ...+|+|| ||+.+|+|..+|... +.++ .++.++.||+.||.|||+. +|||
T Consensus 70 ~HPNIVrl~d~f~de~~~~lyIVM-EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVH 148 (1021)
T PTZ00266 70 KHKNIVRYIDRFLNKANQKLYILM-EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLH 148 (1021)
T ss_pred CCCCcCeEEEEEEecCCCEEEEEE-eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCcee
Confidence 48999999999864 46789999 799999999999753 3344 8999999999999999984 4999
Q ss_pred cCCCCCcEEEcCC---------------CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcccc-CCCchhhhhh
Q 022732 71 RDLKLENTLLDGS---------------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWS 134 (293)
Q Consensus 71 rdlkp~NIl~~~~---------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dvws 134 (293)
|||||+||||+.. +.+.+||+|||++.............||+.|+|||++.+.. ..+.++||||
T Consensus 149 RDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWS 228 (1021)
T PTZ00266 149 RDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228 (1021)
T ss_pred ccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHH
Confidence 9999999999642 23358999999998655444445668999999999986532 2344599999
Q ss_pred hhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 135 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 135 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
||||+|+|++|..||........+...+.. ....+ ....+.++.+||.+||.++|.+||++.++|.|+|++...
T Consensus 229 LG~ILYELLTGk~PF~~~~~~~qli~~lk~----~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 229 LGCIIYELCSGKTPFHKANNFSQLISELKR----GPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHHHHHCCCCCCcCCcHHHHHHHHhc----CCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999999999999999876654443333221 11222 234689999999999999999999999999999997543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=251.46 Aligned_cols=197 Identities=24% Similarity=0.387 Sum_probs=159.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++....+.|+++ ||+.+++|.+++...+ .+. .++.++.|++.||.|||++|++||||+|.||+++.
T Consensus 56 ~~~~i~~~~~~~~~~~~~~l~~-e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~ 134 (256)
T cd06612 56 DSPYIVKYYGSYFKNTDLWIVM-EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE 134 (256)
T ss_pred CCCcEeeeeeeeecCCcEEEEE-ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC
Confidence 7899999999999999999999 7999999999997643 333 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||++....... ......++..|+|||++.+..++.+ +|+||+||++|+|++|+.||............
T Consensus 135 ~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~ 211 (256)
T cd06612 135 EG--QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211 (256)
T ss_pred CC--cEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh
Confidence 55 59999999987654333 2334558899999999887776555 99999999999999999999876543222111
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.. ........+..++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus 212 ~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 212 PN---KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred cc---CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 10 1111122233477899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=256.28 Aligned_cols=201 Identities=25% Similarity=0.328 Sum_probs=160.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|+ ||+ +++|.+++.... .+. +++.++.||+.||.|||++|++|+||||+||+++.
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~-e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~ 134 (286)
T cd07832 57 QHPYVVKLLDVFPHGSGFVLVM-EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA 134 (286)
T ss_pred CCCCCcceeeEEecCCeeEEEe-ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC
Confidence 4899999999999999999999 799 999999997643 233 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
++ .++|+|||++....... ......|+..|+|||++.+......++|+||+||++|+|++|.+||.+......+..
T Consensus 135 ~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 135 DG--VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred CC--cEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 54 59999999987643332 233457899999999987655545669999999999999999888887766554444
Q ss_pred HHHHHhcccc---------------CCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 161 TIQRILSVQY---------------SVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 161 ~~~~~~~~~~---------------~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
+......... ..+ .....+..+.++|.+||.++|.+|||++++++||||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 3332111100 000 0123578999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=254.57 Aligned_cols=200 Identities=26% Similarity=0.419 Sum_probs=162.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
+|+|++++++++...++.|+|+ ||+.|++|.+++... .+. .+..++.|++.||+|||++|++||||+|+||+++.+
T Consensus 74 ~h~~vv~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 74 QHPNIVEMYSSYLVGDELWVVM-EFLEGGALTDIVTHT-RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred CCCChheEEEEEEcCCeEEEEE-eccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 5899999999999999999999 799999999999873 343 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .++|+|||.+...... .......|++.|+|||.+.+..++.+ +|+||+||++|+|++|+.||...+.......
T Consensus 152 ~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~-- 226 (285)
T cd06648 152 G--RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR-- 226 (285)
T ss_pred C--cEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH--
Confidence 4 5999999987643222 12234568999999999877766555 9999999999999999999987654333222
Q ss_pred HHHhccc-cCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 163 QRILSVQ-YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 163 ~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
+.... ........++..+.+|+.+||..+|++|||+.++++||||++..+
T Consensus 227 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 227 --IRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred --HHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 22221 112222337899999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=253.15 Aligned_cols=201 Identities=26% Similarity=0.359 Sum_probs=158.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
+|+|++++++++...+.+++|+ ||+.+++|.++++..+.+. .++.++.|++.||.|||++|++||||+|+||+++.+
T Consensus 66 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~ 144 (272)
T cd06629 66 DHLNIVQYLGFETTEEYLSIFL-EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD 144 (272)
T ss_pred CCCCcceEEEEeccCCceEEEE-ecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC
Confidence 5899999999999999999999 7999999999998877665 888999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhcccc-CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+ .++|+|||+++..... .......|+..|+|||.+.... ....++|+||+|+++|++++|..||..........
T Consensus 145 ~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 222 (272)
T cd06629 145 G--ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF 222 (272)
T ss_pred C--eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH
Confidence 4 5999999998753221 1123345888999999987644 23445999999999999999999997654432222
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
..................++..+.++|.+||.++|.+|||+.++++|||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 223 KLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 21111111111111123468999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=253.85 Aligned_cols=200 Identities=23% Similarity=0.353 Sum_probs=157.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 85 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~ 85 (293)
.|+|+++++++|...+..++|+ ||+.+++|..+. .-....+..++.|++.||.|||++|++|+||||+||+++.++
T Consensus 57 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~- 132 (279)
T cd06619 57 DSPYIIGFYGAFFVENRISICT-EFMDGGSLDVYR--KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG- 132 (279)
T ss_pred CCCCeeeEEEEEEECCEEEEEE-ecCCCCChHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-
Confidence 6899999999999999999999 799999996542 223347889999999999999999999999999999997655
Q ss_pred CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH---HHHHHH
Q 022732 86 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---DFRKTI 162 (293)
Q Consensus 86 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~ 162 (293)
.+||+|||++..... .......||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||....... ......
T Consensus 133 -~~~l~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 209 (279)
T cd06619 133 -QVKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209 (279)
T ss_pred -CEEEeeCCcceeccc-ccccCCCCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHH
Confidence 599999999875432 23344679999999999987776555 999999999999999999996533211 011222
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
..+.............+.++.+++.+||+.+|.+||++.++++||||+..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 22222211111223478899999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=250.74 Aligned_cols=198 Identities=33% Similarity=0.509 Sum_probs=163.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.+...+..|+|+ ||+.+++|.+++.+.+.+. .+..++.||+.||.|||++|++||||+|+||+++.+
T Consensus 51 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~ 129 (265)
T cd05579 51 QSPYVVKLYYSFQGKKNLYLVM-EYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN 129 (265)
T ss_pred CCcchhHHHHheecCcEEEEEE-ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC
Confidence 4899999999999999999999 7999999999998866655 889999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCCCC---------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 84 PAPRLKICDFGYSKSSVLHS---------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
+ .++|+|||++....... ......++..|+|||.+.+...+. ++|+||+|+++|++++|..||.....
T Consensus 130 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 130 G--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK-TVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred C--CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 5 49999999987533221 123346888999999987766544 49999999999999999999987664
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH---HHHHcCccccc
Q 022732 155 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI---PEIMKHQWFLK 211 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~---~ell~h~~~~~ 211 (293)
.. ....+.......+....++..+.+++.+||+.+|.+|||+ .++++||||++
T Consensus 207 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 207 EE----IFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HH----HHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 33 2333333334444443458999999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=252.41 Aligned_cols=204 Identities=23% Similarity=0.375 Sum_probs=161.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc---CCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL---GLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~---~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl 79 (293)
.|+|++++++.+...++.|+|+ ||+.|++|..++... +.+. .+..++.|++.||.|||+ .|++||||||+||+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 135 (286)
T cd06622 57 VSPYIVDFYGAFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVL 135 (286)
T ss_pred CCCcHHhhhhheecCCeEEEEE-eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEE
Confidence 5899999999999999999999 799999999998774 2333 899999999999999997 59999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccC-----CCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
++.++ .+||+|||++..... .......+++.|+|||.+.+... ...++|+||+||++|++++|+.||.....
T Consensus 136 ~~~~~--~~~l~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 212 (286)
T cd06622 136 VNGNG--QVKLCDFGVSGNLVA-SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212 (286)
T ss_pred ECCCC--CEEEeecCCcccccC-CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence 97644 599999999875422 23344568899999999855332 23459999999999999999999976544
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 155 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
.... .....+.... ....+..++.++.+||.+||..+|.+||++.+++.||||......
T Consensus 213 ~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 213 ANIF-AQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred hhHH-HHHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 3322 2222222221 112233488999999999999999999999999999999765433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=248.86 Aligned_cols=236 Identities=23% Similarity=0.365 Sum_probs=178.0
Q ss_pred Ccchhhhhceee------eceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 7 SSSEYAMLGVSV------KMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 7 ~~~~v~~~~~~~------~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
|+|+|+++.+|. +....|+|| ||+.. +|...+.....-..+++++.|++.|++|||+.||+||||||+||++
T Consensus 74 ~~nii~l~n~ftP~~~l~~~~e~y~v~-e~m~~-nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv 151 (369)
T KOG0665|consen 74 HKNIISLLNVFTPQKTLEEFQEVYLVM-ELMDA-NLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV 151 (369)
T ss_pred ccceeeeeeccCccccHHHHHhHHHHH-Hhhhh-HHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee
Confidence 789999999995 456789999 67764 8888888555555899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
..+. .+||.|||+|+.....-..+..+.|..|+|||++.+.++..+ +||||+||++.||++|+..|.+.+..+++.+
T Consensus 152 ~~~~--~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~k 228 (369)
T KOG0665|consen 152 NSDC--TLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNK 228 (369)
T ss_pred cchh--heeeccchhhcccCcccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHH
Confidence 7665 499999999997666555667789999999999999997766 9999999999999999999999887777766
Q ss_pred HHHHHhcccc---------------------------CCCCC---------CCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 022732 161 TIQRILSVQY---------------------------SVPDT---------NPISQECRDLISRIFVADPAARITIPEIM 204 (293)
Q Consensus 161 ~~~~~~~~~~---------------------------~~~~~---------~~~s~~~~~li~~~L~~dp~~Rpt~~ell 204 (293)
++........ .+|.. ..-+..+++++.+||..||++|.+++++|
T Consensus 229 i~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 229 IIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 6553322110 01110 01236689999999999999999999999
Q ss_pred cCcccccCCCCCccchhcccCCCCCCCCCCCCHHHHHHHHHHh
Q 022732 205 KHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEA 247 (293)
Q Consensus 205 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (293)
+|||++-......++.++.............+.+....++.+.
T Consensus 309 ~HPY~~vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~e 351 (369)
T KOG0665|consen 309 RHPYIKVWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKE 351 (369)
T ss_pred cCCeeeeecccccccCCCCchhhhhcccccCCHHHHHHHHHHH
Confidence 9999984444443333333311122223333455555555443
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=254.79 Aligned_cols=200 Identities=25% Similarity=0.363 Sum_probs=160.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++......|+|| ||+.+++|..++.+.+ .+. .++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~ 138 (280)
T cd06611 60 KHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL 138 (280)
T ss_pred CCCceeEEEEEEecCCeEEEEe-eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC
Confidence 3899999999999999999999 7999999999997743 344 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccc----cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
++ .++|+|||++...... .......+++.|+|||++... .....++|+||+||++|+|++|+.||........
T Consensus 139 ~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~ 216 (280)
T cd06611 139 DG--DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV 216 (280)
T ss_pred CC--CEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH
Confidence 54 5999999988653322 223345689999999997532 1123449999999999999999999987654332
Q ss_pred HHHHHHHHhccc-cCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 158 FRKTIQRILSVQ-YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 158 ~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+. .+.... .....+..++.++.++|.+||..+|.+||++.++++||||...
T Consensus 217 ~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 217 LL----KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HH----HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 22 222221 1222334578999999999999999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=249.18 Aligned_cols=196 Identities=28% Similarity=0.380 Sum_probs=162.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++.+...+..++|+ ||+.|++|.+++.... .++ .+..++.|++.||.|||++|++|+||+|+||+++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~ 135 (256)
T cd08220 57 SHPNIIEYYENFLEDKALMIVM-EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135 (256)
T ss_pred CCCchhheeeeEecCCEEEEEE-ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 5899999999999999999999 7999999999997743 233 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ +.+||+|||.+.............|++.|+|||.+.+..++.+ +|+||+|+++|+|++|+.||...+.......+
T Consensus 136 ~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 213 (256)
T cd08220 136 KHK-MVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKI 213 (256)
T ss_pred CCC-CEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHH
Confidence 543 2589999999986654444445678999999999987666555 99999999999999999999876654333222
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
. ... ..+.+..++.++.+++.+||.++|.+|||+.++++||||
T Consensus 214 ~----~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 214 M----SGT-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred H----hcC-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 2 111 112233478999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=251.29 Aligned_cols=198 Identities=24% Similarity=0.362 Sum_probs=159.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++.+...+..|++| ||+.+++|..++... ..+. ++..++.|++.||.|||++|++|+||+|+||+++.
T Consensus 58 ~h~~i~~~~~~~~~~~~~~l~~-e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 136 (262)
T cd06613 58 RHPNIVAYFGSYLRRDKLWIVM-EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE 136 (262)
T ss_pred CCCChhceEEEEEeCCEEEEEE-eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC
Confidence 6899999999999999999999 799999999999776 4444 89999999999999999999999999999999986
Q ss_pred CCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccc---cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||++....... ......++..|+|||.+.+. .++. ++|+||+||++|+|++|+.||.........
T Consensus 137 ~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~-~~Di~slG~~l~~~~tg~~p~~~~~~~~~~ 213 (262)
T cd06613 137 DG--DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRAL 213 (262)
T ss_pred CC--CEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 55 49999999987543322 23345788999999998765 5554 499999999999999999999876644332
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
......... .........++.++.+|+++||..+|.+|||+.+++.|+|
T Consensus 214 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 214 FLISKSNFP-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHhccCC-CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 222111000 1111122346788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=250.97 Aligned_cols=188 Identities=20% Similarity=0.239 Sum_probs=154.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.||+|.+++.+...++ .+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 43 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~ 121 (237)
T cd05576 43 CVPNMVCLHKYIVSEDSVFLVL-QHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121 (237)
T ss_pred CCCceeehhhheecCCeEEEEE-ecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC
Confidence 4799999999999999999999 7999999999998776655 889999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .++++|||.+..... ......++..|+|||.+.+..++.+ +|+||+||++|++++|+.||...... .
T Consensus 122 ~--~~~l~df~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~------~- 189 (237)
T cd05576 122 G--HIQLTYFSRWSEVED--SCDGEAVENMYCAPEVGGISEETEA-CDWWSLGAILFELLTGKTLVECHPSG------I- 189 (237)
T ss_pred C--CEEEecccchhcccc--ccccCCcCccccCCcccCCCCCCch-hhHHHHHHHHHHHHHCcchhhcCchh------c-
Confidence 5 499999998765432 2234456778999999877666544 89999999999999999887643211 0
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH-----HHHHcCccc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITI-----PEIMKHQWF 209 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~h~~~ 209 (293)
........+..++..++++|.+||+.||++||++ .++++||||
T Consensus 190 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 190 ---NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ---ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0011112233478999999999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=249.25 Aligned_cols=197 Identities=28% Similarity=0.412 Sum_probs=160.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++......|+|+ ||+.+++|.+++.+.+.+. .+..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~ 138 (258)
T cd06632 60 QHPNIVQYLGTEREEDNLYIFL-ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN 138 (258)
T ss_pred CCCCchheeeeEecCCeEEEEE-EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 5899999999999999999999 7999999999998877555 888899999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||++.............|++.|+|||.+........++|+||+||++|++++|+.||...........
T Consensus 139 ~--~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~--- 213 (258)
T cd06632 139 G--VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK--- 213 (258)
T ss_pred C--CEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH---
Confidence 4 59999999987654443344567899999999987655234459999999999999999999977653222222
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
..........+..++..+.+++.+||..+|.+||++.+++.|||+
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 214 -IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -HHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 111111112233478999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=257.34 Aligned_cols=203 Identities=21% Similarity=0.326 Sum_probs=162.7
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.+|+|+++++++|...++.|+|+ ||+.+++|.+++.+... ..++..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 73 ~~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~ 151 (297)
T cd06656 73 NKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD 151 (297)
T ss_pred CCCCCEeeEEEEEecCCEEEEee-cccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 47899999999999999999999 79999999999976442 23889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .++|+|||++........ .....+++.|+|||.+.+..+.. ++|+||+||++|++++|+.||.+.+.........
T Consensus 152 ~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~ 228 (297)
T cd06656 152 G--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (297)
T ss_pred C--CEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec
Confidence 5 599999999875433222 23456889999999988766654 4999999999999999999998765432211111
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.........+..++..+++|+.+||..+|.+||++.++++||||+...+
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 229 ---TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred ---cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 1111122233457889999999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=250.73 Aligned_cols=197 Identities=25% Similarity=0.364 Sum_probs=163.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.+...+..|+|+ ||+.|++|..++.+...+. ++..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 58 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 136 (258)
T cd05578 58 NHPFLVNLWYSFQDEENMYLVV-DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136 (258)
T ss_pred CCCChHHHHHhhcCCCeEEEEE-eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence 5899999999999999999999 7999999999998875555 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .++|+|||++.............|+..|+|||.+.+..++.+ +|+||+||++|++++|+.||...... .......
T Consensus 137 ~--~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~ 212 (258)
T cd05578 137 G--HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRA 212 (258)
T ss_pred C--CEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHH
Confidence 5 599999999876544434455678899999999877776555 99999999999999999999876642 1112222
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH--HHHHcCccc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITI--PEIMKHQWF 209 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~--~ell~h~~~ 209 (293)
..... ....+..++.++.++|.+||..+|.+||++ .+++.||||
T Consensus 213 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 213 KQETA--DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred Hhccc--cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 22211 223334578999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=253.79 Aligned_cols=199 Identities=21% Similarity=0.322 Sum_probs=156.4
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|++++++.+......|+|+ ||+.+++|.+++...+.+. ++..++.|++.||.|||++|++||||||+||+++.
T Consensus 63 ~~h~~ii~~~~~~~~~~~~~iv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~ 141 (267)
T cd06646 63 CKHCNIVAYFGSYLSREKLWICM-EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD 141 (267)
T ss_pred cCCCCeeeeeEEEEeCCEEEEEE-eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 36899999999999999999999 7999999999998776655 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhcc---ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||++....... ......|++.|+|||.+.+ ..+ ..++|+||+||++|+|++|+.||.........
T Consensus 142 ~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~ 218 (267)
T cd06646 142 NG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218 (267)
T ss_pred CC--CEEECcCccceeecccccccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhh
Confidence 55 49999999987543222 2234568899999998753 223 34599999999999999999999654432211
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
..+..... .....+....++..+.+||++||..+|.+|||++++++|+|
T Consensus 219 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 219 FLMSKSNF-QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred eeeecCCC-CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 11111000 01111222347899999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=256.11 Aligned_cols=200 Identities=30% Similarity=0.508 Sum_probs=160.6
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|++++++.+...+++|+|| ||+.|++|.+++...+.+. .+..++.|++.||.|||++|++||||||.||+++.
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~ 136 (305)
T cd05609 58 AENPFVVSMFCSFETKRHLCMVM-EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136 (305)
T ss_pred CCCCCeeeeEEEEecCCEEEEEE-ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC
Confidence 36899999999999999999999 7999999999998877665 78889999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC----------------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCC
Q 022732 83 SPAPRLKICDFGYSKSSVLHS----------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 146 (293)
++ .+||+|||+++...... ......++..|+|||.+.+..+..+ +|+||+||++|++++|.
T Consensus 137 ~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~ 213 (305)
T cd05609 137 MG--HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGC 213 (305)
T ss_pred CC--CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCC
Confidence 54 59999999986311100 0112357889999999877666545 99999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHhccccCCCCC-CCCCHHHHHHHHHccccCCCCCCC---HHHHHcCcccccC
Q 022732 147 YPFEDPDEPKDFRKTIQRILSVQYSVPDT-NPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLKN 212 (293)
Q Consensus 147 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~h~~~~~~ 212 (293)
.||.+....... ..........+.. ..++.++.++|.+||+++|.+||+ +.++++||||+..
T Consensus 214 ~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 214 VPFFGDTPEELF----GQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred CCCCCCCHHHHH----HHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 999876543322 2222222222221 247899999999999999999997 7899999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=265.38 Aligned_cols=196 Identities=21% Similarity=0.339 Sum_probs=155.0
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--------------------------------------
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-------------------------------------- 44 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-------------------------------------- 44 (293)
.++.|+|+++++++|...+..|+|| ||+.+|+|.++++...
T Consensus 97 ~l~~h~nIv~~~~~~~~~~~~~lv~-ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (374)
T cd05106 97 HLGQHKNIVNLLGACTHGGPVLVIT-EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSS 175 (374)
T ss_pred hhccCCceeeEeeEecCCCCeEEeH-hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccc
Confidence 3468999999999999999999999 7999999999996532
Q ss_pred --------------------------------CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEE
Q 022732 45 --------------------------------LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 90 (293)
Q Consensus 45 --------------------------------~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl 90 (293)
.+. +++.++.||+.||.|||++|++||||||+||+++.++ .+||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL 253 (374)
T cd05106 176 QGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKI 253 (374)
T ss_pred cccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEE
Confidence 122 6789999999999999999999999999999997654 5999
Q ss_pred ecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHHHHHHHHh
Q 022732 91 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRIL 166 (293)
Q Consensus 91 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~ 166 (293)
+|||+++....... .....+++.|+|||++.+..++.+ +||||+||++|+|++ |+.||........+....
T Consensus 254 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~---- 328 (374)
T cd05106 254 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV---- 328 (374)
T ss_pred eeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----
Confidence 99999875432221 112235678999999877776555 999999999999997 999998765433332222
Q ss_pred ccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 167 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
......+.+..+++++.+++.+||+.+|.+|||+.++++.
T Consensus 329 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred HcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222223334478999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=251.26 Aligned_cols=196 Identities=27% Similarity=0.369 Sum_probs=155.4
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+|+|++++++++.. .+..|+++ ||+.+++|.+++...+.+. .++.++.|++.||.|||+++++||||||+||+++
T Consensus 62 ~h~~i~~~~~~~~~~~~~~~~l~~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~ 140 (266)
T cd06651 62 QHERIVQYYGCLRDRAEKTLTIFM-EYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD 140 (266)
T ss_pred CCCCeeeEEEEEEcCCCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 58999999999876 36788888 7999999999998876655 7888999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCC----CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
.++ .+||+|||+++..... .......++..|+|||.+.+..++.+ +|+||+||++|++++|+.||........
T Consensus 141 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~ 217 (266)
T cd06651 141 SAG--NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAA 217 (266)
T ss_pred CCC--CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHH
Confidence 654 5999999998754221 11223458889999999987666544 9999999999999999999987654333
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
... ..........+..+++.++++| +||..+|++||++.++++||||+
T Consensus 218 ~~~----~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 218 IFK----IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHH----HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 222 2221111122234688899999 67778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=252.52 Aligned_cols=201 Identities=24% Similarity=0.419 Sum_probs=160.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++.+...+..|+|+ ||+.+++|.+++... ..+. .+..++.|++.||.|||+ .|++|+||||+||+++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 57 NSPYIVGFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred CCCchhhhheeeecCCEEEEEE-EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 3899999999999999999999 799999999999875 4444 888999999999999999 9999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc-hHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-PKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~ 160 (293)
.++ .++|+|||.+........ ....++..|+|||.+.+..+..+ +|+||+||++|++++|..||..... ......
T Consensus 136 ~~~--~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (265)
T cd06605 136 SRG--QIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211 (265)
T ss_pred CCC--CEEEeecccchhhHHHHh-hcccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHH
Confidence 754 599999999875432222 22678899999999987766555 9999999999999999999976421 111222
Q ss_pred HHHHHhccccCCCCCC-CCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTN-PISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
..+.+..... ...+. .++.+++++|.+||..+|.+|||+.+++.||||++.
T Consensus 212 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 212 LLQYIVNEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHhcCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 3333322221 11111 278999999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=261.59 Aligned_cols=202 Identities=23% Similarity=0.320 Sum_probs=147.8
Q ss_pred CCcchhhhhceee--eceeEEEeehhhccCchhHHHHHHcC---------CHH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 6 SSSSEYAMLGVSV--KMKFVFLSLSFFFSLCLFFMWLLLLG---------LLV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~--~~~~~~lv~~ey~~gg~L~~~l~~~~---------~~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
.|+|++++++++. ....+|+|+ ||+.+ +|..++.... .++ .++.++.||+.||.|||++|++|||
T Consensus 56 ~h~niv~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~D 133 (317)
T cd07867 56 KHPNVIALQKVFLSHSDRKVWLLF-DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRD 133 (317)
T ss_pred CCCCeeeEEEEEeccCCCeEEEEE-eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 5899999999985 457888999 79775 7777775321 122 7889999999999999999999999
Q ss_pred CCCCcEEEcCC--CCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCC
Q 022732 73 LKLENTLLDGS--PAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 73 lkp~NIl~~~~--~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 146 (293)
|||+||++... ..+++||+|||+++...... ......||+.|+|||++.+....+.++||||+||++|+|+||+
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~ 213 (317)
T cd07867 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred CCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCC
Confidence 99999999532 23469999999997543221 1234568999999999877554456699999999999999999
Q ss_pred CCCCCCCch---------HHHHHHHHHHh------------------------ccccC--------CCCCCCCCHHHHHH
Q 022732 147 YPFEDPDEP---------KDFRKTIQRIL------------------------SVQYS--------VPDTNPISQECRDL 185 (293)
Q Consensus 147 ~pf~~~~~~---------~~~~~~~~~~~------------------------~~~~~--------~~~~~~~s~~~~~l 185 (293)
.||...... ..+..+..... ..... .......+..+.+|
T Consensus 214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 293 (317)
T cd07867 214 PIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLL 293 (317)
T ss_pred CCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHH
Confidence 999754321 11111111000 00000 00011245678899
Q ss_pred HHHccccCCCCCCCHHHHHcCccc
Q 022732 186 ISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 186 i~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
|.+||+.||.+|||+.++|+||||
T Consensus 294 l~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 294 LQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHhccCcccccCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=249.05 Aligned_cols=195 Identities=24% Similarity=0.365 Sum_probs=156.6
Q ss_pred CCcchhhhhceeee-ceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVK-MKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~-~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
+|+|.+++++.+.. .+..|+|+ ||+.+++|.+++... ..++ +++.++.|++.||.|||++|++||||||+||++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~lv~-e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~ 135 (257)
T cd08223 57 KHPNIVAYRESWEGEDGLLYIVM-GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL 135 (257)
T ss_pred CCCCeeeeeeeecCCCCEEEEEe-cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE
Confidence 58899999998864 45788999 799999999999763 2233 899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+.++ .++|+|||++...... .......+++.|+|||++.+..++.+ +|+||+||+++++++|+.||...+.....
T Consensus 136 ~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~- 211 (257)
T cd08223 136 TRTN--IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLV- 211 (257)
T ss_pred ecCC--cEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHH-
Confidence 7654 5999999998754322 22334568999999999887776655 89999999999999999999876543222
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
..+..... .+.+..+++++.+++.+||..+|.+|||+.++++||||
T Consensus 212 ---~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 212 ---YRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ---HHHHhcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 22222221 12234588999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=258.96 Aligned_cols=205 Identities=24% Similarity=0.380 Sum_probs=159.4
Q ss_pred CCcchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+++++++|... .+.|+|+ ||+.+ +|...+...-....+..++.|++.||.|||++|++||||||+||+
T Consensus 73 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil 150 (353)
T cd07850 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVM-ELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 150 (353)
T ss_pred CCCCCcceeeeeccCCCccccCcEEEEE-eccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 689999999988644 4679999 79865 888887665334488999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ .+||+|||+++............+++.|+|||++.+..+..+ +|+||+||++|+|++|+.||...+....+.
T Consensus 151 ~~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 151 VKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred ECCCC--CEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 97655 599999999986544444445578999999999988777655 999999999999999999998776544443
Q ss_pred HHHHHHhcc------------------ccC--------------CCC-----CCCCCHHHHHHHHHccccCCCCCCCHHH
Q 022732 160 KTIQRILSV------------------QYS--------------VPD-----TNPISQECRDLISRIFVADPAARITIPE 202 (293)
Q Consensus 160 ~~~~~~~~~------------------~~~--------------~~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~e 202 (293)
.+....... ... .+. ....+..++++|.+||+.||.+|||+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 307 (353)
T cd07850 228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307 (353)
T ss_pred HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence 332211100 000 000 1124667899999999999999999999
Q ss_pred HHcCcccccCCCC
Q 022732 203 IMKHQWFLKNLPA 215 (293)
Q Consensus 203 ll~h~~~~~~~~~ 215 (293)
+|.||||+.....
T Consensus 308 iL~~~~~~~~~~~ 320 (353)
T cd07850 308 ALQHPYINVWYDP 320 (353)
T ss_pred HhcChhHhhccCC
Confidence 9999999866553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=254.37 Aligned_cols=199 Identities=27% Similarity=0.387 Sum_probs=158.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++.+...+..|+|| ||+.|++|..++.+. ..+. .++.++.|++.||.|||++|++||||||+||+++.
T Consensus 67 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~ 145 (292)
T cd06644 67 NHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL 145 (292)
T ss_pred CCCcEeeeEEEEEeCCeEEEEE-ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC
Confidence 4899999999999999999999 799999999888653 3333 89999999999999999999999999999999975
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhcc-----ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++ .+||+|||++...... .......+++.|+|||++.+ ..++ .++|+||+||++|+|++|..||...+...
T Consensus 146 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~ 222 (292)
T cd06644 146 DG--DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMR 222 (292)
T ss_pred CC--CEEEccCccceeccccccccceecCCccccCceeeccccccCCCCC-chhhhHhHHHHHHHHhcCCCCCccccHHH
Confidence 54 5999999998643221 22234568899999999853 2233 34999999999999999999998765432
Q ss_pred HHHHHHHHHhcc-ccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 157 DFRKTIQRILSV-QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.... +... ......+..++.++.++|.+||..+|++||++.++++||||...
T Consensus 223 ~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 223 VLLK----IAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHH----HhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 2222 2111 11223344578999999999999999999999999999999654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=254.49 Aligned_cols=201 Identities=24% Similarity=0.394 Sum_probs=161.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
+|+|+++++++|...+..|+|+ ||+.+++|..++..... ...++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 76 ~hp~i~~~~~~~~~~~~~~iv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~ 154 (297)
T cd06659 76 QHQNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG 154 (297)
T ss_pred CCCchhhhhhheeeCCeEEEEE-ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC
Confidence 5899999999999999999999 79999999998865432 238999999999999999999999999999999997665
Q ss_pred CCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.+||+|||++....... ......|++.|+|||++.+..++.+ +|+||+||++|+|++|+.||...........+ .
T Consensus 155 --~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~ 230 (297)
T cd06659 155 --RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-R 230 (297)
T ss_pred --cEEEeechhHhhcccccccccceecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-h
Confidence 59999999986433221 2234568999999999987766544 99999999999999999999876543332221 1
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.. ..........++..+.++|.+||+.+|.+||++.++++||||.+..
T Consensus 231 ~~--~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 231 DS--PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred cc--CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 11 1111222334789999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=253.08 Aligned_cols=201 Identities=24% Similarity=0.413 Sum_probs=159.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|+ ||+.++.|..+....+.+. +++.++.||+.||.|||++|++||||+|+||+++.+
T Consensus 58 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~ 136 (286)
T cd07846 58 RHENLVNLIEVFRRKKRLYLVF-EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS 136 (286)
T ss_pred CCcchhhHHHhcccCCeEEEEE-ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC
Confidence 5899999999999999999999 7999999998876655444 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .++|+|||++...... .......++..|+|||++.+....+.++|+||+||++|+|++|+.||...........+.
T Consensus 137 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 137 G--VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred C--cEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 5 5999999998754322 222345688999999998765544556999999999999999999998765433333322
Q ss_pred HHHhcc---------------ccCCC----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 163 QRILSV---------------QYSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 163 ~~~~~~---------------~~~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...... ....+ ....++..+++|+.+||..+|.+||++.++++||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 215 KCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 111000 00000 123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=253.61 Aligned_cols=204 Identities=26% Similarity=0.350 Sum_probs=157.8
Q ss_pred CCCCcchhhhhceeeecee-----EEEeehhhccCchhHHHHHHcC-----CHH--HHHHHHHHHHHHHHHHHHcCCeec
Q 022732 4 VGSSSSEYAMLGVSVKMKF-----VFLSLSFFFSLCLFFMWLLLLG-----LLV--QARFFFQQLISGVSYCHAMQVCHR 71 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~-----~~lv~~ey~~gg~L~~~l~~~~-----~~~--~~~~~~~qil~~l~~LH~~~iiHr 71 (293)
+..|+|++++++++..... .|+|| ||+.+ +|..++.... .+. .++.++.||+.||.|||++|++||
T Consensus 57 l~~~~~i~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~ 134 (295)
T cd07837 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVF-EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHR 134 (295)
T ss_pred ccCCCCccceeeeEeecCCCCCceEEEEe-eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 4457999999999988776 89999 79986 7888876532 223 899999999999999999999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCC
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 150 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 150 (293)
||||+||+++.+ .+.+||+|||++...... .......+++.|+|||++.+......++|+||+||++|+|++|..||.
T Consensus 135 dl~~~nil~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 135 DLKPQNLLVDKQ-KGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred CCChHHEEEecC-CCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999762 235999999998754322 222334678899999998764444455999999999999999999998
Q ss_pred CCCchHHHHHHHHHHhccccC-------------CC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 151 DPDEPKDFRKTIQRILSVQYS-------------VP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~-------------~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
+.+.......+...+...... .+ ....++.++.+||.+||.+||.+|||+.+++.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 214 GDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred CCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 877655554444322111000 00 01237899999999999999999999999999999
Q ss_pred cc
Q 022732 209 FL 210 (293)
Q Consensus 209 ~~ 210 (293)
|+
T Consensus 294 ~~ 295 (295)
T cd07837 294 FD 295 (295)
T ss_pred cC
Confidence 84
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=271.92 Aligned_cols=203 Identities=22% Similarity=0.322 Sum_probs=153.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-------CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-------LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-------~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++...+..|+|+ +++. ++|.+++.... ...+++.++.||+.||.|||++||+||||||+||
T Consensus 221 ~HpnIv~l~~~~~~~~~~~lv~-e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI 298 (501)
T PHA03210 221 NHENILKIEEILRSEANTYMIT-QKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298 (501)
T ss_pred CCCCcCcEeEEEEECCeeEEEE-eccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 5899999999999999999999 5765 57777775432 1227889999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCC-CCCCC--
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPD-- 153 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p-f~~~~-- 153 (293)
|++.++ .+||+|||+++....... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..+ |....
T Consensus 299 Ll~~~~--~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 299 FLNCDG--KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred EECCCC--CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 997654 599999999975433222 234579999999999988877655 9999999999999998754 43322
Q ss_pred chHHHHHHHHHHhccccCCC--------------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q 022732 154 EPKDFRKTIQRILSVQYSVP--------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQ 207 (293)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~ 207 (293)
....+..++..+......++ ....++.++.++|.+||+.||.+|||+.|+|.||
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 22233333222110000000 0123567888999999999999999999999999
Q ss_pred ccccCC
Q 022732 208 WFLKNL 213 (293)
Q Consensus 208 ~~~~~~ 213 (293)
||....
T Consensus 456 ~f~~~~ 461 (501)
T PHA03210 456 LFSAEE 461 (501)
T ss_pred hhhcCC
Confidence 997643
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=251.44 Aligned_cols=203 Identities=22% Similarity=0.376 Sum_probs=162.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++.+...+..|+|+ ||+.+++|..++.+.+.+. .++.++.|++.||.|||+ .+++||||||+||+++.
T Consensus 61 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~ 139 (284)
T cd06620 61 RSPYIVSFYGAFLNENNICMCM-EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS 139 (284)
T ss_pred CCCCcceEeeeEecCCEEEEEE-ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC
Confidence 5899999999999999999999 7999999999998876555 889999999999999997 58999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch-------
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------- 155 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~------- 155 (293)
++ .++|+|||++..... .......|+..|+|||++.+..++.+ +|+||+||++|++++|+.||......
T Consensus 140 ~~--~~~l~d~gl~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~ 215 (284)
T cd06620 140 RG--QIKLCDFGVSGELIN-SIADTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215 (284)
T ss_pred CC--cEEEccCCcccchhh-hccCccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhh
Confidence 54 599999999864322 22234578999999999877766555 99999999999999999999865432
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..+......+............++.++.+|+.+||.+||.+|||+.++++|+||.+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 216 MGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 1112233333222211111223678999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=255.62 Aligned_cols=196 Identities=27% Similarity=0.399 Sum_probs=156.8
Q ss_pred hhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH----HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC---
Q 022732 11 YAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV----QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--- 83 (293)
Q Consensus 11 v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~----~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~--- 83 (293)
+++.++|.-.+++|+|++ ..|-+++++|..++..+ +++.+.+||+.+++|||+.+++|-||||+|||+-.+
T Consensus 154 v~m~~wFdyrghiCivfe--llG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFE--LLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred EeeehhhhccCceEEEEe--ccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 677889999999999996 66779999999876544 999999999999999999999999999999998421
Q ss_pred ---------------CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 84 ---------------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 84 ---------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p 148 (293)
....||++|||.|+.. .....+.+.|.+|+|||++++-+++.+ +||||+|||++|+.+|...
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETL 308 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeecccee
Confidence 1224899999999843 233366789999999999999999887 9999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhccc------------------cCCCC-------------C----------CCCCHHHHHHHH
Q 022732 149 FEDPDEPKDFRKTIQRILSVQ------------------YSVPD-------------T----------NPISQECRDLIS 187 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~------------------~~~~~-------------~----------~~~s~~~~~li~ 187 (293)
|...++.+.+ .++++++..- ..++. . ...-.++.+||+
T Consensus 309 FqtHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 309 FQTHENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cccCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 9988765543 3333332211 00000 0 001245789999
Q ss_pred HccccCCCCCCCHHHHHcCcccccC
Q 022732 188 RIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 188 ~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+||..||.+|+|+.|+|.||||...
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcC
Confidence 9999999999999999999999764
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=247.05 Aligned_cols=195 Identities=25% Similarity=0.384 Sum_probs=161.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...+..++|+ ||+.+++|.+++... ..+. ++..++.|++.||.|||+.|++||||+|+||+++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~~~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~ 135 (256)
T cd08221 57 QHPNIIAYYNHFMDDNTLLIEM-EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT 135 (256)
T ss_pred CCCCeeEEEeEEecCCeEEEEE-EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe
Confidence 5899999999999999999999 799999999999775 2233 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .+||+|||++....... ......|++.|+|||++.+..++.+ +|+||+||++|+|++|..||...........
T Consensus 136 ~~~--~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 136 KAG--LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred CCC--CEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 655 59999999987543322 2345568999999999887766555 8999999999999999999987665433332
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+...... +....++.++.++|.+||.++|.+||++.++++|+|+
T Consensus 213 ----~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 213 ----IVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ----HHcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 2222222 2234578999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=255.70 Aligned_cols=204 Identities=20% Similarity=0.336 Sum_probs=156.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+++++++|...+..|++| ||+.+++|.+++.... .+. .++.++.|++.||+|||++||+||||||+||+++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~~~-e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~ 135 (314)
T cd08216 57 QHPNILPYVTSFIVDSELYVVS-PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS 135 (314)
T ss_pred CCcchhhhhheeecCCeEEEEE-eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe
Confidence 5899999999999999999999 7999999999997642 233 8889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--------CCCCCcCCCCccchhhhccc--cCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
.++ .+||+|||.+....... ......++..|+|||++.+. .+. .++|+||+||++|+|++|..||..
T Consensus 136 ~~~--~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 136 GDG--KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred cCC--ceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCC
Confidence 655 59999999886432211 12334577889999998653 344 449999999999999999999987
Q ss_pred CCchHHHHHHHHHHhccc----------------------------cCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHH
Q 022732 152 PDEPKDFRKTIQRILSVQ----------------------------YSVPDTNPISQECRDLISRIFVADPAARITIPEI 203 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el 203 (293)
.................. ...+....++.++.+|+.+||..||++|||+.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 292 (314)
T cd08216 213 MPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292 (314)
T ss_pred CCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH
Confidence 654332222111100000 0000111245788999999999999999999999
Q ss_pred HcCcccccCC
Q 022732 204 MKHQWFLKNL 213 (293)
Q Consensus 204 l~h~~~~~~~ 213 (293)
++||||+...
T Consensus 293 l~~p~~~~~~ 302 (314)
T cd08216 293 LNHSFFKQCK 302 (314)
T ss_pred hcCchHhhhc
Confidence 9999997554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=252.25 Aligned_cols=200 Identities=25% Similarity=0.418 Sum_probs=157.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...+..|+|| ||+. ++|.+++... +.+. .++.++.|++.||+|||++|++||||+|+||+++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~-e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~ 134 (284)
T cd07860 57 NHPNIVKLLDVIHTENKLYLVF-EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 134 (284)
T ss_pred CCCCCcchhhhcccCCcEEEEe-eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 5899999999999999999999 7996 5888888653 2333 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .+||+|||++....... ......+++.|+|||++.+....+.++|+|||||++|+|+||+.||...+.......
T Consensus 135 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 212 (284)
T cd07860 135 TEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212 (284)
T ss_pred CCC--CEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 665 49999999987543222 223345788999999887655545569999999999999999999988765544433
Q ss_pred HHHHHhccc--------------cCCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRILSVQ--------------YSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~~~~--------------~~~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
......... ..++. ...++.+++++|.+||..||.+|||+.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 213 IFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 332211100 00000 12368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=246.49 Aligned_cols=199 Identities=28% Similarity=0.448 Sum_probs=159.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..++|+ ||+.+++|.+++...+.+. .++.++.|++.||.|||++|++|+||+|.||+++.+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~ 135 (264)
T cd06626 57 KHPNLVKYYGVEVHREKVYIFM-EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135 (264)
T ss_pred CCCChhheeeeEecCCEEEEEE-ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 5789999999999999999999 7999999999998875554 889999999999999999999999999999999775
Q ss_pred CCCCEEEecCCCCcCcCCCCCC-----CCCcCCCCccchhhhcccc--CCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
+ .+||+|||++......... ....+++.|+|||++.+.. ....++|+||+||++|++++|+.||.......
T Consensus 136 ~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~ 213 (264)
T cd06626 136 G--VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF 213 (264)
T ss_pred C--CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH
Confidence 4 5999999998754332221 1346788999999987654 12344999999999999999999997654332
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
....... .......|....++..+.+||.+||+.+|.+|||+.+++.|||+
T Consensus 214 ~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 214 QIMFHVG--AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHh--cCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 2211111 12222344444468999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=251.96 Aligned_cols=200 Identities=26% Similarity=0.361 Sum_probs=158.0
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++... +..|+|+ ||+.+ +|.+++..... +. +++.++.||+.||.|||++|++|+||||+||++
T Consensus 62 ~h~ni~~~~~~~~~~~~~~~~lv~-e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 62 QHPNIVTVKEVVVGSNLDKIYMVM-EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred CCCCEEEEEEEEEecCCCcEEEEe-hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 389999999999888 8999999 79985 89888876443 33 899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+.++ .+||+|||++...... .......+++.|+|||.+.+....+.++|+||+||++|+|++|..||........+.
T Consensus 140 ~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~ 217 (293)
T cd07843 140 NNRG--ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN 217 (293)
T ss_pred CCCC--cEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 7665 4999999998865433 223345678999999998765544556999999999999999999998876655444
Q ss_pred HHHHHHhcc-----------------cc--------CCCCCCC-CCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 160 KTIQRILSV-----------------QY--------SVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 160 ~~~~~~~~~-----------------~~--------~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
++....... .. ....+.. +++.+.++|++||+.+|++|||+.+++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 218 KIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 433221100 00 0000111 58899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=276.39 Aligned_cols=197 Identities=25% Similarity=0.411 Sum_probs=159.8
Q ss_pred CCCCCCCcchhhhhcee-ee------ceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcC--
Q 022732 1 MHPVGSSSSEYAMLGVS-VK------MKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQ-- 67 (293)
Q Consensus 1 ~~~~~~~~~~v~~~~~~-~~------~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~-- 67 (293)
|+-+=||+|+|.+++.+ .. ...++|+| |||.||.|.+++.++ ..|. ++++|+.++++|+.+||..+
T Consensus 88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm-EyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pP 166 (738)
T KOG1989|consen 88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM-EYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPP 166 (738)
T ss_pred HHHhcCCCceeeEeccccccccCCCceeEEEeeh-hhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCc
Confidence 55677999999999932 21 24455666 899999999999754 3344 99999999999999999988
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCC----------CCcCCCCccchhhhc---cccCCCchhhhhh
Q 022732 68 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----------STVGTPAYIAPEVLL---RHEYDGKIADVWS 134 (293)
Q Consensus 68 iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~----------~~~gt~~y~aPE~~~---~~~~~~~~~Dvws 134 (293)
|||||||.+||||..++ ++||||||.|.......... ...-|+.|+|||++. +.+.+.+ +||||
T Consensus 167 iIHRDLKiENvLls~~g--~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWA 243 (738)
T KOG1989|consen 167 IIHRDLKIENVLLSADG--NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWA 243 (738)
T ss_pred cchhhhhhhheEEcCCC--CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHH
Confidence 99999999999997665 59999999987432222111 124699999999984 4555555 99999
Q ss_pred hhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 135 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 135 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
|||+||-|+....||.+... ..|++..+.+|...++|..+++||+.||+.||.+||++.+++.+-+-
T Consensus 244 LGclLYkLCy~t~PFe~sg~--------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 244 LGCLLYKLCYFTTPFEESGK--------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred HHHHHHHHHHhCCCcCcCcc--------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 99999999999999998643 24678899999988999999999999999999999999988876543
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=253.33 Aligned_cols=201 Identities=22% Similarity=0.281 Sum_probs=156.0
Q ss_pred CCCCcchhhhhceeeec-----eeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 4 VGSSSSEYAMLGVSVKM-----KFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~-----~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
+-.|+|+++++++|... ...|+|+ ||+.|++|.+++.. ...+. .++.++.|++.||+|||++|++|||
T Consensus 75 l~~h~ni~~~~~~~~~~~~~~~~~~~lv~-ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~d 153 (291)
T cd06639 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVL-ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRD 153 (291)
T ss_pred hcCCCCeEEEEEEEEeccccCCCeeEEEE-EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 34689999999998754 3689999 79999999998863 23333 8899999999999999999999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccC----CCchhhhhhhhhHHHHHHhCCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEY----DGKIADVWSCGVTLYVMLVGGY 147 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~DvwslG~il~el~~g~~ 147 (293)
|||+||+++.++ .+||+|||++....... ......|+..|+|||++..... .+.++|+||+||++|+|++|+.
T Consensus 154 lkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~ 231 (291)
T cd06639 154 VKGNNILLTTEG--GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231 (291)
T ss_pred CCHHHEEEcCCC--CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCC
Confidence 999999997655 49999999987543222 2234568999999999754321 2345999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 148 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
||...........+.. ........+..++..+.++|.+||+++|.+||++.++++||||+
T Consensus 232 p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 232 PLFDMHPVKTLFKIPR---NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCcHHHHHHHHhc---CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 9987654333322211 11112222334678999999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=257.33 Aligned_cols=205 Identities=25% Similarity=0.332 Sum_probs=161.8
Q ss_pred CCcchhhhhceeeece-----eEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMK-----FVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~-----~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++.... .+|+|| +|+.+ +|..++.....+. .++.++.||+.||+|||++|++||||||.||
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~ni 134 (330)
T cd07834 57 RHENIIGLLDILRPPSPEDFNDVYIVT-ELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNI 134 (330)
T ss_pred CCcchhhhhhhhcccCcccccceEEEe-cchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 4899999999998875 899999 79884 8999998776655 8899999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
+++.+ ++++|+|||++....... ......+++.|+|||++.+....+.++|+||+||++|+|++|..||.+...
T Consensus 135 li~~~--~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 135 LVNSN--CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred EEcCC--CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 99766 459999999998654432 233456899999999988773344559999999999999999999988775
Q ss_pred hHHHHHHHHHHhcccc----------------------CC---CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 155 PKDFRKTIQRILSVQY----------------------SV---PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~~----------------------~~---~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...+..+......... .. .....++.++.++|.+||+++|.+|||+.+++.||||
T Consensus 213 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 4443333321110000 00 0012367899999999999999999999999999999
Q ss_pred ccCCC
Q 022732 210 LKNLP 214 (293)
Q Consensus 210 ~~~~~ 214 (293)
++...
T Consensus 293 ~~~~~ 297 (330)
T cd07834 293 AQLHD 297 (330)
T ss_pred Hhhcc
Confidence 76543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=262.46 Aligned_cols=195 Identities=24% Similarity=0.338 Sum_probs=154.4
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--------------------------------------
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-------------------------------------- 45 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-------------------------------------- 45 (293)
++.|+|+++++++|......|+|| ||+.||+|..++.....
T Consensus 95 l~~HpnIv~l~~~~~~~~~~~lv~-E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (375)
T cd05104 95 LGNHINIVNLLGACTVGGPTLVIT-EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKP 173 (375)
T ss_pred hcCCcceeeeeeeeccCCcceeee-hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCC
Confidence 457999999999999999999999 79999999999975321
Q ss_pred -------------------------------------HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCC
Q 022732 46 -------------------------------------LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 86 (293)
Q Consensus 46 -------------------------------------~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~ 86 (293)
+. .+..++.||+.||.|||++|++||||||+|||++.+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-- 251 (375)
T cd05104 174 GVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-- 251 (375)
T ss_pred CcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--
Confidence 11 5778999999999999999999999999999997654
Q ss_pred CEEEecCCCCcCcCCCCCC---CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHHHHH
Q 022732 87 RLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 87 ~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~ 162 (293)
.+||+|||+++........ ....++..|+|||++.+..++.+ +|+||+||++|+|++ |..||........+...+
T Consensus 252 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~ 330 (375)
T cd05104 252 ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330 (375)
T ss_pred cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH
Confidence 5999999998754322211 12334667999999987777655 999999999999998 889998765443333332
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
. .......+...+.++++++.+||+.||++|||+.++++.
T Consensus 331 ~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 331 K----EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred H----hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 2 222222233467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=247.60 Aligned_cols=217 Identities=25% Similarity=0.435 Sum_probs=177.6
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
++..|.+...|+++.++++|+ ||+.||+|.-.++....++ .|++|...|+.||.|||++||++||||.+|+|++..+
T Consensus 310 ~pflvglhscfqtesrlffvi-eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg 388 (593)
T KOG0695|consen 310 NPFLVGLHSCFQTESRLFFVI-EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG 388 (593)
T ss_pred CCeEEehhhhhcccceEEEEE-EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC
Confidence 566788999999999999999 7999999999999888888 8999999999999999999999999999999997655
Q ss_pred CCCEEEecCCCCcC-cCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC--CchHH--HH
Q 022732 85 APRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP--DEPKD--FR 159 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~--~~~~~--~~ 159 (293)
++||+|+|+++. ........+.+|||+|.|||++.+..|... +|+|+||++++||+.|+.||.-. ++++. -.
T Consensus 389 --hikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~nted 465 (593)
T KOG0695|consen 389 --HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTED 465 (593)
T ss_pred --ceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhH
Confidence 599999999985 445566778899999999999999888555 99999999999999999999532 11111 11
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC------CHHHHHcCcccccCCCCCccchhcccCCCCCC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI------TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 230 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp------t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
-..+-++..+.++|.. +|-.+..+++..|.+||.+|. .+.++..|+||+ ....+...+++..+++.+.
T Consensus 466 ylfqvilekqiriprs--lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr-~idwd~leqk~v~ppf~p~ 539 (593)
T KOG0695|consen 466 YLFQVILEKQIRIPRS--LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR-SIDWDLLEQKQVLPPFQPQ 539 (593)
T ss_pred HHHHHHhhhcccccce--eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh-hCCHHHHhhcccCCCCCCc
Confidence 2233344445555544 788888999999999999997 468999999998 5666666666666655443
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=254.09 Aligned_cols=203 Identities=25% Similarity=0.338 Sum_probs=157.6
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++... +.+|+|| ||+.+ +|.+++... ..+. +++.++.||+.||.|||++|++||||||+||++
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 141 (309)
T cd07845 64 RHPNIVELKEVVVGKHLDSIFLVM-EYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141 (309)
T ss_pred CCCCCcceEEEEecCCCCeEEEEE-ecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 588999999999765 5689999 79975 788887653 3333 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+.++ .+||+|||++....... ......+++.|+|||++.+......++|+||+||++|+|++|+.||.+.+....+.
T Consensus 142 ~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~ 219 (309)
T cd07845 142 TDKG--CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD 219 (309)
T ss_pred CCCC--CEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 7654 59999999987654322 22333568889999998765444555999999999999999999999877655554
Q ss_pred HHHHHHhcc---------------ccCCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 160 KTIQRILSV---------------QYSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 160 ~~~~~~~~~---------------~~~~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.+....... ....+. ....++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 220 LIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred HHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 444321110 000000 01258899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=250.05 Aligned_cols=198 Identities=26% Similarity=0.382 Sum_probs=159.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|++++++.+.+.+..|+|| ||+.|++|.+++.....-. ++..++.|++.||.|||+++++|+||+|+||+++.++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~ 138 (277)
T cd06640 60 DSPYVTKYYGSYLKGTKLWIIM-EYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG 138 (277)
T ss_pred CCCCEeeEEEEEEECCEEEEEE-ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC
Confidence 6899999999999999999999 7999999999997643222 8889999999999999999999999999999997654
Q ss_pred CCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.++|+|||++....... ......++..|+|||.+.+...+.+ +|+||+||++|+|++|..||..........
T Consensus 139 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~---- 211 (277)
T cd06640 139 --DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLF---- 211 (277)
T ss_pred --CEEEcccccceeccCCccccccccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhh----
Confidence 59999999987543322 2233468889999999877666545 999999999999999999998765432221
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.+.. .........++..+.+++.+||..+|.+||++.++++|+||.+.
T Consensus 212 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 212 LIPK-NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred hhhc-CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 1111 11112223467899999999999999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=251.37 Aligned_cols=203 Identities=24% Similarity=0.360 Sum_probs=158.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCH----HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLL----VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~----~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...++.|+|+ ||+. ++|..++...... ..++.++.||+.||+|||++|++||||+|+||+++
T Consensus 59 ~h~~i~~~~~~~~~~~~~~lv~-e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 59 QHGNIVRLQDVVHSEKRLYLVF-EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred cCCCEeeEEEEEecCCeEEEEE-eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 5899999999999999999999 7996 4788888665433 27889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
..+ +.+||+|||++...... .......+++.|+|||.+.+......++|+||+||++|+|++|+.||........+.+
T Consensus 137 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~ 215 (294)
T PLN00009 137 RRT-NALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215 (294)
T ss_pred CCC-CEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 543 35899999999754322 2223456789999999987654445559999999999999999999987765544444
Q ss_pred HHHHHhccc--------------cCCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 161 TIQRILSVQ--------------YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 161 ~~~~~~~~~--------------~~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
+........ ...+ ....++..+.+++.+||+.+|.+||++.+++.||||..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 216 IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 332111000 0000 01246889999999999999999999999999999975
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=254.95 Aligned_cols=206 Identities=25% Similarity=0.365 Sum_probs=154.2
Q ss_pred CCcchhhhhceeeec-----eeEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKM-----KFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~-----~~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++... .++|+|+ ||+.+ +|..++..... ...++.++.|++.||.|||++|++||||||+||+
T Consensus 61 ~h~niv~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nil 138 (336)
T cd07849 61 KHENIIGILDIIRPPSFESFNDVYIVQ-ELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLL 138 (336)
T ss_pred CCCCcCchhheeecccccccceEEEEe-hhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence 389999999987654 4689999 79875 78877765432 2289999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
++.++ .+||+|||++....... ......|++.|+|||.+.+....+.++|+||+||++|+|++|+.||.+.+..
T Consensus 139 l~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~ 216 (336)
T cd07849 139 LNTNC--DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216 (336)
T ss_pred ECCCC--CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 97654 59999999987543222 1223568999999998765443455699999999999999999999876543
Q ss_pred HHHHHHHHHHhc----------------------cccCCC---CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 156 KDFRKTIQRILS----------------------VQYSVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 156 ~~~~~~~~~~~~----------------------~~~~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
..+..+...... .....+ ....++.++.++|.+||+.+|.+|||+.++++||||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 217 HQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred HHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 322222110000 000000 0123678899999999999999999999999999998
Q ss_pred cCCCC
Q 022732 211 KNLPA 215 (293)
Q Consensus 211 ~~~~~ 215 (293)
.....
T Consensus 297 ~~~~~ 301 (336)
T cd07849 297 QYHDP 301 (336)
T ss_pred ccCCC
Confidence 77644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=250.88 Aligned_cols=200 Identities=23% Similarity=0.334 Sum_probs=155.9
Q ss_pred CCCCcchhhhhceeeece------eEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHcCCeec
Q 022732 4 VGSSSSEYAMLGVSVKMK------FVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAMQVCHR 71 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~------~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~~iiHr 71 (293)
+..|+|++++++++.... +.|+|| ||+.+++|.+++... ..+. .++.++.|++.||.|||++|++|+
T Consensus 59 ~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~ 137 (275)
T cd06608 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVM-ELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHR 137 (275)
T ss_pred hcCCCChheEEEEEEecCCCCcceEEEEEE-EcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 457999999999997654 589999 799999999998653 2333 889999999999999999999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhcccc----CCCchhhhhhhhhHHHHHHhCC
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~il~el~~g~ 146 (293)
||+|+||+++.++ .+||+|||.+..... ........|++.|+|||++.... ....++|+||+||++|++++|.
T Consensus 138 ~l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~ 215 (275)
T cd06608 138 DIKGQNILLTKNA--EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215 (275)
T ss_pred CCCHHHEEEccCC--eEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCC
Confidence 9999999997654 599999999864322 22234456899999999875422 1234489999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 147 YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 147 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.||...........+... ..........++..+++||.+||..||.+|||+.++++|||+
T Consensus 216 ~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 216 PPLCDMHPMRALFKIPRN---PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCccccchHHHHHHhhcc---CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 999865543333322211 111222223377899999999999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=247.30 Aligned_cols=199 Identities=27% Similarity=0.395 Sum_probs=156.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCH----HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLL----VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~----~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++...+..|+|+ ||+.+++|..++... +.+ ..+..++.||+.||.|||++|++||||||+||++
T Consensus 63 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~ 141 (268)
T cd06624 63 KHRNIVQYLGSDSENGFFKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141 (268)
T ss_pred CCCCeeeeeeeeccCCEEEEEE-ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 6899999999999999999999 799999999999864 333 2788899999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhcccc-CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+... +.+||+|||.+...... .......|++.|+|||.+.+.. ....++|+||+|+++|+|++|+.||.........
T Consensus 142 ~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~ 220 (268)
T cd06624 142 NTYS-GVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA 220 (268)
T ss_pred cCCC-CeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh
Confidence 7533 35999999998754221 2223345889999999986533 2344599999999999999999999765432211
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.... ........ .+..++.++++|+.+||..+|.+|||+.+++.||||
T Consensus 221 ~~~~-~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 221 MFKV-GMFKIHPE--IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred Hhhh-hhhccCCC--CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 1111 11111112 233478999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=252.83 Aligned_cols=204 Identities=20% Similarity=0.346 Sum_probs=154.9
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccC--chhHHHHH--HcCCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCC
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSL--CLFFMWLL--LLGLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLE 76 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~g--g~L~~~l~--~~~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~ 76 (293)
+.+|+|++++++++..++..+++| ||+.+ .++...+. ..+.++ .+..++.|++.||+|||+. |++||||||+
T Consensus 59 ~~~~~~iv~~~~~~~~~~~~~~~~-e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~ 137 (288)
T cd06616 59 SSDCPYIVKFYGALFREGDCWICM-ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPS 137 (288)
T ss_pred hcCCCCEeeeeeEEecCCcEEEEE-ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHH
Confidence 346899999999999999999999 68765 23333332 223444 8899999999999999975 9999999999
Q ss_pred cEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccc--cCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 77 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 77 NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
||+++.++ .+||+|||+++............|++.|+|||++.+. ...+.++|+||+||++|++++|+.||.....
T Consensus 138 Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 215 (288)
T cd06616 138 NILLDRNG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215 (288)
T ss_pred HEEEccCC--cEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch
Confidence 99997654 4999999998754433333455789999999998765 2334459999999999999999999976542
Q ss_pred hHHHHHHHHHHhccc-cCC--CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 155 PKDFRKTIQRILSVQ-YSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~-~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
. ........... ... .....++.++.+||.+||+++|.+|||+.++++||||++..
T Consensus 216 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 216 --V-FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred --H-HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 1 12222222211 111 12234789999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=250.10 Aligned_cols=192 Identities=21% Similarity=0.311 Sum_probs=155.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHHHHHcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSYCHAMQ 67 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~LH~~~ 67 (293)
+|+|++++++++......|+++ ||+.+++|.+++.... .+. .+..++.|++.||.|||++|
T Consensus 66 ~h~~i~~~~~~~~~~~~~~~~~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~ 144 (283)
T cd05048 66 QHPNIVCLLGVCTKEQPTCMLF-EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH 144 (283)
T ss_pred CCcccceEEEEEcCCCceEEEE-ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5889999999999999999999 7999999999997652 222 78899999999999999999
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh
Q 022732 68 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144 (293)
Q Consensus 68 iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 144 (293)
++||||||+||+++.++ .+||+|||+++...... ......+++.|+|||.+.+..++.+ +|+||+||++|+|++
T Consensus 145 i~H~dlkp~Nil~~~~~--~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~ 221 (283)
T cd05048 145 FVHRDLAARNCLVGEGL--TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFS 221 (283)
T ss_pred eeccccccceEEEcCCC--cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHc
Confidence 99999999999997654 59999999987532221 2233456889999999877776554 999999999999998
Q ss_pred -CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 -GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|..||.+....+.. ..+... ...+.+..++.++.+++.+||+.||.+||++.+++++
T Consensus 222 ~g~~p~~~~~~~~~~----~~i~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 222 YGLQPYYGFSNQEVI----EMIRSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCCCCCCCCCHHHHH----HHHHcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999886653322 222222 1223344588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=247.31 Aligned_cols=196 Identities=28% Similarity=0.392 Sum_probs=155.8
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++.+. +.+|+|+ ||+.|++|.+++...+.+. .+..++.|++.||.|||++|++|+||||+||+++
T Consensus 62 ~h~~i~~~~~~~~~~~~~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (265)
T cd06652 62 LHERIVQYYGCLRDPMERTLSIFM-EHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140 (265)
T ss_pred CCCCeeeEEeEeccCCCceEEEEE-EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 588999999998763 5788899 7999999999998776555 7889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCC----CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
.++ .+||+|||+++..... .......|+..|+|||++.+..++. ++|+||+||++|+|++|+.||........
T Consensus 141 ~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 141 SVG--NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGR-KADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred CCC--CEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCc-chhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 654 5999999998753221 1223346889999999987766654 49999999999999999999987644332
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
.. ...........+..++..+.++|.+|+. +|++||+++++++|||+.
T Consensus 218 ~~----~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 218 IF----KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HH----HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 22 2222221222234478899999999985 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=250.11 Aligned_cols=201 Identities=25% Similarity=0.421 Sum_probs=159.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|+ ||+.++.+..++.+...+. ++..++.||+.||.|||.+|++||||+|+||+++.+
T Consensus 58 ~~~~i~~~~~~~~~~~~~~iv~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~ 136 (288)
T cd07833 58 RHENIVNLKEAFRRKGRLYLVF-EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES 136 (288)
T ss_pred CCCCeeehhheEEECCEEEEEE-ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 4899999999999999999999 7999988887776655555 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
+ .+||+|||++....... ......++..|+|||++.+......++|+||+||++|++++|+.||.+.........+
T Consensus 137 ~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 214 (288)
T cd07833 137 G--VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI 214 (288)
T ss_pred C--CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4 59999999987654433 3344568899999999887733445599999999999999999999876554433322
Q ss_pred HHHHhccc------------c---CCC-----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 162 IQRILSVQ------------Y---SVP-----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 162 ~~~~~~~~------------~---~~~-----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
........ . ..+ ....++.++++||++||..+|++|||++++++||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 215 QKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 21110000 0 000 111248899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=251.15 Aligned_cols=205 Identities=26% Similarity=0.376 Sum_probs=164.5
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+.+|+|++++++.|...+..|+|+ ||+.+++|.+++...+.+. .+..++.|++.||.|||++|++||||+|+||+++
T Consensus 61 l~~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~ 139 (290)
T cd05613 61 IRQSPFLVTLHYAFQTDTKLHLIL-DYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139 (290)
T ss_pred cccCCChhceeeEeecCCeEEEEE-ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC
Confidence 457899999999999999999999 7999999999998877665 8888889999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhcccc-CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
.++ ++||+|||++....... ......|+..|+|||.+.+.. ....++|+||+||++|++++|..||.........
T Consensus 140 ~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 217 (290)
T cd05613 140 SNG--HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217 (290)
T ss_pred CCC--CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH
Confidence 654 59999999987543221 223456899999999986532 2234599999999999999999999754433333
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccCC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNL 213 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~~ 213 (293)
..+...+...... .+..++..+.+++.+||..+|.+|| ++.+++.||||.+..
T Consensus 218 ~~~~~~~~~~~~~--~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 218 AEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHhhccCCC--CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 3444443333322 2344789999999999999999997 899999999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=249.54 Aligned_cols=197 Identities=24% Similarity=0.335 Sum_probs=158.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCH-HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLL-VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~-~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
+|+|++++++.+...++.|+|+ ||+.+++|.+++.....- ..++.++.|++.||.|||++|++|+||+|+||+++.++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~ 138 (277)
T cd06642 60 DSPYITRYYGSYLKGTKLWIIM-EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG 138 (277)
T ss_pred CCCccHhhhcccccCCceEEEE-EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC
Confidence 5899999999999999999999 799999999998754322 28899999999999999999999999999999997654
Q ss_pred CCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.++|+|||++........ .....|+..|+|||.+.+..++.+ +|+||+||++|++++|+.||..........
T Consensus 139 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~---- 211 (277)
T cd06642 139 --DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLF---- 211 (277)
T ss_pred --CEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHh----
Confidence 599999999875433221 223468899999999987766555 999999999999999999997654432221
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.+... ........++.++.++|.+||..+|.+||++.++++||||.+
T Consensus 212 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 212 LIPKN-SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred hhhcC-CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 11111 111122346789999999999999999999999999999865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=253.56 Aligned_cols=195 Identities=23% Similarity=0.347 Sum_probs=155.3
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CH--HHHHHHHHHHHHHHHHHH
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LL--VQARFFFQQLISGVSYCH 64 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~--~~~~~~~~qil~~l~~LH 64 (293)
.+++|+|++++++++...+..|+|| ||+.+++|.+++...+ .+ .+++.++.||+.||+|||
T Consensus 63 ~l~~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 141 (303)
T cd05088 63 KLGHHPNIINLLGACEHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 141 (303)
T ss_pred HhcCCCCcceEEEEECCCCCceEEE-EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH
Confidence 3568999999999999999999999 7999999999997653 12 288999999999999999
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 144 (293)
++|++||||||+|||++.++ .+||+|||++.............++..|+|||.+.+..++. ++|+||+||++|+++|
T Consensus 142 ~~gi~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt 218 (303)
T cd05088 142 QKQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVS 218 (303)
T ss_pred hCCccccccchheEEecCCC--cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcc-cccchhhhhHHHHHHh
Confidence 99999999999999997655 59999999986432222222223466799999987766654 4999999999999998
Q ss_pred -CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 -GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|..||...+...... .+ ......+.+..++.++.+++.+||..+|++||++.+++.+
T Consensus 219 ~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 219 LGGTPYCGMTCAELYE----KL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCcccCChHHHHH----HH-hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999998765533222 22 1222223334578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=256.79 Aligned_cols=206 Identities=25% Similarity=0.348 Sum_probs=157.9
Q ss_pred CCcchhhhhceee----eceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSV----KMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~----~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
+|+|+++++++|. ....+|+|+ ||+. ++|..++...+.++ .++.++.||+.||.|||++|++||||||+||+
T Consensus 62 ~h~~iv~~~~~~~~~~~~~~~~~lv~-e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil 139 (334)
T cd07855 62 KHDNIIAIRDILRPPGADFKDVYVVM-DLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLL 139 (334)
T ss_pred CCCCccCHHHhccccCCCCceEEEEE-ehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 4899999999886 346789999 7996 58999997766655 89999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCC-----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
++.++ .+||+|||++........ .....|+.+|+|||++.+......++|+||+||++|+|++|+.||.+.+.
T Consensus 140 ~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 140 VNEDC--ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred EcCCC--cEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 97655 599999999875432221 12346899999999986644345559999999999999999999987654
Q ss_pred hHHHHHHHHHHh--------------------ccccCCCC-----CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 155 PKDFRKTIQRIL--------------------SVQYSVPD-----TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 155 ~~~~~~~~~~~~--------------------~~~~~~~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...+..+..... ......+. ....+.+++++|++||+.+|.+|||+.+++.||||
T Consensus 218 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred HHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 433222221100 00000000 12368999999999999999999999999999999
Q ss_pred ccCCCC
Q 022732 210 LKNLPA 215 (293)
Q Consensus 210 ~~~~~~ 215 (293)
.+...+
T Consensus 298 ~~~~~~ 303 (334)
T cd07855 298 AQYHDP 303 (334)
T ss_pred hhccCC
Confidence 765433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=250.33 Aligned_cols=196 Identities=21% Similarity=0.288 Sum_probs=151.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC---------------------HHHHHHHHHHHHHHHHHHH
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL---------------------LVQARFFFQQLISGVSYCH 64 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~---------------------~~~~~~~~~qil~~l~~LH 64 (293)
.|+|++++++++.+.+..|+|| ||+.+|+|.+++..... ...+..++.||+.||.|||
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 155 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMIT-EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEE-ecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 6899999999999999999999 79999999999965421 1267899999999999999
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHH
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 141 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e 141 (293)
++|++||||||+|||++.++ .+||+|||+++...... ......++..|+|||++.+..++.+ +|+||+||++|+
T Consensus 156 ~~~ivH~dlkp~Nill~~~~--~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~e 232 (304)
T cd05096 156 SLNFVHRDLATRNCLVGENL--TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWE 232 (304)
T ss_pred HCCccccCcchhheEEcCCc--cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHH
Confidence 99999999999999997654 59999999987542221 1123345788999999887776555 999999999999
Q ss_pred HHh--CCCCCCCCCchHHHHHHHHHHhcc--ccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 142 MLV--GGYPFEDPDEPKDFRKTIQRILSV--QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 142 l~~--g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|++ +..||........+.......... ......+..++..+.+++.+||..+|.+|||+.++.+
T Consensus 233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 986 567887765544333222211111 1111223457899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=244.64 Aligned_cols=192 Identities=24% Similarity=0.378 Sum_probs=158.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc---------CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL---------GLLV--QARFFFQQLISGVSYCHAMQVCHRDLK 74 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~---------~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlk 74 (293)
+|+|++++++++.....+++|| ||+.+++|.+++... ..++ ++..++.|++.||.|||++|++|||||
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~ 132 (262)
T cd00192 54 GHPNVVRLLGVCTEEEPLYLVL-EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLA 132 (262)
T ss_pred CCCChheeeeeecCCCceEEEE-EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccC
Confidence 3999999999999999999999 799999999999875 4444 999999999999999999999999999
Q ss_pred CCcEEEcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCC
Q 022732 75 LENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFE 150 (293)
Q Consensus 75 p~NIl~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~ 150 (293)
|+||+++.++ .+||+|||.+...... .......+++.|+|||.+.+..++.+ +|+||+||++|+|++ |..||.
T Consensus 133 p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~ 209 (262)
T cd00192 133 ARNCLVGEDL--VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYP 209 (262)
T ss_pred cceEEECCCC--cEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCC
Confidence 9999997764 5999999999865433 22334567889999999877666544 999999999999999 699998
Q ss_pred CCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 151 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
........ ..+.. ....+.+..++.++.+++.+||..+|.+|||+.+++++
T Consensus 210 ~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 210 GLSNEEVL----EYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCHHHHH----HHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 87553332 22222 22334445578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=248.99 Aligned_cols=200 Identities=26% Similarity=0.382 Sum_probs=157.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++.+.+..|+|+ ||+. ++|.+++.... .+. .+..++.|++.||.|||+++++||||+|+||+++
T Consensus 56 ~~~~iv~~~~~~~~~~~~~iv~-e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~ 133 (283)
T cd07835 56 NHPNIVRLLDVVHSENKLYLVF-EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID 133 (283)
T ss_pred CCCCccCHhheeccCCeEEEEE-eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc
Confidence 4899999999999999999999 7985 68999997765 333 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .++|+|||++....... ......+++.|+|||++.+......++|+||+||++|+|++|+.||...+.......
T Consensus 134 ~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 134 REG--ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred CCC--cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 754 59999999987543222 223346788999999887654444559999999999999999999987765444433
Q ss_pred HHHHHhccc--------------cCC---------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRILSVQ--------------YSV---------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~~~~--------------~~~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+.+...... ... .....++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 332111000 000 0123477899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=248.69 Aligned_cols=206 Identities=27% Similarity=0.384 Sum_probs=163.6
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.+.+|+|++++++.+...+..|+|+ ||+.+++|..++...+.+. .++.++.|++.||.|||+.|++||||||.||++
T Consensus 60 ~~~~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~ 138 (288)
T cd05583 60 AVRRCPFLVTLHYAFQTDTKLHLIL-DYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138 (288)
T ss_pred hccCCcchhhhheeeecCCEEEEEE-ecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence 3457999999999999999999999 7999999999998766554 888999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhcccc-CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
+.++ .++|+|||+++....... .....|+..|+|||.+.+.. ....++|+||+|+++|+|++|..||........
T Consensus 139 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 216 (288)
T cd05583 139 DSEG--HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216 (288)
T ss_pred CCCC--CEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch
Confidence 7654 599999999875433221 22346899999999986643 234459999999999999999999975433322
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC---HHHHHcCcccccCC
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLKNL 213 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~ell~h~~~~~~~ 213 (293)
...+.+.+..... +.+..++..+.++|.+||+.+|++||| +.++++||||+...
T Consensus 217 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 217 QSEISRRILKSKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHHHccCC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 3333344433333 233347899999999999999999998 56789999996543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=249.01 Aligned_cols=202 Identities=26% Similarity=0.389 Sum_probs=161.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|++++++.|...++.|+|| ||+.+++|.+++.... ....++.++.|++.||+|||++|++||||+|+||+++.++
T Consensus 75 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~ 153 (292)
T cd06657 75 QHENVVEMYNSYLVGDELWVVM-EFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG 153 (292)
T ss_pred CCcchhheeeEEEeCCEEEEEE-ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC
Confidence 5899999999999999999999 7999999999886543 2228899999999999999999999999999999997654
Q ss_pred CCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.++|+|||++....... ......|++.|+|||.+.+..++. ++|+||+||++|+|++|..||.+......... ..
T Consensus 154 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~ 229 (292)
T cd06657 154 --RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IR 229 (292)
T ss_pred --CEEEcccccceecccccccccccccCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HH
Confidence 59999999886543221 223456899999999987666644 49999999999999999999987654332222 21
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.... ...+....++..+.+++.+||..+|.+||++.+++.||||.+...
T Consensus 230 ~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 230 DNLP--PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred hhCC--cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 1111 122223347899999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=246.69 Aligned_cols=199 Identities=29% Similarity=0.431 Sum_probs=162.3
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~~~ 83 (293)
|+|++++++++...+..|+|+ ||+.+++|.+++...+.+. .+..++.|++.||.|||+ +|++||||+|+||+++.+
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~ 136 (264)
T cd06623 58 SPYVVKCYGAFYKEGEISIVL-EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK 136 (264)
T ss_pred CCCeeeEEEEEccCCeEEEEE-EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC
Confidence 889999999999999999999 7999999999998766655 889999999999999999 999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCC-CCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .++|+|||++.......... ...++..|+|||.+.+..++. ++|+||||+++|++++|..||...... ......
T Consensus 137 ~--~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~ 212 (264)
T cd06623 137 G--EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY-AADIWSLGLTLLECALGKFPFLPPGQP-SFFELM 212 (264)
T ss_pred C--CEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHH
Confidence 4 59999999987654333322 456889999999987765544 499999999999999999999877521 112223
Q ss_pred HHHhccccCCCCCCC-CCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 163 QRILSVQYSVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
..+.... ....... ++..+.++|.+||.++|++|||+.++++|||++.
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 213 QAICDGP-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHhcCC-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 3333222 2222333 7899999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=249.65 Aligned_cols=199 Identities=22% Similarity=0.317 Sum_probs=154.4
Q ss_pred CCCCcchhhhhceee-----eceeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 4 VGSSSSEYAMLGVSV-----KMKFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~-----~~~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
+..|+|++++++++. ..++.|+|| ||+.|++|.+++.. .+.+. .+..++.|++.||.|||+++++|||
T Consensus 71 l~~h~~i~~~~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 149 (286)
T cd06638 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVL-ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRD 149 (286)
T ss_pred HhcCCCeeeeeeeeeecccCCCCeEEEEE-eecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence 346899999999884 456789999 79999999998753 23343 7889999999999999999999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhcc-----ccCCCchhhhhhhhhHHHHHHhCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~ 146 (293)
|||+||+++.++ .+||+|||+++...... ......|++.|+|||++.. ..+ +.++|+||+||++|+|++|+
T Consensus 150 lkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~ 226 (286)
T cd06638 150 VKGNNILLTTEG--GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGD 226 (286)
T ss_pred CCHHhEEECCCC--CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCC
Confidence 999999997655 49999999987543222 2234568999999998753 223 34599999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 147 YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 147 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.||........+..... ........+..++..+.++|.+||+.+|.+|||+.++++|+||
T Consensus 227 ~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 227 PPLADLHPMRALFKIPR---NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCCCCchhHHHhhccc---cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 99987654332222111 1111112223367899999999999999999999999999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=249.72 Aligned_cols=200 Identities=26% Similarity=0.433 Sum_probs=152.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.+.++.|+|| ||+.+ +|.+++...+ .+. .++.++.|++.||.|||++|++||||||+||+++.
T Consensus 61 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~ 138 (291)
T cd07844 61 KHANIVTLHDIIHTKKTLTLVF-EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE 138 (291)
T ss_pred CCcceeeEEEEEecCCeEEEEE-ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC
Confidence 5889999999999999999999 79985 8999887643 233 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch-HHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRK 160 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~ 160 (293)
++ .+||+|||+++..... .......++..|+|||++.+......++|+||+||++|+|++|+.||.+.... ..+..
T Consensus 139 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~ 216 (291)
T cd07844 139 RG--ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK 216 (291)
T ss_pred CC--CEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 55 5999999998753221 12223457889999999876443345599999999999999999999776532 22222
Q ss_pred HHHHHhcc---------------ccCCC---------CCCCCC--HHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRILSV---------------QYSVP---------DTNPIS--QECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~~~---------------~~~~~---------~~~~~s--~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+....... ....+ ....++ .++.++|.+||.++|.+|||+.+++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 217 IFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 21110000 00000 001234 888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=249.33 Aligned_cols=200 Identities=22% Similarity=0.415 Sum_probs=156.1
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCCc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLEN 77 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~N 77 (293)
.+|+|++++++++...+.+|+|+ ||+. ++|.+++... ..++ .++.++.|++.||.|||++ +++||||||+|
T Consensus 57 ~~~~~iv~~~~~~~~~~~~~lv~-e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~n 134 (283)
T cd06617 57 VDCPYTVTFYGALFREGDVWICM-EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSN 134 (283)
T ss_pred cCCCCeeeeeEEEecCCcEEEEh-hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHH
Confidence 57899999999999999999999 7997 5777777542 2333 8889999999999999997 99999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc----ccCCCchhhhhhhhhHHHHHHhCCCCCCCCC
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 153 (293)
|+++.++ .+||+|||++.............|+..|+|||++.+ ..++ .++|+||+||++|+|++|+.||....
T Consensus 135 il~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (283)
T cd06617 135 VLINRNG--QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWK 211 (283)
T ss_pred EEECCCC--CEEEeecccccccccccccccccCCccccChhhcCCcccccccC-ccccchhhHHHHHHHHhCCCCCCccc
Confidence 9997655 599999999876533333334568999999998865 2233 44999999999999999999997533
Q ss_pred ch-HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 154 EP-KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 154 ~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.. ..+..... ......+ ...+|.++.++|.+||..+|.+|||+.+++.||||.+..
T Consensus 212 ~~~~~~~~~~~---~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 212 TPFQQLKQVVE---EPSPQLP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHh---cCCCCCC-ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 22 22222211 1111222 224789999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=257.51 Aligned_cols=204 Identities=18% Similarity=0.271 Sum_probs=153.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+++++++|....+.|+|+ ||+.+++|.++++.... ++ .++.++.|++.||.|||++|++||||||+||+++
T Consensus 57 ~h~niv~~~~~~~~~~~~~~v~-e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~ 135 (328)
T cd08226 57 RHPNIMTSWTVFTTGSWLWVIS-PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135 (328)
T ss_pred CCCCcceEeeeEecCCceEEEE-ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe
Confidence 5899999999999999999999 79999999999987532 33 7889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--------CCCCcCCCCccchhhhccccC-CCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEY-DGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
.++ .+|++||+.+........ .....++..|+|||++.+... .+.++|+||+||++|+|++|+.||...
T Consensus 136 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 136 GDG--LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred CCC--cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 654 599999986432111110 011234567999999876321 245599999999999999999999876
Q ss_pred CchHHHHHHHHHHh-----------------------------------------ccccCCCCCCCCCHHHHHHHHHccc
Q 022732 153 DEPKDFRKTIQRIL-----------------------------------------SVQYSVPDTNPISQECRDLISRIFV 191 (293)
Q Consensus 153 ~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~s~~~~~li~~~L~ 191 (293)
.............. ......+....++..+++||++||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 293 (328)
T cd08226 214 LRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQ 293 (328)
T ss_pred ChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHcc
Confidence 54332222211000 0000111122367889999999999
Q ss_pred cCCCCCCCHHHHHcCcccccC
Q 022732 192 ADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 192 ~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.||.+|||+.++++||||+..
T Consensus 294 ~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 294 QDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred CCcccCCCHHHHhhCHHHHHH
Confidence 999999999999999999654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=249.96 Aligned_cols=194 Identities=23% Similarity=0.355 Sum_probs=154.4
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CH--HHHHHHHHHHHHHHHHHHH
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LL--VQARFFFQQLISGVSYCHA 65 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~--~~~~~~~~qil~~l~~LH~ 65 (293)
+..|+|++++++++......|+|+ ||+.+++|.+++.+.+ .+ ..++.++.|++.||+|||+
T Consensus 59 l~~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 137 (297)
T cd05089 59 LGHHPNIINLLGACENRGYLYIAI-EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE 137 (297)
T ss_pred hcCCCchhheEEEEccCCcceEEE-EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 457999999999999999999999 7999999999997643 12 2789999999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV- 144 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~- 144 (293)
+|++||||||+||+++.++ .+||+|||++..............+..|+|||++.+..++.+ +|||||||++|+|++
T Consensus 138 ~~ivH~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~ 214 (297)
T cd05089 138 KQFIHRDLAARNVLVGENL--ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSL 214 (297)
T ss_pred CCcccCcCCcceEEECCCC--eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcC
Confidence 9999999999999997654 499999999864322111222233557999999877776554 999999999999997
Q ss_pred CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|..||........... +.. ....+.+..++..+.+|+.+||..+|.+|||++++++.
T Consensus 215 g~~pf~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 215 GGTPYCGMTCAELYEK----LPQ-GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHH----Hhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999987665433322 221 22223344588999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=245.26 Aligned_cols=195 Identities=22% Similarity=0.375 Sum_probs=159.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...++.|+|+ ||+.+++|.+++.... .++ ++..++.|++.||.|||++|++|+||+|+||+++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~ 135 (256)
T cd08218 57 KHPNIVQYQESFEENGNLYIVM-DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 135 (256)
T ss_pred CCCCeeeeEeeecCCCeEEEEE-ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 4789999999999999999999 7999999999997643 223 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .++|+|||++........ .....|++.|+|||++.+...+.+ +|+||+||+++++++|+.||.........
T Consensus 136 ~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~-- 210 (256)
T cd08218 136 KDG--TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLV-- 210 (256)
T ss_pred CCC--CEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHH--
Confidence 655 499999999875432221 223468899999999877766555 99999999999999999999876543332
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
..+..... .+.+..++.++.++|.+||..+|.+||++.++++||||
T Consensus 211 --~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 211 --LKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred --HHHhcCCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 22222222 22334578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=252.19 Aligned_cols=236 Identities=22% Similarity=0.297 Sum_probs=166.8
Q ss_pred CCCCcchhhhhceeeec----eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 4 VGSSSSEYAMLGVSVKM----KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~----~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
+..|+|++++++.+... ..+|+++ +|+. ++|.+++.....+. .++.++.||+.||.|||++|++||||||+|
T Consensus 58 l~~h~~iv~~~~~~~~~~~~~~~~~~~~-e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~N 135 (332)
T cd07857 58 FRGHKNITCLYDMDIVFPGNFNELYLYE-ELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGN 135 (332)
T ss_pred hcCCCChheeeeeeeeccccCCcEEEEE-eccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 44789999999875432 5677877 6776 68999997766655 889999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCC-----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
|+++.++ .+||+|||+++...... ......||+.|+|||.+.+......++|+||+||++|++++|+.||...
T Consensus 136 ili~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 136 LLVNADC--ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred eEEcCCC--CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 9997655 59999999987543221 1223468999999998766433345599999999999999999999876
Q ss_pred CchHHHHHHHHHHhc----------------------cc--cCC-CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q 022732 153 DEPKDFRKTIQRILS----------------------VQ--YSV-PDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 207 (293)
Q Consensus 153 ~~~~~~~~~~~~~~~----------------------~~--~~~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~ 207 (293)
+....+..+...... .. ..+ ......+..+.+|+.+||+.+|.+|||+.+++.||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 543333222221100 00 000 01123578999999999999999999999999999
Q ss_pred ccccCCCCCccchhcccCCCCCCCCCCCCHHHHHHHHH
Q 022732 208 WFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIA 245 (293)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (293)
|+++...+..... -...+..+-....+.+.++..+.
T Consensus 294 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 329 (332)
T cd07857 294 YLAIWHDPDDEPV--CQKPFDFSFESEDSMEELRDMII 329 (332)
T ss_pred hhhhhcCcccccc--ccccccCCccccccHHHHHHHHh
Confidence 9976543322221 22333333334445555544443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=253.64 Aligned_cols=204 Identities=23% Similarity=0.312 Sum_probs=162.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...++.|+|| ||+. |+|.+++.....+. .+..++.|++.||.|||++|++||||+|+||+++.+
T Consensus 78 ~h~~iv~~~~~~~~~~~~~lv~-e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 78 KHENIMGLVDVYVEGDFINLVM-DIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK 155 (335)
T ss_pred CCcceeeeeEEEecCCcEEEEE-eccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC
Confidence 4799999999999999999999 7987 58999998766555 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC---------------CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 84 PAPRLKICDFGYSKSSVL---------------HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p 148 (293)
+ .+||+|||++..... ........+++.|+|||.+.+....+.++|+||+||++|+|++|..|
T Consensus 156 ~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 156 G--ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred C--CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 5 599999999875431 11112335688999999987655445569999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhccccC-CC---------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYS-VP---------------------DTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~-~~---------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|.+.+....+..+.......... ++ .....+.++.++|.+||.++|.+|||+++++.|
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 99887665554444322111100 00 012357889999999999999999999999999
Q ss_pred cccccCC
Q 022732 207 QWFLKNL 213 (293)
Q Consensus 207 ~~~~~~~ 213 (293)
|||+...
T Consensus 314 ~~~~~~~ 320 (335)
T PTZ00024 314 EYFKSDP 320 (335)
T ss_pred cccCCCC
Confidence 9997653
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=248.17 Aligned_cols=203 Identities=25% Similarity=0.368 Sum_probs=155.6
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
+|+|+++++++|... +..|+|| ||+.|++|.+++.. ...+. .+..++.||+.||.|||+.|++|+||+|.|
T Consensus 57 ~h~~iv~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~n 135 (287)
T cd06621 57 KSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135 (287)
T ss_pred CCCCeeeeeeEEEccCCCeEEEEE-EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 589999999998654 4789999 79999999988754 22233 788999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch-H
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-K 156 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~ 156 (293)
|+++.++ .++|+|||++....... .....++..|+|||.+.+..++.+ +|+||+||++|+|++|..||...... .
T Consensus 136 il~~~~~--~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~ 211 (287)
T cd06621 136 ILLTRKG--QVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPL 211 (287)
T ss_pred EEEecCC--eEEEeeccccccccccc-cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCC
Confidence 9997655 49999999987543222 224467889999999887777655 89999999999999999999876220 0
Q ss_pred HHHHHHHHHhccc-cCC----CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 157 DFRKTIQRILSVQ-YSV----PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 157 ~~~~~~~~~~~~~-~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
........+.... ... +....+++.+.+||.+||.++|.+|||+.++++||||++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 212 GPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred ChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 0011122222111 111 11123568899999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=241.35 Aligned_cols=194 Identities=34% Similarity=0.504 Sum_probs=161.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++.+...+.+|+|| ||+.+++|.+++...+.+. .+..++.|++.||.|||+++++|+||+|.||+++.+
T Consensus 51 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~ 129 (250)
T cd05123 51 NHPFIVKLHYAFQTEEKLYLVL-EYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD 129 (250)
T ss_pred CCCcHHHHHHHeecCCeeEEEE-ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC
Confidence 4899999999999999999999 7999999999998876555 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .++|+|||++...... .......++..|+|||.+.+.....+ +|+||||+++|++++|..||...+.. ...
T Consensus 130 ~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~----~~~ 202 (250)
T cd05123 130 G--HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRK----EIY 202 (250)
T ss_pred C--cEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHH----HHH
Confidence 5 5999999998754332 23345568899999999877665444 99999999999999999999776542 223
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH---HHHHcCccc
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI---PEIMKHQWF 209 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~---~ell~h~~~ 209 (293)
..+.... .+.+..++..+.++|++||..||.+||++ .+++.||||
T Consensus 203 ~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 203 EKILKDP--LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHhcCC--CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 3333333 33334468999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=245.77 Aligned_cols=191 Identities=19% Similarity=0.287 Sum_probs=154.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...++.|+|| ||+.+|+|.+++... +.++ +++.++.||+.||+|||++|++||||||+||+++.
T Consensus 64 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~ 142 (266)
T cd05064 64 DHSNIVRLEGVITRGNTMMIVT-EYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS 142 (266)
T ss_pred CCCCcCeEEEEEecCCCcEEEE-EeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC
Confidence 6899999999999999999999 799999999999774 3444 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC--CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+|++|||.+......... ....++..|+|||.+.+..++.+ +|+||+||++|++++ |+.||.+........
T Consensus 143 ~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~ 219 (266)
T cd05064 143 DL--VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIK 219 (266)
T ss_pred CC--cEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 54 5999999987643222111 12335678999999887777555 999999999999775 999998766543322
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
. +.. ....+.+..++..+.+++.+||..+|.+||++.++++
T Consensus 220 ~----~~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 220 A----VED-GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred H----HHC-CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 2 222 2233445558899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=242.58 Aligned_cols=196 Identities=24% Similarity=0.362 Sum_probs=159.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+|+|++++++.+......|+|+ ||+.+++|.+++..... +. .+..++.|++.||.|||+++++|+||||+||+++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~ 135 (257)
T cd08225 57 KHPNIVTFFASFQENGRLFIVM-EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS 135 (257)
T ss_pred CCCChhhhhheeccCCeEEEEE-ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc
Confidence 6899999999999999999999 79999999999976542 22 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++. .+||+|||.+........ .....|++.|+|||++.+..++.+ +|+||+||+++++++|..||...+.......
T Consensus 136 ~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 213 (257)
T cd08225 136 KNGM-VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213 (257)
T ss_pred CCCC-eEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 6543 479999999875433221 223468999999999877666555 9999999999999999999987654333222
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
..... ..+....++.+++++|.+||..+|++|||+.++++||||
T Consensus 214 ----~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 214 ----ICQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----Hhccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 22221 122334578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=238.60 Aligned_cols=208 Identities=24% Similarity=0.329 Sum_probs=161.0
Q ss_pred CCcchhhhhceeee-ceeEEEeehhhccCchhHHHHHHcC-----CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVK-MKFVFLSLSFFFSLCLFFMWLLLLG-----LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~-~~~~~lv~~ey~~gg~L~~~l~~~~-----~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.|+|.|.+..+|.. ...+++++ ||.+- +|...|+-.. .++ .++.++.||+.|+.|||++=|+||||||.|
T Consensus 85 ~h~nvi~Lv~Vfl~~d~~v~l~f-dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaN 162 (438)
T KOG0666|consen 85 KHPNVISLVKVFLSHDKKVWLLF-DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPAN 162 (438)
T ss_pred cCCcchhHHHHHhccCceEEEEe-hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcce
Confidence 48899999999988 89999999 79886 7888885432 222 899999999999999999999999999999
Q ss_pred EEEcCCC--CCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 78 TLLDGSP--APRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 78 Il~~~~~--~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
|++..++ .|+|||+|||+++.....- .....+-|.||+|||.++|....+++.|+||+|||+.||+|-++.|.+
T Consensus 163 IlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 163 ILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred EEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9996553 3679999999998643221 233456899999999999999888999999999999999999998877
Q ss_pred CCc---------hHHHHHHHHHHhcccc-C------CCCC------------C------------CCCHHHHHHHHHccc
Q 022732 152 PDE---------PKDFRKTIQRILSVQY-S------VPDT------------N------------PISQECRDLISRIFV 191 (293)
Q Consensus 152 ~~~---------~~~~~~~~~~~~~~~~-~------~~~~------------~------------~~s~~~~~li~~~L~ 191 (293)
... .+++.+++.-+..... . .|.. . .-++...+|+.+||+
T Consensus 243 ~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~ 322 (438)
T KOG0666|consen 243 REEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLT 322 (438)
T ss_pred hhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhc
Confidence 432 2233333321111100 0 0110 0 124558899999999
Q ss_pred cCCCCCCCHHHHHcCcccccCCCC
Q 022732 192 ADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 192 ~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
.||.+|+|+.++++|+||+...-+
T Consensus 323 yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 323 YDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred cCchhhccHHHHhcccccccCCCC
Confidence 999999999999999999876544
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=247.25 Aligned_cols=196 Identities=30% Similarity=0.510 Sum_probs=161.9
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..|+|++++++++...+..|+|| ||+.+++|.+++.+.+.+. .++.++.|++.||.|||++|++|+||+|+||+++
T Consensus 58 l~~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~ 136 (280)
T cd05581 58 LNGHPGIIKLYYTFQDEENLYFVL-EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136 (280)
T ss_pred cccCCCchhHHHHhcCCceEEEEE-cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 335999999999999999999999 7999999999998886665 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC---------------------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS---------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 140 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ 140 (293)
.++ +++|+|||++....... ......++..|+|||++.+..++. ++|+|||||+++
T Consensus 137 ~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Di~slG~~l~ 213 (280)
T cd05581 137 KDM--HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIY 213 (280)
T ss_pred CCC--CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCCh-hhhHHHHHHHHH
Confidence 655 59999999987533221 122345788999999987766544 499999999999
Q ss_pred HHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH----HHHHcCccc
Q 022732 141 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI----PEIMKHQWF 209 (293)
Q Consensus 141 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~h~~~ 209 (293)
++++|+.||........+ +.+....... +..+++.+.+||.+||+.+|.+|||+ .++++||||
T Consensus 214 ~l~~g~~p~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 214 QMLTGKPPFRGSNEYLTF----QKILKLEYSF--PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHhCCCCCCCccHHHHH----HHHHhcCCCC--CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 999999999887643332 2222233333 33478999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=245.90 Aligned_cols=195 Identities=22% Similarity=0.337 Sum_probs=154.1
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC------------------CHHHHHHHHHHHHHHHHHHH
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG------------------LLVQARFFFQQLISGVSYCH 64 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~------------------~~~~~~~~~~qil~~l~~LH 64 (293)
.++.|+|++++++++...+..|+|| ||+.+|+|.+++.... ...+++.++.|++.||+|||
T Consensus 51 ~l~~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH 129 (270)
T cd05047 51 KLGHHPNIINLLGACEHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 129 (270)
T ss_pred hhccCCCeeeEEEEEecCCCceEEE-EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3567999999999999999999999 7999999999997643 22388999999999999999
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 144 (293)
++|++||||||+||+++.++ .+||+|||++..............+..|+|||++.+..++.+ +|+|||||++|+|++
T Consensus 130 ~~~i~H~dikp~nili~~~~--~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~ 206 (270)
T cd05047 130 QKQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVS 206 (270)
T ss_pred HCCEeecccccceEEEcCCC--eEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHc
Confidence 99999999999999997654 599999999864322222222234567999999877666544 999999999999997
Q ss_pred -CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 -GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|..||.+.+...... .+. .....+.+..++.++.+++.+||..+|.+|||+.+++..
T Consensus 207 ~g~~pf~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 207 LGGTPYCGMTCAELYE----KLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred CCCCCccccCHHHHHH----HHh-CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 999997765433222 221 222233344578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=247.27 Aligned_cols=201 Identities=23% Similarity=0.306 Sum_probs=159.6
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.+|+|++++++++...+..|+|| ||+ +|+|.+++.... .+. ++..++.|++.||.|||++|++|+||+|.||++
T Consensus 55 ~~h~~i~~~~~~~~~~~~~~lv~-e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i 132 (283)
T cd07830 55 NEHPNIVKLKEVFRENDELYFVF-EYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV 132 (283)
T ss_pred cCCCCchhHHHHhhcCCcEEEEE-ecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence 35899999999999999999999 799 789999987764 333 899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+.++ .++|+|||+++............++..|+|||++.+......++|+||+|+++++|++|+.||...........
T Consensus 133 ~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~ 210 (283)
T cd07830 133 SGPE--VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210 (283)
T ss_pred cCCC--CEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence 7655 49999999998654444445567899999999886544344559999999999999999999988766544433
Q ss_pred HHHHHhcc---------------ccCCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRILSV---------------QYSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~~~---------------~~~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+....... ....+ .....+..+.++|++||+.+|.+|||+.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 211 ICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 32211000 00000 011236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=247.34 Aligned_cols=191 Identities=23% Similarity=0.348 Sum_probs=153.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-------------HH--HHHHHHHHHHHHHHHHHHcCCee
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-------------LV--QARFFFQQLISGVSYCHAMQVCH 70 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-------------~~--~~~~~~~qil~~l~~LH~~~iiH 70 (293)
.|+|++++++++...+..|+|+ ||+.+++|.+++...+. ++ ++..++.|++.||+|||++|++|
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H 143 (288)
T cd05093 65 QHEHIVKFYGVCVEGDPLIMVF-EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVH 143 (288)
T ss_pred CCCCcceEEEEEecCCccEEEE-EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 5899999999999999999999 79999999999976541 33 88999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CC
Q 022732 71 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GG 146 (293)
Q Consensus 71 rdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~ 146 (293)
|||||+||+++.++ .+||+|||+++...... ......+++.|+|||++.+..++.+ +|+|||||++|+|++ |.
T Consensus 144 ~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~ 220 (288)
T cd05093 144 RDLATRNCLVGENL--LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGK 220 (288)
T ss_pred cccCcceEEEccCC--cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCC
Confidence 99999999997654 59999999987543221 1223345778999999887766554 999999999999998 89
Q ss_pred CCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 147 YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 147 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.||.......... .+..... .+....++.++.+++.+||++||.+|||+.+++.
T Consensus 221 ~p~~~~~~~~~~~----~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 221 QPWYQLSNNEVIE----CITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCHHHHHH----HHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9998766543332 2222221 2223347899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=254.43 Aligned_cols=203 Identities=25% Similarity=0.350 Sum_probs=156.4
Q ss_pred CCcchhhhhceeeec-----eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKM-----KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~-----~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++... ..+|+|+ ||+. ++|.+++.+.+.+. .+..++.|++.||.|||+++++||||||+||
T Consensus 62 ~h~ni~~~~~~~~~~~~~~~~~~~lv~-e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Ni 139 (337)
T cd07858 62 DHENVIAIKDIMPPPHREAFNDVYIVY-ELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL 139 (337)
T ss_pred CCCCccchHHheecccccccCcEEEEE-eCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 689999999988755 3589999 7986 68999998777665 8999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
+++.++ .+||+|||+++..... .......++..|+|||.+.+....+.++|+||+||++|+|++|+.||.+.+....
T Consensus 140 l~~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 217 (337)
T cd07858 140 LLNANC--DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ 217 (337)
T ss_pred EEcCCC--CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 997654 5999999999754332 2233456899999999986533344559999999999999999999987643222
Q ss_pred HHHHHHHH-------------------hc---cccCC---CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 158 FRKTIQRI-------------------LS---VQYSV---PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 158 ~~~~~~~~-------------------~~---~~~~~---~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
...+.... .. ..... .....++.++.++|++||+.+|.+|||+.++++||||...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 218 LKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 21111100 00 00000 0123478999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=249.46 Aligned_cols=201 Identities=21% Similarity=0.313 Sum_probs=161.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|++++++.+...+..|+|+ ||+.+++|.+++.+.. ...++..++.|++.||.|||++|++||||||+||+++.++
T Consensus 74 ~hp~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~ 152 (293)
T cd06647 74 KHPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 152 (293)
T ss_pred CCCCeeehhheeeeCCcEEEEE-ecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC
Confidence 5899999999999999999999 7999999999997654 3338899999999999999999999999999999997654
Q ss_pred CCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.+||+|||++....... ......|++.|+|||.+.+..++.+ +|+||+||++|++++|+.||...+.........
T Consensus 153 --~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~- 228 (293)
T cd06647 153 --SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA- 228 (293)
T ss_pred --CEEEccCcceecccccccccccccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-
Confidence 59999999886443322 2234468899999999877666554 999999999999999999998765432211111
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.......+.+..++..+.++|.+||..+|.+||++.+++.|+||+...
T Consensus 229 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 229 --TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred --cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 111222223344778999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=249.43 Aligned_cols=196 Identities=23% Similarity=0.371 Sum_probs=157.0
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.++.|+|++++++++...+..|+|+ ||+.+|+|.+++.... ...++..++.|++.||.|||+++++|+||||+||
T Consensus 94 ~l~~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Ni 172 (302)
T cd05055 94 HLGNHENIVNLLGACTIGGPILVIT-EYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172 (302)
T ss_pred hccCCCCcceEEEEEecCCceEEEE-EcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceE
Confidence 3467999999999999999999999 7999999999997643 2238899999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCc
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE 154 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~ 154 (293)
+++.++ .+||+|||+++....... .....+++.|+|||.+.+..++.+ +|+||+||++|++++ |..||.....
T Consensus 173 l~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~ 249 (302)
T cd05055 173 LLTHGK--IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPV 249 (302)
T ss_pred EEcCCC--eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence 997554 599999999875432221 122346778999999877776555 999999999999998 9999987665
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 155 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
...+..... .....+.+...+.++.+++.+||.++|++|||+.++++.
T Consensus 250 ~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 250 DSKFYKLIK----EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred hHHHHHHHH----cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 443333222 222223334478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=243.32 Aligned_cols=191 Identities=20% Similarity=0.231 Sum_probs=150.9
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
-+|+|++++++++......++|| ||+.+|+|.+++...+. +. .+..++.||+.||+|||++|++||||||+||+++
T Consensus 56 ~~h~~iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~ 134 (258)
T cd05078 56 LSHKHLVLNYGVCVCGDESIMVQ-EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134 (258)
T ss_pred CCCCChhheeeEEEeCCCcEEEE-ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence 36899999999999999999999 79999999999987543 33 7888999999999999999999999999999997
Q ss_pred CCCC------CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCC-CCCCCCCc
Q 022732 82 GSPA------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDE 154 (293)
Q Consensus 82 ~~~~------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~-~pf~~~~~ 154 (293)
.++. +.++++|||++..... .....+++.|+|||++.+....+.++|+||+||++|++++|. .||.....
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred cccccccCCCceEEecccccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 6543 1379999999865422 233568889999999876543345599999999999999985 56655443
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 155 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
... .. ........| ...+.++.+++.+||+.+|++|||++++++.
T Consensus 212 ~~~-~~----~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 212 QKK-LQ----FYEDRHQLP--APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHH-HH----HHHccccCC--CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 221 11 111222222 2367899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=245.87 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=158.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC---CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG---LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~---~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++...++.|+|+ ||+.+ +|.+++...+ .+. ++..++.|++.||.|||++|++||||||+||++
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~ 133 (284)
T cd07836 56 KHENIVRLHDVIHTENKLMLVF-EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI 133 (284)
T ss_pred cCCCEeeeeeeEeeCCcEEEEE-ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 5899999999999999999999 79986 8888887644 233 899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+.++ .+||+|||++....... ......+++.|+|||++.+......++|+||+||++|++++|+.||.+.+......
T Consensus 134 ~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 211 (284)
T cd07836 134 NKRG--ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211 (284)
T ss_pred CCCC--cEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 7654 59999999987543221 22345678999999998765544556999999999999999999999877655544
Q ss_pred HHHHHHhccc--------------cCCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 160 KTIQRILSVQ--------------YSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 160 ~~~~~~~~~~--------------~~~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.+........ ...+. ...++..++++|.+||+.||.+||++.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 212 KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 4432211000 00000 11357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=245.82 Aligned_cols=199 Identities=26% Similarity=0.378 Sum_probs=160.2
Q ss_pred CCcchhhhhceeeecee-----EEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVKMKF-----VFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~-----~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.|+|.+++++++..... +|+++ ||+.+ +|.+++..... ++ .++.++.|++.||.|||+++++|+||+|+
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~~~~~l~~-e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~ 136 (287)
T cd07838 59 EHPNIVRLLDVCHGPRTDRELKLTLVF-EHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQ 136 (287)
T ss_pred CCCCcceEEEEEeeccCCCCceeEEEe-hhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChh
Confidence 48999999999998887 99999 79875 78888876432 33 89999999999999999999999999999
Q ss_pred cEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 77 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 77 NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
||+++.++ .+||+|||.+.............+++.|+|||++.+..+..+ +|+||+||++|+|++|..||.+.....
T Consensus 137 nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~ 213 (287)
T cd07838 137 NILVTSDG--QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEAD 213 (287)
T ss_pred hEEEccCC--CEEEeccCcceeccCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHH
Confidence 99997764 599999999876544444445568899999999987776655 999999999999999999999877766
Q ss_pred HHHHHHHHHhccc-cCCC-----------C---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 157 DFRKTIQRILSVQ-YSVP-----------D---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 157 ~~~~~~~~~~~~~-~~~~-----------~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.+.++........ ...+ . ...++..+.++|.+||+.||.+||++.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 214 QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 5555554321100 0000 0 01356788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=246.77 Aligned_cols=200 Identities=23% Similarity=0.366 Sum_probs=150.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|+ ||+. ++|..++... +.+. +++.++.|++.||.|||++|++||||||+||+++.
T Consensus 61 ~h~ni~~~~~~~~~~~~~~lv~-e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~ 138 (291)
T cd07870 61 KHANIVLLHDIIHTKETLTFVF-EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY 138 (291)
T ss_pred CCCCEeEEEEEEecCCeEEEEE-eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC
Confidence 5899999999999999999999 7996 5776666543 3222 88899999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH-HHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-DFRK 160 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~ 160 (293)
++ .+||+|||+++..... .......+++.|+|||++.+......++|+||+||++|+|++|..||....... .+..
T Consensus 139 ~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 216 (291)
T cd07870 139 LG--ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216 (291)
T ss_pred CC--cEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Confidence 55 5999999998753222 222344678999999998764433445999999999999999999998655421 1111
Q ss_pred HHHHHhcc------------c-----cCC--C-------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRILSV------------Q-----YSV--P-------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~~~------------~-----~~~--~-------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+....... . ... + .....+..+.+++.+||..||.+|||+.+++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 11100000 0 000 0 001235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=241.87 Aligned_cols=195 Identities=24% Similarity=0.354 Sum_probs=157.5
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHH-----HcCCeecC
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCH-----AMQVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH-----~~~iiHrd 72 (293)
.|+|++++++++.. ....|+++ ||+.+++|.+++... +.+. .++.++.||+.||.||| +.+++|+|
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~~~~~-e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~d 135 (265)
T cd08217 57 KHPNIVRYYDRIIDRSNQTLYIVM-EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD 135 (265)
T ss_pred CCCccceeeeeeecCCCCEEEEEe-hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecC
Confidence 57899999998764 46688898 799999999999763 3333 88999999999999999 89999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
|||+||+++.++ .+||+|||++........ .....+++.|+|||++.+..++.+ +|+||||++++++++|..||..
T Consensus 136 l~p~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 136 LKPANIFLDANN--NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred CCHHHEEEecCC--CEEEecccccccccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccC
Confidence 999999997654 599999999886544333 344578999999999877666544 9999999999999999999987
Q ss_pred CCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 152 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.... ...+.+..... .+.+..++..+.+++.+||..+|.+|||+.++++|||+
T Consensus 213 ~~~~----~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 213 RNQL----QLASKIKEGKF-RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cCHH----HHHHHHhcCCC-CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 6632 22222222222 12234578999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=245.88 Aligned_cols=194 Identities=20% Similarity=0.282 Sum_probs=154.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-------HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-------LV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-------~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.|+|++++++++.+....|+|| ||+.|++|.+++...+. +. .+..++.||+.||+|||++|++||||||+
T Consensus 67 ~~~~i~~~~~~~~~~~~~~lv~-e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~ 145 (277)
T cd05036 67 NHQNIVRLIGVSFERLPRFILL-ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAAR 145 (277)
T ss_pred CCCCEeeEEEEEccCCCcEEEE-ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchh
Confidence 5889999999999999999999 79999999999976542 22 78899999999999999999999999999
Q ss_pred cEEEcCCC-CCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCC
Q 022732 77 NTLLDGSP-APRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFED 151 (293)
Q Consensus 77 NIl~~~~~-~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~ 151 (293)
||+++.++ ...+||+|||+++....... ......++.|+|||++.+..++.+ +|+|||||++|+|++ |..||.+
T Consensus 146 nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~ 224 (277)
T cd05036 146 NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPG 224 (277)
T ss_pred eEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCC
Confidence 99997654 23589999999975422111 112234567999999987777655 999999999999997 9999987
Q ss_pred CCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 152 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
....... . .+.. ....+.+..++..+.+++.+||..+|++|||+.++++|
T Consensus 225 ~~~~~~~-~---~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 225 RTNQEVM-E---FVTG-GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCHHHHH-H---HHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6653322 2 2211 12223344578999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=250.85 Aligned_cols=202 Identities=23% Similarity=0.318 Sum_probs=151.7
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcC-----CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLG-----LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~-----~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.|+|++++++++... ...|+|+ ||+.+ +|.+++.... .++ .++.++.||+.||.|||+++++||||||+
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~ 137 (316)
T cd07842 60 KHENVVSLVEVFLEHADKSVYLLF-DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPA 137 (316)
T ss_pred CCCCccceEEEEeCCCCceEEEEE-eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHH
Confidence 589999999999998 8999999 79876 6666664321 333 78899999999999999999999999999
Q ss_pred cEEEcCCC--CCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCC
Q 022732 77 NTLLDGSP--APRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 150 (293)
Q Consensus 77 NIl~~~~~--~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 150 (293)
||+++.++ .+.+||+|||++........ .....+++.|+|||++.+......++|+||+||++|+|++|+.||.
T Consensus 138 Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 138 NILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred HEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 99997611 34699999999875433222 2344678999999998765544555999999999999999999998
Q ss_pred CCCchH---------HHHHHHHHHh----------------------ccccCCC---------CCCCCCHHHHHHHHHcc
Q 022732 151 DPDEPK---------DFRKTIQRIL----------------------SVQYSVP---------DTNPISQECRDLISRIF 190 (293)
Q Consensus 151 ~~~~~~---------~~~~~~~~~~----------------------~~~~~~~---------~~~~~s~~~~~li~~~L 190 (293)
+..... .+..+...+. ......+ .....+.++.++|.+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 297 (316)
T cd07842 218 GREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297 (316)
T ss_pred CCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHh
Confidence 654321 1111111100 0000001 00146788999999999
Q ss_pred ccCCCCCCCHHHHHcCccc
Q 022732 191 VADPAARITIPEIMKHQWF 209 (293)
Q Consensus 191 ~~dp~~Rpt~~ell~h~~~ 209 (293)
..||++|||+.+++.||||
T Consensus 298 ~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 298 EYDPTKRITAEEALEHPYF 316 (316)
T ss_pred cCCcccCcCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=252.22 Aligned_cols=204 Identities=23% Similarity=0.331 Sum_probs=157.9
Q ss_pred CCcchhhhhceeeecee------EEEeehhhccCchhHHHHHHcC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMKF------VFLSLSFFFSLCLFFMWLLLLG-LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~------~~lv~~ey~~gg~L~~~l~~~~-~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++..... .|+|+ ||+ +++|.+++.... ....++.++.|++.||.|||++|++||||||+||
T Consensus 72 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Ni 149 (343)
T cd07851 72 DHENVIGLLDVFTPASSLEDFQDVYLVT-HLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI 149 (343)
T ss_pred cCCCHHHHHHHhhccccccccccEEEEE-ecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 58999999998876655 89999 687 669999987643 2238999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+++.++ .+||+|||++..... ......++..|+|||.+.+....+.++|+||+||++|++++|+.||.+.......
T Consensus 150 ll~~~~--~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~ 225 (343)
T cd07851 150 AVNEDC--ELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL 225 (343)
T ss_pred EECCCC--CEEEccccccccccc--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 997654 599999999875432 2344568899999999865434445599999999999999999999877654443
Q ss_pred HHHHHHHhccc-------------------cCC------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 159 RKTIQRILSVQ-------------------YSV------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 159 ~~~~~~~~~~~-------------------~~~------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..+........ ... .....++.++.+||.+||+.+|.+|||+.++++||||.+..
T Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 226 KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 33322110000 000 00123689999999999999999999999999999998764
Q ss_pred CC
Q 022732 214 PA 215 (293)
Q Consensus 214 ~~ 215 (293)
..
T Consensus 306 ~~ 307 (343)
T cd07851 306 DP 307 (343)
T ss_pred CC
Confidence 44
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=241.96 Aligned_cols=192 Identities=20% Similarity=0.311 Sum_probs=153.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.... .+. .++.++.|++.||.|||++|++||||||+||+++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~ 138 (263)
T cd05052 60 KHPNLVQLLGVCTREPPFYIIT-EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138 (263)
T ss_pred CCCChhheEEEEcCCCCcEEEE-EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 5899999999999999999999 7999999999997643 233 7889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCC--CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||++......... ....+++.|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+.......
T Consensus 139 ~~~--~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~ 215 (263)
T cd05052 139 ENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY 215 (263)
T ss_pred CCC--cEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 654 5999999998754332211 11234567999999887777655 999999999999998 99999876543322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. +. .....+.+..++.++.++|.+||..+|++|||+.++++.
T Consensus 216 ~~----~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 216 EL----LE-KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HH----HH-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 22 21 122333445588999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=243.82 Aligned_cols=191 Identities=23% Similarity=0.327 Sum_probs=154.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--------------HH--HHHHHHHHHHHHHHHHHHcCCe
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--------------LV--QARFFFQQLISGVSYCHAMQVC 69 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--------------~~--~~~~~~~qil~~l~~LH~~~ii 69 (293)
.|+|++++++++......|+|| ||+.+++|.+++...+. +. ++..++.|++.||.|||++|++
T Consensus 66 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~ 144 (280)
T cd05049 66 QHENIVKFYGVCTEGDPPIMVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV 144 (280)
T ss_pred CCCCchheeeEEecCCCeEEEE-ecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCee
Confidence 5889999999999999999999 79999999999976532 22 7899999999999999999999
Q ss_pred ecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-C
Q 022732 70 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-G 145 (293)
Q Consensus 70 Hrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g 145 (293)
||||||+||+++.++ .+||+|||+++...... ......+++.|+|||++.+..++.+ +|+|||||++|+|++ |
T Consensus 145 h~dlkp~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g 221 (280)
T cd05049 145 HRDLATRNCLVGYDL--VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYG 221 (280)
T ss_pred ccccccceEEEcCCC--eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcC
Confidence 999999999997664 59999999987432211 1223446788999999988777655 999999999999998 9
Q ss_pred CCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 146 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 146 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..||.+........ .+..... .+.+..++..+.+++.+||.+||.+|||+.++++
T Consensus 222 ~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 222 KQPWYGLSNEEVIE----CITQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCCHHHHHH----HHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99998766543322 2222222 1223458899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=241.74 Aligned_cols=190 Identities=21% Similarity=0.231 Sum_probs=150.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.. ...++|| ||+.+++|.+++...+.+. .+..++.|++.||+|||++|++||||||.||+++.+
T Consensus 54 ~h~~i~~~~~~~~~-~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~ 131 (257)
T cd05116 54 DNPYIVRMIGICEA-ESWMLVM-ELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ 131 (257)
T ss_pred CCCCcceEEEEEcC-CCcEEEE-ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC
Confidence 68999999998864 4668899 7999999999998776655 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
+ .+||+|||+++....... .....+++.|+|||.+....++. ++|+|||||++|++++ |..||.........
T Consensus 132 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 208 (257)
T cd05116 132 H--YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS-KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208 (257)
T ss_pred C--eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4 599999999875433222 12223457899999987666554 4999999999999998 99999876543322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..+... ...+.+..++.+++++|.+||+.||.+||++.++..
T Consensus 209 ----~~i~~~-~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 209 ----QMIESG-ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ----HHHHCC-CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 222222 223334458999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=246.47 Aligned_cols=199 Identities=23% Similarity=0.384 Sum_probs=161.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|.+++++.+...+..|+|+ ||+.|++|.+++...+ .+. .+..++.|++.||.|||++|++|+||+|+||+++.
T Consensus 73 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~ 151 (286)
T cd06614 73 KHPNIVDYYDSYLVGDELWVVM-EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK 151 (286)
T ss_pred CCCCeeEEEEEEEECCEEEEEE-eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC
Confidence 4789999999999999999999 7999999999998875 444 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .++|+|||++....... ......+++.|+|||.+.+..++.+ +|+||+||++|+|++|+.||...........+
T Consensus 152 ~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~ 228 (286)
T cd06614 152 DG--SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228 (286)
T ss_pred CC--CEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 54 59999999876432221 2234457889999999887766555 99999999999999999999876543322222
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.. ......+....++..+.++|.+||+.+|.+|||+.+++.|+||++
T Consensus 229 ~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 229 TT---KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred Hh---cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 11 111122223337899999999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=240.63 Aligned_cols=197 Identities=27% Similarity=0.413 Sum_probs=161.6
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++.+... +..|+|+ ||+.+++|.+++.+...+. .+..++.|++.||.|||++|++|+||+|+||+++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~ 135 (260)
T cd06606 57 QHPNIVRYYGSERDEEKNTLNIFL-EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD 135 (260)
T ss_pred CCCCEeeEEEEEecCCCCeEEEEE-EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc
Confidence 389999999999998 8999999 7999999999998876554 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
.++ .++|+|||.+........ .....++..|+|||.+.+.....+ +|+||+|+++|++++|..||.......
T Consensus 136 ~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~-- 210 (260)
T cd06606 136 SDG--VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPM-- 210 (260)
T ss_pred CCC--CEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchH--
Confidence 654 599999999876544432 345678999999999877665444 999999999999999999998766322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.....+.........+..++..+++||.+||..+|.+||++.++++||||
T Consensus 211 -~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 211 -AALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -HHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 22222222122222334478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=248.53 Aligned_cols=198 Identities=24% Similarity=0.349 Sum_probs=154.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|+ ||+.| ++.+++.. .+.+. .+..++.|++.||.|||++|++||||+|.||+++.
T Consensus 73 ~h~niv~~~~~~~~~~~~~lv~-e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~ 150 (307)
T cd06607 73 RHPNTIEYKGCYLREHTAWLVM-EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150 (307)
T ss_pred CCCCEEEEEEEEEeCCeEEEEH-HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC
Confidence 5899999999999999999999 79885 56666543 33333 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc---ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||++..... .....+++.|+|||++.+ ..+. .++|+||+|+++|+|++|+.||.+........
T Consensus 151 ~~--~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~ 224 (307)
T cd06607 151 PG--TVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (307)
T ss_pred CC--CEEEeecCcceecCC---CCCccCCccccCceeeeccCCCCCC-cccchHHHHHHHHHHHcCCCCCCCccHHHHHH
Confidence 55 599999999875422 234568889999998742 3343 44999999999999999999998765433222
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
. +............++..++++|.+||..+|.+||++.+++.||||.+..++
T Consensus 225 ~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 276 (307)
T cd06607 225 H----IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP 276 (307)
T ss_pred H----HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence 1 111111111123368899999999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=243.68 Aligned_cols=192 Identities=18% Similarity=0.275 Sum_probs=152.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC------------HHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL------------LVQARFFFQQLISGVSYCHAMQVCHRDL 73 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~------------~~~~~~~~~qil~~l~~LH~~~iiHrdl 73 (293)
+|+|++++++++....+.|+|| ||+.+++|.+++.+... ...+..++.|++.||.|||++|++||||
T Consensus 67 ~~~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dl 145 (277)
T cd05062 67 NCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDL 145 (277)
T ss_pred CCCCeeeEEEEEcCCCCeEEEE-ecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCc
Confidence 5899999999999999999999 79999999999976331 2277889999999999999999999999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCC
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPF 149 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf 149 (293)
||+||+++.++ .+||+|||+++....... .....+++.|+|||.+.+..++.+ +|+|||||++|+|++ |..||
T Consensus 146 kp~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~ 222 (277)
T cd05062 146 AARNCMVAEDF--TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 222 (277)
T ss_pred chheEEEcCCC--CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCC
Confidence 99999997654 599999999874322111 122345778999999887666554 999999999999999 78899
Q ss_pred CCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 150 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+....... ..+..... .+.+..++..+++++.+||+.+|.+|||+.+++++
T Consensus 223 ~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 223 QGMSNEQVL----RFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCHHHHH----HHHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 876553322 22222221 22234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=245.93 Aligned_cols=192 Identities=22% Similarity=0.327 Sum_probs=154.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC----------------HH--HHHHHHHHHHHHHHHHHHcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL----------------LV--QARFFFQQLISGVSYCHAMQ 67 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~----------------~~--~~~~~~~qil~~l~~LH~~~ 67 (293)
.|+|++++++++...+..++|| ||+.+++|.+++...+. ++ .++.++.||+.||+|||++|
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 143 (291)
T cd05094 65 QHEHIVKFYGVCGDGDPLIMVF-EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 143 (291)
T ss_pred CCCCcceEEEEEccCCceEEEE-ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5899999999999999999999 79999999999976432 22 78999999999999999999
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh
Q 022732 68 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144 (293)
Q Consensus 68 iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 144 (293)
++||||||+||+++.++ .+||+|||+++...... ......++..|+|||.+.+..+..+ +|+||+||++|+|++
T Consensus 144 i~H~dlkp~Nil~~~~~--~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t 220 (291)
T cd05094 144 FVHRDLATRNCLVGANL--LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFT 220 (291)
T ss_pred eeecccCcceEEEccCC--cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHh
Confidence 99999999999997655 59999999987543221 1233456788999999887776555 999999999999998
Q ss_pred -CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 -GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|+.||.......... .+.... ........+..+.+++.+||+++|.+|||+.++++.
T Consensus 221 ~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 221 YGKQPWFQLSNTEVIE----CITQGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCCCCCCCHHHHHH----HHhCCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 999997766533222 222221 112233478999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=250.74 Aligned_cols=204 Identities=27% Similarity=0.378 Sum_probs=157.2
Q ss_pred CCCCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 4 VGSSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
+..|+|+++++++|... ...|+|+ ||+.+ +|..++... .+. .++.++.||+.||.|||++|++||||||+||+
T Consensus 63 l~~h~ni~~~~~~~~~~~~~~~~lv~-e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nil 139 (337)
T cd07852 63 LGDHPNIVKLLNVIKAENDKDIYLVF-EYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNIL 139 (337)
T ss_pred hcCCCCccceeeeeccCCCceEEEEe-ccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 35799999999998654 4689999 79975 999988775 333 78889999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCC
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 153 (293)
++.++ .+||+|||++....... ......|++.|+|||.+.+......++|+||+||++|+|++|+.||.+..
T Consensus 140 l~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 140 LNSDC--RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred EcCCC--cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 97665 59999999987543222 22334689999999988665544556999999999999999999998766
Q ss_pred chHHHHHHHHHHhc-----------------------cccC--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 154 EPKDFRKTIQRILS-----------------------VQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 154 ~~~~~~~~~~~~~~-----------------------~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
.......+...... .... ......++.++.++|.+||+.+|.+|||+.++++|||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~ 297 (337)
T cd07852 218 TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297 (337)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence 54433322221100 0000 0011226899999999999999999999999999999
Q ss_pred cccC
Q 022732 209 FLKN 212 (293)
Q Consensus 209 ~~~~ 212 (293)
+++.
T Consensus 298 ~~~~ 301 (337)
T cd07852 298 VAQF 301 (337)
T ss_pred hhhh
Confidence 9764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=245.65 Aligned_cols=200 Identities=27% Similarity=0.358 Sum_probs=158.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|+ ||+.+ +|.+++... +.+. .+..++.|++.||.|||++|++|+||||+||+++.
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~-e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~ 133 (283)
T cd05118 56 NHPNIIKLLDVFRHKGDLYLVF-EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT 133 (283)
T ss_pred cCCCcchHHHhhccCCCEEEEE-eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC
Confidence 3899999999999999999999 79976 888888764 3433 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||.+....... ......++..|+|||.+.+....+.++|+||+||++|++++|+.||...+....+..+
T Consensus 134 ~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 134 EG--VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred CC--cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 54 59999999987544332 2234568889999999877633455599999999999999999999887765544443
Q ss_pred HHHHhcccc---------------CCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 162 IQRILSVQY---------------SVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 162 ~~~~~~~~~---------------~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
......... ..+ ....++.++++||.+||.+||.+||++.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 322111100 000 112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=239.11 Aligned_cols=195 Identities=27% Similarity=0.411 Sum_probs=159.2
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
++|++++++++......++++ ||+.|++|.+++... +.+. .+..++.|++.||.|||.+|++||||+|+||+++.+
T Consensus 56 ~~~i~~~~~~~~~~~~~~l~~-e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~ 134 (253)
T cd05122 56 HPNIVKYYGSYLKKDELWIVM-EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD 134 (253)
T ss_pred CCCEeEEEEEEecCCeEEEEE-ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC
Confidence 789999999999999999999 799999999999776 3444 889999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .++|+|||.+.............++..|+|||.+.+...+.+ +|+||+|+++|++++|+.||...+..........
T Consensus 135 ~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 211 (253)
T cd05122 135 G--EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIAT 211 (253)
T ss_pred C--eEEEeeccccccccccccccceecCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Confidence 4 599999999876544332345678999999999877665444 9999999999999999999987654332222211
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
......+....++..+.++|.+||..||.+|||+.++++|||
T Consensus 212 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ---NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 112222333335899999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=221.89 Aligned_cols=202 Identities=25% Similarity=0.372 Sum_probs=167.9
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
|+|+|++++.-..++.+.+|+ |||.. +|..+..+- |.+. .++.++.|+++||.|+|++++.|||+||.|+||+.+
T Consensus 60 hknivrl~dvlhsdkkltlvf-e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n 137 (292)
T KOG0662|consen 60 HKNIVRLHDVLHSDKKLTLVF-EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN 137 (292)
T ss_pred hcceeehhhhhccCceeEEeH-HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC
Confidence 789999999999999999999 69875 787777653 4444 889999999999999999999999999999999776
Q ss_pred CCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~ 161 (293)
+. +||+|||+|+..+... .....+-|.||++|.++.|.+....+.|+||.|||+.|+.. |++.|.+.+..++++++
T Consensus 138 ge--lkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri 215 (292)
T KOG0662|consen 138 GE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_pred Cc--EEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH
Confidence 64 9999999999766554 34456789999999999998877777999999999999986 88999999988888888
Q ss_pred HHHHhcccc-CCCC------C----------------CCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQY-SVPD------T----------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~-~~~~------~----------------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
...+....- .+|. . +.++...+++++++|.-+|.+|++++++++||||...
T Consensus 216 f~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 216 FRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred HHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 865432221 1111 1 1245668899999999999999999999999999753
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=242.89 Aligned_cols=194 Identities=20% Similarity=0.283 Sum_probs=149.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-------HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-------LVQARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-------~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++.+......|+|| ||+.+|+|.+++..... ...++.++.||+.||+|||++|++||||||+||
T Consensus 53 ~h~nii~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 131 (269)
T cd05042 53 NHPNVLQCLGQCIESIPYLLVL-EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131 (269)
T ss_pred CCCCcceEEEEECCCCceEEEE-EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhhe
Confidence 5899999999999999999999 79999999999977532 126789999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccc------cCCCchhhhhhhhhHHHHHHh-CCCC
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLV-GGYP 148 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslG~il~el~~-g~~p 148 (293)
|++.++ .+||+|||++....... ......+++.|+|||++... ...+.++|+||+||++|+|++ |..|
T Consensus 132 ll~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (269)
T cd05042 132 QLTADL--SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209 (269)
T ss_pred EecCCC--cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCC
Confidence 997655 59999999986432211 12233467789999997532 223456999999999999999 7889
Q ss_pred CCCCCchHHHHHHHHHHhccccCCC---CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYSVP---DTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|........+...... .....+ ....++..+.+++..|+ .||++|||++++++.
T Consensus 210 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 210 YPDLSDEQVLKQVVRE---QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred CCcCCHHHHHHHHhhc---cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 9876654433333322 111111 12357889999999998 599999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=247.02 Aligned_cols=195 Identities=19% Similarity=0.299 Sum_probs=155.8
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC----------------HH--HHHHHHHHHHHHHHHHH
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL----------------LV--QARFFFQQLISGVSYCH 64 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~----------------~~--~~~~~~~qil~~l~~LH 64 (293)
.++.|+|++++++++......|+|| ||+.+|+|.+++..... ++ .+..++.||+.||.|||
T Consensus 76 ~l~~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 154 (304)
T cd05101 76 MIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA 154 (304)
T ss_pred hhccCCCchheeEEEecCCceEEEE-ecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH
Confidence 3568999999999999999999999 79999999999976421 22 68889999999999999
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHH
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 141 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e 141 (293)
++|++||||||+||+++.++ .+||+|||+++...... ......+++.|+|||++.+..++.+ +|+||+||++|+
T Consensus 155 ~~givH~dlkp~Nili~~~~--~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~e 231 (304)
T cd05101 155 SQKCIHRDLAARNVLVTENN--VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWE 231 (304)
T ss_pred HCCeeecccccceEEEcCCC--cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHH
Confidence 99999999999999997654 59999999997543222 1223345678999999877777655 999999999999
Q ss_pred HHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 142 MLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 142 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+++ |..||.+.+.... ...+. .......+..++.++.+|+.+||..+|.+|||+.++++.
T Consensus 232 l~~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 232 IFTLGGSPYPGIPVEEL----FKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHcCCCCCcccCCHHHH----HHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 998 7888877654332 22222 222223344588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=243.74 Aligned_cols=197 Identities=20% Similarity=0.308 Sum_probs=155.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC------------HHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL------------LVQARFFFQQLISGVSYCHAMQVCHRDL 73 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~------------~~~~~~~~~qil~~l~~LH~~~iiHrdl 73 (293)
+|+|++++++++...+..|+|| ||+.+|+|.+++...+. ...+..++.|++.||.|||++|++||||
T Consensus 67 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~di 145 (288)
T cd05061 67 TCHHVVRLLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145 (288)
T ss_pred CCCCeeeEEEEEcCCCCcEEEE-eCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCC
Confidence 5889999999999999999999 79999999999976431 1267889999999999999999999999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCC
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPF 149 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf 149 (293)
||+||+++.++ .+||+|||+++....... .....++..|+|||.+.+..++.+ +|+||+||++|++++ |..||
T Consensus 146 kp~nili~~~~--~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~ 222 (288)
T cd05061 146 AARNCMVAHDF--TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPY 222 (288)
T ss_pred ChheEEEcCCC--cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCC
Confidence 99999997654 599999999875322211 122345678999999877666554 999999999999998 78899
Q ss_pred CCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc------Cccccc
Q 022732 150 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK------HQWFLK 211 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~------h~~~~~ 211 (293)
.+...... ...+.... ..+.+...+..+.+++.+||+.+|++|||+.++++ ||||..
T Consensus 223 ~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 223 QGLSNEQV----LKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCHHHH----HHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 87654332 22222221 12223346799999999999999999999999987 787753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=242.35 Aligned_cols=190 Identities=23% Similarity=0.290 Sum_probs=149.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++......++|| ||+.+++|..++... +.+. .+..++.||+.||+|||++|++||||||.|||++.
T Consensus 62 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 140 (262)
T cd05077 62 SHKHIVLLYGVCVRDVENIMVE-EFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAR 140 (262)
T ss_pred CCCCEeeEEEEEecCCCCEEEE-ecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEec
Confidence 6899999999999999999999 799999999988754 3344 88999999999999999999999999999999975
Q ss_pred CCC-----CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHH-hCCCCCCCCCchH
Q 022732 83 SPA-----PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~~-----~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~-~g~~pf~~~~~~~ 156 (293)
++. +.+|++|||++.... ......++..|+|||.+......+.++||||+||++|+|+ +|..||.......
T Consensus 141 ~~~~~~~~~~~~l~d~g~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 141 EGIDGECGPFIKLSDPGIPITVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred CCccCCCCceeEeCCCCCCcccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 432 138999999986432 2234568889999998864443445599999999999998 5888887644322
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
. .. ...... ....+.+.++.++|.+||+.||.+||++.+++++
T Consensus 218 ~-~~----~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 218 K-ER----FYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred H-HH----HHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 1 11 111111 2223356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=247.90 Aligned_cols=195 Identities=21% Similarity=0.320 Sum_probs=153.9
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHHHH
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSYCH 64 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~LH 64 (293)
.+..|+|++++++++...+.+|+|| ||+.+|+|.+++.... .+. ++..++.||+.||.|||
T Consensus 73 ~l~~h~~iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH 151 (314)
T cd05099 73 LIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE 151 (314)
T ss_pred hccCCCCeeeEEEEEccCCceEEEE-ecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 3557999999999999999999999 7999999999997642 122 78889999999999999
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHH
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 141 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e 141 (293)
++|++||||||+||+++.++ .+||+|||+++....... .....+++.|+|||++.+..++.+ +|+||+||++|+
T Consensus 152 ~~gi~H~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~e 228 (314)
T cd05099 152 SRRCIHRDLAARNVLVTEDN--VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWE 228 (314)
T ss_pred HCCeeeccccceeEEEcCCC--cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHH
Confidence 99999999999999997654 599999999975432111 122234568999999877666555 999999999999
Q ss_pred HHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 142 MLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 142 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+++ |..||.+......+.. +.. ......+..++.++++++.+||..+|++|||+.++++.
T Consensus 229 l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 229 IFTLGGSPYPGIPVEELFKL----LRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999 8899977654332222 111 11222334578999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=247.59 Aligned_cols=194 Identities=22% Similarity=0.352 Sum_probs=154.6
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHHHHH
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSYCHA 65 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~LH~ 65 (293)
++.|+|++++++++......|+|| ||+.+|+|..++.... .+. .+..++.|++.||.|||+
T Consensus 72 l~~h~~i~~~~~~~~~~~~~~li~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 150 (293)
T cd05053 72 IGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS 150 (293)
T ss_pred hcCCCCeeeEEEEEcCCCCeEEEE-EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 457999999999999999999999 7999999999997532 222 788999999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHH
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 142 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 142 (293)
+|++||||||.||+++.++ .+||+|||+++....... .....++..|+|||++.+..++.+ +|+||+||++|++
T Consensus 151 ~~ivH~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el 227 (293)
T cd05053 151 KKCIHRDLAARNVLVTEDH--VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEI 227 (293)
T ss_pred CCccccccceeeEEEcCCC--eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHH
Confidence 9999999999999997654 599999999875432211 122235678999999877776555 9999999999999
Q ss_pred Hh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 143 LV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 143 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
++ |..||...........+. .....+.+...+..+.+|+.+||..+|++|||+.+++++
T Consensus 228 ~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 228 FTLGGSPYPGIPVEELFKLLK-----EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred hcCCCCCCCCCCHHHHHHHHH-----cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 97 999998765433322221 222223334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=246.83 Aligned_cols=199 Identities=24% Similarity=0.334 Sum_probs=156.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|.+++++++.+.+..|+|| ||+.| +|..++... ..+. ++..++.||+.||.|||++|++||||+|+||+++.
T Consensus 79 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~ 156 (313)
T cd06633 79 KHPNTIEYKGCYLKEHTAWLVM-EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 156 (313)
T ss_pred CCCCCccEEEEEEeCCEEEEEE-ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC
Confidence 5899999999999999999999 79965 677776553 3344 88899999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc--ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
++ .+||+|||++... .......|+..|+|||++.. ......++|+||+||++|+|++|..||...+.......
T Consensus 157 ~~--~~kL~dfg~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~ 231 (313)
T cd06633 157 PG--QVKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 231 (313)
T ss_pred CC--CEEEeecCCCccc---CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 54 5999999998643 22345578999999999742 22234459999999999999999999987665433332
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
+.. ..........++..+++|+.+||+++|.+||++.++++||||+.....
T Consensus 232 ~~~----~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~ 282 (313)
T cd06633 232 IAQ----NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282 (313)
T ss_pred HHh----cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchh
Confidence 221 111111223467889999999999999999999999999999875433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=240.42 Aligned_cols=192 Identities=25% Similarity=0.369 Sum_probs=155.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++.+.+.+++|+|+ ||+.+++|.+++.... .+. .++.++.|++.||.|||++|++|+||||.||+++
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~ 134 (255)
T cd08219 56 KHPNIVAFKESFEADGHLYIVM-EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT 134 (255)
T ss_pred CCCCcceEEEEEEECCEEEEEE-eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC
Confidence 5899999999999999999999 7999999999986532 233 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ .++|+|||.+....... ......|++.|+|||++.+..++.+ +|+||+|+++|+|++|..||...+....
T Consensus 135 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~--- 208 (255)
T cd08219 135 QNG--KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNL--- 208 (255)
T ss_pred CCC--cEEEcccCcceeecccccccccccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHH---
Confidence 655 59999999987543222 2234568999999999887776555 9999999999999999999987654222
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
...+..... .+.+..++..+.++|.+||..||.+|||+.+++.-
T Consensus 209 -~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 209 -ILKVCQGSY-KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -HHHHhcCCC-CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 222222222 22334578999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=248.15 Aligned_cols=194 Identities=21% Similarity=0.320 Sum_probs=153.9
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHHHHH
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSYCHA 65 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~LH~ 65 (293)
++.|+|++++++++...+..|+|| ||+.+|+|.+++...+ .+. ++..++.|++.||+|||+
T Consensus 80 l~~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 158 (307)
T cd05098 80 IGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158 (307)
T ss_pred hcCCCCEeeEEEEEecCCceEEEE-ecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 457999999999999999999999 7999999999997642 122 789999999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHH
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 142 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 142 (293)
+|++||||||+||+++.++ .+||+|||+++....... .....+++.|+|||++.+..++.+ +|+||+||++|+|
T Consensus 159 ~gi~H~dlkp~Nill~~~~--~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el 235 (307)
T cd05098 159 KKCIHRDLAARNVLVTEDN--VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEI 235 (307)
T ss_pred CCcccccccHHheEEcCCC--cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHH
Confidence 9999999999999997654 599999999875432111 112234568999999887766544 9999999999999
Q ss_pred Hh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 143 LV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 143 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
++ |..||.+..... +...+. .....+.+..++.++.+++.+||..+|.+|||+.+++++
T Consensus 236 ~~~g~~p~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 236 FTLGGSPYPGVPVEE-LFKLLK----EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HcCCCCCCCcCCHHH-HHHHHH----cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 98 888987654322 222221 222233344578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=239.74 Aligned_cols=191 Identities=23% Similarity=0.369 Sum_probs=151.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+|+|++++++++...+..|+|| ||+.+++|.+++...+ .+. .++.++.|++.||.|||++|++||||||+||+++.
T Consensus 51 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~ 129 (252)
T cd05084 51 SHPNIVRLIGVCTQKQPIYIVM-ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE 129 (252)
T ss_pred CCCCcceEEEEEcCCCCeEEEE-eeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcC
Confidence 6899999999999999999999 7999999999997654 233 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCC---CCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||++.......... ...++..|+|||.+.+..++.+ +|+||+||++|++++ |..||........
T Consensus 130 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~- 205 (252)
T cd05084 130 KN--VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT- 205 (252)
T ss_pred CC--cEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHH-
Confidence 54 59999999987533211111 1123456999999887776555 999999999999998 8889976554222
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..... .....+.+..++..+.+++.+||+++|++|||+.++++
T Consensus 206 ~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 206 REAIE----QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHH----cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12111 12222334457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=240.23 Aligned_cols=191 Identities=21% Similarity=0.326 Sum_probs=153.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++......|+|| ||+.+|+|.+++... +.++ .++.++.|++.||.|||++|++||||||+||+++.
T Consensus 57 ~h~~i~~~~~~~~~~~~~~iv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 57 SHPKLVQLYGVCTQQKPLYIVT-EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred CCCCceeEEEEEccCCCEEEEE-EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 5899999999999999999999 799999999999753 3333 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC--CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||.++........ ....++..|+|||++.+..+..+ +|+||+||++|++++ |+.||...+......
T Consensus 136 ~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05114 136 TG--VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE 212 (256)
T ss_pred CC--eEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 54 5999999998754322211 12235668999999887776555 999999999999999 899998766543333
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.+ .... ....+...+..+.+++.+||..+|.+||++.++++
T Consensus 213 ~i----~~~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 213 MI----SRGF-RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HH----HCCC-CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 32 2221 22223346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=243.56 Aligned_cols=190 Identities=24% Similarity=0.282 Sum_probs=150.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+|+|++++++++......|+|| ||+.+|+|..++.+. +.++ .+..++.||+.||+|||++|++||||||.||+++.
T Consensus 74 ~h~niv~~~~~~~~~~~~~lv~-ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 74 SHIHLAFVHGVCVRGSENIMVE-EFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152 (274)
T ss_pred CCCCeeeEEEEEEeCCceEEEE-ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEec
Confidence 6899999999999999999999 799999999999763 4434 88899999999999999999999999999999975
Q ss_pred CC-----CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHH-hCCCCCCCCCchH
Q 022732 83 SP-----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~-----~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~-~g~~pf~~~~~~~ 156 (293)
.+ .+.+|++|||++.... ......++..|+|||.+.+....+.++|+||+||++|+++ +|..||.......
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~---~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTAL---SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCcccCccceeeecCCccccccc---cccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 33 2248999999876432 1223457888999998876443455599999999999985 6899998765432
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
. .... ......+ .+.+..+.++|.+||+.+|.+|||+.+++++
T Consensus 230 ~-~~~~----~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 230 K-ERFY----EKKHRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred H-HHHH----HhccCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2 1111 1122222 2356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=244.98 Aligned_cols=202 Identities=25% Similarity=0.371 Sum_probs=156.1
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEE
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTL 79 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl 79 (293)
..+|+|++++++++...+..|+|+ ||+.+ +|..++.. .+.++ .+..++.|++.||.|||+ .|++||||+|+||+
T Consensus 70 ~~~~~~i~~~~~~~~~~~~~~~v~-e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nil 147 (296)
T cd06618 70 SHDCPYIVKCYGYFITDSDVFICM-ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNIL 147 (296)
T ss_pred ccCCCchHhhheeeecCCeEEEEe-eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEE
Confidence 347899999999999999999999 68754 66666655 33344 778999999999999997 59999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcccc----CCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
++.++ .+||+|||++.............+++.|+|||.+.+.. ++. ++|+||+||++|+|++|+.||......
T Consensus 148 l~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~ 224 (296)
T cd06618 148 LDASG--NVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDI-RADVWSLGISLVELATGQFPYKNCKTE 224 (296)
T ss_pred EcCCC--CEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCcccccc-chhHHHHHHHHHHHHhCCCCCCcchhH
Confidence 97654 59999999987543333334446788999999986543 433 499999999999999999999764322
Q ss_pred HHHHHHHHHHhcc-ccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 156 KDFRKTIQRILSV-QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 156 ~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
. .....+... ....+....++.++.+|+.+||..+|.+||++.++++||||....
T Consensus 225 ~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 225 F---EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred H---HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 1 112222222 222333334789999999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=250.65 Aligned_cols=196 Identities=20% Similarity=0.346 Sum_probs=154.2
Q ss_pred CCCCCcchhhhhceeee-ceeEEEeehhhccCchhHHHHHHcC-------------------------------------
Q 022732 3 PVGSSSSEYAMLGVSVK-MKFVFLSLSFFFSLCLFFMWLLLLG------------------------------------- 44 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~-~~~~~lv~~ey~~gg~L~~~l~~~~------------------------------------- 44 (293)
.++.|+|++++++++.. ...+|+++ ||+.+++|.+++....
T Consensus 66 ~l~~h~niv~~~~~~~~~~~~~~~v~-ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (337)
T cd05054 66 HIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSAS 144 (337)
T ss_pred hhccCcchhheeeeEecCCCCEEEEE-ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccc
Confidence 35679999999998864 46788888 7999999999986532
Q ss_pred ------------------------CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 45 ------------------------LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 45 ------------------------~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
.+. .+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~ 222 (337)
T cd05054 145 SGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARD 222 (337)
T ss_pred cccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchh
Confidence 122 7889999999999999999999999999999997654 599999999975
Q ss_pred cCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCC
Q 022732 99 SVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD 174 (293)
Q Consensus 99 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (293)
..... ......++..|+|||++.+..++.+ +||||+||++|++++ |..||.+......+...+... .....
T Consensus 223 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~ 297 (337)
T cd05054 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG----TRMRA 297 (337)
T ss_pred cccCcchhhccCCCCCccccCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc----CCCCC
Confidence 43221 1223456778999999988877666 999999999999998 999998755433333333221 11222
Q ss_pred CCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 175 TNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 175 ~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+...+.++.+++.+||+.+|.+||++.++++|
T Consensus 298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33478999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=242.21 Aligned_cols=192 Identities=20% Similarity=0.274 Sum_probs=153.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC------------HHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL------------LVQARFFFQQLISGVSYCHAMQVCHRDL 73 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~------------~~~~~~~~~qil~~l~~LH~~~iiHrdl 73 (293)
+|+|++++++++....+.|+|| ||+.+++|.+++..... ...+..++.|++.||.|||++|++||||
T Consensus 67 ~~~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di 145 (277)
T cd05032 67 NCHHVVRLLGVVSTGQPTLVVM-ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDL 145 (277)
T ss_pred CCCceeEEEEEEcCCCCcEEEE-ecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccc
Confidence 6899999999999999999999 79999999999975431 2278889999999999999999999999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCC
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPF 149 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf 149 (293)
||+||+++.++ .+||+|||+++...... ......++..|+|||.+.+..++.+ +|+|||||++|++++ |..||
T Consensus 146 ~p~nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~ 222 (277)
T cd05032 146 AARNCMVAEDL--TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222 (277)
T ss_pred ChheEEEcCCC--CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCC
Confidence 99999997665 59999999987543222 1223456788999999877666555 999999999999998 99999
Q ss_pred CCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 150 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+.+...... .+. .....+.+..++.++.+++.+||+.+|++|||+.+++..
T Consensus 223 ~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 223 QGLSNEEVLK----FVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred ccCCHHHHHH----HHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8765433222 222 122223344478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=239.86 Aligned_cols=192 Identities=21% Similarity=0.342 Sum_probs=153.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++......|+|| ||+.+++|.+++...+ .+. +++.++.||+.||.|||++|++|+||||.||+++.
T Consensus 57 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 57 SHEKLVQLYGVCTKQRPIYIVT-EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred CCCCeeeEEEEEccCCCcEEEE-EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 5899999999999999999999 7999999999997643 333 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||.++....... .....++..|+|||++.+..++.+ +|+|||||++|+|++ |..||..........
T Consensus 136 ~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05113 136 QG--CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVE 212 (256)
T ss_pred CC--CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 54 599999999875432221 112235678999999977666555 999999999999998 999998766543333
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+ .... ..+.....+..+++++.+||..+|.+||++.+++.+
T Consensus 213 ~~----~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 213 KV----SQGL-RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HH----hcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 22 2221 122233468999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=245.52 Aligned_cols=199 Identities=23% Similarity=0.347 Sum_probs=150.3
Q ss_pred CCcchhhhhceeeece--------eEEEeehhhccCchhHHHHHHcC-C--HHHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 022732 6 SSSSEYAMLGVSVKMK--------FVFLSLSFFFSLCLFFMWLLLLG-L--LVQARFFFQQLISGVSYCHAMQVCHRDLK 74 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~--------~~~lv~~ey~~gg~L~~~l~~~~-~--~~~~~~~~~qil~~l~~LH~~~iiHrdlk 74 (293)
.|+|++++++++.... ..|+|+ ||+.+ +|..++.... . ..+++.++.||+.||.|||++|++|+|||
T Consensus 69 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~ 146 (310)
T cd07865 69 KHENVVNLIEICRTKATPYNRYKGSFYLVF-EFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMK 146 (310)
T ss_pred CCCCccceEEEEecccccccCCCceEEEEE-cCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 5899999999987654 459999 79875 7777776653 2 33899999999999999999999999999
Q ss_pred CCcEEEcCCCCCCEEEecCCCCcCcCCCCC-----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC
Q 022732 75 LENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 149 (293)
Q Consensus 75 p~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 149 (293)
|+||+++.++ .+||+|||++........ .....++..|+|||.+.+....+.++|+||+|+++|+|++|+.||
T Consensus 147 p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 147 AANILITKDG--ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred HHHEEECCCC--cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999997655 599999999875432221 123457889999998876543345599999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhcc-c---------------cCCCC-----------CCCCCHHHHHHHHHccccCCCCCCCHHH
Q 022732 150 EDPDEPKDFRKTIQRILSV-Q---------------YSVPD-----------TNPISQECRDLISRIFVADPAARITIPE 202 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~-~---------------~~~~~-----------~~~~s~~~~~li~~~L~~dp~~Rpt~~e 202 (293)
.+.+.......+. .+... . ...+. ....+..+++||.+||..||.+|||+++
T Consensus 225 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 225 QGNTEQHQLTLIS-QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred CCCCHHHHHHHHH-HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 8766543322222 21110 0 00000 0013577889999999999999999999
Q ss_pred HHcCccc
Q 022732 203 IMKHQWF 209 (293)
Q Consensus 203 ll~h~~~ 209 (293)
+++||||
T Consensus 304 ~l~h~~f 310 (310)
T cd07865 304 ALNHDFF 310 (310)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=242.66 Aligned_cols=198 Identities=24% Similarity=0.364 Sum_probs=159.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|++++++++...++.|+|+ ||+.+++|..++..... ...+..++.|++.|+.|||++|++|+||+|.||+++.++
T Consensus 60 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~ 138 (277)
T cd06641 60 DSPYVTKYYGSYLKDTKLWIIM-EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG 138 (277)
T ss_pred CCCCEeEEEEEEEeCCeEEEEE-EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC
Confidence 5899999999999999999999 79999999999875432 228899999999999999999999999999999997654
Q ss_pred CCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.++|+|||++....... ......++..|+|||.+.+.....+ +|+||+||++|++++|..||........ ..
T Consensus 139 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~ 211 (277)
T cd06641 139 --EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKV----LF 211 (277)
T ss_pred --CEEEeecccceecccchhhhccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHH----HH
Confidence 59999999987543222 1233468889999999876665544 9999999999999999999986554222 22
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.+.... .......++.++.+++.+||..+|.+||++.++++||||.+.
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 212 LIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHhcCC-CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 221111 111223478999999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=242.57 Aligned_cols=192 Identities=18% Similarity=0.323 Sum_probs=153.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-----------------CHH--HHHHHHHHHHHHHHHHHHc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-----------------LLV--QARFFFQQLISGVSYCHAM 66 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-----------------~~~--~~~~~~~qil~~l~~LH~~ 66 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.... .+. ++..++.|++.||.|||++
T Consensus 65 ~h~niv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 143 (283)
T cd05090 65 HHPNIVCLLGVVTQEQPVCMLF-EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH 143 (283)
T ss_pred CCCCeeeEEEEEecCCceEEEE-EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc
Confidence 5899999999999999999999 7999999999996432 122 7788999999999999999
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHH
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 143 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 143 (293)
|++||||||+||+++.+. .+||+|||+++...... ......++..|+|||.+.+..++.+ +|+||+||++|+|+
T Consensus 144 ~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~ 220 (283)
T cd05090 144 FFVHKDLAARNILIGEQL--HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIF 220 (283)
T ss_pred CeehhccccceEEEcCCC--cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHH
Confidence 999999999999997665 49999999997543221 1233446778999999887766554 99999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 144 V-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 144 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+ |..||.+..... +..... .....+.+..++..+++++.+||+++|.+||++.+++++
T Consensus 221 ~~g~~p~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 221 SFGLQPYYGFSNQE-VIEMVR----KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCCCCCCCCCHHH-HHHHHH----cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8 999998765422 222221 122233344578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=255.81 Aligned_cols=195 Identities=24% Similarity=0.389 Sum_probs=154.3
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC---------------------------------------
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--------------------------------------- 44 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--------------------------------------- 44 (293)
++.|+|++++++++...+.+|+|| ||+.+|+|.+++.+..
T Consensus 97 l~~HpnIv~l~~~~~~~~~~~lv~-Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (400)
T cd05105 97 LGPHLNIVNLLGACTKSGPIYIIT-EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKG 175 (400)
T ss_pred cCCCCCeeeEEEEEccCCceEEEE-EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccc
Confidence 456999999999999999999999 7999999999986532
Q ss_pred ---------------------------------------------------------CHH--HHHHHHHHHHHHHHHHHH
Q 022732 45 ---------------------------------------------------------LLV--QARFFFQQLISGVSYCHA 65 (293)
Q Consensus 45 ---------------------------------------------------------~~~--~~~~~~~qil~~l~~LH~ 65 (293)
.+. ++..++.||+.||.|||+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 255 (400)
T cd05105 176 DYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS 255 (400)
T ss_pred cccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 111 567899999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHH
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 142 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 142 (293)
++++||||||+|||++.++ .+||+|||+++...... ......+++.|+|||++.+..+..+ +|||||||++|+|
T Consensus 256 ~~ivH~dikp~Nill~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~el 332 (400)
T cd05105 256 KNCVHRDLAARNVLLAQGK--IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEI 332 (400)
T ss_pred CCeeCCCCChHhEEEeCCC--EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHH
Confidence 9999999999999997654 59999999987542221 1223456788999999987776555 9999999999999
Q ss_pred Hh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 143 LV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 143 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
++ |..||........+...+ ......+.+..++.++.+++.+||+.+|++|||+.++.+.
T Consensus 333 lt~g~~P~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 333 FSLGGTPYPGMIVDSTFYNKI----KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HHCCCCCCcccchhHHHHHHH----hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 97 899998754433222222 2222334445588999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=247.83 Aligned_cols=191 Identities=19% Similarity=0.324 Sum_probs=152.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++... ..++|+ +|+.+|+|.+++.+.. .+. .+..++.||+.||+|||++|++||||||+||+++.
T Consensus 67 ~h~niv~~~g~~~~~-~~~~v~-e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~ 144 (316)
T cd05108 67 DNPHVCRLLGICLTS-TVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT 144 (316)
T ss_pred CCCCCCeEEEEEcCC-Cceeee-ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC
Confidence 689999999999875 467788 6999999999998754 233 78899999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCC---CCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||+++......... ...++..|+|||++.+..++.+ +|+||+||++|+|++ |+.||.+.... .+
T Consensus 145 ~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~-~~ 220 (316)
T cd05108 145 PQ--HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPAS-EI 220 (316)
T ss_pred CC--cEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHH-HH
Confidence 55 49999999998654332221 2234668999999987777655 999999999999997 99999875432 22
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..+ .......+.+..++.++.+++.+||..+|.+||++.+++.+
T Consensus 221 ~~~----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 221 SSI----LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHH----HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222 22333344445578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=241.63 Aligned_cols=200 Identities=28% Similarity=0.424 Sum_probs=157.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|.+++++++......|+|+ ||+.+ +|.+++.+. ..+. .+..++.|++.||.|||++|++||||+|+||+++.
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~-e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~ 133 (282)
T cd07829 56 KHPNIVKLLDVIHTERKLYLVF-EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR 133 (282)
T ss_pred CCCCHHHHHhhhhcCCceEEEe-cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC
Confidence 4899999999999999999999 79885 899999876 3344 89999999999999999999999999999999977
Q ss_pred CCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++...... ......++..|+|||.+.+....+.++|+||+||++|++++|+.||........+.++
T Consensus 134 ~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 134 DG--VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred CC--CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 54 59999999987543322 2233456788999999876633445599999999999999999999887654444333
Q ss_pred HHHHhcc--------------ccCCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 162 IQRILSV--------------QYSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 162 ~~~~~~~--------------~~~~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
....... ....+. ...++..+.++|.+||..+|.+||++.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 3211100 000010 11247899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=239.42 Aligned_cols=195 Identities=28% Similarity=0.398 Sum_probs=156.2
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++.+. +..++|+ ||+.+++|.+++...+.+. .++.++.|++.||.|||++|++|+||||+||+++
T Consensus 62 ~h~~i~~~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 140 (264)
T cd06653 62 RHDRIVQYYGCLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD 140 (264)
T ss_pred CCCCcceEEEEEEcCCCCEEEEEE-EeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 588999999998764 5688888 7999999999998766554 8889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCC----CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
.++ .++|+|||+++..... .......|+..|+|||++.+...+.+ +|+||+||++|++++|+.||........
T Consensus 141 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 141 SAG--NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred CCC--CEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 654 5999999998754221 11223468899999999887666544 9999999999999999999987654333
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+. ...........+..++..+.++|.+||+ +|..||++.+++.|||.
T Consensus 218 ~~----~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 218 IF----KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HH----HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 22 2222222222344588999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=236.77 Aligned_cols=194 Identities=25% Similarity=0.328 Sum_probs=159.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++......|+|+ ||+.+++|..++... ..+. .+..++.|++.||.|||++|++|+||+|.||+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~ 135 (256)
T cd08530 57 NHPNIISYKEAFLDGNKLCIVM-EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANIL 135 (256)
T ss_pred CCCCchhhhhhhccCCEEEEEe-hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEE
Confidence 4899999999999999999999 799999999998762 2233 78899999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ .+||+|||++...... ......+++.|+|||.+.+..++.+ +|+||+|+++|++++|+.||...+....
T Consensus 136 ~~~~~--~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~-- 209 (256)
T cd08530 136 LVAND--LVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDL-- 209 (256)
T ss_pred EecCC--cEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 97654 5999999998765433 3344568999999999987766544 9999999999999999999987664322
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...+..... .+....++.++++++.+||..+|++|||+.++++||++
T Consensus 210 --~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 210 --RYKVQRGKY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --HHHHhcCCC-CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 222222221 12223578999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=238.81 Aligned_cols=191 Identities=20% Similarity=0.305 Sum_probs=154.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.... .+. +++.++.||+.||.|||++|++||||||+||+++
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~ 138 (261)
T cd05148 60 RHKHLISLFAVCSVGEPVYIIT-ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138 (261)
T ss_pred CCcchhheeeeEecCCCeEEEE-eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc
Confidence 5899999999999999999999 7999999999997642 233 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
.++ .+||+|||.+........ .....++..|+|||.+.+..+..+ +|+||+||++|++++ |+.||........+.
T Consensus 139 ~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~ 215 (261)
T cd05148 139 EDL--VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYD 215 (261)
T ss_pred CCc--eEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 655 599999999875432211 123345678999999877666555 999999999999998 899998766433333
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.+. .....+.+..++..+.+++.+||..+|.+|||+.++++
T Consensus 216 ~~~-----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 216 QIT-----AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHH-----hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 222 22333445568899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=238.63 Aligned_cols=190 Identities=23% Similarity=0.322 Sum_probs=152.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
+|+|++++++++. .+..++|+ ||+.+++|.+++...+.+. .+..++.|++.||.|||.+|++||||||+||+++.+
T Consensus 54 ~h~~iv~~~~~~~-~~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~ 131 (257)
T cd05060 54 DHPCIVRLIGVCK-GEPLMLVM-ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR 131 (257)
T ss_pred CCCCeeeEEEEEc-CCceEEEE-EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC
Confidence 6899999999876 45678999 7999999999998877555 889999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCCCCCCC----CCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
+ .+||+|||+++......... ...++..|+|||.+.+..++.+ +|+|||||++|++++ |..||...+.....
T Consensus 132 ~--~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~~ 208 (257)
T cd05060 132 H--QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208 (257)
T ss_pred C--cEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 5 49999999988553332211 1123467999999887776555 999999999999998 99999876553322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. +.. ....+.+..++..++++|.+||..+|++||++.++++
T Consensus 209 -~~---~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 209 -AM---LES-GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -HH---HHc-CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22 211 2223344558899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=239.25 Aligned_cols=192 Identities=19% Similarity=0.305 Sum_probs=153.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|+ ||+.|++|.+++...+ .+. .+..++.|++.||.|||++|++||||||+||+++.
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05059 57 SHPNLVQLYGVCTKQRPIFIVT-EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135 (256)
T ss_pred CCCCEEEEEEEEcCCCceEEEE-ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC
Confidence 5899999999999999999999 7999999999997643 333 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC--CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||+++........ ....++..|+|||.+.+..++.+ +|+||+||++|++++ |+.||..........
T Consensus 136 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05059 136 DN--VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVE 212 (256)
T ss_pred CC--cEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Confidence 55 4999999998754322111 11223457999999887777655 999999999999999 899998765533322
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+. .....+.+..++..+.+++.+||..+|++|||+.++++.
T Consensus 213 ----~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 213 ----SVS-AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ----HHH-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 222 122233344578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=237.66 Aligned_cols=191 Identities=21% Similarity=0.308 Sum_probs=154.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++.. +..++|+ ||+.+++|.+++.... .+. .+..++.|++.||.|||++|++||||||+||+++
T Consensus 54 ~h~~iv~~~~~~~~-~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~ 131 (257)
T cd05040 54 DHENLIRLYGVVLT-HPLMMVT-ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA 131 (257)
T ss_pred CCCCccceeEEEcC-CeEEEEE-EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe
Confidence 48999999999998 8999999 7999999999998764 233 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 156 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~ 156 (293)
.++ .+||+|||+++....... .....++..|+|||.+.+..++.+ +|+||+||++|+|++ |..||...+...
T Consensus 132 ~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~ 208 (257)
T cd05040 132 SDD--KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208 (257)
T ss_pred cCC--EEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 664 599999999876433211 123356788999999887776555 999999999999998 999998765543
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
....+. ......+.+...+..+.+++.+||..+|++|||+.+++.
T Consensus 209 ~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 209 ILKKID----KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHH----hcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 332222 122223333457899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=229.11 Aligned_cols=242 Identities=20% Similarity=0.278 Sum_probs=174.9
Q ss_pred Ccchhhhhceeeec--------eeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 022732 7 SSSEYAMLGVSVKM--------KFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKL 75 (293)
Q Consensus 7 ~~~~v~~~~~~~~~--------~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp 75 (293)
|.|++.++++|... ..+|+|| .+|+. +|+.+|... .+++ +++.++.+++.||.|+|.+.|+|||+||
T Consensus 75 Henv~nliEic~tk~Tp~~r~r~t~ylVf-~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKa 152 (376)
T KOG0669|consen 75 HENVVNLIEICRTKATPTNRDRATFYLVF-DFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKA 152 (376)
T ss_pred chhHHHHHHHHhhccCCcccccceeeeeH-HHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccH
Confidence 66777777776432 3489999 68886 888888665 3343 9999999999999999999999999999
Q ss_pred CcEEEcCCCCCCEEEecCCCCcCcCCCC-----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCC
Q 022732 76 ENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 150 (293)
Q Consensus 76 ~NIl~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 150 (293)
+|+||+.++ .+||+|||+++...... ..+..+-|.||++||.++|...++++.|+|..|||+.+|+++.+.|.
T Consensus 153 aNvLIt~dg--ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 153 ANVLITKDG--ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred hhEEEcCCc--eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 999996654 59999999997543222 23345679999999999998877888999999999999999999999
Q ss_pred CCCchHHHHHHHHHHhccccC-CCC---------------C-------------CCCCHHHHHHHHHccccCCCCCCCHH
Q 022732 151 DPDEPKDFRKTIQRILSVQYS-VPD---------------T-------------NPISQECRDLISRIFVADPAARITIP 201 (293)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~-~~~---------------~-------------~~~s~~~~~li~~~L~~dp~~Rpt~~ 201 (293)
+.++..++..+.+-....... +|. + -.-.+++.+|+.++|..||.+|+++.
T Consensus 231 gnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad 310 (376)
T KOG0669|consen 231 GNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDAD 310 (376)
T ss_pred CChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchH
Confidence 988877665544322111100 000 0 00135789999999999999999999
Q ss_pred HHHcCcccccCCCCCc-cc---hhcccCCCCCCCCCCCCHHHHHHHHHHhCCCCC
Q 022732 202 EIMKHQWFLKNLPADL-VD---EKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAV 252 (293)
Q Consensus 202 ell~h~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (293)
+++.|.||.+...+.. +. .....+.++-..++..+........+..+.+..
T Consensus 311 ~alnh~~F~kdp~pqanl~~ml~t~~~s~fey~~~~~~~~~~~~~q~~~q~~nq~ 365 (376)
T KOG0669|consen 311 QALNHDFFWKDPMPQANLQDMLSTHLQSMFEYLAQPRRSNQMRNYQQQLQTMNQK 365 (376)
T ss_pred hhhchhhhhcCCcchhhHHHHHHHhHHHHHHHhcCcchhhhhhhHHHHhcCCCcc
Confidence 9999999976543311 11 112234444444555555555555555444433
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=241.70 Aligned_cols=191 Identities=20% Similarity=0.335 Sum_probs=153.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC---------------HH--HHHHHHHHHHHHHHHHHHcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL---------------LV--QARFFFQQLISGVSYCHAMQV 68 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~---------------~~--~~~~~~~qil~~l~~LH~~~i 68 (293)
+|+|++++++++......|+|+ ||+.+++|.+++...+. +. .+..++.||+.||+|||++|+
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i 143 (280)
T cd05092 65 QHQHIVRFYGVCTEGRPLLMVF-EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF 143 (280)
T ss_pred CCCCCceEEEEEecCCceEEEE-ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 6899999999999999999999 79999999999976532 22 789999999999999999999
Q ss_pred eecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-
Q 022732 69 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV- 144 (293)
Q Consensus 69 iHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~- 144 (293)
+||||||+||+++.++ .+||+|||+++....... .....+++.|+|||.+.+..++.+ +|+|||||++|+|++
T Consensus 144 ~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~ 220 (280)
T cd05092 144 VHRDLATRNCLVGQGL--VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTY 220 (280)
T ss_pred ecccccHhhEEEcCCC--CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcC
Confidence 9999999999997654 599999999874422211 122345778999999887777655 999999999999998
Q ss_pred CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 145 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 145 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|..||............. ... ..+.+..+++.+.++|.+||++||.+||++.++++
T Consensus 221 g~~p~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 221 GKQPWYQLSNTEAIECIT----QGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCCCccCCHHHHHHHHH----cCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 899997765543332222 211 22333458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=240.21 Aligned_cols=193 Identities=22% Similarity=0.315 Sum_probs=148.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-----H--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-----L--VQARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-----~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
+|+|++++++++.+....|+|| ||+.+|+|.+++..... . ..++.++.|++.||.|||++|++||||||+||
T Consensus 53 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~ni 131 (269)
T cd05087 53 QHSNLLQCLGQCTEVTPYLLVM-EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNC 131 (269)
T ss_pred CCCCEeeEEEEEcCCCCcEEEE-ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceE
Confidence 5899999999999999999999 79999999999975331 1 26778999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccC------CCchhhhhhhhhHHHHHHh-CCCC
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEY------DGKIADVWSCGVTLYVMLV-GGYP 148 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~------~~~~~DvwslG~il~el~~-g~~p 148 (293)
+++.++ .+||+|||+++...... ......+++.|+|||++.+... .+.++|+||+||++|+|++ |+.|
T Consensus 132 l~~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p 209 (269)
T cd05087 132 LLTADL--TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209 (269)
T ss_pred EEcCCC--cEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC
Confidence 997654 59999999987432221 1223457788999999864221 2345999999999999996 9999
Q ss_pred CCCCCchHHHHHHHHHHhccccCCCC---CCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYSVPD---TNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|.............. ......+. ....+..+.+++++|+ .+|.+|||++++++
T Consensus 210 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 210 YRHLSDEQVLTYTVR---EQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCChHHHHHHHhh---cccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 987655433222221 11111121 2246789999999998 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=238.47 Aligned_cols=194 Identities=23% Similarity=0.322 Sum_probs=153.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++.+...+..|+|+ ||+.+++|.+++.. ...++ .++.++.||+.||.|||++|++|+||||+||+
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nil 138 (267)
T cd08229 60 NHPNVIKYYASFIEDNELNIVL-ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 138 (267)
T ss_pred cCCchhhhhheeEeCCeEEEEE-EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 5899999999999999999999 79999999999864 22233 88999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++.++ .++|+|||++........ .....|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||.+.... .
T Consensus 139 i~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~ 213 (267)
T cd08229 139 ITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--L 213 (267)
T ss_pred EcCCC--CEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--H
Confidence 97654 599999999875433222 234568999999999977776555 99999999999999999999764432 1
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
....+.+............++..+++++.+||..+|.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 214 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 22223332222221222347889999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=241.97 Aligned_cols=200 Identities=23% Similarity=0.370 Sum_probs=156.9
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|.+++++++... +..|+|+ ||+.+ +|.+++... ..+. +++.++.||+.||+|||++|++|+||+|+||++
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~ 133 (287)
T cd07840 56 RHPNIVRLKEIVTSKGKGSIYMVF-EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI 133 (287)
T ss_pred cCCCeeeheeeEecCCCCcEEEEe-ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE
Confidence 489999999999988 8999999 79975 888888765 3344 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+.++ .+||+|||++....... ......++..|+|||.+.+....+.++|+||+||++|+|++|+.||...+....+
T Consensus 134 ~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 134 NNDG--VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred cCCC--CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 7655 59999999987554332 1233467889999998766444455699999999999999999999887765544
Q ss_pred HHHHHHHhcccc-CCCC-----------------------CCC-CCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 159 RKTIQRILSVQY-SVPD-----------------------TNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 159 ~~~~~~~~~~~~-~~~~-----------------------~~~-~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
..+......... .++. ... ++..+.+++++||..+|.+||++.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 443332111000 0000 011 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=249.62 Aligned_cols=203 Identities=23% Similarity=0.300 Sum_probs=153.4
Q ss_pred CCcchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+++++++|... ...|+|+ ||+.. +|..++...-....+..++.|++.||+|||++|++||||||+||+
T Consensus 72 ~h~niv~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIl 149 (342)
T cd07879 72 QHENVIGLLDVFTSAVSGDEFQDFYLVM-PYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLA 149 (342)
T ss_pred CCCCccchhheecccccCCCCceEEEEe-ccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 589999999998765 3468898 68864 676665433334488999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ .+||+|||+++.... ......+++.|+|||++.+....+.++|+||+||++|+|++|+.||.+.+....+.
T Consensus 150 l~~~~--~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~ 225 (342)
T cd07879 150 VNEDC--ELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 225 (342)
T ss_pred ECCCC--CEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 97654 599999999875422 22345678999999998764333455999999999999999999998766444333
Q ss_pred HHHHHHh-------------------ccccCCC------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 160 KTIQRIL-------------------SVQYSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 160 ~~~~~~~-------------------~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.++.... ......+ .....+..+.+||.+||+.||.+||++.+++.||||....+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 226 QILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 3222100 0000000 01236788999999999999999999999999999977544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=238.68 Aligned_cols=197 Identities=19% Similarity=0.258 Sum_probs=149.8
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC----HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL----LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~----~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
-.|+|++++++.+......|+|| ||+.+|+|.+++.+... .. .++.++.||+.||+|||+++++||||||+||
T Consensus 52 l~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ni 130 (268)
T cd05086 52 LQHPNILQCLGQCVEAIPYLLVF-EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNC 130 (268)
T ss_pred cCCcchhheEEEecCCCccEEEE-ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceE
Confidence 47899999999999999999999 79999999999976432 22 6788999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhcccc------CCCchhhhhhhhhHHHHHHh-CCCC
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHE------YDGKIADVWSCGVTLYVMLV-GGYP 148 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DvwslG~il~el~~-g~~p 148 (293)
|++.++ .+||+|||++...... .......++..|+|||++.... ..+.++|+||+||++|+|++ |..|
T Consensus 131 l~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 208 (268)
T cd05086 131 FLTSDL--TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208 (268)
T ss_pred EEcCCc--cEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence 997654 5999999998642211 1123456888999999875321 11345899999999999997 5678
Q ss_pred CCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|........+...................++..+.+++.+|+ .+|.+||++.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 209 YSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 877665444444333211111111223347899999999999 68999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=255.82 Aligned_cols=199 Identities=30% Similarity=0.511 Sum_probs=170.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHH-HcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLL-LLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~-~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+.+|.+-..|++..++++|| |-+.|.-|...|. ++++++ ..++.+.||+.||+|||-+||+|+||||+|||+..
T Consensus 621 ~HPGiV~le~M~ET~ervFVVM-EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas 699 (888)
T KOG4236|consen 621 HHPGIVNLECMFETPERVFVVM-EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLAS 699 (888)
T ss_pred CCCCeeEEEEeecCCceEEEEe-hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeecc
Confidence 4788899999999999999999 6777766665553 457888 77899999999999999999999999999999975
Q ss_pred C-CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 S-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~-~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
. +-+++||||||+|+.++......+.+|||.|.|||++..++|+.. -|+||+|+|+|.-+.|..||....+ +
T Consensus 700 ~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEd------I 772 (888)
T KOG4236|consen 700 ASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDED------I 772 (888)
T ss_pred CCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccc------h
Confidence 4 345899999999999888888899999999999999999999766 7999999999999999999987543 2
Q ss_pred HHHHhccccC--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
-..+.+..+. ...|..+|..+.+||..+|+..-.+|.|....+.|||++..
T Consensus 773 ndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 773 NDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred hHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 2333444443 34567899999999999999999999999999999999754
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=236.19 Aligned_cols=195 Identities=26% Similarity=0.408 Sum_probs=160.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|.+++++++...+..|+|+ ||+.+++|.+++...+.+. .+..++.|++.||.|||++|++||||+|+||+++.+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 57 KHPNIVKYIGSIETSDSLYIIL-EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135 (254)
T ss_pred CCCCccEEEEEEEeCCEEEEEE-ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence 5789999999999999999999 7999999999998876665 889999999999999999999999999999999764
Q ss_pred CCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .++|+|||.+........ .....++..|+|||.+.+..+. .++|+||+|+++|++++|..||.............
T Consensus 136 ~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 136 G--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred C--CEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 4 599999999875443322 2345688999999998776654 45999999999999999999998765433222211
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
... ..+.+..++..+.+++.+||..+|++|||+.+++.||||
T Consensus 213 ---~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 ---QDD--HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---ccC--CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 111 122334578999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=236.97 Aligned_cols=195 Identities=26% Similarity=0.362 Sum_probs=160.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|.+++++.+......++|+ ||+.+++|.+++... ..++ .+..++.|++.||.|||++|++|+||+|+||+
T Consensus 57 ~~~~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil 135 (258)
T cd08215 57 NHPNIIKYYESFEEKGKLCIVM-EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIF 135 (258)
T ss_pred CCCChhheEEEEecCCEEEEEE-EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeE
Confidence 3899999999999999999999 799999999999774 3343 89999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++.++ .++|+|||.+....... ......|++.|+|||.+.+..+..+ +|+||+|++++++++|..||.......
T Consensus 136 ~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~-- 210 (258)
T cd08215 136 LTSNG--LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLE-- 210 (258)
T ss_pred EcCCC--cEEECCccceeecccCcceecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHH--
Confidence 97654 59999999987543332 2334568899999999877776555 999999999999999999997765432
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
......... ..+.+..++.++.+++.+||..+|.+|||+.++++||||
T Consensus 211 --~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 211 --LALKILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --HHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 222222222 122233578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=238.36 Aligned_cols=191 Identities=20% Similarity=0.293 Sum_probs=153.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CH--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LL--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++.+...+..|+|+ ||+.+++|.+++.... .+ ..+..++.|++.||+|||+++++||||||+||+++
T Consensus 59 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~ 137 (261)
T cd05072 59 QHDKLVRLYAVVTKEEPIYIIT-EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 137 (261)
T ss_pred CCCCeeeEEEEEcCCCCcEEEE-ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec
Confidence 5899999999999999999999 7999999999997642 22 37889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||++........ .....++..|+|||.+.+..++.+ +|+||+||++|+|++ |..||.........
T Consensus 138 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05072 138 ESL--MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214 (261)
T ss_pred CCC--cEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHH
Confidence 654 599999999975432211 122345678999999877766544 999999999999998 99999876543322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. +. .....+....++.++.+++.+||..+|++|||++++.+
T Consensus 215 ~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 215 SA----LQ-RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HH----HH-cCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22 22 12233444558899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=239.38 Aligned_cols=195 Identities=25% Similarity=0.329 Sum_probs=153.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++...+..|+|+ ||+.+++|..++.. ...++ .+..++.|++.||.|||++|++|+||||+||+
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil 138 (267)
T cd08228 60 NHPNVIKYLDSFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVF 138 (267)
T ss_pred CCcceeeeeeeEEECCeEEEEE-EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEE
Confidence 6899999999999999999999 79999999988853 22233 78999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++.++ .++|+|||++....... ......|++.|+|||.+.+..++.+ +|+||+||++|+|++|+.||...... .
T Consensus 139 ~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~--~ 213 (267)
T cd08228 139 ITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--L 213 (267)
T ss_pred EcCCC--CEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCcccccc--H
Confidence 97655 49999999987543222 1234568899999999887776554 99999999999999999999764321 1
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
......+............++..+.+++.+||..+|.+||++.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 214 FSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 222233222222211123477899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=248.47 Aligned_cols=203 Identities=24% Similarity=0.321 Sum_probs=152.6
Q ss_pred CCcchhhhhceeeec--------------eeEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHHcCCee
Q 022732 6 SSSSEYAMLGVSVKM--------------KFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCH 70 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--------------~~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~~~iiH 70 (293)
.|+|++++++.+... ...|+|+ ||+. ++|..++..... ...++.++.||+.||.|||++|++|
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~-e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH 137 (342)
T cd07854 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQ-EYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLH 137 (342)
T ss_pred CCCcchhhHhhhcccccccccccccccccceEEEEe-eccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 688999999776654 4688999 7997 488888865432 2299999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCC
Q 022732 71 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 71 rdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 146 (293)
|||||+||+++..+ +.+||+|||+++...... ......++..|+|||++.+......++|+|||||++|+|++|+
T Consensus 138 ~dikp~Nili~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~ 216 (342)
T cd07854 138 RDLKPANVFINTED-LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216 (342)
T ss_pred CCCCHHHEEEcCCC-ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCC
Confidence 99999999997543 358999999987532211 1123357889999998766444455699999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHhc---------------------cccCCC---CCCCCCHHHHHHHHHccccCCCCCCCHHH
Q 022732 147 YPFEDPDEPKDFRKTIQRILS---------------------VQYSVP---DTNPISQECRDLISRIFVADPAARITIPE 202 (293)
Q Consensus 147 ~pf~~~~~~~~~~~~~~~~~~---------------------~~~~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~e 202 (293)
.||.+................ .....+ ....++.++++||.+||+.||.+|||+.+
T Consensus 217 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 296 (342)
T cd07854 217 PLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296 (342)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHH
Confidence 999876654443333221100 000000 01247889999999999999999999999
Q ss_pred HHcCccccc
Q 022732 203 IMKHQWFLK 211 (293)
Q Consensus 203 ll~h~~~~~ 211 (293)
++.||||+.
T Consensus 297 ll~h~~~~~ 305 (342)
T cd07854 297 ALMHPYMSC 305 (342)
T ss_pred HhCCCcccc
Confidence 999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=240.81 Aligned_cols=192 Identities=19% Similarity=0.304 Sum_probs=153.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHHHHHcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSYCHAMQ 67 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~LH~~~ 67 (293)
.|+|++++++++......++++ ||+.+++|..++.... .+. .+..++.|++.||.|||++|
T Consensus 66 ~h~~iv~~~~~~~~~~~~~~~~-e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g 144 (283)
T cd05091 66 QHPNIVCLLGVVTKEQPLSMIF-SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH 144 (283)
T ss_pred CCCCcCeEEEEEcCCCceEEEE-EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC
Confidence 5899999999999999999999 7999999999985321 122 68899999999999999999
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh
Q 022732 68 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144 (293)
Q Consensus 68 iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 144 (293)
++||||||+||+++.+. .+||+|||+++....... .....+++.|+|||.+.+..++.+ +|+||+||++|+|++
T Consensus 145 i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~ 221 (283)
T cd05091 145 VVHKDLATRNVLVFDKL--NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFS 221 (283)
T ss_pred ccccccchhheEecCCC--ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHc
Confidence 99999999999997654 499999999875432221 223456789999999877776555 999999999999998
Q ss_pred -CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 -GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|..||.+..... +...+..... .+.+..++..+.+++.+||+.+|.+||++.+++..
T Consensus 222 ~g~~p~~~~~~~~----~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 222 YGLQPYCGYSNQD----VIEMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCCCCCCCCCHHH----HHHHHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 888998765533 2233322222 22334588999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=243.07 Aligned_cols=200 Identities=24% Similarity=0.356 Sum_probs=153.9
Q ss_pred CCcchhhhhceeeece----------eEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 6 SSSSEYAMLGVSVKMK----------FVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~----------~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
.|+|++++++++.+.. ++|+|+ ||+.+ ++..++.+. ..+. +++.++.|++.||+|||++|++|||
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~d 141 (302)
T cd07864 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVF-EYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRD 141 (302)
T ss_pred CCCCeeeeeheecCcchhhhccccCCcEEEEE-cccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 5899999999998766 899999 79987 666666653 2333 9999999999999999999999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 150 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 150 (293)
|||+||+++.++ .+||+|||++....... ......++..|+|||++.+......++|+||+||++++|++|+.||.
T Consensus 142 l~p~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 142 IKCSNILLNNKG--QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred CCHHHEEECCCC--cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999997655 49999999987543322 11223567889999988654433455999999999999999999998
Q ss_pred CCCchHHHHHHHHHHhcccc-CC-----------------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 151 DPDEPKDFRKTIQRILSVQY-SV-----------------------PDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~-~~-----------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.......+..+......... .. .....++..+.++|.+||..+|.+|||+.+++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 220 ANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 76655444443332111100 00 0112368999999999999999999999999999
Q ss_pred ccc
Q 022732 207 QWF 209 (293)
Q Consensus 207 ~~~ 209 (293)
|||
T Consensus 300 ~~~ 302 (302)
T cd07864 300 PWL 302 (302)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=240.03 Aligned_cols=191 Identities=19% Similarity=0.345 Sum_probs=150.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.. ...++++ +|+.+|+|.+++... +.+. .+..++.|++.||.|||++|++||||||+|||++.
T Consensus 67 ~~~~i~~~~~~~~~-~~~~l~~-~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~ 144 (279)
T cd05109 67 GSPYVCRLLGICLT-STVQLVT-QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS 144 (279)
T ss_pred CCCCCceEEEEEcC-CCcEEEE-EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 57899999999875 4567888 799999999999764 3344 88999999999999999999999999999999966
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC---CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||+++........ ....+++.|+|||.+.+..++.+ +|+|||||++||+++ |..||....... +
T Consensus 145 ~~--~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~ 220 (279)
T cd05109 145 PN--HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-I 220 (279)
T ss_pred CC--cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-H
Confidence 54 5999999998755332221 12234678999999987776555 999999999999998 899997654322 2
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
...+. .....+.+..++.++.+++.+||..||++||++.+++..
T Consensus 221 ~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 221 PDLLE----KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHH----CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22222 222334445588999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=243.39 Aligned_cols=198 Identities=24% Similarity=0.356 Sum_probs=156.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|.+++++++...+..|+|| ||+.| +|.+.+.. ...+. ++..++.|++.||.|||++|++||||+|+||+++.
T Consensus 83 ~h~~iv~~~~~~~~~~~~~lv~-e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~ 160 (317)
T cd06635 83 KHPNSIEYKGCYLREHTAWLVM-EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 160 (317)
T ss_pred CCCCEEEEEEEEeeCCeEEEEE-eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC
Confidence 5899999999999999999999 79976 66666644 33343 88899999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc---ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||++.... ......|++.|+|||.+.. ..+ ..++|+||+||++|+|++|+.||..........
T Consensus 161 ~~--~~kl~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 234 (317)
T cd06635 161 PG--QVKLADFGSASIAS---PANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALY 234 (317)
T ss_pred CC--CEEEecCCCccccC---CcccccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 54 59999999986432 2334568999999999742 334 445999999999999999999998765433322
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
. +............++..+++++.+||+.+|.+||++.++++|+|+....+.
T Consensus 235 ~----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 235 H----IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred H----HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 2 222222222233478899999999999999999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=237.15 Aligned_cols=194 Identities=27% Similarity=0.374 Sum_probs=156.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++.+....|+|+ ||+.+++|..++... ..+. +++.++.|++.||.|||++|++|+||+|+||+
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nil 138 (260)
T cd08222 60 DHPAIVKFHASFLERDAFCIIT-EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIF 138 (260)
T ss_pred CCCcHHHHHHHHhcCCceEEEE-EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheE
Confidence 5899999999999999999999 799999999988642 2333 88999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++.+ .+||+|||++...... .......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||........
T Consensus 139 i~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~- 213 (260)
T cd08222 139 LKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSV- 213 (260)
T ss_pred eecC---CEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHH-
Confidence 9642 4999999998754322 22234568899999999877666555 9999999999999999999976544222
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...+.... ....+..++.++.++|.+||..+|.+||++.++++||||
T Consensus 214 ---~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 214 ---VLRIVEGP-TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---HHHHHcCC-CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 22222221 111233578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=243.39 Aligned_cols=197 Identities=23% Similarity=0.328 Sum_probs=154.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|.+++++++...+..|+|+ ||+.| ++..++.. ...+. .+..++.|++.||.|||+++++||||+|+||+++.
T Consensus 73 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~ 150 (308)
T cd06634 73 RHPNTIQYRGCYLREHTAWLVM-EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150 (308)
T ss_pred CCCCcccEEEEEEcCCeeEEEE-EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC
Confidence 5889999999999999999999 79974 77776654 33344 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc---ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||++.... ......|++.|+|||.+.+ ..++ .++|+||+||++|+|++|..||..........
T Consensus 151 ~~--~~kl~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 224 (308)
T cd06634 151 PG--LVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (308)
T ss_pred CC--cEEECCcccceeec---CcccccCCccccCHHHHhhcccCCCC-cccchHHHHHHHHHHHcCCCCCccccHHHHHH
Confidence 54 59999999987532 2234568899999999753 2333 44999999999999999999997755432222
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.. ............++..+.++|++||..+|.+||++.++++|||+....+
T Consensus 225 ~~----~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 225 HI----AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HH----hhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 21 1121111122347889999999999999999999999999999976533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=239.80 Aligned_cols=196 Identities=25% Similarity=0.317 Sum_probs=149.1
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++... ...|+|| ||+.+++|.+++..... ..+++.++.|++.||.|||++|++||||||+||+++.
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~ 142 (283)
T cd05080 64 YHENIVKYKGCCSEQGGKGLQLIM-EYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN 142 (283)
T ss_pred CCCCEeeEEEEEecCCCceEEEEe-cCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC
Confidence 689999999988654 4688999 79999999999976542 2289999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH-
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD- 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~- 157 (293)
++ .+||+|||+++....... .....++..|+|||.+.+..++.+ +|+|||||++|+|++|..||........
T Consensus 143 ~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~ 219 (283)
T cd05080 143 DR--LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEE 219 (283)
T ss_pred CC--cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhh
Confidence 54 599999999875432221 122345667999999877666555 9999999999999999999865432100
Q ss_pred -H--------HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 158 -F--------RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 158 -~--------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
. ..............+.+..++..+.+++.+||..+|++|||+++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 220 MIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 00000111111222334457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=239.01 Aligned_cols=191 Identities=19% Similarity=0.268 Sum_probs=150.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.. ...++++ ||+.+|+|.+++.... .++ .+..++.||+.||.|||++|++||||||+||+++.
T Consensus 67 ~h~~iv~~~~~~~~-~~~~~i~-e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~ 144 (279)
T cd05111 67 DHAYIVRLLGICPG-ASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144 (279)
T ss_pred CCCCcceEEEEECC-CccEEEE-EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC
Confidence 68999999998864 5577888 7999999999997643 333 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||+++....... .....++..|+|||.+.+..++.+ +|+||+||++|++++ |..||.+..... .
T Consensus 145 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~-~ 220 (279)
T cd05111 145 DS--IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHE-V 220 (279)
T ss_pred CC--cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-H
Confidence 54 599999999975432221 223456778999999887777555 999999999999998 999998765422 2
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
...+ ......+.+...+.++.+++.+||..+|++|||+.++++.
T Consensus 221 ~~~~----~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 221 PDLL----EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHH----HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2222 2222233334467899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=245.64 Aligned_cols=195 Identities=21% Similarity=0.312 Sum_probs=155.3
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC----------------H--HHHHHHHHHHHHHHHHHHH
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL----------------L--VQARFFFQQLISGVSYCHA 65 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~----------------~--~~~~~~~~qil~~l~~LH~ 65 (293)
+..|+|+++++++|...+.+|+|+ ||+.+|+|.+++.+... + .++..++.|++.||.|||+
T Consensus 74 l~~h~~iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 152 (334)
T cd05100 74 IGKHKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS 152 (334)
T ss_pred hcCCCCeeeeeEEEccCCceEEEE-ecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 457999999999999999999999 79999999999976421 2 2778899999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHH
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 142 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 142 (293)
+|++||||||+||+++.++ .+||+|||+++....... .....++..|+|||++.+..++.+ +|+||+||++|+|
T Consensus 153 ~givH~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el 229 (334)
T cd05100 153 QKCIHRDLAARNVLVTEDN--VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEI 229 (334)
T ss_pred CCeeccccccceEEEcCCC--cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHH
Confidence 9999999999999997654 599999999875432211 122234568999999987777655 9999999999999
Q ss_pred Hh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q 022732 143 LV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 207 (293)
Q Consensus 143 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~ 207 (293)
++ |..||.+.+...... .+. .....+.+...+.++.+++.+||..+|.+|||+.+++.+-
T Consensus 230 ~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 230 FTLGGSPYPGIPVEELFK----LLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HhcCCCCCCCCCHHHHHH----HHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 98 889998765433222 222 2222333445789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=236.07 Aligned_cols=191 Identities=20% Similarity=0.272 Sum_probs=149.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.. ...++|| ||+.+++|.+++... +.++ .+..++.|++.||.|||++|++||||||+||+++.
T Consensus 53 ~h~~ii~~~~~~~~-~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~ 130 (257)
T cd05115 53 DNPYIVRMIGVCEA-EALMLVM-EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130 (257)
T ss_pred CCCCeEEEEEEEcC-CCeEEEE-EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC
Confidence 68999999998864 5788999 799999999999753 3333 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .+||+|||++........ .....+++.|+|||++.+..++.+ +|+|||||++|++++ |..||........
T Consensus 131 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~ 207 (257)
T cd05115 131 QH--YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEV 207 (257)
T ss_pred CC--cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 54 599999999874332221 111223578999999877666554 999999999999996 9999987665332
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. .+.. ....+.+...++++.++|.+||..+|++||++.++.+.
T Consensus 208 ~~----~~~~-~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 208 MS----FIEQ-GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HH----HHHC-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22 1211 12223334578999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=239.26 Aligned_cols=193 Identities=20% Similarity=0.338 Sum_probs=156.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC---------CHH--HHHHHHHHHHHHHHHHHHcCCeecCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG---------LLV--QARFFFQQLISGVSYCHAMQVCHRDLK 74 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~---------~~~--~~~~~~~qil~~l~~LH~~~iiHrdlk 74 (293)
.|+|++++++++......|+|| ||+.+++|.+++.... .++ .+..++.|++.||+|||++|++|||||
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlk 144 (275)
T cd05046 66 SHKNVVRLLGLCREAEPHYMIL-EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLA 144 (275)
T ss_pred CCcceeeeEEEECCCCcceEEE-EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCc
Confidence 5899999999999999999999 7999999999998755 344 899999999999999999999999999
Q ss_pred CCcEEEcCCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCC
Q 022732 75 LENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFED 151 (293)
Q Consensus 75 p~NIl~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~ 151 (293)
|+||+++.++ .++++|||+++...... ......+++.|+|||.+.+.... .++|+||+||++|++++ |..||..
T Consensus 145 p~Nili~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 145 ARNCLVSSQR--EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred cceEEEeCCC--cEEEcccccccccCcccccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccc
Confidence 9999997665 49999999986432211 12233567789999998776655 44999999999999998 7889976
Q ss_pred CCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 152 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..... ............+....++..+.+++.+||..+|.+|||+.+++..
T Consensus 222 ~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 222 LSDEE----VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cchHH----HHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 55432 2333333333344445688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=240.52 Aligned_cols=191 Identities=24% Similarity=0.373 Sum_probs=152.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC------------------------CHH--HHHHHHHHHHHH
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG------------------------LLV--QARFFFQQLISG 59 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~------------------------~~~--~~~~~~~qil~~ 59 (293)
.|+|++++++.+...+..|+|+ ||+.+++|.+++.... .+. .+..++.|++.|
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~ 139 (290)
T cd05045 61 NHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRG 139 (290)
T ss_pred CCCCEeeEEEEEecCCCcEEEE-EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHH
Confidence 5899999999999999999999 7999999999987532 122 778999999999
Q ss_pred HHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhh
Q 022732 60 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 136 (293)
Q Consensus 60 l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG 136 (293)
|.|||++|++||||||+||+++.++ .+||+|||+++....... .....++..|+|||.+.+..++.+ +|+||||
T Consensus 140 l~~LH~~~ivH~dikp~nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG 216 (290)
T cd05045 140 MQYLAEMKLVHRDLAARNVLVAEGR--KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFG 216 (290)
T ss_pred HHHHHHCCeehhhhhhheEEEcCCC--cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHH
Confidence 9999999999999999999997654 599999999875322211 122345678999999877666544 9999999
Q ss_pred hHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 137 VTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 137 ~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|++|+|++ |..||.+....... ... ......+.+..++.++.+++.+||..+|.+||++.++++
T Consensus 217 ~~l~el~t~g~~p~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 217 VLLWEIVTLGGNPYPGIAPERLF-NLL----KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHH-HHH----hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999998 99999776543322 222 222233344558899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=246.18 Aligned_cols=203 Identities=24% Similarity=0.302 Sum_probs=155.9
Q ss_pred CCcchhhhhceeeece------eEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVKMK------FVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~------~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.|+|++++++++.... ..|+|+ +|+ |++|..++... .++ .++.++.||+.||.|||++|++||||||+|
T Consensus 72 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~-e~~-~~~l~~~~~~~-~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~N 148 (343)
T cd07880 72 KHENVIGLLDVFTPDLSLDRFHDFYLVM-PFM-GTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGN 148 (343)
T ss_pred CCCCccceeeeecCCccccccceEEEEE-ecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 5899999999987654 458888 688 77898888653 333 899999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
|+++.++ .+||+|||++..... ......+++.|+|||++.+....+.++|+||+||++|++++|+.||.+......
T Consensus 149 ill~~~~--~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 224 (343)
T cd07880 149 LAVNEDC--ELKILDFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224 (343)
T ss_pred EEEcCCC--CEEEeeccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9997654 599999999875422 223456789999999987643345559999999999999999999987665443
Q ss_pred HHHHHHHHhcc-------------------ccCC------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 158 FRKTIQRILSV-------------------QYSV------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 158 ~~~~~~~~~~~-------------------~~~~------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
...+....... .... .....++.++.++|.+||..||.+|||+.+++.||||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 225 LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 33322210000 0000 0113478899999999999999999999999999999875
Q ss_pred CCC
Q 022732 213 LPA 215 (293)
Q Consensus 213 ~~~ 215 (293)
...
T Consensus 305 ~~~ 307 (343)
T cd07880 305 HDP 307 (343)
T ss_pred cCc
Confidence 443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=237.23 Aligned_cols=192 Identities=21% Similarity=0.305 Sum_probs=154.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.... .+. ++..++.|++.||.|||++|++||||||+||+++.
T Consensus 63 ~h~~i~~~~~~~~~~~~~~iv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~ 141 (266)
T cd05033 63 DHPNIIRLEGVVTKSRPVMIIT-EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS 141 (266)
T ss_pred CCCCcceEeEEEecCCceEEEE-EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence 5899999999999999999999 7999999999997643 333 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC-C--CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ-P--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~-~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||+++....... . ....+++.|+|||.+.+..++.+ +|+||+||++|++++ |..||.........
T Consensus 142 ~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~ 218 (266)
T cd05033 142 NL--VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVI 218 (266)
T ss_pred CC--CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHH
Confidence 54 599999999986531111 1 12234678999999887776555 999999999999998 99999776543322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..+.. ....+.+..++..+.+++.+||+.+|++||++.+++++
T Consensus 219 ----~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 219 ----KAVED-GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ----HHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22222 22334445588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=241.05 Aligned_cols=196 Identities=22% Similarity=0.293 Sum_probs=154.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-----------CHH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-----------LLV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-----------~~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
.|+|++++++++......++|+ ||+.+++|..++.... .+. .++.++.|++.||.|||++|++|||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~d 155 (296)
T cd05051 77 SDPNIARLLGVCTVDPPLCMIM-EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD 155 (296)
T ss_pred CCCCEeEEEEEEecCCCcEEEE-ecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Confidence 5889999999999999999999 7999999999997765 333 8899999999999999999999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh--CCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGY 147 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~--g~~ 147 (293)
|||+||+++.++ .++|+|||+++...... ......+++.|+|||++.+..+..+ +||||+||++|+|++ +..
T Consensus 156 lkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 156 LATRNCLVGKNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred cchhceeecCCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCC
Confidence 999999997664 59999999987532221 1223456788999999877666555 999999999999998 678
Q ss_pred CCCCCCchHHHHHHHHHHhc--cccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 148 PFEDPDEPKDFRKTIQRILS--VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
||........+......... .....+.+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 233 PYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 88776554443333221111 11112233446799999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=236.17 Aligned_cols=191 Identities=21% Similarity=0.285 Sum_probs=152.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...+..|+|+ ||+.+++|.+++.... .+. ++..++.|++.||.|||++|++||||||+||+++
T Consensus 59 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 137 (261)
T cd05068 59 RHPKLIQLYAVCTLEEPIYIVT-ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG 137 (261)
T ss_pred CCCCccceeEEEecCCCeeeee-ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc
Confidence 4899999999999999999999 7999999999997654 233 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCC--CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||+++........ .....+..|+|||.+.+..++.+ +|+||+||++|+|++ |+.||.+.......
T Consensus 138 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 214 (261)
T cd05068 138 ENN--ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214 (261)
T ss_pred CCC--CEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 665 4999999998764322111 11123457999999877766555 999999999999999 99999876653333
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..+. .....+....++..+.+++.+||..+|.+||++.++++
T Consensus 215 ~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 215 QQVD-----QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHH-----cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2221 12223334457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=242.59 Aligned_cols=200 Identities=23% Similarity=0.342 Sum_probs=150.8
Q ss_pred CCcchhhhhceeeece--------eEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCC
Q 022732 6 SSSSEYAMLGVSVKMK--------FVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLK 74 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~--------~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlk 74 (293)
.|+|++++++++.... .+|+|+ ||+.+ +|...+... ..++ +++.++.|+++||.|||++|++|||||
T Consensus 65 ~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~-~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~ 142 (311)
T cd07866 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVT-PYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIK 142 (311)
T ss_pred CCCCccchhhheecccccccccCceEEEEE-ecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 6899999999886544 568999 78876 566666543 3344 899999999999999999999999999
Q ss_pred CCcEEEcCCCCCCEEEecCCCCcCcCCCCC------------CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHH
Q 022732 75 LENTLLDGSPAPRLKICDFGYSKSSVLHSQ------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 142 (293)
Q Consensus 75 p~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 142 (293)
|+||+++.++ .+||+|||+++....... .....+++.|+|||.+.+......++|+||+||++|+|
T Consensus 143 p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el 220 (311)
T cd07866 143 AANILIDNQG--ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220 (311)
T ss_pred HHHEEECCCC--CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHH
Confidence 9999997655 599999999874322111 12335788999999887654334559999999999999
Q ss_pred HhCCCCCCCCCchHHHHHHHHHHhcccc-------------------CCC-----CCCCCCHHHHHHHHHccccCCCCCC
Q 022732 143 LVGGYPFEDPDEPKDFRKTIQRILSVQY-------------------SVP-----DTNPISQECRDLISRIFVADPAARI 198 (293)
Q Consensus 143 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~~~-----~~~~~s~~~~~li~~~L~~dp~~Rp 198 (293)
++|+.||.+.+.......+......... ..+ ....+++.+.+||.+||..+|.+||
T Consensus 221 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 221 FTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc
Confidence 9999999887765544443332111000 000 0123557899999999999999999
Q ss_pred CHHHHHcCccc
Q 022732 199 TIPEIMKHQWF 209 (293)
Q Consensus 199 t~~ell~h~~~ 209 (293)
|+.+++.||||
T Consensus 301 t~~ell~~~~f 311 (311)
T cd07866 301 TASDALEHPYF 311 (311)
T ss_pred CHHHHhcCCCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=235.42 Aligned_cols=189 Identities=21% Similarity=0.316 Sum_probs=149.5
Q ss_pred CCcchhhhhcee-eeceeEEEeehhhccCchhHHHHHHcCC--H--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVS-VKMKFVFLSLSFFFSLCLFFMWLLLLGL--L--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~-~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++ ...+..|+|+ ||+.+++|.+++++.+. + ..+..++.|++.||+|||++|++||||||+||++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~ 135 (256)
T cd05082 57 RHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV 135 (256)
T ss_pred CCCCeeeEEEEEEcCCCceEEEE-ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE
Confidence 578999999975 4557789999 79999999999987543 2 2888999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
+.++ .+||+|||+++..... .....++..|+|||++.+..++.+ +|+||+||++|+|++ |+.||........
T Consensus 136 ~~~~--~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~-- 208 (256)
T cd05082 136 SEDN--VAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDV-- 208 (256)
T ss_pred cCCC--cEEecCCccceecccc--CCCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 7655 5999999998753222 223345678999999877766555 999999999999998 9999976554222
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
...+.. .........+++.+.+++.+||..+|++|||+.++++
T Consensus 209 --~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 209 --VPRVEK-GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred --HHHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 222211 1222233457899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=235.09 Aligned_cols=190 Identities=22% Similarity=0.347 Sum_probs=152.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.... .+. .+..++.|++.||.|||++|++||||||+||+++
T Consensus 58 ~~~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~ 136 (256)
T cd05039 58 RHPNLVQLLGVVLQGNPLYIVT-EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS 136 (256)
T ss_pred CCcceeeeEEEEcCCCCeEEEE-EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe
Confidence 4889999999999999999999 7999999999998765 333 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~ 160 (293)
.++ .+||+|||.++...... ....++..|+|||.+.+..+..+ +|+||+||++|++++ |+.||........ ..
T Consensus 137 ~~~--~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~ 210 (256)
T cd05039 137 EDL--VAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDV-VP 210 (256)
T ss_pred CCC--CEEEccccccccccccc--ccCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHH-HH
Confidence 654 59999999998652221 13344667999999877666544 999999999999997 9999977654322 22
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
... .......+..+++.+.++|.+||..+|.+|||+.++++.
T Consensus 211 ~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 211 HVE----KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHh----cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 221 112222334578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=233.15 Aligned_cols=192 Identities=21% Similarity=0.315 Sum_probs=152.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..++|| ||+.+++|.+++.... .+. .+..++.|++.||.|||++|++||||||+||+++.
T Consensus 50 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~ 128 (250)
T cd05085 50 DHPNIVKLIGVCTQRQPIYIVM-ELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE 128 (250)
T ss_pred CCCCcCeEEEEEecCCccEEEE-ECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC
Confidence 5899999999999999999999 7999999999987643 333 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC--CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||++......... ....+++.|+|||++.+..++.+ +|+||+||++|++++ |..||..........
T Consensus 129 ~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~ 205 (250)
T cd05085 129 NN--VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQARE 205 (250)
T ss_pred CC--eEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 55 5999999998743222111 12234567999999877666555 999999999999998 999998765433222
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
. +. .......+..++..+.+++.+||..+|.+||++.++++.
T Consensus 206 ~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 206 Q----VE-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred H----HH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 2 21 122223344588999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=241.12 Aligned_cols=191 Identities=28% Similarity=0.411 Sum_probs=147.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+++++|++...+..++|+ ||+.+|+|.++|... ..+. ++..++.||+.||.|||+++++|++|++.||+++
T Consensus 59 ~h~ni~~~~g~~~~~~~~~lv~-e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 59 RHPNIVKLYGFCIENEPLFLVM-EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp SBTTBE-EEEEEESSSSEEEEE-E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred cccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 6899999999999888899999 799999999999987 3333 8899999999999999999999999999999998
Q ss_pred CCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
.++ .+||+|||++....... ......+...|+|||.+.+..++.+ +||||||+++||+++ |+.||........
T Consensus 138 ~~~--~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 138 SNG--QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp TTT--EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred ccc--ccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccc
Confidence 765 59999999987542111 1233456778999999887776544 999999999999999 7899987755332
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
...+. .....+.+..++..+.++|.+||..+|.+|||+.++++
T Consensus 215 ----~~~~~-~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 215 ----IEKLK-QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ----HHHHH-TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ----ccccc-ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 22222 22223344558999999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=244.58 Aligned_cols=204 Identities=23% Similarity=0.351 Sum_probs=153.8
Q ss_pred CCcchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++... +..|+++ +++ |++|..++..... ...++.++.|++.||+|||++|++||||||+||
T Consensus 74 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~-~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 151 (345)
T cd07877 74 KHENVIGLLDVFTPARSLEEFNDVYLVT-HLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 151 (345)
T ss_pred CCCcccceeeeeeecccccccccEEEEe-hhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence 589999999988643 4577777 565 7899888765432 228899999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+++.++ .+||+|||+++... .......+++.|+|||.+.+....+.++|+||+||++|+|++|+.||.........
T Consensus 152 ll~~~~--~~kl~dfg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 152 AVNEDC--ELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred EEcCCC--CEEEeccccccccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 997655 59999999987532 22334568999999999866433345599999999999999999999876554433
Q ss_pred HHHHHHHhc-------------------cccCCCC------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 159 RKTIQRILS-------------------VQYSVPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 159 ~~~~~~~~~-------------------~~~~~~~------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..+...... .....+. ....++++.+||.+||++||.+|||+.+++.||||++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 332221100 0000000 113578999999999999999999999999999998754
Q ss_pred CC
Q 022732 214 PA 215 (293)
Q Consensus 214 ~~ 215 (293)
.+
T Consensus 308 ~~ 309 (345)
T cd07877 308 DP 309 (345)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=229.22 Aligned_cols=196 Identities=25% Similarity=0.379 Sum_probs=154.9
Q ss_pred CCcchhhhhceeeecee-----EEEeehhhccCchhHHHHHHc---CC-HH--HHHHHHHHHHHHHHHHHHcC--CeecC
Q 022732 6 SSSSEYAMLGVSVKMKF-----VFLSLSFFFSLCLFFMWLLLL---GL-LV--QARFFFQQLISGVSYCHAMQ--VCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~-----~~lv~~ey~~gg~L~~~l~~~---~~-~~--~~~~~~~qil~~l~~LH~~~--iiHrd 72 (293)
.|+|.++++++...+.. .|+++ +|...|+|.+.+... +. ++ ++..|+.+|++||++||+.. ..|||
T Consensus 76 ~s~~vl~l~dh~l~~~~D~~~~~yll~-Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~D 154 (302)
T KOG2345|consen 76 NSPNVLRLVDHQLREEKDGKHEAYLLL-PYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRD 154 (302)
T ss_pred CCcchHHHHHHHHHhhccCceeEEEEe-ehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccC
Confidence 35899999999876654 99999 799999999888653 32 33 89999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCC----------CCcCCCCccchhhhccccCC--CchhhhhhhhhHHH
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----------STVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLY 140 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~----------~~~gt~~y~aPE~~~~~~~~--~~~~DvwslG~il~ 140 (293)
|||.|||+..++ .++|.|||.++........+ ....|..|+|||.+.-..+. +.++|||||||++|
T Consensus 155 iKP~NILls~~~--~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 155 IKPANILLSDSG--LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred CCcceeEecCCC--ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence 999999997654 58999999987543332221 23579999999998643221 34499999999999
Q ss_pred HHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 141 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 141 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.|+.|..||...-. +...+.-.+.+.++.+|...++|+.+.++|+.||+.||.+||++.+++.+
T Consensus 233 a~mf~~sPfe~~~~--~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 233 AMMFGESPFERIYQ--QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHHcCCcchHHhh--cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 99999999964211 11111223456677888888899999999999999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=249.10 Aligned_cols=195 Identities=22% Similarity=0.383 Sum_probs=155.0
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--------------------------------------
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-------------------------------------- 45 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-------------------------------------- 45 (293)
+++|+|++++++++...+.+|+|+ ||+.+|+|.+++.+.+.
T Consensus 97 l~~H~niv~~~~~~~~~~~~~iv~-E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (401)
T cd05107 97 LGPHLNIVNLLGACTKGGPIYIIT-EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESD 175 (401)
T ss_pred cCCCCCeEEEEEEEccCCCcEEEE-eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccC
Confidence 456999999999999999999999 79999999999975421
Q ss_pred ------------------------------------------------------------H--HHHHHHHHHHHHHHHHH
Q 022732 46 ------------------------------------------------------------L--VQARFFFQQLISGVSYC 63 (293)
Q Consensus 46 ------------------------------------------------------------~--~~~~~~~~qil~~l~~L 63 (293)
+ ..+..++.||+.||.||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 255 (401)
T cd05107 176 GGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL 255 (401)
T ss_pred ccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1 15678899999999999
Q ss_pred HHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHH
Q 022732 64 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 140 (293)
Q Consensus 64 H~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ 140 (293)
|+++++||||||+|||++.++ .+||+|||+++...... ......+++.|+|||.+.+..+.. ++|+||+||++|
T Consensus 256 H~~~ivHrdlkp~NiLl~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslGvil~ 332 (401)
T cd05107 256 ASKNCVHRDLAARNVLICEGK--LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT-LSDVWSFGILLW 332 (401)
T ss_pred hcCCcCcccCCcceEEEeCCC--EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc-HhHHHHHHHHHH
Confidence 999999999999999997654 59999999987532211 122345788999999998766654 499999999999
Q ss_pred HHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 141 VMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 141 el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
++++ |..||............+ ......+.+..++.++.+++.+||.++|.+||++.++++.
T Consensus 333 e~l~~g~~P~~~~~~~~~~~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 333 EIFTLGGTPYPELPMNEQFYNAI----KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCCCCCCCchHHHHHHH----HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9998 889997755433322222 2222333344578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=236.39 Aligned_cols=192 Identities=22% Similarity=0.317 Sum_probs=150.2
Q ss_pred CCcchhhhhceeeecee------EEEeehhhccCchhHHHHHHcC------CHH--HHHHHHHHHHHHHHHHHHcCCeec
Q 022732 6 SSSSEYAMLGVSVKMKF------VFLSLSFFFSLCLFFMWLLLLG------LLV--QARFFFQQLISGVSYCHAMQVCHR 71 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~------~~lv~~ey~~gg~L~~~l~~~~------~~~--~~~~~~~qil~~l~~LH~~~iiHr 71 (293)
.|+|++++++++..... .++|+ ||+.+++|..++.... .++ .+..++.|++.||.|||++|++||
T Consensus 59 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~-e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~ 137 (273)
T cd05035 59 DHPNVMKLIGVCFEASSLQKIPKPMVIL-PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR 137 (273)
T ss_pred CCCCeeeEEeeeccCCccccCcccEEEE-eccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 58899999998866554 78888 7999999999985432 223 789999999999999999999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCC
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGY 147 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~ 147 (293)
||||+||+++.++ .+||+|||+++....... .....++..|+|||.+.+..++.+ +|+||+||++|+|++ |..
T Consensus 138 dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 138 DLAARNCMLREDM--TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred ccchheEEECCCC--eEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCC
Confidence 9999999997654 599999999875432221 112235678999999876666555 999999999999999 889
Q ss_pred CCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 148 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
||.+......... +... ...+.+..++..+.+++.+||+.||++|||+.+++++
T Consensus 215 p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 215 PYPGVENHEIYDY----LRHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCCHHHHHHH----HHcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9987665433322 2222 1223344588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=238.12 Aligned_cols=196 Identities=20% Similarity=0.273 Sum_probs=152.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-------------HHHHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-------------LVQARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-------------~~~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
.|+|++++++++......|+|| ||+.+++|.+++..... ...+..++.|++.||+|||++|++|||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~d 155 (296)
T cd05095 77 KDPNIIRLLAVCITSDPLCMIT-EYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRD 155 (296)
T ss_pred CCCCcceEEEEEecCCccEEEE-EeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 5899999999999999999999 79999999999977532 126899999999999999999999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh--CCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGY 147 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~--g~~ 147 (293)
|||+||+++.++ .++|+|||+++....... .....+++.|+|||+..+..++.+ +|+||+||++|+|++ |..
T Consensus 156 lkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 156 LATRNCLVGKNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred CChheEEEcCCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCC
Confidence 999999997654 599999999875432211 112334678999999877776555 999999999999998 778
Q ss_pred CCCCCCchHHHHHHHHHHhc--cccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 148 PFEDPDEPKDFRKTIQRILS--VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
||.................. .....+.+..++..+.+|+.+||+.||.+||++.++++
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 233 PYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred CccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99776554433222111111 11123334457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=236.00 Aligned_cols=192 Identities=21% Similarity=0.317 Sum_probs=148.8
Q ss_pred CCcchhhhhceeee------ceeEEEeehhhccCchhHHHHHHcC------CHH--HHHHHHHHHHHHHHHHHHcCCeec
Q 022732 6 SSSSEYAMLGVSVK------MKFVFLSLSFFFSLCLFFMWLLLLG------LLV--QARFFFQQLISGVSYCHAMQVCHR 71 (293)
Q Consensus 6 ~~~~~v~~~~~~~~------~~~~~lv~~ey~~gg~L~~~l~~~~------~~~--~~~~~~~qil~~l~~LH~~~iiHr 71 (293)
.|+|++++++++.. ....++|+ ||+.+|+|..++.... .++ .+..++.|++.||+|||++|++||
T Consensus 58 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 136 (272)
T cd05075 58 DHPNVMRLIGVCLQTVESEGYPSPVVIL-PFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR 136 (272)
T ss_pred CCCCcceEEEEEccCCcccCCCCcEEEE-EeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 68999999998743 23578888 7999999999885321 122 789999999999999999999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCC
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGY 147 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~ 147 (293)
||||+|||++.++ .+||+|||+++....... .....+++.|+|||.+.+..++.+ +|+||+||++|++++ |+.
T Consensus 137 dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~ 213 (272)
T cd05075 137 DLAARNCMLNENM--NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQT 213 (272)
T ss_pred ccchhheEEcCCC--CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCC
Confidence 9999999997654 599999999986433221 122346778999999887766554 999999999999999 889
Q ss_pred CCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 148 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
||.+..... +...+.... ..+....++..+.++|.+||+.+|.+|||+.+++++
T Consensus 214 p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 214 PYPGVENSE----IYDYLRQGN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHH----HHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 998755432 222222222 223344578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=249.93 Aligned_cols=198 Identities=28% Similarity=0.406 Sum_probs=157.0
Q ss_pred chhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-----HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 9 SEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-----QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 9 ~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-----~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
+.|+++-+|...+|+|||++ ....+|.+.|++.|.-. .++.|+.|++.||..|-.+||+|.||||.|||++.+
T Consensus 495 Hclrl~r~F~hknHLClVFE--~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFE--PLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHHHhhhcceeEEEeh--hhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence 45899999999999999995 44569999999988654 899999999999999999999999999999999876
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.. .+||||||.|........ +.+.-+..|+|||+++|.+|... .|+||+||+||||.||+..|.+.++..-+.-.+.
T Consensus 573 k~-iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 573 KN-ILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cc-eeeeccCccccccccccc-cHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 55 689999999875433322 33446778999999999999888 8999999999999999999999887543322221
Q ss_pred H-------Hh-cccc-----C------------------------C-C---------------C-CCCCCHHHHHHHHHc
Q 022732 164 R-------IL-SVQY-----S------------------------V-P---------------D-TNPISQECRDLISRI 189 (293)
Q Consensus 164 ~-------~~-~~~~-----~------------------------~-~---------------~-~~~~s~~~~~li~~~ 189 (293)
- ++ .+.+ . + | . ...+-.++++||.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 0 00 0000 0 0 0 0 000125689999999
Q ss_pred cccCCCCCCCHHHHHcCccccc
Q 022732 190 FVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 190 L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
|.+||.+|.|+.++|+||||..
T Consensus 730 l~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred hccChhhcCCHHHHhcCCcccC
Confidence 9999999999999999999964
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=235.31 Aligned_cols=191 Identities=20% Similarity=0.310 Sum_probs=153.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.... .++ ++..++.|++.||.|||++|++||||||+||+++.
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 141 (267)
T cd05066 63 DHPNIIHLEGVVTKSKPVMIVT-EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS 141 (267)
T ss_pred CCCCcceEEEEEecCCccEEEE-EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC
Confidence 5899999999999999999999 7999999999997753 333 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC----CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .++|+|||++......... ....++..|+|||.+.+..++.+ +|+||+||++|++++ |..||........
T Consensus 142 ~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~ 218 (267)
T cd05066 142 NL--VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDV 218 (267)
T ss_pred CC--eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHH
Confidence 54 5999999998754332211 11223568999999987776555 999999999999886 9999987665333
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
...+ .. ....+....++..+.+++.+||+++|.+||++.++++
T Consensus 219 ~~~~----~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 219 IKAI----EE-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHH----hC-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 2222 22 2233444557899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=233.24 Aligned_cols=188 Identities=21% Similarity=0.247 Sum_probs=148.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+|+|++++++++.. ...++|+ ||+.+|+|.+++...+ .++ .+..++.||+.||.|||++|++||||||+||+++.
T Consensus 59 ~h~~i~~~~~~~~~-~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~ 136 (259)
T cd05037 59 SHKHLVKLYGVCVR-DENIMVE-EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVAR 136 (259)
T ss_pred CCcchhheeeEEec-CCcEEEE-EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEec
Confidence 68999999999988 7789999 7999999999998766 344 88899999999999999999999999999999976
Q ss_pred CCCC-----CEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccc-cCCCchhhhhhhhhHHHHHHh-CCCCCCCCCch
Q 022732 83 SPAP-----RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP 155 (293)
Q Consensus 83 ~~~~-----~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~ 155 (293)
++.. .+||+|||++..... .....++..|+|||++.+. ...+.++|+||+||++|+|++ |..||......
T Consensus 137 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 137 YGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred CccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 5521 599999999875432 2344577889999998765 233455999999999999999 57888766432
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. ..... .....+. +.+..+.++|.+||..+|.+|||+.++++
T Consensus 214 ~~-~~~~~----~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 214 EK-ERFYQ----DQHRLPM--PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred hH-HHHHh----cCCCCCC--CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 21 11111 1111222 23489999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=235.17 Aligned_cols=192 Identities=21% Similarity=0.321 Sum_probs=153.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...++.|+|| ||+.+++|..++... +.++ ++..++.|++.||.|||++|++||||||+||+++.
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~ 142 (268)
T cd05063 64 SHHNIIRLEGVVTKFKPAMIIT-EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS 142 (268)
T ss_pred CCCCeeEEEEEEccCCCcEEEE-EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC
Confidence 5889999999999999999999 799999999999764 3444 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC----CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .+||+|||++......... .....++.|+|||++.+..++.+ +|+||+||++|++++ |..||........
T Consensus 143 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~ 219 (268)
T cd05063 143 NL--ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEV 219 (268)
T ss_pred CC--cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHH
Confidence 54 5999999998754322111 11123457999999887776555 999999999999997 9999977655332
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
... +.. ....+....++..+.+++.+||..+|++||++.++++.
T Consensus 220 ~~~----i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 220 MKA----IND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHH----Hhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 222 222 22334445578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=233.76 Aligned_cols=194 Identities=25% Similarity=0.360 Sum_probs=153.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++.+...+..++|| ||+.+++|..++... ..+. ++..++.|++.||.|||+.|++||||+|+||+
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil 138 (267)
T cd08224 60 DHPNVIKYLASFIENNELNIVL-ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVF 138 (267)
T ss_pred CCCCeeeeeeeeecCCeEEEEE-ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEE
Confidence 5889999999999999999999 799999999998642 2233 88999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++.++ .++|+|||++....... ......+++.|+|||.+.+..+..+ +|+||+||++|+|++|+.||...... .
T Consensus 139 ~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~ 213 (267)
T cd08224 139 ITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--L 213 (267)
T ss_pred ECCCC--cEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCcc--H
Confidence 97655 59999999987543322 2234568999999999887777555 99999999999999999999664421 1
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
......+............++..+.++|.+||..+|++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 214 YSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 22222222221111111247789999999999999999999998876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=235.34 Aligned_cols=195 Identities=22% Similarity=0.300 Sum_probs=156.3
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCC
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLE 76 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~ 76 (293)
...|+|++++++++...++.|+|+ ||+.|++|.+++.. ...+. .++.++.|++.||.|||+ .|++|+||+|.
T Consensus 65 ~~~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ 143 (269)
T cd08528 65 QLRHPNIVRYYKTFLENDRLYIVM-DLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143 (269)
T ss_pred cCCCCCeeeEEeeEccCCeEEEEE-ecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHH
Confidence 357899999999999999999999 79999999988853 22333 889999999999999996 78999999999
Q ss_pred cEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 77 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 77 NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
||+++.++ .+||+|||.+.............|+..|+|||++.+..++. ++|+||+|+++|+|++|+.||.......
T Consensus 144 nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Dv~slG~ll~~l~~g~~p~~~~~~~~ 220 (269)
T cd08528 144 NIMLGEDD--KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGE-KADVWAFGCILYQMCTLQPPFYSTNMLS 220 (269)
T ss_pred HEEECCCC--cEEEecccceeecccccccccccCcccCcChhhhcCCCCch-HHHHHHHHHHHHHHHhCCCcccccCHHH
Confidence 99997654 59999999997654443444567899999999998766644 4999999999999999999997765433
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. ..+............++..+.+++.+||..||++||++.++..+
T Consensus 221 ~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 221 LA----TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HH----HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 22 22222222222223478999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=233.36 Aligned_cols=190 Identities=21% Similarity=0.294 Sum_probs=149.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++.+.. ...|+|| ||+.+|+|.+++.+.. ....+..++.|++.||.|||++|++||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~~-~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~ 136 (262)
T cd05071 59 RHEKLVQLYAVVSE-EPIYIVT-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 136 (262)
T ss_pred CCCCcceEEEEECC-CCcEEEE-EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc
Confidence 58899999998754 5688999 7999999999997632 2238899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||.++....... .....++..|+|||++.+..++.+ +|+||+||++|++++ |..||.+.......
T Consensus 137 ~~~--~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~ 213 (262)
T cd05071 137 ENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVL 213 (262)
T ss_pred CCC--cEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence 654 599999999875432221 123346678999999877776555 999999999999999 88899876543322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
. .+.. ....+....++..+.+++.+||.++|++||++.+++.
T Consensus 214 ~----~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 214 D----QVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred H----HHhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 2 2211 2223334558899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=231.53 Aligned_cols=191 Identities=23% Similarity=0.351 Sum_probs=153.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+|+|++++++++.+.+..|++| ||+.+++|.+++..... +. ++..++.|++.||.|||++|++||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~i~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~ 137 (258)
T smart00219 59 DHPNIVKLLGVCTEEEPLMIVM-EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG 137 (258)
T ss_pred CCCchheEEEEEcCCCeeEEEE-eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc
Confidence 7899999999999999999999 79999999999976543 33 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCC--CCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .++|+|||++.......... ...+++.|+|||.+.+..++. ++|+||+||++|+|++ |..||...+.....
T Consensus 138 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~ 214 (258)
T smart00219 138 ENL--VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTS-KSDVWSFGVLLWEIFTLGESPYPGMSNEEVL 214 (258)
T ss_pred cCC--eEEEcccCCceecccccccccccCCCcccccChHHhccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 665 59999999987544332211 123678999999986655554 4999999999999998 78898875543322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. +... ...+....++.++.+++.+||..+|.+|||+.++++
T Consensus 215 ~~----~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 215 EY----LKKG-YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HH----HhcC-CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 22 2222 122333448899999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=252.63 Aligned_cols=193 Identities=24% Similarity=0.320 Sum_probs=163.6
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
..|+|+|++||+......+|+|| |+|.||+|.++|++.+. ++ +...++.+.+.||+|||+++++||||-..|+|++
T Consensus 218 l~H~NVVr~yGVa~~~~Pl~ivm-El~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~ 296 (474)
T KOG0194|consen 218 LNHPNVVRFYGVAVLEEPLMLVM-ELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS 296 (474)
T ss_pred CCCCCEEEEEEEEcCCCccEEEE-EecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec
Confidence 57999999999999999999999 79999999999999875 44 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCC-CCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
.+.. +||+|||+++......... ...-...|+|||.+...-++.+ +||||+||++||+++ |..||.+....
T Consensus 297 ~~~~--vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~---- 369 (474)
T KOG0194|consen 297 KKGV--VKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNY---- 369 (474)
T ss_pred CCCe--EEeCccccccCCcceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHH----
Confidence 6553 7999999998653222222 2234678999999988877666 999999999999998 78899998764
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.....+....++.+.+...+.++..++.+|+..+|++|||+.++.+
T Consensus 370 ~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 370 EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 4444554566666766678899999999999999999999988876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=257.39 Aligned_cols=191 Identities=22% Similarity=0.322 Sum_probs=160.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--------------HH--HHHHHHHHHHHHHHHHHHcCCe
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--------------LV--QARFFFQQLISGVSYCHAMQVC 69 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--------------~~--~~~~~~~qil~~l~~LH~~~ii 69 (293)
.|+|+|+++|+|..++..|+|+ ||+.-|+|.++|+..++ +. +...++.||+.|+.||-++.+|
T Consensus 547 ~H~nIVrLlGVC~~~~P~~MvF-EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FV 625 (774)
T KOG1026|consen 547 QHPNIVRLLGVCREGDPLCMVF-EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFV 625 (774)
T ss_pred cCCCeEEEEEEEccCCeeEEEE-EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCccc
Confidence 6999999999999999999999 79999999999976431 33 8899999999999999999999
Q ss_pred ecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-C
Q 022732 70 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-G 145 (293)
Q Consensus 70 Hrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g 145 (293)
||||-..|+||..+- .|||+|||+++..-... ......-.++|||||.|...++++. |||||+||++||+++ |
T Consensus 626 HRDLATRNCLVge~l--~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 626 HRDLATRNCLVGENL--VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYG 702 (774)
T ss_pred ccchhhhhceeccce--EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccc
Confidence 999999999996654 49999999998542221 1112223568999999999999887 999999999999998 8
Q ss_pred CCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 146 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 146 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+.||.+..+.+.+ +.+..... ++.+..++.++.+|+..||+.+|++||++.+|-.
T Consensus 703 ~QPy~glSn~EVI----e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 703 KQPYYGLSNQEVI----ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred cCcccccchHHHH----HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999998885544 44444444 6667779999999999999999999999998743
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=264.08 Aligned_cols=194 Identities=23% Similarity=0.316 Sum_probs=150.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-----------C--HHHHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-----------L--LVQARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-----------~--~~~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
.|+|++++++++.+.+..|+|| ||+.||+|.+++.... . ...+..++.||+.||+|||++|++|||
T Consensus 60 ~HPNIVkl~~v~~d~~~lyLVM-EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRD 138 (932)
T PRK13184 60 IHPGIVPVYSICSDGDPVYYTM-PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRD 138 (932)
T ss_pred CCcCcCeEEEEEeeCCEEEEEE-EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 4899999999999999999999 7999999999986421 1 126788999999999999999999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCC-------------------CCCCCCcCCCCccchhhhccccCCCchhhhh
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLH-------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 133 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvw 133 (293)
|||+||+++.++ .+||+|||+++..... ......+||+.|+|||++.+..++.+ +|+|
T Consensus 139 LKPeNILLd~dg--~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIW 215 (932)
T PRK13184 139 LKPDNILLGLFG--EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIY 215 (932)
T ss_pred CchheEEEcCCC--CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHH
Confidence 999999997655 4999999998754110 01122469999999999988777554 9999
Q ss_pred hhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 134 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 134 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|+||++|+|++|+.||.......... ...............+++.+.+++.+||..||++|++..+.+..
T Consensus 216 SLGVILyELLTG~~PF~~~~~~ki~~---~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 216 ALGVILYQMLTLSFPYRRKKGRKISY---RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhhh---hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999998754322111 11111111222234578999999999999999999976665543
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=232.59 Aligned_cols=193 Identities=20% Similarity=0.330 Sum_probs=152.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC---------CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG---------LLVQARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~---------~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.|+|++++++++......|+|| ||+.+++|.+++.... ...++..++.|++.||+|||+++++|+||||+
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ 135 (269)
T cd05044 57 NHPNIVKLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAAR 135 (269)
T ss_pred CCCCeeeEeeeecCCCCeEEEE-eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 6899999999999999999999 7999999999997531 12378899999999999999999999999999
Q ss_pred cEEEcCCC---CCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCC
Q 022732 77 NTLLDGSP---APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPF 149 (293)
Q Consensus 77 NIl~~~~~---~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf 149 (293)
||+++.+. ...++|+|||+++...... ......++..|+|||.+.+..+..+ +|+|||||++|+|++ |..||
T Consensus 136 nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~ 214 (269)
T cd05044 136 NCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPY 214 (269)
T ss_pred eEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCC
Confidence 99997654 1259999999987542221 1123345778999999887776544 999999999999998 99999
Q ss_pred CCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 150 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.......... .+. .......+..++..+.++|.+||.++|.+||++.++++
T Consensus 215 ~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 215 PALNNQEVLQ----HVT-AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccCHHHHHH----HHh-cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8765433222 221 12223334457899999999999999999999999876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=235.84 Aligned_cols=196 Identities=22% Similarity=0.277 Sum_probs=151.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--------------CHHHHHHHHHHHHHHHHHHHHcCCeec
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--------------LLVQARFFFQQLISGVSYCHAMQVCHR 71 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--------------~~~~~~~~~~qil~~l~~LH~~~iiHr 71 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.... ....+..++.|++.||.|||++|++||
T Consensus 75 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 153 (295)
T cd05097 75 KNPNIIRLLGVCVSDDPLCMIT-EYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153 (295)
T ss_pred CCCCcCeEEEEEcCCCccEEEE-ecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 5789999999999999999999 7999999999996542 122788999999999999999999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh--CC
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GG 146 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~--g~ 146 (293)
||||+||+++.++ .+||+|||++........ .....+++.|+|||++.+..++.+ +|+|||||++|+|++ |.
T Consensus 154 dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~ 230 (295)
T cd05097 154 DLATRNCLVGNHY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKE 230 (295)
T ss_pred ccChhhEEEcCCC--cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCC
Confidence 9999999997654 599999999875322211 122345678999999877776544 999999999999998 66
Q ss_pred CCCCCCCchHHHHHHHHHHhc--cccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 147 YPFEDPDEPKDFRKTIQRILS--VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 147 ~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.||........+....+.... .......+...+..+.+++.+||..+|.+|||+.++++
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 231 QPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 788876554433332221111 11111223347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=232.49 Aligned_cols=190 Identities=22% Similarity=0.297 Sum_probs=149.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|.+++++++. .+..|+|| ||+.+++|.+++.... ....+..++.|++.||.|||++|++||||||+||+++
T Consensus 59 ~h~~i~~~~~~~~-~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~ 136 (260)
T cd05069 59 RHDKLVPLYAVVS-EEPIYIVT-EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG 136 (260)
T ss_pred CCCCeeeEEEEEc-CCCcEEEE-EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 5889999999885 46688999 7999999999997643 2337889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .++|+|||+++....... .....++..|+|||.+.+...+.+ +|+||+||++|++++ |..||.+.......
T Consensus 137 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 213 (260)
T cd05069 137 DNL--VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVL 213 (260)
T ss_pred CCC--eEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 655 499999999875432221 122345678999999877666544 999999999999999 89999876654332
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. +.. ....+.+...+..+++++++||.++|.+||++.++++
T Consensus 214 ~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 214 EQ----VER-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HH----HHc-CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22 211 2223334457899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=232.66 Aligned_cols=190 Identities=21% Similarity=0.291 Sum_probs=149.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|.+++++++. ....|+|| ||+.+++|.+++.... ....++.++.|++.||.|||++|++||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~-~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~ 136 (260)
T cd05070 59 RHDKLVQLYAVVS-EEPIYIVT-EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG 136 (260)
T ss_pred CCCceEEEEeEEC-CCCcEEEE-EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe
Confidence 5789999999885 45688999 7999999999997643 2338999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .++|+|||++........ .....++..|+|||.+.+..++.+ +|+|||||++|++++ |..||.+.+.....
T Consensus 137 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~ 213 (260)
T cd05070 137 DGL--VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVL 213 (260)
T ss_pred CCc--eEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 654 599999999875432221 122335668999999877666545 999999999999999 89999876543332
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. +.. ....+.+...+..+.+++.+||.++|.+|||+.++..
T Consensus 214 ~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 214 EQ----VER-GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HH----HHc-CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 22 221 2233344557899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=232.03 Aligned_cols=192 Identities=20% Similarity=0.291 Sum_probs=147.1
Q ss_pred CCcchhhhhceee-eceeEEEeehhhccCchhHHHHHHcCC---HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSV-KMKFVFLSLSFFFSLCLFFMWLLLLGL---LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~-~~~~~~lv~~ey~~gg~L~~~l~~~~~---~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+|+|++++++++. ..+..|+|+ ||+.+++|.+++..... ...+..++.|++.||.|||+++++||||||+|||++
T Consensus 54 ~h~~iv~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~ 132 (262)
T cd05058 54 SHPNVLSLLGICLPSEGSPLVVL-PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD 132 (262)
T ss_pred CCCCcceEEEEeecCCCCcEEEE-ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc
Confidence 6899999999775 455678888 79999999999976432 237788999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC-----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhC-CCCCCCCCch
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEP 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g-~~pf~~~~~~ 155 (293)
.++ .+||+|||+++...... ......++..|+|||.+.+..++.+ +|||||||++|+|++| .+||......
T Consensus 133 ~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~ 209 (262)
T cd05058 133 ESF--TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSF 209 (262)
T ss_pred CCC--cEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 654 59999999987432211 1123345778999999877776555 9999999999999995 5667654432
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
. +...+... ...+.+..++..+.+++.+||..+|++||++.++++.
T Consensus 210 ~----~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 210 D----ITVYLLQG-RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred H----HHHHHhcC-CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 2 22222222 1222233468999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=236.37 Aligned_cols=196 Identities=22% Similarity=0.304 Sum_probs=150.0
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++... ...|+|| ||+.|++|.+++.+.. .+. .+..++.|++.||+|||++|++||||||+||++
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~ 142 (284)
T cd05079 64 YHENIVKYKGICTEDGGNGIKLIM-EFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 142 (284)
T ss_pred CCCCeeeeeeEEecCCCCceEEEE-EccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE
Confidence 689999999999875 6788999 7999999999997653 233 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc--
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-- 154 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-- 154 (293)
+.++ .+||+|||+++....... .....++..|+|||++.+..++.+ +|+||+||++|+|+++..|+.....
T Consensus 143 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~ 219 (284)
T cd05079 143 ESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLF 219 (284)
T ss_pred cCCC--CEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchh
Confidence 7654 599999999875433221 123456778999999877666554 9999999999999998766533211
Q ss_pred ---------hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 155 ---------PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 155 ---------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.......... .......+.+..++..+.+|+.+||+.+|.+|||+.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 220 LKMIGPTHGQMTVTRLVRV-LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhcccccccccHHHHHHH-HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0001111111 11122333445588999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=231.27 Aligned_cols=192 Identities=22% Similarity=0.341 Sum_probs=152.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++....+.|+|+ ||+.|++|.+++.+.. .+. .+..++.|++.||.|||++|++||||||+||+++.
T Consensus 50 ~~~~i~~~~~~~~~~~~~~~v~-e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~ 128 (251)
T cd05041 50 DHPNIVKLIGVCVQKQPIYIVM-ELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE 128 (251)
T ss_pred CCCCeEEEEEEEecCCCeEEEE-EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcC
Confidence 5889999999999999999999 7999999999997643 233 88899999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC---CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ ++||+|||++......... ....++..|+|||.+.+..++.+ +|+||+||++|++++ |..||.........
T Consensus 129 ~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~ 205 (251)
T cd05041 129 NN--VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTR 205 (251)
T ss_pred CC--cEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHH
Confidence 54 5999999998754311111 11233567999999877666544 999999999999999 88999776543222
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. +. .....+.+..++..+.+++.+||..+|.+|||+.++++.
T Consensus 206 ~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 206 ER----IE-SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248 (251)
T ss_pred HH----Hh-cCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 21 11 122333344578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=235.50 Aligned_cols=191 Identities=20% Similarity=0.297 Sum_probs=151.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC----------------------HH--HHHHHHHHHHHHHH
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL----------------------LV--QARFFFQQLISGVS 61 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~----------------------~~--~~~~~~~qil~~l~ 61 (293)
+|+|++++++++....+.|+|+ ||+.+++|.+++..... ++ .+..++.|++.||.
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~ 144 (288)
T cd05050 66 DHPNIVKLLGVCAVGKPMCLLF-EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144 (288)
T ss_pred CCCchheEEEEEcCCCccEEEE-ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence 6899999999999999999999 79999999999975421 22 67899999999999
Q ss_pred HHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhH
Q 022732 62 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 138 (293)
Q Consensus 62 ~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i 138 (293)
|||.+|++||||||.||+++.++ .+||+|||++........ .....+++.|+|||.+.+..++.+ +|+||+||+
T Consensus 145 ~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i 221 (288)
T cd05050 145 YLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVV 221 (288)
T ss_pred HHHhCCeecccccHhheEecCCC--ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHH
Confidence 99999999999999999997654 599999999874322211 122335677999999887777655 999999999
Q ss_pred HHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 139 LYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 139 l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+|+|++ |..||.+....... ..+..... .+.+..++.++.+||.+||+.+|.+|||+.++++
T Consensus 222 l~el~~~~~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 222 LWEIFSYGMQPYYGMAHEEVI----YYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhCCCCCCCCCCHHHHH----HHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 999997 88899776543322 22222221 2223347899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=233.66 Aligned_cols=192 Identities=21% Similarity=0.322 Sum_probs=152.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++......++|+ ||+.+++|.+++...+ .+. +++.++.|++.||.|||++|++||||||+||+++.
T Consensus 63 ~h~ni~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~ 141 (269)
T cd05065 63 DHPNIIHLEGVVTKSRPVMIIT-EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS 141 (269)
T ss_pred CCcCcceEEEEECCCCceEEEE-ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC
Confidence 5899999999999999999999 7999999999997643 333 88999999999999999999999999999999965
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC---CCCc---CCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCch
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP---KSTV---GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP 155 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~---gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~ 155 (293)
+. .+||+|||++......... .... .+..|+|||.+.+..++.+ +|+||+||++||+++ |..||......
T Consensus 142 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 142 NL--VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred CC--cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 54 5999999998643322211 1111 2457999999887777555 999999999999886 99999876653
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.... .+. .....+.+..++..+.+++.+||.++|.+||++.+++..
T Consensus 219 ~~~~----~i~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 219 DVIN----AIE-QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHH----HHH-cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3222 221 223344445678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=232.10 Aligned_cols=191 Identities=21% Similarity=0.273 Sum_probs=153.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CH--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LL--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++......|+|| ||+.+++|.+++.+.. .+ ..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~ 137 (261)
T cd05034 59 RHDKLVQLYAVCSEEEPIYIVT-EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG 137 (261)
T ss_pred CCCCEeeeeeeeecCCceEEEE-eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc
Confidence 4899999999999999999999 7999999999997653 23 38899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||+++....... .....++..|+|||.+.+.....+ +|+||+||++|++++ |+.||.+.+....+
T Consensus 138 ~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05034 138 ENL--VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVL 214 (261)
T ss_pred CCC--CEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 664 599999999875432111 112234568999999887666544 999999999999998 99999876654333
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..+. .....+.+...+.++.+++.+||..+|.+||++.+++.
T Consensus 215 ~~~~-----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 215 EQVE-----RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHH-----cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 3222 12233444457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=239.74 Aligned_cols=201 Identities=26% Similarity=0.411 Sum_probs=152.3
Q ss_pred CCcchhhhhceeee-ceeEEEeehhhccCchhHHHHHHcCCH-HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVK-MKFVFLSLSFFFSLCLFFMWLLLLGLL-VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~-~~~~~lv~~ey~~gg~L~~~l~~~~~~-~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.. .+..|+|+ ||+ +++|..++...... ..+..++.|++.||.|||++|++||||+|.||+++.+
T Consensus 67 ~hpniv~~~~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 67 RHENIISLSDIFISPLEDIYFVT-ELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN 144 (328)
T ss_pred CCCCeeeEeeeEecCCCcEEEEe-ehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC
Confidence 58999999999976 56788888 687 56898888654422 2788899999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||.+.... .......+++.|+|||.+.+....+.++|+||+||++|++++|+.||...........+..
T Consensus 145 ~--~~~l~dfg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~ 220 (328)
T cd07856 145 C--DLKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220 (328)
T ss_pred C--CEEeCccccccccC--CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 4 59999999987532 2223456788999999876634345569999999999999999999987654222211111
Q ss_pred HH--------------------hccc--cCCC---CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 164 RI--------------------LSVQ--YSVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~--------------------~~~~--~~~~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.. .... ...+ ....++..+.++|++||+.+|.+|||+.+++.||||...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00 0000 0001 012367899999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=240.98 Aligned_cols=196 Identities=21% Similarity=0.365 Sum_probs=150.7
Q ss_pred CCCCCcchhhhhceeeec-eeEEEeehhhccCchhHHHHHHcC-------------------------------------
Q 022732 3 PVGSSSSEYAMLGVSVKM-KFVFLSLSFFFSLCLFFMWLLLLG------------------------------------- 44 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~-~~~~lv~~ey~~gg~L~~~l~~~~------------------------------------- 44 (293)
.++.|+|++++++++... +.+|+|| ||+.+|+|.+++....
T Consensus 66 ~l~~h~niv~~~~~~~~~~~~~~lv~-ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (343)
T cd05103 66 HIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS 144 (343)
T ss_pred hccCCccHhhhcceeecCCCceEEEE-eccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence 345789999999988654 5678888 7999999999997532
Q ss_pred --------------------------------CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEec
Q 022732 45 --------------------------------LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 92 (293)
Q Consensus 45 --------------------------------~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~D 92 (293)
...++..++.||+.||.|||++|++||||||.||+++.++ .+||+|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~d 222 (343)
T cd05103 145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICD 222 (343)
T ss_pred cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEe
Confidence 1116678999999999999999999999999999997654 599999
Q ss_pred CCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHHHHHHHHhcc
Q 022732 93 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 168 (293)
Q Consensus 93 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 168 (293)
||++........ .....+++.|+|||++.+..++.+ +|+||+||++|++++ |..||........+..... .
T Consensus 223 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~ 297 (343)
T cd05103 223 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----E 297 (343)
T ss_pred cccccccccCcchhhcCCCCCCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh----c
Confidence 999875422111 122345678999999877776555 999999999999997 8999977554332222221 1
Q ss_pred ccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 169 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 169 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
....+.+...++++.+++.+||+.+|.+|||+.++++|
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 298 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred cCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12222233478899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=230.26 Aligned_cols=189 Identities=20% Similarity=0.341 Sum_probs=149.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC----HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL----LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~----~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++.+... ..|+|| ||+.+++|.+++...+. ...+..++.|++.||.|||++|++||||||+||+++
T Consensus 57 ~~~~i~~~~~~~~~~-~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~ 134 (254)
T cd05083 57 HHKNLVRLLGVILHN-GLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134 (254)
T ss_pred CCCCcCeEEEEEcCC-CcEEEE-ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc
Confidence 589999999998765 478999 79999999999987542 227889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~ 160 (293)
.++ .+||+|||++..... .......+..|+|||.+.+..+..+ +|+||+||++|+|++ |+.||..........
T Consensus 135 ~~~--~~kl~Dfg~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~- 208 (254)
T cd05083 135 EDG--VAKVSDFGLARVGSM--GVDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE- 208 (254)
T ss_pred CCC--cEEECCCccceeccc--cCCCCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHHH-
Confidence 654 599999999875322 1223345678999999877666544 999999999999997 999998765433222
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+. .....+....++..+.+++.+||..+|.+||++++++..
T Consensus 209 ---~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 209 ---CVE-KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred ---HHh-CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 122233344578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=232.24 Aligned_cols=191 Identities=20% Similarity=0.306 Sum_probs=151.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+|+|++++++++.. ...|+|| ||+.+++|.+++.+.+ .+. .+..++.|++.||.|||++|++||||||+||+++.
T Consensus 65 ~h~~i~~~~~~~~~-~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~ 142 (270)
T cd05056 65 DHPHIVKLIGVITE-NPVWIVM-ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS 142 (270)
T ss_pred CCCchhceeEEEcC-CCcEEEE-EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec
Confidence 58999999999876 5578999 7999999999998754 233 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC--CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||+++........ ....+++.|+|||.+.+..+..+ +|+|||||++|++++ |..||..........
T Consensus 143 ~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~ 219 (270)
T cd05056 143 PD--CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219 (270)
T ss_pred CC--CeEEccCceeeecccccceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 55 5999999998754322211 12234568999999877666555 999999999999986 999998776543332
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+. . ....+.+..++..+.+++.+||..+|.+|||+.+++..
T Consensus 220 ~~~----~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 220 RIE----N-GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHH----c-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 221 1 12223445588999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=229.80 Aligned_cols=192 Identities=21% Similarity=0.331 Sum_probs=152.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++......|+|+ ||+.+++|.+++... +.+. .++.++.|++.||+|||++|++||||||+||+++.
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 57 SHPKLVQLYGVCTERSPICLVF-EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred CCCCeeeEEEEEccCCceEEEE-EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 5789999999999999999999 799999999999764 3333 88999999999999999999999999999999975
Q ss_pred CCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||++........ .....++..|+|||.+.+..+.. ++|+||+||++|++++ |+.||.........
T Consensus 136 ~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~- 211 (256)
T cd05112 136 NQ--VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS-KSDVWSFGVLMWEVFSEGKTPYENRSNSEVV- 211 (256)
T ss_pred CC--eEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcCh-HHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-
Confidence 54 599999999874322211 11233567899999987766654 4999999999999998 99999876543322
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..+... .....+...+..+.+++.+||..+|++|||+.+++++
T Consensus 212 ---~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 212 ---ETINAG-FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---HHHhCC-CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 222211 1222233468999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=235.57 Aligned_cols=191 Identities=18% Similarity=0.310 Sum_probs=150.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++... ..++|+ +|+.+|+|.+++.... .+. .+..++.|++.||.|||++|++||||||+||+++.
T Consensus 67 ~h~niv~~~~~~~~~-~~~~v~-e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~ 144 (303)
T cd05110 67 DHPHLVRLLGVCLSP-TIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS 144 (303)
T ss_pred CCCCcccEEEEEcCC-Cceeee-hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC
Confidence 689999999998764 467888 7999999999998754 233 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||+++....... .....++..|+|||++.+..++.+ +|+|||||++|++++ |..||.+... ...
T Consensus 145 ~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~ 220 (303)
T cd05110 145 PN--HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REI 220 (303)
T ss_pred CC--ceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHH
Confidence 54 499999999975432221 122345778999999877776555 999999999999997 8999976543 222
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.... ......+.+...+.++.+++.+||..+|++||++.++++.
T Consensus 221 ~~~~----~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 221 PDLL----EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHH----HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222 2223334444578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=230.56 Aligned_cols=190 Identities=19% Similarity=0.281 Sum_probs=150.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++. ....|+|+ ||+.+++|.+++.+.. .+. ++..++.|++.||+|||+.|++||||||+||+++
T Consensus 59 ~h~~i~~~~~~~~-~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 136 (260)
T cd05067 59 QHPRLVRLYAVVT-QEPIYIIT-EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS 136 (260)
T ss_pred CCcCeeeEEEEEc-cCCcEEEE-EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc
Confidence 5889999999874 56789999 7999999999997643 233 8889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .++|+|||++........ .....++..|+|||++.+..+..+ +|+||+||++|++++ |+.||.+.+.....
T Consensus 137 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 213 (260)
T cd05067 137 ETL--CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213 (260)
T ss_pred CCC--CEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence 665 499999999875432111 122345678999999877666544 999999999999999 99999876654332
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..+. .....+.+...+.++.+++.+||..+|++|||+++++.
T Consensus 214 ~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 214 QNLE-----RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHH-----cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2221 22233444557899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=231.87 Aligned_cols=190 Identities=22% Similarity=0.329 Sum_probs=151.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+|+|++++++++.. ...++|+ ||+.+|+|.+++.... .+. .+..++.|++.||+|||++|++||||||+||+++.
T Consensus 67 ~h~~i~~~~~~~~~-~~~~~v~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~ 144 (279)
T cd05057 67 DHPHVVRLLGICLS-SQVQLIT-QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKT 144 (279)
T ss_pred CCCCcceEEEEEec-CceEEEE-ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcC
Confidence 68999999999987 7889999 7999999999997743 333 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCC---CcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||+++.......... ..++..|+|||.+....++.+ +|+||+||++|++++ |+.||.+.....
T Consensus 145 ~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-- 219 (279)
T cd05057 145 PQ--HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVE-- 219 (279)
T ss_pred CC--eEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHH--
Confidence 54 499999999976543222111 223567999999876666555 999999999999998 999998765432
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+.+.+.. ....+.+...+..+.+++.+||..+|.+||++.++++
T Consensus 220 --~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 220 --IPDLLEK-GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred --HHHHHhC-CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2222222 2223334447899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=234.00 Aligned_cols=192 Identities=16% Similarity=0.169 Sum_probs=142.4
Q ss_pred CCcchhhhhceeeece----eEEEeehhhccCchhHHHHHHcCC--HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMK----FVFLSLSFFFSLCLFFMWLLLLGL--LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~----~~~lv~~ey~~gg~L~~~l~~~~~--~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|.+++++++.+.... ..|+++ +++.. ++...+..... ...++.++.|++.||.|||+++++||||||+|||
T Consensus 81 ~h~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil 158 (294)
T PHA02882 81 DHLGIPKYYGCGSFKRCRMYYRFILL-EKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM 158 (294)
T ss_pred CCCCCCcEEEeeeEecCCceEEEEEE-ehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 5778888888766543 456777 45543 55555554432 2378899999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC--------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
++.++ .++|+|||+|+...... ......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+
T Consensus 159 l~~~~--~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 159 VDGNN--RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred EcCCC--cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCc
Confidence 97654 59999999997543211 1123469999999999988777554 9999999999999999999987
Q ss_pred CCchHHHHH-----HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 152 PDEPKDFRK-----TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 152 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
......+.. .+.++....... ...++.+.++++.|+..+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 236 FGHNGNLIHAAKCDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred cccchHHHHHhHHHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 743222211 122222222222 236799999999999999999999999876
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=232.54 Aligned_cols=191 Identities=21% Similarity=0.332 Sum_probs=150.3
Q ss_pred CCcchhhhhceeee-ceeEEEeehhhccCchhHHHHHHcC--------CHH--HHHHHHHHHHHHHHHHHHcCCeecCCC
Q 022732 6 SSSSEYAMLGVSVK-MKFVFLSLSFFFSLCLFFMWLLLLG--------LLV--QARFFFQQLISGVSYCHAMQVCHRDLK 74 (293)
Q Consensus 6 ~~~~~v~~~~~~~~-~~~~~lv~~ey~~gg~L~~~l~~~~--------~~~--~~~~~~~qil~~l~~LH~~~iiHrdlk 74 (293)
+|+|++++++++.. ....++++ +|+.+++|..++.... .+. .+..++.|++.||+|||+++++|||||
T Consensus 66 ~h~ni~~~~~~~~~~~~~~~~~~-~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~ 144 (280)
T cd05043 66 SHQNILPILHVCIEDGEPPFVLY-PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIA 144 (280)
T ss_pred CCCCCCeEEEEEecCCCCCEEEE-EcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 79999999998776 46667777 7999999999997642 233 889999999999999999999999999
Q ss_pred CCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCC
Q 022732 75 LENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFE 150 (293)
Q Consensus 75 p~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~ 150 (293)
|+||+++.+. .+||+|||+++....... .....++..|+|||++.+..++.+ +||||+||++|++++ |+.||.
T Consensus 145 p~nil~~~~~--~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 145 ARNCVIDEEL--QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred HhhEEEcCCC--cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcC
Confidence 9999997654 599999999975432211 122345678999999877776555 999999999999999 999998
Q ss_pred CCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 151 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
...... + ...+. .....+....++.++.+++.+||..+|++|||+.++++
T Consensus 222 ~~~~~~-~---~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 222 EIDPFE-M---AAYLK-DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCHHH-H---HHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 765422 2 22221 22333344457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=259.33 Aligned_cols=90 Identities=23% Similarity=0.297 Sum_probs=82.0
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
-.|+|++++++.+...+++|+|| ||+.|++|..++...+.+. .++.++.||+.||.|||.+||+||||||+|||++.
T Consensus 61 l~hp~Iv~~~~~~~~~~~~~lVm-Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~ 139 (669)
T cd05610 61 SKSPFIVHLYYSLQSANNVYLVM-EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN 139 (669)
T ss_pred cCCCCcCeEEEEEEECCEEEEEE-eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC
Confidence 36899999999999999999999 7999999999998776655 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCc
Q 022732 83 SPAPRLKICDFGYSK 97 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~ 97 (293)
++ ++||+|||+++
T Consensus 140 ~g--~vkL~DFGls~ 152 (669)
T cd05610 140 EG--HIKLTDFGLSK 152 (669)
T ss_pred CC--CEEEEeCCCCc
Confidence 54 59999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=224.29 Aligned_cols=197 Identities=35% Similarity=0.542 Sum_probs=162.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCH--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLL--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.++|++++++++......++++ ||+.+++|.+++.....+ ..+..++.+++.++.|||+.+++|+||+|.||+++.+
T Consensus 45 ~~~~i~~~~~~~~~~~~~~l~~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~ 123 (244)
T smart00220 45 KHPNIVRLYDVFEDEDKLYLVM-EYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED 123 (244)
T ss_pred CCCcHHHHHhheeeCCEEEEEE-eCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC
Confidence 7899999999999999999999 799999999999876633 3899999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .++|+|||.+.............++..|+|||.+.+..++. ++|+||+|++++++++|..||.......... .
T Consensus 124 ~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~---~ 197 (244)
T smart00220 124 G--HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELF---K 197 (244)
T ss_pred C--cEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---H
Confidence 4 59999999998655444455667899999999987766655 5999999999999999999998744333222 2
Q ss_pred HHhccccCCCCCCC-CCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 164 RILSVQYSVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 164 ~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.............. ++.++.+++.+||..+|++||++.++++||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 198 KIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 22222222222222 78999999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=228.63 Aligned_cols=190 Identities=22% Similarity=0.310 Sum_probs=150.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++.. ...|+|| ||+.+++|.+++.+.. .+. .+..++.|++.||.|||++|++||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~~-~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~ 136 (260)
T cd05073 59 QHDKLVKLHAVVTK-EPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 136 (260)
T ss_pred CCCCcceEEEEEcC-CCeEEEE-EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc
Confidence 48899999999988 7788999 7999999999997743 222 7888999999999999999999999999999996
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
..+ .+||+|||.+........ .....++..|+|||++.+..++.+ +|+||+||++|++++ |..||.+.+.....
T Consensus 137 ~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~ 213 (260)
T cd05073 137 ASL--VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213 (260)
T ss_pred CCC--cEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 654 599999999875432211 122345677999999877666544 999999999999998 89999876553332
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..+ ......+.....+.++.+++.+||.++|++||++.+++.
T Consensus 214 ~~~-----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 214 RAL-----ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHH-----hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 221 122233344558899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=269.51 Aligned_cols=195 Identities=14% Similarity=0.187 Sum_probs=141.8
Q ss_pred cchhhhhcee-------eeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 8 SSEYAMLGVS-------VKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 8 ~~~v~~~~~~-------~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.|+.+++++| .....+++++ ||. +++|.++|.... .+. +++.++.||+.||.|||++||+||||||+|
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~N 110 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRAL-ECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSC 110 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhh-ccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchh
Confidence 4777888888 3334555556 555 669999997543 344 999999999999999999999999999999
Q ss_pred EEEcC-----------------CCCCCEEEecCCCCcCcCCC-----------------CCCCCCcCCCCccchhhhccc
Q 022732 78 TLLDG-----------------SPAPRLKICDFGYSKSSVLH-----------------SQPKSTVGTPAYIAPEVLLRH 123 (293)
Q Consensus 78 Il~~~-----------------~~~~~vkl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~ 123 (293)
|||+. +..+.+|++|||+++..... .......||++|||||++.+.
T Consensus 111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 190 (793)
T PLN00181 111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS 190 (793)
T ss_pred EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC
Confidence 99953 22335788888887642110 001124589999999999888
Q ss_pred cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHH
Q 022732 124 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 203 (293)
Q Consensus 124 ~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el 203 (293)
.+..+ +||||+||++|||++|..|+.... ..+..+...... +..........+++.+||.++|.+||++.++
T Consensus 191 ~~~~~-sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 191 SSNCA-SDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLP-----PQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred CCCch-hhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcC-----hhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 88555 999999999999999988875422 111122111111 1111124567899999999999999999999
Q ss_pred HcCcccccC
Q 022732 204 MKHQWFLKN 212 (293)
Q Consensus 204 l~h~~~~~~ 212 (293)
++||||...
T Consensus 263 l~h~~~~~~ 271 (793)
T PLN00181 263 LQSEFINEP 271 (793)
T ss_pred hhchhhhhh
Confidence 999999753
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=231.63 Aligned_cols=197 Identities=21% Similarity=0.284 Sum_probs=147.6
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++.. ....|+|+ ||+.+++|.+++...+ .+. .+..++.|++.||.|||++|++||||||+||++
T Consensus 63 ~h~~iv~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili 141 (284)
T cd05081 63 QHDNIVKYKGVCYSAGRRNLRLVM-EYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV 141 (284)
T ss_pred CCCCeeEEEEEEccCCCCceEEEE-EecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE
Confidence 58999999997643 35688999 7999999999997643 333 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCC----CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
+.++ ++||+|||+++........ ....++..|+|||++.+..++. ++|+||+||++|+|++|..++.......
T Consensus 142 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~~~~~~~~~ 218 (284)
T cd05081 142 ESEN--RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYSDKSCSPPAEF 218 (284)
T ss_pred CCCC--eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcCh-HHHHHHHHHHHHHHhhcCCcCCCcchhh
Confidence 7654 5999999998854322211 1122345699999987766654 4999999999999999877764432110
Q ss_pred -----------HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 157 -----------DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 157 -----------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
................+....++.++.+++.+||..+|++|||+.++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 219 MRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00000111222233344455688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=232.75 Aligned_cols=196 Identities=23% Similarity=0.333 Sum_probs=152.4
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++.. ....|+|| ||+.+++|.+++.... .+. .+..++.|++.||+|||++|++||||||+||++
T Consensus 64 ~~~~i~~~~~~~~~~~~~~~~lv~-e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~ 142 (284)
T cd05038 64 DHENIVKYKGVCEKPGGRSLRLIM-EYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV 142 (284)
T ss_pred CCCChheEEeeeecCCCCceEEEE-ecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE
Confidence 68899999999987 67899999 7999999999997755 233 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCC----CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
+.++ .++|+|||.+......... ....++..|+|||.+.+..+..+ +|+||+||++|+|++|..||.......
T Consensus 143 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~ 219 (284)
T cd05038 143 ESED--LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEF 219 (284)
T ss_pred cCCC--CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchh
Confidence 7654 5999999999765422111 12234567999999877766545 899999999999999999986643211
Q ss_pred ----------HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 157 ----------DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 157 ----------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
................+.+..++.++.+++.+||.++|.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 220 LRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0011122222233334444557789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=246.47 Aligned_cols=190 Identities=20% Similarity=0.313 Sum_probs=149.1
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
|-|++-|+|++....+ .+|.. +|+|.+|+.+|.-.. ++. ..+.|++||++|+.|||.++|||||||..|||+..+
T Consensus 447 H~NIlLFMG~~~~p~~-AIiTq-wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~ 524 (678)
T KOG0193|consen 447 HENILLFMGACMNPPL-AIITQ-WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED 524 (678)
T ss_pred hhhheeeehhhcCCce-eeeeh-hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC
Confidence 6799999999999998 77774 999999999995432 344 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhcc---ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 84 PAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
. +|||+|||++...... .......|+..|||||++.. .+| ++.+||||+|||+|||+||..||. .+..++
T Consensus 525 ~--kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPys-i~~~dq 600 (678)
T KOG0193|consen 525 L--KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYS-IQNRDQ 600 (678)
T ss_pred C--cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcC-CCChhh
Confidence 4 5999999998743322 22344568999999999864 344 445999999999999999999999 444343
Q ss_pred HHHHHHHHhcccc---CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 158 FRKTIQRILSVQY---SVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 158 ~~~~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+.. .+..+.. ........++++++|+..||..++++||.+.++|.
T Consensus 601 Iif---mVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 601 IIF---MVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred eEE---EecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 222 1111211 11122346689999999999999999999999887
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=254.74 Aligned_cols=195 Identities=26% Similarity=0.381 Sum_probs=155.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH-----HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV-----QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~-----~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+|++|+.=.+..+.|+.+ |.|.. +|.+++... .... ..+.++.|++.||++||+.+||||||||.|||
T Consensus 561 ~H~NviRyyc~E~d~qF~YIal-ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNIL 638 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIAL-ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNIL 638 (903)
T ss_pred CCCceEEEEeeccCCceEEEEe-hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEE
Confidence 5899999999999999999999 68875 999999874 1122 56899999999999999999999999999999
Q ss_pred EcC---CCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhC-CCCCCC
Q 022732 80 LDG---SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFED 151 (293)
Q Consensus 80 ~~~---~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g-~~pf~~ 151 (293)
|.. .+..+++|+|||++++...... .....||-.|+|||++....... ++||+|+|||+|+.++| ..||.+
T Consensus 639 I~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 639 ISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred EEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCc
Confidence 986 3445789999999997654433 34456999999999998766544 59999999999999986 899987
Q ss_pred CCchHHHHHHHHHHhccccCCCC-CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 152 PDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.-..+ .+ ++...+..-. ......++.+||.+||.++|..||++.++|.||||
T Consensus 718 ~~~R~--~N----Il~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 718 SLERQ--AN----ILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred hHHhh--hh----hhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 54322 22 3333322111 00011289999999999999999999999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=248.29 Aligned_cols=193 Identities=17% Similarity=0.218 Sum_probs=136.6
Q ss_pred eeceeEEEeehhhccCchhHHHHHHcCCH----------------------HHHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 022732 18 VKMKFVFLSLSFFFSLCLFFMWLLLLGLL----------------------VQARFFFQQLISGVSYCHAMQVCHRDLKL 75 (293)
Q Consensus 18 ~~~~~~~lv~~ey~~gg~L~~~l~~~~~~----------------------~~~~~~~~qil~~l~~LH~~~iiHrdlkp 75 (293)
......++|+ ||+.+++|.+++...... ..+..++.||+.||.|||++||+||||||
T Consensus 205 ~~~~~~~LV~-ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 205 KKEDEYWLVW-RYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred ccCCceEEEE-EecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 4567789999 799999999999764311 14668999999999999999999999999
Q ss_pred CcEEEcCCCCCCEEEecCCCCcCcCC--CCCCCCCcCCCCccchhhhccccCC---------------------Cchhhh
Q 022732 76 ENTLLDGSPAPRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLLRHEYD---------------------GKIADV 132 (293)
Q Consensus 76 ~NIl~~~~~~~~vkl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~Dv 132 (293)
+|||++... +.+||+|||+|+.... .......++++.|+|||.+...... ..++||
T Consensus 284 ~NILl~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 999997532 3599999999975322 2233456799999999976432211 123699
Q ss_pred hhhhhHHHHHHhCCCCCCCCCchHHHHHHHHH----------HhccccC------CCCCCCCCHHHHHHHHHccccCCCC
Q 022732 133 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR----------ILSVQYS------VPDTNPISQECRDLISRIFVADPAA 196 (293)
Q Consensus 133 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~ 196 (293)
||+||++|+|+++..++.. ....+...+.. ....... +......+..+.+||.+||++||.+
T Consensus 363 wSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999997665432 22222222211 0000000 0001112345669999999999999
Q ss_pred CCCHHHHHcCcccccCCC
Q 022732 197 RITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 197 Rpt~~ell~h~~~~~~~~ 214 (293)
|||+.++|+||||.....
T Consensus 441 R~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 441 RISAKAALAHPYFDREGL 458 (566)
T ss_pred CCCHHHHhCCcCcCCCCc
Confidence 999999999999986543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=233.82 Aligned_cols=206 Identities=23% Similarity=0.312 Sum_probs=165.9
Q ss_pred CCcchhhhhceeeec-eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKM-KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAM--QVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~-~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~--~iiHrdlkp~NIl~ 80 (293)
+|+-+||+|++|.-. +..|-|+ |||+|-+|.-||+....++ +|+.|+.||+.||.||... -|||-||||.|||+
T Consensus 525 DHpRIVKlYDyfslDtdsFCTVL-EYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 525 DHPRIVKLYDYFSLDTDSFCTVL-EYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL 603 (775)
T ss_pred Ccceeeeeeeeeeeccccceeee-eecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence 688899999999755 5667777 8999999999999998888 9999999999999999976 49999999999998
Q ss_pred cCC-CCCCEEEecCCCCcCcCCCCC--------CCCCcCCCCccchhhhccc---cCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 81 DGS-PAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 81 ~~~-~~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~el~~g~~p 148 (293)
-.. ..|.+||+|||+++.+..... .....||.||.+||.+.-. +.-+.++||||+|||+|..+.|+.|
T Consensus 604 v~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKP 683 (775)
T KOG1151|consen 604 VNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKP 683 (775)
T ss_pred ecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCC
Confidence 543 356799999999987643322 2335699999999987532 2224459999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
|........+...-.-+......+|..+.+|+++++||++||.+.-+.|..+.++-.||+|...
T Consensus 684 FGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 684 FGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred CCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 9876554333222111233445567667799999999999999999999999999999999754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=256.87 Aligned_cols=191 Identities=20% Similarity=0.307 Sum_probs=158.4
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc------CC---HHHHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL------GL---LVQARFFFQQLISGVSYCHAMQVCHRDLKL 75 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~------~~---~~~~~~~~~qil~~l~~LH~~~iiHrdlkp 75 (293)
..|+|+|+++|++.+....++++ ||++||+|.++|++. .. +.....++.+|++|+.||+++++|||||-.
T Consensus 752 f~HpNiv~liGv~l~~~~~~i~l-eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAa 830 (1025)
T KOG1095|consen 752 FDHPNIVSLIGVCLDSGPPLILL-EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAA 830 (1025)
T ss_pred CCCcceeeEEEeecCCCCcEEEe-hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhh
Confidence 57999999999999988888888 899999999999987 22 128899999999999999999999999999
Q ss_pred CcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCC----cCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCC
Q 022732 76 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFE 150 (293)
Q Consensus 76 ~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~----~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~ 150 (293)
.|+|++.. ..+||+|||+|+.+.. ...+.. .-...|||||.+....++++ +|||||||++||++| |..||.
T Consensus 831 RNCLL~~~--r~VKIaDFGlArDiy~-~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 831 RNCLLDER--RVVKIADFGLARDIYD-KDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred hheeeccc--CcEEEcccchhHhhhh-chheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCC
Confidence 99999766 4599999999993211 111111 22358999999988777777 999999999999998 889999
Q ss_pred CCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 151 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+..+.+.+ ..++... +++.+..++..+.+++..||..+|++||++..+++
T Consensus 907 ~~~n~~v~----~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 907 SRSNFEVL----LDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CcchHHHH----HHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 88774433 2233333 66777779999999999999999999999999887
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=248.61 Aligned_cols=199 Identities=24% Similarity=0.344 Sum_probs=164.8
Q ss_pred CCCcchhhhhceeee-----ceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 022732 5 GSSSSEYAMLGVSVK-----MKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKL 75 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~-----~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp 75 (293)
-.|+|.+.+||+|-. .+.+-||| |||.||+.-++++.. .++. .+..+++.++.||.+||.+.++|||||-
T Consensus 73 ~~hpnv~~fyg~~~k~~~~~~DqLWLVM-EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG 151 (953)
T KOG0587|consen 73 SHHPNVATFYGAFIKKDPGNGDQLWLVM-EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKG 151 (953)
T ss_pred cCCCCcceEEEEEEEecCCCCCeEEEEe-eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccC
Confidence 468999999999964 47899999 799999999999765 3444 7889999999999999999999999999
Q ss_pred CcEEEcCCCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhcc-----ccCCCchhhhhhhhhHHHHHHhCCCCC
Q 022732 76 ENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPF 149 (293)
Q Consensus 76 ~NIl~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~pf 149 (293)
.|||++.++. |||+|||++.... .....++.+|||.|||||++.. ..|+.+ +|+||||++..||.-|.+|+
T Consensus 152 ~NiLLT~e~~--VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl 228 (953)
T KOG0587|consen 152 QNVLLTENAE--VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPL 228 (953)
T ss_pred ceEEEeccCc--EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCc
Confidence 9999987664 9999999987543 3345677899999999999864 344445 99999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 150 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
.+...... ++.-..+.......+..+++++.+||..||.+|..+||+..++|+|||++
T Consensus 229 ~DmHPmra---LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 229 CDMHPMRA---LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred cCcchhhh---hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 88766332 22222233333444567899999999999999999999999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=234.31 Aligned_cols=194 Identities=23% Similarity=0.276 Sum_probs=148.3
Q ss_pred CCcchhhhhceeeece-eEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcC---CeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVKMK-FVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQ---VCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~-~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~---iiHrdlkp~N 77 (293)
.|+|.|+++|+|.+.. +.+||. ||+..|+|.+.|.... .+. +..+|+.++++||+|||... ||||||||+|
T Consensus 129 ~H~Nlv~LlGyC~e~~~~~~LVY-Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 129 RHPNLVKLLGYCLEGGEHRLLVY-EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred CCcCcccEEEEEecCCceEEEEE-EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 4999999999999999 599999 7999999999998765 445 89999999999999999754 9999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCC-CCCCCCC-cCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCC--
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVL-HSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-- 153 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~-- 153 (293)
||+|.+.. .||+|||+|+.... .....+. .||..|+|||.+.....+.+ +||||+|+++.|++||+.+.....
T Consensus 208 ILLD~~~~--aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~ 284 (361)
T KOG1187|consen 208 ILLDEDFN--AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPR 284 (361)
T ss_pred eeECCCCC--EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCc
Confidence 99987665 89999999976543 3333333 89999999999877666555 999999999999999998877542
Q ss_pred chHHHHHH-HH--------HHhccccCCCCCCCCC-----HHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 154 EPKDFRKT-IQ--------RILSVQYSVPDTNPIS-----QECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 154 ~~~~~~~~-~~--------~~~~~~~~~~~~~~~s-----~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
....+... .. .++...... ...+ ..+..+..+|+..+|..||++.++++.
T Consensus 285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 285 GELSLVEWAKPLLEEGKLREIVDPRLKE---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred ccccHHHHHHHHHHCcchhheeCCCccC---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 11111111 11 111111110 1122 235677789999999999999997553
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=221.61 Aligned_cols=192 Identities=20% Similarity=0.368 Sum_probs=146.4
Q ss_pred CCcchhhhhceeeece------eEEEeehhhccCchhHHHHHHcC------CHH--HHHHHHHHHHHHHHHHHHcCCeec
Q 022732 6 SSSSEYAMLGVSVKMK------FVFLSLSFFFSLCLFFMWLLLLG------LLV--QARFFFQQLISGVSYCHAMQVCHR 71 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~------~~~lv~~ey~~gg~L~~~l~~~~------~~~--~~~~~~~qil~~l~~LH~~~iiHr 71 (293)
.|+|++++++++.... ..++++ +|+.+|+|..++.... .++ .+..++.|++.||+|||++|++||
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~ 137 (273)
T cd05074 59 DHPNVIKLIGVSLRSRAKGRLPIPMVIL-PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHR 137 (273)
T ss_pred CCCCcceEEEEEccCCCCCcccceEEEE-ecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence 5899999999886542 246777 7999999998875321 122 789999999999999999999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCC
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGY 147 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~ 147 (293)
||||+||+++.+. .+||+|||+++...... ......+++.|++||.+....++.+ +|+||+||++|+|++ |+.
T Consensus 138 dikp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 138 DLAARNCMLNENM--TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred ccchhhEEEcCCC--CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCC
Confidence 9999999996554 59999999987543221 1223345678999999877666554 999999999999999 889
Q ss_pred CCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 148 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
||.+...... ...+.... ..+.....+..+.+++.+||..+|.+|||+.++++.
T Consensus 215 p~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 215 PYAGVENSEI----YNYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCHHHH----HHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9977654322 22222211 122233477999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=209.18 Aligned_cols=204 Identities=23% Similarity=0.364 Sum_probs=162.0
Q ss_pred CCCCCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 3 PVGSSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
-+.|++|+|+++++..+. ...-+|+ ||+...+...+.. .+. .++.|+.+++.||.|+|+.||.|||+||.|+
T Consensus 88 nL~gg~NIi~L~DiV~Dp~SktpaLiF-E~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNv 163 (338)
T KOG0668|consen 88 NLRGGPNIIKLLDIVKDPESKTPSLIF-EYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNV 163 (338)
T ss_pred hccCCCCeeehhhhhcCccccCchhHh-hhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCccee
Confidence 357899999999999765 6777888 7999987766553 344 8999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC-CCCCchHH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEPKD 157 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~~~~~~~ 157 (293)
+|+.... .++|+|.|+|....+....+..+.+..|--||.+...+....+-|+||+||++..|+..+.|| .+.++.++
T Consensus 164 mIdh~~r-kLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ 242 (338)
T KOG0668|consen 164 MIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 242 (338)
T ss_pred eechhhc-eeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH
Confidence 9987543 699999999987766666677788899999999887665555589999999999999987775 55566666
Q ss_pred HHHHHHHHhcc---------cc-------------CCCC--------C-CCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 158 FRKTIQRILSV---------QY-------------SVPD--------T-NPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 158 ~~~~~~~~~~~---------~~-------------~~~~--------~-~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+.++.+-+... .. .... . .-+++++.+||.++|..|..+|+|+.|++.|
T Consensus 243 LVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 243 LVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 65554311100 00 0000 0 1256999999999999999999999999999
Q ss_pred ccccc
Q 022732 207 QWFLK 211 (293)
Q Consensus 207 ~~~~~ 211 (293)
|||..
T Consensus 323 pyF~~ 327 (338)
T KOG0668|consen 323 PYFAP 327 (338)
T ss_pred chHHH
Confidence 99964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=235.56 Aligned_cols=200 Identities=21% Similarity=0.214 Sum_probs=145.6
Q ss_pred chhhhhceeee--------ceeEEEeehhhccCchhHHHHHHcC--------------------------CHHHHHHHHH
Q 022732 9 SEYAMLGVSVK--------MKFVFLSLSFFFSLCLFFMWLLLLG--------------------------LLVQARFFFQ 54 (293)
Q Consensus 9 ~~v~~~~~~~~--------~~~~~lv~~ey~~gg~L~~~l~~~~--------------------------~~~~~~~~~~ 54 (293)
+.++++++|.. ....++|+ ||+.+++|.+++.... ....++.++.
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~-Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ 316 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVW-KFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMR 316 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEE-EcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHH
Confidence 34667777653 35689999 7999999999986421 1125788999
Q ss_pred HHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCC--CcCCCCccchhhhccccC-------
Q 022732 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVLLRHEY------- 125 (293)
Q Consensus 55 qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~------- 125 (293)
|++.||.|||+++++||||||+||+++.+. .+||+|||+++.......... ..+|+.|+|||++.....
T Consensus 317 ql~~aL~~lH~~~ivHrDLKp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~ 394 (507)
T PLN03224 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDG--QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAP 394 (507)
T ss_pred HHHHHHHHHHHCCeecCCCchHhEEECCCC--cEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchh
Confidence 999999999999999999999999997654 599999999975433222222 235889999998754221
Q ss_pred -------------C-CchhhhhhhhhHHHHHHhCCC-CCCCCCchHH-------HHHHHHHHhccccCCCCCCCCCHHHH
Q 022732 126 -------------D-GKIADVWSCGVTLYVMLVGGY-PFEDPDEPKD-------FRKTIQRILSVQYSVPDTNPISQECR 183 (293)
Q Consensus 126 -------------~-~~~~DvwslG~il~el~~g~~-pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~s~~~~ 183 (293)
. ....|+||+||++|+|++|.. ||.+...... ....+..+....+.++.....+..++
T Consensus 395 ~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~ 474 (507)
T PLN03224 395 AMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGW 474 (507)
T ss_pred hhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHH
Confidence 1 113699999999999999875 7754221110 01112223334445555566899999
Q ss_pred HHHHHccccCC---CCCCCHHHHHcCccccc
Q 022732 184 DLISRIFVADP---AARITIPEIMKHQWFLK 211 (293)
Q Consensus 184 ~li~~~L~~dp---~~Rpt~~ell~h~~~~~ 211 (293)
+|+.+||.++| .+|+|++++|+||||..
T Consensus 475 dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 475 DLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 99999999866 68999999999999964
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=246.74 Aligned_cols=180 Identities=27% Similarity=0.443 Sum_probs=140.6
Q ss_pred eeEEEeehhhccCchhHHHHHHcCCH--H-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 21 KFVFLSLSFFFSLCLFFMWLLLLGLL--V-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 21 ~~~~lv~~ey~~gg~L~~~l~~~~~~--~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
..+|+-| |||+..++..++..+... . .++++++||+.||.|+|++|+|||||||.|||++.+.. |||+|||+|+
T Consensus 669 ~~LYIQM-EyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~--VKIGDFGLAt 745 (1351)
T KOG1035|consen 669 LILYIQM-EYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS--VKIGDFGLAT 745 (1351)
T ss_pred eEEEEEH-hhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC--eeecccccch
Confidence 5566666 899999999999888775 3 99999999999999999999999999999999986654 9999999997
Q ss_pred CcC-------------------CCCCCCCCcCCCCccchhhhcccc---CCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 98 SSV-------------------LHSQPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 98 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
... .....+..+||..|+|||++.+.. |+.+ +|+||||+|++||+. ||...-+
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K-iDmYSLGIVlFEM~y---PF~TsME- 820 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK-IDMYSLGIVLFEMLY---PFGTSME- 820 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch-hhhHHHHHHHHHHhc---cCCchHH-
Confidence 511 011235568999999999997755 6655 999999999999985 4654322
Q ss_pred HHHHHHHHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 156 KDFRKTIQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
. ..++..+..+..+.+ .+.+--+.-..+|+.||+.||.+|||+.++|++.||-
T Consensus 821 -R-a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 821 -R-ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred -H-HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 2 344445544444444 0112235567899999999999999999999999985
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=239.25 Aligned_cols=195 Identities=23% Similarity=0.284 Sum_probs=151.5
Q ss_pred CCCCCCcchhhhhceeeece------eEEEeehhhccCchhHHHHHHcCCHH-----HHHHHHHHHHHHHHHHHHcCCee
Q 022732 2 HPVGSSSSEYAMLGVSVKMK------FVFLSLSFFFSLCLFFMWLLLLGLLV-----QARFFFQQLISGVSYCHAMQVCH 70 (293)
Q Consensus 2 ~~~~~~~~~v~~~~~~~~~~------~~~lv~~ey~~gg~L~~~l~~~~~~~-----~~~~~~~qil~~l~~LH~~~iiH 70 (293)
+-+. |+|+|+++++=++.. .-.+|| |||.||+|+..+++..+-. +.+.++..+..||.|||++||+|
T Consensus 66 kKLn-h~NIVk~f~iee~~~~~~~~~~~vlvm-EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvH 143 (732)
T KOG4250|consen 66 KKLN-HPNIVKLFDIEETKFLGLVTRLPVLVM-EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVH 143 (732)
T ss_pred HHcC-chhhhhhcccCCccccCcccccceEEE-eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCcee
Confidence 3456 999999999887655 567778 7999999999998765432 89999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCC--CEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 71 RDLKLENTLLDGSPAP--RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 71 rdlkp~NIl~~~~~~~--~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p 148 (293)
|||||.||++-....| ..||+|||.|+....+....+.+||+.|.+||+....++++.-+|.||+||++|+.+||..|
T Consensus 144 RDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 144 RDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred ccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 9999999998655434 35999999999988888889999999999999998534444449999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhccc-------------------cCCCCCCCCCHH----HHHHHHHccccCCCCCC
Q 022732 149 FEDPDEPKDFRKTIQRILSVQ-------------------YSVPDTNPISQE----CRDLISRIFVADPAARI 198 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~s~~----~~~li~~~L~~dp~~Rp 198 (293)
|.....+.....+...+.... ..+|.+..+++. +-.++..+|..+|++|-
T Consensus 224 F~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 224 FIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 977655543222222221111 223444344433 45677888899999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=233.88 Aligned_cols=189 Identities=20% Similarity=0.322 Sum_probs=158.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+|+++|+++|+|.+. .+.+|| |.+..|.|.+||+.++ .++ ....|..||+.||.|||++++|||||-..|||+..
T Consensus 449 dHphIikLIGv~~e~-P~Wivm-EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS 526 (974)
T KOG4257|consen 449 DHPHIIKLIGVCVEQ-PMWIVM-ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS 526 (974)
T ss_pred CCcchhheeeeeecc-ceeEEE-ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC
Confidence 699999999999865 567788 7999999999998775 344 77889999999999999999999999999999986
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCc--CCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
... |||+|||+++......-..... -.+.|||||-++...++.. +|||.|||++||++. |..||.+..+.+.+.
T Consensus 527 p~C--VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~ 603 (974)
T KOG4257|consen 527 PQC--VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIG 603 (974)
T ss_pred cce--eeecccchhhhccccchhhccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEE
Confidence 655 9999999999765444333333 3568999999988887666 999999999999986 899999988766554
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 204 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 204 (293)
.+ ....+.|.+..+++.+..++.+||.++|.+||++.++.
T Consensus 604 ~i-----EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 604 HI-----ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred Ee-----cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 32 23456777788999999999999999999999987654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=217.68 Aligned_cols=198 Identities=20% Similarity=0.336 Sum_probs=150.9
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHH-----HHcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcE
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWL-----LLLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENT 78 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l-----~~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NI 78 (293)
-+|+|+|||..-.+.-..+.| |++.- +|..+. .++..++ -.-.+....+.||.||-. .+|||||+||+||
T Consensus 122 cp~IVkfyGa~F~EGdcWiCM-ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNI 199 (361)
T KOG1006|consen 122 CPNIVKFYGALFSEGDCWICM-ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNI 199 (361)
T ss_pred CcHHHHHhhhhhcCCceeeeH-HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhhe
Confidence 478999999999998888998 56553 443333 1223344 455667778999999985 5899999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc--ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
|++..+. |||||||++.........+...|-..|||||.+.. .+|+-+ +|+||||+++||+.||..|+.+-++
T Consensus 200 Lldr~G~--vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s-- 274 (361)
T KOG1006|consen 200 LLDRHGD--VKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS-- 274 (361)
T ss_pred EEecCCC--EeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH--
Confidence 9988776 99999999876544444455678999999999853 456666 9999999999999999999986433
Q ss_pred HHHHHHHHHhccccCCC----CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 157 DFRKTIQRILSVQYSVP----DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
....+..+..+.+..- ....+|..++.||..||.+|-+.||+..+++++||++..
T Consensus 275 -vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 275 -VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred -HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 2333333333333211 123488999999999999999999999999999999754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=205.81 Aligned_cols=162 Identities=22% Similarity=0.229 Sum_probs=122.7
Q ss_pred chhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcC
Q 022732 34 CLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 110 (293)
Q Consensus 34 g~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 110 (293)
|+|.+++...+ .++ +++.++.|++.||.|||+++ ||+|||++.++ .+|+ ||+++.... ....|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~--~~~~--fG~~~~~~~----~~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG--LLKL--DGSVAFKTP----EQSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc--ceee--ccceEeecc----ccCCC
Confidence 68999998744 355 99999999999999999998 99999997654 4888 999875432 12368
Q ss_pred CCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH-HHHHHHHHhccccC-CCCCCCCCH--HHHHHH
Q 022732 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSVQYS-VPDTNPISQ--ECRDLI 186 (293)
Q Consensus 111 t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~s~--~~~~li 186 (293)
|+.|||||++.+..++.+ +||||+||++|+|++|+.||........ +............. .+....++. .++++|
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 999999999988887655 9999999999999999999976544322 22222222111100 011112333 699999
Q ss_pred HHccccCCCCCCCHHHHHcCcccc
Q 022732 187 SRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 187 ~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
.+||..+|.+||++.++++|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=226.79 Aligned_cols=189 Identities=22% Similarity=0.325 Sum_probs=161.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH----HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV----QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~----~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
-|+|.|+++|+|..+...|+|+ ||+..|+|.+||+...+-. .....+.||..|+.||..+++|||||-..|+|+.
T Consensus 321 kHpNLVqLLGVCT~EpPFYIiT-EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg 399 (1157)
T KOG4278|consen 321 KHPNLVQLLGVCTHEPPFYIIT-EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 399 (1157)
T ss_pred cCccHHHHhhhhccCCCeEEEE-ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc
Confidence 3899999999999999999999 7999999999999876544 6678889999999999999999999999999996
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcC---CCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVG---TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
.+. .||++|||+++.+.. ...+...| .+.|.|||-+....+..+ +|||+|||++||+.| |-.||.+.+-
T Consensus 400 Enh--iVKvADFGLsRlMtg-DTYTAHAGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidl--- 472 (1157)
T KOG4278|consen 400 ENH--IVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDL--- 472 (1157)
T ss_pred ccc--eEEeeccchhhhhcC-CceecccCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccH---
Confidence 554 589999999997643 22222233 567999999888887777 999999999999998 7889988763
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 204 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 204 (293)
..+..++...+++..+..+++...+|++.||+++|..||+++++-
T Consensus 473 --SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 473 --SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred --HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 344556677788888888999999999999999999999998864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=237.27 Aligned_cols=197 Identities=24% Similarity=0.426 Sum_probs=162.5
Q ss_pred CCCCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHH
Q 022732 1 MHPVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSY 62 (293)
Q Consensus 1 ~~~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~ 62 (293)
|+.+|.|+|++.++|.+.+...+++|+ ||+..|+|..++++.+ .+. ....++.||+.|++|
T Consensus 355 m~~~g~H~niv~llG~~t~~~~~~~v~-Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~ 433 (609)
T KOG0200|consen 355 LKELGKHPNIVNLLGACTQDGPLYVIV-EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEY 433 (609)
T ss_pred HHHhcCCcchhhheeeeccCCceEEEE-EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHH
Confidence 678999999999999999999999999 7999999999999887 133 889999999999999
Q ss_pred HHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCC--CCcC--CCCccchhhhccccCCCchhhhhhhhhH
Q 022732 63 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVG--TPAYIAPEVLLRHEYDGKIADVWSCGVT 138 (293)
Q Consensus 63 LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~DvwslG~i 138 (293)
|++++++||||-..|||++.+. .+||+|||+|+......... ...| ...|||||.+....++.+ +||||+|++
T Consensus 434 L~~~~~vHRDLAaRNVLi~~~~--~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~ 510 (609)
T KOG0200|consen 434 LASVPCVHRDLAARNVLITKNK--VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGIL 510 (609)
T ss_pred HhhCCccchhhhhhhEEecCCC--EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHH
Confidence 9999999999999999997765 49999999998543322221 1222 345999999988777766 899999999
Q ss_pred HHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 139 LYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 139 l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+||+++ |..|+.+......+ ++ .+....+...+..++.++.++++.||+.+|.+||++.++..
T Consensus 511 L~EifsLG~~PYp~~~~~~~l---~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 511 LWEIFTLGGTPYPGIPPTEEL---LE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHhhCCCCCCCCCCcHHHH---HH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 999998 78999874422222 22 33455566666678999999999999999999999998876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=213.08 Aligned_cols=202 Identities=23% Similarity=0.415 Sum_probs=153.0
Q ss_pred Ccchhhhhceeeec-----eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 7 SSSEYAMLGVSVKM-----KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 7 ~~~~v~~~~~~~~~-----~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
|.|.+..+++-+-. ..+|+|+ |.+. .+|...|.+.+.+. .++-++.||++||+|||+.||.||||||.|+|
T Consensus 111 HdNVLSaLDILQPph~dfFqEiYV~T-ELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLL 188 (449)
T KOG0664|consen 111 HDNVLSLLDILQPANPSFFQELYVLT-ELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLL 188 (449)
T ss_pred cccHHHHHHhcCCCCchHHHHHHHHH-HHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEE
Confidence 55666666654432 3466666 4554 47888888888777 89999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
++.+ ..+||||||+|+....... .+..+-|-.|+|||++.|...++.++||||+|||+.||+..+..|...+...+
T Consensus 189 VNSN--CvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ 266 (449)
T KOG0664|consen 189 VNSN--CILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ 266 (449)
T ss_pred eccC--ceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH
Confidence 9654 4599999999986443322 23345788999999999977777779999999999999999999988877666
Q ss_pred HHHHHHH-------------------HhccccCCCCC---------CCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 158 FRKTIQR-------------------ILSVQYSVPDT---------NPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 158 ~~~~~~~-------------------~~~~~~~~~~~---------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+.-+..- ++......|.. ..-..+...++.++|..+|++|++..+++.|++.
T Consensus 267 L~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 267 LQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 5444432 22222222221 1123567889999999999999999999999987
Q ss_pred ccC
Q 022732 210 LKN 212 (293)
Q Consensus 210 ~~~ 212 (293)
.+.
T Consensus 347 ~e~ 349 (449)
T KOG0664|consen 347 EEG 349 (449)
T ss_pred ccc
Confidence 543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=218.11 Aligned_cols=207 Identities=25% Similarity=0.404 Sum_probs=158.5
Q ss_pred CCCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 2 HPVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 2 ~~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
..+||+.|++++.+.+...+++.+|+ ||++-....++...-+ +.+++.|++.++.||.++|.+|||||||||.|+|.+
T Consensus 89 ~~~gG~~ni~~~~~~~rnnd~v~ivl-p~~~H~~f~~l~~~l~-~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n 166 (418)
T KOG1167|consen 89 YRLGGSDNIIKLNGCFRNNDQVAIVL-PYFEHDRFRDLYRSLS-LAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN 166 (418)
T ss_pred HHhccchhhhcchhhhccCCeeEEEe-cccCccCHHHHHhcCC-HHHHHHHHHHHHHHhhhhhccCccccCCCccccccc
Confidence 45799999999999999999999999 7999999998887655 779999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCc-----------------CC-C----------C---C--------------CCCCcCCCCccc
Q 022732 82 GSPAPRLKICDFGYSKSS-----------------VL-H----------S---Q--------------PKSTVGTPAYIA 116 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~-----------------~~-~----------~---~--------------~~~~~gt~~y~a 116 (293)
... ++-.|.|||+|... .. . . . .....||+.|+|
T Consensus 167 ~~t-~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRa 245 (418)
T KOG1167|consen 167 RRT-QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRA 245 (418)
T ss_pred ccc-CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCc
Confidence 543 46789999998610 00 0 0 0 012359999999
Q ss_pred hhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc-hHHHHHHHH--------HH--hccc----------------
Q 022732 117 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-PKDFRKTIQ--------RI--LSVQ---------------- 169 (293)
Q Consensus 117 PE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~--------~~--~~~~---------------- 169 (293)
||++.+-+-.+.++||||.|+|+.-+++++.||..... ...+..+.. +. ..+.
T Consensus 246 PEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~ 325 (418)
T KOG1167|consen 246 PEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELR 325 (418)
T ss_pred hHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHH
Confidence 99998876666679999999999999999999865432 111111110 00 0000
Q ss_pred -----------cC-------CCCC-CCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 170 -----------YS-------VPDT-NPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 170 -----------~~-------~~~~-~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.. ...+ .-.+..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 326 ~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 326 VNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred hchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00 0000 113457899999999999999999999999999973
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=233.09 Aligned_cols=192 Identities=22% Similarity=0.336 Sum_probs=165.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+|+|+|++-|.....+.+++|. ||++.|+|.++|+++ +++. |....++.|+.|++||-..|.|||||-+.|||++.
T Consensus 688 dHPNIIrLEGVVTks~PvMIiT-EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs 766 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIIT-EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS 766 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEh-hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc
Confidence 7999999999999999999999 799999999999876 5666 99999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC-CCCCCcC---CCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS-QPKSTVG---TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~-~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
+- .+|++|||+++...... ...+..| ...|.|||.|...++++. +||||+|++|||.++ |..||.+.++.+.
T Consensus 767 nL--vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 767 NL--VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred ce--EEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHH
Confidence 54 48999999998653332 2233332 368999999998888766 999999999999775 9999999888777
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+..+. ..+++|.+..++..+..|+..||++|-.+||++.+++.+
T Consensus 844 IkaIe-----~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 844 IKAIE-----QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHH-----hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 66554 456788888899999999999999999999999998764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=216.15 Aligned_cols=202 Identities=26% Similarity=0.377 Sum_probs=151.0
Q ss_pred CCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcC----CHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLG----LLVQARFFFQQLISGVSYCHA-MQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~----~~~~~~~~~~qil~~l~~LH~-~~iiHrdlkp~ 76 (293)
+-+.+|+++++|.. ..|+|||++ +.|.+|..+|+... ++..++.|++||+.||.|||. .||||-||||+
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfE--vLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPE 217 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFE--VLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPE 217 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEeh--hhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcc
Confidence 45678999999974 489999995 56789999998764 344999999999999999995 69999999999
Q ss_pred cEEEc---------------------------------------------------------------------------
Q 022732 77 NTLLD--------------------------------------------------------------------------- 81 (293)
Q Consensus 77 NIl~~--------------------------------------------------------------------------- 81 (293)
|||+.
T Consensus 218 NvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~ 297 (590)
T KOG1290|consen 218 NVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEE 297 (590)
T ss_pred eeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 99992
Q ss_pred ---------------------------------------CC---------------------------CC----------
Q 022732 82 ---------------------------------------GS---------------------------PA---------- 85 (293)
Q Consensus 82 ---------------------------------------~~---------------------------~~---------- 85 (293)
.+ ..
T Consensus 298 ~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n 377 (590)
T KOG1290|consen 298 PNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASN 377 (590)
T ss_pred ccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccc
Confidence 00 00
Q ss_pred -------------CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 86 -------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 86 -------------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
-++||+|||-|.+. ....+.-+.|..|+|||++.|.+|... +||||++|++|||+||...|.-.
T Consensus 378 ~~v~p~~~~~~~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePh 454 (590)
T KOG1290|consen 378 PLVNPDIPLPECDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPH 454 (590)
T ss_pred cccCCCCCCCccceeEEEeeccchhhh--hhhhchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCC
Confidence 03678888887753 344456678999999999999999877 89999999999999999988543
Q ss_pred C------chHHHHHHHHHH--------hccccC---------------CCCC-------------CCCCHHHHHHHHHcc
Q 022732 153 D------EPKDFRKTIQRI--------LSVQYS---------------VPDT-------------NPISQECRDLISRIF 190 (293)
Q Consensus 153 ~------~~~~~~~~~~~~--------~~~~~~---------------~~~~-------------~~~s~~~~~li~~~L 190 (293)
+ +.+.+..++.-+ +.+.+. +..| ..-..++.+||.-||
T Consensus 455 sG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmL 534 (590)
T KOG1290|consen 455 SGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPML 534 (590)
T ss_pred CCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHH
Confidence 2 112222222211 111110 0000 012367889999999
Q ss_pred ccCCCCCCCHHHHHcCcccccC
Q 022732 191 VADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 191 ~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+.+|.+|||+.++|+|||+...
T Consensus 535 ef~PeKR~tA~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 535 EFDPEKRPTAAQCLKHPWLNPV 556 (590)
T ss_pred hcCccccccHHHHhcCccccCC
Confidence 9999999999999999999754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=224.66 Aligned_cols=193 Identities=22% Similarity=0.330 Sum_probs=160.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|.|++||+..+ ..+.||+ |++.+|+|.+.|.+. ..+. ....|+.||+.|+.||.++++|||||-..|+|+.
T Consensus 169 ~H~hliRLyGvVl~-qp~mMV~-ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla 246 (1039)
T KOG0199|consen 169 QHPHLIRLYGVVLD-QPAMMVF-ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA 246 (1039)
T ss_pred cCcceeEEeeeecc-chhhHHh-hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec
Confidence 48899999999998 7889999 799999999999872 2222 7788999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCc----CCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK 156 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~----gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~ 156 (293)
... .|||+|||+.+........+.+. -...|+|||.+...+++.. +|+|++||++|||++ |+-||.+.....
T Consensus 247 spr--tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~q 323 (1039)
T KOG0199|consen 247 SPR--TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQ 323 (1039)
T ss_pred ccc--eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHH
Confidence 644 49999999999776666555433 2456999999998888766 999999999999998 789999988744
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
.+. ++- ..-.++.+..+|+++.+++..||..+|.+|||+..|...-+
T Consensus 324 IL~----~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 324 ILK----NID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHH----hcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 433 332 34456667779999999999999999999999998865433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=218.11 Aligned_cols=196 Identities=20% Similarity=0.282 Sum_probs=157.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|||+++++|.|...+.+|+|+ ||++.|+|.+++.++. ... ....++.||+.|++||.+.++|||||.+.|+|++
T Consensus 593 khPNIveLvGVC~~DePicmI~-EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~ 671 (807)
T KOG1094|consen 593 KHPNIVELLGVCVQDDPLCMIT-EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD 671 (807)
T ss_pred CCCCeeEEEeeeecCCchHHHH-HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec
Confidence 6899999999999999999999 7999999999998873 322 7778999999999999999999999999999996
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCC---CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHH--hCCCCCCCCCchH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--VGGYPFEDPDEPK 156 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~--~g~~pf~~~~~~~ 156 (293)
.+. ++||+|||+++......-. ...+-.+.|||+|.++-.+++.+ +|+|++|+++||++ +...||...++..
T Consensus 672 ~e~--~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 672 GEF--TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred Ccc--cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 554 5999999999853222211 12245689999999988888776 99999999999986 4788998877644
Q ss_pred HHHHHHHHHhcccc---CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 157 DFRKTIQRILSVQY---SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 157 ~~~~~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
...+ ...+...+. -.+.+.-++..+.+++.+||..+..+||+++++-.|
T Consensus 749 vven-~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 749 VVEN-AGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred HHHh-hhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 3332 222222221 233445588999999999999999999999998654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=241.89 Aligned_cols=192 Identities=16% Similarity=0.160 Sum_probs=141.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHH---HcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCH---AMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH---~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|++++++.+.+..|+|| ||+.+|+|.++++. -...++..++.|++.||+||| +.+++||||||+||+++.
T Consensus 741 ~HpnIv~~~~~~~~~~~~~lv~-Ey~~~g~L~~~l~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~ 818 (968)
T PLN00113 741 QHPNIVKLIGLCRSEKGAYLIH-EYIEGKNLSEVLRN-LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818 (968)
T ss_pred CCCCcceEEEEEEcCCCCEEEE-eCCCCCcHHHHHhc-CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC
Confidence 6999999999999999999999 79999999999964 334488999999999999999 679999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch-HHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~ 161 (293)
+.. .++. ||.+.... ......||+.|+|||++.+..++.+ +||||+||++|||+||+.||...... ..+...
T Consensus 819 ~~~--~~~~-~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~ 891 (968)
T PLN00113 819 KDE--PHLR-LSLPGLLC---TDTKCFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891 (968)
T ss_pred CCc--eEEE-eccccccc---cCCCccccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHH
Confidence 654 4443 55443221 1223468999999999988777665 99999999999999999998543211 111111
Q ss_pred HHHHh---------ccccC--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 162 IQRIL---------SVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 162 ~~~~~---------~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+... ..... .+.......++.+++.+||..+|.+|||+.++++.
T Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11100 00000 00011112356789999999999999999999885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=220.03 Aligned_cols=202 Identities=21% Similarity=0.319 Sum_probs=167.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|.+++.+......-++| |||.||+|.+.-.-.+.+. ++.++.+..++||+|||++|-+|||||-.|||++..
T Consensus 70 ~h~nivay~gsylr~dklwicM-EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~ 148 (829)
T KOG0576|consen 70 RHPNIVAYFGSYLRRDKLWICM-EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE 148 (829)
T ss_pred CCcChHHHHhhhhhhcCcEEEE-EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc
Confidence 6899999999999999999999 7999999999999999998 999999999999999999999999999999999777
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhc---cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++ +|++|||.+..++.. ....+.+|||.|||||+.. ..+|+.. +|+|++|+...|+..-.+|.........+.
T Consensus 149 gD--vklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr~l~ 225 (829)
T KOG0576|consen 149 GD--VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMRALF 225 (829)
T ss_pred Cc--eeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHHHHH
Confidence 65 999999998765433 4457789999999999853 3455555 999999999999998888876655533332
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
-+.+. ............+++.+.+|++.+|.++|++||++..+|.|||....
T Consensus 226 LmTkS-~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 226 LMTKS-GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred Hhhcc-CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 22211 11112233456689999999999999999999999999999998754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=212.00 Aligned_cols=144 Identities=26% Similarity=0.435 Sum_probs=131.2
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.+|+|++|++++|++..+.|++|+-.-+|.+||++|..+.++. +++.+++|++.|+++||++||||||||-+|+.++.
T Consensus 626 ~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~ 705 (772)
T KOG1152|consen 626 HSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS 705 (772)
T ss_pred cCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEec
Confidence 4799999999999999999999977888999999999999888 99999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
++. +||+|||.|... ........+||..|.|||++.|.+|-++.-|||++|+++|-++....||..
T Consensus 706 ~g~--~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 706 NGF--VKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CCe--EEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 654 999999998643 234456778999999999999999999999999999999999999989863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=224.40 Aligned_cols=206 Identities=32% Similarity=0.503 Sum_probs=164.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++..+..+.+....+-+| |||.+ +|+.++...+.+. ++..+++|++.|++|+|+.|+.|||+||+|+++..+
T Consensus 379 ~h~~~~e~l~~~~~~~~~~~~m-E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~ 456 (601)
T KOG0590|consen 379 SHPNIIETLDIVQEIDGILQSM-EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN 456 (601)
T ss_pred cCCchhhhHHHHhhcccchhhh-hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC
Confidence 5778888888888887777777 89999 9999999986666 999999999999999999999999999999999776
Q ss_pred CCCCEEEecCCCCcCcCCCCC-----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+ .+||+|||.+........ ....+|+..|+|||++.+..|..+..||||.|++++.|.+|+.||.-....++.
T Consensus 457 g--~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~ 534 (601)
T KOG0590|consen 457 G--ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS 534 (601)
T ss_pred C--ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc
Confidence 5 599999999875433222 234579999999999999999999999999999999999999999876543321
Q ss_pred HHHHHH---HhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 159 RKTIQR---ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 159 ~~~~~~---~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
...... ........+....++...+.+|.+||+++|.+|.|++++++.+||+.....
T Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 535 FKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred hhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 100000 000000111223477899999999999999999999999999999875443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=210.08 Aligned_cols=190 Identities=21% Similarity=0.332 Sum_probs=158.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+|+|.+|+++++.... +-||+ +|+.+|+|.++++.+. ++. ....|..||++|+.|||.++++||||-..||||+.
T Consensus 756 dHpnl~RLLgvc~~s~-~qlvt-q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVks 833 (1177)
T KOG1025|consen 756 DHPNLLRLLGVCMLST-LQLVT-QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKS 833 (1177)
T ss_pred CCchHHHHhhhcccch-HHHHH-HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecC
Confidence 6899999999999887 88888 6999999999998764 343 78999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCc---CCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.. ++|++|||+|+.........+.. -.+.|||-|.+....|+.. +||||+||++||++| |..|+.+...
T Consensus 834 P~--hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~---- 906 (1177)
T KOG1025|consen 834 PN--HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPA---- 906 (1177)
T ss_pred CC--eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCH----
Confidence 54 59999999999765555443332 3567999999988888766 999999999999998 8899988764
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+.+..++....+++.+.-++.++.-++.+||..|+..||+++++..
T Consensus 907 -~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 907 -EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 2333344445556777779999999999999999999999987654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=189.46 Aligned_cols=205 Identities=21% Similarity=0.274 Sum_probs=153.5
Q ss_pred CCCCCcchhhhhce-eeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 3 PVGSSSSEYAMLGV-SVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 3 ~~~~~~~~v~~~~~-~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.++.|.++|..|+. |++.+.+.+++ ||+..|+|.+-+...|.-. -.+.++.|+++|+.|+|++++||||||.+||||
T Consensus 76 ~Ls~H~hIi~tY~vaFqt~d~YvF~q-E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLi 154 (378)
T KOG1345|consen 76 FLSPHQHIIDTYEVAFQTSDAYVFVQ-EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILI 154 (378)
T ss_pred eeccchhhhHHHHHHhhcCceEEEee-ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEE
Confidence 46789999998874 77778777777 8999999999998877666 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcccc----CCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
-.....+|||||||.++..+... ...-.+..|.+||++.... ...+..|+|.+|+++|..+||..||......+
T Consensus 155 f~~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d 232 (378)
T KOG1345|consen 155 FDADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD 232 (378)
T ss_pred ecCCccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence 76666689999999987543222 2223466789999875321 12344899999999999999999998644332
Q ss_pred HHHHHHHHHh-ccccCCC-CCCCCCHHHHHHHHHccccCCCCCC---CHHHHHcCcccc
Q 022732 157 DFRKTIQRIL-SVQYSVP-DTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFL 210 (293)
Q Consensus 157 ~~~~~~~~~~-~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rp---t~~ell~h~~~~ 210 (293)
.-...+.... ......| ...++|+.+..+.++-|..+|++|- ++.......|..
T Consensus 233 ~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 233 KPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred chHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 2222222221 1122223 3466899999999999999999994 555566666653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=177.90 Aligned_cols=145 Identities=25% Similarity=0.398 Sum_probs=114.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHH----HHcCCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWL----LLLGLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l----~~~~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~NI 78 (293)
.-+.+|+|||..-.+..+.+.|+ .+. .+|..+- .+.+.++ -+-+++..++.||.|||++ .++|||+||+||
T Consensus 103 ~CPf~V~FyGa~~regdvwIcME-~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNi 180 (282)
T KOG0984|consen 103 DCPFTVHFYGALFREGDVWICME-LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNI 180 (282)
T ss_pred CCCeEEEeehhhhccccEEEeHH-Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceE
Confidence 44667999999999999999995 444 3554443 3445555 6788999999999999976 899999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc----ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
|++.. |+||+||||++.........+...|-..|||||.+.. .+|+-+ +||||||++++||.+++.||..-..
T Consensus 181 LIn~~--GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 181 LINYD--GQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred EEccC--CcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCC
Confidence 99655 4699999999976543333333568889999999853 466666 9999999999999999999976544
Q ss_pred h
Q 022732 155 P 155 (293)
Q Consensus 155 ~ 155 (293)
+
T Consensus 258 p 258 (282)
T KOG0984|consen 258 P 258 (282)
T ss_pred H
Confidence 3
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=176.10 Aligned_cols=163 Identities=34% Similarity=0.497 Sum_probs=136.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL---GLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~---~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.+++.+++++++......++++ ||+.|++|.+++... .....+..++.+++.++.+||++|++|+||+|.||+++.
T Consensus 49 ~~~~i~~~~~~~~~~~~~~~~~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~ 127 (215)
T cd00180 49 NHPNIVKLYGVFEDENHLYLVM-EYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS 127 (215)
T ss_pred CCCCeeeEeeeeecCCeEEEEE-ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC
Confidence 3478999999999999999999 799999999999876 233389999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
. .++++|+|||.+....... ......+...|++||.+..........|+|++|++++++
T Consensus 128 ~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------- 187 (215)
T cd00180 128 D-NGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------- 187 (215)
T ss_pred C-CCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------
Confidence 2 2359999999987543221 133456788999999987652334558999999999999
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 207 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~ 207 (293)
..+.+++.+|+..+|.+||++.++++++
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6788999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=182.46 Aligned_cols=195 Identities=19% Similarity=0.279 Sum_probs=157.5
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--------CHH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--------LLV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--------~~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
+=++|+|.+.+.+++.+....-+|...+..-|+|..+++... ... +....+.|+..|+.|||+.|+||.|
T Consensus 342 y~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkD 421 (563)
T KOG1024|consen 342 YGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKD 421 (563)
T ss_pred hcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccch
Confidence 457899999999999888666666667888999999998321 122 7888999999999999999999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCC---CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYP 148 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p 148 (293)
|-..|++|+..- ++||+|=.+++..-+ +-..........||+||.+....|++. +|+||||+++|||+| |+.|
T Consensus 422 iAaRNCvIdd~L--qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~P 498 (563)
T KOG1024|consen 422 IAARNCVIDDQL--QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLP 498 (563)
T ss_pred hhhhcceehhhe--eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCC
Confidence 999999997653 699999999884322 111222334668999999988888766 999999999999998 8999
Q ss_pred CCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+..-++.+ +...+...++...+..++.++-.++.-||...|++||+++++..
T Consensus 499 yaeIDPfE-----m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 499 YAEIDPFE-----MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ccccCHHH-----HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 98877532 23344556677777789999999999999999999999998865
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=185.11 Aligned_cols=197 Identities=22% Similarity=0.268 Sum_probs=143.5
Q ss_pred CCcchhhhhceeeec----eeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHH-----c---CCeecC
Q 022732 6 SSSSEYAMLGVSVKM----KFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHA-----M---QVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~----~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~-----~---~iiHrd 72 (293)
-|.|++.|++.=... .+++||. +|=+.|+|++||.....-. ...+++..++.||++||- + .|.|||
T Consensus 263 RHENILgFIaaD~~~~gs~TQLwLvT-dYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD 341 (513)
T KOG2052|consen 263 RHENILGFIAADNKDNGSWTQLWLVT-DYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD 341 (513)
T ss_pred ccchhhhhhhccccCCCceEEEEEee-ecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence 378999998876544 5789999 8999999999998865444 889999999999999994 2 399999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCC-----CCCCCCcCCCCccchhhhccccC-----CCchhhhhhhhhHHHHH
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVM 142 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslG~il~el 142 (293)
||..||||++++. .-|+|+|+|...... ...+..+||..|||||++...-. ..+.+||||+|.|+||+
T Consensus 342 lKSKNILVKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi 419 (513)
T KOG2052|consen 342 LKSKNILVKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI 419 (513)
T ss_pred cccccEEEccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence 9999999977664 999999999743222 23456789999999999854211 13558999999999999
Q ss_pred Hh----------CCCCCCCCCchHHHHHHHHH-HhccccCCCCCCCCC-----HHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 143 LV----------GGYPFEDPDEPKDFRKTIQR-ILSVQYSVPDTNPIS-----QECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 143 ~~----------g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s-----~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+. -+.||.+-.+.+.-.+.+.+ ++....+...+..++ ..+..+++.||..||.-|.|+-.+.+
T Consensus 420 arRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 420 ARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred HHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 84 24688765433322222222 222233332222222 34668899999999999999865544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=185.80 Aligned_cols=193 Identities=20% Similarity=0.232 Sum_probs=139.4
Q ss_pred CCcchhhhhceeeece----eEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHH---------cCCeec
Q 022732 6 SSSSEYAMLGVSVKMK----FVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHA---------MQVCHR 71 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~----~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~---------~~iiHr 71 (293)
-|+|+++|++.=.... .+-||+ +|-..|+|.+||+.+-. .....+++.-+++||+|||+ ..|+||
T Consensus 262 ~h~nIl~Fi~~ekr~t~~~~eywLVt-~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHR 340 (534)
T KOG3653|consen 262 KHENILQFIGAEKRGTADRMEYWLVT-EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHR 340 (534)
T ss_pred cchhHHHhhchhccCCccccceeEEe-eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccc
Confidence 3789999999877665 778888 79999999999987643 34999999999999999995 349999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccC-----CCchhhhhhhhhHHHHHH
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVML 143 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslG~il~el~ 143 (293)
|||..||||..+.. .-|+|||+|....+... ....+||.+|||||++.+.-. ..++.||||+|.|+||++
T Consensus 341 DlkSkNVLvK~DlT--ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~ 418 (534)
T KOG3653|consen 341 DLKSKNVLVKNDLT--CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA 418 (534)
T ss_pred cccccceEEccCCc--EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999999977665 89999999986554332 334689999999999976432 235689999999999999
Q ss_pred hCCCCCC-CCCchH------------HHHHHHHHHhccc--cCCCCC---CCCCHHHHHHHHHccccCCCCCCCHH
Q 022732 144 VGGYPFE-DPDEPK------------DFRKTIQRILSVQ--YSVPDT---NPISQECRDLISRIFVADPAARITIP 201 (293)
Q Consensus 144 ~g~~pf~-~~~~~~------------~~~~~~~~~~~~~--~~~~~~---~~~s~~~~~li~~~L~~dp~~Rpt~~ 201 (293)
+...-+. +..... .+..+...++... ..+|.. -.--.-+++.+..||..||+.|.|+.
T Consensus 419 SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 419 SRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred hhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 7533221 111100 1111111111111 112211 12346789999999999999999984
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=169.88 Aligned_cols=142 Identities=34% Similarity=0.535 Sum_probs=121.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.++|.+++++++......++++ ||+.+++|.+++..... +. .+..++.+++.++.+||+++++|+|++|.||+++.
T Consensus 55 ~~~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~ 133 (225)
T smart00221 55 KHPNIVKLYGVFEDPEPLYLVM-EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM 133 (225)
T ss_pred CCCChhhheeeeecCCceEEEE-eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 5789999999999999999999 79999999999987653 33 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhh-ccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 83 SPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
+ +.++|+|||.+....... ......++..|++||++ ....+.. ++|+|++|++++++++|+.||..
T Consensus 134 ~--~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 134 D--GLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred C--CCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 5 459999999987653332 33455788899999998 4455544 59999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-24 Score=193.33 Aligned_cols=190 Identities=29% Similarity=0.439 Sum_probs=160.0
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
...++..|++.-.|+.....|+++ +|..||.|+..+.+...+. .++.+...++.|+.++|+.+++|||+|++||+++
T Consensus 53 ~~~~~f~v~lhyafqt~~kl~l~l-d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld 131 (612)
T KOG0603|consen 53 VHNTPFLVKLHYAFQTDGKLYLIL-DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL 131 (612)
T ss_pred ccCCCceeeeeeeeccccchhHhh-hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec
Confidence 345788899999999999999999 7999999999998877666 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
..| ++++.|||+++...... ..+||..|||||++. +.. .++|+||+|+++++|++|..||.. .+
T Consensus 132 ~~G--hi~~tdfglske~v~~~---~~cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~--------~~ 195 (612)
T KOG0603|consen 132 LEG--HIKLTDFGLSKEAVKEK---IACGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG--------DT 195 (612)
T ss_pred ccC--ccccCCchhhhHhHhhh---hcccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch--------HH
Confidence 655 59999999998543322 228999999999987 333 348999999999999999999986 34
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~ 212 (293)
...++......|. .++..+++++..++..+|.+|.. +.++++|+||...
T Consensus 196 ~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 196 MKRILKAELEMPR--ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 4445555555444 48899999999999999999984 4789999999643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-21 Score=166.09 Aligned_cols=205 Identities=29% Similarity=0.463 Sum_probs=155.1
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC---CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG---LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~---~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
..+++++++++.+......++++ +|+.++++..++.... .+. .+..++.|++.++.|+|+.+++|||+||+||+
T Consensus 55 ~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil 133 (384)
T COG0515 55 NHPPNIVKLYDFFQDEGSLYLVM-EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENIL 133 (384)
T ss_pred cCCcceeeEEEEEecCCEEEEEE-ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence 34447999999998888889999 7999999998887664 333 99999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC-------CCCCCcCCCCccchhhhccc--cCCCchhhhhhhhhHHHHHHhCCCCCC
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS-------QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFE 150 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~ 150 (293)
++.... .++++|||.++...... ......||..|+|||.+.+. .......|+||+|++++++++|..||.
T Consensus 134 ~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~ 212 (384)
T COG0515 134 LDRDGR-VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212 (384)
T ss_pred ecCCCC-eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 976542 48999999987433322 34567899999999999873 344555999999999999999999987
Q ss_pred CCCc---hHHHHHHHHHHhccccCCCCCCCC----CHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 151 DPDE---PKDFRKTIQRILSVQYSVPDTNPI----SQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 151 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.... .......+..........+..... ...+.+++.+++..+|..|.+......+++...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 213 GEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred CCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 7664 222222222211110111111111 257899999999999999999999888866544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=168.39 Aligned_cols=198 Identities=22% Similarity=0.305 Sum_probs=146.2
Q ss_pred CCCCCcchhhhhceeee---------------------------ceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHH
Q 022732 3 PVGSSSSEYAMLGVSVK---------------------------MKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQ 54 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~---------------------------~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~ 54 (293)
-++-|+|+|++.++|.+ ...+|+||.-| ..+|.+++-.+.+-. ..+-++.
T Consensus 271 hLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY--~~tLr~yl~~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 271 HLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY--RQTLREYLWTRHRSYRTGRVILA 348 (598)
T ss_pred ccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc--hhhHHHHHhcCCCchHHHHHHHH
Confidence 46789999999988853 46789999756 458999998877666 8889999
Q ss_pred HHHHHHHHHHHcCCeecCCCCCcEEEcC--CCCCCEEEecCCCCcCcCCC-------CCCCCCcCCCCccchhhhcccc-
Q 022732 55 QLISGVSYCHAMQVCHRDLKLENTLLDG--SPAPRLKICDFGYSKSSVLH-------SQPKSTVGTPAYIAPEVLLRHE- 124 (293)
Q Consensus 55 qil~~l~~LH~~~iiHrdlkp~NIl~~~--~~~~~vkl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~- 124 (293)
|+++|+.|||.+||.|||+|.+|||+.- +..+.+.++|||.+---... +..-..-|.-..||||+....+
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999999999999999999954 44567899999986422211 1112234778899999975321
Q ss_pred ----CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH
Q 022732 125 ----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 200 (293)
Q Consensus 125 ----~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~ 200 (293)
.+..++|.|+.|-+.||+++...||.+......-...++. .+ -.+.+..+++.+++++..+|+.||++|++.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe---~q-LPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE---SQ-LPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh---hh-CCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 2233489999999999999999999885432111111111 11 123345588999999999999999999975
Q ss_pred ---HHHHcC
Q 022732 201 ---PEIMKH 206 (293)
Q Consensus 201 ---~ell~h 206 (293)
+.+++.
T Consensus 505 ~iAANvl~L 513 (598)
T KOG4158|consen 505 NIAANVLNL 513 (598)
T ss_pred cHHHhHHHH
Confidence 445553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-21 Score=182.68 Aligned_cols=153 Identities=35% Similarity=0.606 Sum_probs=123.1
Q ss_pred HHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC----------------CCCCCcCCCCccchhh
Q 022732 56 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKSTVGTPAYIAPEV 119 (293)
Q Consensus 56 il~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~ 119 (293)
++.+++|||+.||+|||+||+|.+|+.-+ ++|++|||+++...... ..+..+|||.|+|||+
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~mG--hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeecc--cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 37899999999999999999999997654 59999999987422111 1234589999999999
Q ss_pred hccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCC-CCCCCHHHHHHHHHccccCCCCCC
Q 022732 120 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVADPAARI 198 (293)
Q Consensus 120 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rp 198 (293)
+...+|. +.+|||++|+|+|+.+-|..||.+.+..+.+...+.... .+|. ...++++++++|.++|..+|..|.
T Consensus 230 ilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i----~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 230 ILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----EWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc----cccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 9999885 559999999999999999999999888666655554332 2222 345789999999999999999998
Q ss_pred ---CHHHHHcCcccccCCCC
Q 022732 199 ---TIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 199 ---t~~ell~h~~~~~~~~~ 215 (293)
.+-++.+|+||+.....
T Consensus 305 gt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 305 GTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ccchhhhhhhccceeecccc
Confidence 46689999999865444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=153.08 Aligned_cols=190 Identities=21% Similarity=0.271 Sum_probs=153.4
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH----HHHHHHHHHHHHHHHHHHcC--CeecCCCCCc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV----QARFFFQQLISGVSYCHAMQ--VCHRDLKLEN 77 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~----~~~~~~~qil~~l~~LH~~~--iiHrdlkp~N 77 (293)
+-+|+|++.+++.|....+..++. -|+..|+|+..+.....+. |+.+++..+++|++|||+.. |.---|....
T Consensus 243 ifshpnilpvlgacnsppnlv~is-q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~h 321 (448)
T KOG0195|consen 243 IFSHPNILPVLGACNSPPNLVIIS-QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKH 321 (448)
T ss_pred eecCCchhhhhhhccCCCCceEee-eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccce
Confidence 358999999999999999999999 4999999999998876654 99999999999999999863 3344688889
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccC--CCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
++|+.+-..++..+|-.++.. .....-.|.||+||.+.+.+. +.+++|+||+++++|||.|...||.+-.+.
T Consensus 322 vmidedltarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 322 VMIDEDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred EEecchhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 999887766677777554431 123345789999999987544 345699999999999999999999998875
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 204 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 204 (293)
+.-++ +.-...+...++.+|..+..|+.-|+.-||.+||.+..++
T Consensus 396 ecgmk----ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 396 ECGMK----IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hhhhh----hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 54444 3334555666777999999999999999999999887653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-21 Score=172.45 Aligned_cols=175 Identities=24% Similarity=0.356 Sum_probs=131.1
Q ss_pred ceeEEEeehhhccCchhHHHHHHcCC-----HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCC
Q 022732 20 MKFVFLSLSFFFSLCLFFMWLLLLGL-----LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 94 (293)
Q Consensus 20 ~~~~~lv~~ey~~gg~L~~~l~~~~~-----~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg 94 (293)
..+.|+.| .+|...+|.++|..+.. +.....++.|+..|+.| +|.+|||+||.||+...+. ++||.|||
T Consensus 328 ~~~lyI~M-n~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQM-NLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIGDFG 401 (516)
T ss_pred ccchhhhh-hhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhhhhh
Confidence 34688888 69999999999975443 33899999999999999 9999999999999996554 59999999
Q ss_pred CCcCcCCCC-------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHHHHHHHHh
Q 022732 95 YSKSSVLHS-------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRIL 166 (293)
Q Consensus 95 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~ 166 (293)
+........ ......||.+||+||.+.+..|..+ +||||||++++|++. -..+|.. ......+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r 473 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER-------IATLTDIR 473 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH-------HHhhhhhh
Confidence 987544333 3455689999999999999999776 999999999999997 2223321 11122222
Q ss_pred ccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 167 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...++....... ++-..|+..||.+.|.+||++.+.-.|+|.
T Consensus 474 ~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 474 DGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 222221111112 345689999999999999988777777664
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-19 Score=156.68 Aligned_cols=196 Identities=19% Similarity=0.105 Sum_probs=144.8
Q ss_pred Ccchhhhhcee-eeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 7 SSSEYAMLGVS-VKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 7 ~~~~v~~~~~~-~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.+...++++.+ ....+.|+||. ..|.+|.++..... .++ .+..++.|++.+|++||+.|++||||||.|+.+.
T Consensus 79 ~~~~~~~~~~G~~~~~~~~iVM~--l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g 156 (322)
T KOG1164|consen 79 PSHFPKLLDHGRSTEDFNFIVMS--LLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVG 156 (322)
T ss_pred CCCCCEEEEeccCCCceeEEEEe--ccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeec
Confidence 45667778888 57889999996 77889999886554 444 9999999999999999999999999999999997
Q ss_pred CCC-C--CCEEEecCCCCc--CcCCCC--------C-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCC
Q 022732 82 GSP-A--PRLKICDFGYSK--SSVLHS--------Q-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 147 (293)
Q Consensus 82 ~~~-~--~~vkl~Dfg~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 147 (293)
... . ..+.|.|||+|+ ...... . .....||..|+++.+..+.....+ .|+||++.++.++..|..
T Consensus 157 ~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 157 QSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSL 235 (322)
T ss_pred CCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCC
Confidence 653 1 358999999998 311111 1 123459999999999888776544 999999999999999999
Q ss_pred CCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 148 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
||.+...........+........ ......+..+..+...+-..+...+|....+...
T Consensus 236 PW~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 236 PWEALEMTDLKSKFEKDPRKLLTD-RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred CCccccccchHHHHHHHhhhhccc-cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 998766433322222221111111 0122245788888888888899999988766554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-19 Score=171.42 Aligned_cols=191 Identities=23% Similarity=0.338 Sum_probs=139.0
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
++.++|.+-+--+-++.+..|||- .|+.. +|++.|..+..+. +-+.|+.||+.||.-+|..||+|+|||.+||||+
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvR-qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT 154 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVR-QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT 154 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHH-HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe
Confidence 466777777777778888999998 58776 9999998888777 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC-CC-------CCCcCCCCccchhhhcccc---------C-CCchhhhhhhhhHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS-QP-------KSTVGTPAYIAPEVLLRHE---------Y-DGKIADVWSCGVTLYVML 143 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~-~~-------~~~~gt~~y~aPE~~~~~~---------~-~~~~~DvwslG~il~el~ 143 (293)
.=+ .+.|+||..-+..-... .. .+...-..|.|||.+.... . -.++.||+|+||+++||+
T Consensus 155 SWN--W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf 232 (1431)
T KOG1240|consen 155 SWN--WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF 232 (1431)
T ss_pred eec--hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence 544 48999998765321111 10 1112334799999886422 1 235689999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHHHhccccCCCC---CCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 144 V-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD---TNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 144 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+ |++||.-.+ .-.........+. ..--+..++.+|..|++.||.+|.++++.|+.
T Consensus 233 ~Eg~PlF~LSQ--------L~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 233 LEGRPLFTLSQ--------LLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hcCCCcccHHH--------HHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 8 788886421 1111111000000 00023578999999999999999999999985
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=156.38 Aligned_cols=197 Identities=22% Similarity=0.238 Sum_probs=146.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCC-eecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQV-CHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~i-iHrdlkp~NIl~~ 81 (293)
.|.|..+|+|.+.....+++|. +||..|+|.+.+.... .+. -...+++.|+.||.|||.--| .|+.++..|++++
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~-~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd 83 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIW-EYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVD 83 (484)
T ss_pred chhhhhhheeeEecCCceEEEE-eeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceee
Confidence 5899999999999999999999 7999999999998733 333 677889999999999997654 9999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCC---CCCCCCCcCCCCccchhhhccccC------CCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 82 GSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRHEY------DGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
... .+||+|||+...... ........-...|.|||.+.+... ..++.|+||+|++++|+++...||...
T Consensus 84 ~~w--~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~ 161 (484)
T KOG1023|consen 84 SRW--VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR 161 (484)
T ss_pred eeE--EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence 765 499999999764321 011111223456999999876322 245589999999999999999999874
Q ss_pred CchHHHHHHHHHHhcccc-----CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 153 DEPKDFRKTIQRILSVQY-----SVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.......+++..+..... .........+++..++..||..+|.+||++..+..
T Consensus 162 ~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 162 NLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 433222344444433111 11111135567999999999999999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-18 Score=144.17 Aligned_cols=194 Identities=19% Similarity=0.227 Sum_probs=146.4
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
+|+-..+..+|-+..+..+..|||+ +.|-+|.+++.-.++ ++ .+.-++.|++.-++|+|++.+|+|||||+|+||
T Consensus 80 L~g~~GIP~vYYFGqeG~~NiLVid--LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLI 157 (449)
T KOG1165|consen 80 LGGTEGIPQVYYFGQEGKYNILVID--LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLI 157 (449)
T ss_pred HcCCCCCCceeeeccccchhhhhhh--hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceee
Confidence 5778888999999999999999995 556677666665543 33 899999999999999999999999999999999
Q ss_pred cCCCC---CCEEEecCCCCcCcCCC--------CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC
Q 022732 81 DGSPA---PRLKICDFGYSKSSVLH--------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 149 (293)
Q Consensus 81 ~~~~~---~~vkl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 149 (293)
...+. ..|.++|||+|+..... +...+..||..||+-...+|...+.+ .|+-|||-++++.+.|..||
T Consensus 158 Grp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPW 236 (449)
T KOG1165|consen 158 GRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPW 236 (449)
T ss_pred cCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCcc
Confidence 76433 25899999999854322 23356679999999999888776555 99999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhccccCCCC---CCCCCHHHHHHHHHccccCCCCCCCHH
Q 022732 150 EDPDEPKDFRKTIQRILSVQYSVPD---TNPISQECRDLISRIFVADPAARITIP 201 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ 201 (293)
.+.... ..+..+++|....-..+. -..++.++...++-.-..+..+-|..+
T Consensus 237 QGLKA~-tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 237 QGLKAD-TNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred ccccCc-chHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 987642 334555555443322221 123567777777766666777777653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-18 Score=146.24 Aligned_cols=150 Identities=22% Similarity=0.246 Sum_probs=97.5
Q ss_pred CchhHHHH---HHcCCH----H-HH-HHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC
Q 022732 33 LCLFFMWL---LLLGLL----V-QA-RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 103 (293)
Q Consensus 33 gg~L~~~l---~~~~~~----~-~~-~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~ 103 (293)
.++|..++ ...... . .| ..+..|+++.+++||..|++|+||+|+|++++.++ .++|+||+.....+...
T Consensus 122 ~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G--~v~Lg~F~~~~r~g~~~ 199 (288)
T PF14531_consen 122 QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDG--GVFLGDFSSLVRAGTRY 199 (288)
T ss_dssp SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEEE
T ss_pred hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCC--CEEEcChHHHeecCcee
Confidence 45665554 444333 2 44 45559999999999999999999999999997765 59999998776433222
Q ss_pred CCCCCcCCCCccchhhhccc--------cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCC
Q 022732 104 QPKSTVGTPAYIAPEVLLRH--------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 175 (293)
Q Consensus 104 ~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (293)
.. ...+..|.|||..... .+ +.+.|.|+||+++|.|+|++.||........... .+..-
T Consensus 200 ~~--~~~~~~~~PPe~~~~~~~~~~~~~~~-t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----------~f~~C 266 (288)
T PF14531_consen 200 RC--SEFPVAFTPPELESCAGQFGQNNAPY-TFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----------DFSRC 266 (288)
T ss_dssp EG--GGS-TTTS-HHHHHHHTSCHHSEEEE--HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----------GGTTS
T ss_pred ec--cCCCcccCChhhhhhhcccCccccee-eeccCHHHHHHHHHHHHHccCCCCCCCccccccc----------cchhc
Confidence 21 3345779999986442 23 3448999999999999999999987643211100 11112
Q ss_pred CCCCHHHHHHHHHccccCCCCC
Q 022732 176 NPISQECRDLISRIFVADPAAR 197 (293)
Q Consensus 176 ~~~s~~~~~li~~~L~~dp~~R 197 (293)
..+++.++.||..+|++||.+|
T Consensus 267 ~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 267 RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S---HHHHHHHHHHT-SSGGGS
T ss_pred CCcCHHHHHHHHHHccCCcccC
Confidence 2588999999999999999988
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-19 Score=170.34 Aligned_cols=202 Identities=31% Similarity=0.451 Sum_probs=164.6
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHH-HcC-CHH--HHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEc
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLL-LLG-LLV--QARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLD 81 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~-~~~-~~~--~~~~~~~qil~~l~~LH-~~~iiHrdlkp~NIl~~ 81 (293)
|+|++++++........++++ +|..|++++..+. ... ... .+..++.|+..++.|+| ..++.|||+||+|.+++
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~-~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~ 158 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSL-SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD 158 (601)
T ss_pred cccccccCCccCCCccccccc-CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc
Confidence 899999999999999999999 7999999999994 332 222 89999999999999999 99999999999999998
Q ss_pred CCCCCCEEEecCCCCcCcCC-CC---CCCCCcC-CCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 82 GSPAPRLKICDFGYSKSSVL-HS---QPKSTVG-TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~-~~---~~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
.++. .+|++|||+|..... .. .....+| ++.|+|||...+..+..+..|+||.|+++.-+++|..||.......
T Consensus 159 ~s~~-~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 159 ESGS-ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred cCCC-cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 7763 499999999986544 22 2234568 9999999999887788888999999999999999999998765433
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.....+.... .......+..++....+++.+++..+|..|.+.+++..++|+..
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 238 GRYSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccceeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 2111111111 11123445668899999999999999999999999999999977
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.3e-17 Score=133.79 Aligned_cols=139 Identities=13% Similarity=0.066 Sum_probs=102.0
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEEc
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLD 81 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdl-kp~NIl~~ 81 (293)
.+++++++++++++ +..|++| +|+.|.+|...+.. ....++.|++.+|.++|.+||+|||| ||+|||++
T Consensus 57 ~L~~~~~vP~ll~~----~~~~lvm-eyI~G~~L~~~~~~-----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~ 126 (218)
T PRK12274 57 QLDGLPRTPRLLHW----DGRHLDR-SYLAGAAMYQRPPR-----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ 126 (218)
T ss_pred hcCCCCCCCEEEEE----cCEEEEE-eeecCccHHhhhhh-----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc
Confidence 45667778888876 4569999 79999998754422 12357889999999999999999999 79999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCC-----C---------CCcCCCCccchhhhccc-cCCCchhhhhhhhhHHHHHHhCC
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQP-----K---------STVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~-----~---------~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~ 146 (293)
.++ .++|+|||+|......... . -...++.++.|+...-. ..+-.+.++++.|+-+|.++|++
T Consensus 127 ~~g--~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~ 204 (218)
T PRK12274 127 EDG--SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRR 204 (218)
T ss_pred CCC--CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhcc
Confidence 544 5999999999854332210 0 11257788888764322 22223468999999999999999
Q ss_pred CCCCCCC
Q 022732 147 YPFEDPD 153 (293)
Q Consensus 147 ~pf~~~~ 153 (293)
.++.+..
T Consensus 205 ~~~~~~~ 211 (218)
T PRK12274 205 VLHWEDN 211 (218)
T ss_pred CCccccC
Confidence 8876654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=129.79 Aligned_cols=189 Identities=16% Similarity=0.180 Sum_probs=139.8
Q ss_pred chhhhhceeeeceeEEEeehhhccCchhHHHHHHcC---CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC
Q 022732 9 SEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG---LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 85 (293)
Q Consensus 9 ~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~---~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~ 85 (293)
.+.+++-++.+.++..+||. +.|-+|.+++.-.. .+..+.-.+-|++.-++|+|.++++||||||+|+|..-+..
T Consensus 72 GiP~i~~y~~e~~ynvlVMd--LLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh 149 (341)
T KOG1163|consen 72 GIPHIRHYGTEKDYNVLVMD--LLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRH 149 (341)
T ss_pred CCchhhhhccccccceeeee--ccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccc
Confidence 34567777888899999995 55667777765433 33388889999999999999999999999999999964432
Q ss_pred -CCEEEecCCCCcCcCCC--------CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 86 -PRLKICDFGYSKSSVLH--------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 86 -~~vkl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
.++.|+|||+|+..... .......||..|.+-....+...+ ++.|+-|+|.++.+...|..||.+.....
T Consensus 150 ~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 150 CNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchhh
Confidence 26899999999854322 223455699999998877766554 44899999999999999999999976432
Q ss_pred HHHHHHHHHhccccCCCC---CCCCCHHHHHHHHHccccCCCCCCCHH
Q 022732 157 DFRKTIQRILSVQYSVPD---TNPISQECRDLISRIFVADPAARITIP 201 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ 201 (293)
. .....++.....+.+. -..++.++.-.+..|-..-.++-|...
T Consensus 229 k-~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 229 K-KQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred H-HHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 2 2233334333333332 234788999999999888888888653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.2e-16 Score=140.62 Aligned_cols=104 Identities=14% Similarity=0.080 Sum_probs=76.9
Q ss_pred Ccchh-hhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEEcCCC
Q 022732 7 SSSEY-AMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSP 84 (293)
Q Consensus 7 ~~~~v-~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdl-kp~NIl~~~~~ 84 (293)
|+|++ ++++. +..|+|| ||+.|++|.. +... ....++.|+++||.|||++||+|||| ||+|||++.++
T Consensus 80 h~~iv~~l~~~----~~~~LVm-E~~~G~~L~~-~~~~----~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 80 GIGVVPQLLAT----GKDGLVR-GWTEGVPLHL-ARPH----GDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred CCCCCcEEEEc----CCcEEEE-EccCCCCHHH-hCcc----chHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC
Confidence 55655 34432 4689999 7999999972 2111 12567899999999999999999999 99999996544
Q ss_pred CCCEEEecCCCCcCcCCCCCC---------CCCcCCCCccchhhhcc
Q 022732 85 APRLKICDFGYSKSSVLHSQP---------KSTVGTPAYIAPEVLLR 122 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~ 122 (293)
++||+|||+|+........ .+..+++.|+|||.+.-
T Consensus 150 --~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 150 --EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred --CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 5999999999854332211 23457888999998853
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.9e-15 Score=121.08 Aligned_cols=91 Identities=14% Similarity=0.046 Sum_probs=72.9
Q ss_pred CCCCcchhhhhceeeece---eEE-Eeehhh--ccCchhHHHHHHcCCHHHHHHHHHHHHHHH-HHHHHcCCeecCCCCC
Q 022732 4 VGSSSSEYAMLGVSVKMK---FVF-LSLSFF--FSLCLFFMWLLLLGLLVQARFFFQQLISGV-SYCHAMQVCHRDLKLE 76 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~---~~~-lv~~ey--~~gg~L~~~l~~~~~~~~~~~~~~qil~~l-~~LH~~~iiHrdlkp~ 76 (293)
-..|+|++++||++++.. .++ +|+ || +.+++|.+++++. .+.....++.|++.++ +|||+++|+||||||+
T Consensus 57 ~~~h~nIvr~yg~~et~~g~g~v~~~I~-e~~G~~~~tL~~~l~~~-~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~ 134 (210)
T PRK10345 57 LIDWSGIPRYYGTVETDCGTGYVYDVIA-DFDGKPSITLTEFAEQC-RYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQ 134 (210)
T ss_pred CCCCcccceeeEEEEeCCCCeEEEEEEe-cCCCCcchhHHHHHHcc-cccHhHHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 357899999999999984 555 567 79 5589999999764 4554456788999888 9999999999999999
Q ss_pred cEEEcCCC--CCCEEEecCCCC
Q 022732 77 NTLLDGSP--APRLKICDFGYS 96 (293)
Q Consensus 77 NIl~~~~~--~~~vkl~Dfg~a 96 (293)
|||++..+ ..+++|+||+.+
T Consensus 135 NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 135 NILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HEEEeccCCCCCcEEEEECCCC
Confidence 99997532 347999995544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.6e-15 Score=123.02 Aligned_cols=115 Identities=10% Similarity=0.076 Sum_probs=80.7
Q ss_pred Ccchhhhhceeee--------ceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 7 SSSEYAMLGVSVK--------MKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 7 ~~~~v~~~~~~~~--------~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
++++..+..++.. .+..++|| ||++|.+|.++.. +. .....+++.+|..+|..|++|||+||+||
T Consensus 94 ~~GI~~~~d~~~~~~~~~~~~~~~~~lvm-Eyi~G~tL~~~~~----~~--~~~~~~i~~~l~~lH~~gi~H~Dikp~Ni 166 (232)
T PRK10359 94 SEGLASLNDFYLLAERKTLRYAHTYIMLI-EYIEGVELNDMPE----IS--EDVKAKIKASIESLHQHGMVSGDPHKGNF 166 (232)
T ss_pred HCCCCcceEeeeecccccccccCCeEEEE-EEECCccHHHhhh----cc--HHHHHHHHHHHHHHHHcCCccCCCChHHE
Confidence 3455555555443 34688999 7999999977732 11 13466999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 143 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 143 (293)
+++.++ ++|+|||..+....... .........+..+ +|+||||+++..+.
T Consensus 167 li~~~g---i~liDfg~~~~~~e~~a-----------~d~~vler~y~~~-~di~~lg~~~~~~~ 216 (232)
T PRK10359 167 IVSKNG---LRIIDLSGKRCTAQRKA-----------KDRIDLERHYGIK-NEIKDLGYYLLIYK 216 (232)
T ss_pred EEeCCC---EEEEECCCcccccchhh-----------HHHHHHHhHhccc-ccccceeEeehHHH
Confidence 996543 99999998764311110 0113344456544 89999999987664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=7e-15 Score=141.03 Aligned_cols=192 Identities=27% Similarity=0.354 Sum_probs=152.7
Q ss_pred eeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCC
Q 022732 17 SVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 94 (293)
Q Consensus 17 ~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg 94 (293)
|......+||+ +|..|++|.+.|.+.+... -++.++..++++++|||...+.|||++|.|+++...+ +.++++||
T Consensus 873 ~~~rsP~~L~~-~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g--h~~l~~~~ 949 (1205)
T KOG0606|consen 873 FPCRSPLPLVG-HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG--HRPLTDFG 949 (1205)
T ss_pred CCCCCCcchhh-HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC--CcccCccc
Confidence 45567889999 6999999999999988666 7899999999999999999999999999999996655 58999998
Q ss_pred CCcCcC-C---------------C----------------CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHH
Q 022732 95 YSKSSV-L---------------H----------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 142 (293)
Q Consensus 95 ~a~~~~-~---------------~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 142 (293)
...... . . .......||+.|.+||...+...... +|+|++|+++++.
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEV 1028 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhh
Confidence 322100 0 0 00123458999999999988777555 8999999999999
Q ss_pred HhCCCCCCCCCchHHHHHHHHHHhccccCCCC-CCCCCHHHHHHHHHccccCCCCCCCHH---HHHcCcccccCCCCC
Q 022732 143 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVADPAARITIP---EIMKHQWFLKNLPAD 216 (293)
Q Consensus 143 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~---ell~h~~~~~~~~~~ 216 (293)
++|.+||......+.+ +++.+....+|. +...+..+++++.++|..+|.+|..+. ++..|+||+......
T Consensus 1029 l~g~pp~na~tpq~~f----~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQIF----ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred hcCCCCCCCcchhhhh----hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 9999999998875544 445455444443 344789999999999999999999876 899999998754443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.8e-14 Score=120.60 Aligned_cols=192 Identities=15% Similarity=0.217 Sum_probs=132.0
Q ss_pred Ccchhhhhceeeecee-----EEEeehhhccCchhHHHHHHcCCHH------HHHHHHHHHHHHHHHHHHcC--CeecCC
Q 022732 7 SSSEYAMLGVSVKMKF-----VFLSLSFFFSLCLFFMWLLLLGLLV------QARFFFQQLISGVSYCHAMQ--VCHRDL 73 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~-----~~lv~~ey~~gg~L~~~l~~~~~~~------~~~~~~~qil~~l~~LH~~~--iiHrdl 73 (293)
|+|+|+++.++.+.++ +.+++ ||...|++.++|++..... ..++|+.||+.||.|||+.. ++|+++
T Consensus 126 HsnlvkfH~yw~d~K~~e~~rviFit-eymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 126 HSNLVKFHKYWTDKKYEEKPRVIFIT-EYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHhhcccccccccceEEEE-ecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 7889999999976544 67777 7999999999998764332 67899999999999999874 999999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCc-Cc----CCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSK-SS----VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~-~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p 148 (293)
....|++..++ -||+..---.. +. ..........+.+.|.+||.=.-.+.++. +|||++|+...+|..+..-
T Consensus 205 Tc~tifiq~ng--LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 205 TCDTIFIQHNG--LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred chhheeecCCc--eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHHHHheec
Confidence 99999997554 36654322111 00 00011122346788999996444455555 8999999999999988764
Q ss_pred CCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
-............+.+..- .... .--+.++.+||+..|..||++..++.||.+.
T Consensus 282 ~tnseS~~~~ee~ia~~i~---~len-----~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 282 STNSESKVEVEENIANVII---GLEN-----GLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred cCCCcceeehhhhhhhhee---eccC-----ccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 3332221111222222111 1111 1224689999999999999999999999764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.8e-14 Score=117.88 Aligned_cols=71 Identities=24% Similarity=0.162 Sum_probs=60.3
Q ss_pred EEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 24 FLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 24 ~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~L-H~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
++|| ||+.|+++...+...+.++ .+..++.|++.+|.++ |+.|++||||||+||+++. ++++|+|||+|..
T Consensus 93 ~iVm-E~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---~~v~LiDFG~a~~ 166 (190)
T cd05147 93 VLVM-EFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---GKLYIIDVSQSVE 166 (190)
T ss_pred EEEE-EEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC---CcEEEEEcccccc
Confidence 7999 7999988776544445554 8999999999999999 7999999999999999973 3599999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.5e-14 Score=138.92 Aligned_cols=138 Identities=23% Similarity=0.212 Sum_probs=118.2
Q ss_pred cchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-
Q 022732 8 SSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP- 84 (293)
Q Consensus 8 ~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~- 84 (293)
+++.+++..+...+.-+||+ +|...|+|.+++...+.+. .+..+..|++.-++.||..+|||+||||+|++|....
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~-ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~ 832 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVS-EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREIC 832 (974)
T ss_pred cchHHHHHHHccCCcceeee-eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccC
Confidence 46778888999999999999 7999999999999777777 8999999999999999999999999999999995422
Q ss_pred ----CCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCC
Q 022732 85 ----APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 147 (293)
Q Consensus 85 ----~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 147 (293)
..-++|+|||.+.-+.... .....++|-.+-.+|+..|.+|+.. +|.|.++-+++-|+.|++
T Consensus 833 ~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 833 ADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 2248999999997544332 3345578889999999999999877 899999999999999863
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.5e-14 Score=114.00 Aligned_cols=73 Identities=18% Similarity=0.027 Sum_probs=59.6
Q ss_pred EEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCc
Q 022732 23 VFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 99 (293)
Q Consensus 23 ~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~ 99 (293)
.|+|| ||+.|+++.........+. .+..++.|++.++.++|. +|++||||||+||+++ + ++++|+|||+++..
T Consensus 92 ~~lVm-E~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~--~~~~liDFG~a~~~ 167 (190)
T cd05145 92 NVLVM-EFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D--GKPYIIDVSQAVEL 167 (190)
T ss_pred CEEEE-EEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C--CCEEEEEcccceec
Confidence 37999 7999986544433334443 889999999999999999 9999999999999997 3 45999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.9e-12 Score=109.56 Aligned_cols=73 Identities=15% Similarity=0.002 Sum_probs=61.3
Q ss_pred eEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 22 FVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 22 ~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~-iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
..|+|| ||+.|.+|...+.....+. ++..++.|++.++.+||.+| ++||||||+||+++ + +.++|+|||.+..
T Consensus 122 ~~~lV~-E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~--~~i~LiDFg~a~~ 197 (237)
T smart00090 122 RNVLVM-EFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D--GKVVIIDVSQSVE 197 (237)
T ss_pred CceEEE-EEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C--CCEEEEEChhhhc
Confidence 458999 7999998877654444444 67899999999999999999 99999999999997 3 3599999998863
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.1e-12 Score=104.97 Aligned_cols=82 Identities=15% Similarity=0.121 Sum_probs=69.0
Q ss_pred hhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEE
Q 022732 11 YAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 90 (293)
Q Consensus 11 v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl 90 (293)
.....++......++|| ||+.|++|.+++..... ....++.+++.+|.++|+.|++|||++|.||+++ + +.++|
T Consensus 62 ~~p~~~~~~~~~~~lv~-e~~~G~~L~~~~~~~~~--~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~--~~~~l 135 (211)
T PRK14879 62 NVPAVYFVDPENFIIVM-EYIEGEPLKDLINSNGM--EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G--GKIYL 135 (211)
T ss_pred CCCeEEEEeCCCCEEEE-EEeCCcCHHHHHHhccH--HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C--CCEEE
Confidence 33444556677888999 79999999999876543 7888999999999999999999999999999997 3 35999
Q ss_pred ecCCCCcC
Q 022732 91 CDFGYSKS 98 (293)
Q Consensus 91 ~Dfg~a~~ 98 (293)
+|||.+..
T Consensus 136 iDf~~a~~ 143 (211)
T PRK14879 136 IDFGLAEF 143 (211)
T ss_pred EECCcccC
Confidence 99999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6e-12 Score=115.06 Aligned_cols=198 Identities=16% Similarity=0.113 Sum_probs=151.2
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHH----HHHHHHHcCCeecCCCC
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLIS----GVSYCHAMQVCHRDLKL 75 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~----~l~~LH~~~iiHrdlkp 75 (293)
-+..|.|.++.+..++.....|+-+ |+|. .+|.++...... ++ .++.++.+... ||..+|+.+++|-|+||
T Consensus 173 ~i~~~~~~v~~~~~~e~~~~lfiqt-E~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp 250 (524)
T KOG0601|consen 173 KIDSHENPVRDSPAWEGSGILFIQT-ELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKP 250 (524)
T ss_pred ccCccccccccCcccccCCcceeee-cccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccch
Confidence 3578899999999999999999999 6877 688888877665 34 88999999999 99999999999999999
Q ss_pred CcEEEcCCCCCCEEEecCCCCcCcCCCCCCC------CCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC
Q 022732 76 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 149 (293)
Q Consensus 76 ~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 149 (293)
.||+...+. ...+++|||+...+....... ...|...|++||...+.. +...|++++|.++.+..++..++
T Consensus 251 ~~i~~~~~~-~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 251 ANIFTTSDW-TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred hheeccccc-ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccc
Confidence 999997663 348999999987655443221 224777899999876533 45589999999999999887666
Q ss_pred CCC--CchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 150 EDP--DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 150 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
... .....+.... .......+.+..+...+..++..+|..|++++.++.|+++...
T Consensus 328 ~~g~~~~W~~~r~~~-------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 328 SVGKNSSWSQLRQGY-------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred cCCCCCCcccccccc-------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 544 2222221111 1111122356777789999999999999999999999988643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.26 E-value=1e-11 Score=102.17 Aligned_cols=74 Identities=16% Similarity=0.113 Sum_probs=62.4
Q ss_pred eeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCC
Q 022732 16 VSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 95 (293)
Q Consensus 16 ~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~ 95 (293)
++...+..++|| ||+.|++|.+++..... .++.+++.+|.+||+.|++|||++|.||+++ + ++++++|||+
T Consensus 65 ~~~~~~~~~lv~-e~~~g~~l~~~~~~~~~-----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~--~~~~liDfg~ 135 (199)
T TIGR03724 65 YDVDPDNKTIVM-EYIEGKPLKDVIEEGND-----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D--DKLYLIDFGL 135 (199)
T ss_pred EEEECCCCEEEE-EEECCccHHHHHhhcHH-----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C--CcEEEEECCC
Confidence 344566678999 79999999988765432 7889999999999999999999999999997 3 4599999999
Q ss_pred CcC
Q 022732 96 SKS 98 (293)
Q Consensus 96 a~~ 98 (293)
++.
T Consensus 136 a~~ 138 (199)
T TIGR03724 136 GKY 138 (199)
T ss_pred CcC
Confidence 864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.1e-12 Score=117.74 Aligned_cols=81 Identities=17% Similarity=0.098 Sum_probs=67.4
Q ss_pred cchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCC
Q 022732 8 SSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 87 (293)
Q Consensus 8 ~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~ 87 (293)
++++..+.++......++|| ||+.|++|.+++. ....++.|++.+|.+||+.|++||||||+||+++ + +.
T Consensus 396 ~~i~~p~~~~~~~~~~~lv~-E~~~g~~L~~~l~------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~--~~ 465 (535)
T PRK09605 396 AGVPTPVIYDVDPEEKTIVM-EYIGGKDLKDVLE------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D--DR 465 (535)
T ss_pred cCCCeeEEEEEeCCCCEEEE-EecCCCcHHHHHH------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C--Cc
Confidence 44445555566667788999 7999999999886 4567899999999999999999999999999993 2 35
Q ss_pred EEEecCCCCcC
Q 022732 88 LKICDFGYSKS 98 (293)
Q Consensus 88 vkl~Dfg~a~~ 98 (293)
++|+|||+++.
T Consensus 466 ~~liDFGla~~ 476 (535)
T PRK09605 466 LYLIDFGLGKY 476 (535)
T ss_pred EEEEeCccccc
Confidence 99999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.4e-11 Score=103.03 Aligned_cols=69 Identities=20% Similarity=0.127 Sum_probs=56.2
Q ss_pred EEeehhhccC-chhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 24 FLSLSFFFSL-CLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 24 ~lv~~ey~~g-g~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
++|+ ||+.| .+|..++... .++. ..+.||+.+|.+||.+||+||||||.|||++.++ .++|+|||.+..
T Consensus 122 ~lV~-e~l~G~~~L~~~l~~~-~l~~--~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILI-ERIEGARDLVALLQEA-PLSE--EQWQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFDRGEL 191 (239)
T ss_pred eEEE-EecCCCCCHHHHHhcC-CCCH--HHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECCCccc
Confidence 5888 79997 6888888653 3332 2367899999999999999999999999997654 599999998863
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.7e-11 Score=98.99 Aligned_cols=71 Identities=14% Similarity=0.158 Sum_probs=59.3
Q ss_pred eeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 21 KFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 21 ~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
...++|| ||+.|++|...... .....++.+++.++.++|..|++||||||.||+++.+ ++++|+|||.+..
T Consensus 104 ~~~~lv~-e~~~g~~L~~~~~~----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~--~~~~liDfg~~~~ 174 (198)
T cd05144 104 NRHAVVM-EYIDGVELYRVRVL----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD--EKIYIIDWPQMVS 174 (198)
T ss_pred CCceEEE-EEeCCcchhhcccc----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC--CcEEEEECCcccc
Confidence 4568899 79999998765431 3456788899999999999999999999999999764 3599999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.6e-11 Score=110.94 Aligned_cols=194 Identities=18% Similarity=0.149 Sum_probs=139.1
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
++.+.+.++.+..|....+.|+-. |||.++++...+.....+. ..+....|++.++.++|+..++|+|+||+||++.
T Consensus 322 l~~~~~~~g~~~~W~~~r~~~ip~-e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~ 400 (524)
T KOG0601|consen 322 LGSHLPSVGKNSSWSQLRQGYIPL-EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILIS 400 (524)
T ss_pred hhcccccCCCCCCccccccccCch-hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeec
Confidence 567888888888999999999666 8999998877664443333 7899999999999999999999999999999998
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccc-hhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA-PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+++ +-.++.|||.++..... .....+.-++.| +|++........+.|++|+|..+.+.+++...-...+... .
T Consensus 401 ~~~-~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~ 474 (524)
T KOG0601|consen 401 NDG-FFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---T 474 (524)
T ss_pred cch-hhhhcccccccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---e
Confidence 754 34699999998752211 112223344442 5554443333445899999999999999875433322211 1
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
+... ..+.....+.++..+.+.++.+++..|+.+.++..|.=|.
T Consensus 475 ----i~~~--~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 ----IRSG--DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----eecc--cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111 1233333558889999999999999999999888876543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.5e-11 Score=111.06 Aligned_cols=160 Identities=18% Similarity=0.260 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCC----------CCCcCCCCccc
Q 022732 48 QARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----------KSTVGTPAYIA 116 (293)
Q Consensus 48 ~~~~~~~qil~~l~~LH-~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~gt~~y~a 116 (293)
.+..-+.++..|+.|+| +.++||+.|.|++|.++.++. +||+.|+.+......... ....-...|.|
T Consensus 100 ~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a 177 (700)
T KOG2137|consen 100 DGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA 177 (700)
T ss_pred HhhhhhhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence 34444556668999999 569999999999999976665 999999987643321111 11124567999
Q ss_pred hhhhccccCCCchhhhhhhhhHHHHHH-hCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCC
Q 022732 117 PEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 195 (293)
Q Consensus 117 PE~~~~~~~~~~~~DvwslG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 195 (293)
||.+.+... ..++|++|+||++|.+. .|+..+........ ...... ............+++++++-|.+++..++.
T Consensus 178 pE~~~~~~~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~-~~~~~~~~~s~~~p~el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 178 PEYLLGTTN-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRN-LLNAGAFGYSNNLPSELRESLKKLLNGDSA 254 (700)
T ss_pred chhhccccc-cccccceeeeeEEEEEecCCcchhhccCCcch-hhhhhc-ccccccccccccCcHHHHHHHHHHhcCCcc
Confidence 999987544 45599999999999998 45555544432111 111111 111112222356889999999999999999
Q ss_pred CCCCHHHHHcCcccccC
Q 022732 196 ARITIPEIMKHQWFLKN 212 (293)
Q Consensus 196 ~Rpt~~ell~h~~~~~~ 212 (293)
.||++..++..+||.+.
T Consensus 255 ~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 255 VRPTLDLLLSIPFFSDP 271 (700)
T ss_pred cCcchhhhhcccccCCc
Confidence 99999999999999754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-09 Score=101.46 Aligned_cols=131 Identities=15% Similarity=0.184 Sum_probs=97.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH-~~~iiHrdlkp~NIl~~~~~ 84 (293)
-|+|++++++.++.+.++|+|+ |-+. .|..++.+.+. ..+..-+.||+.||.||| .++++|++|.-..|+|+..+
T Consensus 67 RHP~Il~yL~t~e~~~~~ylvT-ErV~--Pl~~~lk~l~~-~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G 142 (690)
T KOG1243|consen 67 RHPNILSYLDTTEEEGTLYLVT-ERVR--PLETVLKELGK-EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG 142 (690)
T ss_pred cCchhhhhhhhhcccCceEEEe-eccc--cHHHHHHHhHH-HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC
Confidence 4899999999999999999999 5554 56666666552 266777899999999998 67899999999999997665
Q ss_pred CCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhC
Q 022732 85 APRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 145 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 145 (293)
..||++|-++........ .....---.|..|+.+....+ . .|.|-|||++++++.|
T Consensus 143 --eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~--s-~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 143 --EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW--S-IDSWGLGCLIEELFNG 199 (690)
T ss_pred --cEEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc--c-hhhhhHHHHHHHHhCc
Confidence 499999988754322221 111222223566775543332 2 6999999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.8e-10 Score=91.85 Aligned_cols=73 Identities=19% Similarity=0.117 Sum_probs=56.7
Q ss_pred eEEEeehhhccCchhHH-HHHHcCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 22 FVFLSLSFFFSLCLFFM-WLLLLGLLVQARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 22 ~~~lv~~ey~~gg~L~~-~l~~~~~~~~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
..++|| ||+.|+.+.. .+.......+++.++.+++.++.++|. .|++||||||+||+++ + +.++|+|||.+..
T Consensus 89 ~~~lv~-e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~--~~~~liDfg~a~~ 163 (187)
T cd05119 89 RHVLVM-EFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D--GKVYIIDVPQAVE 163 (187)
T ss_pred CCEEEE-EEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C--CcEEEEECccccc
Confidence 458899 7999954321 121111115788999999999999999 9999999999999997 3 3599999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.4e-10 Score=88.92 Aligned_cols=82 Identities=20% Similarity=0.188 Sum_probs=67.2
Q ss_pred cchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEEcCCC
Q 022732 8 SSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 8 ~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~---~iiHrdlkp~NIl~~~~~ 84 (293)
....+++.++...+..|+++ ||+.|+.+..+ .......++.+++.+|.++|.. +++|+|++|.||+++..
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~-e~~~g~~~~~~-----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~- 125 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLM-EWIEGETLDEV-----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG- 125 (155)
T ss_pred CCCCeEEEEcCCCCccEEEE-EecCCeecccC-----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-
Confidence 34567777777778899999 79999888765 3346667788999999999974 79999999999999763
Q ss_pred CCCEEEecCCCCc
Q 022732 85 APRLKICDFGYSK 97 (293)
Q Consensus 85 ~~~vkl~Dfg~a~ 97 (293)
+.+++.|||.++
T Consensus 126 -~~~~l~Df~~~~ 137 (155)
T cd05120 126 -KILGIIDWEYAG 137 (155)
T ss_pred -cEEEEEeccccc
Confidence 359999999886
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.6e-09 Score=85.24 Aligned_cols=74 Identities=19% Similarity=0.070 Sum_probs=55.9
Q ss_pred eeEEEeehhhccCchhHHHHHHcCCH--HHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 21 KFVFLSLSFFFSLCLFFMWLLLLGLL--VQARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 21 ~~~~lv~~ey~~gg~L~~~l~~~~~~--~~~~~~~~qil~~l~~L-H~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
+.-++|| ||+.+..+.....+...+ .++..+..+++.+|..| |..|+||+||++.||++.. +.+.|+|||.|.
T Consensus 97 ~~~~lvM-E~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~---~~v~iIDF~qav 172 (197)
T cd05146 97 KKHVLVM-SFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD---GKVWFIDVSQSV 172 (197)
T ss_pred cCCEEEE-EEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC---CcEEEEECCCce
Confidence 5677888 799876443222222222 25677889999999998 8999999999999999964 249999999886
Q ss_pred C
Q 022732 98 S 98 (293)
Q Consensus 98 ~ 98 (293)
.
T Consensus 173 ~ 173 (197)
T cd05146 173 E 173 (197)
T ss_pred e
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-08 Score=93.76 Aligned_cols=75 Identities=13% Similarity=0.022 Sum_probs=55.4
Q ss_pred eEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHH-HHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCc
Q 022732 22 FVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLIS-GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 99 (293)
Q Consensus 22 ~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~-~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~ 99 (293)
..++|| ||+.|++|.+.......-.....++.+++. .+..+|..|++|+|++|.||+++.+ ++++++|||++...
T Consensus 232 ~~vLvm-E~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~--g~i~liDfG~~~~l 307 (437)
T TIGR01982 232 ERVLTM-EWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKD--GKIIALDFGIVGRL 307 (437)
T ss_pred CceEEE-EeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCC--CcEEEEeCCCeeEC
Confidence 457888 799999998876542110123344455555 4678899999999999999999655 45999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.4e-08 Score=78.60 Aligned_cols=73 Identities=19% Similarity=0.181 Sum_probs=57.3
Q ss_pred eeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCC
Q 022732 16 VSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 95 (293)
Q Consensus 16 ~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~ 95 (293)
++.+.+...++| ||++|..|.+.+... . ..++..+-.-+.-||.+||+|+||.++||++.... +.++|||+
T Consensus 67 ~dvD~~~~~I~m-e~I~G~~lkd~l~~~-~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGL 137 (204)
T COG3642 67 YDVDPDNGLIVM-EYIEGELLKDALEEA-R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGL 137 (204)
T ss_pred EEEcCCCCEEEE-EEeCChhHHHHHHhc-c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCc
Confidence 345566677888 799999999888776 2 33444555566779999999999999999996543 89999999
Q ss_pred Cc
Q 022732 96 SK 97 (293)
Q Consensus 96 a~ 97 (293)
+.
T Consensus 138 g~ 139 (204)
T COG3642 138 GE 139 (204)
T ss_pred cc
Confidence 86
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.4e-08 Score=83.64 Aligned_cols=76 Identities=16% Similarity=0.112 Sum_probs=61.7
Q ss_pred eeEEEeehhhccCc-hhHHHHHHc--CC--HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-----CCCCCEEE
Q 022732 21 KFVFLSLSFFFSLC-LFFMWLLLL--GL--LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-----SPAPRLKI 90 (293)
Q Consensus 21 ~~~~lv~~ey~~gg-~L~~~l~~~--~~--~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~-----~~~~~vkl 90 (293)
..-++|+ |++.+. +|.+++... .. ......++.++...+.-||.+|++|+|+++.|||++. .+...+.|
T Consensus 108 ~~s~LVt-e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 108 RTSFIIT-EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred ceeEEEE-eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 4577888 799986 888888642 22 2267789999999999999999999999999999975 23456999
Q ss_pred ecCCCCc
Q 022732 91 CDFGYSK 97 (293)
Q Consensus 91 ~Dfg~a~ 97 (293)
+||+.+.
T Consensus 187 IDl~r~~ 193 (268)
T PRK15123 187 IDLHRAQ 193 (268)
T ss_pred EECCccc
Confidence 9999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.2e-07 Score=82.59 Aligned_cols=175 Identities=13% Similarity=0.112 Sum_probs=113.3
Q ss_pred EEEeehhhccCc-hhHHHH---HHcCCHH-----HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecC
Q 022732 23 VFLSLSFFFSLC-LFFMWL---LLLGLLV-----QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 93 (293)
Q Consensus 23 ~~lv~~ey~~gg-~L~~~l---~~~~~~~-----~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Df 93 (293)
+-++| ..+.|. .+..++ ..++..+ -+.++.+.|+.+.+-||..|.+-+|++++|+|+.... .|.|.|=
T Consensus 85 iGflm-P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~--~V~LVds 161 (637)
T COG4248 85 IGFLM-PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS--KVVLVDS 161 (637)
T ss_pred eEEec-ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc--eEEEEcc
Confidence 66666 466654 222222 1222233 6788999999999999999999999999999997655 4888875
Q ss_pred CCCcCcCCCCCCCCCcCCCCccchhhhc-----cccCCCchhhhhhhhhHHHHHHhC-CCCCCCCCc----hHHHH-HHH
Q 022732 94 GYSKSSVLHSQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDE----PKDFR-KTI 162 (293)
Q Consensus 94 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~el~~g-~~pf~~~~~----~~~~~-~~~ 162 (293)
..-............+|.+.|.+||... +..-+.. .|.|.||+++++++.| +.||.+... +.... .|.
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 4333223344455678999999999764 2222334 7999999999999986 899987421 11111 111
Q ss_pred HHH------hcccc----CCCCCCCCCHHHHHHHHHccccC--CCCCCCHH
Q 022732 163 QRI------LSVQY----SVPDTNPISQECRDLISRIFVAD--PAARITIP 201 (293)
Q Consensus 163 ~~~------~~~~~----~~~~~~~~s~~~~~li~~~L~~d--p~~Rpt~~ 201 (293)
... ....+ ..+.+.-+++++..+..+|+... +.-|||++
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 110 00000 11112336789999999999753 55799874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.1e-08 Score=91.88 Aligned_cols=84 Identities=19% Similarity=0.179 Sum_probs=59.5
Q ss_pred cchhhhhceeeeceeE-------------EEeehhhccCchhHHH--HHHcCC----HH--HHHHHHHHHHHHHHHHHHc
Q 022732 8 SSEYAMLGVSVKMKFV-------------FLSLSFFFSLCLFFMW--LLLLGL----LV--QARFFFQQLISGVSYCHAM 66 (293)
Q Consensus 8 ~~~v~~~~~~~~~~~~-------------~lv~~ey~~gg~L~~~--l~~~~~----~~--~~~~~~~qil~~l~~LH~~ 66 (293)
.|..++...|...+.+ ++|| ||+.|+.+.+. +...+. +. .+..++.|++ ..
T Consensus 208 ~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvm-E~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~ 279 (537)
T PRK04750 208 ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVM-ERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RD 279 (537)
T ss_pred HHHHHHHHHccCCCCeecceeecccCCCceEEE-eeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hC
Confidence 3556666666555444 4899 79999999764 444442 22 4555666655 58
Q ss_pred CCeecCCCCCcEEEcCCC--CCCEEEecCCCCcCc
Q 022732 67 QVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 99 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~--~~~vkl~Dfg~a~~~ 99 (293)
|++|+|+||.||+++.++ .++++++|||++...
T Consensus 280 GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 280 GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 999999999999997654 236999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.60 E-value=6.8e-08 Score=77.13 Aligned_cols=75 Identities=20% Similarity=0.181 Sum_probs=56.4
Q ss_pred hhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCC-----eecCCCCCcEEEcCCCC
Q 022732 11 YAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQV-----CHRDLKLENTLLDGSPA 85 (293)
Q Consensus 11 v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~i-----iHrdlkp~NIl~~~~~~ 85 (293)
.+++.+.. ...++|| ||+.|.++... ......++.+++.+|..||..++ +|+|++|.||+++ +
T Consensus 56 P~~~~~~~--~~~~lv~-e~i~G~~l~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-- 123 (170)
T cd05151 56 PKLYYFDP--ETGVLIT-EFIEGSELLTE------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-- 123 (170)
T ss_pred CceEEEeC--CCCeEEE-EecCCCccccc------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C--
Confidence 34555443 3357888 79999988653 11224456789999999999885 9999999999997 2
Q ss_pred CCEEEecCCCCc
Q 022732 86 PRLKICDFGYSK 97 (293)
Q Consensus 86 ~~vkl~Dfg~a~ 97 (293)
++++++||+.+.
T Consensus 124 ~~~~liDf~~a~ 135 (170)
T cd05151 124 GRLWLIDWEYAG 135 (170)
T ss_pred CeEEEEeccccc
Confidence 259999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.8e-07 Score=74.38 Aligned_cols=82 Identities=16% Similarity=0.089 Sum_probs=64.5
Q ss_pred eeeeceeEEEeehhhccC-chhHHHHHHcCCHH---HH-HHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCC-CEE
Q 022732 16 VSVKMKFVFLSLSFFFSL-CLFFMWLLLLGLLV---QA-RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLK 89 (293)
Q Consensus 16 ~~~~~~~~~lv~~ey~~g-g~L~~~l~~~~~~~---~~-~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~-~vk 89 (293)
+|.+...-.++| ||+.| .++.+++.....-+ +. ..++++|-+.+.-||.+++||+||..+||++...+.. .+.
T Consensus 78 ~~~D~~~~~i~M-E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 78 IFIDTYGGQIYM-EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred EEEecCCCeEEE-EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceE
Confidence 455666777888 78888 58888887764433 33 6888888899999999999999999999999776543 348
Q ss_pred EecCCCCcC
Q 022732 90 ICDFGYSKS 98 (293)
Q Consensus 90 l~Dfg~a~~ 98 (293)
++|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.9e-07 Score=76.32 Aligned_cols=87 Identities=17% Similarity=0.086 Sum_probs=67.2
Q ss_pred hhhhceeeec----eeEEEeehhhccCc-hhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 11 YAMLGVSVKM----KFVFLSLSFFFSLC-LFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 11 v~~~~~~~~~----~~~~lv~~ey~~gg-~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.+.+++.+.. ...++|+ |++.+. +|.+++....... ....++.++...+.-||.+||+|+|+++.|||++..
T Consensus 76 P~pva~~~~r~~~~~~s~lit-e~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~ 154 (206)
T PF06293_consen 76 PEPVAYGERRKGGGYRSYLIT-EALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPD 154 (206)
T ss_pred CcEEEEEEEcCCCceeEEEEE-EeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCC
Confidence 3444444442 3457888 688874 8999998743333 778899999999999999999999999999999876
Q ss_pred C-CCCEEEecCCCCcC
Q 022732 84 P-APRLKICDFGYSKS 98 (293)
Q Consensus 84 ~-~~~vkl~Dfg~a~~ 98 (293)
. ...+.++||+.++.
T Consensus 155 ~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 155 DGQYRFYLIDLDRMRF 170 (206)
T ss_pred CCceeEEEEcchhcee
Confidence 4 33689999997763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.8e-07 Score=73.54 Aligned_cols=73 Identities=15% Similarity=0.158 Sum_probs=49.5
Q ss_pred eEEEeehhhcc--CchhHHHHHHcCCHHHHHHHHHHHHHHHHH-HHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 22 FVFLSLSFFFS--LCLFFMWLLLLGLLVQARFFFQQLISGVSY-CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 22 ~~~lv~~ey~~--gg~L~~~l~~~~~~~~~~~~~~qil~~l~~-LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
.-++|| ||+. |..+..+....-.-.....++.+++..+.. +|..|++|+|+.+.||+++.+ .+.++|||.+..
T Consensus 80 ~~~ivM-E~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf~qav~ 155 (188)
T PF01163_consen 80 RNVIVM-EYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDFGQAVD 155 (188)
T ss_dssp TTEEEE-E--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--GTTEEE
T ss_pred CCEEEE-EecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEecCccee
Confidence 456888 7999 766765444331112566777788885555 579999999999999999765 499999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.1e-06 Score=86.69 Aligned_cols=193 Identities=19% Similarity=0.183 Sum_probs=131.5
Q ss_pred CCCcchhhhhceeeeceeEE---EeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 5 GSSSSEYAMLGVSVKMKFVF---LSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~---lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
+.|+|..+++.+..+.-..- .|+.+||.+-++.+.++..+..+ .++.+..+++.||.|+|+....|.-+...-..
T Consensus 239 ~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~ 318 (1351)
T KOG1035|consen 239 IAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSK 318 (1351)
T ss_pred hccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccc
Confidence 56777777777776553333 34457999999999999988877 88999999999999999996666655444211
Q ss_pred E-cCCCCCCEEEe--cCCCCcCcCCCCCCCCCcCCCCccchhhhccccCC-CchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 80 L-DGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD-GKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 80 ~-~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
- +..+.+.+..+ ||+.++............-+..+.++|........ ....|+|.+|.....+..|..+-.....
T Consensus 319 ~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~- 397 (1351)
T KOG1035|consen 319 ESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV- 397 (1351)
T ss_pred ccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-
Confidence 1 11223335544 88887765554444555566677788876554332 2236999999999999887654322111
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
...++... ......+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 398 ------~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 398 ------PVSLLDVL--------STSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred ------hhhhhccc--------cchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 11111110 11267889999999999999999999999998644
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.5e-05 Score=72.72 Aligned_cols=169 Identities=15% Similarity=0.183 Sum_probs=114.9
Q ss_pred Ccchhhhhceee----eceeEEEeehhhccCchhHHHHHHcCC---------------HH--HHHHHHHHHHHHHHHHHH
Q 022732 7 SSSEYAMLGVSV----KMKFVFLSLSFFFSLCLFFMWLLLLGL---------------LV--QARFFFQQLISGVSYCHA 65 (293)
Q Consensus 7 ~~~~v~~~~~~~----~~~~~~lv~~ey~~gg~L~~~l~~~~~---------------~~--~~~~~~~qil~~l~~LH~ 65 (293)
|.|.|.|-++|. ...-+++|.--|...++|.++-....+ .+ ..|.|+.||..||.++|+
T Consensus 332 h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs 411 (655)
T KOG3741|consen 332 HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS 411 (655)
T ss_pred cCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh
Confidence 568888888887 346788888435556788887743321 11 789999999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhC
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 145 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 145 (293)
.|+.-+-|.|.+||++.+. +++|..-|......... + +.+.+. .+-|.-.||.+++.|.||
T Consensus 412 sGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~------~-------~~le~~----Qq~D~~~lG~ll~aLAt~ 472 (655)
T KOG3741|consen 412 SGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP------T-------EPLESQ----QQNDLRDLGLLLLALATG 472 (655)
T ss_pred cCceeecccHhHeEeeCcc--eEEEecccceeeecCCC------C-------cchhHH----hhhhHHHHHHHHHHHhhc
Confidence 9999999999999996543 58887777654322111 0 112221 226999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 146 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 146 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..--...+..... ....+ ...+|.+++++|.-+...+++. -+..+++.+
T Consensus 473 ~~ns~~~d~~~~s--~~~~I---------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 473 TENSNRTDSTQSS--HLTRI---------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ccccccccchHHH--HHHHh---------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 6432222211111 01111 1227899999999999999886 577777765
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.9e-06 Score=68.22 Aligned_cols=65 Identities=12% Similarity=0.070 Sum_probs=49.9
Q ss_pred EEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 23 VFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 23 ~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
..+|| ||++|..|.+...-.. .+...+++++.-||+.|++|+|..|.|+++..++ +++.||+..+
T Consensus 118 ~~ll~-EYIeG~~l~d~~~i~e------~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k~ 182 (229)
T PF06176_consen 118 YVLLM-EYIEGVELNDIEDIDE------DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGKR 182 (229)
T ss_pred EEEEE-EEecCeecccchhcCH------HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECcccc
Confidence 34677 8999998876542211 2345677789999999999999999999997543 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=9.5e-07 Score=82.26 Aligned_cols=191 Identities=19% Similarity=0.147 Sum_probs=129.3
Q ss_pred Ccc-hhhhhceeeeceeEEEeehhhccCc-hhH-HHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 7 SSS-EYAMLGVSVKMKFVFLSLSFFFSLC-LFF-MWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 7 ~~~-~v~~~~~~~~~~~~~lv~~ey~~gg-~L~-~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
++| .+..++-++.+.+..+++ +|+.++ +-. ..-...-.+. +.....+.-.++++++|+---+||| ||+..
T Consensus 292 ~P~~~v~~~~d~~~E~~~~i~~-~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s 366 (829)
T KOG0576|consen 292 NPNPVVRYLEDYDGEDYLWIPM-RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS 366 (829)
T ss_pred CCCCcccccccCCcccccchhh-hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc
Confidence 455 677888888889999999 699988 221 1111111122 5666667778899999988778888 88876
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.+. .|+++|+...........++..+++.|+|||+.....+... .|.|++|.-..++.-|.+|-..+.. .
T Consensus 367 ~~~---~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~--~---- 436 (829)
T KOG0576|consen 367 EEE---VKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPA--V---- 436 (829)
T ss_pred ccc---cccccccCCcccCcccccccCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCcc--c----
Confidence 543 79999999876655555677889999999999988888777 8999999877777777666543211 0
Q ss_pred HHHHhccc--cCCCCCCCCCHHHH-HHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQ--YSVPDTNPISQECR-DLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~--~~~~~~~~~s~~~~-~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
...+.... .........+.... ++...|+..-|..|++...++.|.+|.+.
T Consensus 437 ~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 437 LPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred cCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 00000000 00000011122222 47788999999999999999999998653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.7e-05 Score=65.81 Aligned_cols=87 Identities=15% Similarity=0.091 Sum_probs=57.1
Q ss_pred hhhhhceeeec---eeEEEeehhhccCchhHHHHHHc-CCHHHHHHHHHHHHHHHHHHHH--------------------
Q 022732 10 EYAMLGVSVKM---KFVFLSLSFFFSLCLFFMWLLLL-GLLVQARFFFQQLISGVSYCHA-------------------- 65 (293)
Q Consensus 10 ~v~~~~~~~~~---~~~~lv~~ey~~gg~L~~~l~~~-~~~~~~~~~~~qil~~l~~LH~-------------------- 65 (293)
..+++.+.... +..++|| ||+.|.++...+... -...+...++.+++++|..||+
T Consensus 59 vp~~~~~~~~~~~~~~~~~v~-e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~ 137 (223)
T cd05154 59 VPKVLALCEDPSVLGTPFYVM-ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLER 137 (223)
T ss_pred CCCEEEECCCCCccCCceEEE-EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHH
Confidence 45556665553 3668899 799999887655311 1112444555555555555552
Q ss_pred ------------------------------------cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 ------------------------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ------------------------------------~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
..++|+|++|.||+++.+..+.+.|+||+.+.
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 138 QVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 34799999999999976423347899999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=5.3e-05 Score=62.33 Aligned_cols=77 Identities=8% Similarity=0.039 Sum_probs=60.6
Q ss_pred eeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCC
Q 022732 21 KFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 96 (293)
Q Consensus 21 ~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a 96 (293)
.+-+||+++.-.-.+|.+++.+... .. +...++.++...+.-||..|+.|+|+.+.||+++..+...++++||--+
T Consensus 98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 4578888434444689888866432 22 6688999999999999999999999999999997555445999999876
Q ss_pred c
Q 022732 97 K 97 (293)
Q Consensus 97 ~ 97 (293)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 5
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=1.6e-05 Score=80.86 Aligned_cols=179 Identities=9% Similarity=0.060 Sum_probs=119.1
Q ss_pred eEEEeehhhccCchhHHHHHHcCC-HH-----HHHHHHHHHHHHHHHHHHc-----CCeecCCCCCcEEEcCCCCCCEEE
Q 022732 22 FVFLSLSFFFSLCLFFMWLLLLGL-LV-----QARFFFQQLISGVSYCHAM-----QVCHRDLKLENTLLDGSPAPRLKI 90 (293)
Q Consensus 22 ~~~lv~~ey~~gg~L~~~l~~~~~-~~-----~~~~~~~qil~~l~~LH~~-----~iiHrdlkp~NIl~~~~~~~~vkl 90 (293)
.-|.++ +|+.+|.+++.|.+... .+ -+.....+.+.+..-+|+. -.+|+++|+-|.+|..+. .+|+
T Consensus 1305 ee~~r~-~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny--~v~~ 1381 (2724)
T KOG1826|consen 1305 EEYIRS-LYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY--NVKL 1381 (2724)
T ss_pred HHHHHH-HHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC--cccc
Confidence 345667 69999999999976532 11 3444445557777777743 278999999999996554 4999
Q ss_pred ecCCCCc-CcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc
Q 022732 91 CDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 169 (293)
Q Consensus 91 ~Dfg~a~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 169 (293)
+++|+.+ ............+++.|++|+..+.-.++.+ +|+|..|+-+|....|..+|.. ......+++....
T Consensus 1382 gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~ 1455 (2724)
T KOG1826|consen 1382 GKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSDGNAYFIF-----FLQPALKGIIDNH 1455 (2724)
T ss_pred cccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhcccHHHHH-----HHHHHHcCccccc
Confidence 9999998 3333333445678889999999888787666 9999999999999888777632 2223333333322
Q ss_pred cCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 170 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 170 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
-....+.-.|.++......+|-..-..||.-...+.-+.+
T Consensus 1456 tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1456 TFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred ccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 2222222234445555555556666788877777766654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00043 Score=58.79 Aligned_cols=72 Identities=11% Similarity=0.101 Sum_probs=52.6
Q ss_pred ceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 20 MKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 20 ~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++-.+|| ||++|-.|...--. ...+..++..|+.-+.-+-..|+||+|+.+-||+++.++. +.++||--+.
T Consensus 179 ~nRHaVvM-e~ieG~eL~~~r~~---~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vIDwPQ~v 250 (304)
T COG0478 179 WNRHAVVM-EYIEGVELYRLRLD---VENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVIDWPQAV 250 (304)
T ss_pred cccceeee-ehcccceeecccCc---ccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--EEEEeCcccc
Confidence 35567778 79999766543321 2245556666666666666899999999999999987655 9999997654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0024 Score=59.91 Aligned_cols=75 Identities=15% Similarity=0.085 Sum_probs=50.3
Q ss_pred ceeEEEeehhhccCchhHHHH--HHcCCHHHHHHHHHHHHHH-HHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCC
Q 022732 20 MKFVFLSLSFFFSLCLFFMWL--LLLGLLVQARFFFQQLISG-VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 96 (293)
Q Consensus 20 ~~~~~lv~~ey~~gg~L~~~l--~~~~~~~~~~~~~~qil~~-l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a 96 (293)
.+...++| ||+.|..+.+.. .+.+.- .+.++..++.+ +.-+-..|+.|.|..|.||++..+ +++-+.|||+.
T Consensus 238 t~~~VLtm-E~i~Gi~i~d~~~l~~~g~d--~k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~--g~i~~lDfGi~ 312 (517)
T COG0661 238 TTRRVLTM-EWIDGIKISDIAALKSAGID--RKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSD--GRIVLLDFGIV 312 (517)
T ss_pred cCCcEEEE-EeeCCEecccHHHHHhcCCC--HHHHHHHHHHHHHHHHHhcCccccCCCccceEEecC--CcEEEEcCcce
Confidence 45667788 799999888774 443332 22222222222 222334899999999999999665 46999999998
Q ss_pred cCc
Q 022732 97 KSS 99 (293)
Q Consensus 97 ~~~ 99 (293)
...
T Consensus 313 g~l 315 (517)
T COG0661 313 GRL 315 (517)
T ss_pred ecC
Confidence 654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0019 Score=52.59 Aligned_cols=85 Identities=15% Similarity=0.063 Sum_probs=64.2
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhH-------HHHHHcCCHHHHHHHHHHHHHHHHHHHH---cCCeecCC
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFF-------MWLLLLGLLVQARFFFQQLISGVSYCHA---MQVCHRDL 73 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~-------~~l~~~~~~~~~~~~~~qil~~l~~LH~---~~iiHrdl 73 (293)
+-+.+..++++|+|. +. +|. ||...+++. .++ ......+..++.++++.+.+++. ..+.-.|+
T Consensus 16 l~~~~~~pk~lG~CG---~~-~v~-E~~~~~~~~~~~~~l~~~~--~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv 88 (188)
T PF12260_consen 16 LQGSEPFPKLLGSCG---RF-YVV-EYVGAGSLYGIYRPLSQFL--QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDV 88 (188)
T ss_pred cCCCCCCCCeeeECC---CE-EEE-EeecCcccccccccccccc--ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeec
Confidence 445568899999995 44 455 688877654 222 23455889999999999999996 34667999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCc
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
+|+|+-++.++ ++|++|...+.
T Consensus 89 ~~~nfgv~~~~--~lk~iDld~v~ 110 (188)
T PF12260_consen 89 SPDNFGVNDDG--RLKLIDLDDVF 110 (188)
T ss_pred chHHeEEeCCC--cEEEEechhcc
Confidence 99999997654 59999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0062 Score=57.18 Aligned_cols=76 Identities=12% Similarity=0.054 Sum_probs=51.3
Q ss_pred eeEEEeehhhccCchhH--HHHHHcCCHHHHHHHHHHHHHHH-HHHHHcCCeecCCCCCcEEEcCC--CCCCEEEecCCC
Q 022732 21 KFVFLSLSFFFSLCLFF--MWLLLLGLLVQARFFFQQLISGV-SYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGY 95 (293)
Q Consensus 21 ~~~~lv~~ey~~gg~L~--~~l~~~~~~~~~~~~~~qil~~l-~~LH~~~iiHrdlkp~NIl~~~~--~~~~vkl~Dfg~ 95 (293)
....|+| ||+.|..+. +.|.+.+.-+. .++..+.++. .-|-..|++|+|-.|.||++..+ +.+++.+.|||+
T Consensus 275 t~RVLtM-E~~~G~~i~Dl~~i~~~gi~~~--~i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl 351 (538)
T KOG1235|consen 275 TKRVLTM-EYVDGIKINDLDAIDKRGISPH--DILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGL 351 (538)
T ss_pred cceEEEE-EecCCccCCCHHHHHHcCCCHH--HHHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccc
Confidence 4567888 799998664 44555554331 2333333332 22335789999999999999864 355799999999
Q ss_pred CcCc
Q 022732 96 SKSS 99 (293)
Q Consensus 96 a~~~ 99 (293)
....
T Consensus 352 ~~~i 355 (538)
T KOG1235|consen 352 YAVI 355 (538)
T ss_pred cccc
Confidence 8744
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.017 Score=47.37 Aligned_cols=88 Identities=20% Similarity=0.071 Sum_probs=63.6
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccC------chhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSL------CLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~g------g~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
-...+.+.++||+.++.--.-+|+ |.+.. -+|.++++..+...... ..+-+-..||-..+|+.+|++|.|
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~-e~I~d~dG~~s~TL~~~l~~~~~~~~~~---~~L~~f~~~l~~~~Iv~~dl~~~N 148 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVV-ELIRDADGNISPTLEDYLKEGGLTEELR---QALDEFKRYLLDHHIVIRDLNPHN 148 (199)
T ss_pred CCcccccccEeEEEecCCceEEEE-EEEECCCCCcCccHHHHHHcCCccHHHH---HHHHHHHHHHHHcCCeecCCCccc
Confidence 345677889999999999999999 55543 37888886654333333 333344567889999999999999
Q ss_pred EEEcCCCCC--CEEEec-CCC
Q 022732 78 TLLDGSPAP--RLKICD-FGY 95 (293)
Q Consensus 78 Il~~~~~~~--~vkl~D-fg~ 95 (293)
|++.....+ ++.|+| ||.
T Consensus 149 Iv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEEEecCCCceEEEEEeCCCC
Confidence 999876544 477777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.015 Score=49.27 Aligned_cols=29 Identities=28% Similarity=0.267 Sum_probs=23.9
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~--~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGK--FSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCc--EEEEEEccccc
Confidence 489999999999997643 36799999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.04 Score=46.23 Aligned_cols=28 Identities=21% Similarity=0.283 Sum_probs=23.6
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++|+|+.|.||+++.++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~---~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG---TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC---cEEEechhcC
Confidence 478999999999996533 8999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.024 Score=47.86 Aligned_cols=74 Identities=16% Similarity=0.058 Sum_probs=52.5
Q ss_pred eeEEEeehhhccCch-hHHHHHHcCCHH-HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 21 KFVFLSLSFFFSLCL-FFMWLLLLGLLV-QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 21 ~~~~lv~~ey~~gg~-L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.+..+|| ||+...- -.-.|+.-+.-. ++..+..++++.+.-|-. .++||+||..-|||+.. + .+.++|+|-|.
T Consensus 139 ~~nVLvM-EfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~-~--~p~iID~~QaV 214 (268)
T COG1718 139 RNNVLVM-EFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD-G--EPYIIDVSQAV 214 (268)
T ss_pred cCCeEEE-EeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC-C--eEEEEECcccc
Confidence 3556788 6776541 111122111111 688889999999998887 89999999999999973 2 48999999876
Q ss_pred C
Q 022732 98 S 98 (293)
Q Consensus 98 ~ 98 (293)
.
T Consensus 215 ~ 215 (268)
T COG1718 215 T 215 (268)
T ss_pred c
Confidence 3
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.019 Score=57.61 Aligned_cols=32 Identities=19% Similarity=0.385 Sum_probs=24.8
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
.+||+|+++.||+++......+-|.|+.++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 59999999999999754332346999998764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.018 Score=53.40 Aligned_cols=83 Identities=16% Similarity=0.153 Sum_probs=57.5
Q ss_pred hhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC-------CCCCCCHHHHHHHHHccccCCCCCCCHH
Q 022732 129 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-------DTNPISQECRDLISRIFVADPAARITIP 201 (293)
Q Consensus 129 ~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 201 (293)
++||||+|.++.++..|...|......+....+.+ +........ ....++..++.++.+|+...|..||...
T Consensus 111 KsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k-~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 111 KSDVWSLGFIILELYLGISLEAELTESEYLEILLK-YYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred chhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHH-hccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 59999999999999999887766554443322222 111111000 0112567788999999999999999999
Q ss_pred HHHcCcccccC
Q 022732 202 EIMKHQWFLKN 212 (293)
Q Consensus 202 ell~h~~~~~~ 212 (293)
++.+++-|...
T Consensus 190 ~~~k~~i~~ev 200 (725)
T KOG1093|consen 190 ELSKRCSFTEV 200 (725)
T ss_pred HHhcCccHHHH
Confidence 99999888654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.061 Score=47.37 Aligned_cols=71 Identities=8% Similarity=0.057 Sum_probs=48.1
Q ss_pred eceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCC
Q 022732 19 KMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 96 (293)
Q Consensus 19 ~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a 96 (293)
+.++-++|| |++.|-.|...-.-. .+..+...++.-+--|...|+||+|..--||+++.+. +++++||--.
T Consensus 179 D~~RH~Vvm-elv~g~Pl~~v~~v~----d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~--~i~vIDFPQm 249 (465)
T KOG2268|consen 179 DHNRHCVVM-ELVDGYPLRQVRHVE----DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD--KIVVIDFPQM 249 (465)
T ss_pred cccceeeHH-HhhcccceeeeeecC----ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC--CEEEeechHh
Confidence 445667777 799987776433221 2223333344445557789999999999999997644 4999999754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.12 Score=46.28 Aligned_cols=73 Identities=21% Similarity=0.242 Sum_probs=51.6
Q ss_pred eceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 19 KMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 19 ~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~-~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
+.-+.|++|. ..|++|. .+ +..+..++..++++.+.-+.-+..+ .+-||++.-.||||+ .| .|.|+||.+++
T Consensus 297 e~~y~yl~~k--dhgt~is-~i-k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G--nvtLIDfklsR 369 (488)
T COG5072 297 ETLYLYLHFK--DHGTPIS-II-KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG--NVTLIDFKLSR 369 (488)
T ss_pred CceEEEEEEe--cCCceee-ee-ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC--ceEEEEeeeee
Confidence 3455666663 3344433 22 2334558888999888877777654 689999999999997 44 49999999998
Q ss_pred C
Q 022732 98 S 98 (293)
Q Consensus 98 ~ 98 (293)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.26 E-value=0.16 Score=44.53 Aligned_cols=30 Identities=33% Similarity=0.453 Sum_probs=25.2
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++||+|+.+.||+++.++ .+.+.||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDS--VKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence 6899999999999997653 35899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.13 E-value=0.21 Score=43.75 Aligned_cols=29 Identities=31% Similarity=0.620 Sum_probs=24.3
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.+++|+|+.+.||+++. + .+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C--cEEEEECcccc
Confidence 57899999999999975 2 38999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.61 E-value=0.097 Score=46.17 Aligned_cols=30 Identities=30% Similarity=0.392 Sum_probs=24.3
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++||+|+.|.||+++.+. ..-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~--~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR--LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc--eEEEEeccccc
Confidence 4899999999999997432 24799999875
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.31 E-value=0.19 Score=44.43 Aligned_cols=37 Identities=27% Similarity=0.215 Sum_probs=26.8
Q ss_pred HHHHHHHHHHHHHHHHH----HcCCeecCCCCCcEEEcCCC
Q 022732 48 QARFFFQQLISGVSYCH----AMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 48 ~~~~~~~qil~~l~~LH----~~~iiHrdlkp~NIl~~~~~ 84 (293)
-++.++.||+.-.-.+- ..+++|-||||.|||+-.+.
T Consensus 280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 57778888866443342 24699999999999996543
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.27 E-value=0.14 Score=41.49 Aligned_cols=29 Identities=24% Similarity=0.393 Sum_probs=24.3
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
..+|+|+.|.||+++.++ ++++||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~---~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG---LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC---EEEEeCCcccC
Confidence 379999999999996543 89999998864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.19 E-value=0.19 Score=42.11 Aligned_cols=31 Identities=26% Similarity=0.543 Sum_probs=25.1
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.+++|+|+.+.||+++.. ++.+.++||-.|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~-~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEE-KNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCC-CCCEEEEEcccCC
Confidence 369999999999999752 1249999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.15 E-value=0.36 Score=42.15 Aligned_cols=31 Identities=35% Similarity=0.614 Sum_probs=24.8
Q ss_pred CCeecCCCCCcEEEcCC--CCCCEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~--~~~~vkl~Dfg~a~ 97 (293)
+++|+|+.|.||+++.+ ..+.++++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999753 01249999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=91.82 E-value=0.29 Score=42.54 Aligned_cols=30 Identities=33% Similarity=0.442 Sum_probs=24.5
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++||+|+.|.||+++.++ .+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDE--LSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCc--eEEEeehhhhc
Confidence 4799999999999997543 35799998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.76 E-value=0.17 Score=41.35 Aligned_cols=32 Identities=22% Similarity=0.264 Sum_probs=25.9
Q ss_pred cCCeecCCCCCcEEEcCCCCC---CEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAP---RLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~---~vkl~Dfg~a~ 97 (293)
+.++|||+.+.||++..++.+ .+.+.||..++
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 469999999999999754432 48999999875
|
subfamily of choline kinases |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=91.55 E-value=0.17 Score=42.56 Aligned_cols=30 Identities=27% Similarity=0.264 Sum_probs=23.6
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.+++|+|+.|.||+++..+ ..-|.||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~--i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGR--LSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCC--EEEEEeCcccC
Confidence 3589999999999996432 24599999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=91.29 E-value=0.33 Score=40.09 Aligned_cols=31 Identities=35% Similarity=0.403 Sum_probs=19.8
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
..++|+|+.|.||+++.++ +++-|.||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~-~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSD-GRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESST-TEEEE--GTT-E
T ss_pred cEEEEeccccccceeeecc-ceeEEEecccce
Confidence 4699999999999998322 345799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.26 E-value=0.19 Score=44.55 Aligned_cols=51 Identities=29% Similarity=0.365 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHHHHHHH----HcCCeecCCCCCcEEEcCCCCC----------------CEEEecCCCCcC
Q 022732 48 QARFFFQQLISGVSYCH----AMQVCHRDLKLENTLLDGSPAP----------------RLKICDFGYSKS 98 (293)
Q Consensus 48 ~~~~~~~qil~~l~~LH----~~~iiHrdlkp~NIl~~~~~~~----------------~vkl~Dfg~a~~ 98 (293)
-++.++.|++.-.--+- ..+++|-||||.|||+-.+... +.+|.||.+|..
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 56667777654321121 3469999999999999544321 357888887764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=90.94 E-value=0.36 Score=39.69 Aligned_cols=40 Identities=25% Similarity=0.290 Sum_probs=33.1
Q ss_pred HHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCC
Q 022732 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 96 (293)
Q Consensus 50 ~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a 96 (293)
..-+.+|++-+..+|..||+-+|+++.|.. + -||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~----G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLGIVPRDVKPRNYR---G----GKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCCeeeccCcccccc---C----CEEEecccC
Confidence 345667888899999999999999999986 3 299999864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=90.77 E-value=0.55 Score=40.52 Aligned_cols=48 Identities=25% Similarity=0.306 Sum_probs=35.4
Q ss_pred HHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 48 QARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 48 ~~~~~~~qil~~l~~LH~~--~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
..+..+..+-.++.-.+.. -+||.|+.|.|++.+..+ .++|+||-.|.
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~--~l~LIDWEyAg 182 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG--GLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC--cEEEEecccCC
Confidence 3444555555666665544 699999999999997633 49999998876
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.76 E-value=0.76 Score=41.96 Aligned_cols=63 Identities=8% Similarity=-0.050 Sum_probs=45.8
Q ss_pred eEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEEcCCC
Q 022732 22 FVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 22 ~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~L-H~~~iiHrdlkp~NIl~~~~~ 84 (293)
+.-+++++|..|.++..+++..+... .++.++.-.++|+--+ --.+++|.|+.|.||++..++
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ccceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 33455557999999999998776655 5566666556665443 356899999999999996443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=90.49 E-value=0.23 Score=42.32 Aligned_cols=28 Identities=25% Similarity=0.388 Sum_probs=24.2
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++|+|+.|.||+++.++ +.++||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC---CEEEeccccC
Confidence 589999999999997543 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=89.48 E-value=0.23 Score=40.96 Aligned_cols=30 Identities=33% Similarity=0.682 Sum_probs=18.9
Q ss_pred cCCeecCCCCCcEEE-cCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~-~~~~~~~vkl~Dfg~a~ 97 (293)
..++|.|+.|.||++ +.++ .++++||-.|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~--~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDG--EVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSS--CEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCC--eEEEecHHHHh
Confidence 358999999999999 3333 49999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.08 E-value=0.61 Score=41.50 Aligned_cols=29 Identities=28% Similarity=0.407 Sum_probs=24.3
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 68 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 68 iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
+||+|+.|.||+++.... .+.+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 999999999999976543 36899999765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=88.69 E-value=0.51 Score=42.29 Aligned_cols=30 Identities=30% Similarity=0.685 Sum_probs=24.9
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++|+|+++.||+++... +.+.++||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 589999999999997532 359999998775
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=87.79 E-value=0.85 Score=40.09 Aligned_cols=29 Identities=21% Similarity=0.249 Sum_probs=24.7
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
++||+|+.+.|++++.++ .+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~--~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR--GGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCC--CEEEEEhhhcc
Confidence 799999999999996654 38999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=86.66 E-value=0.6 Score=48.03 Aligned_cols=33 Identities=33% Similarity=0.468 Sum_probs=26.5
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEE-EecCCCCcC
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSKS 98 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vk-l~Dfg~a~~ 98 (293)
.++||.|+.+.|||++.+..+++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 579999999999999866433465 999998753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=86.36 E-value=1.5 Score=38.95 Aligned_cols=29 Identities=31% Similarity=0.500 Sum_probs=24.3
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 68 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 68 iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
++|.|+.+.||+++.++ +.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~-~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDE-GKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCC-CcEEEEcccccC
Confidence 89999999999996432 259999999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=85.95 E-value=0.74 Score=38.56 Aligned_cols=37 Identities=24% Similarity=0.225 Sum_probs=30.5
Q ss_pred HHHHHHHHH--cCCeecCCCCCcEEEcCCCCCCEEEecCCC
Q 022732 57 ISGVSYCHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGY 95 (293)
Q Consensus 57 l~~l~~LH~--~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~ 95 (293)
+.+|.-.|+ .+.+|+|..|+||+-+..+. +||.|-+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhh
Confidence 466777883 47999999999999977665 99999874
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=85.81 E-value=0.65 Score=40.20 Aligned_cols=31 Identities=23% Similarity=0.304 Sum_probs=24.0
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
.++|+|++|.||+++.++. ..-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhccc
Confidence 4899999999999975321 246999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=85.16 E-value=1.4 Score=38.16 Aligned_cols=31 Identities=23% Similarity=0.423 Sum_probs=25.5
Q ss_pred CCeecCCCCCcEEEcCCCCC---CEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGSPAP---RLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~---~vkl~Dfg~a~ 97 (293)
-++|+|+++.||++..++.+ .+++.||-.++
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeecccccc
Confidence 39999999999999776543 58999998765
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=85.14 E-value=1 Score=46.27 Aligned_cols=33 Identities=24% Similarity=0.294 Sum_probs=25.7
Q ss_pred HcCCeecCCCCCcEEEcCCCCCC---EEEecCCCCc
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSK 97 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~---vkl~Dfg~a~ 97 (293)
..++||.|+++.||+++.+..+. .-|+|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 36899999999999998653222 3699999765
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.71 E-value=1.4 Score=39.06 Aligned_cols=28 Identities=18% Similarity=0.213 Sum_probs=23.3
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++||+|+.+.|||++ + . +.+.||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~--~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-G--PHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-C--cEEEeCCCCC
Confidence 4699999999999994 3 2 6899999765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=83.24 E-value=1 Score=39.83 Aligned_cols=31 Identities=16% Similarity=0.290 Sum_probs=26.4
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCcCc
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 99 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~ 99 (293)
.++|+|+++.|++++..+. +=+.||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRP--TGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCe--eEEEeccccccC
Confidence 4899999999999986654 889999998754
|
|
| >PF10446 DUF2457: Protein of unknown function (DUF2457); InterPro: IPR018853 This entry represents a family of uncharacterised proteins | Back alignment and domain information |
|---|
Probab=81.09 E-value=1.7 Score=39.44 Aligned_cols=24 Identities=25% Similarity=0.339 Sum_probs=16.2
Q ss_pred HHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 183 RDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 183 ~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
-++|++- ..+..++|+.+.|+...
T Consensus 13 ddWi~~~--~~~~~KlTi~DtlkKE~ 36 (458)
T PF10446_consen 13 DDWIRQD--TDYKRKLTINDTLKKEN 36 (458)
T ss_pred hhhhhcc--ccccccccHHHHHHHHH
Confidence 3566664 56777888888877543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 293 | ||||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-104 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-103 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-103 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-102 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-102 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-97 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-33 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-30 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-29 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-29 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-29 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-29 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-28 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-28 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-28 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-28 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-28 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-28 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-28 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-28 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-27 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-27 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-26 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-26 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-25 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-25 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-25 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-25 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-25 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-25 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-25 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-25 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-25 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-25 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-25 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-25 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-25 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-25 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-25 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-25 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-25 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-25 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-25 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-25 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-25 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-25 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-25 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-25 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-25 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-25 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-25 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-25 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-25 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-25 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-25 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-25 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-24 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-24 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-24 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-24 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-24 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-24 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-24 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-24 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-24 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-24 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-24 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-23 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-23 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-23 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-23 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-23 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-23 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-23 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-23 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-23 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-23 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-23 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-23 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-23 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-23 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-23 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-23 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-23 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-23 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-23 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-23 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-23 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-23 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-23 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-23 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-23 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-23 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-23 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-22 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-22 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-22 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-22 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-22 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-22 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-22 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-22 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-21 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-21 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-21 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-21 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-21 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-21 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-21 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-21 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-21 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-21 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-21 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-21 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-21 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-21 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-21 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-21 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-21 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-21 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-21 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-21 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-21 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-21 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-21 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-21 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-21 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-21 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-21 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-21 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-21 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-21 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-21 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-20 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-20 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-20 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-20 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-20 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-20 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-20 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-20 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-20 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-19 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-19 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-19 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-18 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-18 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-18 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-18 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-18 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-18 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-18 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-18 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-18 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-18 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-18 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-18 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-18 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-18 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-18 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-18 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-18 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-18 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-18 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-18 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-18 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-18 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-18 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-18 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-17 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-17 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-17 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-17 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 8e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 9e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 9e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 7e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 9e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 9e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-04 |
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 386 bits (994), Expect = e-135
Identities = 199/246 (80%), Positives = 222/246 (90%), Gaps = 1/246 (0%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARFFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
TVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQRILS
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
V+YS+PD IS EC LISRIFVADPA RI+IPEI H WFLKNLPADL++E SQ+
Sbjct: 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQF 296
Query: 228 EEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSG 287
+EP+QPMQS+D IMQII+EA+IPAV L+ +MTDNLD+ DDDMDD DSESE+DIDSSG
Sbjct: 297 QEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDL-DDDMDDFDSESEIDIDSSG 355
Query: 288 EIIYAL 293
EI+YAL
Sbjct: 356 EIVYAL 361
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 2e-90
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 12/213 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 105
A+ FF QL++GV Y H + + HRD+K EN LLD LKI DFG + +++
Sbjct: 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERL 163
Query: 106 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
GT Y+APE+L R E+ + DVWSCG+ L ML G P++ P + +
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSD 220
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
+ + I L+ +I V +P+ARITIP+I K +W+ K L + S
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTS 280
Query: 225 SQYEEP----DQPMQSVDVIMQIIAEASIPAVG 253
E + +QS + + + P G
Sbjct: 281 GGVSESPSGFSKHIQSNLDFSPVNSASRTPGSG 313
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 5e-86
Identities = 61/174 (35%), Positives = 93/174 (53%), Gaps = 10/174 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 105
A+ FF QL++GV Y H + + HRD+K EN LLD LKI DFG + +++
Sbjct: 106 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERL 163
Query: 106 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQ 163
GT Y+APE+L R E+ + DVWSCG+ L ML G P++ P + +++ +
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
Query: 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADL 217
+ + + I L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 224 K----KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 4e-70
Identities = 67/171 (39%), Positives = 92/171 (53%), Gaps = 17/171 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----KSSVLH 102
QARF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S ++L
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGSDALLS 195
Query: 103 SQPKSTVGTPAYIAPEVL--LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160
+TVGTPA++APE L R + GK DVW+ GVTLY + G PF D K
Sbjct: 196 ----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251
Query: 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
I S PD I+++ +DLI+R+ +P +RI +PEI H W +
Sbjct: 252 ----IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-69
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 105
QA +F QLI G+ Y H+ + H+D+K N LL LKI G +++ +
Sbjct: 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDT 167
Query: 106 -KSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
+++ G+PA+ PE+ + G D+WS GVTLY + G YPFE + K F
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN--- 224
Query: 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTM 223
I Y++P DL+ + +PA R +I +I +H WF K P
Sbjct: 225 -IGKGSYAIPGD--CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIP 281
Query: 224 SS-QYEEPDQPMQSVDVIMQI 243
S ++ + M V + +
Sbjct: 282 PSPDTKDRWRSMTVVPYLEDL 302
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-69
Identities = 68/173 (39%), Positives = 94/173 (54%), Gaps = 8/173 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR FQQ++S V YCH V HRDLK EN LLD KI DFG S ++
Sbjct: 112 EARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRT 169
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
+ G+P Y APEV+ Y G D+WSCGV LY +L G PF+D P F+K I
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRG 225
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 220
+ +P+ +++ L+ + DP R TI +I +H+WF ++LP+ L E
Sbjct: 226 GVFYIPEY--LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 9e-69
Identities = 66/195 (33%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR F+Q++S V YCH ++ HRDLK EN LLD +KI DFG+S + + +
Sbjct: 115 EARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDA 172
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
G P Y APE+ +YDG DVWS GV LY ++ G PF+ + + + +L
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLR 228
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
+Y +P +S +C +L+ R V +P R T+ +IMK +W D +
Sbjct: 229 GKYRIPFY--MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELK----PFVE 282
Query: 228 EEPDQPMQSVDVIMQ 242
E D Q IM
Sbjct: 283 PELDISDQKRIDIMV 297
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-68
Identities = 55/174 (31%), Positives = 90/174 (51%), Gaps = 10/174 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR F Q+I+G+ Y H+ + HRDL L N LL + +KI DFG + + +
Sbjct: 113 EARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHY 170
Query: 108 TV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T+ GTP YI+PE+ R + + +DVWS G Y +L+G PF+ K ++
Sbjct: 171 TLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----VV 225
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 220
Y +P +S E +DLI ++ +PA R+++ ++ H + +N DE
Sbjct: 226 LADYEMPSF--LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-68
Identities = 79/185 (42%), Positives = 103/185 (55%), Gaps = 8/185 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ R FFQQ+I + YCH ++ HRDLK EN LLD + +KI DFG S + K+
Sbjct: 109 EGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKT 166
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
+ G+P Y APEV+ Y G DVWSCG+ LYVMLVG PF+D P F+K + S
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNS 222
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
Y +PD +S + LI R+ VADP RITI EI + WF NLP L + + Y
Sbjct: 223 CVYVMPDF--LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 280
Query: 228 EEPDQ 232
+
Sbjct: 281 ADSRI 285
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-67
Identities = 70/194 (36%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
++R FQQ++SGV YCH V HRDLK EN LLD KI DFG S ++
Sbjct: 117 ESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRT 174
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
+ G+P Y APEV+ Y G D+WS GV LY +L G PF+D P F+K I
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICD 230
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
+ P ++ L+ + DP R TI +I +H+WF ++LP L E S
Sbjct: 231 GIFYTPQY--LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSST 288
Query: 228 EEPDQPMQSVDVIM 241
D+ ++ V
Sbjct: 289 MIDDEALKEVCEKF 302
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 7e-67
Identities = 61/172 (35%), Positives = 91/172 (52%), Gaps = 11/172 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR++ +Q++ G Y H +V HRDLKL N L+ +KI DFG + + K
Sbjct: 116 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKK 173
Query: 108 TV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ GTP YIAPEVL + + + DVWS G +Y +LVG PFE + + + I
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLR----IK 228
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN-LPADL 217
+YS+P I+ LI ++ DP AR TI E++ ++F +PA L
Sbjct: 229 KNEYSIPKH--INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-66
Identities = 62/188 (32%), Positives = 81/188 (43%), Gaps = 20/188 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQ 104
AR FF Q++ V +CH V HRD+K EN L+D + LK+ DFG K +V
Sbjct: 150 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYTD- 207
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
GT Y PE + H Y G+ A VWS G+ LY M+ G PFE +
Sbjct: 208 ---FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E 254
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
I+ Q +S EC+ LI P+ R T EI H W L E +
Sbjct: 255 IIRGQVFFRQR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH 312
Query: 225 SQYEEPDQ 232
S P +
Sbjct: 313 SLSPGPSK 320
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 5e-66
Identities = 63/172 (36%), Positives = 92/172 (53%), Gaps = 11/172 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+AR++ +Q++ G Y H +V HRDLKL N L+ +KI DFG + + K
Sbjct: 142 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKK 199
Query: 108 TV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ GTP YIAPEVL + + + DVWS G +Y +LVG PFE ++T RI
Sbjct: 200 VLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIK 254
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN-LPADL 217
+YS+P I+ LI ++ DP AR TI E++ ++F +PA L
Sbjct: 255 KNEYSIPKH--INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 304
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 9e-66
Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 20/175 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQ 104
+R FF Q+++ + +CH+ V HRD+K EN L+D K+ DFG
Sbjct: 140 PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYTD- 197
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
GT Y PE + RH+Y A VWS G+ LY M+ G PFE Q
Sbjct: 198 ---FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQE 244
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 219
IL + P +S +C LI R P++R ++ EI+ W ++
Sbjct: 245 ILEAELHFP--AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 9e-66
Identities = 60/185 (32%), Positives = 94/185 (50%), Gaps = 15/185 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ + +L + +SYCH+ +V HRD+K EN LL + LKI DFG+S S+
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTD 166
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GT Y+ PE++ +D K D+WS GV Y LVG PFE +T +RI
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISR 221
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY 227
V+++ PD +++ RDLISR+ +P+ R + E+++H W N + +
Sbjct: 222 VEFTFPDF--VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS-----KPSNCQNK 274
Query: 228 EEPDQ 232
E +
Sbjct: 275 ESASK 279
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-65
Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 10/167 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
++ F ++L + YCH +V HRD+K EN L+ LKI DFG+S + + ++
Sbjct: 115 RSATFMEELADALHYCHERKVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRT 171
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GT Y+ PE++ +D K D+W GV Y LVG PF+ P + R+ I++
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVN 226
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
V P +S +DLIS++ P R+ + +M+H W N
Sbjct: 227 VDLKFPPF--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-63
Identities = 48/192 (25%), Positives = 75/192 (39%), Gaps = 31/192 (16%)
Query: 48 QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHS 103
+ + +++ SY H +CHRD+K N L+D + R+K+ DFG S+ +
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGESEYMVDKKIKG 209
Query: 104 QPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
+ GT ++ PE Y+G D+WS G+ LYVM PF +
Sbjct: 210 ----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SLVELF 262
Query: 163 QRILSVQYSVPDTNP-----------------ISQECRDLISRIFVADPAARITIPEIMK 205
I + P +S E D + +PA RIT + +K
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
Query: 206 HQWFLKNLPADL 217
H+W DL
Sbjct: 323 HEWLADTNIEDL 334
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-63
Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
A + F+QL+S V Y + HRD+K EN ++ +K+ DFG + +
Sbjct: 131 LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKLFYT 188
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GT Y APEVL+ + Y G ++WS GVTLY ++ PF + +E +
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVE 238
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK--NLPADLVDEKTMSS 225
P +S+E L+S + P R T+ +++ W + NL +E
Sbjct: 239 AAIHPP--YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVF--- 293
Query: 226 QYEEPD 231
+ +P+
Sbjct: 294 RVNKPE 299
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-55
Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 105
+Q+ S + Y H +CHRD+K EN L + + +K+ DFG SK +
Sbjct: 169 LISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 106 ---KSTVGTPAYIAPEVLLRHEYD-GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
+ GTP ++APEVL G D WS GV L+++L+G PF ++ +
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ- 287
Query: 162 IQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
+L+ + + N +S RDL+S + + R ++H W +
Sbjct: 288 ---VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-54
Identities = 60/171 (35%), Positives = 87/171 (50%), Gaps = 9/171 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 106
A + ++S V+YCH + V HRDLK EN L SP LK+ DFG + +
Sbjct: 107 DAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ VGTP Y++P+VL Y G D WS GV +YV+L G PF P + + K I
Sbjct: 167 TKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IR 220
Query: 167 SVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215
++ P+ +S + LI R+ P RIT + ++H+WF K L +
Sbjct: 221 EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-54
Identities = 43/191 (22%), Positives = 75/191 (39%), Gaps = 20/191 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 104
+ + +++ ++ V H + H DLK N L+ LK+ DFG +
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVV 184
Query: 105 PKSTVGTPAYIAPEVLLRHEYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDE 154
S VGT Y+ PE + +DVWS G LY M G PF+
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244
Query: 155 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL- 213
+ I+ + + + ++ +D++ DP RI+IPE++ H +
Sbjct: 245 QI---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301
Query: 214 PADLVDEKTMS 224
P + + + T
Sbjct: 302 PVNQMAKGTTE 312
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 6e-54
Identities = 42/204 (20%), Positives = 77/204 (37%), Gaps = 19/204 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 104
+ + +++ ++ V H + H DLK N L+ LK+ DFG +
Sbjct: 109 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVV 165
Query: 105 PKSTVGTPAYIAPEVLLRHEYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDE 154
S VGT Y+ PE + +DVWS G LY M G PF+
Sbjct: 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
Query: 155 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
+ I+ + + + ++ +D++ DP RI+IPE++ H +
Sbjct: 226 QIS---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282
Query: 215 ADLVDEKTMSSQYEEPDQPMQSVD 238
K + + + + ++
Sbjct: 283 PVNQMAKGTTEEMKYVLGQLVGLN 306
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 1e-53
Identities = 41/204 (20%), Positives = 77/204 (37%), Gaps = 19/204 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 105
+ + +++ ++ V H + H DLK N L+ LK+ DFG + +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVV 212
Query: 106 -KSTVGTPAYIAPEVLLRHEYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDE 154
S VG Y+ PE + +DVWS G LY M G PF+
Sbjct: 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272
Query: 155 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
+ I+ + + + ++ +D++ DP RI+IPE++ H +
Sbjct: 273 QI---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329
Query: 215 ADLVDEKTMSSQYEEPDQPMQSVD 238
K + + + + ++
Sbjct: 330 PVNQMAKGTTEEMKYVLGQLVGLN 353
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-53
Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 8/164 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 106
+Q+++ ++Y H+ V H+DLK EN L SP +KI DFG ++
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ GT Y+APEV + + K D+WS GV +Y +L G PF + +K
Sbjct: 185 NAAGTALYMAPEV-FKRDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----AT 238
Query: 167 SVQYS-VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+ + + P++ + DL+ ++ DP R + +++ H+WF
Sbjct: 239 YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-52
Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 8/171 (4%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKS 107
A QQ++ ++YCH+ + HR+LK EN LL + +K+ DFG +
Sbjct: 107 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GTP Y++PEVL + Y K D+W+CGV LY++LVG PF D D+ + + + I +
Sbjct: 167 FAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKA 221
Query: 168 VQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216
Y P + ++ E + LI + +P RIT + +K W
Sbjct: 222 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-52
Identities = 35/198 (17%), Positives = 74/198 (37%), Gaps = 32/198 (16%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQP 105
+ + ++ G+++ + HR++K N + + K+ DFG ++ Q
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 106 KSTVGTPAYIAPEVLLRHEYD-------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158
S GT Y+ P++ R G D+WS GVT Y G PF + P+
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 159 RKTIQRILSVQYS-------------------VPDTNPISQECRD----LISRIFVADPA 195
++ + +I++ + S +P + +S+ + +++ I AD
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 196 ARITIPEIMKHQWFLKNL 213
+ + +
Sbjct: 293 KCWGFDQFFAETSDILHR 310
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-52
Identities = 56/166 (33%), Positives = 82/166 (49%), Gaps = 8/166 (4%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 107
+ +F Q++ V Y H + HRDLK EN LL +KI DFG+SK S ++
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 108 TVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
GTP Y+APEVL+ + D WS GV L++ L G PF + +I
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQI 232
Query: 166 LSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
S +Y+ +S++ DL+ ++ V DP AR T E ++H W
Sbjct: 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-52
Identities = 60/182 (32%), Positives = 90/182 (49%), Gaps = 12/182 (6%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 107
+ +F Q++ V Y H + HRDLK EN LL +KI DFG+SK S ++
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300
Query: 108 TVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
GTP Y+APEVL+ + D WS GV L++ L G PF + + +I
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQI 357
Query: 166 LSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWF----LKNLPADLVD 219
S +Y+ +S++ DL+ ++ V DP AR T E ++H W +K DL+
Sbjct: 358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLS 417
Query: 220 EK 221
E+
Sbjct: 418 EE 419
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 7e-52
Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
R + L+ + H + + HRDLK EN LLD +K+ DFG+S + +
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREV 183
Query: 109 VGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
GTP+Y+APE++ D GK D+WS GV +Y +L G PF + R
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM--- 240
Query: 164 RILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADL 217
I+S Y + S +DL+SR V P R T E + H +F + + ++
Sbjct: 241 -IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-51
Identities = 51/184 (27%), Positives = 94/184 (51%), Gaps = 7/184 (3%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
F +Q+ G+ + H M + H DLK EN L A ++KI DFG ++ + K
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GTP ++APEV + +++ D+WS GV Y++L G PF ++ +T+ IL+
Sbjct: 248 NFGTPEFLAPEV-VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILA 302
Query: 168 VQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSS 225
++ + D IS+E ++ IS++ + + + RI+ E +KH W + + + +
Sbjct: 303 CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKN 362
Query: 226 QYEE 229
+ +
Sbjct: 363 RGSD 366
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-51
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 21/199 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP- 105
+A + + + + + H+ + HRD+K EN L LK+ DFG++K
Sbjct: 129 EAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNAL 186
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
++ TP Y+APEVL +YD K D+WS GV +Y++L G PF +RI
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245
Query: 166 LSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTM 223
QY P+ + +S++ + LI + DP R+TI + M H W +++
Sbjct: 246 RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV-------- 297
Query: 224 SSQYEEPDQPMQSVDVIMQ 242
P P+ + V+ +
Sbjct: 298 ------PQTPLHTARVLQE 310
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-51
Identities = 57/171 (33%), Positives = 87/171 (50%), Gaps = 13/171 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ R + L+ VS+ HA + HRDLK EN LLD + +++ DFG+S + +
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQ-IRLSDFGFSCHLEPGEKLRE 258
Query: 108 TVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
GTP Y+APE+L + GK D+W+CGV L+ +L G PF + R
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM-- 316
Query: 163 QRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
I+ QY + S +DLISR+ DP AR+T + ++H +F +
Sbjct: 317 --IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-50
Identities = 55/185 (29%), Positives = 91/185 (49%), Gaps = 9/185 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
+A F +Q++ GV+Y H ++ H DLK EN +L P P +K+ DFG + +
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
K+ GTP ++APE++ G AD+WS GV Y++L G PF + ++T+ I
Sbjct: 176 KNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANI 230
Query: 166 LSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTM 223
SV Y + + S+ +D I ++ V + R+TI E ++H W + +
Sbjct: 231 TSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRES 290
Query: 224 SSQYE 228
E
Sbjct: 291 VVNLE 295
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-50
Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 25/194 (12%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--------- 98
+ F+Q++ +SY H+ + HRDLK N +D S +KI DFG +K+
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILK 174
Query: 99 ------SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152
S +GT Y+A EVL + + D++S G+ + M+ YPF
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTG 231
Query: 153 DEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210
E ++++ SV P + + + +I + DP R ++ W
Sbjct: 232 MERV---NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288
Query: 211 KNLPADLVDEKTMS 224
+++ E S
Sbjct: 289 VKHQDEVIKEALKS 302
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-50
Identities = 57/175 (32%), Positives = 89/175 (50%), Gaps = 8/175 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP- 105
+A + ++L+S VS+ H + V HRDLK EN L D + +KI DFG+++ +QP
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI--- 162
K+ T Y APE+L ++ YD + D+WS GV LY ML G PF+ D +
Sbjct: 167 KTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225
Query: 163 QRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215
++I +S +SQE +DLI + DP R+ + + ++W
Sbjct: 226 KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-50
Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 8/171 (4%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 107
A QQ++ ++YCH+ + HR+LK EN LL + +K+ DFG +
Sbjct: 130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GTP Y++PEVL + Y K D+W+CGV LY++LVG PF D D+ + + + I +
Sbjct: 190 FAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKA 244
Query: 168 VQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216
Y P + ++ E + LI + +P RIT + +K W
Sbjct: 245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-50
Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 9/185 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
+A F +Q++ GV+Y H ++ H DLK EN +L P P +K+ DFG + +
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
K+ GTP ++APE++ G AD+WS GV Y++L G PF + ++T+ I
Sbjct: 176 KNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANI 230
Query: 166 LSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTM 223
+V Y + + S+ +D I ++ V + R+TI E ++H W + +
Sbjct: 231 TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRES 290
Query: 224 SSQYE 228
E
Sbjct: 291 VVNLE 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-50
Identities = 60/168 (35%), Positives = 88/168 (52%), Gaps = 9/168 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 106
A +Q+ SG++Y H + HRDLK EN LL+ +KI DFG S +++ K
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+GT YIAPEVL YD K DVWS GV LY++L G PF +E ++ +
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VE 235
Query: 167 SVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
+ +Y+ IS + +DLI ++ P+ RIT + ++H W K
Sbjct: 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-50
Identities = 36/231 (15%), Positives = 84/231 (36%), Gaps = 32/231 (13%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQP 105
+ + ++ G+++ + HR++K N + + K+ DFG ++ Q
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 106 KSTVGTPAYIAPEVLLRHEYD-------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158
S GT Y+ P++ R G D+WS GVT Y G PF + P+
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 159 RKTIQRILSVQYS-------------------VPDTNPISQECRD----LISRIFVADPA 195
++ + +I++ + S +P + +S+ + +++ I AD
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 196 ARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAE 246
+ + + V + ++ + + +++ +
Sbjct: 293 KCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYK 343
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 7e-50
Identities = 23/171 (13%), Positives = 47/171 (27%), Gaps = 25/171 (14%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
Q+I ++ H + H L+ + +LD + + F V +
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE---HLVRDGARVVS 262
Query: 109 VGTPAYIAPEVLLRHE----------YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158
+ + PE+ R D W+ G+ +Y + P
Sbjct: 263 SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS 322
Query: 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+ + I Q R L+ R+ + M+ +
Sbjct: 323 EWIFRSCKN----------IPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-49
Identities = 60/186 (32%), Positives = 97/186 (52%), Gaps = 9/186 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP 105
+A F +Q+++GV Y H++Q+ H DLK EN +L P PR+KI DFG + ++
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
K+ GTP ++APE++ G AD+WS GV Y++L G PF + ++T+ +
Sbjct: 175 KNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANV 229
Query: 166 LSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTM 223
+V Y D + S +D I R+ V DP R+TI + ++H W + K
Sbjct: 230 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAS 289
Query: 224 SSQYEE 229
+ E+
Sbjct: 290 AVNMEK 295
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 56/171 (32%), Positives = 87/171 (50%), Gaps = 4/171 (2%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK 106
+A + + + Y H++ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ TP Y+APEVL +YD K D+WS GV +Y++L G PF RI
Sbjct: 222 TPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 167 SVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215
QY P+ + +S+E + LI + +P R+TI E M H W +++
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-49
Identities = 59/172 (34%), Positives = 78/172 (45%), Gaps = 11/172 (6%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-K 106
A QQ++S V Y H + HRDLK EN L ++ I DFG SK + +
Sbjct: 108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMS 165
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ GTP Y+APEVL + Y K D WS GV Y++L G PF + E K F K I
Sbjct: 166 TACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IK 220
Query: 167 SVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216
Y + IS+ +D I + DP R T + + H W N
Sbjct: 221 EGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-49
Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 8/181 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK 106
+Q++ GV Y H + H DLK +N LL P +KI DFG S+ + +
Sbjct: 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR 191
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+GTP Y+APE+L D+W+ G+ Y++L PF D + + I
Sbjct: 192 EIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----IS 246
Query: 167 SVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
V + + +SQ D I + V +P R T + H W + +L + S
Sbjct: 247 QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETS 306
Query: 225 S 225
S
Sbjct: 307 S 307
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-49
Identities = 55/166 (33%), Positives = 88/166 (53%), Gaps = 9/166 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
+A F +Q++ GV Y H+ ++ H DLK EN +L P PR+K+ DFG + ++
Sbjct: 109 EATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
K+ GTP ++APE++ G AD+WS GV Y++L G PF + + I
Sbjct: 169 KNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----I 223
Query: 166 LSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+V Y + + S+ +D I R+ V DP R+TI + ++H W
Sbjct: 224 SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-49
Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 7/170 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ + +Q G+ + H + H D+K EN + + A +KI DFG + K
Sbjct: 150 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
T T + APE++ R G D+W+ GV YV+L G PF D+ +T+Q +
Sbjct: 210 TTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKR 264
Query: 168 VQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215
+ + + +S E +D I + +P R+T+ + ++H W +
Sbjct: 265 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-49
Identities = 59/168 (35%), Positives = 83/168 (49%), Gaps = 9/168 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQP 105
+A + V Y HA V HRDLK N L ++ICDFG++K +
Sbjct: 117 EASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 106 KST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI-Q 163
T T ++APEVL R YD D+WS GV LY ML G PF + P D + I
Sbjct: 177 LMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFA--NGPDDTPEEILA 233
Query: 164 RILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
RI S ++S+ N +S +DL+S++ DP R+T +++H W
Sbjct: 234 RIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 8e-49
Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 7/163 (4%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
+ Q+ + + H+ + H D++ EN + + +KI +FG ++ +
Sbjct: 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
P Y APEV D+WS G +YV+L G PF ++ I+ I++
Sbjct: 164 FTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNA 218
Query: 169 QYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+Y+ + IS E D + R+ V + +R+T E ++H W
Sbjct: 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 50/231 (21%), Positives = 82/231 (35%), Gaps = 30/231 (12%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPK 106
R + S + Y H ++ HRDLK EN +L G KI D GY+K
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR-- 164
VGT Y+APE+L + +Y D WS G + + G PF +P + ++
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240
Query: 165 ------------ILSVQYSVPDTNPISQECRDLISRIF----VADPAARITIPEIMKHQW 208
+ +P N +S + R + R T P+
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 209 F--------LKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPA 251
F LK L + + + ++ +Q ++ + + IP
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQ--NLKSWLQQDTGIPE 349
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-48
Identities = 57/179 (31%), Positives = 85/179 (47%), Gaps = 7/179 (3%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKS 107
A +Q++ V+Y H + HRDLK EN L +P LKI DFG SK K+
Sbjct: 150 AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GTP Y APE+L Y G D+WS G+ Y++L G PF D + +RIL+
Sbjct: 210 VCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILN 265
Query: 168 VQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
+Y + +S +DL+ ++ V DP R+T + ++H W + +
Sbjct: 266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQK 324
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 164 bits (415), Expect = 3e-48
Identities = 35/213 (16%), Positives = 64/213 (30%), Gaps = 10/213 (4%)
Query: 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYC 63
+ +YA+ + M + L FS F ++ QLI +
Sbjct: 151 LSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 64 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH 123
+ + H +N + RL + D + P AP L
Sbjct: 211 QSKGLVHGHFTPDNLFIMPD--GRLMLGDVS---ALWKVGTRGPASSVPVTYAPREFLNA 265
Query: 124 EYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF---RKTIQRILSVQYSVPDTNPI 178
+ W G+++Y + PF R +++ + + P+
Sbjct: 266 STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL 325
Query: 179 SQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
+ LI R D R+ E M+ FL+
Sbjct: 326 PDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-48
Identities = 61/180 (33%), Positives = 90/180 (50%), Gaps = 5/180 (2%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 106
A +Q+ SG++Y H + HRDLK EN LL+ +KI DFG S +++ K
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+GT YIAPEVL YD K DVWS GV LY++L G PF +E ++ ++
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR-VETG- 237
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 226
+ +P IS + +DLI ++ P+ RIT + ++H W K S +
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-47
Identities = 54/168 (32%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP-K 106
A + +Q++ + YCH + HRD+K LL + +K+ FG +
Sbjct: 132 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
VGTP ++APEV+ R Y GK DVW CGV L+++L G PF E + + I+
Sbjct: 192 GRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGII 245
Query: 167 SVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
+Y + + IS+ +DL+ R+ + DPA RIT+ E + H W +
Sbjct: 246 KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 59/180 (32%), Positives = 89/180 (49%), Gaps = 5/180 (2%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK 106
A +Q++SGV+Y H + HRDLK EN LL +KI DFG S + K
Sbjct: 137 DAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+GT YIAPEVL + YD K DVWS GV L+++L G PF + + RK +++
Sbjct: 197 ERLGTAYYIAPEVLRKK-YDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK-VEKG- 252
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 226
+ P+ +S+ +DLI ++ D RI+ + ++H W + + S
Sbjct: 253 KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLA 312
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 9/182 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK 106
A +Q++SG+ Y H + HRD+K EN LL + + +KI DFG S + +
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+GT YIAPEVL + Y+ K DVWSCGV +Y++L G PF ++ + I+++
Sbjct: 207 DRLGTAYYIAPEVLKKK-YNEK-CDVWSCGVIMYILLCGYPPFGGQND----QDIIKKVE 260
Query: 167 S--VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
+ D IS E ++LI + D R T E + +W K ++
Sbjct: 261 KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTL 320
Query: 225 SQ 226
Sbjct: 321 CG 322
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-47
Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 9/182 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 106
A +Q++SG++Y H ++ HRDLK EN LL+ S ++I DFG S + K
Sbjct: 127 DAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK 186
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+GT YIAPEVL YD K DVWS GV LY++L G PF +E ++++
Sbjct: 187 DKIGTAYYIAPEVLHGT-YDEK-CDVWSTGVILYILLSGCPPFNGANE----YDILKKVE 240
Query: 167 SVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
+Y+ +S+ +DLI ++ P+ RI+ + + H+W + +
Sbjct: 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSL 300
Query: 225 SQ 226
Sbjct: 301 DN 302
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-47
Identities = 63/185 (34%), Positives = 100/185 (54%), Gaps = 17/185 (9%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQ 104
A QQ++ V +CH M V HR+LK EN LL G+ +K+ DFG + Q
Sbjct: 112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQ 168
Query: 105 P-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
GTP Y++PEVL + Y GK D+W+CGV LY++LVG PF D D+ + +++
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ--- 224
Query: 164 RILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN--LPADLVD 219
I + Y P + ++ E +DLI+++ +P+ RIT E +KH W + + +
Sbjct: 225 -IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHR 283
Query: 220 EKTMS 224
++T+
Sbjct: 284 QETVD 288
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 9e-47
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 7/166 (4%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
A + +Q+ G+ + H H DLK EN + + LK+ DFG + K T
Sbjct: 257 AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
GT + APEV G D+WS GV Y++L G PF ++ +T++ + S
Sbjct: 317 TGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSC 371
Query: 169 QYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
+++ D+ + IS++ +D I ++ +ADP R+TI + ++H W
Sbjct: 372 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-46
Identities = 45/206 (21%), Positives = 77/206 (37%), Gaps = 27/206 (13%)
Query: 48 QARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
F Q V + H + + HRDLK+EN LL +K+CDFG + + +
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDY 194
Query: 106 KST-------------VGTPAYIAPEV--LLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 150
+ TP Y PE+ L + G+ D+W+ G LY++ +PFE
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
Query: 151 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210
D RI++ +YS+P + LI + +P R++I E++ +
Sbjct: 255 DG--------AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306
Query: 211 KNLPADLVDEKTMSSQYEEPDQPMQS 236
+ +
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGSAT 332
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-45
Identities = 43/177 (24%), Positives = 70/177 (39%), Gaps = 17/177 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
Q + + G+ HA HRDLK N LL + + D G + +H +
Sbjct: 135 QILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG--QPVLMDLGSMNQACIHVEGSR 192
Query: 108 T----------VGTPAYIAPEV--LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155
T +Y APE+ + H + DVWS G LY M+ G P++ +
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
D ++ + Q S+P + S L++ + DP R IP ++ L+
Sbjct: 253 GD---SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-45
Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 36/244 (14%)
Query: 36 FFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--------- 86
L L +Q+ SGV++ H++++ HRDLK +N L+ S
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163
Query: 87 --RLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYD------GKIADVW 133
R+ I DFG K S + + GT + APE+L + D++
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 134 SCGVTLYVMLVGGY-PFEDPDEPKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLIS 187
S G Y +L G PF D I+ +S+ + + E DLIS
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYS------RESNIIRGIFSLDEMKCLHDRSLIAEATDLIS 277
Query: 188 RIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYE-EPDQPMQSVDVIMQIIAE 246
++ DP R T ++++H F L +S + E E P ++ + ++
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLF-WPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSD 336
Query: 247 ASIP 250
IP
Sbjct: 337 FVIP 340
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 5e-45
Identities = 28/191 (14%), Positives = 56/191 (29%), Gaps = 19/191 (9%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPK 106
Q+I ++ H + H L+ + +LD + + F + + S
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRDGASAVSPIG 270
Query: 107 STVGTPAYIAPEVLLRHEYDGKI----ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
P A +L ++ + D W+ G+ +Y + P D
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI- 329
Query: 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKT 222
I Q R L+ R+ + M+ + + L +L
Sbjct: 330 ---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTELSAALP 379
Query: 223 MSSQYEEPDQP 233
+ EP +
Sbjct: 380 LYQTDGEPTRE 390
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-44
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 28/199 (14%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSK-------- 97
+A Q + S + + H + HRDLK EN L + +P +KICDF
Sbjct: 112 EASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDC 170
Query: 98 SSVLHSQPKSTVGTPAYIAPEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPD 153
S + + + G+ Y+APEV+ + K D+WS GV LY++L G PF
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230
Query: 154 EPKDFRKTI-----------QRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITI 200
+ I +Y PD IS +DLIS++ V D R++
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 201 PEIMKHQWFLKNLPADLVD 219
++++H W P + +
Sbjct: 291 AQVLQHPWVQGCAPENTLP 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-43
Identities = 42/173 (24%), Positives = 71/173 (41%), Gaps = 15/173 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSK----SSV 100
+ QQ SG+++ H++ + HRDLK N L+ + + I DFG K
Sbjct: 119 EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 101 LHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVMLVGGY-PFEDPDEPKD 157
S+ GT +IAPE+L + D++S G Y ++ G PF +
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--- 235
Query: 158 FRKTIQRILSVQYSVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF 209
R+ + + R+LI ++ DP R + ++KH +F
Sbjct: 236 -RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-42
Identities = 38/167 (22%), Positives = 70/167 (41%), Gaps = 13/167 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
A F+Q+ GV Y H+ ++ +RDLK N L + ++KI DFG S +
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTR 180
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
+ GT Y++PE + +Y + D+++ G+ L +L + K +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDT------AFETSKFFTDLRD 233
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
S + ++ + L+ ++ P R EI++ K P
Sbjct: 234 GIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-42
Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 14/172 (8%)
Query: 48 QARFFFQQLISGVSYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 101
QL + CH V HRDLK N LDG +K+ DFG ++ +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHD 169
Query: 102 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
S K+ VGTP Y++PE + R Y+ K +D+WS G LY + PF ++
Sbjct: 170 TSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKEL 224
Query: 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213
+I ++ S E ++I+R+ R ++ EI+++ L++
Sbjct: 225 AGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-42
Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 18/171 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
RF+ +++S + Y H + HRDLK EN LL+ ++I DFG +K S+
Sbjct: 131 CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQAR 188
Query: 108 T---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
VGT Y++PE+L K +D+W+ G +Y ++ G PF +E Q+
Sbjct: 189 ANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQK 243
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP------EIMKHQWF 209
I+ ++Y P+ + RDL+ ++ V D R+ + H +F
Sbjct: 244 IIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-41
Identities = 48/209 (22%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPK 106
Q +F Q+ + + H ++ HRD+K +N L +++ DFG ++ + +
Sbjct: 126 QILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELAR 183
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ +GTP Y++PE+ Y+ K +D+W+ G LY + + FE + + +I+
Sbjct: 184 ACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKII 238
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 226
S + P + S + R L+S++F +P R ++ I++ + K + EK +S Q
Sbjct: 239 SGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI------EKFLSPQ 291
Query: 227 YEEPDQPMQSVDVIMQIIAEASIPAVGTH 255
+ +++ A PA G +
Sbjct: 292 LIAEEFCLKTFSKFGSQPIPAKRPASGQN 320
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-40
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 39/198 (19%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK 106
+A + + + Y H++ + HRD+K EN L P LK+ DFG
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG------------ 165
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
A E +YD K D+WS GV +Y++L G PF RI
Sbjct: 166 --------FAKET-TGEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 215
Query: 167 SVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
QY P+ + +S+E + LI + +P R+TI E M H W +++
Sbjct: 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV--------- 266
Query: 225 SQYEEPDQPMQSVDVIMQ 242
P P+ + V+ +
Sbjct: 267 -----PQTPLHTSRVLKE 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-40
Identities = 38/162 (23%), Positives = 68/162 (41%), Gaps = 11/162 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
Q + + + +++ H+ + H D+K N L P R K+ DFG +
Sbjct: 158 QVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEV 215
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
G P Y+APE+ L+ Y ADV+S G+T+ + P + +++ Q L
Sbjct: 216 QEGDPRYMAPEL-LQGSYGTA-ADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYLP 270
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
++ T +S E R ++ + DP R T ++
Sbjct: 271 PEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-39
Identities = 43/185 (23%), Positives = 78/185 (42%), Gaps = 13/185 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
+ F +L+ + Y ++ HRD+K +N LLD G + I DF + +Q
Sbjct: 116 TVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQI 171
Query: 106 KSTVGTPAYIAPEVLLRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
+ GT Y+APE+ + G D WS GVT Y +L G P+ ++ +
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVH 230
Query: 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARI-TIPEIMKHQWFLKNLPADLVDEKT 222
+ + P SQE L+ ++ +P R + ++ + ++ D V +K
Sbjct: 231 TFETTVVTYPSA--WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM-NDINWDAVFQKR 287
Query: 223 MSSQY 227
+ +
Sbjct: 288 LIPGF 292
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-38
Identities = 56/170 (32%), Positives = 91/170 (53%), Gaps = 19/170 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
+F+ +L + + H++ + +RDLK EN LLD G +K+ DFG SK S+ H +
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKK 182
Query: 106 KSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+ GT Y+APEV+ R + + AD WS GV ++ ML G PF+ D ++T+
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDR----KETMTM 237
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
IL + +P +S E + L+ +F +PA R+ + EI +H +F
Sbjct: 238 ILKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-38
Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 19/170 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
A F+ ++ + + H + +RDLK EN +L+ G +K+ DFG K S+
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTV 177
Query: 106 KSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
T GT Y+APE+L+R + + D WS G +Y ML G PF + +KTI +
Sbjct: 178 THTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENR----KKTIDK 232
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
IL + ++P ++QE RDL+ ++ + A+R+ E+ H +F
Sbjct: 233 ILKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-37
Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 16/172 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
+ + + +++ + + H + + +RD+KLEN LLD G + + DFG SK V
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETE 215
Query: 106 KST--VGTPAYIAPEVLLRHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
++ GT Y+AP+++ + K D WS GV +Y +L G PF E +
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
Query: 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+RIL + P +S +DLI R+ + DP R+ EI +H +F
Sbjct: 276 RRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 60/166 (36%), Positives = 88/166 (53%), Gaps = 15/166 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
+A F+ ++I G+ + H+ + +RDLKL+N LLD G +KI DFG K ++L
Sbjct: 119 RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAK 174
Query: 106 KSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+T GTP YIAPE+LL +Y D WS GV LY ML+G PF DE +
Sbjct: 175 TNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHS 229
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARI-TIPEIMKHQWF 209
I P + +E +DL+ ++FV +P R+ +I +H F
Sbjct: 230 IRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 57/168 (33%), Positives = 89/168 (52%), Gaps = 15/168 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARF+ +++S + Y H+ V +RD+KLEN +LD +KI DFG K +
Sbjct: 106 RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMK 163
Query: 108 TV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP Y+APEVL ++Y G+ D W GV +Y M+ G PF + D + + IL
Sbjct: 164 TFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELIL 218
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+ P T +S E + L++ + DP R+ E+M+H++F
Sbjct: 219 MEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 54/169 (31%), Positives = 80/169 (47%), Gaps = 18/169 (10%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
+ARF+ ++ S + Y H++ + +RDLK EN LLD G + + DFG K ++ H+
Sbjct: 140 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNST 195
Query: 106 KSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
ST GTP Y+APEVL + Y + D W G LY ML G PF + +
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDN 250
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP----EIMKHQWF 209
IL+ + I+ R L+ + D R+ EI H +F
Sbjct: 251 ILNKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 6/174 (3%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 110
+F QL S + + H+ +V HRD+K N + + +K+ D G + S + S VG
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP Y++PE + + Y+ K +D+WS G LY M PF + + ++I Y
Sbjct: 199 TPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEQCDY 255
Query: 171 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
++ S+E R L++ DP R + + + A ++
Sbjct: 256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-36
Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 10/167 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+A F+ ++ G+ H ++ +RDLK EN LLD ++I D G + K
Sbjct: 287 RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKG 344
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
VGT Y+APEV+ Y D W+ G LY M+ G PF+ + + + +
Sbjct: 345 RVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
V + S + R L S++ DPA R+ + E+ +H F
Sbjct: 404 VPEEYSER--FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 15/170 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
+A F+ Q++SG+ + H + +RDLK EN LLD G ++I D G +
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTK 345
Query: 106 KST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
GTP ++APE+LL EY D ++ GVTLY M+ PF E + ++ QR
Sbjct: 346 TKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 404
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+L + PD S +D + DP R+ + + H F
Sbjct: 405 VLEQAVTYPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-36
Identities = 56/169 (33%), Positives = 87/169 (51%), Gaps = 20/169 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
A+F+ ++ + Y H+ + +RDLK EN LLD G +KI DFG++K +
Sbjct: 107 VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVT 160
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
+ GTP YIAPEV+ Y K D WS G+ +Y ML G PF D + KT ++I
Sbjct: 161 YTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKI 215
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
L+ + P +++ +DL+SR+ D + R+ ++ H WF
Sbjct: 216 LNAELRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-36
Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 16/169 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ARF+ ++IS + + H + +RDLKL+N LLD K+ DFG K + + +
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTA 182
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP YIAPE+L Y G D W+ GV LY ML G PFE +E F IL
Sbjct: 183 TFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----IL 237
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI------TIPEIMKHQWF 209
+ + P + ++ ++ +P R+ I++H +F
Sbjct: 238 NDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-36
Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
A F+ ++ G+ + + + +RDLKL+N +LD G +KI DFG K ++
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVT 177
Query: 106 KSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
T GTP YIAPE++ Y GK D W+ GV LY ML G PFE DE + Q
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQS 232
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
I+ + P + +S+E + + P R+ +I +H +F
Sbjct: 233 IMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 7e-36
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 15/169 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
RF+ ++I G+ + H V +RDLK N LLD G ++I D G + +P
Sbjct: 293 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH----VRISDLGLACD-FSKKKP 347
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
++VGT Y+APEVL + AD +S G L+ +L G PF + KD + +
Sbjct: 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMT 406
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
L++ +PD+ S E R L+ + D R+ E+ + +F
Sbjct: 407 LTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-36
Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 20/169 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
ARF+ Q++ Y H++ + +RDLK EN L+D G +++ DFG++K + +
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRT 195
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
+ GTP +APE++L Y K D W+ GV +Y M G PF + + K I
Sbjct: 196 WTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----I 250
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+S + P S + +DL+ + D R + +I H+WF
Sbjct: 251 VSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 39/188 (20%), Positives = 72/188 (38%), Gaps = 24/188 (12%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------- 97
F Q+ V + H+ + HRDLK N +K+ DFG
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQT 176
Query: 98 ---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154
+++ VGT Y++PE + + Y K D++S G+ L+ +L YPF E
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQME 232
Query: 155 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK-NL 213
+T+ + ++++ P ++ + P R I+++ F +
Sbjct: 233 RV---RTLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288
Query: 214 PADLVDEK 221
P V +
Sbjct: 289 PGKTVLRQ 296
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 62/171 (36%), Positives = 87/171 (50%), Gaps = 17/171 (9%)
Query: 49 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 108
ARF+ +++ + H+M HRD+K +N LLD S LK+ DFG +
Sbjct: 170 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD 227
Query: 109 --VGTPAYIAPEVLLRHEYD---GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
VGTP YI+PEVL D G+ D WS GV LY MLVG PF T
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYS 283
Query: 164 RILSVQYSV--PDTNPISQECRDLISRIFVADPAARIT---IPEIMKHQWF 209
+I++ + S+ PD N IS+E ++LI F+ D R+ + EI +H +F
Sbjct: 284 KIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-35
Identities = 61/169 (36%), Positives = 89/169 (52%), Gaps = 16/169 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 106
+ARF+ +++S + Y H+ + V +RDLKLEN +LD +KI DFG K +
Sbjct: 249 RARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATM 306
Query: 107 STV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
T GTP Y+APEVL ++Y G+ D W GV +Y M+ G PF + D K F I
Sbjct: 307 KTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----I 361
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
L + P T + E + L+S + DP R+ EIM+H++F
Sbjct: 362 LMEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-35
Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 21/176 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
ARF+ ++ ++Y H + +RDLKL+N LLD G +K+ D+G K +
Sbjct: 111 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDT 166
Query: 106 KSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----KDFR 159
ST GTP YIAPE+L +Y G D W+ GV ++ M+ G PF+
Sbjct: 167 TSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 225
Query: 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI------TIPEIMKHQWF 209
Q IL Q +P + +S + ++ DP R+ +I H +F
Sbjct: 226 YLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 35/175 (20%), Positives = 68/175 (38%), Gaps = 23/175 (13%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
F Q+ V + H+ + HRDLK N +K+ DFG + + ++
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQT 222
Query: 108 T-------------VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154
VGT Y++PE + + Y K D++S G+ L+ +L Y F E
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFSTQME 278
Query: 155 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+ I + ++++ + ++ + P R +I+++ F
Sbjct: 279 RV---RIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 26/187 (13%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
ARF+ +++ + H + HRD+K +N L+D + +++ DFG + +S
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQS 233
Query: 108 T--VGTPAYIAPEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
+ VGTP YI+PE+L E G D WS GV +Y ML G PF +T
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VET 289
Query: 162 IQRILSVQYSVP---DTNPISQECRDLISRIFVADPAARIT---IPEIMKHQWF------ 209
+I++ + +S+ +DLI R + R+ I + KH +F
Sbjct: 290 YGKIMNHKERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFFSGIDWD 348
Query: 210 -LKNLPA 215
++N A
Sbjct: 349 NIRNCEA 355
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 53/168 (31%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
A F+ ++ G+ + + + +RDLKL+N +LD +KI DFG K ++
Sbjct: 443 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTK 500
Query: 108 TV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
T GTP YIAPE++ Y GK D W+ GV LY ML G PFE DE + Q I+
Sbjct: 501 TFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIM 555
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 209
+ P + +S+E + + P R+ +I +H +F
Sbjct: 556 EHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 15/173 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
ARF+ +++ + H + HRD+K +N LLD +++ DFG +S
Sbjct: 163 MARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRS 220
Query: 108 T--VGTPAYIAPEVLLRHEYD------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159
VGTP Y++PE+L G D W+ GV Y M G PF + +
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
Query: 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT---IPEIMKHQWF 209
K + + + D + +E RD I R + P R+ + H +F
Sbjct: 281 KIVHYKEHLSLPLVDEG-VPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 21/176 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQP 105
ARF+ ++ ++Y H + +RDLKL+N LLD G +K+ D+G K +
Sbjct: 154 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDT 209
Query: 106 KSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----KDFR 159
ST GTP YIAPE+L +Y G D W+ GV ++ M+ G PF+
Sbjct: 210 TSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268
Query: 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI------TIPEIMKHQWF 209
Q IL Q +P + +S + ++ DP R+ +I H +F
Sbjct: 269 YLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 28/184 (15%), Positives = 62/184 (33%), Gaps = 32/184 (17%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKS 98
F +++ + H ++ H D+K +N +L + L + D G S
Sbjct: 173 LVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 99 SVLHSQPKSTV-----GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDP 152
+ PK T+ T + E+L ++ +I D + T+Y ML G Y ++
Sbjct: 233 --MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNE 289
Query: 153 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH---QWF 209
+R+ P + + + ++++ + F
Sbjct: 290 GGECKPEGLFRRL-----------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
Query: 210 LKNL 213
++
Sbjct: 339 QQHY 342
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-30
Identities = 37/182 (20%), Positives = 67/182 (36%), Gaps = 30/182 (16%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-----------------GSPAPRLKI 90
+ + Q+ G+ Y H+M + H D+K N + S KI
Sbjct: 116 ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175
Query: 91 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPF 149
D G+ S P+ G ++A EVL + + K AD+++ +T+
Sbjct: 176 GDLGHVTR---ISSPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLP 231
Query: 150 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+ D+ + R+ + SQE +L+ + DP R + ++KH
Sbjct: 232 RNGDQWHEIRQGRLPRIPQVL--------SQEFTELLKVMIHPDPERRPSAMALVKHSVL 283
Query: 210 LK 211
L
Sbjct: 284 LS 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 42/192 (21%), Positives = 73/192 (38%), Gaps = 15/192 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 101
+A ++ Q + G+ Y H ++ H D+K +N LL R +CDFG++
Sbjct: 151 RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKS 209
Query: 102 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
GT ++APEV++ D K D+WS + ML G +P+
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRG----PL 264
Query: 162 IQRILSVQYSVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 220
+I S + + P + I +P R + E+ + L +
Sbjct: 265 CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL--K 322
Query: 221 KTMSSQYEEPDQ 232
+Y+EP
Sbjct: 323 SPWKGEYKEPRG 334
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-28
Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST 108
F+ +Q++ G+ Y H Q+ HRD+K +N L++ + + LKI DFG SK + ++ ++
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETF 183
Query: 109 VGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
GT Y+APE++ + Y AD+WS G T+ M G PF + EP
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEP----------Q 232
Query: 167 SVQYSVPDTNP-------ISQECRDLISRIFVADPAARITIPEIMKHQW 208
+ + V +S E + I + F DP R +++ ++
Sbjct: 233 AAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-26
Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 15/167 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
R + +Q++ G+ + H + HRDLK +N + G P +KI D G + S
Sbjct: 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFA 187
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQR 164
K+ +GTP ++APE+ +YD DV++ G+ + M YP+ + +R+
Sbjct: 188 KAVIGTPEFMAPEMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245
Query: 165 ILSVQYSVPDTNP--ISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+ P + E +++I + R +I +++ H +F
Sbjct: 246 VK------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-26
Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 21/192 (10%)
Query: 59 GVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 115
GV+Y H+MQ + HRDLK N LL LKICDFG + + + + G+ A++
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWM 170
Query: 116 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----- 170
APEV Y K DV+S G+ L+ ++ PF+ + RI+ +
Sbjct: 171 APEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRP 223
Query: 171 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH-QWFLKNLPADLVDEKTMSSQYEE 229
+ P + L++R + DP+ R ++ EI+K ++ P +
Sbjct: 224 PLIKNLP--KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281
Query: 230 PDQPMQSVDVIM 241
P + + +
Sbjct: 282 PGEDGRVEPYVD 293
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 56/236 (23%), Positives = 100/236 (42%), Gaps = 57/236 (24%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+ + QL+ ++Y H++ +CHRD+K +N LLD LK+ DFG +K +L + +
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVS 200
Query: 109 -VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG--------------------G 146
+ + Y APE++ Y I D+WS G + ++ G G
Sbjct: 201 YICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259
Query: 147 YPFED------PD---------EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 191
P + P+ P F K + P T P + DLISR+
Sbjct: 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFR---------PRTPP---DAIDLISRLLE 307
Query: 192 ADPAARITIPEIMKHQWF--LKNLPADLVDEKTMSSQYE-EPDQPMQSVDVIMQII 244
P+AR+T E + H +F L+ A + + + + + ++ D+I +++
Sbjct: 308 YTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLV 363
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-24
Identities = 53/189 (28%), Positives = 78/189 (41%), Gaps = 36/189 (19%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+ + QL ++Y H+ +CHRD+K +N LLD A LK+CDFG +K L +
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPNVS 215
Query: 109 -VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVM--LVGGYPFEDPDEPKDFRKTIQR 164
+ + Y APE++ +Y I DVWS G V+ L+ G P D D I +
Sbjct: 216 YICSRYYRAPELIFGATDYTSSI-DVWSAGC---VLAELLLGQPIFPGDSGVDQLVEIIK 271
Query: 165 IL--------------SVQYSVPDTNPI----------SQECRDLISRIFVADPAARITI 200
+L ++ P E L SR+ P AR+T
Sbjct: 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 331
Query: 201 PEIMKHQWF 209
E H +F
Sbjct: 332 LEACAHSFF 340
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 44/207 (21%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
RF+ +++ + YCH+M + HRD+K N ++D +L++ D+G ++ H +
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNV 189
Query: 109 -VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPF---ED------------ 151
V + + PE+L+ YD + D+WS G L M+ PF D
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248
Query: 152 -PDEPKDFRKTIQRILSVQYS--------------VPDTNP--ISQECRDLISRIFVADP 194
++ D+ L +++ V N +S E D + ++ D
Sbjct: 249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 308
Query: 195 AARITIPEIMKHQWFLKNLPADLVDEK 221
+R+T E M+H +F +V ++
Sbjct: 309 QSRLTAREAMEHPYF-----YTVVKDQ 330
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 49/192 (25%), Positives = 81/192 (42%), Gaps = 31/192 (16%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST 108
F QLI+GV++CH+ + HRDLK +N LL S A LKI DFG +++ + + +
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 109 -VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG--------------------G 146
+ T Y PE+LL Y + D+WS ML+ G
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255
Query: 147 YPFED--PDEPK--DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 202
P + P D++++ + + E DL++ + DP RI+
Sbjct: 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315
Query: 203 IMKHQWFLKNLP 214
++H +F +
Sbjct: 316 ALEHPYF-SHND 326
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-23
Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 34/193 (17%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VG 110
F QL+ G+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 111 TPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG--------------------GYPF 149
T Y AP+VL+ Y I D+WSCG L M+ G G P
Sbjct: 171 TLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229
Query: 150 ED--------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 201
E P + ++ R L P+ D + + +P R++
Sbjct: 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK 289
Query: 202 EIMKHQWFLKNLP 214
+ + H WF
Sbjct: 290 QALHHPWF-AEYY 301
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-23
Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 30/186 (16%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
+ QL V + H++ +CHRD+K +N L++ LK+CDFG +K + + +
Sbjct: 144 SIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TLKLCDFGSAKKLIPSEPSVAYI 202
Query: 110 GTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGG--YPFED--------------P 152
+ Y APE++L EY I D+WS G +++G + E P
Sbjct: 203 CSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTP 261
Query: 153 DE-------PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEI 203
+ P + + + +P+ P DL+ +I +P RI E
Sbjct: 262 TKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP--SLAIDLLEQILRYEPDLRINPYEA 319
Query: 204 MKHQWF 209
M H +F
Sbjct: 320 MAHPFF 325
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-22
Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 54 QQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGT 111
++ + + H+ + V HRD+K N L++ ++K+CDFG S V K G
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLV-DDVAKDIDAGC 172
Query: 112 PAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
Y+APE + + Y K +D+WS G+T+ + + +P++ P ++++
Sbjct: 173 KPYMAPERINPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQ---QLKQV-- 226
Query: 168 VQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
V+ P + S E D S+ + R T PE+M+H +F
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 40/194 (20%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VG 110
+ QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + + + V
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVRSYTHEVV 181
Query: 111 TPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG--------------------GYPF 149
T Y AP+VL+ +Y + D+WS G M+ G G P
Sbjct: 182 TLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240
Query: 150 ED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 200
P + + F+ ++ S QE DL+S + DP RI+
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIP-----GFCQEGIDLLSNMLCFDPNKRISA 295
Query: 201 PEIMKHQWFLKNLP 214
+ M H +F K+L
Sbjct: 296 RDAMNHPYF-KDLD 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.3 bits (233), Expect = 2e-22
Identities = 50/192 (26%), Positives = 81/192 (42%), Gaps = 38/192 (19%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
A+ F QL++G++YCH +V HRDLK +N L++ LKI DFG +++ + + +
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYT 158
Query: 108 T-VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-------------------- 145
+ T Y AP+VL+ +Y I D+WS G M+ G
Sbjct: 159 HEIVTLWYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
Query: 146 GYPFED--------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 197
G P P +F + + DL+S++ DP R
Sbjct: 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLK-----GLDESGIDLLSKMLKLDPNQR 272
Query: 198 ITIPEIMKHQWF 209
IT + ++H +F
Sbjct: 273 ITAKQALEHAYF 284
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 43/197 (21%)
Query: 54 QQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 112
+I G++Y ++ HRD+K N L++ +K+CDFG S + S S VGT
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTR 194
Query: 113 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 172
+Y++PE L Y + +D+WS G++L M VG YP PD + ++
Sbjct: 195 SYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253
Query: 173 PDTNPI--------------------------------------SQECRDLISRIFVADP 194
P S E +D +++ + +P
Sbjct: 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313
Query: 195 AARITIPEIMKHQWFLK 211
A R + ++M H + +
Sbjct: 314 AERADLKQLMVHAFIKR 330
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 3e-22
Identities = 49/212 (23%), Positives = 72/212 (33%), Gaps = 52/212 (24%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQP 105
Q++ G+ Y HA V HRDLK N L+ G R +KI D G ++ +
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 106 KSTVGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVG------------------ 145
V T Y APE+LL RH Y I D+W+ G +L
Sbjct: 193 DPVVVTFWYRAPELLLGARH-YTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250
Query: 146 -----------GYPFED------------PDEPKDFRKTIQRILSVQYSVPDTNPISQEC 182
G+P + R T ++Y +
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310
Query: 183 RDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
L+ ++ DP RIT + M+ +F P
Sbjct: 311 FHLLQKLLTMDPIKRITSEQAMQDPYF-LEDP 341
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-22
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 40/215 (18%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VG 110
F QL+ G++YCH +V HRDLK +N L++ LK+ DFG +++ + ++ V
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVV 162
Query: 111 TPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG--------------------GYPF 149
T Y P++LL +Y +I D+W G Y M G G P
Sbjct: 163 TLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221
Query: 150 ED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 200
E+ + + ++ K L + + DL++++ + RI+
Sbjct: 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAP-----RLDSDGADLLTKLLQFEGRNRISA 276
Query: 201 PEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQ 235
+ MKH +F +L + +S + + +Q
Sbjct: 277 EDAMKHPFF-LSLGERIHKLPDTTSIFALKEIQLQ 310
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-22
Identities = 40/173 (23%), Positives = 73/173 (42%), Gaps = 20/173 (11%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 110
+Q G+ Y HA + HRDLK N L +KI DFG + Q + G
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 111 TPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
+ ++APEV+ + Y + +DV++ G+ LY ++ G P+ + + + + R
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQ-SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR--- 240
Query: 168 VQYSVPDTNPISQEC----RDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216
PD + + C + L++ R + P I+ ++ L +
Sbjct: 241 -GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE---IEELARE 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-22
Identities = 41/160 (25%), Positives = 66/160 (41%), Gaps = 22/160 (13%)
Query: 59 GVSYCHAM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 113
G+ Y + HRDL+ N L + K+ DFG S+ +G
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191
Query: 114 YIAPEVLL-RHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY- 170
++APE + E Y K AD +S + LY +L G PF++ K I+ I ++
Sbjct: 192 WMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREE 245
Query: 171 ----SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
++P+ P R++I + DP R I+K
Sbjct: 246 GLRPTIPEDCP--PRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-22
Identities = 47/190 (24%), Positives = 74/190 (38%), Gaps = 36/190 (18%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---ST 108
+Q + G+ + HA + HRDLK EN L+ +K+ DFG ++ +S
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPV 179
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------------GYP 148
V T Y APEVLL+ Y + D+WS G M G P
Sbjct: 180 VVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238
Query: 149 FED--PDEPK--DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 204
ED P + + VQ VP+ + + L+ + +P RI+ +
Sbjct: 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPE---MEESGAQLLLEMLTFNPHKRISAFRAL 295
Query: 205 KHQWFLKNLP 214
+H + K+
Sbjct: 296 QHSYLHKDEG 305
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 50/207 (24%), Positives = 81/207 (39%), Gaps = 31/207 (14%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+ + Q+I+G+ +CH+ + HRD+K EN L+ S +K+CDFG++++ +
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVYDDE 184
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL-- 166
V T Y APE+L+ GK DVW+ G L + G P D D I L
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243
Query: 167 --------------SVQYSVPDTNP----------ISQECRDLISRIFVADPAARITIPE 202
+P+ +S+ DL + DP R E
Sbjct: 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303
Query: 203 IMKHQWFLK-NLPADLVDEKTMSSQYE 228
++ H +F E + Q +
Sbjct: 304 LLHHDFFQMDGFAERFSQELQLKVQKD 330
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-22
Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 26/191 (13%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTP 112
++++ G+ Y H+ + HRD+K N LL +K+ DFG + ++T VGTP
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTP 183
Query: 113 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 172
++APEV+ + YD K AD+WS G+T + G P + P + V + +
Sbjct: 184 FWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELH-P----------MKVLFLI 231
Query: 173 PDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP-----ADLVDEK 221
P NP S+ ++ + +P+ R T E++KH++ L+N +L+D
Sbjct: 232 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRY 291
Query: 222 TMSSQYEEPDQ 232
+ D
Sbjct: 292 KRWKAEQSHDD 302
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 7e-22
Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 38/194 (19%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VG 110
F QL+ G+ +CH+ V HRDLK +N L++ + LK+ +FG +++ + + S V
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVV 163
Query: 111 TPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPF------ED-----------P 152
T Y P+VL Y I D+WS G + G P +D P
Sbjct: 164 TLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 153 DE---P--------KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 201
E P K + S+ VP ++ RDL+ + +P RI+
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATT-SLVNVVPK---LNATGRDLLQNLLKCNPVQRISAE 278
Query: 202 EIMKHQWFLKNLPA 215
E ++H +F +
Sbjct: 279 EALQHPYF-SDFCP 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVG 110
++ + + + H+ QV HRD+K +N LL DG +K+ DFG+ + + S+ + VG
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP ++APEV+ R Y K D+WS G+ M+ G P+ + + P L Y
Sbjct: 179 TPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRALY 226
Query: 171 SVPDTNP--------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
+ +S RD ++R D R + E+++HQ FLK
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ-FLKI 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 28/170 (16%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVG 110
+ ++ ++Y HA V HRD+K ++ LL DG R+K+ DFG+ + S + KS VG
Sbjct: 148 EAVLQALAYLHAQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVG 203
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP ++APEV+ R Y + D+WS G+ + M+ G P+ D P +
Sbjct: 204 TPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMK 251
Query: 171 SVPDTNP--------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
+ D+ P +S RD + R+ V DP R T E++ H FL
Sbjct: 252 RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP-FLLQ 300
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 55/231 (23%), Positives = 79/231 (34%), Gaps = 58/231 (25%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
L R F ++ + H ++ H DLK EN LL +K+ DFG SS Q
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQR 255
Query: 106 KST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG------------------- 145
T + + Y APEV+L Y I D+WS G L +L G
Sbjct: 256 VYTYIQSRFYRAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314
Query: 146 -GYP--------------FEDPDEPKDFRKTIQRILSVQYS-----------VPDTNPIS 179
G P P+ T SV + P++
Sbjct: 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG 374
Query: 180 QECR--------DLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKT 222
+ D + + DPA R+T + ++H W + LP EKT
Sbjct: 375 NALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKT 425
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 45/209 (21%), Positives = 75/209 (35%), Gaps = 39/209 (18%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T 108
+ Q + V++CH HRD+K EN L+ +K+CDFG+++ L
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYD 160
Query: 109 --VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------------G 146
V T Y +PE+L+ G DVW+ G +L G G
Sbjct: 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG 220
Query: 147 YPFED----PDEPKDFRKT----IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 198
+ F + + ++ P+ IS L+ DP R+
Sbjct: 221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN---ISYPALGLLKGCLHMDPTERL 277
Query: 199 TIPEIMKHQWFLK-NLPADLVDEKTMSSQ 226
T +++ H +F DL E ++
Sbjct: 278 TCEQLLHHPYFENIREIEDLAKEHDKPAE 306
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 40/170 (23%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 54 QQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 112
++ + Y V HRD+K N LLD ++K+CDFG S V + G
Sbjct: 131 VAIVKALYYLKEKHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDKAKDRSAGCA 188
Query: 113 AYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
AY+APE + + +YD + ADVWS G++L + G +P+++ + + ++L
Sbjct: 189 AYMAPERIDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTD---FEVLTKVLQ 244
Query: 168 VQY-SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216
+ +P S + + + D R ++++H + + +
Sbjct: 245 EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 35/189 (18%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--V 109
QL+ G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ Q T V
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVV 180
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------------GYPF 149
T Y APEVLL+ Y + D+WS G M G P
Sbjct: 181 VTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 150 ED--PDEPK--DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
E+ P + + ++ V D I + +DL+ + +PA RI+ +
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTD---IDELGKDLLLKCLTFNPAKRISAYSALS 296
Query: 206 HQWFLKNLP 214
H +F ++L
Sbjct: 297 HPYF-QDLE 304
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 12/192 (6%)
Query: 54 QQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 112
+ +++ +++ HRD+K N LLD S +K+CDFG S V G
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCR 189
Query: 113 AYIAPEVL----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
Y+APE + R YD + +DVWS G+TLY + G +P+ + D + +
Sbjct: 190 PYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248
Query: 169 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL--KNLPADLVD--EKTMS 224
Q S + S + ++ D + R E++KH + L + ++ K +
Sbjct: 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILD 308
Query: 225 SQYEEPDQPMQS 236
P PM
Sbjct: 309 QMPATPSSPMYV 320
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 48/202 (23%), Positives = 76/202 (37%), Gaps = 42/202 (20%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQP-K 106
Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 107 STVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-------------------- 145
+ V T Y PE+LL +Y I D+W G + M
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 146 GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 196
G + E + K +R + + DLI ++ V DPA
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK---AYVRDPYALDLIDKLLVLDPAQ 302
Query: 197 RITIPEIMKHQWFLKN-LPADL 217
RI + + H +F + +P+DL
Sbjct: 303 RIDSDDALNHDFFWSDPMPSDL 324
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-21
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 24/158 (15%)
Query: 59 GVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPA 113
G++Y H + HR+LK N L+D +K+CDFG S+ + S KS GTP
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKY--TVKVCDFGLSR--LKASTFLSSKSAAGTPE 204
Query: 114 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--- 170
++APEVL + K +DV+S GV L+ + P+ + + Q + +V +
Sbjct: 205 WMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLN-------PAQVVAAVGFKCK 256
Query: 171 --SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
+P + +I + +P R + IM
Sbjct: 257 RLEIPRNLN--PQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-21
Identities = 31/152 (20%), Positives = 54/152 (35%), Gaps = 14/152 (9%)
Query: 59 GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 116
G+++ H ++ + L + ++D +I S Q + PA++A
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVA 176
Query: 117 PEVLLRHEYDGKI--ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 174
PE L + D AD+WS V L+ ++ PF D + ++
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD----LSNMEIGMKVALEGLRPTI 232
Query: 175 TNPISQECRDLISRIFVADPAARITIPEIMKH 206
IS L+ DPA R I+
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 9e-21
Identities = 47/165 (28%), Positives = 67/165 (40%), Gaps = 29/165 (17%)
Query: 58 SGVSYCHAM---QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKST 108
G++Y H + HRDLK N L+ LKI DFG ++ + S
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-WHRTTKMSA 174
Query: 109 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
G A++APEV+ + +DVWS GV L+ +L G PF D L+V
Sbjct: 175 AGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDG-----------LAV 222
Query: 169 QYSVPDTN---PISQEC----RDLISRIFVADPAARITIPEIMKH 206
Y V PI C L+ + DP +R + I+
Sbjct: 223 AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-21
Identities = 45/245 (18%), Positives = 85/245 (34%), Gaps = 66/245 (26%)
Query: 33 LCLFF--MWLLLLGLL----------VQARFFFQQLISGVSYCHAM-QVCHRDLKLENTL 79
+ + F + LL L+ + + +QL+ G+ Y H + H D+K EN L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 80 LDGSPAPR----LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSC 135
++ +P +KI D G + +++ T Y +PEVLL + D+WS
Sbjct: 165 MEIVDSPENLIQIKIADLG--NACWYDEHYTNSIQTREYRSPEVLLGAPWGCGA-DIWST 221
Query: 136 GVTLYVMLVGGYPFEDPDE----------------------------------------- 154
++ ++ G + FE +
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 281
Query: 155 ---PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211
K ++ +L+ +Y ++E D +S + DP R ++ H W
Sbjct: 282 RNISKLKFWPLEDVLTEKYKFSKDE--AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
Query: 212 NLPAD 216
L +
Sbjct: 340 TLGME 344
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKST 108
+++ G+ Y H HRD+K N LL + ++I DFG S + K+
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 109 VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ---- 163
VGTP ++APEV+ + YD K AD+WS G+T + G P+ K T+Q
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245
Query: 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEK 221
+ + + R +IS DP R T E+++H++F K + + EK
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 43/192 (22%), Positives = 73/192 (38%), Gaps = 37/192 (19%)
Query: 50 RFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ F QLI + H ++ VCHRD+K N L++ + LK+CDFG +K +
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPSEPNVA 190
Query: 108 TVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGG--YPFED------------- 151
+ + Y APE++ Y + D+WS G M++G + ++
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249
Query: 152 -PDE-------PKDFRKTIQRILSVQYS------VPDTNPISQECRDLISRIFVADPAAR 197
P P + + +S E DL+S + P R
Sbjct: 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAK---EAYDLLSALLQYLPEER 306
Query: 198 ITIPEIMKHQWF 209
+ E + H +F
Sbjct: 307 MKPYEALCHPYF 318
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 33/196 (16%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVG 110
Q + G+ Y H M+ HRD+K N LL +G K+ DFG + + + ++ + +G
Sbjct: 132 QSTLKGLEYLHFMRKIHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIG 187
Query: 111 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 170
TP ++APEV+ Y+ AD+WS G+T M G P+ D P + +
Sbjct: 188 TPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYAD-IHP----------MRAIF 235
Query: 171 SVPDTNP--------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP-----ADL 217
+P P S D + + V P R T ++++H F+++ DL
Sbjct: 236 MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP-FVRSAKGVSILRDL 294
Query: 218 VDEKTMSSQYEEPDQP 233
++E + Q
Sbjct: 295 INEAMDVKLKRQESQQ 310
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-20
Identities = 53/196 (27%), Positives = 81/196 (41%), Gaps = 46/196 (23%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST- 108
+ + G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ +
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQ 172
Query: 109 VGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVG--------------------G 146
V T Y APE+L R Y + D+W+ G L +L+ G
Sbjct: 173 VVTRWYRAPELLFGARM-YGVGV-DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230
Query: 147 YPFED--------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 198
P E+ PD F+ + + + + DLI +F+ +P ARI
Sbjct: 231 TPTEEQWPDMCSLPDY-VTFKS--FPGIPLHHIFSA---AGDDLLDLIQGLFLFNPCARI 284
Query: 199 TIPEIMKHQWFLKNLP 214
T + +K ++F N P
Sbjct: 285 TATQALKMKYF-SNRP 299
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-20
Identities = 50/235 (21%), Positives = 77/235 (32%), Gaps = 60/235 (25%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-----------------PRL 88
L R QL + + H Q+ H DLK EN L S +
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 89 KICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-- 145
++ DFG S+ + +T V T Y PEV+L + DVWS G L+ G
Sbjct: 182 RVADFG---SATFDHEHHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFT 237
Query: 146 ------------------GYP-------------FED-----PDEPKDFRKTIQRILSVQ 169
G F + D R + ++
Sbjct: 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK 297
Query: 170 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
+ + + DL+ R+ DPA RIT+ E + H +F P + + +
Sbjct: 298 SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-20
Identities = 34/180 (18%), Positives = 70/180 (38%), Gaps = 34/180 (18%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKS 107
Q+++ G+ Y HA + H+DLK +N D ++ I DFG + + +
Sbjct: 137 QEIVKGMGYLHAKGILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 108 TVGTPAYIAPEVL---------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158
G ++APE++ + + +DV++ G Y + +PF+
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQP----- 247
Query: 159 RKTIQRILSVQY----SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
I + ++ + +E D++ + + R T ++M L+ LP
Sbjct: 248 --AEAIIWQMGTGMKPNLSQIG-MGKEISDILLFCWAFEQEERPTFTKLMDM---LEKLP 301
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 32/176 (18%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VG 110
++++ G+S+ H +V HRD+K +N LL + +K+ DFG S ++T +G
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIG 191
Query: 111 TPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
TP ++APEV+ E YD K +D+WS G+T M G P D P
Sbjct: 192 TPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMH-P---------- 239
Query: 166 LSVQYSVPDTNP-------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
+ + +P S++ + I V + + R ++MKH F+++ P
Sbjct: 240 MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQP 294
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 40/198 (20%), Positives = 70/198 (35%), Gaps = 32/198 (16%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------SSVLH 102
SG++Y H+M + HRDL N L+ + + + DFG ++
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 103 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
+ + VG P ++APE++ YD K DV+S G+ L ++ D
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYL-------PR 228
Query: 163 QRILSVQYSVPDTNPISQEC----RDLISRIFVADPAARITIPEIMKHQWFLKNLPADLV 218
+ C + R DP R + ++ +L+ L L
Sbjct: 229 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE---HWLETLRMHLA 285
Query: 219 DEKTMSSQYEEPDQPMQS 236
+ Q E+ D+
Sbjct: 286 GHLPLGPQLEQLDRGFWE 303
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 52/220 (23%), Positives = 77/220 (35%), Gaps = 60/220 (27%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-----------------PRL 88
L R Q+ V++ H+ ++ H DLK EN L S P +
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 89 KICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-- 145
K+ DFG S+ + ST V T Y APEV+L + DVWS G L +G
Sbjct: 177 KVVDFG---SATYDDEHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFT 232
Query: 146 ------------------GYP-------------FED-----PDEPKDFRKTIQRILSVQ 169
G F + R + ++
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292
Query: 170 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+ + + DLI ++ DPA RIT+ E +KH +F
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 4e-19
Identities = 29/150 (19%), Positives = 54/150 (36%), Gaps = 20/150 (13%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+A + +++ +SY H++ + + DLK EN +L +LK+ D G +
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGY 236
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GTP + APE++ D+++ G TL + + + +
Sbjct: 237 LYGTPGFQAPEIVRTGPTVA--TDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVL-- 291
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAAR 197
L+ R DP R
Sbjct: 292 ---------KTYDSYGRLLRRAIDPDPRQR 312
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-19
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 41/197 (20%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
+ Q++ G+ + H+ + HRDLK N ++ LKI DFG ++++ V
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYV 187
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------------GYPF 149
T Y APEV+L Y + D+WS G + M+ G G P
Sbjct: 188 VTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 150 ED-----------------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 192
+ F K +L S + + RDL+S++ V
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS-EHNKLKASQARDLLSKMLVI 305
Query: 193 DPAARITIPEIMKHQWF 209
D + RI++ E ++H +
Sbjct: 306 DASKRISVDEALQHPYI 322
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-19
Identities = 44/224 (19%), Positives = 84/224 (37%), Gaps = 36/224 (16%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 110 GTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-------------EP 155
Y APE+++ + + D+WS G + M F P
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 156 KDFRKTIQRILS------VQYSVPDTNPI---------SQECRDLISRIFVADPAARITI 200
K + + S ++ S+ + DLI+++ +P RI+
Sbjct: 254 KI--EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311
Query: 201 PEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQII 244
+ ++H + ++L D +D S+ D+ + V + +I
Sbjct: 312 EQALRHP-YFESL-FDPLDLTEGLSERFHFDESVTDVYDMHKIF 353
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-19
Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 37/192 (19%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
R F QL+ G+ Y H+ V HRDLK N ++ + LKI DFG ++ H K
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 109 ---VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------- 154
+ T Y +P +LL + Y I D+W+ G ML G F E
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
Query: 155 ----PKDFRKTIQR-----ILSVQYS--------VPDTNPISQECRDLISRIFVADPAAR 197
++ R+ + I + +P + E D + +I P R
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR---EAVDFLEQILTFSPMDR 297
Query: 198 ITIPEIMKHQWF 209
+T E + H +
Sbjct: 298 LTAEEALSHPYM 309
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-19
Identities = 53/230 (23%), Positives = 75/230 (32%), Gaps = 65/230 (28%)
Query: 46 LVQARFFFQQLISGVSYCHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 103
L R F QQ+ + + + + + H DLK EN LL +KI DFG SS
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLG 212
Query: 104 QPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG----------------- 145
Q + + Y +PEVLL YD I D+WS G L M G
Sbjct: 213 QRIYQYIQSRFYRSPEVLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271
Query: 146 ---------------------------GYPFEDPDEPK-----DFRKTIQRILSVQYSVP 173
+ + + K + + IL V+ P
Sbjct: 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGP 331
Query: 174 DTNPISQECR---------DLISRIFVADPAARITIPEIMKHQWFLKNLP 214
+ DLI R+ DP RI ++H +F K
Sbjct: 332 GGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-19
Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 35/188 (18%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
++ Q++ G+ Y H+ V HRDLK N ++ LKI DFG ++ + + T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTG 182
Query: 109 -VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------ 154
V T Y APEV+L Y+ + D+WS G + ML G F+ D
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241
Query: 155 --PKDFRKTIQRILSVQY--SVPDTNPI---------SQECRDLISRIFVADPAARITIP 201
+F + + + Y S+P T S + DL+ ++ D R+T
Sbjct: 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301
Query: 202 EIMKHQWF 209
+ + H +F
Sbjct: 302 QALTHPFF 309
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 8e-19
Identities = 47/199 (23%), Positives = 78/199 (39%), Gaps = 45/199 (22%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+ Q++ G+ + H+ + HRDLK N ++ LKI DFG +++ + T
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTP 222
Query: 109 -VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------------GY 147
V T Y APEV+L Y + D+WS G + M+ G
Sbjct: 223 YVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281
Query: 148 PFED-----------------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 190
P + F K L S + + + RDL+S++
Sbjct: 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL-KASQARDLLSKML 340
Query: 191 VADPAARITIPEIMKHQWF 209
V DPA RI++ + ++H +
Sbjct: 341 VIDPAKRISVDDALQHPYI 359
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-19
Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVG 110
+Q++ +++ H+ ++ HRDLK N L+ +G +++ DFG S K+ + S +G
Sbjct: 124 RQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIG 179
Query: 111 TPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
TP ++APEV++ YD K AD+WS G+TL M P + P
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP---------- 227
Query: 166 LSVQYSVPDTNP--------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP--- 214
+ V + ++P S E RD + +P R + ++++H +
Sbjct: 228 MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287
Query: 215 -ADLVDEK 221
+LV E
Sbjct: 288 LRELVAEA 295
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 18/150 (12%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP 112
Q+ S + HA HRD+K EN L+ S + DFG + + +Q +TVGT
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTL 199
Query: 113 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-VQYS 171
Y+APE + AD+++ LY L G P++ + + + + +
Sbjct: 200 YYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQG--------DQLSVMGAHINQA 250
Query: 172 VP---DTNP-ISQECRDLISRIFVADPAAR 197
+P P I +I+R +P R
Sbjct: 251 IPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 35/188 (18%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+F Q++ G+ Y HA + HRDLK N ++ LKI DFG ++ + + T
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTG 184
Query: 109 -VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------ 154
V T Y APEV+L Y + D+WS G + M+ G F+ D
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243
Query: 155 --PKDFRKTIQRILSVQY--SVPDTNPI---------SQECRDLISRIFVADPAARITIP 201
P +F + +Q + Y +P+ S +L+ ++ V D R+T
Sbjct: 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303
Query: 202 EIMKHQWF 209
E + H +F
Sbjct: 304 EALAHPYF 311
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 35/188 (18%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+F Q++ G+ Y H+ + HRDLK N ++ LKI DFG ++ + + T
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTG 188
Query: 109 -VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------ 154
V T Y APE++L Y+ + D+WS G + +L G F D
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 155 --PKDFRKTIQRILSVQY--SVPDTNPI---------SQECRDLISRIFVADPAARITIP 201
+ K I + Y S+ + + DL+ ++ V D RIT
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
Query: 202 EIMKHQWF 209
+ + H +F
Sbjct: 308 QALAHAYF 315
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-18
Identities = 47/228 (20%), Positives = 77/228 (33%), Gaps = 68/228 (29%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-------------------- 85
+ + + +++ ++Y M + H DLK EN LLD
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 86 ---PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 141
+K+ DFG + S + + T Y APEV+L +D D+WS G L
Sbjct: 196 TKSTGIKLIDFG---CATFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAE 251
Query: 142 MLVG--------------------GYP---------------FEDPDEPK----DFRKTI 162
+ G + + DE K + +I
Sbjct: 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSI 311
Query: 163 QRILSVQYSVPDTNPISQEC-RDLISRIFVADPAARITIPEIMKHQWF 209
I V+ +P I E D + I DP R + E++KH++
Sbjct: 312 NSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 27/163 (16%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHS 103
+A +++ H + HRD+K N ++ S +K+ DFG + S +
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVT 174
Query: 104 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
Q + +GT Y++PE D + +DV+S G LY +L G PF D P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTG-DSP-------- 224
Query: 164 RILSVQY--------SVPDTNP-ISQECRDLISRIFVADPAAR 197
+SV Y + +S + ++ + +P R
Sbjct: 225 --VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 49/190 (25%), Positives = 77/190 (40%), Gaps = 33/190 (17%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
+F Q++ G+ Y H+ V HRDLK N LL+ + LKICDFG ++ +
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFL 188
Query: 109 ---VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---------- 154
V T Y APE++L Y I D+WS G L ML F
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247
Query: 155 ----PKDFRKTIQRILSVQY--SVPDTNPI---------SQECRDLISRIFVADPAARIT 199
++ I + + Y S+P N + + DL+ ++ +P RI
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307
Query: 200 IPEIMKHQWF 209
+ + + H +
Sbjct: 308 VEQALAHPYL 317
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 39/219 (17%), Positives = 73/219 (33%), Gaps = 55/219 (25%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQP 105
Q ++ + Y H M HR +K + L+ + + + + V+H P
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 106 KSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFED------------ 151
K +V +++PEVL + YD K +D++S G+T + G PF+D
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 152 ----------------------------PDEPKDFRKTIQRILSVQYSVPDTNPISQECR 183
T + S P S
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 184 DLISRIFVADPAARITIPEIMKHQWF--LKNLPADLVDE 220
+ + +P AR + ++ H +F +K ++ + E
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPE 350
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 35/205 (17%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
+ G++Y H+ + HRD+K N LL G +K+ DFG + + S VGT
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGT 213
Query: 112 PAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 168
P ++APEV+L +YDGK DVWS G+T + P + +S
Sbjct: 214 PYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFN-MNA----------MSA 261
Query: 169 QYSVPDTNP-------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP----ADL 217
Y + S+ R+ + P R T ++KH++ L+ P DL
Sbjct: 262 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 321
Query: 218 VDEKTMSSQYEEPDQPMQSVDVIMQ 242
+ + + + Q + ++ Q
Sbjct: 322 IQRTKDAVRELDNLQYRKMKKILFQ 346
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP 105
A F Q++ G+ + H M++ HRD+K +N L+D LKI DFG +K S +Q
Sbjct: 112 TAINFTNQILDGIKHAHDMRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQT 169
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----KDFRK 160
+GT Y +PE D D++S G+ LY MLVG PF + K +
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQD 227
Query: 161 TIQRILSVQYSVPDTNP-ISQECRDLISRIFVADPAAR 197
++ + + D I Q ++I R D A R
Sbjct: 228 SVPNVTT------DVRKDIPQSLSNVILRATEKDKANR 259
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 55/201 (27%), Positives = 81/201 (40%), Gaps = 47/201 (23%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQP 105
++F Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEP 172
Query: 106 KST-------VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG------------ 145
V T Y APEV+L +Y + DVWSCG L + +
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQ 231
Query: 146 --------GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI---------SQECRDLISR 188
G P D D + + S+P + + DL+ R
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIK---SLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 189 IFVADPAARITIPEIMKHQWF 209
+ V DPA RIT E ++H +
Sbjct: 289 MLVFDPAKRITAKEALEHPYL 309
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-17
Identities = 36/182 (19%), Positives = 67/182 (36%), Gaps = 36/182 (19%)
Query: 58 SGVSYCHAMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQ 104
SG+ + H + HRDLK +N L+ + I D G + ++ +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVKFISDTNEVDIP 202
Query: 105 PKSTVGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---PK 156
P + VGT Y+ PEVL H +AD++S G+ L+ + +E P
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 157 DFRKTIQRILSVQYSV-------------PDTNPISQECRDLISRIFVADPAARITIPEI 203
+ ++ ++ L++ + +PA+R+T +
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 204 MK 205
K
Sbjct: 323 KK 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 6e-17
Identities = 37/183 (20%), Positives = 71/183 (38%), Gaps = 38/183 (20%)
Query: 58 SGVSYCHA--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQ 104
SG+++ H + HRDLK +N L+ + I D G + + +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIA 207
Query: 105 PKSTVGTPAYIAPEVL-----LRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-- 156
P VGT Y+APEVL ++H E + AD+++ G+ + + ++ +
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 157 --DFRKTIQRILSVQYSV------------PDTNPISQECRDLISRIFVADPAARITIPE 202
D + + ++ V + + ++ + A+ AAR+T
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 203 IMK 205
I K
Sbjct: 327 IKK 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 8e-17
Identities = 39/189 (20%), Positives = 72/189 (38%), Gaps = 38/189 (20%)
Query: 52 FFQQLISGVSYCHAMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----S 98
+ SG+++ H + HRDLK +N L+ + + I D G + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLAVMHSQST 167
Query: 99 SVLHSQPKSTVGTPAYIAPEVL------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152
+ L VGT Y+APEVL + + D+W+ G+ L+ +
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIV 226
Query: 153 DEPKD-FRKTIQRILSVQY------------SVPDT---NPISQECRDLISRIFVADPAA 196
++ K F + S + ++P+ +P L+ + +P+A
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSA 286
Query: 197 RITIPEIMK 205
R+T I K
Sbjct: 287 RLTALRIKK 295
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 47/224 (20%), Positives = 77/224 (34%), Gaps = 67/224 (29%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 108
++ QLI + Y H+ + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNI 169
Query: 109 ---------------------VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG- 145
V T Y APE+LL +Y I D+WS G L +L G
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGK 228
Query: 146 -------------------GYPFED------------------PDEPKDFRKTIQRILSV 168
+P +
Sbjct: 229 PIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKW 288
Query: 169 QYSVPDTNP---ISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+ + NP ++E DL+ ++ +P RI+ + +KH +
Sbjct: 289 KNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 43/237 (18%), Positives = 71/237 (29%), Gaps = 80/237 (33%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
+ L+ G ++ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVN 189
Query: 110 GTPA-----------------------YIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG 145
Y APE++L + Y I D+WS G +L
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNM 248
Query: 146 ------------------------GYPFEDPDEPKDFRKTIQRILSV------------- 168
K R + I ++
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN 308
Query: 169 -----QY--SVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQWF 209
+Y P PI S + +L+ + +P RITI + + H +
Sbjct: 309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-14
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 11/107 (10%)
Query: 57 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPA 113
I G+ H + HRD+K +N LL + I DFG + T VGT
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 114 YIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155
Y+APEVL + + + D+++ G+ L+ + + P +
Sbjct: 199 YMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 46/245 (18%), Positives = 73/245 (29%), Gaps = 88/245 (35%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
+ L+ GV Y H+ + HRDLK N L++ +K+CDFG +++ S +
Sbjct: 159 KTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQL 216
Query: 110 GTPA----------------------------YIAPEVLLR-HEYDGKIADVWSCG---- 136
Y APE++L Y I DVWS G
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIFA 275
Query: 137 -----------------------VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----- 168
+ + + R + I ++
Sbjct: 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS 335
Query: 169 -------------QY--SVPDTNPI---------SQECRDLISRIFVADPAARITIPEIM 204
+Y P S + L+ R+ V +P RITI E +
Sbjct: 336 EEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECL 395
Query: 205 KHQWF 209
H +F
Sbjct: 396 AHPFF 400
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-13
Identities = 41/212 (19%), Positives = 67/212 (31%), Gaps = 49/212 (23%)
Query: 58 SGVSYCHAM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SS 99
G++Y H + HRDL N L+ I DFG S
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPG 179
Query: 100 VLHSQPKSTVGTPAYIAPEVL------LRHEYDGKIADVWSCGVTLYVML---------- 143
+ S VGT Y+APEVL E K D+++ G+ + +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 144 -VGGY--PFEDPDEPKDFRKTIQRILSVQY---SVPDTNPISQECRDLISRIFV----AD 193
V Y F+ + +Q ++S + P+ + + D
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 194 PAARITIPEIMKHQWFLKNLPADLVDEKTMSS 225
AR+T + + L K++S
Sbjct: 300 AEARLTAQXAEER---MAELMMIWERNKSVSP 328
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 5e-12
Identities = 42/254 (16%), Positives = 71/254 (27%), Gaps = 93/254 (36%)
Query: 46 LVQARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLD----------------------- 81
L + QQ++ G+ Y H ++ H D+K EN LL
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 82 ------------------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 117
+ ++KI D G + +H + T Y +
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSL 262
Query: 118 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE--DPDEPKDFRKTIQRILSV------- 168
EVL+ Y+ AD+WS + + G Y FE +E I I+ +
Sbjct: 263 EVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321
Query: 169 ---------QYSVPDTNPIS------------------------QECRDLISRIFVADPA 195
++ + D + + P
Sbjct: 322 LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE 381
Query: 196 ARITIPEIMKHQWF 209
R T E ++H W
Sbjct: 382 KRATAAECLRHPWL 395
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 20/151 (13%), Positives = 35/151 (23%), Gaps = 30/151 (19%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
A Q L + H V + S +
Sbjct: 130 GAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV--SIDGDVV------------------ 169
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
+ PA + D+ G +LY +LV +P + +
Sbjct: 170 -LAYPATMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAG 220
Query: 168 VQYSVPDTNP-ISQECRDLISRIFVADPAAR 197
D + I + + +R D R
Sbjct: 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 59 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYI 115
G+++ H HRD+K N LLD + KI DFG ++ S ++ VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 116 APEVLLRHEYDGKIADVWSCGVTLYVMLVG 145
APE L K +D++S GV L ++ G
Sbjct: 203 APEALRGEITP-K-SDIYSFGVVLLEIITG 230
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 4e-08
Identities = 37/90 (41%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 59 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPAYI 115
G+ Y H + HRD+K N LLD + P KI DFG SK Q STV GT YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 116 APEVLLRHEYDGKIADVWSCGVTLYVMLVG 145
PE ++ K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK-SDVYSFGVVLFEVLCA 237
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 11/119 (9%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
+ Q+ G+ + + + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 112 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQR 164
A + APE + Y + +DVWS GV L+ + +G P+ ++F + ++
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 26/103 (25%), Positives = 43/103 (41%), Gaps = 6/103 (5%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
Q+ S + Y HR+L N L+ + +K+ DFG S+ +
Sbjct: 323 MATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAK 380
Query: 112 PAY--IAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
APE L +++ K +DVW+ GV L+ + G P+
Sbjct: 381 FPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 29/104 (27%), Positives = 43/104 (41%), Gaps = 11/104 (10%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 113
+G+ Y + HRDL N L+ LKI DFG S+ + G
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLR 275
Query: 114 YI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
+ APE L Y + +DVWS G+ L+ +G P+ +
Sbjct: 276 QVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPN 318
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
+ Q+ G+ Y + HRDL N L+ + R+KI DFG +K + + V
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTKV-LPQDKEYYKVKE 206
Query: 112 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY 140
P APE L ++ +DVWS GV LY
Sbjct: 207 PGESPIFWYAPESLTESKFSVA-SDVWSFGVVLY 239
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
+ Q+ G+ Y + HRDL N L+ + R+KI DFG +K + + V
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTKV-LPQDKEFFKVKE 175
Query: 112 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY 140
P APE L ++ +DVWS GV LY
Sbjct: 176 PGESPIFWYAPESLTESKFSVA-SDVWSFGVVLY 208
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 28/103 (27%), Positives = 43/103 (41%), Gaps = 6/103 (5%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
Q+ SG++Y M HRDL+ N L+ + K+ DFG ++ +
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAK 342
Query: 112 PAY--IAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
APE L + K +DVWS G+ L + G P+
Sbjct: 343 FPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-07
Identities = 32/124 (25%), Positives = 51/124 (41%), Gaps = 10/124 (8%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
+ Q+ G+ Y + + HRDL N L+ S A +KI DFG +K + + V
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAKL-LPLDKDYYVVRE 188
Query: 112 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRI 165
P APE L + + + +DVWS GV LY + E + +
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
Query: 166 LSVQ 169
++
Sbjct: 248 PALS 251
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 28/103 (27%), Positives = 43/103 (41%), Gaps = 6/103 (5%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
Q+ SG++Y M HRDL+ N L+ + K+ DFG ++ +
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAK 425
Query: 112 PAY--IAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
APE L + K +DVWS G+ L + G P+
Sbjct: 426 FPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 4e-07
Identities = 31/92 (33%), Positives = 41/92 (44%), Gaps = 20/92 (21%)
Query: 59 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----G 110
G++Y H ++ HRD+K N LLD + DFG +K L + V G
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVRG 197
Query: 111 TPAYIAPEVLLRHEYDGKI---ADVWSCGVTL 139
T +IAPE L GK DV+ GV L
Sbjct: 198 TIGHIAPEYLST----GKSSEKTDVFGYGVML 225
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 8e-07
Identities = 28/107 (26%), Positives = 41/107 (38%), Gaps = 12/107 (11%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KST 108
+ Q+ G+ Y + + HRDL N LL + +KI DFG + L
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQ 181
Query: 109 VGTPAYI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
APE L + +D W GVTL+ + G P+
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 9e-07
Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P 112
Q+ G++Y ++ HRDL N L+ +P +KI DFG +K + G P
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 113 -AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
++A E +L Y + +DVWS GVT++ +M G P++
Sbjct: 183 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 9e-07
Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 12/104 (11%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F + + Y HRDL N L+ K+ DFG +K + +
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTG 346
Query: 112 PAYI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
+ APE L ++ K +DVWS G+ L+ + G P+
Sbjct: 347 KLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPR 389
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 36/111 (32%), Positives = 48/111 (43%), Gaps = 16/111 (14%)
Query: 42 LLGLLVQARFFFQQLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 94
L L + QL+ G++Y HA HRDL N LL + +KI DFG
Sbjct: 122 LRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL-DNDR-LVKIGDFG 179
Query: 95 YSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY 140
+K+ V V APE L +++ +DVWS GVTLY
Sbjct: 180 LAKA-VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLY 228
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 8/104 (7%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
Q+ S + Y HRDL N L+ + +K+ DFG S+ + + G
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRL-MTGDTYTAHAGA 172
Query: 112 --PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
P + APE L +++ K +DVW+ GV L+ + G P+
Sbjct: 173 KFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPG 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
+ Q+ G+ Y + HR+L N LL SP+ ++++ DFG + +L K + +
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYS 175
Query: 112 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
A A E + +Y + +DVWS GVT++ +M G P+
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 113
+ G++Y V HRDL N L+ + +K+ DFG ++ VL Q S+ GT
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRF-VLDDQYTSSTGTKF 167
Query: 114 YI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
+ +PEV Y K +DVWS GV ++ V G P+E+
Sbjct: 168 PVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F Q+ G+++ HRDL+ N L+ S KI DFG ++ + ++ + G
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGA 345
Query: 112 PAYI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
I APE + + K +DVWS G+ L ++ G P+
Sbjct: 346 KFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPG 388
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVG 110
+ Q+ G+ Y + Q HRDL N L+ S ++KI DFG +K + + + TV
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVK 186
Query: 111 TPAYI-----APEVLLRHEYDGKIADVWSCGVTLY 140
APE L++ ++ +DVWS GVTL+
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLH 220
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 8/103 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTP 112
+ + +G+ Y + HRDL N L+D + K+ DFG S+ +T G
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 113 AYI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
I APE + + +DVWS GV ++ V+ G P+ +
Sbjct: 216 IPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 3e-06
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 8/102 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 113
+ G+++ + Q HRDL N L+D +K+ DFG ++ VL Q S+VGT
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRY-VLDDQYVSSVGTKF 167
Query: 114 YI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
+ APEV +Y K +DVW+ G+ ++ V +G P++
Sbjct: 168 PVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-06
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 12/104 (11%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F + + Y HRDL N L+ S K+ DFG +K + +
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTG 174
Query: 112 PAYI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
+ APE L ++ K +DVWS G+ L+ + G P+
Sbjct: 175 KLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-06
Identities = 27/104 (25%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
Q+ G+++ HRDL+ N L+ + + KI DFG ++ + ++ + G
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARL-IEDNEYTAREGA 170
Query: 112 PAYI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
I APE + + K +DVWS G+ L ++ G P+
Sbjct: 171 KFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 7/104 (6%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
+ Q+ G++Y ++ HRDL N L+ +P +KI DFG +K + G
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 112 --P-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
P ++A E +L Y + +DVWS GVT++ +M G P++
Sbjct: 180 KVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 6e-06
Identities = 32/105 (30%), Positives = 46/105 (43%), Gaps = 12/105 (11%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 110
Q+ G+ Y HRDL N LL + KI DFG SK L + K+
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTH 179
Query: 111 T--P-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
P + APE + +++ K +DVWS GV ++ G P+
Sbjct: 180 GKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 8/103 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTP 112
+ + +G+ Y M HRDL N L++ + K+ DFG S+ + +T G
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 113 AYI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
I APE + ++ +DVWS G+ ++ VM G P+ +
Sbjct: 212 IPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 6e-06
Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 12/105 (11%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 110
Q+ G+ Y HRDL N LL + KI DFG SK L + +
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSA 172
Query: 111 T--P-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
P + APE + ++ + +DVWS GVT++ + G P++
Sbjct: 173 GKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 12/105 (11%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 110
+ + SG+ Y M HRDL N L++ + K+ DFG + VL P +T G
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRG 209
Query: 111 TPAYI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
I +PE + ++ +DVWS G+ L+ VM G P+ +
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 12/107 (11%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KST 108
Q+ G+ Y HR+L N LL + KI DFG SK L + +
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTAR 496
Query: 109 VGTPAYI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
+ APE + ++ + +DVWS GVT++ + G P++
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 16/106 (15%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQP 105
Q+I+ V + H+ HRD+K +N L+ G A ++ I DFG +K S+ H +
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 106 KSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 148
K+ GT Y + L E D D+ S G L L G P
Sbjct: 171 KNLTGTARYASVNTHLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 8/102 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 113
+ + + Y + Q HRDL N L++ +K+ DFG S+ VL + S+VG+
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRY-VLDDEYTSSVGSKF 183
Query: 114 YI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
+ PEVL+ ++ K +D+W+ GV ++ + +G P+E
Sbjct: 184 PVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 11/100 (11%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
Q+ G+++ + HRDL N LL KICDFG ++ + + V A
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKNDSNYVVKGNAR 208
Query: 115 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 148
+ APE + Y + +DVWS G+ L+ + +G P
Sbjct: 209 LPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 27/99 (27%), Positives = 40/99 (40%), Gaps = 10/99 (10%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI- 115
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLP 249
Query: 116 ----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
PE + + K D WS GV L+ + +G P+
Sbjct: 250 VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 27/99 (27%), Positives = 40/99 (40%), Gaps = 10/99 (10%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI- 115
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLP 208
Query: 116 ----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
PE + + K D WS GV L+ + +G P+
Sbjct: 209 VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 26/108 (24%), Positives = 44/108 (40%), Gaps = 18/108 (16%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---S 103
Q+++ V H + +RD+K +N L+ + A + + DFG K + H
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 104 QPKSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 148
+ K+ GT Y++ L E D D+ + G L G P
Sbjct: 174 EKKNLSGTARYMSINTHLGREQSRRD----DLEALGHVFMYFLRGSLP 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-05
Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 11/100 (11%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
Q+ G+++ + HRD+ N LL + KI DFG ++ + + V A
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMNDSNYIVKGNAR 227
Query: 115 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 148
+ APE + Y + +DVWS G+ L+ + +G P
Sbjct: 228 LPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNP 266
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 5e-05
Identities = 46/291 (15%), Positives = 92/291 (31%), Gaps = 66/291 (22%)
Query: 39 WLLLLGLL---VQARFFFQQL-ISGVSYCH-------AMQ-VCHRDLKLENTLLDGSPAP 86
W+ L L VQ + F+ ++ + C+ +Q + ++ + D S
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLN-LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 87 RLKICDFGYSKSSVLHSQPKST-------VGTPAYIAP-----EVLL--RHEYDGKIADV 132
+L+I +L S+P V ++LL R ++ D
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR---FKQVTDF 280
Query: 133 WSCGVTLYVMLVGGYPFEDPDEPKD-FRKTI-QRILSVQYSVPDTNP-----ISQECRDL 185
S T ++ L PDE K K + R + V TNP I++ RD
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 186 ISRIFVADPAARITIPEIMKH-QWFLKNLPADLVDEKTMSSQYEE----PDQPMQSVDVI 240
++ D + ++ + L L + ++ P S +
Sbjct: 341 LATW---DNWKHVNCDKLTTIIESSLNVL-----EPAEYRKMFDRLSVFPP----SAHIP 388
Query: 241 MQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIY 291
++ S+ + + + M ++ L S ++ I
Sbjct: 389 TILL---SL-------IWFDVIKSDVM--VVVNKLHKYSLVEKQPKESTIS 427
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 29/108 (26%), Positives = 44/108 (40%), Gaps = 18/108 (16%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---S 103
QLIS + Y H+ + +RD+K EN L+ ++ DF +K + H
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 104 QPKSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 148
+ KS GT Y++ L E D D+ + G L G P
Sbjct: 173 EHKSLTGTARYMSINTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 27/102 (26%), Positives = 52/102 (50%), Gaps = 10/102 (9%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-T 111
QL + ++Y + + HRD+ N L+ + +K+ DFG S+ + K++ G
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKL 554
Query: 112 PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
P ++APE + + +DVW GV ++ +++ G PF+
Sbjct: 555 PIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 7e-05
Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 8/101 (7%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P 112
QL + ++Y + + HRD+ N L+ + +K+ DFG S+ + S P
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLP 180
Query: 113 A-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
++APE + + +DVW GV ++ +++ G PF+
Sbjct: 181 IKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 11/100 (11%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
Q+ G+ Y + + HRDL N L+ + +KI DFG ++ +H T
Sbjct: 199 QVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DIHHIDYYKKTTNGR 254
Query: 115 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 148
+ APE L Y + +DVWS GV L+ + +GG P
Sbjct: 255 LPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSP 293
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 9e-05
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 11/101 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
Q+ G+ + + + HRDL N LL +KICDFG ++ ++ P A
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLAR--DIYKDPDYVRKGDAR 211
Query: 115 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
+ APE + Y + +DVWS GV L+ + +G P+
Sbjct: 212 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 11/101 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
+ G+ Y + HRDL N +L + + DFG S+ ++S G +
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYYRQGCASK 200
Query: 115 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
+ A E L + Y +DVW+ GVT++ +M G P+
Sbjct: 201 LPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 21/109 (19%), Positives = 41/109 (37%), Gaps = 18/109 (16%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKS 107
+QL + + + + H ++ +N LL + K+ D G S + + +
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE 179
Query: 108 TVGTPAYIAPEVLLRHEYDGKI----ADVWSCGVTLY-VMLVGGYPFED 151
+ ++ PE + + K D WS G TL+ + G P
Sbjct: 180 RI---PWVPPECIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 1e-04
Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 11/98 (11%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-- 115
SG+ Y + HRDL N L+ +KI DFG S+ ++S VG +
Sbjct: 144 SGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPI 199
Query: 116 ---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
PE ++ ++ + +DVWS GV L+ + G P+
Sbjct: 200 RWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 42/174 (24%), Positives = 70/174 (40%), Gaps = 23/174 (13%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
QL G+ Y + + HRDL N L+ + +KI DFG ++ +++ T
Sbjct: 211 QLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYKKTTNGR 266
Query: 115 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGG--YPFEDPDEPKDFRKTIQRIL 166
+ APE L Y + +DVWS GV ++ + +GG YP +E K R+
Sbjct: 267 LPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM- 324
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 220
P E ++ + A P+ R T ++ L + +E
Sbjct: 325 ----DKPANCT--NELYMMMRDCWHAVPSQRPTFKQL---VEDLDRILTLTTNE 369
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 11/100 (11%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
QL G+ Y + + HRDL N L+ + +KI DFG ++ +++ T
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNIDYYKKTTNGR 220
Query: 115 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 148
+ APE L Y + +DVWS GV ++ + +GG P
Sbjct: 221 LPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 25/101 (24%), Positives = 47/101 (46%), Gaps = 11/101 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
++ G++Y +A + HRDL N ++ + +KI DFG ++ ++ G
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKGL 201
Query: 115 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
+ +PE L + +DVWS GV L+ + + P+
Sbjct: 202 LPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 30/104 (28%), Positives = 44/104 (42%), Gaps = 11/104 (10%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F + G+ Y HRDL N +L + + DFG SK ++S G
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYRQGR 207
Query: 112 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
A + A E L Y K +DVW+ GVT++ + G P+
Sbjct: 208 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 11/101 (10%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 114
Q+ G+ Y M++ HRDL N L+ +KI DFG S+ ++ + +
Sbjct: 158 QISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD--VYEEDSYVKRSQGR 213
Query: 115 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
I A E L H Y + +DVWS GV L+ ++ +GG P+
Sbjct: 214 IPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 3e-04
Identities = 23/102 (22%), Positives = 43/102 (42%), Gaps = 8/102 (7%)
Query: 54 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 113
Q+ ++Y ++ HRD+ + N L+ +K+ DFG S+ + T
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRY-IEDEDYYKASVTRL 176
Query: 114 YI---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 151
I +PE + + +DVW V ++ ++ G PF
Sbjct: 177 PIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 30/97 (30%), Positives = 43/97 (44%), Gaps = 11/97 (11%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-- 115
G+ + HRDL N L+ +KICDFG ++ + S V A +
Sbjct: 183 KGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARD--IMSDSNYVVRGNARLPV 238
Query: 116 ---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 148
APE L Y K +DVWS G+ L+ + +G P
Sbjct: 239 KWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 31/106 (29%), Positives = 45/106 (42%), Gaps = 16/106 (15%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQP 105
Q+IS + Y H+ HRD+K +N L+ G + I DFG +K + H +
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 106 KSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 148
K+ GT Y + L E D D+ S G L +G P
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRD----DLESLGYVLMYFNLGSLP 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 11/98 (11%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-- 115
+G+ Y + HRDL N L+ +KI DFG S+ ++S VG +
Sbjct: 169 AGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRVGGRTMLPI 224
Query: 116 ---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
PE +L ++ + +DVWS GV L+ + G P+
Sbjct: 225 RWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 11/43 (25%), Positives = 21/43 (48%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 31/103 (30%), Positives = 44/103 (42%), Gaps = 14/103 (13%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F + G+ Y Q HRDL N L+ + KI DFG S+ ++ T
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVY-----VKKT 199
Query: 112 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 148
+ A E L Y +DVWS GV L+ ++ +GG P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F Q+ G+ + + + HRDL N +LD +K+ DFG ++ T
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKT 254
Query: 112 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
A + A E L ++ K +DVWS GV L+ +M G P+
Sbjct: 255 GAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 10/43 (23%), Positives = 22/43 (51%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 11/98 (11%)
Query: 58 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-- 115
+G++Y + HRDL N L+ +KI DFG S++ ++S I
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN--IYSADYYKADGNDAIPI 240
Query: 116 ---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
PE + + Y + +DVW+ GV L+ + G P+
Sbjct: 241 RWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 11/69 (15%), Positives = 26/69 (37%), Gaps = 8/69 (11%)
Query: 55 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH-----SQPK 106
+L+ + + H + H ++ EN +D ++ + +G++ S H
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226
Query: 107 STVGTPAYI 115
G +I
Sbjct: 227 PHEGDLEFI 235
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 11/105 (10%)
Query: 52 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 111
F Q+ G+ Y + + HRDL N +LD +K+ DFG ++ + + S
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARD-MYDKEYYSVHNK 189
Query: 112 PA------YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 149
++A E L ++ K +DVWS GV L+ +M G P+
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 293 | |||
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.68 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.31 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.5 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.23 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.03 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.88 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.77 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.52 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 94.69 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 93.55 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 92.23 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 90.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 90.14 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 88.52 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 88.19 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 86.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 84.8 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 81.95 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 80.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 80.3 |
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=393.97 Aligned_cols=286 Identities=71% Similarity=1.128 Sum_probs=191.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.+.++.|+|| ||+.||+|.+++...+.++ .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 ~hpniv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~ 152 (361)
T 3uc3_A 74 RHPNIVRFKEVILTPTHLAIIM-EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS 152 (361)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS
T ss_pred CCCCCCcEEEEEeeCCEEEEEE-EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC
Confidence 5899999999999999999999 7999999999998877665 999999999999999999999999999999999877
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+.+++||+|||+++...........+||+.|+|||++.+..+.++++||||+||++|+|++|+.||.+......+...++
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~ 232 (361)
T 3uc3_A 153 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232 (361)
T ss_dssp SSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH
T ss_pred CCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH
Confidence 66679999999998655555556678999999999998888877778999999999999999999998776666677777
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCCccchhcccCCCCCCCCCCCCHHHHHHH
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQI 243 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
.+.......+....+++++++||.+||.+||.+|||+.++++||||.+..+...........++..+.++.++.+.+.+.
T Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (361)
T 3uc3_A 233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQI 312 (361)
T ss_dssp HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC------------------CCHHHHHHH
T ss_pred HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCchhhhccccccccccCCcccccCHHHHHHH
Confidence 77777777777777999999999999999999999999999999999988887777666677778888899999999999
Q ss_pred HHHhCCCCCCCCCccccccCCCCCCCcccccccccccccCCCCCcccccC
Q 022732 244 IAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYAL 293 (293)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~d~~~~~~~~d~d~~g~~~~~~ 293 (293)
+.+...+..........+.++.+.|| +++++|++++.|+|+||+|.||+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~d~d~-~~~~~d~~~~~d~d~~g~~~~~~ 361 (361)
T 3uc3_A 313 ISEATIPAVRNRCLDDFMTDNLDLDD-DMDDFDSESEIDIDSSGEIVYAL 361 (361)
T ss_dssp HHHHTCC-------------------------------------------
T ss_pred HhhccCcccccccchhcccccccccc-ccccccchhhhccCCCCcEEecC
Confidence 99999998876665666655554443 44445677889999999999996
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=370.28 Aligned_cols=200 Identities=37% Similarity=0.629 Sum_probs=164.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|.+.+++|+|| ||| +|+|.+++.+.+.++ +++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 71 ~HpnIv~~~~~~~~~~~~~ivm-Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~ 148 (275)
T 3hyh_A 71 RHPHIIKLYDVIKSKDEIIMVI-EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH 148 (275)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT
T ss_pred CCCCCCeEEEEEEECCEEEEEE-eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC
Confidence 5999999999999999999999 799 689999999988877 999999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ ++||+|||+|+.........+.+||+.|||||++.+..+.+.++||||+||++|+|++|+.||.+.+... +.+
T Consensus 149 ~--~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~ 222 (275)
T 3hyh_A 149 L--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----LFK 222 (275)
T ss_dssp C--CEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH
T ss_pred C--CEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHH
Confidence 4 5999999999876655666678999999999999998887777999999999999999999998866533 334
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
.+......+| ..+|+++++||.+||++||++|||++++++||||+...+.
T Consensus 223 ~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p~ 272 (275)
T 3hyh_A 223 NISNGVYTLP--KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPE 272 (275)
T ss_dssp HHHHTCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred HHHcCCCCCC--CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCCCh
Confidence 4444444444 4589999999999999999999999999999999866543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=373.92 Aligned_cols=203 Identities=25% Similarity=0.394 Sum_probs=172.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|+|++|++|.+.+++|+|| |||.||+|.+++.+.+... +++.|+.||+.||+|||++||+||||||+|||++.++
T Consensus 129 ~HpnIV~l~~~~~~~~~~~ivm-Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g 207 (346)
T 4fih_A 129 QHENVVEMYNSYLVGDELWVVM-EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 207 (346)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred CCCCCCcEEEEEEECCEEEEEE-eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC
Confidence 5999999999999999999999 7999999999998754333 9999999999999999999999999999999997655
Q ss_pred CCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
++||+|||+|+..... ....+.+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+....+..+..
T Consensus 208 --~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 284 (346)
T 4fih_A 208 --RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 284 (346)
T ss_dssp --CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred --CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 5999999999865433 34567789999999999988888655 9999999999999999999998776554443332
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
. .....+.+..+|+++++||.+||++||++|||+.|+|+||||++..++
T Consensus 285 ~---~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 285 N---LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp S---SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred C---CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 1 122334445689999999999999999999999999999999876544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=371.89 Aligned_cols=197 Identities=25% Similarity=0.458 Sum_probs=171.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|++.+++|+|| |||.||+|++++++.+.+. +++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus 90 ~HpnIv~l~~~~~~~~~~yivm-Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~ 168 (311)
T 4aw0_A 90 DHPFFVKLYFTFQDDEKLYFGL-SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168 (311)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CCCCCCeEEEEEEeCCEEEEEE-ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC
Confidence 6999999999999999999999 7999999999999988777 999999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC---CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+ ++||+|||+|+.... .....+.+||+.|||||++.+..|+. ++||||+||++|+|++|+.||.+.+...
T Consensus 169 g--~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~---- 241 (311)
T 4aw0_A 169 M--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEGL---- 241 (311)
T ss_dssp S--CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHH----
T ss_pred C--CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 5 599999999986532 22345678999999999999888855 4999999999999999999999876543
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHH------HHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE------IMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e------ll~h~~~~~~ 212 (293)
+..++....+.+|. .+|+++++||.+||++||.+|||+.| +++||||+.-
T Consensus 242 ~~~~i~~~~~~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 242 IFAKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHHHTCCCCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHcCCCCCCc--ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 44445555555554 58999999999999999999999887 6899999754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=367.59 Aligned_cols=196 Identities=30% Similarity=0.470 Sum_probs=169.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|++.+++|+|| |||.||+|++++.+.+.++ +++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 84 ~HpnIv~l~~~~~~~~~~~ivm-Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 162 (304)
T 3ubd_A 84 NHPFIVKLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 162 (304)
T ss_dssp CCTTEECEEEEEEETTEEEEEE-CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT
T ss_pred CCCCCCeEEEEEEECCEEEEEE-EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC
Confidence 6999999999999999999999 7999999999999988776 999999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ ++||+|||+|+.... .....+.+||+.|||||++.+..|+.+ +||||+||++|+|+||+.||.+.+....+
T Consensus 163 g--~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~---- 235 (304)
T 3ubd_A 163 G--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETM---- 235 (304)
T ss_dssp S--CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----
T ss_pred C--CEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHH----
Confidence 5 599999999985433 344567789999999999998888765 99999999999999999999987764433
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCccccc
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLK 211 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~ 211 (293)
..+......+| ..+|+++++||.+||++||++||| ++++++||||+.
T Consensus 236 ~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 236 TMILKAKLGMP--QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHcCCCCCC--CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 34444444444 458999999999999999999998 579999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=374.49 Aligned_cols=204 Identities=25% Similarity=0.391 Sum_probs=173.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|+|++|++|.+.+++|+|| |||.||+|.+++...+.-. +++.|+.||+.||+|||++|||||||||+|||++.++
T Consensus 206 ~HpnIV~l~~~~~~~~~~~iVm-Ey~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g 284 (423)
T 4fie_A 206 QHENVVEMYNSYLVGDELWVVM-EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 284 (423)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC
T ss_pred CCCCCCceEEEEEECCEEEEEE-eCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC
Confidence 5999999999999999999999 7999999999997655333 9999999999999999999999999999999997655
Q ss_pred CCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
++||+|||+|+..... ....+.+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+....+..+..
T Consensus 285 --~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 361 (423)
T 4fie_A 285 --RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 361 (423)
T ss_dssp --CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred --CEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 5999999999865433 34467789999999999988888655 9999999999999999999998776554443332
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~ 216 (293)
. .....+.+..+|+++++||.+||++||++|||+.|+|+||||++..++.
T Consensus 362 ~---~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~ 411 (423)
T 4fie_A 362 N---LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 411 (423)
T ss_dssp S---CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred C---CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCCc
Confidence 1 1223444566999999999999999999999999999999998765443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=371.29 Aligned_cols=200 Identities=21% Similarity=0.337 Sum_probs=169.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+|+++++|++.+.+|+|| |||.||+|+++|...+. +. +++.|+.||+.||.|||++||+||||||+|||++
T Consensus 81 ~HpnIV~~~~~~~~~~~~yiVm-Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 159 (350)
T 4b9d_A 81 KHPNIVQYRESFEENGSLYIVM-DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 159 (350)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC
T ss_pred CCCCCCcEEEEEEECCEEEEEE-eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC
Confidence 5899999999999999999999 79999999999976542 33 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ ++||+|||+|+...... ...+.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+....+..
T Consensus 160 ~~g--~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~ 236 (350)
T 4b9d_A 160 KDG--TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLK 236 (350)
T ss_dssp TTC--CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCC--CEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence 655 59999999998653321 2245679999999999998888655 9999999999999999999998776444443
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
+..... .+.+..+|+++++||.+||++||++|||+.++|+||||++...
T Consensus 237 ----i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 237 ----IISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp ----HHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred ----HHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 333332 2344568999999999999999999999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=358.05 Aligned_cols=198 Identities=21% Similarity=0.394 Sum_probs=164.1
Q ss_pred CCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcC--CeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQ--VCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~--iiHrdlkp~N 77 (293)
.|+|+|++|++|++ .+.+|+|| |||.||+|.+++.+.+.++ .++.|+.||+.||+|||++| |+||||||+|
T Consensus 83 ~HpnIV~~~~~~~~~~~~~~~~~lvm-Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~N 161 (290)
T 3fpq_A 83 QHPNIVRFYDSWESTVKGKKCIVLVT-ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 161 (290)
T ss_dssp CCTTBCCEEEEEEEEETTEEEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGG
T ss_pred CCCCCCcEEEEEeeccCCCcEEEEEE-eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhh
Confidence 59999999999976 46789999 7999999999999888766 89999999999999999998 9999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
||++.. ++.+||+|||+|+.. ......+.+||+.|||||++.+ +|+.+ +|||||||++|+|+||+.||.+......
T Consensus 162 ILl~~~-~g~vKl~DFGla~~~-~~~~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~ 237 (290)
T 3fpq_A 162 IFITGP-TGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQ 237 (290)
T ss_dssp EEESST-TSCEEECCTTGGGGC-CTTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred eeEECC-CCCEEEEeCcCCEeC-CCCccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHH
Confidence 999642 245999999999753 2334456789999999999865 56554 9999999999999999999987766544
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
+.. .+.........+..+++++++||.+||.+||++|||+.++|+||||++
T Consensus 238 ~~~---~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 238 IYR---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHH---HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHH---HHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 333 333322222223447899999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=361.99 Aligned_cols=200 Identities=22% Similarity=0.313 Sum_probs=167.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|++|++|.+.+++|+|| |||.||+|+++|++.+.++ +++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus 108 ~HpnIV~l~~~~~~~~~~~ivm-Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 186 (336)
T 4g3f_A 108 SSPRIVPLYGAVREGPWVNIFM-ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD 186 (336)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTT
T ss_pred CCCCCCcEEEEEEECCEEEEEE-eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCC
Confidence 6999999999999999999999 7999999999999988776 999999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
+. ++||+|||+|+...... .....+||+.|||||++.+..|+.+ +||||+||++|+|++|+.||.+.+....
T Consensus 187 g~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~ 264 (336)
T 4g3f_A 187 GS-RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPL 264 (336)
T ss_dssp SC-CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCC
T ss_pred CC-EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 42 59999999998643322 1234579999999999999888665 9999999999999999999988766544
Q ss_pred HHHHHHHHhccccCC-CCCCCCCHHHHHHHHHccccCCCCCCCHHHH-------------HcCcccccC
Q 022732 158 FRKTIQRILSVQYSV-PDTNPISQECRDLISRIFVADPAARITIPEI-------------MKHQWFLKN 212 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el-------------l~h~~~~~~ 212 (293)
+..+... .... ..+..+|+++++||.+||++||.+|||+.|+ ++|||+.+.
T Consensus 265 ~~~i~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 265 CLKIASE----PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHS----CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHcC----CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 4444332 2111 2234589999999999999999999999997 468887643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=353.76 Aligned_cols=205 Identities=23% Similarity=0.389 Sum_probs=161.2
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
+.+|+|+|+++++|.+.+++|+|| ||+.||+|.+++.. -...+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 76 ~~~h~nIv~l~~~~~~~~~~~lvm-E~~~g~~L~~~~~~-l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~ 153 (361)
T 4f9c_A 76 AGGQDNVMGVKYCFRKNDHVVIAM-PYLEHESFLDILNS-LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR 153 (361)
T ss_dssp TCSBTTBCCCSEEEEETTEEEEEE-ECCCCCCHHHHHTT-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT
T ss_pred hcCCCCCceEEEEEEECCEEEEEE-eCCCcccHHHHHcC-CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCC
Confidence 568999999999999999999999 79999999999842 3344999999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-----------------------------CCCCCCcCCCCccchhhhccccCCCchhhhhh
Q 022732 84 PAPRLKICDFGYSKSSVLH-----------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 134 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws 134 (293)
. +++||+|||+|+..... ....+.+||++|||||++.+..+.+.++||||
T Consensus 154 ~-~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWS 232 (361)
T 4f9c_A 154 L-KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232 (361)
T ss_dssp T-TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred C-CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhh
Confidence 2 36999999999743211 11234579999999999988765566699999
Q ss_pred hhhHHHHHHhCCCCCCCCCc-hHHHHHHHHHH----------------------------------hccc----------
Q 022732 135 CGVTLYVMLVGGYPFEDPDE-PKDFRKTIQRI----------------------------------LSVQ---------- 169 (293)
Q Consensus 135 lG~il~el~~g~~pf~~~~~-~~~~~~~~~~~----------------------------------~~~~---------- 169 (293)
+||++|+|++|+.||....+ ..++..+..-. ....
T Consensus 233 lG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~ 312 (361)
T 4f9c_A 233 AGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDI 312 (361)
T ss_dssp HHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------
T ss_pred hHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccc
Confidence 99999999999999965543 23333222110 0000
Q ss_pred ----cCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 170 ----YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 170 ----~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
...+.+..+|+++++||++||++||++|||++|+|+||||+.
T Consensus 313 ~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 313 QGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred ccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 011223458999999999999999999999999999999974
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=353.01 Aligned_cols=205 Identities=24% Similarity=0.353 Sum_probs=170.2
Q ss_pred CCcchhhhhceeee------ceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVK------MKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~------~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.|+|+|++++++.. .+++|+|| |||. |+|+.++.+.+.+. +++.|++||+.||.|||++||+||||||+|
T Consensus 111 ~HpnIv~l~~~~~~~~~~~~~~~~~ivm-E~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~N 188 (398)
T 4b99_A 111 KHDNIIAIKDILRPTVPYGEFKSVYVVL-DLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSN 188 (398)
T ss_dssp CCTTBCCEEEECCCSSCTTTCCCEEEEE-ECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred CCCCcceEeeeeecccccccCCEEEEEE-eCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccc
Confidence 59999999998764 47899999 7996 67999998888776 999999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCC-----CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
||++.++ .+||+|||+|+.... .....+.+||++|||||++.+..+.+.++||||+||++|+|++|+.||.+.
T Consensus 189 Il~~~~~--~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 189 LLVNENC--ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp EEECTTC--CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cccCCCC--CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 9997655 599999999985432 233456789999999999988777677799999999999999999999998
Q ss_pred CchHHHHHHHHHHhccccC----------------CCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q 022732 153 DEPKDFRKTIQRILSVQYS----------------VPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQ 207 (293)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~----------------~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~ 207 (293)
+...++..+.......... .+. ...+|+++++||.+||.+||.+|||+.++|+||
T Consensus 267 ~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 267 NYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp SHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 8877776665543222110 010 124789999999999999999999999999999
Q ss_pred ccccCCC
Q 022732 208 WFLKNLP 214 (293)
Q Consensus 208 ~~~~~~~ 214 (293)
||++...
T Consensus 347 ~f~~~~~ 353 (398)
T 4b99_A 347 FLAKYHD 353 (398)
T ss_dssp GGTTTCC
T ss_pred hhCcCCC
Confidence 9987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=370.47 Aligned_cols=199 Identities=27% Similarity=0.382 Sum_probs=171.2
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|+|+++++|++.+++|+|| |||.||+|+.+|.+.+.++ .++.|++||+.||.|||++|||||||||+|||++.
T Consensus 249 ~~HP~IV~l~~~f~~~~~lylVm-Ey~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~ 327 (689)
T 3v5w_A 249 GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 327 (689)
T ss_dssp SCCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT
T ss_pred CCCCCEeEEEEEEEECCEEEEEE-ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeC
Confidence 47999999999999999999999 7999999999999988877 99999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccc-cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ ++||+|||+|+.... ....+.+||+.|||||++.+. .|+ .++|||||||++|+|++|+.||.+.+... ...+
T Consensus 328 ~G--~vKL~DFGlA~~~~~-~~~~t~~GTp~YmAPEvl~~~~~y~-~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i 402 (689)
T 3v5w_A 328 HG--HVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEI 402 (689)
T ss_dssp TS--CEEECCCTTCEECSS-CCCCSCCSCGGGCCHHHHSTTCCCC-THHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHH
T ss_pred CC--CEEecccceeeecCC-CCCCCccCCcCccCHHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHH
Confidence 65 599999999986533 345677999999999999754 554 55999999999999999999998754322 2344
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCccccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~ 211 (293)
...+......+| ..+|+++++||.+||++||.+|++ ++++++||||+.
T Consensus 403 ~~~i~~~~~~~p--~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 403 DRMTLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHCCCCCC--TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHhhcCCCCCCC--ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 555555555444 459999999999999999999997 799999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=362.64 Aligned_cols=202 Identities=24% Similarity=0.379 Sum_probs=174.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++++|.+.+++|+|| |||.||+|+++|... +.+. +++.|++||+.||.|||++||+||||||+|||++.
T Consensus 212 ~hpnIv~l~~~~~~~~~~~iv~-E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~ 290 (573)
T 3uto_A 212 RHPTLVNLHDAFEDDNEMVMIY-EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290 (573)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCeEEEEEEECCEEEEEE-eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC
Confidence 5899999999999999999999 799999999999643 4555 99999999999999999999999999999999987
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+..+++||+|||+|+.........+.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+....+
T Consensus 291 ~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~~---- 365 (573)
T 3uto_A 291 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETL---- 365 (573)
T ss_dssp SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----
T ss_pred CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHH----
Confidence 6556799999999997766555667789999999999999888554 99999999999999999999988764443
Q ss_pred HHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..+....+.++ .+..+|+++++||.+||++||.+|||+.++|+||||+...
T Consensus 366 ~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 366 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 33444443333 3356899999999999999999999999999999998653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=335.17 Aligned_cols=196 Identities=19% Similarity=0.322 Sum_probs=151.4
Q ss_pred CCcchhhhhceeeece------------eEEEeehhhccCchhHHHHHHcCCHH-----HHHHHHHHHHHHHHHHHHcCC
Q 022732 6 SSSSEYAMLGVSVKMK------------FVFLSLSFFFSLCLFFMWLLLLGLLV-----QARFFFQQLISGVSYCHAMQV 68 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~------------~~~lv~~ey~~gg~L~~~l~~~~~~~-----~~~~~~~qil~~l~~LH~~~i 68 (293)
.|+|+|++|++|.+.+ ++|+|| |||.||+|.+++...+.+. .++.++.||+.||+|||++||
T Consensus 61 ~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivm-E~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~I 139 (299)
T 4g31_A 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQM-QLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGL 139 (299)
T ss_dssp CCTTBCCEEEEEEEEC----------CEEEEEEE-ECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCeEEEEEEecCccccccccCCCcEEEEEE-ecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcC
Confidence 6999999999998665 479999 7999999999999877665 588999999999999999999
Q ss_pred eecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC-------------CCCCCcCCCCccchhhhccccCCCchhhhhhh
Q 022732 69 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSC 135 (293)
Q Consensus 69 iHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl 135 (293)
+||||||+|||++.++ ++||+|||+|+...... ...+.+||+.|||||++.+..|+.+ +|||||
T Consensus 140 iHRDlKp~NILl~~~~--~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSl 216 (299)
T 4g31_A 140 MHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSL 216 (299)
T ss_dssp CCCCCCGGGEEECTTC--CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHH
T ss_pred ccccCcHHHeEECCCC--cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHH
Confidence 9999999999997665 59999999998643321 1234579999999999998888655 999999
Q ss_pred hhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 136 GVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 136 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
||++|||++ ||.+... . ...+..+.....+ +.....++.+.+||.+||++||.+|||+.++++||||+..
T Consensus 217 Gvilyell~---Pf~~~~~--~-~~~~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 217 GLILFELLY---PFSTQME--R-VRTLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHHHS---CCSSHHH--H-HHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHHHcc---CCCCccH--H-HHHHHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 999999996 7764321 1 2222333222211 1122356788999999999999999999999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=330.37 Aligned_cols=196 Identities=20% Similarity=0.291 Sum_probs=154.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++|++.. +.+|+|| |||.||+|.++|... +.++ ++..++.||+.||+|||+++||||||||+|||++.
T Consensus 90 ~HpNIV~l~g~~~~-~~~~iVm-Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~ 167 (307)
T 3omv_A 90 RHVNILLFMGYMTK-DNLAIVT-QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHE 167 (307)
T ss_dssp CCTTBCCEEEEECS-SSCEEEE-ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEET
T ss_pred CCCCEeeEEEEEEC-CeEEEEE-EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECC
Confidence 59999999998865 5689999 799999999999764 3444 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC---CCCCCCCcCCCCccchhhhccc---cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 83 SPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++ ++||+|||+|+.... .....+.+||+.|||||++.+. .|+ .++|||||||++|||+||+.||.+.+...
T Consensus 168 ~~--~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~-~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~ 244 (307)
T 3omv_A 168 GL--TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS-FQSDVYSYGIVLYELMTGELPYSHINNRD 244 (307)
T ss_dssp TE--EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred CC--cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCC-cHHHhHhHHHHHHHHHHCCCCCCCCChHH
Confidence 65 599999999985432 2233456899999999998753 344 45999999999999999999999877755
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+...+............+..+++++.+|+.+||+.||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 245 QIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 54444432211111112334589999999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=327.24 Aligned_cols=194 Identities=22% Similarity=0.323 Sum_probs=161.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-------------CHH--HHHHHHHHHHHHHHHHHHcCCee
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-------------LLV--QARFFFQQLISGVSYCHAMQVCH 70 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-------------~~~--~~~~~~~qil~~l~~LH~~~iiH 70 (293)
.|+|+|++||+|.+.+.+|+|| |||.+|+|.++|.+.+ .++ ++..++.||+.||.|||+++|+|
T Consensus 73 ~HpnIV~l~g~~~~~~~~~lV~-Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiH 151 (299)
T 4asz_A 73 QHEHIVKFYGVCVEGDPLIMVF-EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVH 151 (299)
T ss_dssp CCTTBCCEEEEECSSSSEEEEE-ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CCCCCccEEEEEeeCCEEEEEE-EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 5999999999999999999999 7999999999998754 233 89999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CC
Q 022732 71 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GG 146 (293)
Q Consensus 71 rdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~ 146 (293)
|||||+|||++.++ .+||+|||+|+...... ......||+.|||||++.+..|+.+ +||||+||++|||+| |+
T Consensus 152 RDlKp~NILl~~~~--~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~ 228 (299)
T 4asz_A 152 RDLATRNCLVGENL--LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGK 228 (299)
T ss_dssp SCCSGGGEEECGGG--CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTC
T ss_pred CccCHhhEEECCCC--cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCC
Confidence 99999999997665 49999999997543222 2234569999999999998888665 999999999999998 89
Q ss_pred CCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 147 YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 147 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
.||.+.+....+.. +.... ..+.+..+|+++.+|+.+||+.||++|||+.++. +|++
T Consensus 229 ~Pf~~~~~~~~~~~----i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 229 QPWYQLSNNEVIEC----ITQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp CTTTTSCHHHHHHH----HHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred CCCCCCCHHHHHHH----HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 99998776444333 32222 2344456899999999999999999999999984 4553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=328.46 Aligned_cols=192 Identities=20% Similarity=0.309 Sum_probs=155.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC---------------CHH--HHHHHHHHHHHHHHHHHHcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG---------------LLV--QARFFFQQLISGVSYCHAMQV 68 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~---------------~~~--~~~~~~~qil~~l~~LH~~~i 68 (293)
.|+|+|++||+|.+.+.+|+|| |||.+|+|.+++.+.+ .+. ++..++.||+.||.|||+++|
T Consensus 101 ~HpnIV~l~g~~~~~~~~~lV~-Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i 179 (329)
T 4aoj_A 101 QHQHIVRFFGVCTEGRPLLMVF-EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF 179 (329)
T ss_dssp CCTTBCCEEEEECSSSSEEEEE-ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCcEEEEEEECCEEEEEE-EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 6999999999999999999999 7999999999997643 233 889999999999999999999
Q ss_pred eecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-
Q 022732 69 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV- 144 (293)
Q Consensus 69 iHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~- 144 (293)
|||||||+|||++.+. ++||+|||+|+..... ......+||+.|||||++.+..++.+ +|||||||++|||+|
T Consensus 180 iHRDLKp~NILl~~~~--~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~ 256 (329)
T 4aoj_A 180 VHRDLATRNCLVGQGL--VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTY 256 (329)
T ss_dssp CCSCCCGGGEEEETTT--EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTT
T ss_pred ecccccHhhEEECCCC--cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcC
Confidence 9999999999997665 5999999999854322 22345679999999999998888655 999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|+.||.+.+....+..+. .. ...+.+..+++++.+|+.+||+.||++|||+.+++++
T Consensus 257 G~~Pf~~~~~~~~~~~i~----~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 257 GKQPWYQLSNTEAIDCIT----QG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp SCCTTCSSCHHHHHHHHH----HT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHH----cC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 899999877644433332 22 2334455689999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=323.76 Aligned_cols=192 Identities=19% Similarity=0.297 Sum_probs=162.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHHHHHcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSYCHAMQ 67 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~LH~~~ 67 (293)
.|+|+|+++|+|.+.+.+|+|| |||.+|+|.++|.... .+. ++..++.||+.||+|||+++
T Consensus 87 ~HpNIV~l~g~~~~~~~~~lV~-Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 165 (308)
T 4gt4_A 87 QHPNVVCLLGVVTKDQPLSMIF-SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH 165 (308)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCCCcceEEEECCEEEEEE-EcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5999999999999999999999 7999999999997642 233 88999999999999999999
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh
Q 022732 68 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144 (293)
Q Consensus 68 iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 144 (293)
||||||||+|||++.++ ++||+|||+|+..... ......+||+.|||||++.+..++.+ +||||+||++|||+|
T Consensus 166 iiHRDLK~~NILl~~~~--~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t 242 (308)
T 4gt4_A 166 VVHKDLATRNVLVYDKL--NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFS 242 (308)
T ss_dssp CCCSCCSGGGEEECGGG--CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHT
T ss_pred CCCCCccccceEECCCC--CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHh
Confidence 99999999999997665 4999999999854322 23345679999999999998888665 999999999999998
Q ss_pred -CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 -GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|+.||.+.+....+ ..+.. ....|.+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus 243 ~g~~Pf~~~~~~~~~----~~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 243 YGLQPYCGYSNQDVV----EMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCTTTTCCHHHHH----HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHH----HHHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999987764333 33332 23345556689999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=317.69 Aligned_cols=200 Identities=34% Similarity=0.617 Sum_probs=175.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+.+|+|| ||+.||+|.+++...+.+. +++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 72 ~hpnIv~l~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~ 150 (328)
T 3fe3_A 72 NHPNIVKLFEVIETEKTLYLIM-EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD 150 (328)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CCCCEeeEEEEEEECCEEEEEE-ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC
Confidence 5899999999999999999999 7999999999998887766 999999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||+++...........+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+... ...
T Consensus 151 ~--~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~ 224 (328)
T 3fe3_A 151 M--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE----LRE 224 (328)
T ss_dssp S--CEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH
T ss_pred C--CEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----HHH
Confidence 5 5999999999876555556677899999999999988887777999999999999999999998876533 334
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.+.......|. .+|+++.+||++||..||.+|||+.++++||||+....
T Consensus 225 ~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 225 RVLRGKYRIPF--YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHHCCCCCCT--TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred HHHhCCCCCCC--CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 44445554444 48999999999999999999999999999999986543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=331.11 Aligned_cols=194 Identities=22% Similarity=0.380 Sum_probs=160.7
Q ss_pred CCCcchhhhhceeeec-eeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHHHHH
Q 022732 5 GSSSSEYAMLGVSVKM-KFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSYCHA 65 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~-~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~LH~ 65 (293)
.-|+|+|+++|+|.+. +.+|+|| |||.+|+|.++|++.. .+. ++..++.||+.||+|||+
T Consensus 125 ~hhpnIV~l~g~~~~~~~~~~iV~-Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~ 203 (353)
T 4ase_A 125 GHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 203 (353)
T ss_dssp CCCTTBCCEEEEECCTTSCCEEEE-ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcEEEEEEEEEecCCEEEEEE-EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh
Confidence 4468999999998764 6789999 7999999999998642 122 889999999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHH
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 142 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 142 (293)
++||||||||+|||++.++ .+||+|||+|+....... ..+.+||+.|||||++.+..|+.+ +|||||||++|||
T Consensus 204 ~~iiHRDLK~~NILl~~~~--~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El 280 (353)
T 4ase_A 204 RKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEI 280 (353)
T ss_dssp TTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHH
T ss_pred CCeecCccCccceeeCCCC--CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHH
Confidence 9999999999999997665 499999999986433222 234578999999999998888655 9999999999999
Q ss_pred Hh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 143 LV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 143 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+| |+.||.+......+...+.. ....+.+..+++++.+++.+||+.||.+|||+.++++|
T Consensus 281 ~t~G~~Pf~~~~~~~~~~~~i~~----g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 281 FSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp TTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHHc----CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 98 89999987655444443332 23344455689999999999999999999999999997
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=318.52 Aligned_cols=199 Identities=27% Similarity=0.440 Sum_probs=166.8
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..|+|+++++++|.+.+++|+|| ||+.||+|..++.+.+.+. .++.++.||+.||.|||++||+||||||+|||++
T Consensus 80 ~~~hp~Iv~l~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~ 158 (353)
T 3txo_A 80 ARNHPFLTQLFCCFQTPDRLFFVM-EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158 (353)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred ccCCCceeeEEEEEEeCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC
Confidence 347999999999999999999999 7999999999999887766 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ ++||+|||+|+... ......+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....
T Consensus 159 ~~g--~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~--- 232 (353)
T 3txo_A 159 HEG--HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDL--- 232 (353)
T ss_dssp TTS--CEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH---
T ss_pred CCC--CEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHHH---
Confidence 655 59999999998532 2334456689999999999988777655 9999999999999999999998776443
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH------HHHHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI------PEIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~h~~~~~~ 212 (293)
...+......+|. .++.++.+||++||.+||.+||++ .++++||||+..
T Consensus 233 -~~~i~~~~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 233 -FEAILNDEVVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp -HHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred -HHHHHcCCCCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 3444445444444 489999999999999999999998 899999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=319.85 Aligned_cols=201 Identities=25% Similarity=0.414 Sum_probs=169.1
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|+++++++|.+.+++|+|| ||+.||+|..++.+.+.++ .++.++.||+.||.|||++||+||||||+|||++.
T Consensus 110 ~~hp~Iv~l~~~~~~~~~~~lV~-E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~ 188 (396)
T 4dc2_A 110 SNHPFLVGLHSCFQTESRLFFVI-EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 188 (396)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred CCCCCcCeeEEEEEECCEEEEEE-EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECC
Confidence 47999999999999999999999 7999999999999887766 99999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcC-cCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH-----
Q 022732 83 SPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----- 156 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----- 156 (293)
++ ++||+|||+|+. ........+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......
T Consensus 189 ~g--~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~ 265 (396)
T 4dc2_A 189 EG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265 (396)
T ss_dssp TS--CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------C
T ss_pred CC--CEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchh
Confidence 65 599999999985 333344566789999999999988887555 999999999999999999997543211
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH------HHHHcCccccc
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI------PEIMKHQWFLK 211 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~h~~~~~ 211 (293)
....+.+.+......+|. .+|.++++||++||++||.+||++ .++++||||+.
T Consensus 266 ~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 266 TEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp CHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred hHHHHHHHHhccccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 112233444445444443 489999999999999999999984 79999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=310.51 Aligned_cols=197 Identities=30% Similarity=0.509 Sum_probs=168.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.+.+++|+|| ||+.||+|..++...+.+. .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 63 ~hp~iv~l~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 141 (337)
T 1o6l_A 63 RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD 141 (337)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred CCCcCcceEEEEEeCCEEEEEE-eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC
Confidence 5899999999999999999999 7999999999998887665 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ ++||+|||+++... ......+.+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+.... .
T Consensus 142 g--~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~----~ 214 (337)
T 1o6l_A 142 G--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERL----F 214 (337)
T ss_dssp S--CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----H
T ss_pred C--CEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHH----H
Confidence 5 59999999998532 2334456789999999999988777555 9999999999999999999988765333 3
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
..+......+| ..+|+++++||.+||.+||.+|| ++.++++||||+..
T Consensus 215 ~~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 215 ELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHCCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 33334444444 35899999999999999999999 89999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.80 Aligned_cols=198 Identities=27% Similarity=0.480 Sum_probs=169.9
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..|+++++++++|.+.+++|+|| ||+.||+|..++...+.+. .++.++.||+.||.|||++||+||||||+|||++
T Consensus 77 ~~~hp~iv~l~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~ 155 (353)
T 2i0e_A 77 PGKPPFLTQLHSCFQTMDRLYFVM-EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 155 (353)
T ss_dssp TTCCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred cCCCCEEeeEEEEEEcCCEEEEEE-eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc
Confidence 457999999999999999999999 7999999999999877666 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ ++||+|||+++... ........+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+...
T Consensus 156 ~~g--~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~---- 228 (353)
T 2i0e_A 156 SEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDE---- 228 (353)
T ss_dssp TTS--CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----
T ss_pred CCC--cEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHH----
Confidence 655 59999999998532 2334456789999999999988777554 999999999999999999998876543
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCccccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLK 211 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~ 211 (293)
+.+.+......+| ..+|.++++||.+||.+||.+||+ +.++++||||+.
T Consensus 229 ~~~~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 229 LFQSIMEHNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHHhCCCCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 3344444444444 358999999999999999999994 699999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=314.31 Aligned_cols=200 Identities=29% Similarity=0.464 Sum_probs=171.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.+.+.+|+|| ||+.||+|.+++...+.+. .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 73 ~hpnIv~l~~~~~~~~~~~lv~-e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~ 151 (361)
T 2yab_A 73 LHPNIITLHDVYENRTDVVLIL-ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDK 151 (361)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCT
T ss_pred CCcCCCcEEEEEEeCCEEEEEE-EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCC
Confidence 4899999999999999999999 7999999999998877665 999999999999999999999999999999999765
Q ss_pred CC--CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 PA--PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~~--~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
+. .++||+|||+++...........+||+.|+|||++.+..++.+ +|+||+||++|+|++|..||.+.+....+
T Consensus 152 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~~--- 227 (361)
T 2yab_A 152 NIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETL--- 227 (361)
T ss_dssp TSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH---
T ss_pred CCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 42 2699999999987655555567789999999999988777554 99999999999999999999987664433
Q ss_pred HHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 162 IQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
..+....+.++ .+..+|..+++||.+||.+||.+|||+.++++||||+.
T Consensus 228 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 228 -ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp -HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred -HHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 33444443333 22458999999999999999999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=312.62 Aligned_cols=198 Identities=30% Similarity=0.514 Sum_probs=169.6
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|+++++++|.+.+++|+|| ||+.||+|..++.+.+.+. +++.++.||+.||.|||++||+||||||+|||++.
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 153 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVM-EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 153 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred CCCCCCCcEEEEEEeCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECC
Confidence 47999999999999999999999 7999999999999877665 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ ++||+|||+++.... .......+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+....
T Consensus 154 ~g--~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~---- 226 (345)
T 1xjd_A 154 DG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEEL---- 226 (345)
T ss_dssp TS--CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----
T ss_pred CC--CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHHH----
Confidence 55 599999999985432 233456789999999999988777554 9999999999999999999988765433
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHH-HHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP-EIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~-ell~h~~~~~~ 212 (293)
...+......+| ..++.++++||.+||..||.+||++. ++++||||+..
T Consensus 227 ~~~i~~~~~~~p--~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 227 FHSIRMDNPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHhCCCCCC--cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 333434444444 34899999999999999999999998 99999999753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=312.59 Aligned_cols=199 Identities=38% Similarity=0.624 Sum_probs=169.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+.+|+|| ||+ +|+|.+++...+.+. +++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 67 ~hpnIv~l~~~~~~~~~~~lv~-E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~ 144 (336)
T 3h4j_B 67 RHPHIIKLYDVITTPTDIVMVI-EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN 144 (336)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT
T ss_pred CCCCCCeEEEEEEeCCEEEEEE-ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC
Confidence 5899999999999999999999 799 789999998877666 999999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||++............+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+...... ..
T Consensus 145 ~--~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----~~ 218 (336)
T 3h4j_B 145 L--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----FK 218 (336)
T ss_dssp C--CEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----BC
T ss_pred C--CEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----HH
Confidence 5 59999999998766555566778999999999998888766779999999999999999999987654221 11
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.+...... .+..+|+++.+||.+||..||.+|||+.++++||||+...+
T Consensus 219 ~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 219 KVNSCVYV--MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp CCCSSCCC--CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HHHcCCCC--CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 12222222 23448999999999999999999999999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=305.71 Aligned_cols=195 Identities=30% Similarity=0.525 Sum_probs=168.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.+...+|+|| ||+.||+|.+++...+.++ .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 64 ~hp~Iv~~~~~~~~~~~~~lv~-e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 142 (318)
T 1fot_A 64 THPFIIRMWGTFQDAQQIFMIM-DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN 142 (318)
T ss_dssp CBTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT
T ss_pred CCCCCceEeEEEEeCCEEEEEE-eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC
Confidence 6899999999999999999999 7999999999999877665 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ ++||+|||+++... ....+.+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+....+ .
T Consensus 143 g--~~kL~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~----~ 213 (318)
T 1fot_A 143 G--HIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTY----E 213 (318)
T ss_dssp S--CEEECCCSSCEECS--SCBCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----H
T ss_pred C--CEEEeecCcceecC--CccccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHH----H
Confidence 4 59999999998543 23346689999999999988777655 99999999999999999999887664433 3
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
.+......+| ..++.+++++|.+||..||.+|| +++++++||||+..
T Consensus 214 ~i~~~~~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 214 KILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHCCCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHhCCCCCC--CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 4444444444 34899999999999999999999 89999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=329.21 Aligned_cols=279 Identities=25% Similarity=0.389 Sum_probs=208.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.+.+.+|+|| ||+.||+|.+++...+.+. .++.++.||+.||.|||++||+||||||+|||++..
T Consensus 94 ~hpniv~~~~~~~~~~~~~lv~-e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 172 (494)
T 3lij_A 94 DHPNIMKLYDFFEDKRNYYLVM-ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172 (494)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS
T ss_pred CCCCCCeEEEEEEeCCEEEEEE-ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC
Confidence 6999999999999999999999 7999999999998877665 899999999999999999999999999999999764
Q ss_pred C-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 P-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+.+||+|||+++...........+||+.|+|||++.+ .++. ++||||+||++|+|++|..||.+......+..+
T Consensus 173 ~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i- 249 (494)
T 3lij_A 173 EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDE-KCDVWSIGVILFILLAGYPPFGGQTDQEILRKV- 249 (494)
T ss_dssp STTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred CCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCC-chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence 3 34699999999987655555566789999999999864 4544 599999999999999999999987764443333
Q ss_pred HHHhccccC--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC--------CccchhcccCCCCCCC-
Q 022732 163 QRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA--------DLVDEKTMSSQYEEPD- 231 (293)
Q Consensus 163 ~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~--------~~~~~~~~~~~~~~~~- 231 (293)
...... .+.+..+|+.+++||.+||+.||.+|||+.++|+||||++.... ..........++....
T Consensus 250 ---~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (494)
T 3lij_A 250 ---EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQK 326 (494)
T ss_dssp ---HHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCH
T ss_pred ---HhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHH
Confidence 333332 23345689999999999999999999999999999999753110 0000001111121111
Q ss_pred -------------CCCCCHHHHHHHHHHhCCCCCCCCCccccccCCC----------CCCCcccccccccccccCCCCCc
Q 022732 232 -------------QPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL----------DMDDDDMDDLDSESELDIDSSGE 288 (293)
Q Consensus 232 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~d~~~d~~~~~~~~d~d~~g~ 288 (293)
........+.+.+...+.+..|..+.+++..... .....+.+-+......|.|++|.
T Consensus 327 l~qa~l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~ 406 (494)
T 3lij_A 327 LAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGY 406 (494)
T ss_dssp HHHHHHHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSS
T ss_pred HHHHHHHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCc
Confidence 1233456788888888998888877766532211 01111333455666778888888
Q ss_pred ccc
Q 022732 289 IIY 291 (293)
Q Consensus 289 ~~~ 291 (293)
|++
T Consensus 407 I~~ 409 (494)
T 3lij_A 407 IDY 409 (494)
T ss_dssp EEH
T ss_pred CcH
Confidence 875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=299.82 Aligned_cols=202 Identities=22% Similarity=0.345 Sum_probs=169.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|+++++++|...+..|+|| ||+.||+|.+++.....-. +++.++.|++.||.|||++|++||||||+|||++.++
T Consensus 75 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~ 153 (297)
T 3fxz_A 75 KNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153 (297)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred CCCCCCeEeEEEEECCEEEEEE-ECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC
Confidence 6899999999999999999999 7999999999998765333 9999999999999999999999999999999997655
Q ss_pred CCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
.+||+|||++....... ......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.........+..
T Consensus 154 --~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 230 (297)
T 3fxz_A 154 --SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (297)
T ss_dssp --CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred --CEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 59999999987544332 2345679999999999988877655 9999999999999999999988776544433332
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
. .......+..++..+.+||.+||..||.+|||+.++++||||+...+
T Consensus 231 ~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 231 N---GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp H---CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred C---CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 2 22233344568999999999999999999999999999999986543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=307.95 Aligned_cols=202 Identities=25% Similarity=0.421 Sum_probs=168.0
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..|+|+++++++|.+.+++|+|| ||+.||+|..++.+.+.++ .++.++.||+.||.|||++||+||||||+|||++
T Consensus 66 ~~~hp~iv~l~~~~~~~~~~~lv~-e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 144 (345)
T 3a8x_A 66 ASNHPFLVGLHSCFQTESRLFFVI-EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 144 (345)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred cCCCCccCeEEEEEEeCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC
Confidence 347999999999999999999999 7999999999998877666 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch-----
Q 022732 82 GSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----- 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----- 155 (293)
.++ ++||+|||+++... ........+||+.|+|||++.+..++. ++|+|||||++|+|++|+.||......
T Consensus 145 ~~g--~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 221 (345)
T 3a8x_A 145 SEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221 (345)
T ss_dssp TTS--CEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTTTC------
T ss_pred CCC--CEEEEeccccccccCCCCcccccCCCccccCccccCCCCCCh-HHhHHHHHHHHHHHHhCCCCcCCccccccccc
Confidence 654 59999999998532 233445678999999999998877754 499999999999999999999753221
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH------HHHHcCccccc
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI------PEIMKHQWFLK 211 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~------~ell~h~~~~~ 211 (293)
.....+.+.+......+| ..+|.++++||.+||.+||.+||++ .++++||||+.
T Consensus 222 ~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 222 NTEDYLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp -CHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred ccHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 111223344444444444 4589999999999999999999985 89999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=315.89 Aligned_cols=200 Identities=30% Similarity=0.524 Sum_probs=170.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.+.++.|+|| ||+.||+|.+.+...+.+. .+..++.||+.||.|||++||+||||||+|||++..
T Consensus 68 ~hpnIv~l~~~~~~~~~~~lv~-E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~ 146 (444)
T 3soa_A 68 KHPNIVRLHDSISEEGHHYLIF-DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK 146 (444)
T ss_dssp CBTTBCCEEEEEECSSEEEEEE-CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBS
T ss_pred CCcCCCeEEEEEEECCEEEEEE-EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecc
Confidence 6899999999999999999999 7999999999999887766 899999999999999999999999999999999754
Q ss_pred -CCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 -PAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 -~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
..+.+||+|||+++...... ......||+.|+|||++.+..++.+ +||||+||++|+|++|..||.+.+....+..
T Consensus 147 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~~- 224 (444)
T 3soa_A 147 LKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQ- 224 (444)
T ss_dssp STTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-
T ss_pred CCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHHHH-
Confidence 34569999999997654332 2345689999999999988777655 9999999999999999999988776444333
Q ss_pred HHHHhccccC--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 162 IQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
+...... .+.+..+|+++++||.+||+.||.+|||+.++|+||||+.
T Consensus 225 ---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 225 ---IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ---HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ---HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 3333333 3344568999999999999999999999999999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=309.36 Aligned_cols=199 Identities=28% Similarity=0.441 Sum_probs=169.7
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
...|+|+++++++|.+.+++|+|| ||+.||+|..++.+.+.+. .++.++.||+.||.|||++||+||||||+|||++
T Consensus 95 ~~~hp~Iv~l~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~ 173 (373)
T 2r5t_A 95 NVKHPFLVGLHFSFQTADKLYFVL-DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 173 (373)
T ss_dssp CCCCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred hCCCCCCCCEEEEEEeCCEEEEEE-eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC
Confidence 357999999999999999999999 7999999999998877665 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ ++||+|||+++... ......+.+||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.+....+
T Consensus 174 ~~g--~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~-- 248 (373)
T 2r5t_A 174 SQG--HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMY-- 248 (373)
T ss_dssp TTS--CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHHH--
T ss_pred CCC--CEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHH--
Confidence 655 59999999998532 3344566789999999999988777555 99999999999999999999887654433
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH----HHHHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI----PEIMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~ell~h~~~~~~ 212 (293)
..+......++ ..++.++++||.+||++||.+||++ .++++||||+..
T Consensus 249 --~~i~~~~~~~~--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 249 --DNILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp --HHHHHSCCCCC--SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred --HHHHhcccCCC--CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 33444433333 3489999999999999999999986 699999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=310.45 Aligned_cols=203 Identities=29% Similarity=0.444 Sum_probs=169.4
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
..|+|+++++++|.+.+++|+|| ||+.||+|.++++....-. .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 126 l~hp~Iv~l~~~~~~~~~~~lV~-E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~ 204 (410)
T 3v8s_A 126 ANSPWVVQLFYAFQDDRYLYMVM-EYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204 (410)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEE-CCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CCCCCCCeEEEEEEECCEEEEEE-eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC
Confidence 36899999999999999999999 7999999999997754323 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccC---CCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~---~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+ ++||+|||+|+...... ...+.+||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+.+....+
T Consensus 205 g--~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 282 (410)
T 3v8s_A 205 G--HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 282 (410)
T ss_dssp S--CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred C--CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH
Confidence 5 59999999997543332 2346789999999999976541 245599999999999999999999987765555
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCC--CCCHHHHHcCcccccC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA--RITIPEIMKHQWFLKN 212 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~ 212 (293)
..+..... ...+|....+|.++++||.+||..+|.+ |+++.++++||||+..
T Consensus 283 ~~i~~~~~--~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 283 SKIMNHKN--SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHTHHH--HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHhccc--cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 44443321 2344555569999999999999999988 9999999999999764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=311.30 Aligned_cols=206 Identities=25% Similarity=0.310 Sum_probs=163.0
Q ss_pred CCCCcchhhhhceeeece--eEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 4 VGSSSSEYAMLGVSVKMK--FVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~--~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
+.+|+|++++++++...+ .+|+|| ||+. ++|..++.....-. .++.++.||+.||+|||++||+||||||+|||+
T Consensus 65 l~~h~niv~l~~~~~~~~~~~~~lv~-e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 142 (388)
T 3oz6_A 65 LSGHENIVNLLNVLRADNDRDVYLVF-DYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142 (388)
T ss_dssp TTTCTTBCCEEEEEECTTSSCEEEEE-ECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ccCCCCCCeeeeEEecCCCCEEEEEe-cccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence 457999999999997654 789999 7998 58999998754333 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCC----------------------CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhH
Q 022732 81 DGSPAPRLKICDFGYSKSSVL----------------------HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 138 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i 138 (293)
+.++ .+||+|||+|+.... .......+||++|+|||++.+....+.++||||+||+
T Consensus 143 ~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~i 220 (388)
T 3oz6_A 143 NAEC--HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220 (388)
T ss_dssp CTTC--CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred cCCC--CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHH
Confidence 7654 599999999975422 1112345799999999999874444556999999999
Q ss_pred HHHHHhCCCCCCCCCchHHHHHHHHHHhcccc-----------------------------------------CCCCCCC
Q 022732 139 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----------------------------------------SVPDTNP 177 (293)
Q Consensus 139 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~ 177 (293)
+|+|++|+.||.+.+...++..+...+..... .......
T Consensus 221 l~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (388)
T 3oz6_A 221 LGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300 (388)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCC
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccccc
Confidence 99999999999998877766665533211100 0001125
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 178 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 178 ~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 301 ~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred CCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 789999999999999999999999999999997643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=310.02 Aligned_cols=200 Identities=28% Similarity=0.530 Sum_probs=170.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.+.+..|+|| ||+.||+|.+++...+.+. .++.++.||+.||.|||++||+||||||+|||++..
T Consensus 86 ~hpnIv~~~~~~~~~~~~~lv~-e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~ 164 (362)
T 2bdw_A 86 QHPNIVRLHDSIQEESFHYLVF-DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 164 (362)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCS
T ss_pred CCCCCCeEEEEEEeCCEEEEEE-ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC
Confidence 5899999999999999999999 7999999999998877655 899999999999999999999999999999999765
Q ss_pred C-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 P-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+.+||+|||+++............||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+
T Consensus 165 ~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~~---- 239 (362)
T 2bdw_A 165 AKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLY---- 239 (362)
T ss_dssp STTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----
T ss_pred CCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHH----
Confidence 3 34699999999987655555556789999999999988777655 99999999999999999999887654333
Q ss_pred HHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 163 QRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 163 ~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
..+......++ .+..+++++++||.+||.+||.+|||+.++++||||..
T Consensus 240 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 240 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 33333333333 23458999999999999999999999999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=310.60 Aligned_cols=201 Identities=22% Similarity=0.369 Sum_probs=169.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.+.+.+|+|| ||+.||+|.+++...+ .++ +++.++.||+.||.|||++|++||||||+|||++.
T Consensus 59 ~hpnIv~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~ 137 (321)
T 1tki_A 59 RHRNILHLHESFESMEELVMIF-EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCeEeEEEecCCEEEEEE-EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc
Confidence 5899999999999999999999 7999999999997654 344 89999999999999999999999999999999987
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
...+.+||+|||+++............||+.|+|||++.+..++ .++||||+||++|+|++|..||.+......+..
T Consensus 138 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-- 214 (321)
T 1tki_A 138 RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIEN-- 214 (321)
T ss_dssp SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--
T ss_pred CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH--
Confidence 54567999999999866544444556799999999999877665 459999999999999999999998776443333
Q ss_pred HHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+......++ .+..+|.++.+||.+||..||.+|||+.++++||||++.
T Consensus 215 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 215 --IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp --HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred --HHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 333333322 124589999999999999999999999999999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=305.75 Aligned_cols=198 Identities=20% Similarity=0.203 Sum_probs=147.4
Q ss_pred CCcchhhhhceeeece----eEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHc--------CCeecC
Q 022732 6 SSSSEYAMLGVSVKMK----FVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAM--------QVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~----~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~--------~iiHrd 72 (293)
.|+|+|++++++.+.+ .+|+|| ||+.||+|.+++...+... .+..++.|++.||+|||++ +|+|||
T Consensus 55 ~HpNIv~l~g~~~~~~~~~~~~~lV~-Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRD 133 (303)
T 3hmm_A 55 RHENILGFIAADNKDNGTWTQLWLVS-DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp CCTTBCCEEEEEEEECSSSEEEEEEE-ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSC
T ss_pred CCCCCCcEEEEEEecCCCceEEEEEe-cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeecc
Confidence 5999999999998764 689999 7999999999998765433 8899999999999999987 999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCC-----CCCCCcCCCCccchhhhccccC-----CCchhhhhhhhhHHHHH
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVM 142 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslG~il~el 142 (293)
|||+|||++.++ ++||+|||+|+...... .....+||+.|||||++.+... .+.++|||||||++|||
T Consensus 134 lKp~NILl~~~~--~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El 211 (303)
T 3hmm_A 134 LKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp CCGGGEEECTTS--CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CCcccEEECCCC--CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHH
Confidence 999999997665 59999999997543222 2234579999999999875421 23459999999999999
Q ss_pred HhCCCCCCCCCc----------h-HHHHHHHHHHhccccCCCCC-----CCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 143 LVGGYPFEDPDE----------P-KDFRKTIQRILSVQYSVPDT-----NPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 143 ~~g~~pf~~~~~----------~-~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+||..||..... . .....+...+.....+.+.+ ...+..+.+|+.+||+.||++|||+.++++.
T Consensus 212 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 999776643211 0 01122223333333222211 1133578899999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=317.97 Aligned_cols=200 Identities=35% Similarity=0.603 Sum_probs=173.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+.+|+|| ||+.||+|.+++.+.+.+. +++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 74 ~HpnIv~l~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~ 152 (476)
T 2y94_A 74 RHPHIIKLYQVISTPSDIFMVM-EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH 152 (476)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT
T ss_pred CCCCCCcEEEEEEECCEEEEEE-eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC
Confidence 5899999999999999999999 7999999999998877665 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||+++.........+.+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+....... .
T Consensus 153 ~--~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~----~ 226 (476)
T 2y94_A 153 M--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF----K 226 (476)
T ss_dssp C--CEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH----H
T ss_pred C--CeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH----H
Confidence 5 599999999987655555567789999999999988877677799999999999999999999987764433 3
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.+.......| ..+++++.+||.+||..||.+|||+.++++||||++..+
T Consensus 227 ~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 227 KICDGIFYTP--QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp HHHTTCCCCC--TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred HHhcCCcCCC--ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 3444433333 348999999999999999999999999999999987644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=305.84 Aligned_cols=195 Identities=26% Similarity=0.445 Sum_probs=168.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.+.+++|+|| ||+.||+|.+++.+.+.+. .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~-e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 177 (350)
T 1rdq_E 99 NFPFLVKLEFSFKDNSNLYMVM-EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177 (350)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CCCCCCeEEEEEEcCCEEEEEE-cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC
Confidence 6899999999999999999999 7999999999999877665 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ ++||+|||+++.... ...+.+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+.... ..
T Consensus 178 g--~~kL~DFg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~----~~ 248 (350)
T 1rdq_E 178 G--YIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQI----YE 248 (350)
T ss_dssp S--CEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH
T ss_pred C--CEEEcccccceeccC--CcccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHHH----HH
Confidence 5 599999999985432 3346689999999999988877655 9999999999999999999988765433 33
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~ 212 (293)
.+......+| ..++.++.++|.+||+.||.+||+ +.++++||||+..
T Consensus 249 ~i~~~~~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 249 KIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHCCCCCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 4444444444 458999999999999999999998 9999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=304.71 Aligned_cols=201 Identities=30% Similarity=0.496 Sum_probs=170.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|......|+|| ||+.|++|.+++...+.+. +++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 72 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~ 150 (326)
T 2y0a_A 72 QHPNVITLHEVYENKTDVILIL-ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 150 (326)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCS
T ss_pred CCCCCCcEEEEEEeCCEEEEEE-EcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecC
Confidence 4899999999999999999999 7999999999998777665 999999999999999999999999999999999765
Q ss_pred C--CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 P--APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~--~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
+ ..++||+|||+++............||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+..+
T Consensus 151 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 151 NVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp SSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 4 22699999999987655555566789999999999987777555 99999999999999999999887654433332
Q ss_pred HHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
. ......+ .+..++..+.+||.+||.+||.+|||+.++++||||+..
T Consensus 230 ~----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 230 S----AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp H----HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred H----hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 2 2222222 124578999999999999999999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=314.16 Aligned_cols=206 Identities=28% Similarity=0.477 Sum_probs=160.6
Q ss_pred CCCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 5 GSSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
..|+|+++++++|.. ..++|+|| ||+.||+|.+++...+. +. +++.++.||+.||.|||++||+||||||+
T Consensus 112 ~~hp~iv~l~~~~~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 190 (400)
T 1nxk_A 112 SQCPHIVRIVDVYENLYAGRKCLLIVM-ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190 (400)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEE-ECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred cCCCCcceEeEEEeecccCCcEEEEEE-EeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc
Confidence 468999999999986 78899999 79999999999987542 33 89999999999999999999999999999
Q ss_pred cEEEcCCC-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 77 NTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 77 NIl~~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
|||++... .+.+||+|||+++...........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....
T Consensus 191 Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~ 269 (400)
T 1nxk_A 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred eEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccc
Confidence 99998632 45699999999986655555567789999999999988777655 99999999999999999999876532
Q ss_pred HHHHHHHHHHhccccCC--CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 156 KDFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.........+....+.+ +.+..++.++++||.+||..||.+|||+.++++||||.+.
T Consensus 270 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 270 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp SSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 21111122222333333 3345689999999999999999999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=314.18 Aligned_cols=197 Identities=31% Similarity=0.509 Sum_probs=166.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+++++++|...+++|+|| ||+.||+|..++...+.+. .++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 206 ~h~~iv~l~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~ 284 (446)
T 4ejn_A 206 RHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 284 (446)
T ss_dssp SCTTSCCEEEEEEETTEEEEEE-CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS
T ss_pred CCCeEeeEEEEEeeCCEEEEEE-eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC
Confidence 5899999999999999999999 7999999999998887665 899999999999999998 99999999999999976
Q ss_pred CCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ ++||+|||+|+... ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.....
T Consensus 285 ~~--~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~--- 358 (446)
T 4ejn_A 285 DG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLF--- 358 (446)
T ss_dssp SS--CEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH---
T ss_pred CC--CEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHH---
Confidence 55 59999999998532 2333456789999999999988877555 99999999999999999999887654333
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
..+......+| ..+++++.+||.+||.+||.+|| |+.++++||||...
T Consensus 359 -~~i~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 359 -ELILMEEIRFP--RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp -HHHHHCCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -HHHHhCCCCCC--ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 33333444333 44899999999999999999999 99999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=304.56 Aligned_cols=203 Identities=33% Similarity=0.512 Sum_probs=169.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.+.+..|+|| ||+.||+|.+++...+.+. +++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 63 ~hpnIv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~ 141 (323)
T 3tki_A 63 NHENVVKFYGHRREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141 (323)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CCCCCCeEEEEEecCCeEEEEE-EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC
Confidence 5899999999999999999999 7999999999998776555 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+ .+||+|||+++..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...........
T Consensus 142 ~--~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 219 (323)
T 3tki_A 142 D--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219 (323)
T ss_dssp C--CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH
T ss_pred C--CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 5 5999999999753222 2234567999999999998877766679999999999999999999987665432222
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
. ........+....++..+.+||.+||..||.+|||+.++++||||++...
T Consensus 220 ~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 220 D---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp H---HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred H---HhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 2 22222333334568999999999999999999999999999999986543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=325.61 Aligned_cols=279 Identities=26% Similarity=0.413 Sum_probs=210.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.+..+.|+|| ||+.||+|.+++...+.++ .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 104 ~hpniv~~~~~~~~~~~~~lv~-e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 104 DHPNIIKLFDVFEDKKYFYLVT-EFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182 (504)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESST
T ss_pred CCCCCCeEEEEEEcCCEEEEEE-ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecC
Confidence 5899999999999999999999 7999999999998887766 899999999999999999999999999999999865
Q ss_pred CC-CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~-~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+. ..+||+|||+++...........+||+.|+|||++.+ .++. ++||||+||++|+|++|..||.+.+....+..
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-- 258 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNE-KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK-- 258 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--
T ss_pred CCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCc-hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence 43 3699999999987655555566789999999999864 4544 59999999999999999999998776444333
Q ss_pred HHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCCcc-chh------cccCCCCCCC--
Q 022732 163 QRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLV-DEK------TMSSQYEEPD-- 231 (293)
Q Consensus 163 ~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~-~~~------~~~~~~~~~~-- 231 (293)
+......++ .+..+|+++++||.+||.+||.+|||+.++|+||||++....... ... ....++....
T Consensus 259 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 336 (504)
T 3q5i_A 259 --VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKL 336 (504)
T ss_dssp --HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHH
T ss_pred --HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHH
Confidence 333333222 235689999999999999999999999999999999875443211 100 0011222111
Q ss_pred ------------CCCCCHHHHHHHHHHhCCCCCCCCCccccccC----------CCCCCCcccccccccccccCCCCCcc
Q 022732 232 ------------QPMQSVDVIMQIIAEASIPAVGTHGLNCYMTD----------NLDMDDDDMDDLDSESELDIDSSGEI 289 (293)
Q Consensus 232 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~d~~~d~~~~~~~~d~d~~g~~ 289 (293)
........+.+.+...+.+..|..+.++.... .......+.+-.......|.|++|.|
T Consensus 337 ~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I 416 (504)
T 3q5i_A 337 AQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYI 416 (504)
T ss_dssp HHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSE
T ss_pred HHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcE
Confidence 12234566888888999998888777664210 00111223334556667778888888
Q ss_pred cc
Q 022732 290 IY 291 (293)
Q Consensus 290 ~~ 291 (293)
++
T Consensus 417 ~~ 418 (504)
T 3q5i_A 417 EY 418 (504)
T ss_dssp EH
T ss_pred eH
Confidence 75
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=310.19 Aligned_cols=202 Identities=23% Similarity=0.360 Sum_probs=170.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+++++++|.+....|+|| ||+.||+|.+++...+ .+. +++.++.||+.||.|||++||+||||||+|||++.
T Consensus 106 ~hpnIv~~~~~~~~~~~~~lv~-E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 184 (387)
T 1kob_A 106 HHPKLINLHDAFEDKYEMVLIL-EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184 (387)
T ss_dssp CSTTBCCEEEEEECSSEEEEEE-ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCcCCCeEEEEEEeCCEEEEEE-EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec
Confidence 5899999999999999999999 7999999999997654 344 89999999999999999999999999999999986
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+..+.+||+|||+++............||+.|+|||++.+..++. ++|||||||++|+|++|..||.+.+....+..+
T Consensus 185 ~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i- 262 (387)
T 1kob_A 185 KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF-YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV- 262 (387)
T ss_dssp TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-
T ss_pred CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCC-cccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence 555679999999998665444445567999999999998877754 499999999999999999999987664443333
Q ss_pred HHHhccccC--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
...... .+.+..++.++++||.+||..||.+|||+.++++||||+...
T Consensus 263 ---~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 263 ---KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp ---HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ---HhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 222222 223346899999999999999999999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=306.86 Aligned_cols=199 Identities=21% Similarity=0.330 Sum_probs=168.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.+...+|+|| ||+.||+|..++...+.+. .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 73 ~hp~Iv~l~~~~~~~~~~~lv~-e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~ 151 (384)
T 4fr4_A 73 EHPFLVNLWYSFQDEEDMFMVV-DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH 151 (384)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CCCCCCcEEEEEEeCCEEEEEE-ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC
Confidence 6899999999999999999999 7999999999999887666 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc---ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+ ++||+|||+++.........+.+||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||....... ...
T Consensus 152 g--~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~ 227 (384)
T 4fr4_A 152 G--HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKE 227 (384)
T ss_dssp S--CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHH
T ss_pred C--CEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCC-ccceeechHHHHHHHHhCCCCCCCCCCcc-HHH
Confidence 5 599999999987655556667889999999999864 3354 44999999999999999999998644322 133
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-HHHHHcCccccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-IPEIMKHQWFLK 211 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~ell~h~~~~~ 211 (293)
+...+.......| ..++.++.+||.+||.+||.+||+ +.++++||||..
T Consensus 228 ~~~~~~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 228 IVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHhhcccCCC--CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 3333333333333 458999999999999999999998 899999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=305.03 Aligned_cols=205 Identities=29% Similarity=0.490 Sum_probs=169.5
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..|+|+++++++|.+.+++|+|| ||+.||+|.+++...+.+. +++.++.||+.||.|||++||+||||||+|||+.
T Consensus 72 ~~~hp~iv~~~~~~~~~~~~~lv~-E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~ 150 (342)
T 2qr7_A 72 YGQHPNIITLKDVYDDGKYVYVVT-ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYV 150 (342)
T ss_dssp HTTSTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred hcCCCCcCeEEEEEEcCCEEEEEE-eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEe
Confidence 357999999999999999999999 7999999999998887665 8999999999999999999999999999999985
Q ss_pred CCCC--CCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 82 GSPA--PRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~--~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
.... +.+||+|||+++..... ....+.+||+.|+|||++.+..++. ++|||||||++|+|++|..||.+... ...
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~-~~~ 228 (342)
T 2qr7_A 151 DESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTMLTGYTPFANGPD-DTP 228 (342)
T ss_dssp SSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHH-HHHHHHHHHHHHHHHHSSCSSCSSTT-SCH
T ss_pred cCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCC-ccCeeeHhHHHHHHhcCCCCCCCCCc-CCH
Confidence 4321 35999999999854332 3344668999999999998776654 49999999999999999999986422 112
Q ss_pred HHHHHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 159 RKTIQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
..+...+.......+ .+..+|.++++||.+||..||.+|||+.++++||||..
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 229 EEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 334444444444333 23568999999999999999999999999999999964
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.50 Aligned_cols=198 Identities=27% Similarity=0.482 Sum_probs=172.1
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..|+++++++++|++.+++|+|| ||+.||+|..+++..+.+. .++.|+.||+.||.|||++||+||||||+|||++
T Consensus 398 ~~~~~~i~~l~~~~~~~~~~~lV~-E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~ 476 (674)
T 3pfq_A 398 PGKPPFLTQLHSCFQTMDRLYFVM-EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476 (674)
T ss_dssp TTCCTTBCCEEEECBCSSEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC
T ss_pred ccCCCeEEEEEEEEEeCCEEEEEE-eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc
Confidence 467999999999999999999999 7999999999999887766 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcC-CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
.++ ++||+|||+|+... ......+.+||+.|+|||++.+..++.+ +|||||||++|||++|+.||.+.+.. .
T Consensus 477 ~~g--~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~----~ 549 (674)
T 3pfq_A 477 SEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDED----E 549 (674)
T ss_dssp SSS--CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----H
T ss_pred CCC--cEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHH----H
Confidence 665 59999999998532 2334456789999999999988887555 99999999999999999999987663 3
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCH-----HHHHcCccccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI-----PEIMKHQWFLK 211 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~-----~ell~h~~~~~ 211 (293)
+.+.+......+|. .+|.++++||.+||.+||.+||++ .++++||||+.
T Consensus 550 ~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 550 LFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHHHSSCCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHHHHhCCCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 44455555555544 489999999999999999999987 99999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=294.72 Aligned_cols=202 Identities=23% Similarity=0.319 Sum_probs=166.8
Q ss_pred CCcchhhhhceeeece-----eEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVKMK-----FVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~-----~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.|+|++++++++.... ++|+|| ||+.+ +|.+++..... ++ +++.++.||+.||.|||++|++||||||+
T Consensus 72 ~h~niv~~~~~~~~~~~~~~~~~~lv~-e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 149 (308)
T 3g33_A 72 EHPNVVRLMDVCATSRTDREIKVTLVF-EHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149 (308)
T ss_dssp CCTTBCCEEEEEEECCSSSEEEEEEEE-ECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred CCCCeEEeeeeeeccCCCCceeEEEEe-hhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 4899999999998765 689999 79885 99999987754 33 89999999999999999999999999999
Q ss_pred cEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 77 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 77 NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
||+++.++ ++||+|||+++............||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.....
T Consensus 150 Nil~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~ 226 (308)
T 3g33_A 150 NILVTSGG--TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEAD 226 (308)
T ss_dssp TEEECTTS--CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHH
T ss_pred HEEEcCCC--CEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99997655 599999999987655555566789999999999988887655 999999999999999999999988776
Q ss_pred HHHHHHHHHhccccC-CC--------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 157 DFRKTIQRILSVQYS-VP--------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~-~~--------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.+..+.......... ++ ....++..+.+||.+||.+||.+|||+.++|+||||++.
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 227 QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 666655543221100 00 012478999999999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=299.35 Aligned_cols=197 Identities=28% Similarity=0.463 Sum_probs=163.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...++.|+|| ||+.|++|.+++...+.+. .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 79 KHPFIVDLIYAFQTGGKLYLIL-EYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp CCTTBCCEEEEEECSSCEEEEE-ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT
T ss_pred CCCCccceeEEEEcCCEEEEEE-eCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC
Confidence 4899999999999999999999 7999999999998877655 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ ++||+|||+++.... .......+||+.|+|||++.+..++. ++|+|||||++|+|++|+.||.+.+....+.
T Consensus 158 ~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~--- 231 (327)
T 3a62_A 158 G--HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR-AVDWWSLGALMYDMLTGAPPFTGENRKKTID--- 231 (327)
T ss_dssp S--CEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---
T ss_pred C--cEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCC-cccchhHHHHHHHHHHCCCCCCCCCHHHHHH---
Confidence 4 599999999875322 22334567999999999998877755 4999999999999999999999876644333
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
.+.......| ..++.++++||.+||..||.+|| ++.++++||||+..
T Consensus 232 -~i~~~~~~~p--~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 232 -KILKCKLNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp -HHHHTCCCCC--TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred -HHHhCCCCCC--CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 3333333333 34899999999999999999999 88999999999753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=310.71 Aligned_cols=203 Identities=26% Similarity=0.439 Sum_probs=167.4
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
..|+|+++++++|.+.+++|+|| ||+.||+|.+++.+ .+.++ .++.++.||+.||.|||++||+||||||+|||++
T Consensus 131 ~~hp~Iv~l~~~~~~~~~~~lV~-Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~ 209 (437)
T 4aw2_A 131 GDSKWITTLHYAFQDDNNLYLVM-DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209 (437)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEE-CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CCCCCEEEEEEEEeeCCEEEEEE-ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc
Confidence 36899999999999999999999 79999999999987 34454 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhc-----cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
.++ ++||+|||+|+....... ....+||+.|+|||++. ...+ +.++||||+||++|||++|+.||.+.+.
T Consensus 210 ~~g--~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 210 MNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp TTS--CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CCC--CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 655 599999999975433222 23468999999999987 3344 4459999999999999999999998876
Q ss_pred hHHHHHHHHHHhccccCCCCC-CCCCHHHHHHHHHccccCCCC--CCCHHHHHcCcccccCC
Q 022732 155 PKDFRKTIQRILSVQYSVPDT-NPISQECRDLISRIFVADPAA--RITIPEIMKHQWFLKNL 213 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dp~~--Rpt~~ell~h~~~~~~~ 213 (293)
...+..+...... ..+|.. ..+|+++++||++||..+|++ |++++++++||||+...
T Consensus 287 ~~~~~~i~~~~~~--~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 287 VETYGKIMNHKER--FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp HHHHHHHHTHHHH--CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred hHHHHhhhhcccc--ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 5555554432221 222322 458999999999999988888 99999999999997643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=312.39 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=158.6
Q ss_pred CCcchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+++++++|... .++|+|| ||+.++ |...+...-....++.++.||+.||+|||++||+||||||+|||
T Consensus 119 ~hpnIv~l~~~~~~~~~~~~~~~~~lv~-E~~~~~-l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIl 196 (464)
T 3ttj_A 119 NHKNIISLLNVFTPQKTLEEFQDVYLVM-ELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196 (464)
T ss_dssp CCTTBCCCSEEECSCCSTTTCCEEEEEE-ECCSEE-HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCCCCCcEEEEEccCCccccCCeEEEEE-eCCCCC-HHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEE
Confidence 689999999999655 5679999 799875 66666554444489999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ ++||+|||+|+...........+||++|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+...++.
T Consensus 197 l~~~~--~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~ 273 (464)
T 3ttj_A 197 VKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273 (464)
T ss_dssp ECTTS--CEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EeCCC--CEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 97655 599999999987665555667789999999999998888655 999999999999999999999988777766
Q ss_pred HHHHHHhcccc---------------CCCCCCC---------------------CCHHHHHHHHHccccCCCCCCCHHHH
Q 022732 160 KTIQRILSVQY---------------SVPDTNP---------------------ISQECRDLISRIFVADPAARITIPEI 203 (293)
Q Consensus 160 ~~~~~~~~~~~---------------~~~~~~~---------------------~s~~~~~li~~~L~~dp~~Rpt~~el 203 (293)
.++..+..... ..+.... .++++++||.+||..||.+|||+.++
T Consensus 274 ~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 353 (464)
T 3ttj_A 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353 (464)
T ss_dssp HHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 66553321100 0000000 15679999999999999999999999
Q ss_pred HcCcccccCC
Q 022732 204 MKHQWFLKNL 213 (293)
Q Consensus 204 l~h~~~~~~~ 213 (293)
|+||||....
T Consensus 354 L~Hp~~~~~~ 363 (464)
T 3ttj_A 354 LQHPYINVWY 363 (464)
T ss_dssp HTSTTTGGGC
T ss_pred hcChhhhhcc
Confidence 9999998644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=307.12 Aligned_cols=201 Identities=25% Similarity=0.433 Sum_probs=169.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++...+ .+. .++.++.||+.||.|||++||+||||||+|||+..
T Consensus 144 ~hpnIv~~~~~~~~~~~~~lv~-E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 222 (373)
T 2x4f_A 144 DHANLIQLYDAFESKNDIVLVM-EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222 (373)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE
T ss_pred CCCCCCeEEEEEEECCEEEEEE-eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec
Confidence 6899999999999999999999 7999999999997643 233 88999999999999999999999999999999965
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+..+++||+|||+++............||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 223 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 301 (373)
T 2x4f_A 223 RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301 (373)
T ss_dssp TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 455579999999998765555556678999999999997766654 4999999999999999999999887655544444
Q ss_pred HHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
. .....+ ....+++++++||.+||.+||.+|||+.++++||||...
T Consensus 302 ~----~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 302 A----CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp H----TCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred h----ccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 3 222222 234589999999999999999999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=300.81 Aligned_cols=203 Identities=31% Similarity=0.475 Sum_probs=160.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG- 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~- 82 (293)
.|+|+++++++|...+..|+|| ||+.|++|.+++...+.+. +++.++.||+.||.|||++|++||||||+|||++.
T Consensus 106 ~h~niv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~ 184 (349)
T 2w4o_A 106 SHPNIIKLKEIFETPTEISLVL-ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP 184 (349)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS
T ss_pred CCCCCcceeeeEecCCeEEEEE-EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC
Confidence 4899999999999999999999 7999999999998877655 89999999999999999999999999999999975
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+..+.+||+|||+++............||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... .
T Consensus 185 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~---~ 260 (349)
T 2w4o_A 185 APDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFM---F 260 (349)
T ss_dssp STTCCEEECCCC----------------CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHH---H
T ss_pred CCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHHH---H
Confidence 2245699999999986554444556789999999999988777555 99999999999999999999876654322 2
Q ss_pred HHHhccccCC--CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..+....... +.+..++.++++||.+||..||.+|||+.++++||||....
T Consensus 261 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 261 RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 2333333322 23356899999999999999999999999999999997654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=294.69 Aligned_cols=203 Identities=25% Similarity=0.342 Sum_probs=163.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.+.++.|+|| ||+.+ +|.+++.... .+. .++.++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~ 154 (311)
T 3niz_A 77 HHPNIVSLIDVIHSERCLTLVF-EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS 154 (311)
T ss_dssp CCTTBCCEEEEECCSSCEEEEE-ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CCCCEeeeeeEEccCCEEEEEE-cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECC
Confidence 5899999999999999999999 79986 7777776653 233 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++..... .......||+.|+|||++.+....+.++||||+||++|+|++|+.||.+......+..+
T Consensus 155 ~~--~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 232 (311)
T 3niz_A 155 DG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232 (311)
T ss_dssp TC--CEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred CC--CEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 55 5999999999865332 23345578999999999877554455699999999999999999999988776666655
Q ss_pred HHHHhccccC-C--------------C---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQYS-V--------------P---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~-~--------------~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.......... + . ....+++++.+||.+||++||.+|||+.++++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 5433221110 0 0 012368899999999999999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=296.55 Aligned_cols=207 Identities=26% Similarity=0.408 Sum_probs=161.7
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.+|+|++++++++...++.|+|| ||+.|++|.+++...+.+. .++.++.||+.||.|||++|++||||||+|||++.
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 146 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVF-EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEE-ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESC
T ss_pred cCCCCeeeEEEEEeeCCEEEEEE-EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEcc
Confidence 57999999999999999999999 7999999999998877655 89999999999999999999999999999999976
Q ss_pred CCC-CCEEEecCCCCcCcCCCC--------CCCCCcCCCCccchhhhcc-----ccCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 83 SPA-PRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 83 ~~~-~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~p 148 (293)
++. ..+||+|||++....... .....+||+.|+|||++.+ ..++. ++|||||||++|+|++|+.|
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DiwslG~il~~l~~g~~p 225 (316)
T 2ac3_A 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK-RCDLWSLGVILYILLSGYPP 225 (316)
T ss_dssp SSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTT-THHHHHHHHHHHHHHHSSCS
T ss_pred CCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCc-ccccHhHHHHHHHHHHCCCC
Confidence 542 359999999987543211 1234569999999999875 33444 49999999999999999999
Q ss_pred CCCCCchH-----------HHHHHHHHHhccccCCCC--CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 149 FEDPDEPK-----------DFRKTIQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 149 f~~~~~~~-----------~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
|.+..... ........+......++. ...++.++++||.+||..||.+|||+.++++||||+...
T Consensus 226 f~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred CcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 98754311 112233334444443332 135889999999999999999999999999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=290.44 Aligned_cols=204 Identities=24% Similarity=0.349 Sum_probs=159.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.+.++.|+|| ||+.++.+..+....+.+. .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~ 137 (292)
T 3o0g_A 59 KHKNIVRLHDVLHSDKKLTLVF-EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137 (292)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CCCCEeeEEeEEEeCCEEEEEE-ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 5899999999999999999999 7998755544444455555 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC-CCCCchHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEPKDFRKT 161 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~~~~~~~~~~~ 161 (293)
+ .+||+|||+++..... .......||+.|+|||++.+....+.++||||+||++|+|++|..|| .+.+....+..+
T Consensus 138 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i 215 (292)
T 3o0g_A 138 G--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp S--CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred C--CEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 5 5999999999754322 33345679999999999987764456699999999999999888775 444443444443
Q ss_pred HHHHhccccC-----------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQYS-----------------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~-----------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.......... ......++.++++||.+||+.||.+|||+.++++||||++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 216 FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 3322211100 01112478999999999999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=291.85 Aligned_cols=202 Identities=26% Similarity=0.390 Sum_probs=161.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...++.|+|| ||+.+ +|.+++... +.+. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 58 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 135 (288)
T 1ob3_A 58 KHSNIVKLYDVIHTKKRLVLVF-EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (288)
T ss_dssp CCTTBCCEEEEEECSSCEEEEE-ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCCCEeeeeeEEccCCeEEEEE-EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 5899999999999999999999 79986 899988764 3333 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++..... .......||+.|+|||++.+....+.++||||+||++|+|++|+.||.+......+..+
T Consensus 136 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 213 (288)
T 1ob3_A 136 EG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (288)
T ss_dssp TS--CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CC--CEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 55 5999999998754322 22344578999999999877554455699999999999999999999988776666555
Q ss_pred HHHHhcccc--------------CCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 162 IQRILSVQY--------------SVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~--------------~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
......... ..+ ....++.++.+||.+||..||.+|||+.++++||||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 543221110 000 11347899999999999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=313.48 Aligned_cols=204 Identities=29% Similarity=0.499 Sum_probs=169.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+.+|+|| ||+.||+|.+++...+.++ .++.++.||+.||.|||++||+||||||+|||++..
T Consensus 79 ~hpniv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~ 157 (486)
T 3mwu_A 79 DHPNIMKLFEILEDSSSFYIVG-ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157 (486)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS
T ss_pred CCCCcCeEEEEEEcCCEEEEEE-EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC
Confidence 5899999999999999999999 7999999999998877666 899999999999999999999999999999999653
Q ss_pred C-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 P-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+.+||+|||+++...........+||+.|+|||++.+ .++ .++||||+||++|+|++|+.||.+......+..+.
T Consensus 158 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 235 (486)
T 3mwu_A 158 EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (486)
T ss_dssp STTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2 34699999999987655555566789999999999875 454 45999999999999999999999877644443333
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.. ......+.+..+|+++++||.+||.+||.+|||+.++|+||||++...
T Consensus 236 ~~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 236 TG--KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HT--CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred hC--CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 22 112233444568999999999999999999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.38 Aligned_cols=206 Identities=25% Similarity=0.351 Sum_probs=153.5
Q ss_pred CCcchhhhhceee-----eceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSV-----KMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~-----~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|+++++++|. ..+.+|+|| ||+ +++|..++...+.+. .++.++.||+.||.|||++||+||||||+||
T Consensus 110 ~h~niv~l~~~~~~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NI 187 (458)
T 3rp9_A 110 NHDHVVKVLDIVIPKDVEKFDELYVVL-EIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANC 187 (458)
T ss_dssp CCTTBCCEEEECCCSCTTTCCCEEEEE-CCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred CCCCCCceEEEEecCCcccCceEEEEE-ecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhE
Confidence 5899999999994 446899999 686 579999998877666 8999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCC----------------------------CCCCCcCCCCccchhhhccccCCCchh
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHS----------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIA 130 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 130 (293)
|++.++ .+||+|||+|+...... .....+||++|+|||++......+.++
T Consensus 188 Ll~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~ 265 (458)
T 3rp9_A 188 LVNQDC--SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265 (458)
T ss_dssp EECTTC--CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHH
T ss_pred EECCCC--CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHh
Confidence 997655 59999999998643221 223457899999999875544345559
Q ss_pred hhhhhhhHHHHHHh-----------CCCCCCCCCc--------------------hHHHHHHHHHHhccc----------
Q 022732 131 DVWSCGVTLYVMLV-----------GGYPFEDPDE--------------------PKDFRKTIQRILSVQ---------- 169 (293)
Q Consensus 131 DvwslG~il~el~~-----------g~~pf~~~~~--------------------~~~~~~~~~~~~~~~---------- 169 (293)
|||||||++|||++ |+++|.+... ..++..+...+....
T Consensus 266 DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 345 (458)
T 3rp9_A 266 DVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE 345 (458)
T ss_dssp HHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCH
T ss_pred HHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCH
Confidence 99999999999998 6777766431 122222221110000
Q ss_pred ------cCC---------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 170 ------YSV---------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 170 ------~~~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
... .....++.++.+||.+||..||.+|||+.++|+||||+.....
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred HHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 000 0123468999999999999999999999999999999876443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=318.32 Aligned_cols=201 Identities=26% Similarity=0.379 Sum_probs=169.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+++++++|.+.+++|+|| ||+.||+|..++...+. +. .++.++.||+.||.|||++||+||||||+|||++
T Consensus 242 ~hp~Iv~l~~~~~~~~~l~lVm-Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld 320 (576)
T 2acx_A 242 NSRFVVSLAYAYETKDALCLVL-TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD 320 (576)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CCCCEeeEEEEEeeCCEEEEEE-EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe
Confidence 5899999999999999999999 79999999999987653 43 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ ++||+|||+++...........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+
T Consensus 321 ~~g--~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i 397 (576)
T 2acx_A 321 DHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397 (576)
T ss_dssp TTS--CEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH
T ss_pred CCC--CeEEEecccceecccCccccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHH
Confidence 655 599999999987655444456789999999999988777655 99999999999999999999886532222333
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
...+......++ ..+|+++++||.+||.+||.+|| ++.++++||||+..
T Consensus 398 ~~~i~~~~~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 398 ERLVKEVPEEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHhhcccccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 344443433333 45899999999999999999999 78999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=288.88 Aligned_cols=204 Identities=27% Similarity=0.511 Sum_probs=171.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++...+.++ .+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 63 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~ 141 (284)
T 3kk8_A 63 QHPNIVRLHDSIQEESFHYLVF-DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 141 (284)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS
T ss_pred CCCCcCeEEEEEEcCCEEEEEE-ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecC
Confidence 5899999999999999999999 7999999999998887665 899999999999999999999999999999999765
Q ss_pred C-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 P-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+.+||+|||++.............||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.........+.
T Consensus 142 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 220 (284)
T 3kk8_A 142 AKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 220 (284)
T ss_dssp STTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH
Confidence 4 24599999999986655555556789999999999988777555 999999999999999999998876644333332
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.. ......+....+++++.+||.+||..||.+|||+.++++||||+...
T Consensus 221 ~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 221 AG--AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HT--CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred hc--cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 22 11222333456899999999999999999999999999999997653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=300.45 Aligned_cols=207 Identities=28% Similarity=0.453 Sum_probs=151.8
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+.+|+|+++++++|.+..+.|+|| ||+.||+|.+++...+.+. +++.++.||+.||.|||++||+||||||+|||++
T Consensus 62 l~~h~niv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~ 140 (325)
T 3kn6_A 62 CEGHPNIVKLHEVFHDQLHTFLVM-ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT 140 (325)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred hcCCCCeeEEEEEEEcCCEEEEEE-EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEe
Confidence 457999999999999999999999 7999999999999887666 8999999999999999999999999999999997
Q ss_pred CCC-CCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch---H
Q 022732 82 GSP-APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---K 156 (293)
Q Consensus 82 ~~~-~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~ 156 (293)
.++ ...+||+|||+++..... ......+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.... .
T Consensus 141 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 219 (325)
T 3kn6_A 141 DENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCT 219 (325)
T ss_dssp C----CEEEECCCTTCEECCC----------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CC
T ss_pred cCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccc
Confidence 644 236999999999754332 23345678999999999988777655 99999999999999999999875431 1
Q ss_pred HHHHHHHHHhccccCCCC--CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 157 DFRKTIQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
........+......++. +..+|+++++||.+||..||.+|||+.++++||||+..
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 220 SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 123444455444443332 13489999999999999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=304.85 Aligned_cols=201 Identities=25% Similarity=0.454 Sum_probs=164.3
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
..|+|+++++++|.+.+++|+|| ||+.||+|.+++.+.+ .++ .++.++.||+.||.|||++||+||||||+|||++
T Consensus 118 ~~hp~Iv~l~~~~~~~~~~~lVm-E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld 196 (412)
T 2vd5_A 118 GDRRWITQLHFAFQDENYLYLVM-EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD 196 (412)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred cCCCCeeeEEEEEeeCCEEEEEE-cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec
Confidence 36899999999999999999999 7999999999998754 444 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhcc-------ccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLR-------HEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
.++ ++||+|||+++....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.
T Consensus 197 ~~g--~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 197 RCG--HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp TTS--CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCC--CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 655 599999999976543322 234689999999999873 344 45599999999999999999999987
Q ss_pred CchHHHHHHHHHHhccccCCCC-CCCCCHHHHHHHHHccccCCCCC---CCHHHHHcCcccccC
Q 022732 153 DEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVADPAAR---ITIPEIMKHQWFLKN 212 (293)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~R---pt~~ell~h~~~~~~ 212 (293)
+....+..+...... ..+|. ...+|.++++||++||. +|.+| ++++++++||||+.-
T Consensus 274 ~~~~~~~~i~~~~~~--~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 274 STAETYGKIVHYKEH--LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp SHHHHHHHHHTHHHH--CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHhcccC--cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 765554444432111 22222 24589999999999999 99998 599999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=293.53 Aligned_cols=205 Identities=23% Similarity=0.397 Sum_probs=165.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC------CH--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG------LL--VQARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~------~~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.|+|++++++++...+..|+|| ||+.| +|.+++.... .+ ..++.++.||+.||.|||++||+||||||+|
T Consensus 61 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~N 138 (317)
T 2pmi_A 61 KHENIVRLYDVIHTENKLTLVF-EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQN 138 (317)
T ss_dssp CBTTBCCEEEEECCTTEEEEEE-ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CCCCcceEEEEEEECCeEEEEE-EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHH
Confidence 5899999999999999999999 79984 8999987642 23 3889999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
||++.++ .+||+|||+++..... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+...
T Consensus 139 Il~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 216 (317)
T 2pmi_A 139 LLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216 (317)
T ss_dssp EEECTTC--CEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred eEEcCCC--CEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9997655 5999999999764322 233456799999999998775444556999999999999999999999887766
Q ss_pred HHHHHHHHHhccccC--------------C--------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 157 DFRKTIQRILSVQYS--------------V--------------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~--------------~--------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
.+..+.......... . .....++.++.+||.+||++||.+|||+.++++|||
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 217 QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 655554432211000 0 011247899999999999999999999999999999
Q ss_pred cccCCC
Q 022732 209 FLKNLP 214 (293)
Q Consensus 209 ~~~~~~ 214 (293)
|++...
T Consensus 297 f~~~~~ 302 (317)
T 2pmi_A 297 FAEYYH 302 (317)
T ss_dssp GGGGCC
T ss_pred hhcccc
Confidence 986543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=298.24 Aligned_cols=199 Identities=27% Similarity=0.535 Sum_probs=163.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++...+.+|+|| ||+.|++|..++.... .+. .++.++.||+.||.|||++||+||||||+|||
T Consensus 84 ~hpnIv~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl 162 (351)
T 3c0i_A 84 KHPHIVELLETYSSDGMLYMVF-EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162 (351)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCCCCCcEEEEEEeCCEEEEEE-eCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeE
Confidence 5899999999999999999999 7999999998886542 233 89999999999999999999999999999999
Q ss_pred EcCCC-CCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 80 LDGSP-APRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 80 ~~~~~-~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
++.++ ...+||+|||+++....... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...
T Consensus 163 ~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~--- 238 (351)
T 3c0i_A 163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTKE--- 238 (351)
T ss_dssp ECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSHH---
T ss_pred EecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcHH---
Confidence 97643 34599999999976543322 345679999999999988777554 9999999999999999999987432
Q ss_pred HHHHHHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 158 FRKTIQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.....+.......+ .+..++.++++||.+||..||.+|||+.++++||||+.
T Consensus 239 --~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 239 --RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp --HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred --HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 22333333333222 12458999999999999999999999999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=301.54 Aligned_cols=204 Identities=18% Similarity=0.297 Sum_probs=160.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+++++++|...+.+|+|| ||+.+|+|.+++... +.+. .++.++.||+.||.|||++||+||||||+|||++
T Consensus 84 ~h~niv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~ 162 (389)
T 3gni_B 84 NHPNIVPYRATFIADNELWVVT-SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 162 (389)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CCCCCCcEeEEEEECCEEEEEE-EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 5899999999999999999999 799999999999875 3333 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCC--------CCCCCCCcCCCCccchhhhcc--ccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 82 GSPAPRLKICDFGYSKSSVL--------HSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
.++ .+||+|||.+..... .......+||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+
T Consensus 163 ~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 163 VDG--KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp TTC--CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC--CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCC
Confidence 655 599999998753211 122334579999999999987 4554 459999999999999999999988
Q ss_pred CCchHHHHHHHHHHhcc----------------------------------------ccCCCCCCCCCHHHHHHHHHccc
Q 022732 152 PDEPKDFRKTIQRILSV----------------------------------------QYSVPDTNPISQECRDLISRIFV 191 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~s~~~~~li~~~L~ 191 (293)
......+..+....... ....+.+..+++++.+||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp CCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred CCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 76654443332211100 00111234478999999999999
Q ss_pred cCCCCCCCHHHHHcCcccccCC
Q 022732 192 ADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 192 ~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.||.+|||+.++++||||+...
T Consensus 320 ~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 320 RNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp SCTTTSCCHHHHTTSGGGGGC-
T ss_pred cCcccCCCHHHHhcCHHHHHHh
Confidence 9999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=297.06 Aligned_cols=193 Identities=26% Similarity=0.406 Sum_probs=166.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCc-hhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLC-LFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg-~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+++++++|...+..|+|| ||+.+| +|..++...+.+. .++.++.||+.||.|||++|++||||||+|||++.
T Consensus 87 ~h~~Iv~~~~~~~~~~~~~lv~-e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 165 (335)
T 3dls_A 87 EHANIIKVLDIFENQGFFQLVM-EKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE 165 (335)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCCCEeeEEEEEeeCCEEEEEE-EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC
Confidence 6899999999999999999999 688666 9999999887666 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
++ .+||+|||+++...........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.....
T Consensus 166 ~~--~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------- 235 (335)
T 3dls_A 166 DF--TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------- 235 (335)
T ss_dssp TS--CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------
T ss_pred CC--cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------
Confidence 54 59999999998765555555678999999999998888766679999999999999999999976322
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.... ....+..+++++.+||.+||.+||.+|||+.++++||||++..
T Consensus 236 --~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 236 --TVEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp --GTTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred --HHhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 1111 2223344899999999999999999999999999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=293.94 Aligned_cols=198 Identities=34% Similarity=0.549 Sum_probs=162.7
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++.+ ..++|+|| ||+.+++|.+++... .+. +++.++.||+.||.|||++|++||||||+|||++
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVF-ELVNQGPVMEVPTLK-PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEE-ECCTTCBSCCSSCSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEE-ecCCCCcHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 58999999999987 67899999 799999998876443 333 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccC--CCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
.++ ++||+|||+++...... ......||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+.....
T Consensus 172 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-- 247 (298)
T 2zv2_A 172 EDG--HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC-- 247 (298)
T ss_dssp TTS--CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred CCC--CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH--
Confidence 654 59999999997543322 2345679999999999876542 3566899999999999999999998765432
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
....+.......+....+++++.+||.+||..||.+|||+.++++||||++
T Consensus 248 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 248 --LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp --HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred --HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 233333344455555668999999999999999999999999999999963
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=288.65 Aligned_cols=202 Identities=30% Similarity=0.512 Sum_probs=168.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.+.+..|+|| ||+.|++|.+++...+.+. .++.++.|++.||.|||++|++||||||+||++..+
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 142 (277)
T 3f3z_A 64 DHPNIIRLYETFEDNTDIYLVM-ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD 142 (277)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred CCCCEeeEEEEEecCCeEEEEE-eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC
Confidence 6899999999999999999999 7999999999998887665 899999999999999999999999999999999331
Q ss_pred -CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 -PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
..+.+||+|||++.............||+.|+|||++.+. ++ .++|+||+||++|+|++|+.||...........
T Consensus 143 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-- 218 (277)
T 3f3z_A 143 SPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YG-PECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK-- 218 (277)
T ss_dssp STTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--
T ss_pred CCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CC-chhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH--
Confidence 2346999999999866555555667899999999998654 44 459999999999999999999988776443333
Q ss_pred HHHhccccCCCC--CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 163 QRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 163 ~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
+.......+. ...+++.+.++|.+||..||.+|||+.++++||||++...
T Consensus 219 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 219 --IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp --HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred --HHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 2233332222 1257899999999999999999999999999999976433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=287.79 Aligned_cols=199 Identities=24% Similarity=0.450 Sum_probs=157.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++.+....|+|| ||+.+|+|.+++... ..+. .++.++.||+.||.|||++|++||||||+||+
T Consensus 78 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl 156 (285)
T 3is5_A 78 DHPNIIKIFEVFEDYHNMYIVM-ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156 (285)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred CCchHHhHHHheecCCeEEEEE-EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEE
Confidence 5899999999999999999999 799999999999653 3343 89999999999999999999999999999999
Q ss_pred EcCC-CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~-~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++.. ..+.+||+|||+++............||+.|+|||++.+ .+ +.++|+|||||++|+|++|+.||.+.......
T Consensus 157 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~ 234 (285)
T 3is5_A 157 FQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ 234 (285)
T ss_dssp ESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9653 245699999999986655555566789999999999753 44 45599999999999999999999887653332
Q ss_pred HHHHHHHhccccCC-CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 159 RKTIQRILSVQYSV-PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 159 ~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.. ........ .....+++++.+||.+||..||.+|||+.++++||||++
T Consensus 235 ~~----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 235 QK----ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HH----HHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred hh----hccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 22 21122111 122347899999999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=297.25 Aligned_cols=206 Identities=26% Similarity=0.397 Sum_probs=166.4
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
+..|+|+++++++|...+..|+|| ||+.||+|.+++... +.+. +++.++.||+.||.|||++|++||||||+||+
T Consensus 85 l~~~~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl 163 (327)
T 3lm5_A 85 AKSCPRVINLHEVYENTSEIILIL-EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163 (327)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEE-ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred ccCCCCEEEEEEEEEeCCeEEEEE-EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEE
Confidence 457899999999999999999999 799999999998543 3333 89999999999999999999999999999999
Q ss_pred EcCCC-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++... .+.+||+|||+++............||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.......
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETY 242 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 97621 34699999999986655555556789999999999988777655 99999999999999999999887765544
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..+... ......+....++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 243 ~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 243 LNISQV--NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHHT--CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHHhc--ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 433322 22233334456899999999999999999999999999999997653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=315.16 Aligned_cols=279 Identities=24% Similarity=0.394 Sum_probs=203.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|.+.+..|+|| ||+.||+|.+++...+.++ .++.++.||+.||.|||++||+||||||+|||++..
T Consensus 84 ~hpniv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 162 (484)
T 3nyv_A 84 DHPNIMKLYEFFEDKGYFYLVG-EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 162 (484)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred CCCCCCcEEEEEEeCCEEEEEE-ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC
Confidence 6999999999999999999999 7999999999998887766 899999999999999999999999999999999642
Q ss_pred -CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 -PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
..+.+||+|||+++...........+||+.|+|||++.+ .++ .++||||+||++|+|++|+.||.+.+....+..+
T Consensus 163 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i- 239 (484)
T 3nyv_A 163 SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKV- 239 (484)
T ss_dssp STTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred CCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-
Confidence 345699999999986655444456689999999999876 454 4599999999999999999999987764444333
Q ss_pred HHHhcccc--CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCCccch-------hcccCCCCCCC--
Q 022732 163 QRILSVQY--SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE-------KTMSSQYEEPD-- 231 (293)
Q Consensus 163 ~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~~~~~-------~~~~~~~~~~~-- 231 (293)
..... ..+.+..+|+++++||.+||++||.+|||+.++++||||+.......... .....++....
T Consensus 240 ---~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 316 (484)
T 3nyv_A 240 ---EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKL 316 (484)
T ss_dssp ---HHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHH
T ss_pred ---HcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHH
Confidence 33332 23344568999999999999999999999999999999975432111000 00000000000
Q ss_pred ------------CCCCCHHHHHHHHHHhCCCCCCCCCcccc----cc--CCCCCCCc-------ccccccccccccCCCC
Q 022732 232 ------------QPMQSVDVIMQIIAEASIPAVGTHGLNCY----MT--DNLDMDDD-------DMDDLDSESELDIDSS 286 (293)
Q Consensus 232 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~d~-------~~d~~~~~~~~d~d~~ 286 (293)
........+.+.+...+.+..|..+.+++ .. ........ +.+-+......|.|++
T Consensus 317 ~qa~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~ 396 (484)
T 3nyv_A 317 AQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKN 396 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTT
T ss_pred HHHHHHHHHhccCcHHHHHHHHHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCC
Confidence 01123446677788888888887766655 11 10111111 2333455666778888
Q ss_pred Ccccc
Q 022732 287 GEIIY 291 (293)
Q Consensus 287 g~~~~ 291 (293)
|.|++
T Consensus 397 g~i~~ 401 (484)
T 3nyv_A 397 GYIEY 401 (484)
T ss_dssp SEEEH
T ss_pred CeEeH
Confidence 88875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=293.07 Aligned_cols=203 Identities=23% Similarity=0.392 Sum_probs=159.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.| +|.+++...+. +. .++.++.||+.||.|||++||+||||||+||+++.
T Consensus 58 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 135 (324)
T 3mtl_A 58 KHANIVTLHDIIHTEKSLTLVF-EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE 135 (324)
T ss_dssp CCTTBCCEEEEEECSSCEEEEE-ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT
T ss_pred CCCCCCeeeeEEeeCCEEEEEe-ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC
Confidence 5899999999999999999999 79985 88888877643 33 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++..... .......||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+
T Consensus 136 ~~--~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 213 (324)
T 3mtl_A 136 RG--ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213 (324)
T ss_dssp TC--CEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CC--CEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 55 5999999998754322 22344578999999999887544455699999999999999999999998776655555
Q ss_pred HHHHhccccC---------------CC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQYS---------------VP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~---------------~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.......... .+ ....+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 214 FRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 4432211100 00 112478999999999999999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=294.55 Aligned_cols=201 Identities=29% Similarity=0.470 Sum_probs=169.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++...+.++ .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 73 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~ 151 (321)
T 2a2a_A 73 LHHNVITLHDVYENRTDVVLIL-ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDK 151 (321)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCT
T ss_pred CCCCcceEEEEEecCCEEEEEE-EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecC
Confidence 4899999999999999999999 7999999999998877665 899999999999999999999999999999999765
Q ss_pred CC--CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 PA--PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~~--~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
+. .++||+|||+++............||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.+......+.
T Consensus 152 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~-- 228 (321)
T 2a2a_A 152 NIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA-- 228 (321)
T ss_dssp TSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH--
T ss_pred CCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHHH--
Confidence 52 1599999999986655555566789999999999987777555 999999999999999999998876544333
Q ss_pred HHHHhccccCCCC--CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.+.......+. ...++..+.+||.+||..||.+|||+.++++||||...
T Consensus 229 --~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 229 --NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp --HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred --HHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 33333322221 23578999999999999999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.11 Aligned_cols=201 Identities=34% Similarity=0.602 Sum_probs=161.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++...+.+. .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~ 147 (276)
T 2h6d_A 69 RHPHIIKLYQVISTPTDFFMVM-EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH 147 (276)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT
T ss_pred CCCCEeEEEEEEecCCeEEEEE-eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC
Confidence 5899999999999999999999 7999999999998877665 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||++.............||+.|+|||++.+..+.+.++|+|||||++|+|++|+.||......... .
T Consensus 148 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~ 221 (276)
T 2h6d_A 148 M--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF----K 221 (276)
T ss_dssp S--CEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----H
T ss_pred C--CEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH----H
Confidence 4 599999999986554444456679999999999987776566799999999999999999999876553332 2
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
.+....... +..++..+.++|.+||..||.+|||+.++++||||++..+.
T Consensus 222 ~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 222 KIRGGVFYI--PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271 (276)
T ss_dssp HHHHCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred HhhcCcccC--chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCchh
Confidence 333333223 33478999999999999999999999999999999876543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=295.35 Aligned_cols=205 Identities=25% Similarity=0.331 Sum_probs=162.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.| +|.+++...+.+. .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~ 168 (329)
T 3gbz_A 91 QHRNIIELKSVIHHNHRLHLIF-EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVS 168 (329)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-
T ss_pred CCCCcceEEEEEecCCEEEEEE-ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecC
Confidence 5899999999999999999999 79985 9999998887665 899999999999999999999999999999999643
Q ss_pred C---CCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 84 P---APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 84 ~---~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+ .+.+||+|||+++..... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+.
T Consensus 169 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 248 (329)
T 3gbz_A 169 DASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248 (329)
T ss_dssp ----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH
Confidence 2 235999999999754322 233455789999999999876544556999999999999999999999888766666
Q ss_pred HHHHHHhccccC--------------CCCC----------CCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 160 KTIQRILSVQYS--------------VPDT----------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 160 ~~~~~~~~~~~~--------------~~~~----------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.+.......... .+.. ..++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred HHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 655543211110 0000 1167999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=292.75 Aligned_cols=194 Identities=20% Similarity=0.209 Sum_probs=155.5
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
..|+|+++++++|.+.+..|+|| ||+ +++|.+++...+ .++ .++.++.||+.||.|||++||+||||||+|||++
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQT-ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEE-ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred cCCCcEEEEEEEEEeCCEEEEEE-ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 47999999999999999999999 799 668888887654 344 8999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++ .+||+|||+++............||+.|+|||++.+ .++ .++||||+||++|+|++|..||.+...
T Consensus 192 ~~~--~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~el~~g~~~~~~~~~------- 260 (311)
T 3p1a_A 192 PRG--RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYG-TAADVFSLGLTILEVACNMELPHGGEG------- 260 (311)
T ss_dssp GGG--CEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCS-THHHHHHHHHHHHHHHHTCCCCSSHHH-------
T ss_pred CCC--CEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCC-chhhHHHHHHHHHHHHhCCCCCCCccH-------
Confidence 655 599999999986655555566679999999999876 554 459999999999999999777655322
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
...+............+++++.+||.+||.+||.+|||+.++++||||++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 261 WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 12222221111122448899999999999999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=302.47 Aligned_cols=207 Identities=23% Similarity=0.290 Sum_probs=155.6
Q ss_pred CCcchhhhhceeeec-----eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKM-----KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~-----~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++... +.+|+|| ||+. ++|..++...+.+. .++.++.||+.||.|||++||+||||||+||
T Consensus 83 ~h~nIv~l~~~~~~~~~~~~~~~~lv~-e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NI 160 (432)
T 3n9x_A 83 KSDYIIRLYDLIIPDDLLKFDELYIVL-EIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANC 160 (432)
T ss_dssp CCTTBCCEEEECCCSCTTTCCCEEEEE-ECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCCCcceEEEEEecCCCCcCCeEEEEE-ecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHe
Confidence 489999999999877 6799999 6877 59999998877665 9999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCC-----------------------CCCCCcCCCCccchhhhccccCCCchhhhhhh
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHS-----------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSC 135 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl 135 (293)
|++.++ .+||+|||+|+...... .....+||++|+|||++......+.++||||+
T Consensus 161 Ll~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSl 238 (432)
T 3n9x_A 161 LLNQDC--SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238 (432)
T ss_dssp EECTTC--CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred EECCCC--CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchH
Confidence 997654 59999999998543221 23567899999999997555544566999999
Q ss_pred hhHHHHHHhC-----------CCCCCCCCc-----------------hHHHHHHHHHHhc--------------------
Q 022732 136 GVTLYVMLVG-----------GYPFEDPDE-----------------PKDFRKTIQRILS-------------------- 167 (293)
Q Consensus 136 G~il~el~~g-----------~~pf~~~~~-----------------~~~~~~~~~~~~~-------------------- 167 (293)
||++|+|++| .++|.+.+. ..++..+...+..
T Consensus 239 G~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 318 (432)
T 3n9x_A 239 GCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318 (432)
T ss_dssp HHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred HHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh
Confidence 9999999984 444444321 1222222211110
Q ss_pred cccCCCC-----CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCC
Q 022732 168 VQYSVPD-----TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216 (293)
Q Consensus 168 ~~~~~~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~ 216 (293)
.....+. ...+++++.+||.+||..||.+|||+.++|+||||+......
T Consensus 319 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred CCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 0011110 134799999999999999999999999999999998754433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=290.43 Aligned_cols=202 Identities=25% Similarity=0.396 Sum_probs=166.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++.....-. .+..++.||+.||.|||++|++||||||+||+++.++
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-CCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred CCCCcceEEEEEEECCEEEEEE-ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC
Confidence 5899999999999999999999 7999999999987644322 9999999999999999999999999999999997654
Q ss_pred CCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
++||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........+..
T Consensus 179 --~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 255 (321)
T 2c30_A 179 --RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD 255 (321)
T ss_dssp --CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred --cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 5999999998754332 22345679999999999987777555 9999999999999999999988765443332221
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
. ..........+++.+.+||.+||..||.+|||+.++++||||.+...
T Consensus 256 ~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 256 S---PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp S---SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred C---CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCC
Confidence 1 11122233457899999999999999999999999999999986543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.79 Aligned_cols=200 Identities=27% Similarity=0.379 Sum_probs=167.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+++++++|.+...+|+|| ||+.||+|..++...+ .+. .++.++.||+.||.|||++||+||||||+|||
T Consensus 243 ~hp~Iv~l~~~~~~~~~l~lVm-E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NIL 321 (543)
T 3c4z_A 243 HSRFIVSLAYAFETKTDLCLVM-TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL 321 (543)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCCCEeeEEEEEeeCCEEEEEE-EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEE
Confidence 5899999999999999999999 7999999999997643 333 89999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++.++ ++||+|||+++....... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.......
T Consensus 322 l~~~g--~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~ 398 (543)
T 3c4z_A 322 LDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVEN 398 (543)
T ss_dssp ECTTS--CEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCH
T ss_pred EeCCC--CEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhH
Confidence 97655 599999999986544333 234589999999999988777655 99999999999999999999876533223
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCccccc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLK 211 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~ 211 (293)
..+.+.+......+| ..+|..+++||.+||.+||.+||+ +.++++||||+.
T Consensus 399 ~~~~~~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 399 KELKQRVLEQAVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHhhcccCCC--cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 344455554444444 458999999999999999999996 489999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=302.53 Aligned_cols=207 Identities=23% Similarity=0.327 Sum_probs=165.1
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
-.++|++++++.+...+++|+|| ||+. ++|.+++..... +. .++.++.||+.||.|||++||+||||||+|||+
T Consensus 156 ~~~~~iv~~~~~~~~~~~~~lv~-e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl 233 (429)
T 3kvw_A 156 DNTMNVIHMLENFTFRNHICMTF-ELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233 (429)
T ss_dssp TSCSCBCCEEEEEEETTEEEEEE-CCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE
T ss_pred cCCcCEEEEEeecccCCeEEEEE-eccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 36789999999999999999999 7986 589999987642 33 899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+.++...+||+|||+|+.. .....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..
T Consensus 234 ~~~~~~~vkL~DFG~a~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~ 310 (429)
T 3kvw_A 234 KQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310 (429)
T ss_dssp SSTTSCCEEECCCTTCEET--TCCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccCCCcceEEeecccceec--CCcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 8766545999999999753 233456789999999999988887655 9999999999999999999999887666655
Q ss_pred HHHHHhccccC----------------C-----------------------------CC--------CCCCCHHHHHHHH
Q 022732 161 TIQRILSVQYS----------------V-----------------------------PD--------TNPISQECRDLIS 187 (293)
Q Consensus 161 ~~~~~~~~~~~----------------~-----------------------------~~--------~~~~s~~~~~li~ 187 (293)
+.......... . +. ....++++.+||.
T Consensus 311 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~ 390 (429)
T 3kvw_A 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390 (429)
T ss_dssp HHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHH
T ss_pred HHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHH
Confidence 55432111000 0 00 0123788999999
Q ss_pred HccccCCCCCCCHHHHHcCcccccCCCCC
Q 022732 188 RIFVADPAARITIPEIMKHQWFLKNLPAD 216 (293)
Q Consensus 188 ~~L~~dp~~Rpt~~ell~h~~~~~~~~~~ 216 (293)
+||++||.+|||+.++|+||||++..+..
T Consensus 391 ~~L~~dP~~Rpta~e~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 391 QCLEWDPAVRMTPGQALRHPWLRRRLPKP 419 (429)
T ss_dssp HHTCSSTTTSCCHHHHHTSTTTC------
T ss_pred HHCCCChhhCCCHHHHhCChhhccCCCCC
Confidence 99999999999999999999998765443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=288.35 Aligned_cols=205 Identities=21% Similarity=0.321 Sum_probs=162.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.+++|..++...+.++ .++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (311)
T 4agu_A 60 KHPNLVNLLEVFRRKRRLHLVF-EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH 138 (311)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CCCCccchhheeecCCeEEEEE-EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC
Confidence 4899999999999999999999 7999999999998776665 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+++..... .......||+.|+|||++.+....+.++|+||+||++|+|++|+.||.+.........+.
T Consensus 139 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 139 S--VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp S--CEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred C--CEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4 5999999999754322 223456799999999999874444556999999999999999999999887665544443
Q ss_pred HHHhcc---------------ccCCCC----------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSV---------------QYSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~---------------~~~~~~----------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
...... ....+. ...++.++.+||.+||..||.+|||+.++++||||+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp HHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 322110 001111 134789999999999999999999999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=298.09 Aligned_cols=199 Identities=33% Similarity=0.569 Sum_probs=167.3
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.+|+|++++++++......|+|| ||+.|++|.+++.....+. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 157 ~~hp~iv~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 157 AGHPHIITLIDSYESSSFMFLVF-DLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235 (365)
T ss_dssp TTCTTBCCEEEEEEBSSEEEEEE-CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred cCCCCEeEEEEEEeeCCEEEEEE-EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 47999999999999999999999 7999999999998876665 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccc------cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++ ++||+|||++.............||+.|+|||++.+. .+ +.++|||||||++|+|++|+.||.+.....
T Consensus 236 ~~--~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~ 312 (365)
T 2y7j_A 236 NM--QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQIL 312 (365)
T ss_dssp TC--CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CC--CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 54 5999999999876555555667899999999998642 34 345999999999999999999998866543
Q ss_pred HHHHHHHHHhccccCC--CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 157 DFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.+.. +....... +.+..++..+.+||.+||..||.+|||+.++++||||++
T Consensus 313 ~~~~----i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 313 MLRM----IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHH----HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHH----HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 3333 22222222 223457899999999999999999999999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=286.34 Aligned_cols=197 Identities=32% Similarity=0.556 Sum_probs=163.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.+....|+|| ||+.+++|..++...+.+. .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 67 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~ 145 (279)
T 3fdn_A 67 RHPNILRLYGYFHDATRVYLIL-EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA 145 (279)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT
T ss_pred CCCCCcchhheEecCCEEEEEE-ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC
Confidence 4899999999999999999999 7999999999998877665 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||......... .
T Consensus 146 ~--~~~l~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~ 217 (279)
T 3fdn_A 146 G--ELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETY----K 217 (279)
T ss_dssp S--CEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----H
T ss_pred C--CEEEEeccccccCCc-ccccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHHH----H
Confidence 5 599999999865432 23345679999999999987776555 99999999999999999999877654333 2
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.+.......+ ..++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 218 ~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 218 RISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHTCCCCC--TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHhCCCCCC--CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 3333333333 34889999999999999999999999999999997643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=296.74 Aligned_cols=203 Identities=27% Similarity=0.391 Sum_probs=166.4
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|++++++++...+..|+|| ||+.+++|.+++...+.+. .++.++.||+.||.|||++||+||||||+|||++.
T Consensus 116 ~~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 116 RQSPFLVTLHYAFQTETKLHLIL-DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS 194 (355)
T ss_dssp HTCTTBCCEEEEEEETTEEEEEE-CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred cCCCceeEEEEEEeeCceEEEEe-ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 36899999999999999999999 7999999999998877665 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC--CCCCCCcCCCCccchhhhccc-cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++ ++||+|||+++..... ......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||..........
T Consensus 195 ~~--~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 272 (355)
T 1vzo_A 195 NG--HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272 (355)
T ss_dssp TS--CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred CC--cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH
Confidence 54 5999999998754222 222345799999999998753 223455999999999999999999998654433334
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
.+...+....... +..++..+.+||.+||.+||.+|| |+.++++||||++.
T Consensus 273 ~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 273 EISRRILKSEPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhccCCCC--CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 4444444443333 345899999999999999999999 99999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=295.74 Aligned_cols=204 Identities=25% Similarity=0.387 Sum_probs=152.5
Q ss_pred CCcchhhhhceeeece------eEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMK------FVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~------~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++...+ .+|+|| ||+.+ +|.+++...-....++.++.||+.||.|||++||+||||||+|||
T Consensus 82 ~hpniv~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl 159 (371)
T 2xrw_A 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVM-ELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 159 (371)
T ss_dssp CCTTBCCEEEEECSCCSTTTCCEEEEEE-ECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCCCccceEEeeccccccccccceEEEE-EcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEE
Confidence 5899999999998765 889999 79985 788888755445589999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ .+||+|||+++............||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.
T Consensus 160 ~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~ 236 (371)
T 2xrw_A 160 VKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236 (371)
T ss_dssp ECTTS--CEEECCCCC----------------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EcCCC--CEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 97654 599999999986554444456789999999999988777655 999999999999999999999887655554
Q ss_pred HHHHHHhcc------------------ccCC--------------CCC----CCCCHHHHHHHHHccccCCCCCCCHHHH
Q 022732 160 KTIQRILSV------------------QYSV--------------PDT----NPISQECRDLISRIFVADPAARITIPEI 203 (293)
Q Consensus 160 ~~~~~~~~~------------------~~~~--------------~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~el 203 (293)
.+....... .... +.. ...+.++++||.+||..||.+|||+.++
T Consensus 237 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 316 (371)
T 2xrw_A 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316 (371)
T ss_dssp HHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence 443321100 0000 000 0015789999999999999999999999
Q ss_pred HcCcccccCCC
Q 022732 204 MKHQWFLKNLP 214 (293)
Q Consensus 204 l~h~~~~~~~~ 214 (293)
++||||.....
T Consensus 317 l~hp~~~~~~~ 327 (371)
T 2xrw_A 317 LQHPYINVWYD 327 (371)
T ss_dssp HHSHHHHTTCC
T ss_pred hCCcchhhhcC
Confidence 99999976543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=294.74 Aligned_cols=200 Identities=22% Similarity=0.339 Sum_probs=161.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...++.|+|| ||+ +++|.+++..... +. .++.++.||+.||.|||++||+||||||+|||++
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 171 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIF-EPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLD 171 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEE-CCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred CCCCeecccceeeECCeeEEEE-cCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEc
Confidence 5999999999999999999999 799 9999999987652 33 8999999999999999999999999999999997
Q ss_pred CC-----------------------CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhH
Q 022732 82 GS-----------------------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 138 (293)
Q Consensus 82 ~~-----------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i 138 (293)
.. ..+.+||+|||+|+... .......||+.|+|||++.+..++.+ +|||||||+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~i 248 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCV 248 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHH
Confidence 51 24569999999997532 23346689999999999988887655 999999999
Q ss_pred HHHHHhCCCCCCCCCchHHHHHHHHHHhccc----------------------cCCCCC------------------CCC
Q 022732 139 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------------------YSVPDT------------------NPI 178 (293)
Q Consensus 139 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~------------------~~~ 178 (293)
+|+|++|+.||.+......+..+........ ..+|.. ...
T Consensus 249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328 (360)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence 9999999999998776554433332111000 000100 012
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 179 SQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 179 s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
++.+.+||.+||++||.+|||+.++|+||||+
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 47788999999999999999999999999995
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.15 Aligned_cols=203 Identities=24% Similarity=0.322 Sum_probs=163.3
Q ss_pred CCcchhhhhceeeece------eEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMK------FVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~------~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++.... .+|+|| ||+ +++|..+++....-. .++.++.||+.||.|||++||+||||||+||
T Consensus 82 ~hpnIv~l~~~~~~~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NI 159 (367)
T 1cm8_A 82 RHENVIGLLDVFTPDETLDDFTDFYLVM-PFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL 159 (367)
T ss_dssp CBTTBCCCSEEECSCSSTTTCCCCEEEE-ECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCcCCCCceeeEecCCccccCceEEEEE-ecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHE
Confidence 4899999999998763 469999 798 889999998744222 8999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
|++.++ .+||+|||+++... ......+||++|+|||++.+....+.++|+||+||++|+|++|+.||.+.+...++
T Consensus 160 ll~~~~--~~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l 235 (367)
T 1cm8_A 160 AVNEDC--ELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 235 (367)
T ss_dssp EECTTC--CEEECCCTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEcCCC--CEEEEeeecccccc--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 997654 59999999998643 23455689999999999887333345599999999999999999999998876666
Q ss_pred HHHHHHHhccc-------------------cCC------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 159 RKTIQRILSVQ-------------------YSV------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 159 ~~~~~~~~~~~-------------------~~~------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..+........ ... .....+++++.+||.+||..||.+|||+.++++||||....
T Consensus 236 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 236 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 55544321110 000 01234789999999999999999999999999999998654
Q ss_pred C
Q 022732 214 P 214 (293)
Q Consensus 214 ~ 214 (293)
.
T Consensus 316 ~ 316 (367)
T 1cm8_A 316 D 316 (367)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=299.23 Aligned_cols=206 Identities=23% Similarity=0.338 Sum_probs=163.8
Q ss_pred CCcchhhhhceeeec------eeEEEeehhhccCchhHHHHH---HcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCC
Q 022732 6 SSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLL---LLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLK 74 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~---~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlk 74 (293)
.|+|+++++++|... .++|+|| ||+.++.+..... ..+.++ .++.++.||+.||.|||++||+|||||
T Consensus 90 ~h~niv~l~~~~~~~~~~~~~~~~~lv~-e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 168 (394)
T 4e7w_A 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVL-EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIK 168 (394)
T ss_dssp CCTTBCCEEEEEEEESSSSSCEEEEEEE-ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred CCCCcceEEEEEEecCCCCCceEEEEEe-eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence 589999999999554 3489999 7999865544332 233444 899999999999999999999999999
Q ss_pred CCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 75 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 75 p~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
|+|||++.. .+.+||+|||+|+...........+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.
T Consensus 169 p~Nill~~~-~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 169 PQNLLLDPP-SGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp GGGEEEETT-TTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHEEEcCC-CCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999732 3369999999998765556666778999999999997765445569999999999999999999999887
Q ss_pred hHHHHHHHHHHhccc-------------cCCC----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 155 PKDFRKTIQRILSVQ-------------YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~-------------~~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
...+..+.+...... ..++ ....+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 248 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred HHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 776666655321110 0111 11237899999999999999999999999999999986
Q ss_pred CC
Q 022732 212 NL 213 (293)
Q Consensus 212 ~~ 213 (293)
..
T Consensus 328 ~~ 329 (394)
T 4e7w_A 328 LR 329 (394)
T ss_dssp TT
T ss_pred hc
Confidence 54
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=296.47 Aligned_cols=199 Identities=22% Similarity=0.372 Sum_probs=161.0
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
++|++++++++...+.+|+|| | +.+++|.+++...+.+. +++.++.||+.||.|||++||+||||||+|||++.
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~-E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-- 190 (390)
T 2zmd_A 115 SDKIIRLYDYEITDQYIYMVM-E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-- 190 (390)
T ss_dssp CTTBCCEEEEEECSSEEEEEE-E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--
T ss_pred CCeEEEEEEEEecCCEEEEEE-e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--
Confidence 689999999999999999999 6 67889999999877665 89999999999999999999999999999999953
Q ss_pred CCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccc----------cCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 85 APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRH----------EYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
+.+||+|||+++...... .....+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||..
T Consensus 191 -~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 191 -GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp -SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 359999999998653322 23456799999999998652 2234559999999999999999999987
Q ss_pred CCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 152 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..... .....+.......+.+...+.++.+||.+||..||.+|||+.++++||||+...
T Consensus 270 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 270 IINQI---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCHH---HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hhHHH---HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 55422 223334444444444445689999999999999999999999999999997543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=283.84 Aligned_cols=196 Identities=31% Similarity=0.528 Sum_probs=166.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++...+.+. .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 72 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~ 150 (284)
T 2vgo_A 72 RHPNILRMYNYFHDRKRIYLML-EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK 150 (284)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT
T ss_pred CCCCEeeEEEEEEcCCEEEEEE-EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC
Confidence 5899999999999999999999 7999999999998877655 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ .+||+|||++..... .......|++.|+|||++.+..++.+ +|+|||||++|+|++|..||........ ..
T Consensus 151 ~--~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~----~~ 222 (284)
T 2vgo_A 151 G--ELKIADFGWSVHAPS-LRRRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTET----HR 222 (284)
T ss_dssp C--CEEECCCTTCEECSS-SCBCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHH----HH
T ss_pred C--CEEEecccccccCcc-cccccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHH----HH
Confidence 5 599999999875432 22345679999999999988777555 9999999999999999999988765333 23
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.+.......+ ..++.+++++|.+||..||.+|||+.++++||||+..
T Consensus 223 ~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 223 RIVNVDLKFP--PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHTTCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHhccccCCC--CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 3333333333 4489999999999999999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=283.90 Aligned_cols=201 Identities=30% Similarity=0.497 Sum_probs=168.4
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.+|+|++++++++...+..|+|| ||+.+++|.+++...+.+. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 81 ~~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 81 SGHPNIIQLKDTYETNTFFFLVF-DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159 (298)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred cCCCCEeeeeeeeccCCeEEEEE-eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC
Confidence 46999999999999999999999 7999999999998876655 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc------ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++ .+||+|||++.............||+.|+|||++.+ ..+ +.++|+|||||++|+|++|+.||.......
T Consensus 160 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 236 (298)
T 1phk_A 160 DM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236 (298)
T ss_dssp TC--CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CC--cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence 55 599999999986655555566789999999999852 233 445999999999999999999998876543
Q ss_pred HHHHHHHHHhccccCC--CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 157 DFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
....+ ....... +....++..+.++|.+||..||.+|||+.++++||||++..
T Consensus 237 ~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 237 MLRMI----MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHH----HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHHH----hcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 33322 2222222 23345899999999999999999999999999999997653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=290.50 Aligned_cols=198 Identities=22% Similarity=0.389 Sum_probs=158.4
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
++|++++++++...+++|+|| | +.+++|.+++...+.+. +++.++.||+.||.|||++||+||||||+|||++.
T Consensus 68 ~~~iv~~~~~~~~~~~~~lv~-e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-- 143 (343)
T 3dbq_A 68 SDKIIRLYDYEITDQYIYMVM-E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-- 143 (343)
T ss_dssp CTTBCCEEEEEECSSEEEEEE-C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--
T ss_pred CCceEEEeeeEeeCCEEEEEE-e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--
Confidence 389999999999999999999 6 67889999999887665 89999999999999999999999999999999963
Q ss_pred CCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhcc-----------ccCCCchhhhhhhhhHHHHHHhCCCCCC
Q 022732 85 APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLR-----------HEYDGKIADVWSCGVTLYVMLVGGYPFE 150 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DvwslG~il~el~~g~~pf~ 150 (293)
+.+||+|||+++...... .....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.
T Consensus 144 -~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 144 -GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp -TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcch
Confidence 359999999998653322 2235679999999999865 334 445999999999999999999998
Q ss_pred CCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 151 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
...... .....+.........+...+.++.+||.+||..||.+|||+.++++||||+...
T Consensus 222 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 222 QIINQI---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp TCCSHH---HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hhhhHH---HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 754422 222333333334444445788999999999999999999999999999997543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=294.42 Aligned_cols=203 Identities=26% Similarity=0.432 Sum_probs=161.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--------------------------------------CC--
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--------------------------------------GL-- 45 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--------------------------------------~~-- 45 (293)
.|+|++++++++.+.+..|+|| ||+.||+|.+++... ..
T Consensus 86 ~hpniv~~~~~~~~~~~~~lv~-e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (345)
T 3hko_A 86 HHPNIARLYEVYEDEQYICLVM-ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV 164 (345)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHH
T ss_pred CCCCcceeehhhccCCeEEEEE-eCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence 4899999999999999999999 799999999998420 01
Q ss_pred HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC-----CCCCCcCCCCccchh
Q 022732 46 LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPE 118 (293)
Q Consensus 46 ~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE 118 (293)
+. .++.++.||+.||.|||++|++||||||+||+++.++...+||+|||+++...... ......||+.|+|||
T Consensus 165 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 244 (345)
T 3hko_A 165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence 12 78899999999999999999999999999999987665579999999997542211 234567999999999
Q ss_pred hhcc--ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCC
Q 022732 119 VLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 196 (293)
Q Consensus 119 ~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~ 196 (293)
++.+ ..+ +.++|||||||++|+|++|+.||.+.........+..... ....+....+++++.+||.+||..||.+
T Consensus 245 ~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 245 VLNTTNESY-GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL--CFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHTCSSSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred hhccCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc--ccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 9875 344 4559999999999999999999998876555444433211 1122223347899999999999999999
Q ss_pred CCCHHHHHcCcccccC
Q 022732 197 RITIPEIMKHQWFLKN 212 (293)
Q Consensus 197 Rpt~~ell~h~~~~~~ 212 (293)
|||+.++++||||+..
T Consensus 322 Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 322 RFDAMRALQHPWISQF 337 (345)
T ss_dssp SCCHHHHHHSHHHHTT
T ss_pred CCCHHHHhcChhhccC
Confidence 9999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.54 Aligned_cols=201 Identities=32% Similarity=0.523 Sum_probs=168.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++.+.+..|+|| ||+.+++|.+++...+.+. +++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 99 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 177 (335)
T 2owb_A 99 AHQHVVGFHGFFEDNDFVFVVL-ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 177 (335)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCCCCCeEEEEEecCCeEEEEE-ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC
Confidence 6899999999999999999999 7999999999998877655 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ ++||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..........
T Consensus 178 ~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~--- 251 (335)
T 2owb_A 178 L--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYL--- 251 (335)
T ss_dssp C--CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---
T ss_pred C--CEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHH---
Confidence 4 5999999999764322 22345679999999999987776544 999999999999999999998866543332
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~ 216 (293)
.+.......+ ..++..+.+||.+||..||.+|||+.++++||||.....+.
T Consensus 252 -~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 252 -RIKKNEYSIP--KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp -HHHHTCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred -HHhcCCCCCC--ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 2333333333 35889999999999999999999999999999998765433
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=282.07 Aligned_cols=199 Identities=32% Similarity=0.517 Sum_probs=168.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++...+.+. +++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 73 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (294)
T 2rku_A 73 AHQHVVGFHGFFEDNDFVFVVL-ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 151 (294)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred CCCCEeeeeeeeccCCEEEEEE-ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC
Confidence 6899999999999999999999 7999999999998877655 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ ++||+|||+++..... .......||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.........
T Consensus 152 ~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~---- 224 (294)
T 2rku_A 152 L--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETY---- 224 (294)
T ss_dssp C--CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----
T ss_pred C--CEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----
Confidence 4 5999999999764422 22344579999999999987776544 99999999999999999999887654332
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
..+....... +..++..+.++|.+||..||.+|||+.++++||||.....
T Consensus 225 ~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 225 LRIKKNEYSI--PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHHHTTCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHhhccCCC--ccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 2333333333 3458899999999999999999999999999999987643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=289.42 Aligned_cols=206 Identities=23% Similarity=0.337 Sum_probs=160.8
Q ss_pred CCcchhhhhceeee--------ceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCC
Q 022732 6 SSSSEYAMLGVSVK--------MKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLK 74 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--------~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlk 74 (293)
.|+|++++++++.. .+.+|+|| ||+.+ +|...+... ..+. +++.++.||+.||.|||++||+|||||
T Consensus 74 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 151 (351)
T 3mi9_A 74 KHENVVNLIEICRTKASPYNRCKGSIYLVF-DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 151 (351)
T ss_dssp CCTTBCCEEEEEEEC--------CEEEEEE-ECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred cCCCcccHhheeeccccccccCCceEEEEE-eccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 48999999999987 45789999 79986 666666553 3343 999999999999999999999999999
Q ss_pred CCcEEEcCCCCCCEEEecCCCCcCcCC-----CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC
Q 022732 75 LENTLLDGSPAPRLKICDFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 149 (293)
Q Consensus 75 p~NIl~~~~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 149 (293)
|+|||++.++ .+||+|||+++.... ........||+.|+|||++.+....+.++|||||||++|+|++|+.||
T Consensus 152 p~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 152 AANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp GGGEEECTTS--CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred HHHEEEcCCC--CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 9999997655 599999999975431 222345678999999999877554455699999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhccccCC-CCCC-------------------------CCCHHHHHHHHHccccCCCCCCCHHHH
Q 022732 150 EDPDEPKDFRKTIQRILSVQYSV-PDTN-------------------------PISQECRDLISRIFVADPAARITIPEI 203 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~-------------------------~~s~~~~~li~~~L~~dp~~Rpt~~el 203 (293)
.+......+..+........... +... ..++.+.+||.+||..||.+|||+.++
T Consensus 230 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 309 (351)
T 3mi9_A 230 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309 (351)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH
Confidence 98877665555444322221110 0000 026889999999999999999999999
Q ss_pred HcCcccccCCCC
Q 022732 204 MKHQWFLKNLPA 215 (293)
Q Consensus 204 l~h~~~~~~~~~ 215 (293)
++||||.....+
T Consensus 310 l~hp~f~~~~~~ 321 (351)
T 3mi9_A 310 LNHDFFWSDPMP 321 (351)
T ss_dssp HTSGGGGSSSCC
T ss_pred hCCCCcCCCCCc
Confidence 999999765443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=288.75 Aligned_cols=204 Identities=25% Similarity=0.326 Sum_probs=167.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+++++++|...+..|+|| ||+.+ +|..++.... .+. +++.++.|++.||.|||++|++||||||+|||++.
T Consensus 70 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 147 (346)
T 1ua2_A 70 SHPNIIGLLDAFGHKSNISLVF-DFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE 147 (346)
T ss_dssp CCTTBCCEEEEECCTTCCEEEE-ECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred CCCCCCeEEEEEeeCCceEEEE-EcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC
Confidence 5899999999999999999999 79987 7888887654 344 99999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+++..... .......||+.|+|||++.+....+.++|||||||++|+|++|..||.+......+..+
T Consensus 148 ~~--~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i 225 (346)
T 1ua2_A 148 NG--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225 (346)
T ss_dssp TC--CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CC--CEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 54 5999999999865332 33445679999999999876554456699999999999999999999998876666666
Q ss_pred HHHHhccccC-CCC---------------------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 162 IQRILSVQYS-VPD---------------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 162 ~~~~~~~~~~-~~~---------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.......... ++. ...++.++++||.+||..||.+|||+.++++||||....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 5543221110 000 134679999999999999999999999999999998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=294.62 Aligned_cols=203 Identities=22% Similarity=0.336 Sum_probs=164.0
Q ss_pred CCcchhhhhceeee--------------------------------------ceeEEEeehhhccCchhHHHHH----Hc
Q 022732 6 SSSSEYAMLGVSVK--------------------------------------MKFVFLSLSFFFSLCLFFMWLL----LL 43 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--------------------------------------~~~~~lv~~ey~~gg~L~~~l~----~~ 43 (293)
.|+|+++++++|.. ..+.|+|| ||+.| +|.+.+. ..
T Consensus 58 ~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~-e~~~~-~L~~~l~~~~~~~ 135 (383)
T 3eb0_A 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM-EYVPD-TLHKVLKSFIRSG 135 (383)
T ss_dssp CCTTBCCEEEEEEEC-------------------------------------CCEEEEEE-CCCSE-EHHHHHHHHHHTT
T ss_pred CCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEE-ecCCc-cHHHHHHHHHhcC
Confidence 68999999999943 45589999 79995 6666654 34
Q ss_pred CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhc
Q 022732 44 GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 121 (293)
Q Consensus 44 ~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 121 (293)
+.++ .++.++.||+.||.|||++||+||||||+|||++.. .+.+||+|||+|+............||+.|+|||++.
T Consensus 136 ~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 214 (383)
T 3eb0_A 136 RSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK-DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELML 214 (383)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETT-TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCC-CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhc
Confidence 4444 899999999999999999999999999999999732 2369999999998765556666778999999999988
Q ss_pred cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccc-------------cCCC----------CCCCC
Q 022732 122 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------------YSVP----------DTNPI 178 (293)
Q Consensus 122 ~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------~~~~----------~~~~~ 178 (293)
+....+.++||||+||++|+|++|+.||.+......+..+++...... ..++ .+..+
T Consensus 215 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (383)
T 3eb0_A 215 GATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294 (383)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTC
T ss_pred CCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCC
Confidence 766445569999999999999999999999887777666654322110 0111 12347
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 179 SQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 179 s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
+.++.+||.+||..||.+|||+.++++||||+.
T Consensus 295 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 899999999999999999999999999999964
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=282.34 Aligned_cols=203 Identities=33% Similarity=0.512 Sum_probs=167.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.....+. .++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 141 (276)
T 2yex_A 63 NHENVVKFYGHRREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141 (276)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CCCCceeeeeEEEcCCEEEEEE-EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC
Confidence 5899999999999999999999 7999999999997765554 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+ .+||+|||++...... .......||+.|+|||++.+..+.+.++|+|||||++|+|++|+.||...........
T Consensus 142 ~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 219 (276)
T 2yex_A 142 D--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219 (276)
T ss_dssp C--CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH
T ss_pred C--CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 4 5999999998754222 2234567999999999998777656669999999999999999999987665322222
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
. +.......+....++..+.++|.+||..||.+|||+.++++||||++...
T Consensus 220 ~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 220 D---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp H---HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred H---hhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 1 22222223333458999999999999999999999999999999986543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=296.41 Aligned_cols=204 Identities=25% Similarity=0.362 Sum_probs=162.1
Q ss_pred CCcchhhhhceeee------ceeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCC
Q 022732 6 SSSSEYAMLGVSVK------MKFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAMQVCHRDL 73 (293)
Q Consensus 6 ~~~~~v~~~~~~~~------~~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdl 73 (293)
.|+|+++++++|.. ..++++|| ||+.+ +|...+.. ...+. .++.++.||+.||.|||++||+||||
T Consensus 105 ~hpniv~l~~~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 182 (420)
T 1j1b_A 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDI 182 (420)
T ss_dssp CCTTBCCEEEEEEEEETTTTEEEEEEEE-ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred CCCCccceeeEEeccCCCCcceeEEeeh-hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 58999999999854 34578899 79987 55555532 33444 89999999999999999999999999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCC
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 153 (293)
||+|||++.++ +.+||+|||+++...........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+
T Consensus 183 kp~NILl~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 183 KPQNLLLDPDT-AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp SGGGEEEETTT-TEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ChhhEEEeCCC-CeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999997543 25899999999866555555667899999999999775444555999999999999999999999988
Q ss_pred chHHHHHHHHHHhcc-------------ccCCCC----------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 154 EPKDFRKTIQRILSV-------------QYSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 154 ~~~~~~~~~~~~~~~-------------~~~~~~----------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
....+..+++.+... .+.++. ...++.++++||.+||.+||.+|||+.++++||||.
T Consensus 262 ~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 262 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 777666665532111 011111 124689999999999999999999999999999997
Q ss_pred cC
Q 022732 211 KN 212 (293)
Q Consensus 211 ~~ 212 (293)
..
T Consensus 342 ~~ 343 (420)
T 1j1b_A 342 EL 343 (420)
T ss_dssp GG
T ss_pred cc
Confidence 54
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=302.08 Aligned_cols=201 Identities=29% Similarity=0.441 Sum_probs=155.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++... ..|+|| ||+.+|+|.+++...+.+. +++.++.||+.||.|||++||+||||||+|||++..
T Consensus 198 ~hpniv~l~~~~~~~-~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~ 275 (419)
T 3i6u_A 198 NHPCIIKIKNFFDAE-DYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275 (419)
T ss_dssp CCTTBCCCCEEEESS-EEEEEE-ECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred CCCCEeeEEEEEecC-ceEEEE-EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC
Confidence 689999999998655 578999 7999999999998777665 899999999999999999999999999999999754
Q ss_pred C-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc--ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 P-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+ ...+||+|||+++...........+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||........+..
T Consensus 276 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 355 (419)
T 3i6u_A 276 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355 (419)
T ss_dssp SSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH
T ss_pred CCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH
Confidence 3 34699999999987655555566789999999999854 22234559999999999999999999987654333332
Q ss_pred HHHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 161 TIQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 161 ~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.+. ....... .+..++..+.+||.+||+.||.+|||+.++++||||+.
T Consensus 356 ~i~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 356 QIT---SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHH---TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHh---cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 222 2222211 12458899999999999999999999999999999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.70 Aligned_cols=197 Identities=18% Similarity=0.221 Sum_probs=158.0
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
+..|+|++++++++.+.++.|+|| ||+.|++|.+++... +.++ +++.++.||+.||.|||++|++||||||+|
T Consensus 67 l~~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N 145 (289)
T 1x8b_A 67 LGQHSHVVRYFSAWAEDDHMLIQN-EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN 145 (289)
T ss_dssp SCSCTTBCCEEEEEEETTEEEEEE-ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred hCCCCCeeeeeeeeecCCeEEEEE-EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHH
Confidence 347999999999999999999999 799999999999875 3333 899999999999999999999999999999
Q ss_pred EEEcCCC-----------------CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHH
Q 022732 78 TLLDGSP-----------------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 140 (293)
Q Consensus 78 Il~~~~~-----------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ 140 (293)
|+++.++ ...+||+|||.+..... .....||+.|+|||++.+....+.++|||||||++|
T Consensus 146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ 222 (289)
T 1x8b_A 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 222 (289)
T ss_dssp EEEC--------------------CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHH
T ss_pred EEEcCCCCCcccccccccccccCCceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHH
Confidence 9997432 23699999999875432 234569999999999987645555699999999999
Q ss_pred HHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 141 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 141 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+|++|..++..... ... +..... ...+..++.++.++|.+||..||.+|||+.++++||||+..
T Consensus 223 ~l~~~~~~~~~~~~---~~~----~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 223 CAAGAEPLPRNGDQ---WHE----IRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHTTCCCCCSSSHH---HHH----HHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHhcCCCCCcchhH---HHH----HHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 99999887754322 122 222211 22234589999999999999999999999999999999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=292.20 Aligned_cols=202 Identities=25% Similarity=0.387 Sum_probs=162.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++...+.+. .+..++.|++.||.|||++ |++||||||+||+++.
T Consensus 89 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~ 167 (360)
T 3eqc_A 89 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 167 (360)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT
T ss_pred CCCCEEEEeEEEEECCEEEEEE-ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECC
Confidence 6899999999999999999999 7999999999998877665 8999999999999999986 9999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH---
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR--- 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--- 159 (293)
++ .+||+|||++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..........
T Consensus 168 ~~--~~kl~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 243 (360)
T 3eqc_A 168 RG--EIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 243 (360)
T ss_dssp TC--CEEECCCCCCHHHHH-HC----CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC
T ss_pred CC--CEEEEECCCCccccc-ccccCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 55 599999999864322 22345679999999999988777554 999999999999999999998765422111
Q ss_pred -----------------------------------HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 022732 160 -----------------------------------KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 204 (293)
Q Consensus 160 -----------------------------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 204 (293)
.....+............++.++.+||.+||..||.+|||+.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 323 (360)
T 3eqc_A 244 CQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323 (360)
T ss_dssp ------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred ccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 111122222222222234789999999999999999999999999
Q ss_pred cCcccccC
Q 022732 205 KHQWFLKN 212 (293)
Q Consensus 205 ~h~~~~~~ 212 (293)
+||||+..
T Consensus 324 ~hp~~~~~ 331 (360)
T 3eqc_A 324 VHAFIKRS 331 (360)
T ss_dssp TSHHHHHH
T ss_pred hChHhhcc
Confidence 99999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=284.63 Aligned_cols=207 Identities=19% Similarity=0.325 Sum_probs=163.6
Q ss_pred CCCCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+.+|+|++++++++.. ....|+|| ||+.+++|..+++. -...+++.++.||+.||.|||++|++||||||+|||++
T Consensus 87 l~~~~~i~~~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~ 164 (330)
T 3nsz_A 87 LRGGPNIITLADIVKDPVSRTPALVF-EHVNNTDFKQLYQT-LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164 (330)
T ss_dssp HTTSTTBCCEEEEEECTTTCCEEEEE-ECCCCCCHHHHGGG-CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred cCCCCCEEEeeeeeccCCCCceEEEE-eccCchhHHHHHHh-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc
Confidence 3469999999999998 78899999 79999999998853 33448999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch-HHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRK 160 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~ 160 (293)
.++. .+||+|||+++............||+.|+|||++.+....+.++|||||||++|+|++|+.||...... ..+..
T Consensus 165 ~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~ 243 (330)
T 3nsz_A 165 HEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243 (330)
T ss_dssp TTTT-EEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred CCCC-EEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH
Confidence 5542 599999999986655555667789999999999887444455699999999999999999999654432 22222
Q ss_pred HHHHHh---------ccccC----------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 161 TIQRIL---------SVQYS----------------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 161 ~~~~~~---------~~~~~----------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+..... ..... ......+++++.+||.+||..||.+|||+.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp HHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 211110 00000 01112278999999999999999999999999999999
Q ss_pred ccCC
Q 022732 210 LKNL 213 (293)
Q Consensus 210 ~~~~ 213 (293)
+...
T Consensus 324 ~~~~ 327 (330)
T 3nsz_A 324 YTVV 327 (330)
T ss_dssp TTCC
T ss_pred hhhc
Confidence 7643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=295.05 Aligned_cols=206 Identities=23% Similarity=0.306 Sum_probs=151.8
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHcC---------CHH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLLG---------LLV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~~---------~~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
.|+|+++++++|.. ...+|+|| ||+.+ +|.+++.... .+. .++.++.||+.||.|||++||+|||
T Consensus 76 ~hpniv~~~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~D 153 (405)
T 3rgf_A 76 KHPNVISLQKVFLSHADRKVWLLF-DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153 (405)
T ss_dssp CCTTBCCCCEEEEETTTTEEEEEE-ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCCeeeEeeEEecCCCCeEEEEE-eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCC
Confidence 48999999999954 78999999 79875 7877775321 122 8999999999999999999999999
Q ss_pred CCCCcEEEcCC--CCCCEEEecCCCCcCcCCC----CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCC
Q 022732 73 LKLENTLLDGS--PAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 73 lkp~NIl~~~~--~~~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 146 (293)
|||+|||+... ..+.+||+|||+|+..... ......+||+.|+|||++.+....+.++|||||||++|+|++|+
T Consensus 154 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 233 (405)
T 3rgf_A 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233 (405)
T ss_dssp CCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCC
Confidence 99999999432 2346999999999864322 22345679999999999987664566699999999999999999
Q ss_pred CCCCCCCc---------hHHHHHHHHHHhccccC-C-------------------------------CCCCCCCHHHHHH
Q 022732 147 YPFEDPDE---------PKDFRKTIQRILSVQYS-V-------------------------------PDTNPISQECRDL 185 (293)
Q Consensus 147 ~pf~~~~~---------~~~~~~~~~~~~~~~~~-~-------------------------------~~~~~~s~~~~~l 185 (293)
.||.+... ...+..+...+...... + ......+..+.+|
T Consensus 234 ~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 313 (405)
T 3rgf_A 234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313 (405)
T ss_dssp CTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHH
T ss_pred CCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHH
Confidence 99976553 23333333322111000 0 0011136789999
Q ss_pred HHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 186 ISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 186 i~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
|.+||..||.+|||+.++|+||||+...
T Consensus 314 l~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 314 LQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred HHHHccCCcccCCCHHHHhcChhhccCC
Confidence 9999999999999999999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=282.55 Aligned_cols=198 Identities=28% Similarity=0.504 Sum_probs=142.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++... +.++ +++.++.|++.||.|||++|++||||||+||+++.
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~ 147 (278)
T 3cok_A 69 KHPSILELYNYFEDSNYVYLVL-EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR 147 (278)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT
T ss_pred CCCCeEeEEEEEccCCeEEEEE-ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 5899999999999999999999 799999999999875 3333 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||++...... .......||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||........
T Consensus 148 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~---- 220 (278)
T 3cok_A 148 NM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNT---- 220 (278)
T ss_dssp TC--CEEECCCTTCEECC----------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC------
T ss_pred CC--CEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHH----
Confidence 54 5999999999754322 22335679999999999887766555 9999999999999999999987654332
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
...+...... .+..++.++.++|.+||..||.+|||+.++++||||.+..
T Consensus 221 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 221 LNKVVLADYE--MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ---CCSSCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHhhcccC--CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 2222222222 2344899999999999999999999999999999997643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.84 Aligned_cols=203 Identities=31% Similarity=0.485 Sum_probs=166.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG- 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~- 82 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++...+.+. .++.++.||+.||.|||++|++||||||+||++..
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~ 142 (304)
T 2jam_A 64 KHENIVTLEDIYESTTHYYLVM-QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP 142 (304)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS
T ss_pred CCCCeeehhhhcccCCEEEEEE-EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC
Confidence 5899999999999999999999 7999999999998877655 89999999999999999999999999999999942
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+..+.+||+|||+++.... .......||+.|+|||++.+..++. ++|+|||||++|+|++|+.||...........+.
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (304)
T 2jam_A 143 EENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVITYILLCGYPPFYEETESKLFEKIK 220 (304)
T ss_dssp STTCCEEBCSCSTTCCCCC-BTTHHHHSCCCBCCTTTBSSCSCCH-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCCCEEEccCCcceecCC-CccccccCCCCccChHHhccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 2234699999999875322 2233456999999999998777654 4999999999999999999998876644333332
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.... ....+....++..+.+||.+||..||.+|||+.++++||||....
T Consensus 221 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 221 EGYY--EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HCCC--CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred cCCC--CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 2211 112233456899999999999999999999999999999997653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=283.35 Aligned_cols=200 Identities=30% Similarity=0.494 Sum_probs=163.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++...+.+. +++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 66 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 144 (283)
T 3bhy_A 66 RHPNIITLHDIFENKTDVVLIL-ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDK 144 (283)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS
T ss_pred CCCCeeehhheecCCCeEEEEE-eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecC
Confidence 4899999999999999999999 7999999999998876655 999999999999999999999999999999999765
Q ss_pred C--CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 P--APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~--~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
+ .+++||+|||++.............||+.|+|||++.+..++.+ +|+|||||++|+|++|..||.+......+..
T Consensus 145 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~- 222 (283)
T 3bhy_A 145 NVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTN- 222 (283)
T ss_dssp SSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-
T ss_pred CCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHHH-
Confidence 4 23699999999986554444456679999999999987776555 9999999999999999999988765433322
Q ss_pred HHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 162 IQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
+.......+ ....++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 223 ---ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ---HHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ---hHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 222222221 12357899999999999999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=281.51 Aligned_cols=203 Identities=24% Similarity=0.319 Sum_probs=167.2
Q ss_pred CCcchhhhhceee-----eceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSV-----KMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~-----~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.|+|++++++++. .....|+|| ||+. |+|.+++..... +. .++.++.||+.||.|||++|++||||||+
T Consensus 72 ~h~~i~~~~~~~~~~~~~~~~~~~lv~-e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~ 149 (326)
T 1blx_A 72 EHPNVVRLFDVCTVSRTDRETKLTLVF-EHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 149 (326)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEE-ECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CCCCeEeeeeeeeecccCCCceEEEEE-ecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHH
Confidence 6999999999998 678899999 7998 599999987543 33 89999999999999999999999999999
Q ss_pred cEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 77 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 77 NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
||+++.++ .+||+|||+++............||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.....
T Consensus 150 Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (326)
T 1blx_A 150 NILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVD 226 (326)
T ss_dssp GEEECTTC--CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HeEEcCCC--CEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 99997655 599999999986554444456679999999999988777555 999999999999999999999887766
Q ss_pred HHHHHHHHHhcccc-CC--------------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 157 DFRKTIQRILSVQY-SV--------------------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 157 ~~~~~~~~~~~~~~-~~--------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.+..+......... .+ .....++..+++||.+||..||.+|||+.++++||||+...
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 227 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 66555543221100 00 01235789999999999999999999999999999997643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.87 Aligned_cols=200 Identities=21% Similarity=0.321 Sum_probs=149.8
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCC
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLE 76 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~ 76 (293)
...|+|++++++++...+..|+|| ||+.| +|.+++.. .+.++ .++.++.||+.||.|||++ |++||||||+
T Consensus 62 ~~~h~~iv~~~~~~~~~~~~~lv~-e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~ 139 (290)
T 3fme_A 62 TVDCPFTVTFYGALFREGDVWICM-ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139 (290)
T ss_dssp TCCCTTBCCEEEEEECSSSEEEEE-ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGG
T ss_pred hCCCCeEEEEeeeeeccCCEEEEE-ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence 357999999999999999999999 79985 77777654 33444 8999999999999999998 9999999999
Q ss_pred cEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhh----ccccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 77 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 77 NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
||+++.++ ++||+|||+++............||+.|+|||++ .+..+ +.++|+||+||++|+|++|+.||...
T Consensus 140 Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 140 NVLINALG--QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp GCEECTTC--CEEBCCC---------------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred HEEECCCC--CEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 99997654 5999999999866555555556799999999997 33344 45599999999999999999999874
Q ss_pred CchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 153 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
...... ..... ...........++.++.++|.+||..||.+|||+.++++||||+.
T Consensus 217 ~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 217 GTPFQQ--LKQVV-EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp SCHHHH--HHHHH-HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CchHHH--HHHHh-ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 443221 11212 222222223458999999999999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=287.05 Aligned_cols=206 Identities=24% Similarity=0.347 Sum_probs=164.1
Q ss_pred CCcchhhhhceeeec-----eeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKM-----KFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~-----~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++... ...|+|| ||+.| +|.+++.....-. +++.++.||+.||.|||++||+||||||+|||
T Consensus 83 ~h~niv~~~~~~~~~~~~~~~~~~iv~-e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 160 (364)
T 3qyz_A 83 RHENIIGINDIIRAPTIEQMKDVYIVQ-DLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 160 (364)
T ss_dssp CCTTBCCCCEEECCSSTTTCCCEEEEE-ECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCCCCccceeEEecCCccccceEEEEE-cccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEE
Confidence 489999999999765 4789999 79885 8999997754333 89999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
++.++ .+||+|||+++...... .....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+....
T Consensus 161 ~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 161 LNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp ECTTC--CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG
T ss_pred ECCCC--CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH
Confidence 97655 59999999997543221 2345589999999999776554455699999999999999999999988876
Q ss_pred HHHHHHHHHHhcccc----------------CCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 156 KDFRKTIQRILSVQY----------------SVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~----------------~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
..+..+......... ..+ ....++.++.+||.+||..||.+|||+.++++||||+
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 318 (364)
T 3qyz_A 239 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318 (364)
T ss_dssp GHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 666555432211110 000 0134789999999999999999999999999999998
Q ss_pred cCCCC
Q 022732 211 KNLPA 215 (293)
Q Consensus 211 ~~~~~ 215 (293)
+...+
T Consensus 319 ~~~~~ 323 (364)
T 3qyz_A 319 QYYDP 323 (364)
T ss_dssp TTCCG
T ss_pred hccCc
Confidence 76543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=279.45 Aligned_cols=198 Identities=21% Similarity=0.387 Sum_probs=160.2
Q ss_pred CCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcC--CeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQ--VCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~--iiHrdlkp~N 77 (293)
.|+|+++++++|.. ..++|+|| ||+.+++|.+++...+.+. .++.++.||+.||.|||++| ++||||||+|
T Consensus 83 ~h~~iv~~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~N 161 (290)
T 1t4h_A 83 QHPNIVRFYDSWESTVKGKKCIVLVT-ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 161 (290)
T ss_dssp CCTTBCCEEEEEEEESSSCEEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGG
T ss_pred CCCCeeeeeeeeccccCCCceEEEEE-EecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHH
Confidence 68999999999876 47789999 7999999999998866655 89999999999999999999 9999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
|+++.. .+.+||+|||++.... ........||+.|+|||++.+ .++ .++|+|||||++|+|++|+.||........
T Consensus 162 il~~~~-~~~~kl~Dfg~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 237 (290)
T 1t4h_A 162 IFITGP-TGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237 (290)
T ss_dssp EEESST-TSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred EEEECC-CCCEEEeeCCCccccc-ccccccccCCcCcCCHHHHhc-cCC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHH
Confidence 999632 2359999999996432 223345679999999998764 454 459999999999999999999988666444
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.... +.............++++.++|.+||..||.+|||+.++++||||+.
T Consensus 238 ~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 238 IYRR---VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHH---HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHH---HhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 3322 22222222223346799999999999999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=287.84 Aligned_cols=198 Identities=23% Similarity=0.333 Sum_probs=161.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+. |+|.+++.. .+.+. .++.++.|++.||.|||++|++||||||+|||++.
T Consensus 112 ~hpniv~~~~~~~~~~~~~lv~-e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 189 (348)
T 1u5q_A 112 RHPNTIQYRGCYLREHTAWLVM-EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 189 (348)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred CCCCEeeEEEEEEECCeEEEEE-ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 5899999999999999999999 7998 577777754 34444 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhc---cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||+++.... .....||+.|+|||++. +..++ .++|||||||++|+|++|+.||.+.+....+.
T Consensus 190 ~~--~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 263 (348)
T 1u5q_A 190 PG--LVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALY 263 (348)
T ss_dssp TT--EEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CC--CEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 54 599999999975432 34567999999999985 34444 45999999999999999999998876644433
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
.+. ...........++..+.+||.+||..||.+|||+.++++||||....++
T Consensus 264 ~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 264 HIA----QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp HHH----HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHH----hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 322 2222222334589999999999999999999999999999999765443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=289.50 Aligned_cols=204 Identities=23% Similarity=0.360 Sum_probs=149.5
Q ss_pred CCcchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++... +.+|+|+ ||+ +++|..++.....-. .++.++.||+.||.|||++||+||||||+||
T Consensus 86 ~hpnIv~~~~~~~~~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 163 (367)
T 2fst_X 86 KHENVIGLLDVFTPARSLEEFNDVYLVT-HLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 163 (367)
T ss_dssp CCTTBCCCSEEECSCSSGGGCCCCEEEE-ECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCCCCCcEEEEEecCCccccCCeEEEEe-ccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhE
Confidence 489999999999754 6789999 687 789999987643222 8999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
|++.++ .+||+|||+++... ......+||++|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+
T Consensus 164 ll~~~~--~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l 239 (367)
T 2fst_X 164 AVNEDC--ELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 239 (367)
T ss_dssp EECTTC--CEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EECCCC--CEEEeecccccccc--ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 997654 59999999998543 22345689999999999887444455599999999999999999999998876666
Q ss_pred HHHHHHHhccc-------------------cCCCC------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 159 RKTIQRILSVQ-------------------YSVPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 159 ~~~~~~~~~~~-------------------~~~~~------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..+...+.... ...+. ....++.+.+||.+||..||.+|||+.++|+||||....
T Consensus 240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 240 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 65554322110 00000 124689999999999999999999999999999998754
Q ss_pred CC
Q 022732 214 PA 215 (293)
Q Consensus 214 ~~ 215 (293)
.+
T Consensus 320 ~~ 321 (367)
T 2fst_X 320 DP 321 (367)
T ss_dssp CG
T ss_pred CC
Confidence 43
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=291.33 Aligned_cols=205 Identities=27% Similarity=0.464 Sum_probs=141.7
Q ss_pred CCCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 5 GSSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.+|+|++++++++.. ....|+|| ||+.||+|.+++...+ .+. +++.++.||+.||.|||++|++||||||+
T Consensus 79 ~~h~~i~~~~~~~~~~~~~~~~~~lv~-e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~ 157 (336)
T 3fhr_A 79 SGGPHIVCILDVYENMHHGKRCLLIIM-ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157 (336)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEE-ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred cCCCChHHHHHHHhhccCCCceEEEEE-eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 468999999999987 66789999 7999999999998764 333 99999999999999999999999999999
Q ss_pred cEEEcCCC-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 77 NTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 77 NIl~~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
||+++.++ .+.+||+|||+++.... .......||+.|+|||++.+..++. ++|||||||++|+|++|+.||......
T Consensus 158 NIll~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 158 NLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp GEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHH-HHHHHHHHHHHHHHHHSSCCC------
T ss_pred HEEEEecCCCceEEEeccccceeccc-cccccCCCCcCccChhhhCCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 99997643 34699999999975432 2334567899999999987777654 499999999999999999999876543
Q ss_pred HHHHHHHHHHhcccc--CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 156 KDFRKTIQRILSVQY--SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.........+..... ..+.+..++.++.+||.+||..||.+|||+.++++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 322222222222222 223345689999999999999999999999999999999764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=286.05 Aligned_cols=204 Identities=25% Similarity=0.416 Sum_probs=162.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.+++|..++...+.+. .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 82 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~ 160 (331)
T 4aaa_A 82 RHENLVNLLEVCKKKKRWYLVF-EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS 160 (331)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred CCCCEeeEEEEeecCCEEEEEE-ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC
Confidence 4899999999999999999999 7999999999887666555 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+++..... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+.
T Consensus 161 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 161 G--VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp S--CEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred C--cEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 5 5999999999754332 233456799999999999876444556999999999999999999999887766555444
Q ss_pred HHHhcc---------------ccCCCC----------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSV---------------QYSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~---------------~~~~~~----------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
...... ....+. ...+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred HHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 322110 001111 12478999999999999999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=283.75 Aligned_cols=200 Identities=27% Similarity=0.341 Sum_probs=160.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CH--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LL--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.+.+++++++++...++.|+|| ||+ +++|.+++...+ .+ ..++.++.||+.||.|||++|++||||||+|||++
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~-e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 152 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVF-ELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFV 152 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEE-ECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CceeeEeeecccccCCcEEEEE-cCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 4567899999999999999999 799 889999998875 23 38999999999999999999999999999999997
Q ss_pred CCC-----------------CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh
Q 022732 82 GSP-----------------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144 (293)
Q Consensus 82 ~~~-----------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 144 (293)
... .+.+||+|||+++... .......||+.|+|||++.+..++.+ +|||||||++|+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~ 229 (339)
T 1z57_A 153 QSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYL 229 (339)
T ss_dssp CCCEEEEEC----CEEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHH
T ss_pred ccccccccCCccccccccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHh
Confidence 643 4469999999997532 23345689999999999988777655 999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHHHhcccc------------------C---------------------CCCCCCCCHHHHHH
Q 022732 145 GGYPFEDPDEPKDFRKTIQRILSVQY------------------S---------------------VPDTNPISQECRDL 185 (293)
Q Consensus 145 g~~pf~~~~~~~~~~~~~~~~~~~~~------------------~---------------------~~~~~~~s~~~~~l 185 (293)
|+.||...+.......+.. +..... . .......++++.+|
T Consensus 230 g~~pf~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 308 (339)
T 1z57_A 230 GFTVFPTHDSKEHLAMMER-ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308 (339)
T ss_dssp SSCSCCCSCHHHHHHHHHH-HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHH-HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHH
Confidence 9999988766544333222 111000 0 00111235788999
Q ss_pred HHHccccCCCCCCCHHHHHcCccccc
Q 022732 186 ISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 186 i~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
|.+||..||.+|||+.++++||||+.
T Consensus 309 i~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 309 IQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred HHHHhCcCcccccCHHHHhcCHHHHH
Confidence 99999999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=286.86 Aligned_cols=208 Identities=20% Similarity=0.324 Sum_probs=155.5
Q ss_pred CCcchhhhhceee-----eceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSV-----KMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~-----~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.|+|++++++++. ...++|+|| ||+. |+|.+++.... .+. .++.++.||+.||.|||++|++||||||+|
T Consensus 87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~-e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 164 (362)
T 3pg1_A 87 HHPNILGLRDIFVHFEEPAMHKLYLVT-ELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN 164 (362)
T ss_dssp CCTTBCCCSEEEEECCTTTCCEEEEEE-ECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCcCccceeeeEEeccCCCcceEEEEE-ccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHH
Confidence 5899999999994 445789999 7998 57888776553 333 899999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
|+++.++ .+||+|||+++............||+.|+|||++.+....+.++|+||+||++|+|++|+.||.+......
T Consensus 165 Il~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNN--DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTC--CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCC--CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9997655 59999999998655555556678999999999988744445569999999999999999999998876655
Q ss_pred HHHHHHHHhccc--------------------cCCC------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 158 FRKTIQRILSVQ--------------------YSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 158 ~~~~~~~~~~~~--------------------~~~~------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
+..+........ ...+ ....+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 555443221110 0000 01246899999999999999999999999999999987
Q ss_pred CCCCCc
Q 022732 212 NLPADL 217 (293)
Q Consensus 212 ~~~~~~ 217 (293)
...+..
T Consensus 323 ~~~~~~ 328 (362)
T 3pg1_A 323 LFDPLD 328 (362)
T ss_dssp TCCGGG
T ss_pred ccCccc
Confidence 654443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=290.62 Aligned_cols=201 Identities=26% Similarity=0.297 Sum_probs=160.8
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CH--HHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEE
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LL--VQARFFFQQLISGVSYCH--AMQVCHRDLKLENTLL 80 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~--~~~~~~~~qil~~l~~LH--~~~iiHrdlkp~NIl~ 80 (293)
+.+++++++++...++.|+|| ||+.+ +|.+++.... .+ ..++.++.||+.||.||| .+||+||||||+|||+
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~-e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVF-EMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEE-ECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEE
T ss_pred ceeEEEeeeeeccCCceEEEE-ecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEE
Confidence 346899999999999999999 79965 9999998763 23 389999999999999999 5799999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+.+..+.+||+|||+++... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 269 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNK 269 (382)
T ss_dssp SSTTSCCEEECCCTTCEETT--CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ecCCCCcEEEEeccCceecc--cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 76555679999999998643 33456789999999999988877655 9999999999999999999999887666655
Q ss_pred HHHHHhcccc---------------------------------CCCCCCC-------------------------CCHHH
Q 022732 161 TIQRILSVQY---------------------------------SVPDTNP-------------------------ISQEC 182 (293)
Q Consensus 161 ~~~~~~~~~~---------------------------------~~~~~~~-------------------------~s~~~ 182 (293)
+......... ..+.... .+.++
T Consensus 270 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (382)
T 2vx3_A 270 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKF 349 (382)
T ss_dssp HHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHH
T ss_pred HHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHH
Confidence 5543211100 0000000 01478
Q ss_pred HHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 183 RDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 183 ~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
++||.+||+.||.+|||+.++|+||||++.
T Consensus 350 ~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 350 KDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=287.99 Aligned_cols=206 Identities=20% Similarity=0.282 Sum_probs=161.7
Q ss_pred CCcchhhhhceeeecee-------EEEeehhhccCchhHHHH---HHcCCHH--HHHHHHHHHHHHHHHHH--HcCCeec
Q 022732 6 SSSSEYAMLGVSVKMKF-------VFLSLSFFFSLCLFFMWL---LLLGLLV--QARFFFQQLISGVSYCH--AMQVCHR 71 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~-------~~lv~~ey~~gg~L~~~l---~~~~~~~--~~~~~~~qil~~l~~LH--~~~iiHr 71 (293)
.|+|+++++++|..... .|+|| ||+.++.+..+. .....+. .++.++.|++.||.||| ++||+||
T Consensus 77 ~h~niv~~~~~~~~~~~~~~~~~~~~lv~-e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~ 155 (360)
T 3e3p_A 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVM-EYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR 155 (360)
T ss_dssp CCTTBCCEEEEEEEECSSCTTCEEEEEEE-ECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCS
T ss_pred CCCCcccHHHhhhccccccccceeEEEEe-ecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence 58999999999976544 88999 799986433222 2333333 88999999999999999 9999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
||||+|||++.. .+.+||+|||+++............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+
T Consensus 156 Dlkp~NIll~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 156 DIKPHNVLVNEA-DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp CCCGGGEEEETT-TTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCHHHEEEeCC-CCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 999999999752 2369999999998766555556678999999999987766445569999999999999999999999
Q ss_pred CCchHHHHHHHHHHhcccc--------------------------CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 152 PDEPKDFRKTIQRILSVQY--------------------------SVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.+....+..+......... ........+.++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 235 DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 8776665555543211100 00111225789999999999999999999999999
Q ss_pred CcccccCC
Q 022732 206 HQWFLKNL 213 (293)
Q Consensus 206 h~~~~~~~ 213 (293)
||||++..
T Consensus 315 hp~f~~~~ 322 (360)
T 3e3p_A 315 HPYFDELH 322 (360)
T ss_dssp SGGGGGGG
T ss_pred CccccccC
Confidence 99998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=282.62 Aligned_cols=207 Identities=25% Similarity=0.314 Sum_probs=157.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH--------cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL--------LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKL 75 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~--------~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp 75 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++.. .+.+. .++.++.||+.||.|||++|++||||||
T Consensus 71 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p 149 (303)
T 2vwi_A 71 HHPNIVSYYTSFVVKDELWLVM-KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA 149 (303)
T ss_dssp CCTTBCCEEEEEESSSCEEEEE-ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred CCCCEeeEEEEEeecCCcEEEe-hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 5899999999999999999999 79999999999974 23333 8999999999999999999999999999
Q ss_pred CcEEEcCCCCCCEEEecCCCCcCcCCC------CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC
Q 022732 76 ENTLLDGSPAPRLKICDFGYSKSSVLH------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 149 (293)
Q Consensus 76 ~NIl~~~~~~~~vkl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 149 (293)
+||+++.++ .+||+|||++...... .......||+.|+|||++.+....+.++|+|||||++|+|++|+.||
T Consensus 150 ~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 227 (303)
T 2vwi_A 150 GNILLGEDG--SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227 (303)
T ss_dssp GGEEECTTC--CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred hhEEEcCCC--CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999997654 5999999998643221 12234579999999999876333345599999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhccc----cCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 150 EDPDEPKDFRKTIQRILSVQ----YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
.................... ........++.++.++|.+||..||.+|||+.++++||||++....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 228 HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp TTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred ccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 88776554433322111000 0011224578999999999999999999999999999999865443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.19 Aligned_cols=203 Identities=23% Similarity=0.317 Sum_probs=158.9
Q ss_pred CCcchhhhhceeeeceeE------EEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFV------FLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~------~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+++++++|...+.. |+|| ||+. ++|..++...-....++.++.||+.||.|||++||+||||||+|||
T Consensus 99 ~h~niv~~~~~~~~~~~~~~~~~~~lv~-e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 176 (371)
T 4exu_A 99 QHENVIGLLDVFTPASSLRNFYDFYLVM-PFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 176 (371)
T ss_dssp CCTTBCCCSEEECSCSSSTTCCCCEEEE-ECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCCCchhhhhheeccCCcccceeEEEEE-cccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeE
Confidence 489999999999988766 9999 7988 5888888555444499999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ .+||+|||+++... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+.
T Consensus 177 l~~~~--~~kL~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 252 (371)
T 4exu_A 177 VNEDC--ELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 252 (371)
T ss_dssp ECTTC--CEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ECCCC--CEEEEecCcccccc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 97654 59999999998543 233456789999999999873334455999999999999999999999887666555
Q ss_pred HHHHHHhcccc-------------------CCC------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 160 KTIQRILSVQY-------------------SVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 160 ~~~~~~~~~~~-------------------~~~------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.+......... ..+ ....+++++.+||.+||+.||.+|||+.++++||||+....
T Consensus 253 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 253 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 54432211100 000 01346899999999999999999999999999999986543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=286.78 Aligned_cols=179 Identities=19% Similarity=0.321 Sum_probs=141.3
Q ss_pred eEEEeehhhccCchhHHHHHHcCCHH-----HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCC
Q 022732 22 FVFLSLSFFFSLCLFFMWLLLLGLLV-----QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 96 (293)
Q Consensus 22 ~~~lv~~ey~~gg~L~~~l~~~~~~~-----~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a 96 (293)
+.|+|| ||+.|++|.+++....... .++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||++
T Consensus 135 ~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a 211 (332)
T 3qd2_B 135 YLYIQM-QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLV 211 (332)
T ss_dssp EEEEEE-ECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTC
T ss_pred eEEEEE-EecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcc
Confidence 489999 7999999999998876654 5899999999999999999999999999999997654 5999999999
Q ss_pred cCcCCC-------------CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 97 KSSVLH-------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 97 ~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|..|+.. ......
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~~------~~~~~~ 284 (332)
T 3qd2_B 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQME------RVRIIT 284 (332)
T ss_dssp EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHHH------HHHHHH
T ss_pred cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChhH------HHHHHH
Confidence 864432 12344579999999999988777555 9999999999999998766532 122222
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
........ ......++++.+||.+||.+||.+|||+.++++||||+.
T Consensus 285 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 285 DVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HhhccCCC-cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 22222111 111235688999999999999999999999999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=280.00 Aligned_cols=200 Identities=31% Similarity=0.528 Sum_probs=167.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|+ ||+.+++|.+++...+.+. +++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 79 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~ 157 (287)
T 2wei_A 79 DHPNIMKLFEILEDSSSFYIVG-ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157 (287)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred cCCCccEEEEEEeCCCeEEEEE-EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecC
Confidence 5899999999999999999999 7999999999998777665 899999999999999999999999999999999764
Q ss_pred C-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 P-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+.+||+|||++.............||+.|+|||++.+. ++ .++|+|||||++|+|++|+.||.+........
T Consensus 158 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--- 232 (287)
T 2wei_A 158 EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILK--- 232 (287)
T ss_dssp STTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---
T ss_pred CCcccEEEeccCcceeecCCCccccccCcccccChHHhcCC-CC-CchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 3 346999999999865544444555789999999998654 44 45999999999999999999998876543332
Q ss_pred HHHhcccc--CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQY--SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.+..... ..+....++.++.++|.+||..||.+|||+.++++||||++.
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 233 -RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp -HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred -HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 2322332 223335689999999999999999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=285.54 Aligned_cols=198 Identities=18% Similarity=0.294 Sum_probs=156.7
Q ss_pred CCcchhhhhceeeeceeE----EEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFV----FLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~----~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++...... |+|| ||+.|++|.+++...+.+. +++.++.||+.||.|||++|++||||||+||+
T Consensus 70 ~hp~iv~~~~~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 148 (311)
T 3ork_A 70 NHPAIVAVYDTGEAETPAGPLPYIVM-EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148 (311)
T ss_dssp CCTTBCCEEEEEEEEETTEEEEEEEE-ECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCCCcceEEEeeeccCCCCcccEEEE-ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEE
Confidence 689999999999877644 9999 7999999999998877665 89999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
++.++ .+||+|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....
T Consensus 149 ~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~ 225 (311)
T 3ork_A 149 ISATN--AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPV 225 (311)
T ss_dssp EETTS--CEEECCCSCC------------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EcCCC--CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 97665 49999999997543321 2234569999999999988777555 99999999999999999999887654
Q ss_pred HHHHHHHHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 156 KDFRKTIQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
........ .....+ ....++.++.++|.+||..||.+||++.+++.|+|++.
T Consensus 226 ~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 226 SVAYQHVR----EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHH----CCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHhc----CCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 43333222 111111 12348899999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=285.07 Aligned_cols=201 Identities=29% Similarity=0.469 Sum_probs=160.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+ .|+|| ||+.+++|.+++...+.+. .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 73 ~h~~i~~~~~~~~~~~-~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 73 NHPCIIKIKNFFDAED-YYIVL-ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150 (322)
T ss_dssp CCTTBCCEEEEEESSS-EEEEE-ECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred CCCCCceEeeEEcCCc-eEEEE-ecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecC
Confidence 5899999999998765 78999 7999999999998777665 899999999999999999999999999999999764
Q ss_pred C-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhc---cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 84 P-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 84 ~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
+ ...+||+|||+++............||+.|+|||++. ...+ +.++|||||||++|+|++|..||........+.
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 229 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229 (322)
T ss_dssp SSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH
T ss_pred CCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHH
Confidence 4 3359999999997653322223456999999999974 2334 455999999999999999999998765433222
Q ss_pred HHHHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 160 KTIQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 160 ~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
..+.. ...... .+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 230 ~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 230 DQITS---GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHH---TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred HHHHh---CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 22221 211111 123478999999999999999999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=279.62 Aligned_cols=200 Identities=24% Similarity=0.338 Sum_probs=155.8
Q ss_pred CCCcchhhhhceeee------ceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCC
Q 022732 5 GSSSSEYAMLGVSVK------MKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLK 74 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~------~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlk 74 (293)
..|+|++++++++.. .+..|+|| ||+.+++|.+++.... .+. .++.++.||+.||.|||++|++|||||
T Consensus 78 ~~h~~i~~~~~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 156 (326)
T 2x7f_A 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVM-EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK 156 (326)
T ss_dssp CCSTTBCCEEEEEEECC--CCCCEEEEEE-ECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred cCCCCeeeeeeEEeeccCccccceEEEEE-EcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 479999999999987 56899999 7999999999998742 333 889999999999999999999999999
Q ss_pred CCcEEEcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhc-----cccCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 75 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 75 p~NIl~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~el~~g~~p 148 (293)
|+||+++.++ .+||+|||++...... .......||+.|+|||++. +..++ .++|||||||++|+|++|..|
T Consensus 157 p~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 157 GQNVLLTENA--EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp GGGEEECTTC--CEEECCCTTTC-------------CCGGGCCHHHHC--------CC-TTHHHHHHHHHHHHHHHSSCT
T ss_pred HHHEEEcCCC--CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCC-ccchHHHHHHHHHHHHhCCCC
Confidence 9999997654 5999999998754322 2234557999999999986 33444 449999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
|.+......... +............++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 234 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 234 LCDMHPMRALFL----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp TTTSCHHHHHHH----HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCCCcHHHHHHH----hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 987765433322 222222222234589999999999999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=276.96 Aligned_cols=204 Identities=23% Similarity=0.344 Sum_probs=166.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++... +.+. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 160 (314)
T 3com_A 82 DSPHVVKYYGSYFKNTDLWIVM-EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT 160 (314)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred CCCCCccEEEEEEeCCEEEEEe-ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECC
Confidence 6899999999999999999999 799999999999743 3344 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ ++||+|||++...... .......||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||...........+
T Consensus 161 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 237 (314)
T 3com_A 161 EG--HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237 (314)
T ss_dssp TC--CEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CC--CEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 54 5999999999754322 22345579999999999988777655 99999999999999999999876654332221
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCCC
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~~ 216 (293)
.. ........+..++..+.+||.+||..||.+|||+.++++||||+......
T Consensus 238 ~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 238 PT---NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp HH---SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred hc---CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence 11 11222223344789999999999999999999999999999998654433
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=281.38 Aligned_cols=194 Identities=32% Similarity=0.431 Sum_probs=162.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccC-chhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSL-CLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~g-g~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
+++|++++++++...+..|+|+ ||+.+ ++|.+++...+.+. .++.++.||+.||.|||++|++||||||+|||++.
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~-e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLIL-ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEE-ECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred CCCCceEEEEEEecCCcEEEEE-EcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC
Confidence 5799999999999999999999 68876 89999998877665 89999999999999999999999999999999973
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+.+||+|||+++.... .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... ..
T Consensus 185 ~-~~~~kL~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~- 255 (320)
T 3a99_A 185 N-RGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI- 255 (320)
T ss_dssp T-TTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH-
T ss_pred C-CCCEEEeeCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hh-
Confidence 2 23599999999976432 233456799999999999887776677999999999999999999997531 11
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
..... .....+++++.+||.+||..||.+|||+.++++||||+....
T Consensus 256 ---~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 256 ---IRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp ---HHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred ---hcccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 11222 223458999999999999999999999999999999987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=282.93 Aligned_cols=201 Identities=18% Similarity=0.291 Sum_probs=158.5
Q ss_pred CCcchhhhhceeeece--eEEEeehhhccCchhHHHHHHcCC---HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMK--FVFLSLSFFFSLCLFFMWLLLLGL---LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~--~~~lv~~ey~~gg~L~~~l~~~~~---~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++.... +.|+|| ||+.|++|.+++..... ++ +++.++.||+.||.|||++|++||||||+||
T Consensus 65 ~h~~iv~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 143 (319)
T 4euu_A 65 NHKNIVKLFAIEEETTTRHKVLIM-EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (319)
T ss_dssp CCTTBCCEEEEEECTTTCCEEEEE-ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCCCcceEEEEeecCCCceEEEEE-eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 4899999999998765 889999 79999999999987542 33 8999999999999999999999999999999
Q ss_pred EEcC--CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhc--------cccCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 79 LLDG--SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--------RHEYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 79 l~~~--~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DvwslG~il~el~~g~~p 148 (293)
++.. +..+.+||+|||+++............||+.|+|||++. +..++ .++|||||||++|+|++|+.|
T Consensus 144 ll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~p 222 (319)
T 4euu_A 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLP 222 (319)
T ss_dssp EEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBC-TTHHHHHHHHHHHHHHHSSCS
T ss_pred EEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCC-cHHHHHHHHHHHHHHHhCCCC
Confidence 9822 223359999999998765555556678999999999986 34444 459999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhcccc-------------------CCCCC----CCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 149 FEDPDEPKDFRKTIQRILSVQY-------------------SVPDT----NPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|............+..+..... ..+.. ..++..+.+||.+||+.||.+|||+.++++
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp EECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 9765544333344444332221 11111 124567889999999999999999999999
Q ss_pred Ccc
Q 022732 206 HQW 208 (293)
Q Consensus 206 h~~ 208 (293)
||-
T Consensus 303 h~~ 305 (319)
T 4euu_A 303 ETS 305 (319)
T ss_dssp HHH
T ss_pred ccH
Confidence 973
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=278.32 Aligned_cols=197 Identities=22% Similarity=0.329 Sum_probs=153.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC---HH--HHHHHHHHHHHHHHHHHHcC--CeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL---LV--QARFFFQQLISGVSYCHAMQ--VCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~---~~--~~~~~~~qil~~l~~LH~~~--iiHrdlkp~NI 78 (293)
.|+|++++++++...+..|+|| ||+.+|+|.+++...+. +. .++.++.||+.||.|||++| ++||||||+||
T Consensus 92 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NI 170 (309)
T 3p86_A 92 RHPNIVLFMGAVTQPPNLSIVT-EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170 (309)
T ss_dssp CCTTBCCEEEEECSTTCCEEEE-ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGE
T ss_pred CCCCEeeEEEEEEECCceEEEE-ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhE
Confidence 4899999999999999999999 79999999999987653 22 88999999999999999999 99999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
+++.++ .+||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......
T Consensus 171 ll~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~ 247 (309)
T 3p86_A 171 LVDKKY--TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQV 247 (309)
T ss_dssp EECTTC--CEEECCCC-----------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred EEeCCC--cEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 997654 5999999999753322 22345679999999999988777555 9999999999999999999988765433
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc--Ccccc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK--HQWFL 210 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~--h~~~~ 210 (293)
... +.......+.+..+++++.+||.+||..||.+|||+.++++ .++++
T Consensus 248 ~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 248 VAA----VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHH----HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHH----HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 322 22222233444568999999999999999999999999988 44444
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=284.64 Aligned_cols=194 Identities=21% Similarity=0.313 Sum_probs=160.1
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC------------------CHHHHHHHHHHHHHHHHHHHH
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG------------------LLVQARFFFQQLISGVSYCHA 65 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~------------------~~~~~~~~~~qil~~l~~LH~ 65 (293)
++.|+|+++++++|...+.+|+|| ||+.||+|.+++...+ ...+++.++.||+.||.|||+
T Consensus 143 l~~hpnIv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 221 (370)
T 2psq_A 143 IGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221 (370)
T ss_dssp SCCCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hcCCCCEeeEEEEEccCCCEEEEE-EcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 457999999999999999999999 7999999999998764 223889999999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHH
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 142 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 142 (293)
+||+||||||+|||++.++ .+||+|||+++...... ......+|+.|+|||++.+..++.+ +|||||||++|+|
T Consensus 222 ~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~el 298 (370)
T 2psq_A 222 QKCIHRDLAARNVLVTENN--VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEI 298 (370)
T ss_dssp TTEECSCCCGGGEEECTTC--CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHH
T ss_pred CCeeccccchhhEEECCCC--CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHH
Confidence 9999999999999997655 59999999997543222 2233457889999999988777555 9999999999999
Q ss_pred Hh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 143 LV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 143 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
++ |..||.+......+..+. .....+.+..++.++.++|.+||..||.+|||+.+++++
T Consensus 299 lt~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 299 FTLGGSPYPGIPVEELFKLLK-----EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HTTSCCSSTTCCGGGHHHHHH-----TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCCCCHHHHHHHHh-----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99 999998876544332221 122233445689999999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.81 Aligned_cols=203 Identities=23% Similarity=0.305 Sum_probs=158.2
Q ss_pred CCcchhhhhceeeecee------EEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKF------VFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~------~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++..... .|+|| ||+. ++|.+++...-...+++.++.||+.||.|||++|++||||||+||+
T Consensus 81 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~-e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl 158 (353)
T 3coi_A 81 QHENVIGLLDVFTPASSLRNFYDFYLVM-PFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 158 (353)
T ss_dssp CCTTBCCCSEEECSCSSGGGCCCCEEEE-ECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred CCCCcccHhheEecccccccceeEEEEe-cccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEe
Confidence 48999999999988765 49999 7998 5888887554344499999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ .+||+|||+++... .......||+.|+|||++.+....+.++|+|||||++|+|++|+.||.+.+....+.
T Consensus 159 ~~~~~--~~kl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 234 (353)
T 3coi_A 159 VNEDC--ELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234 (353)
T ss_dssp ECTTC--CEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH
T ss_pred ECCCC--cEEEeecccccCCC--CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 97654 59999999997543 223456789999999998774444455999999999999999999999877655554
Q ss_pred HHHHHHhccc------------------------cCC-CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 160 KTIQRILSVQ------------------------YSV-PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 160 ~~~~~~~~~~------------------------~~~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.+........ ..+ .....++.++.+||.+||..||.+|||+.++++||||+....
T Consensus 235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 4443211100 000 112357899999999999999999999999999999986543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=278.64 Aligned_cols=204 Identities=25% Similarity=0.335 Sum_probs=159.3
Q ss_pred CCcchhhhhceeeec-----eeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKM-----KFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~-----~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++... ...|+|| ||+. ++|.+++.....-. .++.++.||+.||.|||++|++||||||+||+
T Consensus 67 ~h~~iv~~~~~~~~~~~~~~~~~~lv~-e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil 144 (353)
T 2b9h_A 67 KHENIITIFNIQRPDSFENFNEVYIIQ-ELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL 144 (353)
T ss_dssp CCTTBCCEEEECCCSCSTTCCCEEEEE-CCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred cCCCcCCeeeeecccccCccceEEEEE-eccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 589999999988764 7889999 7988 58999987754322 89999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC-----------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS-----------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p 148 (293)
++.++ .+||+|||+++...... ......||+.|+|||++.+....+.++|+|||||++|+|++|+.|
T Consensus 145 ~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 222 (353)
T 2b9h_A 145 INSNC--DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222 (353)
T ss_dssp ECTTC--CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred EcCCC--cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 97654 59999999997543211 122357899999999987644445669999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhccc--------------------cCCC------CCCCCCHHHHHHHHHccccCCCCCCCHHH
Q 022732 149 FEDPDEPKDFRKTIQRILSVQ--------------------YSVP------DTNPISQECRDLISRIFVADPAARITIPE 202 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~--------------------~~~~------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e 202 (293)
|.+.+....+..+........ ...+ ....+++++.+||.+||..||.+|||+.+
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (353)
T 2b9h_A 223 FPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302 (353)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 998776554444332211110 0000 01357899999999999999999999999
Q ss_pred HHcCcccccCC
Q 022732 203 IMKHQWFLKNL 213 (293)
Q Consensus 203 ll~h~~~~~~~ 213 (293)
+++||||+...
T Consensus 303 ll~hp~~~~~~ 313 (353)
T 2b9h_A 303 ALEHPYLQTYH 313 (353)
T ss_dssp HHTSGGGTTTC
T ss_pred HhcCccccccC
Confidence 99999998654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=289.32 Aligned_cols=184 Identities=16% Similarity=0.186 Sum_probs=141.5
Q ss_pred eeEEEeehhhccCchhHHHHHHcCC-HH--HH------HHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEe
Q 022732 21 KFVFLSLSFFFSLCLFFMWLLLLGL-LV--QA------RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 91 (293)
Q Consensus 21 ~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~------~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~ 91 (293)
.++|+|| ||+. |+|.+++...+. +. .. ..++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 161 ~~~~lv~-e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~ 236 (371)
T 3q60_A 161 ANYLLLM-PAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG--RLMLG 236 (371)
T ss_dssp EEEEEEE-CCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS--CEEEC
T ss_pred eeEEEEe-cCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC--CEEEE
Confidence 5589999 7999 899999987422 22 33 46669999999999999999999999999997655 59999
Q ss_pred cCCCCcCcCCCCCCCCCcCCCCccchhhhcc--ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH--HHH-HHHHHh
Q 022732 92 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--FRK-TIQRIL 166 (293)
Q Consensus 92 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~ 166 (293)
|||+|+.... ......+|+.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+...... +.. ......
T Consensus 237 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 313 (371)
T 3q60_A 237 DVSALWKVGT--RGPASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313 (371)
T ss_dssp CGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCC
T ss_pred ecceeeecCC--CccCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhcc
Confidence 9999985422 2224567899999999976 5554 559999999999999999999987643110 000 000011
Q ss_pred ccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 167 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
......+....+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 314 TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 122333444568999999999999999999999999999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=290.75 Aligned_cols=188 Identities=15% Similarity=0.141 Sum_probs=148.1
Q ss_pred CCcchhhhh-------ceeeece-----------------eEEEeehhhccCchhHHHHHHcCC-------H--HHHHHH
Q 022732 6 SSSSEYAML-------GVSVKMK-----------------FVFLSLSFFFSLCLFFMWLLLLGL-------L--VQARFF 52 (293)
Q Consensus 6 ~~~~~v~~~-------~~~~~~~-----------------~~~lv~~ey~~gg~L~~~l~~~~~-------~--~~~~~~ 52 (293)
.|+|+++++ +++...+ ..|+|| ||+ +|+|.+++...+. + ..+..+
T Consensus 134 ~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~-E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i 211 (377)
T 3byv_A 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY-PRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQL 211 (377)
T ss_dssp CSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEE-ECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHH
T ss_pred CCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEE-ecc-CCCHHHHHHhccccccccccccHHHHHHH
Confidence 689999999 5555443 388999 799 6799999986432 2 267789
Q ss_pred HHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccc---------
Q 022732 53 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH--------- 123 (293)
Q Consensus 53 ~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------- 123 (293)
+.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+... ......+| +.|+|||++.+.
T Consensus 212 ~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~ 286 (377)
T 3byv_A 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDR 286 (377)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCC
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccc
Confidence 99999999999999999999999999997654 59999999998532 23345567 999999999877
Q ss_pred --cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHH
Q 022732 124 --EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 201 (293)
Q Consensus 124 --~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 201 (293)
.++ .++|||||||++|+|++|+.||.+...... ...+ ......+++++.+||.+||..||.+|||+.
T Consensus 287 ~~~~~-~~~DvwSlG~il~elltg~~Pf~~~~~~~~----~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 355 (377)
T 3byv_A 287 RTLMT-FSFDAWALGLVIYWIWCADLPITKDAALGG----SEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPL 355 (377)
T ss_dssp EEECC-HHHHHHHHHHHHHHHHHSSCCC------CC----SGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred cccCC-hhhhHHHHHHHHHHHHHCCCCCcccccccc----hhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHH
Confidence 565 459999999999999999999976543211 1111 122345899999999999999999999999
Q ss_pred HHHcCccccc
Q 022732 202 EIMKHQWFLK 211 (293)
Q Consensus 202 ell~h~~~~~ 211 (293)
++++||||+.
T Consensus 356 e~l~hp~f~~ 365 (377)
T 3byv_A 356 QAMETPEYEQ 365 (377)
T ss_dssp HHHTSHHHHH
T ss_pred HHhhChHHHH
Confidence 9999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=283.96 Aligned_cols=205 Identities=20% Similarity=0.310 Sum_probs=156.1
Q ss_pred CCcchhhhhceeeece----eEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVKMK----FVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~----~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~ 76 (293)
+|+|++++++++...+ ++++|| ||+ +++|.+++.... .++ .++.++.||+.||.|||++ ||+||||||+
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~ 161 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVF-EVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 161 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEE-CCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGG
T ss_pred ccchHHHHHHHhhccCCCCceEEEEE-ecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChH
Confidence 3789999999999766 889999 698 899999998743 233 8999999999999999998 9999999999
Q ss_pred cEEEcCCC----CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 77 NTLLDGSP----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 77 NIl~~~~~----~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
|||++..+ .+.+||+|||+++.... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.
T Consensus 162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 162 NVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp GEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---
T ss_pred HeEEeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCC
Confidence 99996432 23699999999975432 3345679999999999988777554 99999999999999999999865
Q ss_pred Cc------hHHHHHHHHHHhccc------------------------------------cCCCCCCCCCHHHHHHHHHcc
Q 022732 153 DE------PKDFRKTIQRILSVQ------------------------------------YSVPDTNPISQECRDLISRIF 190 (293)
Q Consensus 153 ~~------~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~s~~~~~li~~~L 190 (293)
.. ...+..+...+.... .....+..++.++.+||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 42 122222222111000 000111234678999999999
Q ss_pred ccCCCCCCCHHHHHcCcccccCCCC
Q 022732 191 VADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 191 ~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
+.||.+|||+.++++||||+.....
T Consensus 319 ~~dP~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp CSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred ccCccccCCHHHHhhChhhhcccCc
Confidence 9999999999999999999876543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=284.22 Aligned_cols=200 Identities=26% Similarity=0.447 Sum_probs=164.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHH------HHH--cCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMW------LLL--LGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLK 74 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~------l~~--~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlk 74 (293)
.|+|++++++++...+..|+|| ||+.+++|.++ +.. .+.++ .++.++.||+.||.|||+ +|++|||||
T Consensus 101 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~ 179 (348)
T 2pml_X 101 KNEYCLTCEGIITNYDEVYIIY-EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179 (348)
T ss_dssp CCTTBCCCSEEEESSSEEEEEE-ECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred CCCCcceEEEEEeeCCeEEEEE-eccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence 4899999999999999999999 79999999998 655 34444 899999999999999999 999999999
Q ss_pred CCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccc-cCCCchhhhhhhhhHHHHHHhCCCCCCCCC
Q 022732 75 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153 (293)
Q Consensus 75 p~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~ 153 (293)
|+||+++.++ ++||+|||++...... ......||+.|+|||++.+. .+...++|+||+||++|+|++|+.||....
T Consensus 180 p~Nil~~~~~--~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 180 PSNILMDKNG--RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp GGGEEECTTS--CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hHhEEEcCCC--cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999997655 5999999999754332 33456799999999999876 555536999999999999999999998876
Q ss_pred chHHHHHHHHHHhccccCCCCC-----------------CCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 154 EPKDFRKTIQRILSVQYSVPDT-----------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.... ....+.......+.. ..++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 257 ~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 257 SLVE---LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CSHH---HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cHHH---HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 6322 223333333333321 4589999999999999999999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=272.95 Aligned_cols=202 Identities=26% Similarity=0.360 Sum_probs=160.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC---C--HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG---L--LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~---~--~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.... . ...++.++.||+.||.|||++|++||||||+||++
T Consensus 77 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 155 (295)
T 2clq_A 77 KHKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 155 (295)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCCCEeeEeeEEEeCCcEEEEE-EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE
Confidence 6899999999999999999999 7999999999998752 2 22788899999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhcccc-CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
+.. .+.+||+|||+++..... .......||+.|+|||++.+.. ..+.++|+|||||++|+|++|+.||.........
T Consensus 156 ~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 234 (295)
T 2clq_A 156 NTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234 (295)
T ss_dssp ETT-TCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH
T ss_pred ECC-CCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH
Confidence 762 235999999999754322 2234557999999999987643 2345599999999999999999999765543321
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.... ..... ....+..++.++.++|.+||..||.+|||+.++++||||+..
T Consensus 235 ~~~~-~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 235 MFKV-GMFKV--HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHH-HHHCC--CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHhh-ccccc--cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 1111 11122 222344589999999999999999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=274.02 Aligned_cols=200 Identities=28% Similarity=0.464 Sum_probs=158.1
Q ss_pred CCcchhhhhcee--eeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVS--VKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~--~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++ ...+..|+|| ||+.++ |.+++... +.+. .++.++.||+.||.|||++|++||||||+||+
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~lv~-e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl 141 (305)
T 2wtk_C 64 RHKNVIQLVDVLYNEEKQKMYMVM-EYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLL 141 (305)
T ss_dssp CCTTBCCEEEEEECC---CEEEEE-ECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCCCeeEEEEEEEcCCCCeEEEEe-hhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEE
Confidence 589999999998 5567899999 799987 77777653 2333 89999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhcccc-CCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
++.++ .+||+|||++...... .......||+.|+|||++.+.. ..+.++|+|||||++|+|++|+.||.+....
T Consensus 142 ~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 219 (305)
T 2wtk_C 142 LTTGG--TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY 219 (305)
T ss_dssp ECTTC--CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EcCCC--cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Confidence 97654 5999999999754321 2223456999999999987643 2345699999999999999999999886653
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
.. ...+....... +..++..+.+||.+||..||.+|||+.++++||||++..+.
T Consensus 220 ~~----~~~i~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 220 KL----FENIGKGSYAI--PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HH----HHHHHHCCCCC--CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HH----HHHHhcCCCCC--CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 32 33333333333 34588999999999999999999999999999999876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=287.93 Aligned_cols=200 Identities=22% Similarity=0.338 Sum_probs=152.8
Q ss_pred CCcchhhhhceee----eceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCC
Q 022732 6 SSSSEYAMLGVSV----KMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~----~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~ 76 (293)
.|+|+++++++|. ...++|+|| ||+ +++|.+++... +.+. .++.++.||+.||.|||++ ||+||||||+
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~-e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~ 176 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVF-EVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPE 176 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEE-CCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGG
T ss_pred CcceeeeeecceeecCCCCceEEEEE-ecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 4788999999998 678999999 799 55666666544 2233 8999999999999999998 9999999999
Q ss_pred cEEEcCCC-----------------------------------------------CCCEEEecCCCCcCcCCCCCCCCCc
Q 022732 77 NTLLDGSP-----------------------------------------------APRLKICDFGYSKSSVLHSQPKSTV 109 (293)
Q Consensus 77 NIl~~~~~-----------------------------------------------~~~vkl~Dfg~a~~~~~~~~~~~~~ 109 (293)
|||++.++ ..++||+|||+++.... .....+
T Consensus 177 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~ 254 (397)
T 1wak_A 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDI 254 (397)
T ss_dssp GEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCC
T ss_pred HeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCC
Confidence 99997553 12599999999975432 344567
Q ss_pred CCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc------hHHHHHHHHHHhcc--------ccC----
Q 022732 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------PKDFRKTIQRILSV--------QYS---- 171 (293)
Q Consensus 110 gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~--------~~~---- 171 (293)
||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+. ...+..+....... ...
T Consensus 255 gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 333 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred CCCcccCChhhcCCCCCcH-HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence 9999999999988877655 9999999999999999999986542 12222222211100 000
Q ss_pred ------------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 172 ------------------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 172 ------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
.......+..+.+||.+||++||.+|||+.++++||||+
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 000112346789999999999999999999999999996
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=273.98 Aligned_cols=198 Identities=25% Similarity=0.364 Sum_probs=163.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|++++++++......|+|| ||+.|++|.+++.....-. .++.++.||+.||.|||++|++||||||+||+++.++
T Consensus 78 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 156 (303)
T 3a7i_A 78 DSPYVTKYYGSYLKDTKLWIIM-EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG 156 (303)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred CCCCEeEEEEEEecCCeEEEEE-EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC
Confidence 6899999999999999999999 7999999999997643222 8999999999999999999999999999999997654
Q ss_pred CCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
++||+|||++....... ......||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||...........+
T Consensus 157 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-- 231 (303)
T 3a7i_A 157 --EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLI-- 231 (303)
T ss_dssp --CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--
T ss_pred --CEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh--
Confidence 59999999997543322 2345679999999999988777655 99999999999999999999876654332222
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.... .......++..+.+||.+||..||.+|||+.++++||||.+.
T Consensus 232 --~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 232 --PKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp --HHSC-CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred --hcCC-CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 1111 122334589999999999999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=276.13 Aligned_cols=199 Identities=29% Similarity=0.376 Sum_probs=155.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++...+.++ .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 69 ~hp~iv~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~ 147 (294)
T 4eqm_A 69 SHQNIVSMIDVDEEDDCYYLVM-EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN 147 (294)
T ss_dssp CBTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred CCCCCceEEEeeeeCCeEEEEE-eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 5899999999999999999999 7999999999999887655 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
+ ++||+|||+++...... ......||+.|+|||++.+..++.+ +|+||+||++|+|++|+.||.+..........
T Consensus 148 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 224 (294)
T 4eqm_A 148 K--TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224 (294)
T ss_dssp S--CEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred C--CEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 5 59999999998643322 2234579999999999988777555 99999999999999999999887654433222
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...... .........+++.+.++|.+||.+||.+||+..+.+.+.|.
T Consensus 225 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 225 IQDSVP-NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HSSCCC-CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred hhccCC-CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 221100 00011234588999999999999999999966666666653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=273.65 Aligned_cols=199 Identities=22% Similarity=0.377 Sum_probs=157.0
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
++|++++++++...+..|+|| | +.+++|.+++...+.+. +++.++.||+.||.|||++|++||||||+||+++.
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~-e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-- 162 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVM-E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-- 162 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEE-C-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--
T ss_pred CCceEEEEEEeecCCEEEEEE-e-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--
Confidence 689999999999999999999 6 67889999999877665 89999999999999999999999999999999964
Q ss_pred CCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccc----------cCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 85 APRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRH----------EYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
+.+||+|||+++....... .....||+.|+|||++.+. .....++|||||||++|+|++|+.||..
T Consensus 163 -~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 163 -GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp -TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 3599999999986433221 2345799999999998652 2234559999999999999999999987
Q ss_pred CCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 152 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..... .....+.......+.+...+.++.++|.+||..||.+|||+.++++||||+...
T Consensus 242 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 242 IINQI---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCSHH---HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHHH---HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 65432 122233333333344445789999999999999999999999999999997543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=290.74 Aligned_cols=201 Identities=21% Similarity=0.369 Sum_probs=152.7
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
+..|+|+|++++++.+..+.|+|| ||+. |+|.+++..... .. .+..++.||+.||.|||++||+||||||+|||+
T Consensus 74 l~~HpnIv~l~~~~~~~~~~~lv~-E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll 151 (432)
T 3p23_A 74 SDEHPNVIRYFCTEKDRQFQYIAI-ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILI 151 (432)
T ss_dssp SCCCTTBCCEEEEEEETTEEEEEE-ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEE
T ss_pred ccCCCCcCeEEEEEecCCEEEEEE-ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEE
Confidence 457999999999999999999999 7997 599999987642 22 778999999999999999999999999999999
Q ss_pred cC---CCCCCEEEecCCCCcCcCCC----CCCCCCcCCCCccchhhhcc---ccCCCchhhhhhhhhHHHHHHh-CCCCC
Q 022732 81 DG---SPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLV-GGYPF 149 (293)
Q Consensus 81 ~~---~~~~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~-g~~pf 149 (293)
+. .+..++||+|||+|+..... ......+||+.|+|||++.+ ..+ +.++||||+||++|+|++ |..||
T Consensus 152 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf 230 (432)
T 3p23_A 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPF 230 (432)
T ss_dssp CCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred ecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCc
Confidence 53 23336889999999865432 22345679999999999874 333 345999999999999999 89999
Q ss_pred CCCCchHHHHHHHHHHhccccC-CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 150 EDPDEPKDFRKTIQRILSVQYS-VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
........ ... ....... .......+..+++||.+||+.||.+|||+.++++||||..
T Consensus 231 ~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 231 GKSLQRQA--NIL--LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp BSTTTHHH--HHH--TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred chhhHHHH--HHH--hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 76543221 111 1111111 1112224567899999999999999999999999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=289.95 Aligned_cols=198 Identities=25% Similarity=0.381 Sum_probs=151.7
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH---------HHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV---------QARFFFQQLISGVSYCHAMQVCHRDLKL 75 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~---------~~~~~~~qil~~l~~LH~~~iiHrdlkp 75 (293)
..|+|++++++++.+.+.+|+|| ||+. |+|.+++...+... .++.++.||+.||.|||++||+||||||
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~-E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp 143 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIAL-ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP 143 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEE-CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred cCCCCcCeEEEEEecCCeEEEEE-ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 47999999999999999999999 7996 59999998765433 3467999999999999999999999999
Q ss_pred CcEEEcCC-----------CCCCEEEecCCCCcCcCCCC-----CCCCCcCCCCccchhhhcc-------ccCCCchhhh
Q 022732 76 ENTLLDGS-----------PAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLR-------HEYDGKIADV 132 (293)
Q Consensus 76 ~NIl~~~~-----------~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Dv 132 (293)
+|||++.. ...++||+|||+++...... ......||+.|+|||++.+ ..+ +.++||
T Consensus 144 ~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~Di 222 (434)
T 2rio_A 144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDI 222 (434)
T ss_dssp GGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCC-CTHHHH
T ss_pred HhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCc-chhhhh
Confidence 99999753 23469999999998654322 1234579999999999865 334 455999
Q ss_pred hhhhhHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCC-----CCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 133 WSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD-----TNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 133 wslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|||||++|+|++ |+.||....... ..+.. .....+. ...++.++.+||.+||+.||.+|||+.++++|
T Consensus 223 wSlG~il~ellt~g~~Pf~~~~~~~--~~i~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 223 FSMGCVFYYILSKGKHPFGDKYSRE--SNIIR----GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHHHHHHHHTTSCCTTCSTTTHH--HHHHH----TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HhHHHHHHHHHhCCCCCCCCchhhH--HHHhc----CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 999999999999 999997755432 22222 2222221 11245889999999999999999999999999
Q ss_pred ccccc
Q 022732 207 QWFLK 211 (293)
Q Consensus 207 ~~~~~ 211 (293)
|||..
T Consensus 297 p~f~~ 301 (434)
T 2rio_A 297 PLFWP 301 (434)
T ss_dssp GGGSC
T ss_pred CccCC
Confidence 99964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=275.71 Aligned_cols=201 Identities=23% Similarity=0.345 Sum_probs=158.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+++|..++... +.+. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 74 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~ 152 (302)
T 2j7t_A 74 DHPYIVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 152 (302)
T ss_dssp CCTTBCCEEEEEECC-CEEEEE-ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT
T ss_pred CCCCEeeeeeeeeeCCeEEEEE-EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECC
Confidence 5899999999999999999999 799999999998763 3343 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhc-----cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 83 SPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++ .+||+|||++..... ........||+.|+|||++. +..+ +.++|+|||||++|+|++|..||.......
T Consensus 153 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 229 (302)
T 2j7t_A 153 EG--DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMR 229 (302)
T ss_dssp TS--CEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CC--CEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 55 599999998753211 12223457999999999984 3444 445999999999999999999998876544
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
....+... .......+..++..+.++|.+||..||.+|||+.++++||||....
T Consensus 230 ~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 230 VLLKIAKS---DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHHS---CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHhcc---CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 33332221 1112223345789999999999999999999999999999997644
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=275.17 Aligned_cols=193 Identities=29% Similarity=0.439 Sum_probs=157.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhh-ccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFF-FSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey-~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|+ || +.+++|.+++...+.+. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVL-ERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL 174 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEE-ECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET
T ss_pred CCCCeeeEEEEEecCCeEEEEE-EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC
Confidence 7999999999999999999999 56 89999999998877655 89999999999999999999999999999999973
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
. .+.+||+|||+++.... .......||+.|+|||++.+..+...++|||||||++|+|++|+.||.... .+
T Consensus 175 ~-~~~~kl~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~- 245 (312)
T 2iwi_A 175 R-RGCAKLIDFGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EI- 245 (312)
T ss_dssp T-TTEEEECCCSSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH-
T ss_pred C-CCeEEEEEcchhhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HH-
Confidence 2 23599999999876533 233456799999999999877776656999999999999999999997531 11
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
...... .+..++..+.++|.+||..||.+|||+.++++||||+...
T Consensus 246 ---~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 246 ---LEAELH--FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ---HHTCCC--CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ---hhhccC--CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 112222 2345899999999999999999999999999999997653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=276.84 Aligned_cols=195 Identities=23% Similarity=0.335 Sum_probs=160.3
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHHHH
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSYCH 64 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~LH 64 (293)
.++.|+|++++++++...+..|+|| ||+.+++|.+++...+ .+. +++.++.||+.||.|||
T Consensus 81 ~l~~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 159 (327)
T 1fvr_A 81 KLGHHPNIINLLGACEHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 159 (327)
T ss_dssp TCCCCTTBCCEEEEEEETTEEEEEE-CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred hccCCCchhhhceeeeeCCceEEEE-ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 4568999999999999999999999 7999999999998764 233 89999999999999999
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 144 (293)
++|++||||||+||+++.++ .+||+|||+++............+++.|+|||++.+..++. ++|||||||++|+|++
T Consensus 160 ~~~ivH~dlkp~NIl~~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt 236 (327)
T 1fvr_A 160 QKQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVS 236 (327)
T ss_dssp HTTEECSCCSGGGEEECGGG--CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH-HHHHHHHHHHHHHHHT
T ss_pred hCCccCCCCccceEEEcCCC--eEEEcccCcCccccccccccCCCCCccccChhhhccccCCc-hhcchHHHHHHHHHHc
Confidence 99999999999999997654 59999999997544444444556789999999998777654 4999999999999998
Q ss_pred -CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 -GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|+.||.+...... ...+. .....+.+..++.++.++|.+||..||.+|||+.+++++
T Consensus 237 ~g~~pf~~~~~~~~----~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 237 LGGTPYCGMTCAEL----YEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TSCCTTTTCCHHHH----HHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCcHHHH----HHHhh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999988765332 22222 222334445689999999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=269.61 Aligned_cols=199 Identities=22% Similarity=0.341 Sum_probs=151.3
Q ss_pred CCcchhhhhceeee-------------ceeEEEeehhhccCchhHHHHHHcCC-H--HHHHHHHHHHHHHHHHHHHcCCe
Q 022732 6 SSSSEYAMLGVSVK-------------MKFVFLSLSFFFSLCLFFMWLLLLGL-L--VQARFFFQQLISGVSYCHAMQVC 69 (293)
Q Consensus 6 ~~~~~v~~~~~~~~-------------~~~~~lv~~ey~~gg~L~~~l~~~~~-~--~~~~~~~~qil~~l~~LH~~~ii 69 (293)
.|+|++++++++.. .+..|+|| ||+.|++|.+++...+. + ..++.++.||+.||.|||++|++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~ 138 (303)
T 1zy4_A 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQM-EYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGII 138 (303)
T ss_dssp CCTTBCCEEEEEEECCCCCC------CEEEEEEEE-ECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CchHHHHHHHHHHhhcchhhhhcccccCCceEEEE-ecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCee
Confidence 58999999998865 57889999 79999999999986542 2 38899999999999999999999
Q ss_pred ecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCC---------------CCCCCCcCCCCccchhhhccccCCCchhhhhh
Q 022732 70 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 134 (293)
Q Consensus 70 Hrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws 134 (293)
||||||+||+++.++ .+||+|||+++..... .......||+.|+|||++.+....+.++|+||
T Consensus 139 H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 216 (303)
T 1zy4_A 139 HRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216 (303)
T ss_dssp CSCCCGGGEEECTTS--CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHH
T ss_pred cccCCHHhEEEcCCC--CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHH
Confidence 999999999997654 5999999998754321 12234569999999999986644455699999
Q ss_pred hhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 135 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 135 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
|||++|+|++ ||...... ......+.......+ .....+..++++|.+||..||.+|||+.++++||||+..
T Consensus 217 lG~il~~l~~---p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 217 LGIIFFEMIY---PFSTGMER---VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHHS---CCSSHHHH---HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHHHHHHHh---ccCCchhH---HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 9999999998 55432221 223333333332222 234467889999999999999999999999999999754
Q ss_pred C
Q 022732 213 L 213 (293)
Q Consensus 213 ~ 213 (293)
.
T Consensus 291 ~ 291 (303)
T 1zy4_A 291 H 291 (303)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=274.60 Aligned_cols=204 Identities=26% Similarity=0.380 Sum_probs=158.6
Q ss_pred CCcchhhhhcee--------------eeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCee
Q 022732 6 SSSSEYAMLGVS--------------VKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCH 70 (293)
Q Consensus 6 ~~~~~v~~~~~~--------------~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiH 70 (293)
.|+|++++++++ ...+..|+|| ||+. |+|.+++....... .++.++.||+.||.|||++|++|
T Consensus 66 ~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~-e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 143 (320)
T 2i6l_A 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQ-EYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLH 143 (320)
T ss_dssp CCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEE-ECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred CCCCeeEEEEeccccccccccccccccccCceeEEe-eccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 589999999887 4557899999 7998 59999997644323 89999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCCCEEEecCCCCcCcCCC----CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCC
Q 022732 71 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 71 rdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 146 (293)
|||||+||+++..+ +.+||+|||+++..... .......+|+.|+|||++.+....+.++|+|||||++|+|++|+
T Consensus 144 ~dlkp~Nil~~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 222 (320)
T 2i6l_A 144 RDLKPANLFINTED-LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222 (320)
T ss_dssp CCCSGGGEEEETTT-TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCCHHHEEEcCCC-CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCC
Confidence 99999999997433 35999999999854321 22334568999999999876444456699999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHhcc------------------ccCCC------CCCCCCHHHHHHHHHccccCCCCCCCHHH
Q 022732 147 YPFEDPDEPKDFRKTIQRILSV------------------QYSVP------DTNPISQECRDLISRIFVADPAARITIPE 202 (293)
Q Consensus 147 ~pf~~~~~~~~~~~~~~~~~~~------------------~~~~~------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e 202 (293)
.||.+......+..+....... ....+ ....++.++++||.+||..||.+|||+.+
T Consensus 223 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (320)
T 2i6l_A 223 TLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302 (320)
T ss_dssp CSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH
Confidence 9999887655544443321100 00000 11347899999999999999999999999
Q ss_pred HHcCcccccC
Q 022732 203 IMKHQWFLKN 212 (293)
Q Consensus 203 ll~h~~~~~~ 212 (293)
+++||||+..
T Consensus 303 ll~hp~~~~~ 312 (320)
T 2i6l_A 303 ALSHPYMSIY 312 (320)
T ss_dssp HHTSHHHHTT
T ss_pred HhCCcccccc
Confidence 9999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=277.55 Aligned_cols=200 Identities=23% Similarity=0.278 Sum_probs=155.6
Q ss_pred cchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 8 SSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 8 ~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.+.+++++++...++.|+|| ||+ +++|.+++.... .++ +++.++.||+.||.|||++||+||||||+|||+...
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~-e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 82 FLCVLMSDWFNFHGHMCIAF-ELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159 (355)
T ss_dssp SCBCCEEEEEEETTEEEEEE-ECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCC
T ss_pred eeEEEeeeeeeeCCeEEEEE-ecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecc
Confidence 34788999999999999999 799 566767776553 333 899999999999999999999999999999999432
Q ss_pred -----------------CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCC
Q 022732 84 -----------------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 84 -----------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 146 (293)
..+.+||+|||+++... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~ 236 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGF 236 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSS
T ss_pred cccccccccccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCC
Confidence 23469999999997532 33345689999999999988777655 99999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHhcccc--------------------------------------CCCCCCCCCHHHHHHHHH
Q 022732 147 YPFEDPDEPKDFRKTIQRILSVQY--------------------------------------SVPDTNPISQECRDLISR 188 (293)
Q Consensus 147 ~pf~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~s~~~~~li~~ 188 (293)
.||........+..+......... ........+.++.+||.+
T Consensus 237 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 316 (355)
T 2eu9_A 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316 (355)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence 999987765444333222110000 000011124688999999
Q ss_pred ccccCCCCCCCHHHHHcCcccccC
Q 022732 189 IFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 189 ~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
||..||.+|||+.++++||||+..
T Consensus 317 ~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 317 MLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HhcCChhhCcCHHHHhcChhhcCC
Confidence 999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=274.29 Aligned_cols=201 Identities=22% Similarity=0.332 Sum_probs=149.1
Q ss_pred CCcchhhhhceeeeceeE------EEeehhhccCchhHHHHHHcC------CHH--HHHHHHHHHHHHHHHHHHcCCeec
Q 022732 6 SSSSEYAMLGVSVKMKFV------FLSLSFFFSLCLFFMWLLLLG------LLV--QARFFFQQLISGVSYCHAMQVCHR 71 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~------~lv~~ey~~gg~L~~~l~~~~------~~~--~~~~~~~qil~~l~~LH~~~iiHr 71 (293)
.|+|++++++++...... |+|| ||+.+|+|.+++.... .++ +++.++.||+.||.|||++|++||
T Consensus 83 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~ 161 (323)
T 3qup_A 83 DHPHVAKLVGVSLRSRAKGRLPIPMVIL-PFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR 161 (323)
T ss_dssp CCTTBCCCCEEEECC-------CEEEEE-ECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred CCCceehhhceeeccccccCCCccEEEE-EeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 689999999999888766 8999 7999999999997543 233 899999999999999999999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCC
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGY 147 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~ 147 (293)
||||+|||++.++ .+||+|||+++....... .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..
T Consensus 162 Dikp~NIli~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~ 238 (323)
T 3qup_A 162 DLAARNCMLAEDM--TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQT 238 (323)
T ss_dssp CCSGGGEEECTTS--CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCC
T ss_pred CCCcceEEEcCCC--CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCC
Confidence 9999999997654 599999999975433221 223457789999999988777544 999999999999999 999
Q ss_pred CCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-------HHHHHcCcccccCCCC
Q 022732 148 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-------IPEIMKHQWFLKNLPA 215 (293)
Q Consensus 148 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-------~~ell~h~~~~~~~~~ 215 (293)
||.+.........+.. ....+.+..++.++.+||.+||..||.+||| +++++.|+|+......
T Consensus 239 p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 239 PYAGIENAEIYNYLIG-----GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp TTTTCCGGGHHHHHHT-----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CccccChHHHHHHHhc-----CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 9998776554333222 1223344568999999999999999999999 7788899998765443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=282.83 Aligned_cols=199 Identities=18% Similarity=0.261 Sum_probs=163.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-------HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-------LV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-------~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.|+|++++++++......|+|| ||+.||+|.+++...+. +. +++.++.||+.||.|||++||+||||||+
T Consensus 132 ~hpnIv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 210 (367)
T 3l9p_A 132 NHQNIVRCIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAAR 210 (367)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCCCCCeEEEEEecCCCCEEEE-EeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh
Confidence 6899999999999999999999 79999999999987642 32 89999999999999999999999999999
Q ss_pred cEEEcCCC-CCCEEEecCCCCcCcC---CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCC
Q 022732 77 NTLLDGSP-APRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFED 151 (293)
Q Consensus 77 NIl~~~~~-~~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~ 151 (293)
|||++.++ ...+||+|||+++... .........||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+
T Consensus 211 NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 211 NCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp GEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCC
Confidence 99997543 2359999999987422 2233345578999999999988777555 999999999999998 9999988
Q ss_pred CCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 152 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
....... ..+... ...+.+..++..+.+||.+||+.||.+|||+.+++++.++..
T Consensus 290 ~~~~~~~----~~i~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 290 KSNQEVL----EFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCHHHHH----HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHH----HHHHcC-CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 7654332 222222 223334568999999999999999999999999999987643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=271.55 Aligned_cols=200 Identities=21% Similarity=0.339 Sum_probs=149.3
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEE
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLENTLL 80 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~NIl~ 80 (293)
-.|+|++++++++...+..|+|| ||+ ++.+..+... .+.+. .++.++.||+.||.|||++ |++||||||+||++
T Consensus 81 ~~h~~i~~~~~~~~~~~~~~lv~-e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~ 158 (318)
T 2dyl_A 81 HDCPYIVQCFGTFITNTDVFIAM-ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL 158 (318)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEE-CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE
T ss_pred cCCCceeeEEEEEecCCcEEEEE-ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE
Confidence 36899999999999999999999 798 5556555543 33444 8899999999999999995 99999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhc-----cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
+.++ ++||+|||++.............||+.|+|||++. +..+ ..++||||+||++|+|++|+.||......
T Consensus 159 ~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (318)
T 2dyl_A 159 DERG--QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTD 235 (318)
T ss_dssp CTTS--CEEECCCTTC--------------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred CCCC--CEEEEECCCchhccCCccccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCcc
Confidence 7655 59999999997654444445567999999999985 3334 34599999999999999999999875443
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
....... ........+....++.++.+||.+||..||.+|||+.++++||||++
T Consensus 236 ~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 236 FEVLTKV--LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHH--HHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHH--hccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 2222111 11222233444458999999999999999999999999999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=278.74 Aligned_cols=197 Identities=12% Similarity=0.105 Sum_probs=153.7
Q ss_pred CCcchhhhhceeeec----eeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKM----KFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~----~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++... .+.|+|| ||+ |++|.+++... +.+. +++.++.||+.||.|||++||+||||||+||
T Consensus 106 ~h~~iv~~~~~~~~~~~~~~~~~lv~-e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 106 KYLGVPKYWGSGLHDKNGKSYRFMIM-DRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL 183 (364)
T ss_dssp SCCCSCCEEEEEEEEETTEEEEEEEE-ECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCCCCCeEEeeeeeccCCcceEEEEE-eCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHE
Confidence 589999999999876 6789999 799 99999999876 3444 9999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCC--------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCC
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 150 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 150 (293)
|++.+..+++||+|||+++...... ......||+.|+|||++.+..++. ++|||||||++|+|++|+.||.
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR-RGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCc-hhhHHHHHHHHHHHHhCCCCcc
Confidence 9984445579999999997543221 113445999999999998877754 4999999999999999999998
Q ss_pred CCCchHHHHHHHHHHhcccc-----CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 151 DPDEPKDFRKTIQRILSVQY-----SVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+................... .......++.++.+++.+||..+|.+||++.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 263 DNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp GGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 64332222211111100000 00011347899999999999999999999998876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=280.98 Aligned_cols=198 Identities=14% Similarity=0.118 Sum_probs=156.8
Q ss_pred CCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++.. ....|+|| ||+ |++|.+++...+.+. +++.++.||+.||.|||++|++||||||+|||
T Consensus 106 ~h~ni~~~~~~~~~~~~~~~~~~lv~-e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 183 (345)
T 2v62_A 106 DYLGIPLFYGSGLTEFKGRSYRFMVM-ERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL 183 (345)
T ss_dssp SCCCCCCEEEEEEEESSSCEEEEEEE-ECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cccCcceeecccccccCCCcEEEEEE-ecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEE
Confidence 68999999999998 79999999 799 999999998776554 99999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCC--------CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
++.++.+.+||+|||+++....... .....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR-RSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCccc
Confidence 9877645799999999975432211 13457999999999998876654 49999999999999999999965
Q ss_pred CC-chHHHHHHHHHHhcccc----CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 152 PD-EPKDFRKTIQRILSVQY----SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 152 ~~-~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. ................. .......++.++.++|.+||..||.+|||+.++++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp GTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 32 22222222222111100 000112588999999999999999999999999884
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=279.28 Aligned_cols=193 Identities=21% Similarity=0.319 Sum_probs=160.2
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHHHHHc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSYCHAM 66 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~LH~~ 66 (293)
+.|+|++++++++...+..|+|| ||+.+|+|.+++.... .+. +++.++.||+.||.|||++
T Consensus 132 ~~hpnIv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 210 (382)
T 3tt0_A 132 GKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 210 (382)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCchhhhheeeeccCCceEEEE-EecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 57999999999999999999999 7999999999998764 233 8999999999999999999
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHH
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 143 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 143 (293)
||+||||||+|||++.++ .+||+|||+++..... .......+|+.|+|||++.+..++.+ +|||||||++|+|+
T Consensus 211 ~ivH~Dlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ell 287 (382)
T 3tt0_A 211 KCIHRDLAARNVLVTEDN--VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIF 287 (382)
T ss_dssp TCCCSCCCGGGEEECTTC--CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHH
T ss_pred CEecCCCCcceEEEcCCC--cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHH
Confidence 999999999999997654 5999999999854332 22334457889999999988776555 99999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 144 V-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 144 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+ |..||.+....... ..+. .......+..++.++.+||.+||..||.+|||+.+++++
T Consensus 288 t~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 288 TLGGSPYPGVPVEELF----KLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTSCCSSTTCCHHHHH----HHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCCCCCCHHHHH----HHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9 99999887653322 2222 222333445689999999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=280.58 Aligned_cols=195 Identities=22% Similarity=0.375 Sum_probs=158.9
Q ss_pred CCCCcchhhhhceeeece-eEEEeehhhccCchhHHHHHHcCC-------------------------------------
Q 022732 4 VGSSSSEYAMLGVSVKMK-FVFLSLSFFFSLCLFFMWLLLLGL------------------------------------- 45 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~-~~~lv~~ey~~gg~L~~~l~~~~~------------------------------------- 45 (293)
+..|+|++++++++...+ ..|+|| ||+.||+|.+++.....
T Consensus 82 l~~hpniv~~~~~~~~~~~~~~iv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (359)
T 3vhe_A 82 IGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQ 160 (359)
T ss_dssp HCCCTTBCCEEEEECSTTSCCEEEE-ECCTTEEHHHHHHTTTTSBCSCC-------------------------------
T ss_pred hcCCcceeeeeeeeecCCCceEEEE-EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccc
Confidence 357899999999998765 488889 79999999999987542
Q ss_pred -----------------------------HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCC
Q 022732 46 -----------------------------LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 94 (293)
Q Consensus 46 -----------------------------~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg 94 (293)
+. .++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg 238 (359)
T 3vhe_A 161 SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFG 238 (359)
T ss_dssp -----------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCG
T ss_pred cccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--cEEEEecc
Confidence 33 7899999999999999999999999999999997654 59999999
Q ss_pred CCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHHHHHHHHhcccc
Q 022732 95 YSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY 170 (293)
Q Consensus 95 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 170 (293)
+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......+...+.. ..
T Consensus 239 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~ 313 (359)
T 3vhe_A 239 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GT 313 (359)
T ss_dssp GGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TC
T ss_pred ceeeecccccchhccccCCCceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CC
Confidence 997543222 2234568899999999988777644 999999999999998 99999887765544443332 22
Q ss_pred CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 171 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 171 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..+.+..+++++.++|.+||..||.+|||+.++++|
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 233345589999999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.26 Aligned_cols=194 Identities=25% Similarity=0.328 Sum_probs=152.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~---iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++.....-. .++.++.|++.||.|||++| ++||||||+||+++
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~ 142 (271)
T 3dtc_A 64 KHPNIIALRGVCLKEPNLCLVM-EFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILIL 142 (271)
T ss_dssp CCTTBCCEEEEECCC--CEEEE-ECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEES
T ss_pred CCCCEeeEEEEEecCCceEEEE-EcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEe
Confidence 5899999999999999999999 7999999999986543222 89999999999999999999 89999999999997
Q ss_pred CC------CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 82 GS------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 82 ~~------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
.. ..+.+||+|||+++..... ......||+.|+|||++.+..++. ++|+||+||++|+|++|+.||.+....
T Consensus 143 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~ 220 (271)
T 3dtc_A 143 QKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVIRASMFSK-GSDVWSYGVLLWELLTGEVPFRGIDGL 220 (271)
T ss_dssp SCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSH-HHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred cccccccccCcceEEccCCcccccccc-cccCCCCccceeCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 52 1346999999999754332 223557999999999998777654 499999999999999999999887653
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. ...........+.+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 221 ~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 221 AV----AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HH----HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH----HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 32 223333444445556689999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=278.04 Aligned_cols=200 Identities=23% Similarity=0.359 Sum_probs=138.8
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-----cCCHH--HHHHHHHHHHHHHHHHHHc-CCeecCCCCC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-----LGLLV--QARFFFQQLISGVSYCHAM-QVCHRDLKLE 76 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-----~~~~~--~~~~~~~qil~~l~~LH~~-~iiHrdlkp~ 76 (293)
..|+|++++++++...+..|+|| ||+.+ +|.+++.. .+.+. .+..++.|++.||.|||++ |++||||||+
T Consensus 78 ~~h~niv~~~~~~~~~~~~~lv~-e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~ 155 (327)
T 3aln_A 78 SDCPYIVQFYGALFREGDCWICM-ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPS 155 (327)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEE-CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGG
T ss_pred CCCCcEeeeeeEEEeCCceEEEE-eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHH
Confidence 47999999999999999999999 79986 77777753 33333 8899999999999999999 9999999999
Q ss_pred cEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhc----cccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 77 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 77 NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
||+++.++ .+||+|||+++............||+.|+|||++. +..++ .++|||||||++|+|++|+.||.+.
T Consensus 156 NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 156 NILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp GEEEETTT--EEEECCCSSSCC------------------------------CC-SHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred HEEEcCCC--CEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCc
Confidence 99997654 59999999998654444444557999999999983 44454 4599999999999999999999875
Q ss_pred CchHHHHHHHHHHhcccc---CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 153 DEPKDFRKTIQRILSVQY---SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.... .....+..... .......++..+.+||.+||..||.+|||+.++++||||...
T Consensus 233 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 233 NSVF---DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ----------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred chHH---HHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 4311 11111111111 111123589999999999999999999999999999999653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=273.75 Aligned_cols=192 Identities=20% Similarity=0.304 Sum_probs=156.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.||+|.+++... +.+. +++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 186 (325)
T 3kul_A 108 DHPNIIRLEGVVTRGRLAMIVT-EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS 186 (325)
T ss_dssp CCTTBCCEEEEECGGGCCEEEE-ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCCCCCcEEEEEEeCCccEEEe-eCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECC
Confidence 5899999999999999999999 799999999999765 3444 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .+||+|||+++....... .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......
T Consensus 187 ~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~ 263 (325)
T 3kul_A 187 NL--VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDV 263 (325)
T ss_dssp TC--CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred CC--CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 54 599999999985433221 122346788999999987777555 999999999999999 9999988766443
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
... +. .....+.+..++..+.++|.+||..||.+|||+.++++.
T Consensus 264 ~~~----~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 264 ISS----VE-EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHH----HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH----HH-cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 322 22 223444556689999999999999999999999998873
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=277.23 Aligned_cols=197 Identities=22% Similarity=0.335 Sum_probs=162.6
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-------------------------HHHHHHHHHHHHH
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-------------------------LVQARFFFQQLIS 58 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-------------------------~~~~~~~~~qil~ 58 (293)
++.|+|++++++++...+..|+|| ||+.+|+|.+++..... ...++.++.||+.
T Consensus 105 l~~hp~iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 183 (344)
T 1rjb_A 105 LGSHENIVNLLGACTLSGPIYLIF-EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183 (344)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred hcCCCCeeeEEEEEeeCCccEEEE-ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHH
Confidence 357999999999999999999999 79999999999987542 2288999999999
Q ss_pred HHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhh
Q 022732 59 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSC 135 (293)
Q Consensus 59 ~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl 135 (293)
||.|||++|++||||||+||+++.++ .+||+|||+++....... .....||+.|+|||++.+..++. ++|||||
T Consensus 184 aL~~LH~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~sl 260 (344)
T 1rjb_A 184 GMEFLEFKSCVHRDLAARNVLVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI-KSDVWSY 260 (344)
T ss_dssp HHHHHHHTTEEETTCSGGGEEEETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHH
T ss_pred HHHHHHhCCcccCCCChhhEEEcCCC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh-hHhHHHH
Confidence 99999999999999999999997655 599999999975433222 12345788999999998777654 4999999
Q ss_pred hhHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 136 GVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 136 G~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
||++|+|++ |..||.+......+..... .....+.+..++.++.++|.+||..||.+|||+.+++++..
T Consensus 261 G~il~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 261 GILLWEIFSLGVNPYPGIPVDANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCcccCCcHHHHHHHHh----cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 999999998 9999988776554444333 22333444558999999999999999999999999999743
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=271.18 Aligned_cols=194 Identities=23% Similarity=0.334 Sum_probs=161.3
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC------------------HH--HHHHHHHHHHHHHHHHH
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL------------------LV--QARFFFQQLISGVSYCH 64 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~------------------~~--~~~~~~~qil~~l~~LH 64 (293)
+.|+|++++++++...+..|+|| ||+.+|+|.+++..... +. +++.++.||+.||.|||
T Consensus 84 ~~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 162 (313)
T 1t46_A 84 GNHMNIVNLLGACTIGGPTLVIT-EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162 (313)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEE-ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCeeeEEEEEecCCCcEEEE-ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 57999999999999999999999 79999999999987642 22 89999999999999999
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHH
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 141 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e 141 (293)
++|++||||||+||+++.++ .+||+|||+++....... .....||+.|+|||++.+..++. ++|||||||++|+
T Consensus 163 ~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~e 239 (313)
T 1t46_A 163 SKNCIHRDLAARNILLTHGR--ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWE 239 (313)
T ss_dssp HTTCCCSCCSGGGEEEETTT--EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHH
T ss_pred HCCeecCCCccceEEEcCCC--CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCCh-HHHHHHHHHHHHH
Confidence 99999999999999997654 599999999976543322 22345788999999998777654 4999999999999
Q ss_pred HHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 142 MLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 142 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|++ |+.||.+............. ....+.+..++..+.++|.+||..||.+|||+.+++++
T Consensus 240 llt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 240 LFSLGSSPYPGMPVDSKFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCcccchhHHHHHhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999 99999887765544444433 22233345589999999999999999999999999885
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=266.05 Aligned_cols=199 Identities=16% Similarity=0.125 Sum_probs=157.1
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
+..++|++++++++....+.|+|| ||+ +++|.+++...+. ++ .++.++.||+.||.|||++|++||||||+||++
T Consensus 62 l~~~~~i~~~~~~~~~~~~~~lv~-e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 139 (298)
T 1csn_A 62 LAGCTGIPNVYYFGQEGLHNVLVI-DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139 (298)
T ss_dssp TTTCTTCCCEEEEEEETTEEEEEE-ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred HhcCCCCCeEEeecCCCceeEEEE-Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe
Confidence 457899999999999999999999 799 9999999987542 43 999999999999999999999999999999999
Q ss_pred cCCC---CCCEEEecCCCCcCcCCCC--------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC
Q 022732 81 DGSP---APRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 149 (293)
Q Consensus 81 ~~~~---~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 149 (293)
+.++ .+++||+|||+++...... ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||
T Consensus 140 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf 218 (298)
T 1csn_A 140 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPW 218 (298)
T ss_dssp CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCc
Confidence 7543 2349999999997543322 23455799999999999887765 4599999999999999999999
Q ss_pred CCCCch---HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 150 EDPDEP---KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 150 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+.... ..+..+......... ......+++++.++|.+||..||.+|||+.++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 219 QGLKAATNKQKYERIGEKKQSTPL-RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp SSCCSCCHHHHHHHHHHHHHHSCH-HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred chhhccccHHHHHHHHhhccCccH-HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 885432 222222222111110 01123478999999999999999999999998774
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=269.31 Aligned_cols=198 Identities=23% Similarity=0.324 Sum_probs=157.7
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHcCC----HH--HHHHHHHHHHHHHHHHHHcC-----CeecC
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLLGL----LV--QARFFFQQLISGVSYCHAMQ-----VCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~~~----~~--~~~~~~~qil~~l~~LH~~~-----iiHrd 72 (293)
.|+|++++++++.. .+..|+|| ||+.|++|.+++..... ++ .++.++.||+.||.|||++| ++|||
T Consensus 63 ~h~~i~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~d 141 (279)
T 2w5a_A 63 KHPNIVRYYDRIIDRTNTTLYIVM-EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141 (279)
T ss_dssp CCTTBCCEEEEEEEGGGTEEEEEE-ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCC
T ss_pred CCCCCCeEEEEEecCCCceEEEEE-eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEec
Confidence 58999999998854 67899999 79999999999976431 33 89999999999999999999 99999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC-CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
|||+||+++.++ .+||+|||+++....... .....||+.|+|||++.+..++. ++|+|||||++|+|++|+.||..
T Consensus 142 l~p~NIl~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 142 LKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTA 218 (279)
T ss_dssp CSGGGEEECSSS--CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCH-HHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cchhhEEEcCCC--CEEEecCchheeeccccccccccCCCccccChHHhccCCCCc-hhhHHHHHHHHHHHHHCCCCCcc
Confidence 999999997654 599999999875432211 12346899999999998877654 49999999999999999999988
Q ss_pred CCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 152 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
....... ..+..... .+.+..++.++.++|.+||..||.+|||+.++++|+|+...
T Consensus 219 ~~~~~~~----~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 219 FSQKELA----GKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SSHHHHH----HHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCHHHHH----HHHhhccc-ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 7653322 22222222 12334589999999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=264.32 Aligned_cols=192 Identities=20% Similarity=0.347 Sum_probs=158.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.+.+..|+|| ||+.+++|.+++.... .+. .++.++.|++.||.|||++|++||||||+||+++.
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~ 141 (269)
T 4hcu_A 63 SHPKLVQLYGVCLEQAPICLVF-EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 141 (269)
T ss_dssp CCTTBCCEEEEECSSSSEEEEE-ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCCCEeeEEEEEecCCceEEEE-EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC
Confidence 4899999999999999999999 7999999999997654 233 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC--CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||+++..... .......+|+.|+|||++.+..++.+ +|+||+||++|+|++ |+.||..........
T Consensus 142 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~ 218 (269)
T 4hcu_A 142 NQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 218 (269)
T ss_dssp GG--CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CC--CEEeccccccccccccccccccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 54 5999999999754221 12334457888999999987777554 999999999999999 999998876644332
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
. +... .....+..++..+.++|.+||..||.+|||+.++++|
T Consensus 219 ~----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 219 D----ISTG-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp H----HHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H----HhcC-ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2 2222 2333344579999999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=269.23 Aligned_cols=192 Identities=23% Similarity=0.334 Sum_probs=158.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC------------------------HH--HHHHHHHHHHHH
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL------------------------LV--QARFFFQQLISG 59 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~------------------------~~--~~~~~~~qil~~ 59 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++...+. +. +++.++.||+.|
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 162 (314)
T 2ivs_A 84 NHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162 (314)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHH
T ss_pred CCCceeeEEEEEecCCceEEEE-eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHH
Confidence 5999999999999999999999 79999999999987543 33 899999999999
Q ss_pred HHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhh
Q 022732 60 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 136 (293)
Q Consensus 60 l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG 136 (293)
|.|||++|++||||||+||+++.++ .+||+|||+++...... ......+|+.|+|||++.+..++.+ +||||||
T Consensus 163 l~~lH~~~ivH~dikp~NIli~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG 239 (314)
T 2ivs_A 163 MQYLAEMKLVHRDLAARNILVAEGR--KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFG 239 (314)
T ss_dssp HHHHHHTTEECCCCSGGGEEEETTT--EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHH
T ss_pred HHHHHHCCCcccccchheEEEcCCC--CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHH
Confidence 9999999999999999999997654 59999999997543222 2234457889999999988776554 9999999
Q ss_pred hHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 137 VTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 137 ~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|++|+|++ |..||.+.........+ . .....+.+..+++++.++|.+||..||.+|||+.+++++
T Consensus 240 ~il~el~t~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 240 VLLWEIVTLGGNPYPGIPPERLFNLL----K-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHHTTSCCSSTTCCGGGHHHHH----H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHh----h-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999 99999887664433221 1 122233445689999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=263.92 Aligned_cols=192 Identities=21% Similarity=0.307 Sum_probs=157.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-H--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-L--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++...+. + .+++.++.|++.||.|||++|++||||||+||+++.
T Consensus 61 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~ 139 (268)
T 3sxs_A 61 SHPKLVKFYGVCSKEYPIYIVT-EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR 139 (268)
T ss_dssp CCTTBCCEEEEECSSSSEEEEE-ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT
T ss_pred CCCCEeeEEEEEccCCceEEEE-EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC
Confidence 4899999999999999999999 79999999999987643 3 399999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||++....... ......+|+.|+|||++.+..++.+ +|+||+||++|+|++ |+.||..........
T Consensus 140 ~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 216 (268)
T 3sxs_A 140 DL--CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216 (268)
T ss_dssp TC--CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CC--CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHH
Confidence 55 59999999987543222 1223456778999999988777655 999999999999999 999998876644332
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
. +... .....+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 217 ~----~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 217 K----VSQG-HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp H----HHTT-CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred H----HHcC-CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 2222 2223344578999999999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.04 Aligned_cols=192 Identities=22% Similarity=0.275 Sum_probs=152.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.+.+..|+|| ||+.|++|.+++... +.++ ++..++.||+.||.|||++|++||||||+||+++.
T Consensus 65 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~ 143 (310)
T 3s95_A 65 EHPNVLKFIGVLYKDKRLNFIT-EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE 143 (310)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECT
T ss_pred CCcCcccEEEEEecCCeeEEEE-EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECC
Confidence 5999999999999999999999 799999999999873 3343 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC---------------CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCC
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ---------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 147 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 147 (293)
++ .+||+|||+++....... ....+||+.|+|||++.+..++.+ +||||+||++|+|++|..
T Consensus 144 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~ 220 (310)
T 3s95_A 144 NK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVN 220 (310)
T ss_dssp TS--CEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCC
T ss_pred CC--CEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCC
Confidence 54 599999999975432211 125579999999999988777655 999999999999999999
Q ss_pred CCCCCCchHH-HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 148 PFEDPDEPKD-FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 148 pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
||........ ........... ..+..+++.+.++|.+||..||.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 221 ADPDYLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp SSTTTSCBCTTSSBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcchhhhHHHHhhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9876432110 00000011111 112347889999999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=265.72 Aligned_cols=191 Identities=19% Similarity=0.307 Sum_probs=147.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++. .+..|+|| ||+.+++|.+++...+ .+. .++.++.|++.||.|||++|++||||||+||+++.
T Consensus 74 ~h~~iv~~~~~~~-~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 151 (281)
T 1mp8_A 74 DHPHIVKLIGVIT-ENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 151 (281)
T ss_dssp CCTTBCCEEEEEC-SSSCEEEE-ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE
T ss_pred CCCccceEEEEEc-cCccEEEE-ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC
Confidence 5899999999984 56789999 7999999999998764 333 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||+++....... .....+|+.|+|||++.+..++.+ +|+|||||++|+|++ |..||.+........
T Consensus 152 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~ 228 (281)
T 1mp8_A 152 ND--CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228 (281)
T ss_dssp TT--EEEECC-------------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred CC--CEEECccccccccCcccccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHH
Confidence 54 599999999975433222 223456789999999987777554 999999999999996 999999877654433
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+. .. ...+.+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 229 ~i~----~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 229 RIE----NG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHH----TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH----cC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 322 21 2234445689999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=272.33 Aligned_cols=191 Identities=18% Similarity=0.246 Sum_probs=153.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++. ....|+|| ||+.+|+|.+++... +.+. .+..++.||+.||.|||++|++||||||+|||++.
T Consensus 73 ~h~~iv~~~~~~~-~~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~ 150 (325)
T 3kex_A 73 DHAHIVRLLGLCP-GSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS 150 (325)
T ss_dssp CCTTBCCEEEEEC-BSSEEEEE-ECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESS
T ss_pred CCCCcCeEEEEEc-CCccEEEE-EeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECC
Confidence 6999999999986 56688999 799999999999774 3344 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ ++||+|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.......
T Consensus 151 ~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 227 (325)
T 3kex_A 151 PS--QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVP 227 (325)
T ss_dssp SS--CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHH
T ss_pred CC--eEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHH
Confidence 54 59999999998643322 2234467889999999987777544 999999999999999 99999887654332
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. +. .....+.+..++.++.++|.+||..||.+|||+.+++++
T Consensus 228 ~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 228 DL----LE-KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HH----HH-TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HH----HH-cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22 11 122233344578899999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=263.67 Aligned_cols=192 Identities=18% Similarity=0.292 Sum_probs=157.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.. .+.+. +++.++.|++.||.|||++|++||||||+||+++.
T Consensus 77 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~ 155 (283)
T 3gen_A 77 SHEKLVQLYGVCTKQRPIFIIT-EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 155 (283)
T ss_dssp CCTTBCCEEEEECSSSSEEEEE-CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT
T ss_pred CCCCEeeEEEEEecCCCeEEEE-eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcC
Confidence 4899999999999999999999 79999999999976 33333 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC--CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ ++||+|||+++..... .......+|+.|+|||++.+..++. ++|+||+||++|+|++ |+.||..........
T Consensus 156 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~ 232 (283)
T 3gen_A 156 QG--VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232 (283)
T ss_dssp TS--CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CC--CEEEccccccccccccccccccCCccCcccCCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccChhHHHH
Confidence 54 5999999999754221 1223345788899999998777754 4999999999999998 999998877544333
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+. .. .....+..+++.+.++|.+||..+|.+|||+.++++|
T Consensus 233 ~~~----~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 233 HIA----QG-LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHH----TT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHh----cc-cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 222 22 2233344578999999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=270.12 Aligned_cols=199 Identities=20% Similarity=0.296 Sum_probs=152.3
Q ss_pred CCCcchhhhhceeeec----eeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHc--------CCeec
Q 022732 5 GSSSSEYAMLGVSVKM----KFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAM--------QVCHR 71 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~----~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~--------~iiHr 71 (293)
..|+|++++++++... ...|+|| ||+.+|+|.++++....-. .++.++.|++.||.|||++ |++||
T Consensus 88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 166 (337)
T 3mdy_A 88 MRHENILGFIAADIKGTGSWTQLYLIT-DYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166 (337)
T ss_dssp CCCTTBCCEEEEEEESCGGGCEEEEEE-CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECS
T ss_pred hcCCCeeeEEEEEccCCCCCCceEEEE-eccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEec
Confidence 4799999999999988 7899999 7999999999997764322 8999999999999999998 99999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC-----CCCCcCCCCccchhhhccccCCCc-----hhhhhhhhhHHHH
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGK-----IADVWSCGVTLYV 141 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DvwslG~il~e 141 (293)
||||+|||++.++ ++||+|||+++....... .....||+.|+|||++.+..+... ++|||||||++|+
T Consensus 167 Dikp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 244 (337)
T 3mdy_A 167 DLKSKNILVKKNG--TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE 244 (337)
T ss_dssp CCCGGGEEECTTS--CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHH
T ss_pred ccchHHEEECCCC--CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHH
Confidence 9999999997655 599999999975432222 234579999999999977655443 3899999999999
Q ss_pred HHhC----------CCCCCCCCchHHHHHHHHHHh-ccccCCCCC-----CCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 142 MLVG----------GYPFEDPDEPKDFRKTIQRIL-SVQYSVPDT-----NPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 142 l~~g----------~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|++| ..||................. ........+ ..++.++.++|.+||..||.+|||+.++++
T Consensus 245 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 9999 777765432211111222211 111111111 135678999999999999999999999998
Q ss_pred C
Q 022732 206 H 206 (293)
Q Consensus 206 h 206 (293)
+
T Consensus 325 ~ 325 (337)
T 3mdy_A 325 T 325 (337)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=259.42 Aligned_cols=190 Identities=21% Similarity=0.242 Sum_probs=156.8
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcC--CeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQ--VCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~--iiHrdlkp~N 77 (293)
.|+|++++++++.+. ++.|+|| ||+.+|+|.+++...+. ++ +++.++.||+.||.|||++| ++||||||+|
T Consensus 65 ~h~~iv~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~N 143 (271)
T 3kmu_A 65 SHPNVLPVLGACQSPPAPHPTLIT-HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS 143 (271)
T ss_dssp SCTTEECEEEEECTTTSSSCEEEE-ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGG
T ss_pred CCCchhheEEEEccCCCCCeEeee-cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccce
Confidence 699999999999987 8899999 79999999999988653 33 99999999999999999999 9999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCC--chhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
|+++.++. ++|+|||++.. .......||+.|+|||++.+..+.. .++||||+||++|+|++|+.||.+....
T Consensus 144 il~~~~~~--~~l~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 217 (271)
T 3kmu_A 144 VMIDEDMT--ARISMADVKFS----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM 217 (271)
T ss_dssp EEECTTSC--EEEEGGGSCCT----TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH
T ss_pred EEEcCCcc--eeEEeccceee----ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH
Confidence 99976654 88888877653 2223457899999999998765544 2599999999999999999999887664
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..... ........+.+..++.++.++|.+||..||.+|||+.++++.
T Consensus 218 ~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 218 EIGMK----VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHH----HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHH----HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 43332 222333344455689999999999999999999999999873
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=271.14 Aligned_cols=191 Identities=14% Similarity=0.161 Sum_probs=150.4
Q ss_pred hhceeee-ceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCC
Q 022732 13 MLGVSVK-MKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 87 (293)
Q Consensus 13 ~~~~~~~-~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~ 87 (293)
+++++.. ....|+|| ||+ +++|.+++... +.+. +++.++.||+.||.|||++|++||||||+|||++.++..+
T Consensus 122 ~~~~~~~~~~~~~lv~-e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~ 199 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVL-PSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ 199 (352)
T ss_dssp CCEEEEETTTEEEEEE-ECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEE
T ss_pred hhhccccCCcEEEEEe-cCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCce
Confidence 6667766 78899999 799 99999999875 4444 9999999999999999999999999999999998765336
Q ss_pred EEEecCCCCcCcCCCC--------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCC-chHHH
Q 022732 88 LKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-EPKDF 158 (293)
Q Consensus 88 vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~-~~~~~ 158 (293)
+||+|||+++...... ......||+.|+|||++.+..++. ++|||||||++|+|++|+.||.... ....+
T Consensus 200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 278 (352)
T 2jii_A 200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR-RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI 278 (352)
T ss_dssp EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCcccCCcCHHHH
Confidence 9999999997543221 123447999999999998877654 4999999999999999999998765 33334
Q ss_pred HHHHHHHhccccCCCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPD----TNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.............++. +..++.++.+||.+||..||.+|||+.++++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 279 MKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 4444333322222111 12468999999999999999999999998873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=272.40 Aligned_cols=194 Identities=20% Similarity=0.312 Sum_probs=160.0
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHHHHHHHHHHHHHHHHHHHHcCC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLVQARFFFQQLISGVSYCHAMQV 68 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~~~~~~~~qil~~l~~LH~~~i 68 (293)
+.|+|++++++++...+..|+|| ||+.+|+|.+++...+ ....+..++.||+.||.|||++|+
T Consensus 107 ~~h~~iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 185 (333)
T 2i1m_A 107 GQHENIVNLLGACTHGGPVLVIT-EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC 185 (333)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEE-ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCCCCeeeEEEEEecCCceEEEE-ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCc
Confidence 57999999999999999999999 7999999999997643 223889999999999999999999
Q ss_pred eecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-
Q 022732 69 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV- 144 (293)
Q Consensus 69 iHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~- 144 (293)
+||||||+||+++.++ .+||+|||+++....... .....||+.|+|||++.+..++. ++|||||||++|+|++
T Consensus 186 vH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~ 262 (333)
T 2i1m_A 186 IHRDVAARNVLLTNGH--VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV-QSDVWSYGILLWEIFSL 262 (333)
T ss_dssp ECSCCSGGGCEEEGGG--EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHTTT
T ss_pred ccCCcccceEEECCCC--eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCCh-HHHHHHHHHHHHHHHcC
Confidence 9999999999997655 599999999975433222 23345788999999998777754 4999999999999998
Q ss_pred CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|..||.+......+...... ....+.+..++..+.++|.+||..||.+|||+.+++++
T Consensus 263 g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 263 GLNPYPGILVNSKFYKLVKD----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp SCCSSTTCCSSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccchhHHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 99999887665544443332 22333444578999999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=267.98 Aligned_cols=197 Identities=20% Similarity=0.187 Sum_probs=154.5
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
++.|+|++++++++...+..|+|| ||+ +++|.+++... +.+. .++.++.||+.||.|||++||+||||||+|||+
T Consensus 61 l~~h~~i~~~~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill 138 (330)
T 2izr_A 61 LGSGDGIPQVYYFGPCGKYNAMVL-ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138 (330)
T ss_dssp HCSCTTSCCEEEEEEETTEEEEEE-ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hhCCCCCCEEEEEEecCCccEEEE-EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee
Confidence 357999999999999999999999 799 99999999864 3344 999999999999999999999999999999999
Q ss_pred cCCCC---CCEEEecCCCCcCcCCCCC--------CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC
Q 022732 81 DGSPA---PRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 149 (293)
Q Consensus 81 ~~~~~---~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 149 (293)
+.++. ..+||+|||+++....... .....||+.|+|||++.+..++. ++|||||||++|+|++|+.||
T Consensus 139 ~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~Pf 217 (330)
T 2izr_A 139 GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSR-RDDLEALGHMFMYFLRGSLPW 217 (330)
T ss_dssp CCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCc-hhHHHHHHHHHHHHhcCCCCc
Confidence 76542 2399999999985432221 24567999999999998877754 499999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhccccCCCC---CCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 150 EDPDEPKDFRKTIQRILSVQYSVPD---TNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.+...... ......+.......+. ...++ ++.++|.+||..||.+||++.++++
T Consensus 218 ~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 218 QGLKADTL-KERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp TTCCCSSH-HHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cccccccH-HHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 88543221 2222222211111111 11134 9999999999999999999988776
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=267.64 Aligned_cols=191 Identities=18% Similarity=0.165 Sum_probs=152.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.||+|.+++...+. +. .++.++.||+.||.|||++|++||||||+|||++.
T Consensus 70 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 148 (289)
T 4fvq_A 70 SHKHLVLNYGVCVCGDENILVQ-EFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIR 148 (289)
T ss_dssp CCTTBCCEEEEECCTTCCEEEE-ECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEE
T ss_pred CCCCEeEEEEEEEeCCCCEEEE-ECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEec
Confidence 5899999999999999999999 79999999999987653 33 88999999999999999999999999999999976
Q ss_pred CCCC------CEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 83 SPAP------RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~~~------~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++.. .+||+|||++.... ......||+.|+|||++.+....+.++||||+||++|+|++|..|+.......
T Consensus 149 ~~~~~~~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~ 225 (289)
T 4fvq_A 149 EEDRKTGNPPFIKLSDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225 (289)
T ss_dssp CCBGGGTBCCEEEECCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred CCcccccccceeeeccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence 5531 28999999986432 22334689999999999874444556999999999999999655444443332
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
....... ..... +...+.++.++|.+||..||.+|||+.+++++
T Consensus 226 ~~~~~~~----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 226 RKLQFYE----DRHQL--PAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHH----TTCCC--CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHhh----ccCCC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2222221 22222 33467899999999999999999999999997
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=271.40 Aligned_cols=192 Identities=20% Similarity=0.287 Sum_probs=156.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc------------------------CCHH--HHHHHHHHHHHH
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL------------------------GLLV--QARFFFQQLISG 59 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~------------------------~~~~--~~~~~~~qil~~ 59 (293)
.|+|++++++++...+..|+|| ||+.+|+|.+++... +.+. +++.++.||+.|
T Consensus 108 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~ 186 (343)
T 1luf_A 108 DNPNIVKLLGVCAVGKPMCLLF-EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186 (343)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHH
T ss_pred CCCCEEEEEEEEccCCceEEEE-ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHH
Confidence 6899999999999999999999 799999999999874 2233 889999999999
Q ss_pred HHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhh
Q 022732 60 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 136 (293)
Q Consensus 60 l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG 136 (293)
|.|||++|++||||||+||+++.++ .+||+|||+++..... .......+|+.|+|||++.+..++.+ +|+||||
T Consensus 187 l~~LH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG 263 (343)
T 1luf_A 187 MAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYG 263 (343)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHH
T ss_pred HHHHHhCCeecCCCCcceEEECCCC--eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHH
Confidence 9999999999999999999997654 5999999998743222 22334568999999999988777544 9999999
Q ss_pred hHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 137 VTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 137 ~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|++|+|++ |..||.+....... ..+.... ..+.+..++.++.++|.+||..||.+|||+.+++++
T Consensus 264 ~il~el~t~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 264 VVLWEIFSYGLQPYYGMAHEEVI----YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHH----HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCcCCCCChHHHH----HHHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99999999 99999887653332 2222222 223344589999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=263.72 Aligned_cols=196 Identities=20% Similarity=0.299 Sum_probs=146.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++ .....++|| ||+.|++|.+++.... .+. .+..++.||+.||.|||++|++||||||+||+++.
T Consensus 78 ~h~~iv~~~~~~-~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~ 155 (289)
T 3og7_A 78 RHVNILLFMGYS-TAPQLAIVT-QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE 155 (289)
T ss_dssp CCTTBCCEEEEE-CSSSCEEEE-ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred CCCcEEEEEeec-cCCccEEEE-EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 589999999955 566789999 7999999999996443 233 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC---CCCCCCCcCCCCccchhhhc---cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 83 SPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++ ++||+|||+++.... ........||+.|+|||++. +..+ +.++|||||||++|+|++|+.||.+.....
T Consensus 156 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~ 232 (289)
T 3og7_A 156 DN--TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRD 232 (289)
T ss_dssp TT--EEEECCCC------------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHH
T ss_pred CC--CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHH
Confidence 65 599999999875432 12223457999999999986 3344 445999999999999999999999877766
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+...................+++.+.+||.+||..||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 233 QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp HHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 55554443221111111233588999999999999999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=276.48 Aligned_cols=191 Identities=21% Similarity=0.319 Sum_probs=155.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-H--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-L--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.....+|+|| ||+.+|+|.+++...+. + ..+..++.||+.||+|||++|++||||||+|||++.
T Consensus 170 ~hpniv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~ 248 (377)
T 3cbl_A 170 SHPNIVRLIGVCTQKQPIYIVM-ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE 248 (377)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCCCEEEEEEEEecCCCcEEEE-EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcC
Confidence 6899999999999999999999 79999999999987542 3 389999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|||++ |..||.+.......
T Consensus 249 ~~--~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~ 325 (377)
T 3cbl_A 249 KN--VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTR 325 (377)
T ss_dssp TC--CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHH
T ss_pred CC--cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 54 59999999997532211 1112235678999999987776554 999999999999998 99999887653322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
. . .......+.+..++.++.++|.+||..||.+|||+.++++
T Consensus 326 ~----~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 326 E----F-VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp H----H-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H----H-HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1 1 1223344555568999999999999999999999999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=270.48 Aligned_cols=191 Identities=19% Similarity=0.317 Sum_probs=154.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.... .++|+ +|+.+|+|.+++.... .+. .++.++.||+.||.|||++||+||||||+|||++.
T Consensus 75 ~h~~iv~~~~~~~~~~-~~~v~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~ 152 (327)
T 3poz_A 75 DNPHVCRLLGICLTST-VQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152 (327)
T ss_dssp CBTTBCCEEEEEESSS-EEEEE-ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE
T ss_pred CCCCEeEEEEEEecCC-eEEEE-EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC
Confidence 5899999999999865 67778 6999999999998743 333 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ ++||+|||+++....... .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.......
T Consensus 153 ~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~ 229 (327)
T 3poz_A 153 PQ--HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS 229 (327)
T ss_dssp TT--EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred CC--CEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHH
Confidence 65 599999999975433222 223456889999999988777654 999999999999999 99999887654322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..+ ......+.+..++.++.+++.+||+.||.+|||+.+++++
T Consensus 230 -~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 230 -SIL----EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -HHH----HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -HHH----HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 222 2222344455689999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=268.16 Aligned_cols=195 Identities=22% Similarity=0.374 Sum_probs=158.5
Q ss_pred CCCCcchhhhhceeeece-eEEEeehhhccCchhHHHHHHcCC----------------HH--HHHHHHHHHHHHHHHHH
Q 022732 4 VGSSSSEYAMLGVSVKMK-FVFLSLSFFFSLCLFFMWLLLLGL----------------LV--QARFFFQQLISGVSYCH 64 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~-~~~lv~~ey~~gg~L~~~l~~~~~----------------~~--~~~~~~~qil~~l~~LH 64 (293)
+..|+|++++++++...+ ..|+|| ||+.|++|.+++..... +. .++.++.||+.||.|||
T Consensus 87 l~~hp~iv~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 165 (316)
T 2xir_A 87 IGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165 (316)
T ss_dssp HCCCTTBCCEEEEECCTTSCCEEEE-ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH
T ss_pred cccCCCeeeEEEEEecCCCceEEEE-EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH
Confidence 346899999999988764 588888 79999999999987653 33 89999999999999999
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHH
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 141 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e 141 (293)
++|++||||||+||+++.++ ++||+|||+++....... .....||+.|+|||++.+..++.+ +|+|||||++|+
T Consensus 166 ~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~ 242 (316)
T 2xir_A 166 SRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWE 242 (316)
T ss_dssp HTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHH
T ss_pred hCCcccccCccceEEECCCC--CEEECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHH
Confidence 99999999999999997654 599999999975433222 123457889999999988777544 999999999999
Q ss_pred HHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 142 MLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 142 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|++ |..||.+......+...+.. ....+.+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 243 l~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 243 IFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCcccchhHHHHHHhcc----CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 998 99999887654443333322 12233344589999999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=268.20 Aligned_cols=199 Identities=22% Similarity=0.332 Sum_probs=150.2
Q ss_pred CCCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHH--------HcCCeec
Q 022732 5 GSSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCH--------AMQVCHR 71 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH--------~~~iiHr 71 (293)
-.|+|++++++++.. ....|+|| ||+.+|+|.++++....-. .+..++.||+.||.||| ++|++||
T Consensus 59 l~h~niv~~~~~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 137 (301)
T 3q4u_A 59 LRHENILGFIASDMTSRHSSTQLWLIT-HYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137 (301)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEE-CCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS
T ss_pred ccCcCeeeEEEeeccccCCCceeEEeh-hhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC
Confidence 469999999999655 46789999 7999999999996543222 89999999999999999 9999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC-----CCCCcCCCCccchhhhccccCC-----CchhhhhhhhhHHHH
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYV 141 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwslG~il~e 141 (293)
||||+|||++.++ ++||+|||+++....... .....||+.|+|||++.+.... +.++||||+||++|+
T Consensus 138 Dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~e 215 (301)
T 3q4u_A 138 DLKSKNILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215 (301)
T ss_dssp CCCGGGEEECTTS--CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred CCChHhEEEcCCC--CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHH
Confidence 9999999997655 599999999864322221 2345799999999999775321 245999999999999
Q ss_pred HHhC----------CCCCCCCCchHHHHHHHHHHhccccCCCCC------CCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 142 MLVG----------GYPFEDPDEPKDFRKTIQRILSVQYSVPDT------NPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 142 l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|++| ..||.......................+.. ...+..+.+||.+||..||.+|||+.++++
T Consensus 216 l~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 216 VARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 9999 888866433221122222222222111111 124578999999999999999999999986
Q ss_pred C
Q 022732 206 H 206 (293)
Q Consensus 206 h 206 (293)
.
T Consensus 296 ~ 296 (301)
T 3q4u_A 296 T 296 (301)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=266.17 Aligned_cols=192 Identities=19% Similarity=0.287 Sum_probs=157.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC------------CHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG------------LLVQARFFFQQLISGVSYCHAMQVCHRDL 73 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~------------~~~~~~~~~~qil~~l~~LH~~~iiHrdl 73 (293)
.|+|++++++++...+..|+|| ||+.+|+|.+++...+ ....+..++.||+.||.|||++|++||||
T Consensus 86 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di 164 (322)
T 1p4o_A 86 NCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 164 (322)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred CCCCEeeeEEEEccCCccEEEE-EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 5899999999999999999999 7999999999997643 33489999999999999999999999999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCC
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPF 149 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf 149 (293)
||+||+++.++ ++||+|||+++...... ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||
T Consensus 165 kp~NIli~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~ 241 (322)
T 1p4o_A 165 AARNCMVAEDF--TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPY 241 (322)
T ss_dssp SGGGEEECTTC--CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTSCCTT
T ss_pred ccceEEEcCCC--eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCc-hhhHHHHHHHHHHHHhcCCCcc
Confidence 99999997654 59999999997543222 122345788999999998777654 4999999999999999 89999
Q ss_pred CCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 150 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+........ .+.... ..+.+..++..+.++|.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~----~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 242 QGLSNEQVLR----FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTSCHHHHHH----HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHH----HHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8876533322 222222 223345589999999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=268.06 Aligned_cols=193 Identities=21% Similarity=0.311 Sum_probs=158.3
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC----------------HH--HHHHHHHHHHHHHHHHHHc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL----------------LV--QARFFFQQLISGVSYCHAM 66 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~----------------~~--~~~~~~~qil~~l~~LH~~ 66 (293)
+.|+|++++++++...+..|+|| ||+.+|+|.+++..... +. .++.++.||+.||.|||++
T Consensus 98 ~~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 176 (334)
T 2pvf_A 98 GKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176 (334)
T ss_dssp CCCTTBCCEEEEECSSSCCEEEE-ECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hcCCCEeeEEEEEccCCceEEEE-ECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 47999999999999999999999 79999999999987542 22 8899999999999999999
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHH
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 143 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 143 (293)
|++||||||+||+++.++ .+||+|||+++...... ......+|+.|+|||++.+..++.+ +|||||||++|+|+
T Consensus 177 ~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell 253 (334)
T 2pvf_A 177 KCIHRDLAARNVLVTENN--VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIF 253 (334)
T ss_dssp TEECSCCSGGGEEECTTC--CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHH
T ss_pred CeeCCCCccceEEEcCCC--CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHH
Confidence 999999999999997654 59999999997543322 2233457889999999987776544 99999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 144 V-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 144 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+ |..||.+.........+. .. ...+.+..++.++.++|.+||..||.+|||+.+++++
T Consensus 254 t~g~~p~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 254 TLGGSPYPGIPVEELFKLLK----EG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TTSCCSSTTCCHHHHHHHHH----HT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCcCcCCHHHHHHHHh----cC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9 999998876533322221 11 2233345589999999999999999999999999885
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=277.34 Aligned_cols=189 Identities=22% Similarity=0.312 Sum_probs=155.3
Q ss_pred CCcchhhhhceeeece-eEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMK-FVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~-~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++.... .+|+|| ||+.+|+|.+++++.+. +. .+..++.||+.||.|||++|++||||||+|||+
T Consensus 244 ~h~niv~~~~~~~~~~~~~~iv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill 322 (450)
T 1k9a_A 244 RHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 322 (450)
T ss_dssp CCTTBCCEEEEEECTTSCEEEEE-ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred cCCCEEEEEEEEEcCCCceEEEE-EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE
Confidence 5899999999987765 799999 79999999999988754 23 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
+.++ .+||+|||+++..... .....+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+........
T Consensus 323 ~~~~--~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 397 (450)
T 1k9a_A 323 SEDN--VAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397 (450)
T ss_dssp CTTS--CEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred CCCC--CEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 7654 5999999999853322 233467899999999988777655 999999999999998 999998876644333
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.+. .....+.+..+++++.++|.+||..||.+|||+.++++
T Consensus 398 ~i~-----~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 398 RVE-----KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHH-----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 222 22344455668999999999999999999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=272.44 Aligned_cols=191 Identities=19% Similarity=0.302 Sum_probs=147.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+|+|.+++...+ .+. ++..++.||+.||.|||++|++||||||+|||++.
T Consensus 104 ~h~niv~~~~~~~~~~~~~lv~-e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 182 (373)
T 2qol_A 104 DHPNIIRLEGVVTKSKPVMIVT-EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182 (373)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCCCCCeEEEEEeeCCceEEEE-eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC
Confidence 5899999999999999999999 7999999999998754 343 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .+||+|||+++....... .....+++.|+|||++.+..++.+ +|||||||++|++++ |+.||........
T Consensus 183 ~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~ 259 (373)
T 2qol_A 183 NL--VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDV 259 (373)
T ss_dssp TC--CEEECCC----------------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHH
T ss_pred CC--CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 54 599999999975433221 112235778999999988777655 999999999999998 9999988765433
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
... +. .....+.+..++..+.++|.+||..||.+||++.++++
T Consensus 260 ~~~----i~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 260 IKA----VD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHH----HH-TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH----HH-cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 222 22 22334445568899999999999999999999999887
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=269.31 Aligned_cols=198 Identities=18% Similarity=0.195 Sum_probs=150.0
Q ss_pred CCcchhhhhceeeece----eEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHc----------CCee
Q 022732 6 SSSSEYAMLGVSVKMK----FVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAM----------QVCH 70 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~----~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~----------~iiH 70 (293)
.|+|++++++++.... .+|+|| ||+.+|+|.+++.....-. .++.++.||+.||.|||++ |++|
T Consensus 76 ~hpniv~~~~~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH 154 (322)
T 3soc_A 76 KHENILQFIGAEKRGTSVDVDLWLIT-AFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154 (322)
T ss_dssp CCTTBCCEEEEEEEECSSSEEEEEEE-ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEEC
T ss_pred CCCCchhhcceeccCCCCCceEEEEE-ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEe
Confidence 5899999999999854 479999 7999999999998765322 8999999999999999999 9999
Q ss_pred cCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhcccc----CCCchhhhhhhhhHHHHHH
Q 022732 71 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVML 143 (293)
Q Consensus 71 rdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~il~el~ 143 (293)
|||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+.. ..+.++|||||||++|+|+
T Consensus 155 ~Dlkp~Nill~~~~--~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~ 232 (322)
T 3soc_A 155 RDIKSKNVLLKNNL--TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232 (322)
T ss_dssp SCCSGGGEEECTTC--CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCChHhEEECCCC--eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHH
Confidence 99999999997654 59999999997543322 233467999999999987632 2234589999999999999
Q ss_pred hCCCCCCCCCchH------------HHHHHHHHHhccccCCCCC-----CCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 144 VGGYPFEDPDEPK------------DFRKTIQRILSVQYSVPDT-----NPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 144 ~g~~pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+|+.||.+..... ................... ...+.++.+||.+||..||.+|||+.++++.
T Consensus 233 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 233 SRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp TTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999997653211 1111222222221111111 1124569999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=262.88 Aligned_cols=197 Identities=19% Similarity=0.253 Sum_probs=152.0
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++... .++|+|| ||+.+|+|.+++...+. +. .+..++.||+.||.|||++|++||||||+||++
T Consensus 69 ~h~~iv~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~ 147 (295)
T 3ugc_A 69 QHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147 (295)
T ss_dssp CCTTBCCEEEEECHHHHTSCEEEE-ECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCCEeeEEEEEecCCCCceEEEE-EeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE
Confidence 589999999998654 5689999 79999999999987542 33 899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch-
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP- 155 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~- 155 (293)
+.++ ++||+|||+++...... ......+++.|+|||++.+..++.+ +||||+||++|+|++|..||......
T Consensus 148 ~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~ 224 (295)
T 3ugc_A 148 ENEN--RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEF 224 (295)
T ss_dssp EETT--EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHH
T ss_pred cCCC--eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHH
Confidence 7665 59999999998643322 1223457778999999988777554 99999999999999999998653211
Q ss_pred ----------HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 156 ----------KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 156 ----------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.................+.+..+++++.++|.+||..||.+|||+.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 225 MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 001111112222333445566789999999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=260.92 Aligned_cols=190 Identities=20% Similarity=0.237 Sum_probs=154.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++ ..+..|+|| ||+.+++|.+++...+.+. .++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 76 ~h~~i~~~~~~~-~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~ 153 (291)
T 1xbb_A 76 DNPYIVRMIGIC-EAESWMLVM-EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 153 (291)
T ss_dssp CCTTBCCEEEEE-ESSSEEEEE-ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CCCCEEEEEEEE-CCCCcEEEE-EeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC
Confidence 589999999999 567788999 7999999999999877655 899999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
+ .+||+|||+++....... .....+++.|+|||++.+..++. ++|+|||||++|+|++ |+.||.+.......
T Consensus 154 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 230 (291)
T 1xbb_A 154 H--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230 (291)
T ss_dssp T--EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred C--cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCCh-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 5 599999999975433221 12234678899999998777654 4999999999999999 99999887653322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..+.. ....+.+..++..+.++|.+||..||.+|||+.++++
T Consensus 231 ----~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 231 ----AMLEK-GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----HHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22222 2223334568999999999999999999999999886
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=267.77 Aligned_cols=199 Identities=17% Similarity=0.249 Sum_probs=161.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-------HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-------LV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-------~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
.|+|++++++++......|+|| ||+.|++|.+++..... +. .++.++.||+.||.|||++|++||||||+
T Consensus 91 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~ 169 (327)
T 2yfx_A 91 NHQNIVRCIGVSLQSLPRFILM-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAAR 169 (327)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCCCCCeEEEEEcCCCCcEEEE-ecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHh
Confidence 6899999999999999999999 79999999999987642 22 89999999999999999999999999999
Q ss_pred cEEEcCCC-CCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCC
Q 022732 77 NTLLDGSP-APRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFED 151 (293)
Q Consensus 77 NIl~~~~~-~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~ 151 (293)
|||++.++ ...+||+|||+++..... .......||+.|+|||++.+..++. ++|||||||++|+|++ |..||..
T Consensus 170 NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~ 248 (327)
T 2yfx_A 170 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPS 248 (327)
T ss_dssp GEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred HEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99997543 346999999998643221 2233456899999999998777654 4999999999999998 9999987
Q ss_pred CCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 152 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
....... ..+... ...+.+..++..+.++|.+||..||.+|||+.+++++.|+..
T Consensus 249 ~~~~~~~----~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 249 KSNQEVL----EFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCHHHHH----HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHH----HHHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 7653322 222222 223334558999999999999999999999999999988643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=266.67 Aligned_cols=191 Identities=19% Similarity=0.315 Sum_probs=150.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.... .++|+ +|+.+|+|.+++.... .+. .++.++.||+.||.|||++|++||||||+|||++.
T Consensus 75 ~hp~iv~~~~~~~~~~-~~~v~-~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 152 (327)
T 3lzb_A 75 DNPHVCRLLGICLTST-VQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152 (327)
T ss_dssp CBTTBCCCCEEEESSS-EEEEE-CCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE
T ss_pred CCCCeeEEEEEEecCC-ceEEE-EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcC
Confidence 5899999999999866 67778 6999999999998743 343 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ ++||+|||+++....... .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.......
T Consensus 153 ~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~ 229 (327)
T 3lzb_A 153 PQ--HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS 229 (327)
T ss_dssp TT--EEEECCTTC----------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred CC--CEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 55 599999999975433222 223456889999999988777554 999999999999999 99999887664432
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. + ......+.+..++.++.++|.+||..||.+|||+.++++.
T Consensus 230 ~~-~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 230 SI-L----EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HH-H----HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH-H----HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22 2 2223344455689999999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=260.26 Aligned_cols=193 Identities=22% Similarity=0.317 Sum_probs=158.2
Q ss_pred CCcchhhhhceeee----------------ceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHH
Q 022732 6 SSSSEYAMLGVSVK----------------MKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHA 65 (293)
Q Consensus 6 ~~~~~v~~~~~~~~----------------~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~ 65 (293)
.|+|++++++++.. ...+|+|| ||+.+++|.+++... ..+. .++.++.||+.||.|||+
T Consensus 62 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 140 (284)
T 2a19_B 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM-EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS 140 (284)
T ss_dssp CCTTBCCEEEEEEEEEEC---------CCEEEEEEEEE-CCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCEEEEeeeEeccccCcccccccccccCcceEEEEE-eccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 58999999999865 56689999 799999999999765 3333 899999999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhC
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 145 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 145 (293)
+|++||||||+||+++.++ .+||+|||++.............||+.|+|||++.+..++.+ +|+|||||++|+|++|
T Consensus 141 ~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~ 217 (284)
T 2a19_B 141 KKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHV 217 (284)
T ss_dssp TTEECSCCSGGGEEEEETT--EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSC
T ss_pred CCeeeccCCHHHEEEcCCC--CEEECcchhheeccccccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhc
Confidence 9999999999999997655 599999999986655555556679999999999988776554 9999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 146 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 146 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
..||... ......+.... . +..++..+.++|.+||..||.+|||+.+++++.+..+.
T Consensus 218 ~~~~~~~------~~~~~~~~~~~--~--~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 218 CDTAFET------SKFFTDLRDGI--I--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp CSSHHHH------HHHHHHHHTTC--C--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred CCcchhH------HHHHHHhhccc--c--cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 9887531 12222222221 1 23478999999999999999999999999999886543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=265.04 Aligned_cols=192 Identities=20% Similarity=0.310 Sum_probs=152.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++... +.+. +++.++.||+.||.|||++|++||||||+||+++.
T Consensus 104 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 182 (333)
T 1mqb_A 104 SHHNIIRLEGVISKYKPMMIIT-EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 182 (333)
T ss_dssp CCTTBCCEEEEECSSSSEEEEE-ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCCCCCcEEEEEecCCCcEEEE-eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECC
Confidence 5899999999999999999999 799999999999875 3343 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .+||+|||+++....... .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+......
T Consensus 183 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~ 259 (333)
T 1mqb_A 183 NL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEV 259 (333)
T ss_dssp TC--CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CC--cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 54 599999999975432211 122346788999999987777554 999999999999998 9999987765333
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
. ..+.. ....+.+..++..+.++|.+||..||.+||++.+++++
T Consensus 260 ~----~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 260 M----KAIND-GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp H----HHHHT-TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred H----HHHHC-CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 22222 22344455689999999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=261.68 Aligned_cols=195 Identities=21% Similarity=0.281 Sum_probs=154.8
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++... +.+|+|| ||+.+++|.+++... +.+. .++.++.|++.||.|||++|++||||||+||++
T Consensus 81 ~h~~i~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~ 159 (302)
T 4e5w_A 81 YHENIVKYKGICTEDGGNGIKLIM-EFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 159 (302)
T ss_dssp CCTTBCCEEEEEEC---CCEEEEE-ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCeeeeeeEEecCCCceEEEEE-EeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE
Confidence 589999999999887 7789999 799999999999654 3343 899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCC---
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--- 153 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~--- 153 (293)
+.++ ++||+|||+++...... ......||+.|+|||++.+..++.+ +|+||+||++|+|++|..|+....
T Consensus 160 ~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~ 236 (302)
T 4e5w_A 160 ESEH--QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALF 236 (302)
T ss_dssp EETT--EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred cCCC--CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHH
Confidence 7665 59999999997654332 2334568889999999988777544 999999999999999998864321
Q ss_pred --------chHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 154 --------EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 154 --------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
........... .......+.+..+++.+.++|.+||..||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 237 LKMIGPTHGQMTVTRLVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHCSCCGGGHHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hhccCCcccccCHHHHHHH-HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11111222222 2233344555668999999999999999999999999886
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=256.89 Aligned_cols=192 Identities=20% Similarity=0.331 Sum_probs=157.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.... .+. .+..++.|++.||.|||++|++||||||+||+++.
T Consensus 61 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~ 139 (267)
T 3t9t_A 61 SHPKLVQLYGVCLEQAPICLVT-EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 139 (267)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG
T ss_pred CCCCEeeEEEEEccCCCeEEEE-eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC
Confidence 5899999999999999999999 7999999999998763 233 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC--CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||+++..... .......+++.|+|||++.+..++. ++|+||+||++|+|++ |+.||..........
T Consensus 140 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 216 (267)
T 3t9t_A 140 NQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 216 (267)
T ss_dssp GG--CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CC--CEEEcccccccccccccccccccccccccccChhhhcCCCccc-hhchhhhHHHHHHHhccCCCCCCCCCHHHHHH
Confidence 54 5999999998754221 1223445788999999998777654 5999999999999999 899998876543332
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+... .....+..++..+.+++.+||..||.+|||+.+++++
T Consensus 217 ----~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 217 ----DISTG-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ----HHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----HHhcC-CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22222 2223344578999999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=259.11 Aligned_cols=192 Identities=20% Similarity=0.312 Sum_probs=158.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++..... +. .++.++.||+.||.|||++|++||||||+||+++
T Consensus 67 ~h~~i~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 145 (288)
T 3kfa_A 67 KHPNLVQLLGVCTREPPFYIIT-EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 145 (288)
T ss_dssp CCTTBCCEEEEECSSSSEEEEE-ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC
T ss_pred CCCCEeeEEEEEccCCCEEEEE-EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc
Confidence 4899999999999999999999 79999999999987543 33 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||++........ .....+|+.|+|||++.+..++.+ +|+|||||++|+|++ |..||.+.......
T Consensus 146 ~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~ 222 (288)
T 3kfa_A 146 ENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222 (288)
T ss_dssp GGG--CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCC--CEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 654 599999999975433221 123356889999999988777544 999999999999999 99999887654432
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..+. .....+.+..+++.+.+||.+||..||.+|||+.++++.
T Consensus 223 ~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 223 ELLE-----KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHH-----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHh-----ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 2221 223334455689999999999999999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=262.84 Aligned_cols=193 Identities=21% Similarity=0.263 Sum_probs=147.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|++++++++...+..|+|+ ||+.|++|.+++...+.+. +++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 92 ~hp~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~ 170 (309)
T 2h34_A 92 QEPHVVPIHDFGEIDGQLYVDM-RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD 170 (309)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CCCCeeEEEEEEeeCCeEEEEE-EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC
Confidence 5899999999999999999999 7999999999998877655 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
+ .+||+|||++....... ......||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.... .+...
T Consensus 171 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~ 246 (309)
T 2h34_A 171 D--FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS-VMGAH 246 (309)
T ss_dssp S--CEEECSCCC----------------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHH
T ss_pred C--CEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHHHH
Confidence 4 59999999987543322 2234579999999999987776555 99999999999999999999875432 22222
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-CHHHHHc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-TIPEIMK 205 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-t~~ell~ 205 (293)
+.... .........++.++.++|.+||..||.+|| +++++++
T Consensus 247 ~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 247 INQAI--PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHSCC--CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred hccCC--CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 21111 111122345889999999999999999999 7887776
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=258.49 Aligned_cols=191 Identities=17% Similarity=0.265 Sum_probs=153.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++... ..|+|| ||+.+++|.+++...+. +. .+..++.||+.||.|||++|++||||||+||+++.
T Consensus 71 ~h~~i~~~~~~~~~~-~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~ 148 (281)
T 3cc6_A 71 DHPHIVKLIGIIEEE-PTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS 148 (281)
T ss_dssp CCTTBCCEEEEECSS-SCEEEE-ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE
T ss_pred CCCCcceEEEEEcCC-CCEEEE-ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC
Confidence 589999999998754 568899 79999999999977542 33 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||+++...... ......+|+.|+|||++.+..++. ++|+|||||++|+|++ |+.||..........
T Consensus 149 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~llt~g~~p~~~~~~~~~~~ 225 (281)
T 3cc6_A 149 PE--CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT-ASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 225 (281)
T ss_dssp TT--EEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH
T ss_pred CC--cEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCc-hhccHHHHHHHHHHHhCCCCCcccCChHHHHH
Confidence 55 59999999987543322 123345788999999998777654 4999999999999998 999998766644332
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+.. ....+.+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 226 ~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 226 VLEK-----GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHH-----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhc-----CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 2221 12234445589999999999999999999999999885
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=259.24 Aligned_cols=193 Identities=21% Similarity=0.266 Sum_probs=156.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++ ..+..|+|| ||+.+++|.+++.... .++ .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 68 ~h~~i~~~~~~~-~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 145 (287)
T 1u59_A 68 DNPYIVRLIGVC-QAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 145 (287)
T ss_dssp CCTTBCCEEEEE-ESSSEEEEE-ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE
T ss_pred CCCCEeEEEEEe-cCCCcEEEE-EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcC
Confidence 589999999999 556789999 7999999999996543 233 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .+||+|||+++...... ......+|+.|+|||++.+..++.+ +|+|||||++|+|++ |+.||........
T Consensus 146 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~ 222 (287)
T 1u59_A 146 RH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEV 222 (287)
T ss_dssp TT--EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHH
T ss_pred CC--CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 55 59999999997543222 1233457899999999987776554 999999999999998 9999988776443
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
... +... ...+.+..+++++.++|.+||..||.+|||+.+++++.+
T Consensus 223 ~~~----i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 223 MAF----IEQG-KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHH----HHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHH----HhcC-CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 322 2222 223334568999999999999999999999999998754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.11 Aligned_cols=185 Identities=26% Similarity=0.467 Sum_probs=143.5
Q ss_pred CCCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 5 GSSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
..|+|++++++++.. ..+.|+|| ||+.||+|.+++...+ .++ .++.++.||+.||.|||++|++||||||+
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~ 146 (299)
T 3m2w_A 68 SQCPHIVRIVDVYENLYAGRKCLLIVM-ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 146 (299)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEE-CCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ccCCCchhHHhhhhhhcCCCceEEEEE-eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 478999999999988 88899999 7999999999998865 343 99999999999999999999999999999
Q ss_pred cEEEcCCC-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 77 NTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 77 NIl~~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
||+++... .+.+||+|||++.... +..+ +.++||||+||++|+|++|+.||.+....
T Consensus 147 Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~ 204 (299)
T 3m2w_A 147 NLLYTSKRPNAILKLTDFGFAKETT---------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGL 204 (299)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECT---------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred HEEEecCCCCCcEEEeccccccccc---------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence 99998632 3569999999986421 1233 34499999999999999999999775432
Q ss_pred HHHHHHHHHHhccccCCCC--CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 156 KDFRKTIQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.........+.......+. ...++.++.+||.+||..||.+|||+.++++||||++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 205 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp ---CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred hhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 2111111111111111111 13579999999999999999999999999999999754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=277.18 Aligned_cols=190 Identities=22% Similarity=0.311 Sum_probs=155.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++. ...+|+|| ||+.+|+|.++++... ....+..++.||+.||.|||++|++||||||+|||++
T Consensus 241 ~h~~iv~l~~~~~-~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~ 318 (454)
T 1qcf_A 241 QHDKLVKLHAVVT-KEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 318 (454)
T ss_dssp CCTTBCCEEEEEC-SSSCEEEE-CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC
T ss_pred CCCCEeeEEEEEe-CCccEEEE-eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC
Confidence 5899999999987 66789999 7999999999997542 2338899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCC--CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||+++..... .......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.......
T Consensus 319 ~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~ 395 (454)
T 1qcf_A 319 ASL--VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395 (454)
T ss_dssp TTC--CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCC--cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 654 5999999999854321 11233456789999999987777554 999999999999999 99999987764443
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..+. .....+.+..+++++.++|.+||..||.+|||+.+++.
T Consensus 396 ~~i~-----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 396 RALE-----RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHH-----HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH-----cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 3322 22344555668999999999999999999999999876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=262.07 Aligned_cols=193 Identities=18% Similarity=0.242 Sum_probs=153.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+..|+|| ||+.|++|.+++...+ .+. .++.++.||+.||.|||++|++||||||+||+++.
T Consensus 87 ~h~~iv~~~~~~~~~~~~~iv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~ 165 (319)
T 2y4i_B 87 RHENVVLFMGACMSPPHLAIIT-SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN 165 (319)
T ss_dssp CCTTBCCCCEEEECSSCEEEEC-BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-
T ss_pred CCCCEeEEEEEEecCCceEEEe-ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC
Confidence 5899999999999999999999 7999999999998755 344 99999999999999999999999999999999973
Q ss_pred CCCCCEEEecCCCCcCcCC------CCCCCCCcCCCCccchhhhccc--------cCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 83 SPAPRLKICDFGYSKSSVL------HSQPKSTVGTPAYIAPEVLLRH--------EYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DvwslG~il~el~~g~~p 148 (293)
+.+||+|||+++.... ........||+.|+|||++.+. ...+.++|||||||++|+|++|+.|
T Consensus 166 ---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 242 (319)
T 2y4i_B 166 ---GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242 (319)
T ss_dssp ----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ---CCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 3599999999864321 1222344689999999998752 2234559999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|......... ..+............++.++.++|.+||..||.+|||+.++++.
T Consensus 243 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 243 FKTQPAEAII----WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp SSSCCHHHHH----HHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCCHHHHH----HHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9887654332 22222222222233578999999999999999999999999884
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=269.48 Aligned_cols=192 Identities=17% Similarity=0.246 Sum_probs=146.3
Q ss_pred CCcchhhhhceee-eceeEEEeehhhccCchhHHHHHHcCC-H--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSV-KMKFVFLSLSFFFSLCLFFMWLLLLGL-L--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~-~~~~~~lv~~ey~~gg~L~~~l~~~~~-~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++. ..+..|+|| ||+.+|+|.+++...+. + ..+..++.||+.||.|||++|++||||||+|||++
T Consensus 148 ~hpnIv~~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 226 (373)
T 3c1x_A 148 SHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 226 (373)
T ss_dssp CCTTBCCCCEEECCCSSCCEEEE-ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCCcceEEEEEEcCCCCeEEEE-ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC
Confidence 5999999999865 456889999 79999999999986543 2 28899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC-----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCch
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~ 155 (293)
.++ .+||+|||+++...... ......+|+.|+|||++.+..++. ++|||||||++|+|++ |.+||.+....
T Consensus 227 ~~~--~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 227 EKF--TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp TTC--CEEECCC---------------------CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred CCC--CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCc-HHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 654 59999999997543221 122345788999999998877755 4999999999999999 77888776654
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.....+. .. ...+.+..++..+.++|.+||..||.+|||+.+++++
T Consensus 304 ~~~~~~~----~~-~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 304 DITVYLL----QG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CHHHHHH----TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHH----cC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4332222 22 1223344589999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=279.09 Aligned_cols=192 Identities=20% Similarity=0.322 Sum_probs=158.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++.....+|+|| ||+.+|+|.++++..+. +. .+..++.||+.||.|||++||+||||||+|||++
T Consensus 274 ~hpniv~l~~~~~~~~~~~lv~-E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 352 (495)
T 1opk_A 274 KHPNLVQLLGVCTREPPFYIIT-EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 352 (495)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CCCCEeeEEEEEecCCcEEEEE-EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC
Confidence 5899999999999999999999 79999999999987533 33 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+.....
T Consensus 353 ~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~ 429 (495)
T 1opk_A 353 ENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429 (495)
T ss_dssp GGG--CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCC--cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 654 59999999998643221 1223446788999999988777555 999999999999999 99999887754433
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. + ......+.+..++..+.+||.+||+.||.+|||+.++++.
T Consensus 430 ~~-~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 430 EL-L----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp HH-H----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH-H----HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 22 1 2233444555689999999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=259.81 Aligned_cols=192 Identities=20% Similarity=0.288 Sum_probs=155.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CH--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LL--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++...+ .++|+ ||+.+++|.+++.... .+ ..+..++.||+.||.|||++|++||||||+||+++.
T Consensus 79 ~h~~i~~~~~~~~~~~-~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~ 156 (291)
T 1u46_A 79 DHRNLIRLYGVVLTPP-MKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT 156 (291)
T ss_dssp CCTTBCCEEEEECSSS-CEEEE-ECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE
T ss_pred CCCCcccEEEEEccCC-ceeeE-ecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcC
Confidence 5899999999998876 88899 7999999999998753 23 389999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .+||+|||+++....... .....+|+.|+|||++.+..++. ++|+|||||++|+|++ |+.||.+.....
T Consensus 157 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~- 232 (291)
T 1u46_A 157 RD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQ- 232 (291)
T ss_dssp TT--EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHH-
T ss_pred CC--CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccCCHHH-
Confidence 55 599999999875433221 22345788999999998777654 4999999999999999 999998876533
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
....+.......+....++.++.++|.+||..||.+|||+.+++++
T Consensus 233 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 233 ---ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp ---HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 3333434444455556789999999999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=257.16 Aligned_cols=193 Identities=23% Similarity=0.316 Sum_probs=153.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~--iiHrdlkp~NIl~ 80 (293)
.|+|++++++++.+.. ++|| ||+.+|+|.+++.... .+. .++.++.|++.||.|||++| ++||||||+||++
T Consensus 81 ~h~~i~~~~~~~~~~~--~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~ 157 (287)
T 4f0f_A 81 NHPNIVKLYGLMHNPP--RMVM-EFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL 157 (287)
T ss_dssp CCTTBCCEEEEETTTT--EEEE-ECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEE
T ss_pred CCCCchhhheeecCCC--eEEE-EecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEE
Confidence 5899999999998766 6888 7999999999987654 233 89999999999999999999 9999999999999
Q ss_pred cCCCC---CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc--ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 81 DGSPA---PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 81 ~~~~~---~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
+.++. ..+||+|||+++... .......||+.|+|||++.+ ..+ +.++||||+||++|+|++|+.||......
T Consensus 158 ~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 158 QSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp SCCCTTCSCCEEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred eccCCCCceeEEeCCCCcccccc--ccccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 75432 238999999997432 23345679999999999843 333 44599999999999999999999876543
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. .....+.........+..+++.+.++|.+||..||.+|||+.++++.
T Consensus 235 ~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 235 KI--KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp HH--HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH--HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 32 11222223333334455689999999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=272.22 Aligned_cols=199 Identities=20% Similarity=0.192 Sum_probs=154.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----CH--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----LL--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----~~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++...+..|+|| ||+.+|+|.+++.... .+ .+++.++.||+.||.|||++|++||||||+||+
T Consensus 93 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil 171 (321)
T 2qkw_B 93 RHPHLVSLIGFCDERNEMILIY-KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINIL 171 (321)
T ss_dssp CCTTBCCEEEECCCTTCCEEEE-ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEE
T ss_pred CCCCEeeEEEEEcCCCeEEEEE-EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEE
Confidence 5899999999999999999999 7999999999996543 23 289999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++.++ .+||+|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.....
T Consensus 172 ~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~ 248 (321)
T 2qkw_B 172 LDENF--VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPRE 248 (321)
T ss_dssp ECTTC--CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSS
T ss_pred ECCCC--CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHH
Confidence 97654 59999999997533221 2233468999999999988777655 999999999999999999997654321
Q ss_pred H---HHHHHHHHhcccc--------CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 157 D---FRKTIQRILSVQY--------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 157 ~---~~~~~~~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
. ............. ........+..+.+++.+||..||.+|||+.+++++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 1111111111110 00111224577899999999999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=261.15 Aligned_cols=192 Identities=22% Similarity=0.326 Sum_probs=148.4
Q ss_pred CCcchhhhhceeeecee-----EEEeehhhccCchhHHHHHHc------CCHH--HHHHHHHHHHHHHHHHHHcCCeecC
Q 022732 6 SSSSEYAMLGVSVKMKF-----VFLSLSFFFSLCLFFMWLLLL------GLLV--QARFFFQQLISGVSYCHAMQVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~-----~~lv~~ey~~gg~L~~~l~~~------~~~~--~~~~~~~qil~~l~~LH~~~iiHrd 72 (293)
.|+|++++++++..... .|+|| ||+.+++|..++... +.++ .++.++.||+.||.|||++|++|||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~d 172 (313)
T 3brb_A 94 SHPNVIRLLGVCIEMSSQGIPKPMVIL-PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRD 172 (313)
T ss_dssp CCTTBCCCCEEEEC-------CEEEEE-ECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCC
T ss_pred CCCCeeeeeEEEeeccccCCcccEEEE-ecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 48999999999987653 58999 799999999999542 2233 8999999999999999999999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCC---CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYP 148 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p 148 (293)
|||+||+++.++ .+||+|||+++...... ......+++.|+|||++.+..++.+ +|+|||||++|+|++ |..|
T Consensus 173 ikp~NIli~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p 249 (313)
T 3brb_A 173 LAARNCMLRDDM--TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTP 249 (313)
T ss_dssp CSGGGEEECTTS--CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCS
T ss_pred CCcceEEEcCCC--cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCC
Confidence 999999997654 59999999997543321 2233457889999999987776554 999999999999999 8999
Q ss_pred CCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 149 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|.+.........+. .. ...+.+..++..+.++|.+||..||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 250 YPGVQNHEMYDYLL----HG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp STTCCGGGHHHHHH----TT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHH----cC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98877654333322 21 2233345589999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=257.99 Aligned_cols=192 Identities=22% Similarity=0.328 Sum_probs=152.3
Q ss_pred CCcchhhhhceeeeceeE-EEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFV-FLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~-~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++...+.. |+|| ||+.+|+|.+++...+ .+. .++.++.|++.||.|||++|++||||||+||+++
T Consensus 80 ~h~~iv~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~ 158 (298)
T 3pls_A 80 NHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD 158 (298)
T ss_dssp CCTTBCCCCEEECCSSSCCEEEE-CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCCeeeEEEEEecCCCCcEEEE-ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence 589999999999877666 8888 7999999999998743 233 8899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCC-----CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCC-CCCCCch
Q 022732 82 GSPAPRLKICDFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPDEP 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p-f~~~~~~ 155 (293)
.++ .+||+|||+++.... ........+|+.|+|||.+.+..++.+ +|+||+||++|+|++|..| |...+.
T Consensus 159 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~- 234 (298)
T 3pls_A 159 ESF--TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDP- 234 (298)
T ss_dssp TTC--CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCG-
T ss_pred CCC--cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCH-
Confidence 654 599999999975322 122334568899999999988777554 9999999999999995554 554443
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
......+. .....+.+..++..+.++|.+||..||.+|||+.++++.
T Consensus 235 ~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 235 FDLTHFLA----QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp GGHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhh----cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32222222 222334455689999999999999999999999998873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=261.58 Aligned_cols=191 Identities=27% Similarity=0.396 Sum_probs=147.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCH-----HHHHHHHHHHHHHHHHHHH---cCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLL-----VQARFFFQQLISGVSYCHA---MQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~-----~~~~~~~~qil~~l~~LH~---~~iiHrdlkp~N 77 (293)
.|+|++++++++.+ ..|+|| ||+.||+|.+++...+.. ..+..++.|++.||.|||+ +|++||||||+|
T Consensus 59 ~hp~iv~~~~~~~~--~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~N 135 (307)
T 2eva_A 59 NHPNIVKLYGACLN--PVCLVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135 (307)
T ss_dssp CCTTBCCEEEBCTT--TTEEEE-ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGG
T ss_pred CCCCcCeEEEEEcC--CcEEEE-EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhH
Confidence 58999999999884 488999 799999999999876542 2889999999999999999 899999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
|+++.++. .+||+|||++..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........
T Consensus 136 Ill~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~ 211 (307)
T 2eva_A 136 LLLVAGGT-VLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAF 211 (307)
T ss_dssp EEEETTTT-EEEECCCCC--------------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH
T ss_pred EEEeCCCC-EEEEccccccccccc--ccccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHH
Confidence 99976543 379999999975432 2234569999999999988777555 9999999999999999999986543221
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
........ ....+....++..+.++|.+||..||.+|||+.+++++
T Consensus 212 --~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 212 --RIMWAVHN-GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp --HHHHHHHT-TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHhc-CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 11111111 22233345689999999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=258.58 Aligned_cols=195 Identities=23% Similarity=0.308 Sum_probs=146.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++.. ...+. .++.++.||+.||.|||++|++||||||+||+
T Consensus 90 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl 168 (310)
T 2wqm_A 90 NHPNVIKYYASFIEDNELNIVL-ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 168 (310)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCCCEeeEEEEEEcCCcEEEEE-ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEE
Confidence 5899999999999999999999 79999999999975 23333 89999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++.++ .+||+|||++....... ......|++.|+|||++.+..++.+ +|+|||||++|+|++|..||.+.....
T Consensus 169 ~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~-- 243 (310)
T 2wqm_A 169 ITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNL-- 243 (310)
T ss_dssp ECTTS--CEEECCC------------------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CCH--
T ss_pred EcCCC--CEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchhH--
Confidence 97654 59999999987543322 2234579999999999987776544 999999999999999999997654221
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
......+............++.++.++|.+||..||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 222333333333222234589999999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=264.57 Aligned_cols=196 Identities=21% Similarity=0.304 Sum_probs=155.9
Q ss_pred CCcchhhhhceee--eceeEEEeehhhccCchhHHHHHHc-CCH--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSV--KMKFVFLSLSFFFSLCLFFMWLLLL-GLL--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~--~~~~~~lv~~ey~~gg~L~~~l~~~-~~~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++. ..+..|+|| ||+.+++|.+++... +.+ ..++.++.||+.||.|||++|++||||||+||++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~ 160 (327)
T 3lxl_A 82 HSDFIVKYRGVSYGPGRQSLRLVM-EYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 160 (327)
T ss_dssp CCTTBCCEEEEEECSSSCEEEEEE-ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCceeEEEEEEecCCCceEEEEE-eecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE
Confidence 6899999999887 567799999 799999999999874 223 3899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
+.++ .+||+|||+++...... ......||+.|+|||++.+..++. ++|||||||++|+|++|+.||.......
T Consensus 161 ~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~~~~~ 237 (327)
T 3lxl_A 161 ESEA--HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR-QSDVWSFGVVLYELFTYCDKSCSPSAEF 237 (327)
T ss_dssp EETT--EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred CCCC--CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCCh-HHhHHHHHHHHHHHHhCCCCCccccchh
Confidence 7665 59999999997543322 223446888999999998777654 4999999999999999999986533210
Q ss_pred -----------HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 157 -----------DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 157 -----------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
...... .........+.+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 238 LRMMGCERDVPALSRLL-ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHCC----CCHHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhcccccccccHHHHH-HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111122 2222333445556689999999999999999999999999775
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=257.31 Aligned_cols=192 Identities=18% Similarity=0.258 Sum_probs=151.1
Q ss_pred CCcchhhhhcee-eeceeEEEeehhhccCchhHHHHHHcCC-H--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVS-VKMKFVFLSLSFFFSLCLFFMWLLLLGL-L--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~-~~~~~~~lv~~ey~~gg~L~~~l~~~~~-~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++ ...+..|+|| ||+.+|+|.+++...+. + ..+..++.|++.||.|||++|++||||||+||+++
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~ 162 (298)
T 3f66_A 84 SHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 162 (298)
T ss_dssp CCTTBCCCCEEECCSSSCCEEEE-ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCCEeeeeeEEEcCCCceEEEE-eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC
Confidence 589999999985 5567889999 79999999999976432 3 38899999999999999999999999999999996
Q ss_pred CCCCCCEEEecCCCCcCcCCC-----CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCch
Q 022732 82 GSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP 155 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~ 155 (293)
.++ ++||+|||+++..... .......||+.|+|||++.+..++.+ +|+||+||++|+|++ |.+||.+....
T Consensus 163 ~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~ 239 (298)
T 3f66_A 163 EKF--TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTF 239 (298)
T ss_dssp TTC--CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTT
T ss_pred CCC--CEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 654 5999999999754322 12234467889999999988777554 999999999999999 66777766554
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.....+. ... ....+..++..+.++|.+||..||.+|||+.++++.
T Consensus 240 ~~~~~~~----~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 240 DITVYLL----QGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp THHHHHH----TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHh----cCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3322222 121 223344588999999999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=276.60 Aligned_cols=199 Identities=19% Similarity=0.312 Sum_probs=154.3
Q ss_pred CCcchhhhhceeeece--eEEEeehhhccCchhHHHHHHcCC---HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMK--FVFLSLSFFFSLCLFFMWLLLLGL---LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~--~~~lv~~ey~~gg~L~~~l~~~~~---~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++...+ +.|+|| ||+.||+|.+++..... +. .++.++.||+.||.|||++||+||||||+||
T Consensus 65 ~hpnIv~~~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 143 (396)
T 4eut_A 65 NHKNIVKLFAIEEETTTRHKVLIM-EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (396)
T ss_dssp CCTTBCCEEEEEECTTTCCEEEEE-CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCCCCCeEEEeeccCCCCeeEEEE-ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHE
Confidence 5899999999998765 789999 79999999999976532 33 8999999999999999999999999999999
Q ss_pred EEcC--CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcc--------ccCCCchhhhhhhhhHHHHHHhCCCC
Q 022732 79 LLDG--SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--------HEYDGKIADVWSCGVTLYVMLVGGYP 148 (293)
Q Consensus 79 l~~~--~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DvwslG~il~el~~g~~p 148 (293)
|+.. ++.+.+||+|||+++............||+.|+|||++.+ ..+ +.++||||+||++|+|++|+.|
T Consensus 144 ll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~P 222 (396)
T 4eut_A 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLP 222 (396)
T ss_dssp EEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCS
T ss_pred EEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCC
Confidence 9822 2233599999999986655555556789999999999865 333 3459999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhcccc-------------------CCCCCC----CCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 149 FEDPDEPKDFRKTIQRILSVQY-------------------SVPDTN----PISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 149 f~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|............+.++..... ..+... .++..+.++|.+||..||.+|||+.++++
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp EECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 9764433222333333332221 111111 24467889999999999999999999866
Q ss_pred C
Q 022732 206 H 206 (293)
Q Consensus 206 h 206 (293)
+
T Consensus 303 ~ 303 (396)
T 4eut_A 303 E 303 (396)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=265.27 Aligned_cols=206 Identities=19% Similarity=0.231 Sum_probs=147.8
Q ss_pred CCCCcchhhhhceee-----eceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHc---------CC
Q 022732 4 VGSSSSEYAMLGVSV-----KMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAM---------QV 68 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~-----~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~---------~i 68 (293)
.-.|+|++++++.+. .....|+|| ||+.+|+|.+++.....-. .+..++.||+.||.|||++ ||
T Consensus 63 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~i 141 (336)
T 3g2f_A 63 LMEHDNIARFIVGDERVTADGRMEYLLVM-EYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141 (336)
T ss_dssp TCCCTTBCCEEEEEEEECTTSCEEEEEEE-CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCE
T ss_pred hccCcchhhheecccccccCCCceEEEEE-ecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccce
Confidence 357999999998543 345788999 7999999999998765433 8899999999999999999 99
Q ss_pred eecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCC---------CCCCCCcCCCCccchhhhccc------cCCCchhhhh
Q 022732 69 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---------SQPKSTVGTPAYIAPEVLLRH------EYDGKIADVW 133 (293)
Q Consensus 69 iHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~------~~~~~~~Dvw 133 (293)
+||||||+|||++.++ ++||+|||+++..... .......||+.|+|||++.+. ...+.++|||
T Consensus 142 vH~Dikp~Nill~~~~--~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 219 (336)
T 3g2f_A 142 SHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219 (336)
T ss_dssp ECSSCSGGGEEECTTS--CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred eecccccceEEEcCCC--cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence 9999999999997654 5999999999754321 122345799999999998762 1223458999
Q ss_pred hhhhHHHHHHhCCCCCCCCCchH--------------HHHHHHHHHhcccc--CCCC----CCCCCHHHHHHHHHccccC
Q 022732 134 SCGVTLYVMLVGGYPFEDPDEPK--------------DFRKTIQRILSVQY--SVPD----TNPISQECRDLISRIFVAD 193 (293)
Q Consensus 134 slG~il~el~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~~--~~~~----~~~~s~~~~~li~~~L~~d 193 (293)
||||++|+|++|..||....... .............. .++. ...+++++.+||.+||..|
T Consensus 220 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (336)
T 3g2f_A 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299 (336)
T ss_dssp HHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCC
Confidence 99999999999976654322100 00111111111111 1111 1113458999999999999
Q ss_pred CCCCCCHHHHHc------CcccccC
Q 022732 194 PAARITIPEIMK------HQWFLKN 212 (293)
Q Consensus 194 p~~Rpt~~ell~------h~~~~~~ 212 (293)
|.+|||+.++++ ++|-+++
T Consensus 300 P~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 300 AEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp GGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred hhhCcchHHHHHHHHHHHHHHHhcc
Confidence 999999999954 6665544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=260.03 Aligned_cols=196 Identities=24% Similarity=0.318 Sum_probs=155.9
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHcCC-HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~~~-~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.+ ...+|+|| ||+.+++|.+++...+. ..+++.++.||+.||.|||++|++||||||+||+++.
T Consensus 91 ~h~~iv~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~ 169 (318)
T 3lxp_A 91 YHEHIIKYKGCCEDAGAASLQLVM-EYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN 169 (318)
T ss_dssp CCTTBCCEEEEEEETTTTEEEEEE-CCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCcchhhEEEEEecCCCceEEEEE-ecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcC
Confidence 48999999999988 47899999 79999999999977653 3399999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch---
Q 022732 83 SPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP--- 155 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~--- 155 (293)
++ .+||+|||+++...... ......||+.|+|||++.+..++. ++|||||||++|+|++|..||......
T Consensus 170 ~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 246 (318)
T 3lxp_A 170 DR--LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY-ASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246 (318)
T ss_dssp TC--CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred CC--CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCcccccchhhhh
Confidence 54 59999999997653322 223456888999999998877754 499999999999999999999763211
Q ss_pred -------HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 156 -------KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 156 -------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..-..............+.+..++.++.+||.+||..||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 247 LIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00011122222333344555668999999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=254.31 Aligned_cols=189 Identities=20% Similarity=0.289 Sum_probs=148.3
Q ss_pred CCcchhhhhceeeec-eeEEEeehhhccCchhHHHHHHcCC----HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKM-KFVFLSLSFFFSLCLFFMWLLLLGL----LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~-~~~~lv~~ey~~gg~L~~~l~~~~~----~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++... +..|+|| ||+.+++|.+++...+. ...+..++.|++.||.|||++|++||||||+||++
T Consensus 72 ~h~~iv~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~ 150 (278)
T 1byg_A 72 RHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 150 (278)
T ss_dssp CCTTBCCEEEEECCC--CCEEEE-CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCCEeeEEEEEEcCCCceEEEE-ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE
Confidence 589999999997554 5789999 79999999999987643 22789999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
+.++ ++||+|||++..... ......+++.|+|||++.+..++.+ +|+|||||++|+|++ |+.||..........
T Consensus 151 ~~~~--~~~l~Dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 225 (278)
T 1byg_A 151 SEDN--VAKVSDFGLTKEASS--TQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225 (278)
T ss_dssp CTTS--CEEECCCCC--------------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred eCCC--cEEEeeccccccccc--cccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 7654 599999999875432 2234467899999999987776554 999999999999998 999998876543322
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
. +. .....+.+..+++.+.++|.+||..||.+|||+.++++
T Consensus 226 ~----~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 226 R----VE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp H----HT-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H----Hh-cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 2 22 22233444568999999999999999999999999886
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=262.52 Aligned_cols=199 Identities=19% Similarity=0.195 Sum_probs=153.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC----HH--HHHHHHHHHHHHHHHHHHc---CCeecCCCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL----LV--QARFFFQQLISGVSYCHAM---QVCHRDLKLE 76 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~----~~--~~~~~~~qil~~l~~LH~~---~iiHrdlkp~ 76 (293)
.|+|++++++++...+..|+|| ||+.+|+|.+++..... +. .++.++.|++.||.|||++ |++||||||+
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVY-PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEE-ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred cCCCccceEEEEecCCceEEEE-EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 5899999999999999999999 79999999999986542 33 8999999999999999999 9999999999
Q ss_pred cEEEcCCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC--
Q 022732 77 NTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-- 152 (293)
Q Consensus 77 NIl~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~-- 152 (293)
|||++.++ ++||+|||+++....... .....||+.|+|||++.+..++. ++||||+||++|+|++|+.||...
T Consensus 164 Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~ 240 (326)
T 3uim_A 164 NILLDEEF--EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFDLARL 240 (326)
T ss_dssp GEEECTTC--CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECH-HHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred hEEECCCC--CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCc-cccchhHHHHHHHHHhCCCccccccc
Confidence 99997654 599999999975432222 23446999999999998777654 499999999999999999999521
Q ss_pred --CchHHHHHHHHHHhcccc---------CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 153 --DEPKDFRKTIQRILSVQY---------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 153 --~~~~~~~~~~~~~~~~~~---------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
.................. ........+..+.+++.+||..||.+|||+.++++|-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred ccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 110111111111111100 00111123478999999999999999999999999854
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=255.29 Aligned_cols=193 Identities=16% Similarity=0.152 Sum_probs=146.2
Q ss_pred chhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-CC
Q 022732 9 SEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SP 84 (293)
Q Consensus 9 ~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~-~~ 84 (293)
++..+..++...+..|+|| ||+ +++|.+++... +.++ +++.++.||+.||.|||++|++||||||+||+++. +.
T Consensus 66 ~i~~~~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~ 143 (296)
T 3uzp_A 66 GIPTIRWCGAEGDYNVMVM-ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 143 (296)
T ss_dssp TCCCEEEEEEETTEEEEEE-ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGG
T ss_pred CCCccccccCCCCceEEEE-Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCC
Confidence 3444445556778889999 799 99999999743 3333 89999999999999999999999999999999941 12
Q ss_pred CCCEEEecCCCCcCcCCCCC--------CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc--
Q 022732 85 APRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-- 154 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-- 154 (293)
.+.+||+|||+++....... .....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+...
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 3uzp_A 144 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCc-chhhHHHHHHHHHHHhCCCCCCCcCchh
Confidence 23599999999975433222 24557999999999998877654 49999999999999999999987432
Q ss_pred -hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 155 -PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 155 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
...+..+.......... .....+++++.++|.+||+.||.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 223 KRQKYERISEKKMSTPIE-VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SSSHHHHHHHHHHHSCHH-HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhhcccccCCchH-HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 22233333222211100 012347899999999999999999999999877
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=283.06 Aligned_cols=190 Identities=21% Similarity=0.239 Sum_probs=153.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|++++++.. +..|+|| ||+.+|+|.+++...+.+. .++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 428 ~hpnIv~l~~~~~~-~~~~lv~-E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~ 505 (635)
T 4fl3_A 428 DNPYIVRMIGICEA-ESWMLVM-EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 505 (635)
T ss_dssp CCTTBCCEEEEEES-SSEEEEE-ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET
T ss_pred CCCCEeeEEEEEec-CCEEEEE-EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC
Confidence 58999999999975 4578999 7999999999998877665 899999999999999999999999999999999866
Q ss_pred CCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
+ .+||+|||+++...... ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.......
T Consensus 506 ~--~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~ 582 (635)
T 4fl3_A 506 H--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582 (635)
T ss_dssp T--EEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred C--CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 5 59999999987543222 1223356789999999988777655 999999999999998 99999987764332
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
. .+.. ....+.+..++.++.+||.+||..||.+|||+.++++
T Consensus 583 ~----~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 583 A----MLEK-GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp H----HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H----HHHc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 2 2222 2233445568999999999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=271.54 Aligned_cols=190 Identities=21% Similarity=0.298 Sum_probs=151.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--C--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--G--LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~--~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++.. +.+|+|| ||+.+|+|.+++... . ...++..++.||+.||.|||++|++||||||+|||++
T Consensus 237 ~hp~iv~~~~~~~~-~~~~iv~-e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~ 314 (452)
T 1fmk_A 237 RHEKLVQLYAVVSE-EPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 314 (452)
T ss_dssp CCTTBCCEEEEECS-SSCEEEE-CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCCEeeEEEEEcC-CceEEEe-hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC
Confidence 58999999999977 7789999 799999999999753 2 2338999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.......
T Consensus 315 ~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~ 391 (452)
T 1fmk_A 315 ENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVL 391 (452)
T ss_dssp GGG--CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred CCC--CEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 654 59999999998543221 1223456789999999987777555 999999999999999 99999887654333
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. +. .....+.+..++..+.++|.+||..||.+|||+.++++
T Consensus 392 ~~----i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 392 DQ----VE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HH----HH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH----HH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22 22 23344555668999999999999999999999999887
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=257.79 Aligned_cols=192 Identities=16% Similarity=0.159 Sum_probs=146.6
Q ss_pred cchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE---c
Q 022732 8 SSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---D 81 (293)
Q Consensus 8 ~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~---~ 81 (293)
.++..+..++...+..|+|| ||+ +++|.+++... +.++ .++.++.||+.||.|||++|++||||||+|||+ +
T Consensus 65 ~~i~~~~~~~~~~~~~~lv~-e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~ 142 (296)
T 4hgt_A 65 VGIPTIRWCGAEGDYNVMVM-ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK 142 (296)
T ss_dssp TTCCCEEEEEEETTEEEEEE-ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG
T ss_pred CCCCeeeeecCCCCceEEEE-Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC
Confidence 34444455557778889999 799 99999999853 3333 999999999999999999999999999999999 4
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCC
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 153 (293)
.++ .+||+|||+++...... ......||+.|+|||++.+..++. ++||||+||++|+|++|+.||.+..
T Consensus 143 ~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 143 KGN--LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp GTT--CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCC--eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCc-hhHHHHHHHHHHHHhcCCCCCcccc
Confidence 443 59999999997543322 223557999999999998877654 4999999999999999999998754
Q ss_pred ch---HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 154 EP---KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 154 ~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. ..+..+......... ......+++++.++|.+||..||.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 220 AATKRQKYERISEKKMSTPI-EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CSSSSSHHHHHHHHHHHSCH-HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhhhhhhcccccchh-hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 32 222222222211110 0011347899999999999999999999999887
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=267.68 Aligned_cols=189 Identities=13% Similarity=0.150 Sum_probs=148.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-----cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-----LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-----~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|++++++++...+..|+|| ||+.||+|.+++.. .+.+. .++.++.||+.||+|||++||+||||||+||
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NI 203 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVG-ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNF 203 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEE-CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred hhhhhhhhheeeecCCCcEEEE-eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHE
Confidence 3789999999999999999999 79999999999975 23343 8999999999999999999999999999999
Q ss_pred EEcC---------CCCCCEEEecCCCCcCcC---CCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCC
Q 022732 79 LLDG---------SPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 79 l~~~---------~~~~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 146 (293)
|++. ...+.+||+|||+|+... ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+
T Consensus 204 ll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~ 282 (365)
T 3e7e_A 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGT 282 (365)
T ss_dssp EECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSS
T ss_pred EecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCC
Confidence 9976 113469999999996432 2223345679999999999988887655 99999999999999999
Q ss_pred CCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 147 YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 147 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.||....... ......++ ....++.+.+++.+||..+|.+|++..+.+.+
T Consensus 283 ~pf~~~~~~~---------~~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 283 YMKVKNEGGE---------CKPEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp CCCEEEETTE---------EEECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred CccccCCCCc---------eeechhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 9996543210 00111111 11356889999999999999999755444443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=279.01 Aligned_cols=190 Identities=21% Similarity=0.269 Sum_probs=152.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++.. +.+|+|| ||+.+|+|.+++.... .+. .++.++.||+.||.|||++||+||||||+|||++.
T Consensus 394 ~hpniv~l~~~~~~-~~~~lv~-E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~ 471 (613)
T 2ozo_A 394 DNPYIVRLIGVCQA-EALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471 (613)
T ss_dssp CCTTBCCEEEEEES-SSEEEEE-ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE
T ss_pred CCCCEeeEEEEecc-CCeEEEE-EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC
Confidence 69999999999986 5689999 7999999999997543 233 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .+||+|||+++....... .....+++.|+|||++.+..++.+ +|||||||++|||++ |+.||.+......
T Consensus 472 ~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~ 548 (613)
T 2ozo_A 472 RH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEV 548 (613)
T ss_dssp TT--EEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHH
T ss_pred CC--cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 65 599999999986433221 122345689999999987777655 999999999999998 9999998877543
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
... +.. ....+.+..++.++.++|.+||..+|.+|||+.++++
T Consensus 549 ~~~----i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 549 MAF----IEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHH----HHT-TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHH----HHc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 322 222 2233445568999999999999999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=261.77 Aligned_cols=199 Identities=21% Similarity=0.224 Sum_probs=153.9
Q ss_pred CCCcchhhhhceeeece----eEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHH--------HcCCeec
Q 022732 5 GSSSSEYAMLGVSVKMK----FVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCH--------AMQVCHR 71 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~----~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH--------~~~iiHr 71 (293)
-.|+|++++++++.... ..|+|| ||+.+|+|.+++.+...-. +++.++.|++.||.||| ++|++||
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 171 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVS-DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEE-CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred cCCCcEEEEEeeecccCCccceeEEEE-eecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeC
Confidence 47999999999999886 899999 7999999999998754323 89999999999999999 8999999
Q ss_pred CCCCCcEEEcCCCCCCEEEecCCCCcCcCCCC-----CCCCCcCCCCccchhhhccccCC-----CchhhhhhhhhHHHH
Q 022732 72 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYV 141 (293)
Q Consensus 72 dlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwslG~il~e 141 (293)
||||+||+++.++ ++||+|||+++...... ......||+.|+|||++.+.... +.++|||||||++|+
T Consensus 172 Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 249 (342)
T 1b6c_B 172 DLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249 (342)
T ss_dssp CCSGGGEEECTTS--CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEECCCC--CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHH
Confidence 9999999997655 59999999997543332 23455799999999998765322 145999999999999
Q ss_pred HHhC----------CCCCCCCCchH-HHHHHHHHHhccccCCCCC-----CCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 142 MLVG----------GYPFEDPDEPK-DFRKTIQRILSVQYSVPDT-----NPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 142 l~~g----------~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|++| ..||....... ........+.........+ ...+..+.++|.+||..||.+|||+.++++
T Consensus 250 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 250 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999 78887653211 1122222222222221111 123468899999999999999999999998
Q ss_pred C
Q 022732 206 H 206 (293)
Q Consensus 206 h 206 (293)
+
T Consensus 330 ~ 330 (342)
T 1b6c_B 330 T 330 (342)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=254.11 Aligned_cols=190 Identities=18% Similarity=0.279 Sum_probs=153.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++.. +..|+|| ||+.+++|.+++.... ....+..++.|++.||.|||++|++||||||+||+++
T Consensus 66 ~h~~i~~~~~~~~~-~~~~~v~-e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~ 143 (279)
T 1qpc_A 66 QHQRLVRLYAVVTQ-EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143 (279)
T ss_dssp CCTTBCCEEEEECS-SSCEEEE-ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CCcCcceEEEEEcC-CCcEEEE-ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc
Confidence 58999999999874 5688999 7999999999997542 2338999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||++....... ......+++.|+|||++.+..++.+ +|+|||||++|+|++ |+.||.+.......
T Consensus 144 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~ 220 (279)
T 1qpc_A 144 DTL--SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220 (279)
T ss_dssp TTS--CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred CCC--CEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHH
Confidence 654 59999999997543322 2233457889999999987776544 999999999999999 99999887654333
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.. +.. ......+..++.++.++|.+||..||.+|||+.++++
T Consensus 221 ~~----~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 221 QN----LER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HH----HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH----Hhc-ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 222 2233344568999999999999999999999999887
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=258.61 Aligned_cols=196 Identities=23% Similarity=0.294 Sum_probs=152.9
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc---CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL---GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~---~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++...+..|+|| ||+.+++|.+++... ..+. .++.++.||+.||.|||++|++||||||+||++
T Consensus 88 ~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 88 QHENLVELLGFSSDGDDLCLVY-VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL 166 (307)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CCCCeEEEEEEEecCCceEEEE-EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE
Confidence 5899999999999999999999 799999999999743 2233 889999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
+.++ .+||+|||+++....... .....||+.|+|||++.+. ++ .++|+|||||++|+|++|..||........
T Consensus 167 ~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 167 DEAF--TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-IT-PKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp CTTC--CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-EC-THHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred cCCC--cEEEeecccccccccccccccccccCCCcCcCChHHhcCC-CC-ccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 7654 599999999875432221 2345799999999998653 44 459999999999999999999987654332
Q ss_pred HHHHHHHHhcccc--------CC-CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 158 FRKTIQRILSVQY--------SV-PDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 158 ~~~~~~~~~~~~~--------~~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+..+...+..... .. ......+..+.+++.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2222222211110 00 1112245778999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=260.67 Aligned_cols=191 Identities=25% Similarity=0.402 Sum_probs=134.1
Q ss_pred CCCcchhhhhcee--------eeceeEEEeehhhccCchhHHHHHH---cCCHH--HHHHHHHHHHHHHHHHHHcC--Ce
Q 022732 5 GSSSSEYAMLGVS--------VKMKFVFLSLSFFFSLCLFFMWLLL---LGLLV--QARFFFQQLISGVSYCHAMQ--VC 69 (293)
Q Consensus 5 ~~~~~~v~~~~~~--------~~~~~~~lv~~ey~~gg~L~~~l~~---~~~~~--~~~~~~~qil~~l~~LH~~~--ii 69 (293)
..|+|++++++++ ......|+|| ||+. |+|.+++.. .+.+. .++.++.||+.||.|||++| ++
T Consensus 83 ~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~-e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~iv 160 (337)
T 3ll6_A 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLT-ELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160 (337)
T ss_dssp TTSTTBCCEEEEEEECTTTSTTSSEEEEEEE-ECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCB
T ss_pred ccCCChhhccccccccccccccCCceEEEEE-EecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Confidence 4699999999999 4556788888 7986 688888865 33344 89999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC-------------CCCCcCCCCccchhhhc---cccCCCchhhhh
Q 022732 70 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-------------PKSTVGTPAYIAPEVLL---RHEYDGKIADVW 133 (293)
Q Consensus 70 Hrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~---~~~~~~~~~Dvw 133 (293)
||||||+|||++.++ ++||+|||+++....... .....||+.|+|||++. +..+ +.++|||
T Consensus 161 H~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~ 237 (337)
T 3ll6_A 161 HRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIW 237 (337)
T ss_dssp CCCCCGGGCEECTTS--CEEBCCCTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHH
T ss_pred EccCCcccEEECCCC--CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHH
Confidence 999999999997655 599999999986433221 11446899999999983 3444 4459999
Q ss_pred hhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcc
Q 022732 134 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208 (293)
Q Consensus 134 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~ 208 (293)
||||++|+|++|+.||....... +.......+.....+..+.+||.+||..||.+|||+.+++++-.
T Consensus 238 slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 238 ALGCILYLLCFRQHPFEDGAKLR--------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp HHHHHHHHHHHSSCCC--------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCcchhHHH--------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999997654321 12223334444557788999999999999999999999999854
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=259.43 Aligned_cols=195 Identities=23% Similarity=0.344 Sum_probs=151.0
Q ss_pred CCcchhhhhceee----eceeEEEeehhhccCchhHHHHHH----cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 022732 6 SSSSEYAMLGVSV----KMKFVFLSLSFFFSLCLFFMWLLL----LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKL 75 (293)
Q Consensus 6 ~~~~~v~~~~~~~----~~~~~~lv~~ey~~gg~L~~~l~~----~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp 75 (293)
.|+|++++++++. .....|+|| ||+.+|+|.+++.. .+.+. +++.++.||+.||.|||++|++||||||
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp 162 (317)
T 2buj_A 84 NHPNILRLVAYCLRERGAKHEAWLLL-PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKP 162 (317)
T ss_dssp CCTTBCCCCEEEEEEETTEEEEEEEE-ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred CCCCeeeEEEEEEeccCCCceeEEEE-EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 6899999999997 456889999 79999999999976 23343 8999999999999999999999999999
Q ss_pred CcEEEcCCCCCCEEEecCCCCcCcCCCCCC----------CCCcCCCCccchhhhccccC--CCchhhhhhhhhHHHHHH
Q 022732 76 ENTLLDGSPAPRLKICDFGYSKSSVLHSQP----------KSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVML 143 (293)
Q Consensus 76 ~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~il~el~ 143 (293)
+||+++.++ .+||+|||+++........ ....||+.|+|||++.+... ...++|||||||++|+|+
T Consensus 163 ~NIl~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 163 TNILLGDEG--QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp GGEEECTTS--CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred HHEEEcCCC--CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence 999997655 5999999998743221111 12357999999999865432 234599999999999999
Q ss_pred hCCCCCCCCCch-HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q 022732 144 VGGYPFEDPDEP-KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 207 (293)
Q Consensus 144 ~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~ 207 (293)
+|+.||...... ...... .......+....++.++.++|.+||..||.+|||+.+++++-
T Consensus 241 ~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 241 FGEGPYDMVFQKGDSVALA----VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HSSCTTHHHHHTTSCHHHH----HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hCCCChhhhhcccchhhHH----hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 999999541100 001111 112334455556899999999999999999999999999973
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=256.65 Aligned_cols=196 Identities=19% Similarity=0.253 Sum_probs=153.3
Q ss_pred CCcchhhhhceeeece--eEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMK--FVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~--~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++.... ..|+|| ||+.+++|.+++...+ .+. +++.++.||+.||.|||++|++||||||+||++
T Consensus 100 ~h~~iv~~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli 178 (326)
T 2w1i_A 100 QHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178 (326)
T ss_dssp CCTTBCCEEEEECC----CCEEEE-CCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CCCCeeeEEEEEEecCCCceEEEE-ECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE
Confidence 5899999999987654 789999 7999999999998764 233 899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch-
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP- 155 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~- 155 (293)
+.++ ++||+|||+++....... .....+++.|+|||++.+..++. ++|||||||++|+|++|..||......
T Consensus 179 ~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~tg~~~~~~~~~~~ 255 (326)
T 2w1i_A 179 ENEN--RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYIEKSKSPPAEF 255 (326)
T ss_dssp EETT--EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHHTTCGGGSHHHHH
T ss_pred cCCC--cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCc-hhhHHHHHHHHHHHHhcCCCCCCCHHHH
Confidence 7655 599999999976433321 23345778899999998777654 499999999999999999998643110
Q ss_pred ----------HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 156 ----------KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 156 ----------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
......+..........+.+..++.++.++|.+||..||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 256 MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111112222223334455668999999999999999999999999886
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=283.70 Aligned_cols=204 Identities=23% Similarity=0.309 Sum_probs=159.1
Q ss_pred CCcchhhhhceeee------ceeEEEeehhhccCchhHHHHHHcC---CHH--HHHHHHHHHHHHHHHHHHcCCeecCCC
Q 022732 6 SSSSEYAMLGVSVK------MKFVFLSLSFFFSLCLFFMWLLLLG---LLV--QARFFFQQLISGVSYCHAMQVCHRDLK 74 (293)
Q Consensus 6 ~~~~~v~~~~~~~~------~~~~~lv~~ey~~gg~L~~~l~~~~---~~~--~~~~~~~qil~~l~~LH~~~iiHrdlk 74 (293)
.|+|++++++++.. .+..|+|| ||+.||+|.+++...+ .++ .++.++.||+.||.|||++|++|||||
T Consensus 70 ~HpnIV~l~~v~~~~~~~~~~~~~~LVm-Ey~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLK 148 (676)
T 3qa8_A 70 NHPNVVSAREVPDGLQKLAPNDLPLLAM-EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLK 148 (676)
T ss_dssp CBTTBCCEEECCTTTCCCCTTSSCCCEE-ECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCC
T ss_pred CCCCCCceeeeecccccccCCCeEEEEE-EeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence 58999999999766 78889999 7999999999998754 244 899999999999999999999999999
Q ss_pred CCcEEEcCCCC-CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCC
Q 022732 75 LENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153 (293)
Q Consensus 75 p~NIl~~~~~~-~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 153 (293)
|+||+++.++. ..+||+|||++.............||+.|+|||++.+..++.+ +|+||+||++|+|++|..||....
T Consensus 149 P~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~ 227 (676)
T 3qa8_A 149 PENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNW 227 (676)
T ss_dssp STTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred HHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCccc
Confidence 99999986543 2489999999987665555666789999999999988777655 999999999999999999997653
Q ss_pred chHHHHHHH-----HHH-----hcccc----CCCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 154 EPKDFRKTI-----QRI-----LSVQY----SVPD----TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 154 ~~~~~~~~~-----~~~-----~~~~~----~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
....+.... ... ..... ..+. ...++..+.+||.+||..||.+|||+.++++||||..
T Consensus 228 ~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 228 QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp HHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred chhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 322110000 000 00000 1111 1225689999999999999999999999999999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=272.82 Aligned_cols=191 Identities=21% Similarity=0.298 Sum_probs=155.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--C--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--G--LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~--~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|++++++++.. +.+|+|| ||+.+|+|.++++.. . ...++..++.||+.||.|||++||+||||||+|||++
T Consensus 320 ~hpniv~~~~~~~~-~~~~lv~-e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 397 (535)
T 2h8h_A 320 RHEKLVQLYAVVSE-EPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 397 (535)
T ss_dssp CCTTBCCEEEEECS-SSCEEEE-CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCCEeeEEEEEee-ccceEee-ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc
Confidence 58999999999976 7789999 799999999999753 2 2338999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCC--CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
.++ .+||+|||+++..... .......+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+......+
T Consensus 398 ~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~ 474 (535)
T 2h8h_A 398 ENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVL 474 (535)
T ss_dssp GGG--CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHH
T ss_pred CCC--cEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 654 5999999999754321 11223457789999999987777555 999999999999999 99999887654333
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.. +. .....+.+..++..+.+||.+||..||.+|||+.++++.
T Consensus 475 ~~----i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 475 DQ----VE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HH----HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH----HH-cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22 22 233444555689999999999999999999999998874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=277.40 Aligned_cols=191 Identities=19% Similarity=0.306 Sum_probs=153.2
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|++++++++. .+..|+|| ||+.+|+|.++++..+ .+. .+..++.||+.||.|||++||+||||||+|||++.
T Consensus 449 ~HpnIv~l~~~~~-~~~~~lv~-E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~ 526 (656)
T 2j0j_A 449 DHPHIVKLIGVIT-ENPVWIIM-ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 526 (656)
T ss_dssp CCTTBCCEEEEEC-SSSCEEEE-ECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE
T ss_pred CCCCCCeEEEEEe-cCceEEEE-EcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeC
Confidence 5899999999985 56789999 7999999999998654 233 88999999999999999999999999999999986
Q ss_pred CCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ ++||+|||+++....... .....+|+.|+|||++.+..++.+ +||||+||++|+|++ |..||.+........
T Consensus 527 ~~--~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~ 603 (656)
T 2j0j_A 527 ND--CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603 (656)
T ss_dssp TT--EEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CC--CEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 65 599999999986533222 223456789999999987777554 999999999999997 999999877644433
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+.. . ...+.+..+++.+.++|.+||..||.+|||+.++++.
T Consensus 604 ~i~~----~-~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 604 RIEN----G-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHH----T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHc----C-CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3222 1 2233445689999999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=266.40 Aligned_cols=198 Identities=18% Similarity=0.179 Sum_probs=151.3
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
+..+.++..+..++......|+|| ||+ +++|.+++... +.+. .++.++.||+.||.|||++||+||||||+|||+
T Consensus 59 L~~~~~i~~i~~~~~~~~~~~lvm-e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl 136 (483)
T 3sv0_A 59 LQGGTGIPNVRWFGVEGDYNVLVM-DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136 (483)
T ss_dssp TTTSTTCCCEEEEEEETTEEEEEE-ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hcCCCCCCeEEEEEeeCCEEEEEE-ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEE
Confidence 344566677777888889999999 799 99999999753 3344 999999999999999999999999999999999
Q ss_pred cCC-CCCCEEEecCCCCcCcCCCCC--------CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 81 DGS-PAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 81 ~~~-~~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
+.. ..+.+||+|||+++....... .....||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+
T Consensus 137 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~ 215 (483)
T 3sv0_A 137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQG 215 (483)
T ss_dssp CCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSS
T ss_pred ecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcc
Confidence 421 233599999999975433221 235679999999999988777554 9999999999999999999988
Q ss_pred CCchH---HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 152 PDEPK---DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 152 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..... .+..+......... ......++.++.+||.+||..+|.+||++.++++
T Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~-~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 216 LKAGTKKQKYEKISEKKVATSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CCCSSHHHHHHHHHHHHHHSCH-HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccchhHHHHHHHHhhccccccH-HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 55422 22222222111110 0111347899999999999999999999988765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=263.23 Aligned_cols=189 Identities=13% Similarity=0.107 Sum_probs=144.7
Q ss_pred Ccchhhhhceeee-------------ceeEEEeehhhccCchhHHHHHHcC-CHHHHHHHHHHHHHHHHHHH-HcCCeec
Q 022732 7 SSSEYAMLGVSVK-------------MKFVFLSLSFFFSLCLFFMWLLLLG-LLVQARFFFQQLISGVSYCH-AMQVCHR 71 (293)
Q Consensus 7 ~~~~v~~~~~~~~-------------~~~~~lv~~ey~~gg~L~~~l~~~~-~~~~~~~~~~qil~~l~~LH-~~~iiHr 71 (293)
|+|+++++++|.+ .+++|+|| ||+.+|++.+.+.+.. ...+++.++.||+.||.||| ++||+||
T Consensus 108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~-E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHr 186 (336)
T 2vuw_A 108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVL-EFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR 186 (336)
T ss_dssp CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEE-EEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred cHHHHHHHHHHhhhccccccCccccccCeEEEEE-EecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhCCEeEC
Confidence 7999999999887 78999999 7999997777665432 23399999999999999999 9999999
Q ss_pred CCCCCcEEEcCCCC------------------CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhh
Q 022732 72 DLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 133 (293)
Q Consensus 72 dlkp~NIl~~~~~~------------------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvw 133 (293)
||||+|||++.++. .++||+|||+|+.... ...+||+.|+|||++.+.. ..++|||
T Consensus 187 DlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~~--~~~~Diw 260 (336)
T 2vuw_A 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGDG--DYQFDIY 260 (336)
T ss_dssp CCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCCS--SHHHHHH
T ss_pred CCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCCC--ccceehh
Confidence 99999999987641 1699999999985432 2458999999999998765 4569999
Q ss_pred hhhhH-HHHHHhCCCCCCCCCchHHHHHHHHHHhcc-ccCCCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHH-cC
Q 022732 134 SCGVT-LYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPD----TNPISQECRDLISRIFVADPAARITIPEIM-KH 206 (293)
Q Consensus 134 slG~i-l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~ell-~h 206 (293)
|+|++ .+++++|..||.+... .......+... ...... +..+|+++++||++||++| |+.++| +|
T Consensus 261 sl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 261 RLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhhCCCCcccccccCCCcchhh---hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 98777 7778889999853111 01122222211 111111 1236789999999999976 999999 99
Q ss_pred cccc
Q 022732 207 QWFL 210 (293)
Q Consensus 207 ~~~~ 210 (293)
|||+
T Consensus 333 p~f~ 336 (336)
T 2vuw_A 333 SLFK 336 (336)
T ss_dssp GGGC
T ss_pred CCcC
Confidence 9985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=260.80 Aligned_cols=172 Identities=16% Similarity=0.145 Sum_probs=134.6
Q ss_pred eEEEeehhhccCchhHHHHHH-------cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEec
Q 022732 22 FVFLSLSFFFSLCLFFMWLLL-------LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 92 (293)
Q Consensus 22 ~~~lv~~ey~~gg~L~~~l~~-------~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~D 92 (293)
..+++| ...+++|.++++. .+.+. .+..++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 179 ~~~~~~--~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~--~kL~D 254 (413)
T 3dzo_A 179 SRFFLY--PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTG 254 (413)
T ss_dssp SEEEEE--ECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECC
T ss_pred ceEEEe--ehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCe--EEEEe
Confidence 345555 3567899988852 12233 77788899999999999999999999999999976654 99999
Q ss_pred CCCCcCcCCCCCCCCCcCCCCccchhhhc----------cccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 93 FGYSKSSVLHSQPKSTVGTPAYIAPEVLL----------RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 93 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~----------~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
||+++..... ....+| +.|+|||++. +..++ .++|||||||++|+|++|+.||.........
T Consensus 255 FG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~~~---- 326 (413)
T 3dzo_A 255 FEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMT-FAFDTWTLGLAIYWIWCADLPNTDDAALGGS---- 326 (413)
T ss_dssp GGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC-HHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS----
T ss_pred ccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhhhH----
Confidence 9998754332 345678 9999999983 33343 4599999999999999999999876542211
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.. .+.....+|+++.+||.+||..||.+|||+.++++||||+.
T Consensus 327 ~~------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 327 EW------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp GG------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HH------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 11 12223458899999999999999999999999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-33 Score=272.01 Aligned_cols=184 Identities=18% Similarity=0.160 Sum_probs=147.0
Q ss_pred CCcchhhhhceeeecee-----EEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMKF-----VFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~-----~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|+++++++|...+. .|+|| ||+.|++|.+++...-...+++.++.||+.||.|||++||+||||||+|||+
T Consensus 137 ~hp~iv~~~~~~~~~~~~~~~~~~lv~-E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll 215 (681)
T 2pzi_A 137 VHPSIVQIFNFVEHTDRHGDPVGYIVM-EYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML 215 (681)
T ss_dssp CCTTBCCEEEEEEEECTTSCEEEEEEE-ECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCCCcCeEeeeEeecCCCCCceeEEEE-EeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE
Confidence 58999999999998776 79999 7999999999887644444999999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+.+ .+||+|||+++.... ....+||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.....
T Consensus 216 ~~~---~~kl~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---- 283 (681)
T 2pzi_A 216 TEE---QLKLIDLGAVSRINS---FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDG---- 283 (681)
T ss_dssp CSS---CEEECCCTTCEETTC---CSCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSS----
T ss_pred eCC---cEEEEecccchhccc---CCccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccc----
Confidence 764 599999999986432 25567999999999987643 456999999999999999998887532100
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
..........++.+.++|.+||.+||.+||+..+++.|+|+.
T Consensus 284 --------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 --------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000000112467899999999999999999999999998864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=233.79 Aligned_cols=169 Identities=12% Similarity=0.016 Sum_probs=132.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 85 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~ 85 (293)
.|+|++++++++...+..|+|| ||+.|++|.++++......++..++.||+.||.|||++||+||||||+|||++.++
T Consensus 89 ~hp~iv~~~~~~~~~~~~~lv~-e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g- 166 (286)
T 3uqc_A 89 DKPGVARVLDVVHTRAGGLVVA-EWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG- 166 (286)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-
T ss_pred CCCCcceeeEEEEECCcEEEEE-EecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-
Confidence 6899999999999999999999 79999999999965433338899999999999999999999999999999997665
Q ss_pred CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHH
Q 022732 86 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165 (293)
Q Consensus 86 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 165 (293)
.+||+++|. ++| + +.++|||||||++|+|++|+.||.+.+....+....+ .
T Consensus 167 -~~kl~~~~~-------------------~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-~ 217 (286)
T 3uqc_A 167 -DVVLAYPAT-------------------MPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-D 217 (286)
T ss_dssp -CEEECSCCC-------------------CTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-C
T ss_pred -CEEEEeccc-------------------cCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-H
Confidence 489885542 222 2 4559999999999999999999988654221100000 0
Q ss_pred hccccCC--CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 166 LSVQYSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 166 ~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
....... .....+++++.++|.+||.+||.+| |+.++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 0010000 0123488999999999999999999 99999884
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-32 Score=255.61 Aligned_cols=139 Identities=14% Similarity=0.057 Sum_probs=104.6
Q ss_pred CCCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 2 HPVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 2 ~~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+-+++|+|++++++++++++..|||| ||+.|++|.++|+..+.+.. ..++.||+.||+|||++|||||||||+|||++
T Consensus 296 ~~~~~~~~i~~~~~~~ed~~~~yLVM-Eyv~G~~L~d~i~~~~~l~~-~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~ 373 (569)
T 4azs_A 296 TQPPAGFDAPAVLAHGENAQSGWLVM-EKLPGRLLSDMLAAGEEIDR-EKILGSLLRSLAALEKQGFWHDDVRPWNVMVD 373 (569)
T ss_dssp HSCCTTCCCCCEEEEEECSSEEEEEE-ECCCSEEHHHHHHTTCCCCH-HHHHHHHHHHHHHHHHTTCEESCCCGGGEEEC
T ss_pred HhcCCCCCeeEEEEEEEECCEEEEEE-ecCCCCcHHHHHHhCCCCCH-HHHHHHHHHHHHHHHHCCceeccCchHhEEEC
Confidence 35688999999999999999999999 79999999999999887763 35899999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCC
Q 022732 82 GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 146 (293)
.++ ++||+|||+|+..... ....+.+||+.|||||++.+.. . ..+|+||+|++++++.++.
T Consensus 374 ~dg--~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~-~-~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 374 ARQ--HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENK-S-WNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp TTS--CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred CCC--CEEEeecccCeeCCCCCccccCceechhhccHHHhCCCC-C-Ccccccccccchhhhcccc
Confidence 655 5999999999865432 3345568999999999987643 3 3489999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.5e-23 Score=191.83 Aligned_cols=133 Identities=20% Similarity=0.116 Sum_probs=110.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 85 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~ 85 (293)
.|+|++++..++...+..|+|| ||+.|++|.+++.. +..++.|++.||.|||++||+||||||+|||++.
T Consensus 397 ~h~nIv~~~~~~~~~~~~~lVm-E~~~ggsL~~~l~~------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--- 466 (540)
T 3en9_A 397 KDFGIPAPYIFDVDLDNKRIMM-SYINGKLAKDVIED------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--- 466 (540)
T ss_dssp GGGTCCCCCEEEEETTTTEEEE-ECCCSEEHHHHSTT------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---
T ss_pred CCCCcCceEEEEEeCCccEEEE-ECCCCCCHHHHHHH------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---
Confidence 5789996667777888889999 79999999999976 6789999999999999999999999999999976
Q ss_pred CCEEEecCCCCcCcCCCCC--------CCCCcCCCCccchhhhcc--ccCCCchhhhhhhhhHHHHHHhCCCCCC
Q 022732 86 PRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFE 150 (293)
Q Consensus 86 ~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~ 150 (293)
++||+|||+|+....... ..+..||+.|||||++.. ..|... +|+||..+-..+-..++.+|.
T Consensus 467 -~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 467 -DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp -SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred -eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence 599999999986533211 135679999999999976 555444 899999888888877776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-17 Score=143.84 Aligned_cols=90 Identities=16% Similarity=0.077 Sum_probs=74.7
Q ss_pred chhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCE
Q 022732 9 SEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 88 (293)
Q Consensus 9 ~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~v 88 (293)
| +++++++. .++.|+|| ||+.|++|.+ +. ...+..++.|++.||.|||++|++||||||+|||++ + +++
T Consensus 163 ~-~~v~~~~~-~~~~~lvm-E~~~g~~L~~-l~----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~--~~v 231 (282)
T 1zar_A 163 G-LAVPKVYA-WEGNAVLM-ELIDAKELYR-VR----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E--EGI 231 (282)
T ss_dssp T-SSSCCEEE-EETTEEEE-ECCCCEEGGG-CC----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T--TEE
T ss_pred C-CCcCeEEe-ccceEEEE-EecCCCcHHH-cc----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C--CcE
Confidence 5 77888664 46779999 7999999998 42 234567999999999999999999999999999998 4 469
Q ss_pred EEecCCCCcCcCCCCCCCCCcCCCCccchhhhc
Q 022732 89 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 121 (293)
Q Consensus 89 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 121 (293)
||+|||+|+. +..++|||.+.
T Consensus 232 kl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE------------TTSTTHHHHHH
T ss_pred EEEECCCCeE------------CCCCCHHHHHH
Confidence 9999999863 44678999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1.4e-12 Score=110.70 Aligned_cols=72 Identities=15% Similarity=0.112 Sum_probs=57.6
Q ss_pred eeEEEeehhhccC-c----hhHHHHHHcCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEcCCCCCCEEEecCC
Q 022732 21 KFVFLSLSFFFSL-C----LFFMWLLLLGLLVQARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFG 94 (293)
Q Consensus 21 ~~~~lv~~ey~~g-g----~L~~~l~~~~~~~~~~~~~~qil~~l~~LH-~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg 94 (293)
+..|+|| ||+.+ | +|.+..... ....+..++.|++.||.||| ++||+||||||+|||++. +++|+|||
T Consensus 141 ~~~~lVm-E~~g~~g~~~~~L~~~~~~~-~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~----~~~liDFG 214 (258)
T 1zth_A 141 MKNVLLM-EFIGEDELPAPTLVELGREL-KELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID----KVYFIDMG 214 (258)
T ss_dssp ETTEEEE-ECCEETTEECCBHHHHGGGG-GGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS----SEEECCCT
T ss_pred CCCEEEE-EecCCCCCccccHHHHhhcc-ChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC----cEEEEECc
Confidence 4678999 79942 3 666554321 11277889999999999999 999999999999999975 49999999
Q ss_pred CCcC
Q 022732 95 YSKS 98 (293)
Q Consensus 95 ~a~~ 98 (293)
+|..
T Consensus 215 ~a~~ 218 (258)
T 1zth_A 215 QAVT 218 (258)
T ss_dssp TCEE
T ss_pred cccc
Confidence 9964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.16 E-value=1e-11 Score=110.67 Aligned_cols=85 Identities=11% Similarity=0.002 Sum_probs=63.5
Q ss_pred cchhhhhceeeec------eeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 8 SSEYAMLGVSVKM------KFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 8 ~~~v~~~~~~~~~------~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+|..+++...... +..++|| ||+.|++|..+.. ...+..++.||+.+|.+||++|+|||||||.|||++
T Consensus 165 ~nL~rL~~~gv~vp~p~~~~~~~LVM-E~i~G~~L~~l~~----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 165 AFMKALYEEGFPVPEPIAQSRHTIVM-SLVDALPMRQVSS----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp HHHHHHHHTTCSCCCEEEEETTEEEE-ECCSCEEGGGCCC----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred HHHHHHHhcCCCCCeeeeccCceEEE-EecCCccHhhhcc----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 4555565543322 2336899 7999999865432 235667889999999999999999999999999998
Q ss_pred CCCCC--------CEEEecCCCCc
Q 022732 82 GSPAP--------RLKICDFGYSK 97 (293)
Q Consensus 82 ~~~~~--------~vkl~Dfg~a~ 97 (293)
.++.+ .+.|+||+-+.
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCCcccccccccceEEEEeCCcc
Confidence 76532 27899998765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=5.7e-08 Score=81.95 Aligned_cols=85 Identities=13% Similarity=-0.007 Sum_probs=66.4
Q ss_pred CcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHH---------------------
Q 022732 7 SSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHA--------------------- 65 (293)
Q Consensus 7 ~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~--------------------- 65 (293)
+-...++++++...+..|+|| ||+.|.+|.+.+. .......++.++..+|..||+
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~-e~i~G~~l~~~~~---~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLM-SEADGVLCSEEYE---DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEE-ECCSSEEHHHHCC---TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEE-EecCCeehhhccC---CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHH
Confidence 345678899999889999999 7999999887531 112345678889999999998
Q ss_pred --------------------------------------cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 --------------------------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 --------------------------------------~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.+++|+|++|.||+++.+ ..+.|+||+.+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~--~~~~lIDwe~a~ 212 (263)
T 3tm0_A 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG--KVSGFIDLGRSG 212 (263)
T ss_dssp HHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT--EEEEECCCTTCE
T ss_pred HHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC--cEEEEEEchhcc
Confidence 458999999999999643 235699999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.35 E-value=3.2e-07 Score=79.25 Aligned_cols=122 Identities=18% Similarity=0.085 Sum_probs=77.3
Q ss_pred eEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 022732 22 FVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHA------------------------------------ 65 (293)
Q Consensus 22 ~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~------------------------------------ 65 (293)
..|+|| +++.|.+|.......-...+...++.++...|..||+
T Consensus 90 ~~~~vm-~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 90 MSFAGF-TKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CSCEEE-ECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred cceEEE-cccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 347888 7999999876544333333566677777777777775
Q ss_pred ----------------------cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCc---cch---
Q 022732 66 ----------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY---IAP--- 117 (293)
Q Consensus 66 ----------------------~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y---~aP--- 117 (293)
..++|+|++|.||+++.+....+.++||+.+...... ......... ..|
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSCCHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhccccCHHHH
Confidence 2379999999999998642234789999988643211 000000010 122
Q ss_pred -------------hhhccccCCCchhhhhhhhhHHHHHHhCCCCCC
Q 022732 118 -------------EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 150 (293)
Q Consensus 118 -------------E~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 150 (293)
+...... -. .+.|++|.++|.+.+|..+|.
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~--~~-~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYR--MK-EKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHH--HH-HHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHH--HH-HHHHHHHHHHHHHHcCCHHHH
Confidence 2221111 11 589999999999999987763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.26 E-value=4.3e-07 Score=80.26 Aligned_cols=89 Identities=15% Similarity=0.158 Sum_probs=65.9
Q ss_pred chhhhhceeeec---eeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHH--------------------
Q 022732 9 SEYAMLGVSVKM---KFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHA-------------------- 65 (293)
Q Consensus 9 ~~v~~~~~~~~~---~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~-------------------- 65 (293)
...+++.++.+. +..|+|| ||+.|..+.+.....-...+...++.+++..|..||+
T Consensus 99 pvP~~~~~~~~~~~~g~~~~vm-e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3dxp_A 99 PVAKMYALCEDESVIGRAFYIM-EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQR 177 (359)
T ss_dssp CCCCEEEEECCTTTTSSCEEEE-ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHH
T ss_pred CCCcEEEECCCCCccCCeEEEE-EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHH
Confidence 356777777766 4588999 7999988753211111223677888999999999997
Q ss_pred --------------------------------------cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 66 --------------------------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 66 --------------------------------------~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
.+++|+|++|.||+++.++...+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 178 QIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 368999999999999765432358999998863
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.23 E-value=5.3e-07 Score=75.52 Aligned_cols=79 Identities=16% Similarity=0.027 Sum_probs=56.8
Q ss_pred hhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcC----------------------
Q 022732 10 EYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQ---------------------- 67 (293)
Q Consensus 10 ~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~---------------------- 67 (293)
..++++++...+..|+|| ||+.|.+|. .. .. ....++.++...|..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~-e~i~G~~l~--~~-~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLL-GEVPGQDLL--SS-HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRME 149 (264)
T ss_dssp BCCEEEEEECSSCEEEEE-ECCSSEETT--TS-CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEE-EecCCcccC--cC-cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHh
Confidence 456788888878889999 799999884 21 11 12245556666666666532
Q ss_pred ------------------------------------CeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 68 ------------------------------------VCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 68 ------------------------------------iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
++|+|++|.||+++.+. .+.|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~liD~~~a~ 213 (264)
T 1nd4_A 150 AGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLG 213 (264)
T ss_dssp TTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred cCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence 99999999999996432 35699999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0015 Score=56.22 Aligned_cols=32 Identities=28% Similarity=0.367 Sum_probs=24.3
Q ss_pred CCeecCCCCCcEEEcCC-CCCCE-EEecCCCCcC
Q 022732 67 QVCHRDLKLENTLLDGS-PAPRL-KICDFGYSKS 98 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~-~~~~v-kl~Dfg~a~~ 98 (293)
.++|+|++|.||+++.+ ..+++ .|+||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 46999999999999751 12234 7999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0018 Score=54.24 Aligned_cols=83 Identities=16% Similarity=0.034 Sum_probs=57.5
Q ss_pred hhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHH------------------------
Q 022732 10 EYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHA------------------------ 65 (293)
Q Consensus 10 ~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~------------------------ 65 (293)
..++++++.+.+..|+|| |++.|.++.+...... .....+..++...|.-||.
T Consensus 82 VP~v~~~~~~~~~~~lvm-e~l~G~~~~~~~~~~~--~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLT-TAIPGKTAFQVLEEYP--DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMN 158 (272)
T ss_dssp CCCEEEEEEETTEEEEEE-ECCCSEEHHHHHHHCG--GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEE-EeeCCccccccccCCH--HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHH
Confidence 467888899999999999 7999998877654321 1222344444455555542
Q ss_pred ----------------------------------cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 ----------------------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ----------------------------------~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
..++|+|+.|.||+++..+ .+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~--~~~viDwe~a~ 222 (272)
T 4gkh_A 159 NGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK--LIGCIDVGRVG 222 (272)
T ss_dssp TTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred HhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCe--EEEEEECcccc
Confidence 1278999999999997532 34699999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.88 E-value=0.011 Score=47.98 Aligned_cols=120 Identities=17% Similarity=0.089 Sum_probs=72.7
Q ss_pred chhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCc
Q 022732 34 CLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109 (293)
Q Consensus 34 g~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 109 (293)
.+|.+.|+..+ ++. +++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|. |.+.+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc-----------c
Confidence 47889987764 444 999999999999877632 22234445578999977765 65543 2111 1
Q ss_pred CCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHc
Q 022732 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 189 (293)
Q Consensus 110 gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 189 (293)
....+.|||... .. ...+.=|+|||+++|..+--..| ......+|+++..||..|
T Consensus 99 ~~~~~~~pe~~~-~~-~te~~~IysLG~tLY~ALDygL~-----------------------e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQ-CMETEVIESLGIIIYKALDYGLK-----------------------ENEERELSPPLEQLIDHM 153 (229)
T ss_dssp --------CCSS-SS-SCHHHHHHHHHHHHHHHHTTTCC-----------------------TTEEECCCHHHHHHHHHH
T ss_pred cccCCCChhhcc-cc-chHHHHHHHHHHHHHHHhhcCCC-----------------------cccchhhCHHHHHHHHHH
Confidence 122455787652 12 22336899999999988852211 111234899999999998
Q ss_pred ccc
Q 022732 190 FVA 192 (293)
Q Consensus 190 L~~ 192 (293)
..-
T Consensus 154 t~~ 156 (229)
T 2yle_A 154 ANT 156 (229)
T ss_dssp TTC
T ss_pred Hhc
Confidence 755
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.52 E-value=0.017 Score=49.67 Aligned_cols=30 Identities=27% Similarity=0.461 Sum_probs=25.2
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~--~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE--QIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGG--CEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCC--cEEEEehhhcc
Confidence 5799999999999996443 48999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=94.69 E-value=0.0077 Score=52.56 Aligned_cols=30 Identities=13% Similarity=0.168 Sum_probs=24.3
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
..++|+|++|.||+++. ...+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~--~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRD--FQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEET--TEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeC--CcEEEEEcccccc
Confidence 46999999999999973 2236899999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=93.55 E-value=0.052 Score=48.54 Aligned_cols=32 Identities=19% Similarity=0.257 Sum_probs=26.6
Q ss_pred HHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcC
Q 022732 64 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 98 (293)
Q Consensus 64 H~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~ 98 (293)
+...++|+|++|.||+++.++ ++++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCccccc
Confidence 356799999999999996543 89999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=92.23 E-value=0.12 Score=43.90 Aligned_cols=28 Identities=39% Similarity=0.519 Sum_probs=22.8
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++|+|+.|.||+.+ ++ ++.++||..+.
T Consensus 174 ~l~HgDl~~~Nil~~-~~--~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFLDT-GE--RMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEEEC-SS--CEEECCCTTCE
T ss_pred eeeccCCCcCCEEEC-CC--CEEEEeccccc
Confidence 389999999999953 22 48999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=90.36 E-value=0.13 Score=43.82 Aligned_cols=30 Identities=27% Similarity=0.338 Sum_probs=24.0
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.+++|+|+++.||+++.+. .+.++||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~--~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDE--LSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCc--eEEEecchhcc
Confidence 4699999999999997542 24799998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=90.14 E-value=0.23 Score=42.39 Aligned_cols=28 Identities=18% Similarity=0.170 Sum_probs=23.8
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
..++|+|+++.||+++ + .+.++||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~---~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D---GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S---SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C---CCEEEECCCCC
Confidence 4589999999999997 3 48999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=88.52 E-value=0.17 Score=43.39 Aligned_cols=33 Identities=30% Similarity=0.380 Sum_probs=26.2
Q ss_pred cCCeecCCCCCcEEEcCCC--CCCEEEecCCCCcC
Q 022732 66 MQVCHRDLKLENTLLDGSP--APRLKICDFGYSKS 98 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~--~~~vkl~Dfg~a~~ 98 (293)
..++|+|+.+.||+++.+. .+.+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4699999999999997531 13589999998763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=88.19 E-value=0.55 Score=40.89 Aligned_cols=28 Identities=36% Similarity=0.646 Sum_probs=23.4
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
+++|+|+++.||+++.+ .+.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~---~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK---CLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC----CEEECCCTTCE
T ss_pred EEEeCCCCcccEEecCC---cEEEEEecCCC
Confidence 59999999999999643 38999998775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=86.50 E-value=0.54 Score=41.36 Aligned_cols=30 Identities=20% Similarity=0.237 Sum_probs=24.9
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
...++|+|+.|.||+++.+ .+++.||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~---~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH---ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS---CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC---CeEEEeCcccc
Confidence 3579999999999999654 38999998765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=84.80 E-value=0.55 Score=40.52 Aligned_cols=30 Identities=23% Similarity=0.461 Sum_probs=24.9
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.+++|+|+.+.||+++.++ .+.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~--~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE--SIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGG--CEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCC--eEEEEECCCCe
Confidence 3699999999999996543 48999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=81.95 E-value=0.56 Score=42.00 Aligned_cols=17 Identities=41% Similarity=0.686 Sum_probs=14.7
Q ss_pred CCeecCCCCCcEEEcCC
Q 022732 67 QVCHRDLKLENTLLDGS 83 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~ 83 (293)
.++|+|+.+.||+++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 58999999999999764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=80.78 E-value=0.83 Score=40.22 Aligned_cols=31 Identities=39% Similarity=0.609 Sum_probs=25.1
Q ss_pred CCeecCCCCCcEEEcCC--CCCCEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~--~~~~vkl~Dfg~a~ 97 (293)
.++|+|+.+.||+++.+ ..+.+.++||..|.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 59999999999999765 12358999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=80.30 E-value=0.91 Score=41.06 Aligned_cols=15 Identities=33% Similarity=0.519 Sum_probs=14.1
Q ss_pred CCeecCCCCCcEEEc
Q 022732 67 QVCHRDLKLENTLLD 81 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~ 81 (293)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999997
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 293 | ||||
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-39 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-31 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-31 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-28 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-28 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-28 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-28 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-28 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-27 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-27 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-25 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-22 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-07 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-48
Identities = 63/170 (37%), Positives = 91/170 (53%), Gaps = 8/170 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
A+ FF QL++GV Y H + + HRD+K EN LLD LKI DFG + +++ +
Sbjct: 104 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERL 161
Query: 108 T---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
GT Y+APE+L R E+ + DVWSCG+ L ML G P+ D+P D +
Sbjct: 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSD 218
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
+ + I L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-48
Identities = 59/165 (35%), Positives = 94/165 (56%), Gaps = 10/165 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ + +L + +SYCH+ +V HRD+K EN LL + LKI DFG+S + S+ +
Sbjct: 107 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTT 163
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GT Y+ PE++ +D K D+WS GV Y LVG PFE +++T +RI
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISR 218
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212
V+++ PD +++ RDLISR+ +P+ R + E+++H W N
Sbjct: 219 VEFTFPDF--VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (393), Expect = 1e-45
Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 9/191 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ + +Q G+ + H + H D+K EN + + A +KI DFG + K
Sbjct: 128 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
T T + APE++ R D+W+ GV YV+L G PF D+ +T+Q +
Sbjct: 188 TTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKR 242
Query: 168 VQYSVPDTNP--ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSS 225
+ + +S E +D I + +P R+T+ + ++H W + + + SS
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN--LTSRIPSS 300
Query: 226 QYEEPDQPMQS 236
+Y + Q ++
Sbjct: 301 RYNKIRQKIKE 311
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (384), Expect = 2e-44
Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 8/191 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+A + +Q+ G+ + H H DLK EN + + LK+ DFG + K
Sbjct: 125 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 184
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
T GT + APEV D+WS GV Y++L G PF ++ +T++ + S
Sbjct: 185 TTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKS 239
Query: 168 VQYSVPDTNP--ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSS 225
+++ D+ IS++ +D I ++ +ADP R+TI + ++H W A D + SS
Sbjct: 240 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL-TPGNAPGRDSQIPSS 298
Query: 226 QYEEPDQPMQS 236
+Y + +++
Sbjct: 299 RYTKIRDSIKT 309
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 3e-44
Identities = 45/208 (21%), Positives = 87/208 (41%), Gaps = 9/208 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ + Q+ + + H+ + H D++ EN + + +KI +FG ++ +
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
P Y APEV D+WS G +YV+L G PF ++ I+ I++
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMN 217
Query: 168 VQYSVPDTNP--ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSS 225
+Y+ + IS E D + R+ V + +R+T E ++H W + + V K + +
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER--VSTKVIRT 275
Query: 226 QYEEPDQPMQSVDVIMQIIAEASIPAVG 253
+ +++ A I G
Sbjct: 276 LKHRRYYHTLIKKDLNMVVSAARISCGG 303
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-43
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 4/202 (1%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 106
+A + + + Y H++ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 112 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 171
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ TP Y+APEVL +YD D+WS GV +Y++L G PF RI
Sbjct: 172 TPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230
Query: 167 SVQYSVPDTNP--ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
QY P+ +S+E + LI + +P R+TI E M H W +++ T
Sbjct: 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 290
Query: 225 SQYEEPDQPMQSVDVIMQIIAE 246
E+ ++ + + +A
Sbjct: 291 VLKEDKERWEDVKEEMTSALAT 312
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 1e-42
Identities = 47/215 (21%), Positives = 90/215 (41%), Gaps = 7/215 (3%)
Query: 13 MLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRD 72
L + +++ + + L + Q ++ + + + H+ QV HRD
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIAD 131
+K +N LL +K+ DFG+ +ST VGTP ++APEV+ R Y K D
Sbjct: 142 IKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VD 198
Query: 132 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 191
+WS G+ M+ G P+ + + + + + +S RD ++R
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG---TPELQNPEKLSAIFRDFLNRCLD 255
Query: 192 ADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 226
D R + E+++HQ+ P + +++
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (364), Expect = 3e-42
Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 9/167 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ R + L+ + H + + HRDLK EN LLD +K+ DFG+S + +
Sbjct: 111 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLRE 168
Query: 108 TVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
GTP+Y+APE++ D GK D+WS GV +Y +L G PF + R +
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228
Query: 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+ Q+ P+ + S +DL+SR V P R T E + H +F
Sbjct: 229 SG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-41
Identities = 42/175 (24%), Positives = 79/175 (45%), Gaps = 10/175 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
Q + +Q + ++Y H ++ HRDLK N L +K+ DFG S + Q +
Sbjct: 111 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRD 168
Query: 108 T-VGTPAYIAPEVLLRHEYDGKI----ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
+ +GTP ++APEV++ + ADVWS G+TL M P + + + K
Sbjct: 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228
Query: 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADL 217
+ S ++ + S +D + + + AR T ++++H + + +
Sbjct: 229 K---SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (363), Expect = 1e-41
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 13/176 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ + G++Y H+ + HRD+K N LL +K+ DFG + + + S
Sbjct: 116 EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSAS---IMAPANS 170
Query: 108 TVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
VGTP ++APEV+L +YDGK DVWS G+T + P + + +
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMS----ALYH 225
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 220
I + + S+ R+ + P R T ++KH++ L+ P ++ +
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-41
Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 9/164 (5%)
Query: 48 QARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
R + +Q++ G+ + H + HRDLK +N + G P +KI D G + S
Sbjct: 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFA 170
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
K+ +GTP ++APE+ +YD DV++ G+ + M YP+ + +R+
Sbjct: 171 KAVIGTPEFMAPEMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRV 225
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209
S E +++I + R +I +++ H +F
Sbjct: 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-39
Identities = 63/199 (31%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 13 MLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLL--VQARFFFQQLISGVSYCHAMQVCH 70
+L + L L + F ++ G L AR FF Q++ V +CH V H
Sbjct: 74 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 133
Query: 71 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 130
RD+K EN L+D + LK+ DFG + + GT Y PE + H Y G+ A
Sbjct: 134 RDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 191
Query: 131 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 190
VWS G+ LY M+ G PFE +E I+ Q +S EC+ LI
Sbjct: 192 AVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSECQHLIRWCL 239
Query: 191 VADPAARITIPEIMKHQWF 209
P+ R T EI H W
Sbjct: 240 ALRPSDRPTFEEIQNHPWM 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-39
Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 13 MLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLVQ-ARFFFQQLISGVSYCHAMQVCHR 71
+ V V L L LF L + A F +Q+++GV Y H++Q+ H
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 72 DLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 129
DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LE 196
Query: 130 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLIS 187
AD+WS GV Y++L G PF + + T+ + +V Y D S +D I
Sbjct: 197 ADMWSIGVITYILLSGASPFLGDTKQE----TLANVSAVNYEFEDEYFSNTSALAKDFIR 252
Query: 188 RIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 230
R+ V DP R+TI + ++H W ++ +SS + P
Sbjct: 253 RLLVKDPKKRMTIQDSLQHPWI-----KPKDTQQALSSAWSHP 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 3e-39
Identities = 58/185 (31%), Positives = 85/185 (45%), Gaps = 8/185 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPK 106
A Q++ V Y H + + HRDLK EN L ++ I DFG SK S
Sbjct: 108 DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ GTP Y+APEVL + Y D WS GV Y++L G PF D ++ K ++IL
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAK----LFEQIL 222
Query: 167 SVQYSVPDTNP--ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 224
+Y IS +D I + DP R T + ++H W + D +++S
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVS 282
Query: 225 SQYEE 229
Q ++
Sbjct: 283 EQIKK 287
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 7e-39
Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 17/183 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
RF+ +++S + Y H + HRDLK EN LL+ ++I DFG +K S+
Sbjct: 109 CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQAR 166
Query: 108 T---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
VGT Y++PE+L +D+W+ G +Y ++ G PF +E Q+
Sbjct: 167 ANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEY----LIFQK 221
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW-----FLKNLPADLVD 219
I+ ++Y P+ + RDL+ ++ V D R+ E+ + F +++ + +
Sbjct: 222 IIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279
Query: 220 EKT 222
++T
Sbjct: 280 QQT 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-38
Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 43/220 (19%)
Query: 48 QARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 106
+I G++Y + HRD+K N L++ +K+CDFG S ++ S
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQ-LIDSMAN 161
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------------ 154
S VGT +Y++PE L Y + +D+WS G++L M VG YP PD
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220
Query: 155 --------------------------PKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 188
P + + I++ + S E +D +++
Sbjct: 221 GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280
Query: 189 IFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYE 228
+ +PA R + ++M H + ++ ++ + S
Sbjct: 281 CLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIG 320
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-38
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 14/167 (8%)
Query: 48 QARFFFQQLISGVSYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 102
QL + CH V HRDLK N LDG +K+ DFG ++
Sbjct: 110 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHD 167
Query: 103 SQPKSTVG-TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
+ TP Y++PE + R Y+ K +D+WS G LY + PF + ++
Sbjct: 168 TSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQ----KEL 222
Query: 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208
+I ++ S E ++I+R+ R ++ EI+++
Sbjct: 223 AGKIREGKFRRIPYR-YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-36
Identities = 37/175 (21%), Positives = 72/175 (41%), Gaps = 8/175 (4%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH 102
+++ +Q G+ Y HA + HRDLK N L +KI DFG +
Sbjct: 103 MIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGS 160
Query: 103 SQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160
Q + G+ ++APEV+ + + +DV++ G+ LY ++ G P+ + +
Sbjct: 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220
Query: 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH-QWFLKNLP 214
+ R + + + L++ R P+I+ + ++LP
Sbjct: 221 MVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (326), Expect = 3e-36
Identities = 58/188 (30%), Positives = 97/188 (51%), Gaps = 17/188 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
A+F+ ++ + Y H+ + +RDLK EN LLD + +KI DFG++K + +
Sbjct: 105 VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYT 160
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GTP YIAPEV+ Y+ D WS G+ +Y ML G PF D + KT ++IL+
Sbjct: 161 LCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILN 215
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKT 222
+ P +++ +DL+SR+ D + R+ ++ H WF K + + + +
Sbjct: 216 AELRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF-KEVVWEKLLSRN 272
Query: 223 MSSQYEEP 230
+ + YE P
Sbjct: 273 IETPYEPP 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 9e-36
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 26/222 (11%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ + QL ++Y H+ +CHRD+K +N LLD A K+CDFG +K V S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
+ + Y APE++ DVWS G L +L+G F + I+ + +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 168 -------------VQYSVPDTNP----------ISQECRDLISRIFVADPAARITIPEIM 204
++ P E L SR+ P AR+T E
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 205 KHQWF--LKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQII 244
H +F L++ L + + + + Q + S + I+
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATIL 343
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 129 bits (325), Expect = 1e-35
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 12/185 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
RF+ ++I G+ + H V +RDLK N LLD ++I D G + +P +
Sbjct: 108 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHA 164
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
+VGT Y+APEVL + AD +S G L+ +L G PF + KD + + L+
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLT 223
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIP-----EIMKHQWFLKNLPADLVDEKT 222
+ +PD+ S E R L+ + D R+ E+ + +F ++L +V +
Sbjct: 224 MAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF-RSLDWQMVFLQK 280
Query: 223 MSSQY 227
Sbjct: 281 YPPPL 285
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-35
Identities = 61/184 (33%), Positives = 98/184 (53%), Gaps = 12/184 (6%)
Query: 46 LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 105
L +A F+ ++I G+ + H+ + +RDLKL+N LLD +KI DFG K ++L
Sbjct: 102 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAK 159
Query: 106 KST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+T GTP YIAPE+LL +Y+ D WS GV LY ML+G PF DE +
Sbjct: 160 TNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHS 214
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP-EIMKHQWFLKNLPADLVDEKTM 223
I P + +E +DL+ ++FV +P R+ + +I +H F + + + ++ K +
Sbjct: 215 IRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF-REINWEELERKEI 271
Query: 224 SSQY 227
+
Sbjct: 272 DPPF 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-34
Identities = 47/181 (25%), Positives = 72/181 (39%), Gaps = 24/181 (13%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
+ QL+ G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ S V
Sbjct: 119 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVV 176
Query: 110 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL--- 166
T Y APEVLL+ Y D+WS G M F + K + I
Sbjct: 177 VTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 167 ------------------SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 208
S Q I + +DL+ + +PA RI+ + H +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295
Query: 209 F 209
F
Sbjct: 296 F 296
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-33
Identities = 50/227 (22%), Positives = 82/227 (36%), Gaps = 27/227 (11%)
Query: 13 MLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-LVQARFFFQQLISGVSYCHAMQVCHR 71
+L + L F + + L L + + + G+ Y H + HR
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 72 DLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 130
DLK N LLD + LK+ DFG +KS + V T Y APE+L G
Sbjct: 125 DLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 131 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--------------- 175
D+W+ G L +L+ + + + + +
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 176 -------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215
+ + DLI +F+ +P ARIT + +K ++F N P
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPG 288
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 3e-33
Identities = 58/186 (31%), Positives = 95/186 (51%), Gaps = 16/186 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 106
+ARF+ +++S + Y H+ V +RD+KLEN +LD +KI DFG K + K
Sbjct: 106 RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMK 163
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ GTP Y+APEVL ++Y D W GV +Y M+ G PF + D + + IL
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELIL 218
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEK 221
+ P T +S E + L++ + DP R+ E+M+H++F ++ V +K
Sbjct: 219 MEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-LSINWQDVVQK 275
Query: 222 TMSSQY 227
+ +
Sbjct: 276 KLLPPF 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (305), Expect = 4e-33
Identities = 40/194 (20%), Positives = 79/194 (40%), Gaps = 33/194 (17%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
RF+ +++ + YCH+M + HRD+K N ++D +L++ D+G ++ +
Sbjct: 130 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
V + + PE+L+ ++ D+WS G L M+ PF + D I ++L
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 168 VQY--------------------------------SVPDTNPISQECRDLISRIFVADPA 195
+ + + +S E D + ++ D
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 196 ARITIPEIMKHQWF 209
+R+T E M+H +F
Sbjct: 309 SRLTAREAMEHPYF 322
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-32
Identities = 38/171 (22%), Positives = 67/171 (39%), Gaps = 11/171 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP 105
Q Q+ SG++Y M HRDL+ N L+ + K+ DFG ++ ++
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTAR 171
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
+ + APE L + K +DVWS G+ L + G ++ ++R
Sbjct: 172 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER- 229
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK--HQWFLKNLP 214
Y +P + DL+ + + +P R T + +F P
Sbjct: 230 ---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 6e-32
Identities = 46/202 (22%), Positives = 75/202 (37%), Gaps = 34/202 (16%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLH 102
+ + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG ++ +
Sbjct: 118 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQP 175
Query: 103 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162
++ + V T Y PE+LL G D+W G + M + E
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
Query: 163 QRILSVQYSVPD--------------------------TNPISQECRDLISRIFVADPAA 196
Q S+ V DLI ++ V DPA
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295
Query: 197 RITIPEIMKHQWFLKN-LPADL 217
RI + + H +F + +P+DL
Sbjct: 296 RIDSDDALNHDFFWSDPMPSDL 317
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 6e-32
Identities = 51/229 (22%), Positives = 87/229 (37%), Gaps = 34/229 (14%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHS 103
+F Q++ G+ Y H+ V HRDLK N LL+ + LKICDFG ++
Sbjct: 110 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTG 167
Query: 104 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
V T Y APE++L + K D+WS G L ML F +
Sbjct: 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
Query: 164 ----------------RILSVQYSVPDTNP---------ISQECRDLISRIFVADPAARI 198
+ + S+P N + DL+ ++ +P RI
Sbjct: 228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287
Query: 199 TIPEIMKHQWFLKNLPADLVDEKTMSSQYE-EPDQPMQSVDVIMQIIAE 246
+ + + H + + D DE + ++ + + + + ++I E
Sbjct: 288 EVEQALAHPYLEQY--YDPSDEPIAEAPFKFDMELDDLPKEKLKELIFE 334
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-31
Identities = 46/186 (24%), Positives = 82/186 (44%), Gaps = 26/186 (13%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ + QL+ G+++CH+ +V HRDLK +N L++ +K+ DFG +++ + + +
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYT 160
Query: 108 T-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ--- 163
V T Y APE+LL +Y D+WS G M+ F E + +
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220
Query: 164 ----RILSVQYSVPDTNP----------------ISQECRDLISRIFVADPAARITIPEI 203
+ S+PD P + ++ R L+S++ DP RI+
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 204 MKHQWF 209
+ H +F
Sbjct: 281 LAHPFF 286
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-31
Identities = 59/266 (22%), Positives = 106/266 (39%), Gaps = 43/266 (16%)
Query: 18 VKMKFVFLSLSFFFSLCLFFMWLLLLGLLV------------QARFFFQQLISGVSYCHA 65
+ + VF F++ + +G + + +F Q++ G+ Y HA
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 125
+ HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 140 AGIIHRDLKPGNLAVNEDC--ELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMR 195
Query: 126 DGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQRILSVQY- 170
+ D+WS G + M+ G F+ D P +F + +Q + Y
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 171 -SVPDTNP---------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 220
+P+ S +L+ ++ V D R+T E + H +F ++L D DE
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-ESLH-DTEDE 313
Query: 221 KTMSSQYEEPDQPMQSVDVIMQIIAE 246
+ + D +++D ++ +
Sbjct: 314 PQVQKYDDSFDDVDRTLDEWKRVTYK 339
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-31
Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ F QL+ G+ +CH+ V HRDLK +N L++ + LK+ +FG +++ + + S
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYS 159
Query: 108 -TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
V T Y P+VL + D+WS G + G P ++ D K I R+L
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
Query: 167 --------SVQYSVPDTNP----------------ISQECRDLISRIFVADPAARITIPE 202
+PD P ++ RDL+ + +P RI+ E
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 203 IMKHQWFLKNLP 214
++H +F P
Sbjct: 280 ALQHPYFSDFCP 291
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 115 bits (289), Expect = 3e-31
Identities = 34/205 (16%), Positives = 71/205 (34%), Gaps = 17/205 (8%)
Query: 18 VKMKFVFLSLSFFFSLCLFFMWLLLLGLL------------VQARFFFQQLISGVSYCHA 65
V + + + L M + L +A +++ H
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 66 MQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLRH 123
+ HRD+K N ++ + A ++ + S +Q + +GT Y++PE
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 124 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 183
D + +DV+S G LY +L G PF + ++ + + +S +
Sbjct: 190 SVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG--LSADLD 246
Query: 184 DLISRIFVADPAARITIPEIMKHQW 208
++ + +P R M+
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-31
Identities = 32/159 (20%), Positives = 58/159 (36%), Gaps = 9/159 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
F + + Y HRDL N L+ K+ DFG +K S +
Sbjct: 104 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKE--ASSTQDT 159
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
+ APE L ++ K +DVWS G+ L+ + G KD +++
Sbjct: 160 GKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--- 215
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
Y + + +++ + D A R + ++ +
Sbjct: 216 -GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (292), Expect = 4e-31
Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 17/185 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
ARF+ Q++ Y H++ + +RDLK EN L+D +++ DFG++K + +
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWT 197
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
GTP +APE++L Y+ D W+ GV +Y M G PF + ++I+S
Sbjct: 198 LCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVS 252
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKT 222
+ P S + +DL+ + D R + +I H+WF + ++
Sbjct: 253 GKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF-ATTDWIAIYQRK 309
Query: 223 MSSQY 227
+ + +
Sbjct: 310 VEAPF 314
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-30
Identities = 34/162 (20%), Positives = 61/162 (37%), Gaps = 9/162 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 104
F Q+ G+ + HRDL N L+ +KICDFG ++ S +
Sbjct: 165 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLARDIMSDSNYVV 222
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+ ++APE L Y K +DVWS G+ L+ + G P +
Sbjct: 223 RGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVN---PYPGIPVDANFYK 278
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
++ + + ++E ++ + D R + P +
Sbjct: 279 LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 4e-30
Identities = 46/186 (24%), Positives = 84/186 (45%), Gaps = 9/186 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ + + +++ + + H + + +RD+KLEN LLD + L + +
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189
Query: 108 TVGTPAYIAPEVLLRHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
GT Y+AP+++ + K D WS GV +Y +L G PF E + +RIL
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEK 221
+ P +S +DLI R+ + DP R+ EI +H +F + + D + K
Sbjct: 250 KSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF-QKINWDDLAAK 306
Query: 222 TMSSQY 227
+ + +
Sbjct: 307 KVPAPF 312
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 7e-30
Identities = 36/170 (21%), Positives = 69/170 (40%), Gaps = 10/170 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 104
+ Q+ G++Y ++ HRDL N L+ +KI DFG +K +
Sbjct: 112 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYH 169
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+ ++A E +L Y + +DVWS GVT++ ++ G D + I
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE----ISS 224
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214
IL +P + + ++ + ++ D +R E++ + P
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 8e-30
Identities = 36/159 (22%), Positives = 61/159 (38%), Gaps = 7/159 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
Q F + G+ Y Q HRDL N L+ + KI DFG S+ ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
++A E L Y +DVWS GV L+ ++ G + + + +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--- 241
Query: 168 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
Y + E DL+ + + P R + +I+
Sbjct: 242 -GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 111 bits (278), Expect = 2e-29
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 34/224 (15%)
Query: 18 VKMKFVFLSLSFFFSLCLFFMWLLLLGLL--------VQARFFFQQLISGVSYCHAMQVC 69
VK+ V + + L L V A+ F QL++G++YCH +V
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 70 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGK 128
HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 123 HRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 129 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------YSVPDTNP---- 177
D+WS G M+ G F E + + + + +P +P
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 178 ------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 209
+ + DL+S++ DP RIT + ++H +F
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 4e-29
Identities = 45/224 (20%), Positives = 82/224 (36%), Gaps = 31/224 (13%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+F Q++ G+ Y H+ + HRDLK N ++ LKI DFG ++ +
Sbjct: 122 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTG 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
V T Y APE++L + + D+WS G + +L G F D + ++ + +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 168 VQYSVPDTNP-------------------------ISQECRDLISRIFVADPAARITIPE 202
+ + DL+ ++ V D RIT +
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 203 IMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAE 246
+ H +F + D DE + + +D + +
Sbjct: 298 ALAHAYFAQYHDPD--DEPVADPYDQSFESRDLLIDEWKSLTYD 339
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-28
Identities = 33/194 (17%), Positives = 67/194 (34%), Gaps = 15/194 (7%)
Query: 32 SLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 91
L F + F Q+ G+ + + + HRDL N +LD +K+
Sbjct: 115 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVA 172
Query: 92 DFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 146
DFG ++ ++A E L ++ K +DVWS GV L+ ++ G
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRG 231
Query: 147 YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
P D + + + +++ + + R + E++
Sbjct: 232 APPYPDVNTFDITVYLLQ----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
Query: 207 QWFLKNLPADLVDE 220
+ + + + E
Sbjct: 288 ---ISAIFSTFIGE 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (272), Expect = 2e-28
Identities = 35/161 (21%), Positives = 65/161 (40%), Gaps = 10/161 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 104
+ +Q+ +G++Y + HRDL N L+ + +KI DFG S+ S+ +
Sbjct: 141 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKA 198
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+ ++ PE + + Y + +DVW+ GV L+ + G P + I
Sbjct: 199 DGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGMAHEEVIYY 254
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
+ N E +L+ + PA R + I +
Sbjct: 255 VRDGNILACPEN-CPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-28
Identities = 33/162 (20%), Positives = 57/162 (35%), Gaps = 8/162 (4%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 104
+ Q+ G+ Y + + HRDL N LL +KI DFG + + H
Sbjct: 112 TLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDDHYV 169
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+ P L+ +D W GVTL+ M G P + + + +
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHK 226
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
I +P Q+ +++ + + P R T +
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 3e-28
Identities = 35/169 (20%), Positives = 61/169 (36%), Gaps = 14/169 (8%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHS 103
Q+ G+ Y HRDL N LL + I DFG SK ++
Sbjct: 110 NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYT 167
Query: 104 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
+ + APE + ++ + +DVWS GVT++ L G P + + +
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQK---PYKKMKGPEVMA 223
Query: 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI---MKHQWF 209
I + + E L+S ++ R + M+ ++
Sbjct: 224 FIEQGKR-MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 6e-28
Identities = 32/166 (19%), Positives = 60/166 (36%), Gaps = 11/166 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ Q+ G+++ HRDL+ N L+ KI DFG ++ +
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAR 167
Query: 108 T--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
+ APE + + K +DVWS G+ L ++ G + + ++R
Sbjct: 168 EGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER- 225
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK--HQWF 209
Y + + +E L+ + P R T + +F
Sbjct: 226 ---GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 7e-28
Identities = 38/198 (19%), Positives = 77/198 (38%), Gaps = 11/198 (5%)
Query: 13 MLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLL--VQARFFFQQLISGVSYCHAMQVCH 70
+ GV K + +F+ + + CL + Q + + + Y + Q H
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 71 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGK 128
RDL N L++ +K+ DFG S+ + S + PEVL+ ++ K
Sbjct: 124 RDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 129 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 188
+D+W+ GV ++ + G P E +T + I + + S++ ++
Sbjct: 182 -SDIWAFGVLMWEIYSLGKM---PYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYS 236
Query: 189 IFVADPAARITIPEIMKH 206
+ R T ++ +
Sbjct: 237 CWHEKADERPTFKILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 7e-28
Identities = 30/161 (18%), Positives = 59/161 (36%), Gaps = 9/161 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP 105
+ G++Y V HRDL N L+ + +K+ DFG ++ ++
Sbjct: 102 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSS 159
Query: 106 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
T + +PEV Y K +DVWS GV ++ + G + + + I
Sbjct: 160 TGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST- 217
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
+ + S +++ + P R +++
Sbjct: 218 ---GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 9e-28
Identities = 34/161 (21%), Positives = 68/161 (42%), Gaps = 9/161 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ QL + ++Y + + HRD+ N L+ + +K+ DFG S+ + K+
Sbjct: 109 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKA 166
Query: 108 T--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 165
+ ++APE + + +DVW GV ++ +L+ G P + I RI
Sbjct: 167 SKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRI 222
Query: 166 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
+ + +P L+++ + DP+ R E+
Sbjct: 223 ENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (266), Expect = 1e-27
Identities = 33/165 (20%), Positives = 62/165 (37%), Gaps = 13/165 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 101
Q + + +G+ Y M HRDL N L++ + K+ DFG S+ S
Sbjct: 129 QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPT 186
Query: 102 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161
++ + APE + ++ +DVWS G+ ++ ++ G +D
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
I++ Y +P L+ + D R +I+
Sbjct: 246 IEQ----DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (265), Expect = 1e-27
Identities = 36/179 (20%), Positives = 76/179 (42%), Gaps = 11/179 (6%)
Query: 47 VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQ 104
V + Q+ S + Y HRDL N L+ + +K+ DFG S+ + ++
Sbjct: 115 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTA 172
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+ APE L +++ K +DVW+ GV L+ + G + + +++
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK--HQWFLKNLPADLVDEK 221
Y + ++ +L+ + +P+ R + EI + F ++ +D V+++
Sbjct: 232 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 1e-27
Identities = 36/182 (19%), Positives = 66/182 (36%), Gaps = 14/182 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHS 103
Q + + +G+ Y M HRDL N L++ + K+ DFG S+
Sbjct: 111 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATY 168
Query: 104 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
+ APE + ++ +DVWS G+ ++ ++ G + K I
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 227
Query: 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTM 223
+ +P L+ + + + A R +I+ L P L KT+
Sbjct: 228 D----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL---KTL 280
Query: 224 SS 225
+
Sbjct: 281 AD 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-27
Identities = 33/173 (19%), Positives = 59/173 (34%), Gaps = 13/173 (7%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHS 103
Q+ G+ Y HRDL N LL KI DFG SK+ +
Sbjct: 108 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYK 165
Query: 104 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163
+ APE + +++ K +DVWS GV ++ G + + ++
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224
Query: 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI--MKHQWFLKNLP 214
+ + +E DL++ + D R + ++ +
Sbjct: 225 K----GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (261), Expect = 5e-27
Identities = 36/184 (19%), Positives = 67/184 (36%), Gaps = 17/184 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------S 98
Q+IS + Y H+ HRD+K +N L+ G + I DFG +K
Sbjct: 104 TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163
Query: 99 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158
+ + + K+ GT Y + L E + D+ S G L +G P++
Sbjct: 164 HIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKR 222
Query: 159 RKTIQRILSVQYSVPD---TNPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLKN 212
+K +RI + S P E ++ + + ++ ++ + +
Sbjct: 223 QK-YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
Query: 213 LPAD 216
D
Sbjct: 282 FSYD 285
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 8e-27
Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 9/162 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 104
+ Q+ G+ + + + HRDL N LL +KICDFG ++ + +
Sbjct: 135 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPDYVR 192
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
++APE + Y + +DVWS GV L+ + G P + R
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCR 248
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
L + + + E + + +P+ R T E+++H
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 103 bits (258), Expect = 1e-26
Identities = 30/172 (17%), Positives = 60/172 (34%), Gaps = 16/172 (9%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSK------- 97
+Q+++ V H + +RD+K +N L+ + + + DFG K
Sbjct: 102 TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161
Query: 98 -SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156
+ + + K+ GT Y++ L E + D+ + G L G P++
Sbjct: 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAAT 220
Query: 157 DFRKTIQRILSVQYSVPDTNP---ISQECRDLISRIFVADPAARITIPEIMK 205
+ +K +RI + S P +E + A +
Sbjct: 221 NKQK-YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-25
Identities = 49/233 (21%), Positives = 94/233 (40%), Gaps = 39/233 (16%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
+ + Q++ G+ + H+ + HRDLK N ++ LKI DFG ++++
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTP 177
Query: 108 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 167
V T Y APEV+L Y + D+WS G + M+ F D + K I+++ +
Sbjct: 178 YVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 168 -----------------------VQYSVPDTNP-------------ISQECRDLISRIFV 191
+ P P + + RDL+S++ V
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 192 ADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQII 244
DPA RI++ + ++H + V+ ++ D+ +++ ++I
Sbjct: 297 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 9e-25
Identities = 36/161 (22%), Positives = 62/161 (38%), Gaps = 9/161 (5%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 107
F Q+ G+++ + HRDL N LL KICDFG ++ S
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKNDSNYVV 203
Query: 108 T---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
++APE + Y + +DVWS G+ L+ + G +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS---KFYK 259
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205
++ + + E D++ + ADP R T +I++
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 3e-24
Identities = 28/160 (17%), Positives = 60/160 (37%), Gaps = 6/160 (3%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPK 106
Q+ G+ Y + + HRDL N L+ ++ + +
Sbjct: 136 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 107 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 166
+ ++APE L Y + +DVWS GV L+ + G ++ K ++
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-- 252
Query: 167 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
+ + + + E ++ + A P+ R T ++++
Sbjct: 253 --GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.8 bits (242), Expect = 6e-24
Identities = 41/216 (18%), Positives = 78/216 (36%), Gaps = 46/216 (21%)
Query: 46 LVQARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLH 102
L+ + +QL+ G+ Y H + H D+K EN L++ SP ++I +
Sbjct: 124 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 103 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK-- 160
+++ T Y +PEVLL + AD+WS ++ ++ G + FE + +
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242
Query: 161 TIQRILSVQYSVPD----------------------------------------TNPISQ 180
I +I+ + +P + ++
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302
Query: 181 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 216
E D +S + DP R ++ H W L +
Sbjct: 303 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 7e-22
Identities = 29/162 (17%), Positives = 65/162 (40%), Gaps = 10/162 (6%)
Query: 48 QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 104
+ ++ G++Y +A + HRDL N ++ +KI DFG ++ + + +
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRK 191
Query: 105 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 164
+ +++PE L + DVWS GV L+ + P + + ++
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRF 247
Query: 165 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206
++ + + +L+ + +P R + EI+
Sbjct: 248 VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 9e-21
Identities = 39/192 (20%), Positives = 69/192 (35%), Gaps = 36/192 (18%)
Query: 48 QARFFFQQLISGVSYCHA--------MQVCHRDLKLENTLLDGSPAPRLKICDFG----- 94
SG+++ H + HRDLK +N L+ + I D G
Sbjct: 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRH 158
Query: 95 YSKSSVLHSQPKSTVGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPF 149
S + + P VGT Y+APEVL ++H K AD+++ G+ + +
Sbjct: 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218
Query: 150 E---------------DPDEPKDFRKTIQRILSVQY-SVPDTNPISQECRDLISRIFVAD 193
DP + + ++ L + + + ++ + A+
Sbjct: 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278
Query: 194 PAARITIPEIMK 205
AAR+T I K
Sbjct: 279 GAARLTALRIKK 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 48.2 bits (114), Expect = 2e-07
Identities = 15/89 (16%), Positives = 27/89 (30%), Gaps = 14/89 (15%)
Query: 50 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 109
++ V+ + + H DL N L+ + I DF SV +
Sbjct: 106 DEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP---QSVEVGEEGW-- 157
Query: 110 GTPAYIAPEVLLRHEYDGK----IADVWS 134
+ +V Y + D+ S
Sbjct: 158 --REILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 293 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.55 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.34 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.87 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 87.01 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=355.32 Aligned_cols=203 Identities=33% Similarity=0.512 Sum_probs=171.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|++++++.+.+.+|+|| |||.||+|++++++.+.++ +++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 61 ~HpnIv~~~~~~~~~~~~~ivm-Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~ 139 (271)
T d1nvra_ 61 NHENVVKFYGHRREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 139 (271)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCCCEeeEeeeeccCceeEEEE-eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC
Confidence 5999999999999999999999 7999999999998777665 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+ ++||+|||+|+..... ....+.+||+.|||||++.+..+.++++||||+||++|+|++|+.||...........
T Consensus 140 ~--~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~ 217 (271)
T d1nvra_ 140 D--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217 (271)
T ss_dssp C--CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH
T ss_pred C--CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 5 5999999999854322 2345668999999999998888877779999999999999999999987655433222
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 214 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~ 214 (293)
.. .......+.+..+|+++++||.+||++||++|||++++++||||++..+
T Consensus 218 ~~---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 218 DW---KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp HH---HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HH---hcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 22 2222233334568999999999999999999999999999999986543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=349.24 Aligned_cols=195 Identities=33% Similarity=0.555 Sum_probs=170.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|.+.+++|+|| |||.||+|.+++.+.+.+. +++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 64 ~hpnIv~~~~~~~~~~~~~ivm-Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~ 142 (263)
T d2j4za1 64 RHPNILRLYGYFHDATRVYLIL-EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA 142 (263)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred CCCCCCeEEEEEEECCEEEEEE-eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC
Confidence 6999999999999999999999 7999999999999887766 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ ++||+|||+|+.... .......||+.|||||++.+..++.+ +||||+||++|+|++|+.||.+.+... ...
T Consensus 143 ~--~~kl~DFG~a~~~~~-~~~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~----~~~ 214 (263)
T d2j4za1 143 G--ELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQE----TYK 214 (263)
T ss_dssp S--CEEECCCCSCSCCCC-CCCEETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH
T ss_pred C--CEeecccceeeecCC-CcccccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHHH----HHH
Confidence 5 599999999986533 33456689999999999998887655 999999999999999999998876533 334
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
.+......+| ..+|+++++||.+||++||.+|||++++|+||||..
T Consensus 215 ~i~~~~~~~p--~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 215 RISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHTTCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHcCCCCCC--ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 4445554444 348999999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=347.54 Aligned_cols=201 Identities=22% Similarity=0.336 Sum_probs=170.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 84 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~ 84 (293)
.|+|+|+++++|.+.+++|+|| |||.||+|.+++.++..-. +++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 75 ~HpnIv~~~~~~~~~~~~~ivm-Ey~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~ 153 (293)
T d1yhwa1 75 KNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153 (293)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred CCCCEeeEeEEEEECCEEEEEE-EecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC
Confidence 5899999999999999999999 7999999999887754333 9999999999999999999999999999999997654
Q ss_pred CCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 85 APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 85 ~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
++||+|||+|+..... ......+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+....+..+..
T Consensus 154 --~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 230 (293)
T d1yhwa1 154 --SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (293)
T ss_dssp --CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred --cEeeccchhheeeccccccccccccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh
Confidence 5999999999865433 33455679999999999998887654 9999999999999999999988776554443333
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
. .....+.+..+|+++++||.+||.+||.+|||+.++|+||||+...
T Consensus 231 ~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 231 N---GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp H---CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred C---CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 2 2233444556899999999999999999999999999999997543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-50 Score=351.60 Aligned_cols=201 Identities=31% Similarity=0.517 Sum_probs=160.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|.+.+++|+|| |||.||+|.+++...+.++ +++.++.||+.||.|||++||+||||||+||++...
T Consensus 65 ~HpnIv~l~~~~~~~~~~~lvm-E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~ 143 (307)
T d1a06a_ 65 KHPNIVALDDIYESGGHLYLIM-QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 143 (307)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred CCCCCCcEEEEEEECCEEEEEE-eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc
Confidence 6899999999999999999999 7999999999999887776 999999999999999999999999999999999652
Q ss_pred -CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 -PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
..+++||+|||+|+.........+.+||+.|||||++.+..++.+ +||||+||++|+|++|+.||.+.......
T Consensus 144 ~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~---- 218 (307)
T d1a06a_ 144 DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLF---- 218 (307)
T ss_dssp STTCCEEECCC------------------CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----
T ss_pred CCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHH----
Confidence 345799999999987665556667789999999999988887655 99999999999999999999987664433
Q ss_pred HHHhccccCC--CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
..+....... +.+..+|+++++||.+||++||.+|||++|+++||||+..
T Consensus 219 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 3344443333 3445689999999999999999999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=342.85 Aligned_cols=197 Identities=25% Similarity=0.456 Sum_probs=167.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|.+.+.+|+|| |||.||+|.+++...+.++ +++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 66 ~HpnIv~l~~~~~~~~~~~ivm-Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~ 144 (288)
T d1uu3a_ 66 DHPFFVKLYFTFQDDEKLYFGL-SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 144 (288)
T ss_dssp CSTTBCCEEEEEECSSEEEEEE-CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CCCCeeEEEEEEEECCEEEEEE-EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC
Confidence 6899999999999999999999 7999999999999888776 899999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+ ++||+|||+|+..... ....+.+||+.|+|||++.+..++. ++||||+||++|+|++|+.||.+.+...
T Consensus 145 ~--~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~---- 217 (288)
T d1uu3a_ 145 M--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEYL---- 217 (288)
T ss_dssp S--CEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHH----
T ss_pred c--eEEecccccceecccCCcccccccccCCccccCceeeccCCCCc-ccceehhhHHHHHHhhCCCCCCCcCHHH----
Confidence 5 5999999999865322 2334568999999999998888765 4999999999999999999999876543
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHH------HHcCcccccC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE------IMKHQWFLKN 212 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e------ll~h~~~~~~ 212 (293)
+..++......+| ..+|+++++||.+||++||.+|||++| +++||||+.-
T Consensus 218 ~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 218 IFQKIIKLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHHHHTTCCCCC--TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHcCCCCCC--ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 3444555555444 458999999999999999999999987 6889999653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=349.45 Aligned_cols=202 Identities=25% Similarity=0.383 Sum_probs=163.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~-~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++++|.+.+++|+|| ||+.||+|.+++.+.+.+. .++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 62 ~HpnIv~l~~~~~~~~~~~iVm-Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~ 140 (322)
T d1s9ja_ 62 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 140 (322)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT
T ss_pred CCCCCCcEEEEEEECCEEEEEE-EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC
Confidence 5899999999999999999999 7999999999999887766 899999999999999997 59999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH--
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK-- 160 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-- 160 (293)
++ ++||+|||+|+.... ....+.+||+.|+|||++.+..|+.+ +||||+||++|||++|+.||.+.+.......
T Consensus 141 ~~--~vkl~DFGla~~~~~-~~~~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 216 (322)
T d1s9ja_ 141 RG--EIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216 (322)
T ss_dssp TC--CEEECCCCCCHHHHH-HTC---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-
T ss_pred CC--CEEEeeCCCccccCC-CccccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 54 599999999985432 33456789999999999999888766 9999999999999999999987654221000
Q ss_pred ------------------------------------HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 022732 161 ------------------------------------TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 204 (293)
Q Consensus 161 ------------------------------------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell 204 (293)
....+............+|.++++||.+||++||.+|||++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L 296 (322)
T d1s9ja_ 217 CQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296 (322)
T ss_dssp -----------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 01111111111111123689999999999999999999999999
Q ss_pred cCcccccC
Q 022732 205 KHQWFLKN 212 (293)
Q Consensus 205 ~h~~~~~~ 212 (293)
+||||++.
T Consensus 297 ~Hpf~~~~ 304 (322)
T d1s9ja_ 297 VHAFIKRS 304 (322)
T ss_dssp TSHHHHHH
T ss_pred hCHhhCcC
Confidence 99999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=344.88 Aligned_cols=201 Identities=30% Similarity=0.502 Sum_probs=173.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|.+.+++|+|| |||.||+|.+++...+.++ +++.++.||+.||+|||++||+||||||+||+++.+
T Consensus 71 ~HpnIv~~~~~~~~~~~~~iv~-E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~ 149 (293)
T d1jksa_ 71 QHPNVITLHEVYENKTDVILIL-ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 149 (293)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS
T ss_pred CCCCCCcEEEEEEECCEEEEEE-EcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecC
Confidence 5899999999999999999999 7999999999998887766 899999999999999999999999999999999765
Q ss_pred CC--CCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 84 PA--PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 84 ~~--~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
+. .++||+|||+|+.........+..||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+....+
T Consensus 150 ~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~--- 225 (293)
T d1jksa_ 150 NVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETL--- 225 (293)
T ss_dssp SSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH---
T ss_pred CCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHH---
Confidence 43 3599999999987766666677789999999999988777555 99999999999999999999987764443
Q ss_pred HHHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
..+.......+ .+..+|.++++||++||++||.+|||++++++||||+..
T Consensus 226 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 226 -ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp -HHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred -HHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 33333433332 224589999999999999999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-49 Score=352.56 Aligned_cols=201 Identities=25% Similarity=0.389 Sum_probs=172.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++++|.+.+++|+|| |||.||+|.+++.. .+.++ +++.++.||+.||.|||++||+||||||+|||++.
T Consensus 81 ~HpnIv~~~~~~~~~~~~~ivm-E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~ 159 (350)
T d1koaa2 81 RHPTLVNLHDAFEDDNEMVMIY-EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 159 (350)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCcEEEEEEECCEEEEEE-EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc
Confidence 5899999999999999999999 79999999999954 34555 99999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+..+++||+|||+|+.........+..||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..+
T Consensus 160 ~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i- 237 (350)
T d1koaa2 160 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNV- 237 (350)
T ss_dssp TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence 5556799999999987665555567789999999999998887644 99999999999999999999987765444433
Q ss_pred HHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.......+ ....+|+++++||.+||++||++|||++++|+||||+..
T Consensus 238 ---~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 238 ---KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp ---HHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred ---HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 33333322 234589999999999999999999999999999999764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=345.89 Aligned_cols=197 Identities=30% Similarity=0.515 Sum_probs=171.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|++.+++|+|| ||+.||+|.+++.+.+.++ .++.+++||+.||+|||++||+||||||+|||++.+
T Consensus 63 ~hp~Iv~l~~~~~~~~~~~iv~-ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~ 141 (337)
T d1o6la_ 63 RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD 141 (337)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred CCCCEEEEEeeeccccccccce-eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC
Confidence 5999999999999999999999 7999999999999988876 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ ++||+|||+|+.... .......+||+.|+|||++.+.+|+.+ +|||||||++|+|++|+.||.+.+... +.
T Consensus 142 g--~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~----~~ 214 (337)
T d1o6la_ 142 G--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214 (337)
T ss_dssp S--CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HH
T ss_pred C--CEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHH----HH
Confidence 4 599999999986433 344456789999999999999888655 999999999999999999999877643 33
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~ 212 (293)
+.+......+| ..+|+++++||.+||++||.+|++ ++++++||||+..
T Consensus 215 ~~i~~~~~~~p--~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 215 ELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHCCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHhcCCCCCC--ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 44444444444 459999999999999999999994 8999999999753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-49 Score=351.26 Aligned_cols=202 Identities=23% Similarity=0.366 Sum_probs=174.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++++|.+.+++|+|| |||.||+|++++.+.+ .++ +++.++.||+.||.|||++||+||||||+|||++.
T Consensus 84 ~HpnIv~~~~~~~~~~~~~ivm-E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~ 162 (352)
T d1koba_ 84 HHPKLINLHDAFEDKYEMVLIL-EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 162 (352)
T ss_dssp CSTTBCCEEEEEECSSEEEEEE-ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCcEEEEEEECCEEEEEE-EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc
Confidence 5899999999999999999999 7999999999886654 454 99999999999999999999999999999999986
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
...+++||+|||+|+.........+..||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+....+..
T Consensus 163 ~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-- 239 (352)
T d1koba_ 163 KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQN-- 239 (352)
T ss_dssp TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH--
T ss_pred cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence 5666799999999987766666667789999999999988888655 9999999999999999999998776544433
Q ss_pred HHHhccccCCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
+......++ .+..+|+++++||.+||++||.+|||+.++|+||||+...
T Consensus 240 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 240 --VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp --HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred --HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 333333333 3356899999999999999999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-49 Score=343.02 Aligned_cols=199 Identities=23% Similarity=0.340 Sum_probs=168.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|.+.+++|+|| |||.||+|..++...+.++ +++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 73 ~HpnIv~~~~~~~~~~~~~iv~-E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~ 151 (309)
T d1u5ra_ 73 RHPNTIQYRGCYLREHTAWLVM-EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151 (309)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred CCCCEeeEEEEEEECCEEEEEE-EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC
Confidence 5999999999999999999999 7999999998888777666 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccc---cCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+ ++||+|||+|+... .....+||+.|||||++.+. .|+. ++||||+||++|+|++|+.||.+......+..
T Consensus 152 ~--~~Kl~DFG~a~~~~---~~~~~~GT~~Y~APE~~~~~~~~~y~~-~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~ 225 (309)
T d1u5ra_ 152 G--LVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYH 225 (309)
T ss_dssp T--EEEECCCTTCBSSS---SBCCCCSCGGGCCHHHHTTTTSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred C--CEEEeecccccccC---CCCccccCccccCHHHHhccCCCCcCc-hhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 5 59999999998543 33456899999999998642 3544 59999999999999999999998776544433
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCCCC
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 215 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~~~ 215 (293)
+. ...........+|+++++||.+||++||.+|||++++|+||||.+..+.
T Consensus 226 i~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~ 276 (309)
T d1u5ra_ 226 IA----QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (309)
T ss_dssp HH----HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HH----hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence 33 3333333445689999999999999999999999999999999765443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=336.10 Aligned_cols=197 Identities=21% Similarity=0.391 Sum_probs=162.7
Q ss_pred CCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcC--CeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQ--VCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~--iiHrdlkp~N 77 (293)
.|+|+|++|++|.+ .+.+|+|| ||+.||+|.+++.+.+.++ .++.++.||+.||+|||++| |+||||||+|
T Consensus 66 ~HpnIv~~~~~~~~~~~~~~~~~ivm-E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~N 144 (270)
T d1t4ha_ 66 QHPNIVRFYDSWESTVKGKKCIVLVT-ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 144 (270)
T ss_dssp CCTTBCCEEEEEEEESSSCEEEEEEE-ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGG
T ss_pred CCCCeeeEEEEEeeccccCCEEEEEE-eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhh
Confidence 59999999999976 46789999 7999999999999887666 88999999999999999998 9999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
||++.. ++.+||+|||+|+... .....+.+||+.|||||++.+ +++. ++||||+||++|+|++|+.||.+......
T Consensus 145 ILl~~~-~~~~Kl~DFGla~~~~-~~~~~~~~GT~~Y~aPE~~~~-~~~~-~~DIwSlGvilyel~~g~~Pf~~~~~~~~ 220 (270)
T d1t4ha_ 145 IFITGP-TGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQ 220 (270)
T ss_dssp EEESST-TSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CCCT-HHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred ceeeCC-CCCEEEeecCcceecc-CCccCCcccCccccCHHHhCC-CCCC-cCchhhHHHHHHHHHHCCCCCCCcccHHH
Confidence 999642 2359999999997532 233456789999999999865 5654 59999999999999999999987766544
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 210 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~ 210 (293)
+.. .+.........+..+++++++||.+||.+||++|||++|+++||||+
T Consensus 221 ~~~---~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 221 IYR---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHH---HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHH---HHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 333 33332222222344789999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=340.47 Aligned_cols=200 Identities=24% Similarity=0.352 Sum_probs=166.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++++|.+.+.+|+|| |||.||+|.+++.+. +.++ +++.++.||+.||.|||++||+||||||+|||++.
T Consensus 67 ~HpnIv~l~~~~~~~~~~~lvm-Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~ 145 (288)
T d2jfla1 67 DHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145 (288)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred CCCCCCeEEEEEeeCCeEEEEE-ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC
Confidence 5899999999999999999999 799999999998764 3454 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhcc-----ccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
++ ++||+|||+|+..... ....+.+||+.|+|||++.. ..|+ .++||||+||++|+|++|+.||.+.+...
T Consensus 146 ~~--~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~-~k~DiwSlGvilyemltg~~Pf~~~~~~~ 222 (288)
T d2jfla1 146 DG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMR 222 (288)
T ss_dssp TS--CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTT-THHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred CC--CEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCC-hhhhHHHHHHHHHHHhhCCCCCCCCCHHH
Confidence 65 5999999999743221 22345689999999999853 3344 45999999999999999999999887766
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.+..+... .....+.+..+|+++++||.+||++||++|||++++++||||+..
T Consensus 223 ~~~~i~~~---~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 223 VLLKIAKS---EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHS---CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHcC---CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 55444432 112233345689999999999999999999999999999999643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=347.95 Aligned_cols=207 Identities=28% Similarity=0.482 Sum_probs=172.0
Q ss_pred CCCcchhhhhceeee----ceeEEEeehhhccCchhHHHHHHcC--CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 022732 5 GSSSSEYAMLGVSVK----MKFVFLSLSFFFSLCLFFMWLLLLG--LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLE 76 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~----~~~~~lv~~ey~~gg~L~~~l~~~~--~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~ 76 (293)
..|+|+|+++++|.+ .+++|+|| |||.||+|+++|.+.+ .++ +++.++.||+.||+|||++||+||||||+
T Consensus 62 ~~hpnIv~l~~~~~~~~~~~~~~~ivm-Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~ 140 (335)
T d2ozaa1 62 SQCPHIVRIVDVYENLYAGRKCLLIVM-ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 140 (335)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEE-ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCCCCCCeEEEEEeecccCCCEEEEEE-ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence 469999999999976 58899999 7999999999998754 454 89999999999999999999999999999
Q ss_pred cEEEcCCC-CCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCch
Q 022732 77 NTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 155 (293)
Q Consensus 77 NIl~~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 155 (293)
|||++... .+++||+|||+|+...........+||+.|+|||++.+..|+.+ +|||||||++|+|+||+.||.+.+..
T Consensus 141 NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp GEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred ccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 99998643 45799999999987666666677889999999999988887655 99999999999999999999887665
Q ss_pred HHHHHHHHHHhccccCCCCC--CCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 156 KDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
.....+...+......+|.. ..+|+++++||.+||++||++|||+.++++||||++..
T Consensus 220 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 220 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp --------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 54445555554444444432 34899999999999999999999999999999997543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.6e-49 Score=336.15 Aligned_cols=200 Identities=30% Similarity=0.473 Sum_probs=171.7
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|+|+++++|.+.+++|+|| ||+.||+|.++++.++.++ +++.++.||+.||+|||++||+||||||+||+++.
T Consensus 67 ~~hpnIv~~~~~~~~~~~~~ivm-E~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~ 145 (277)
T d1phka_ 67 SGHPNIIQLKDTYETNTFFFLVF-DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 145 (277)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred cCCCCeEEEEeecccCcceEEEE-EcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcC
Confidence 46999999999999999999999 7999999999999888777 99999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhcccc-----CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
++ .+||+|||+++............||+.|+|||++.+.. ..+.++||||+||++|+|++|+.||.+.+....
T Consensus 146 ~~--~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~ 223 (277)
T d1phka_ 146 DM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 223 (277)
T ss_dssp TC--CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CC--CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH
Confidence 55 59999999998766655666778999999999986422 224559999999999999999999998876444
Q ss_pred HHHHHHHHhccccC--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 158 FRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 158 ~~~~~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
...+ ...... .+....+|+++++||.+||++||.+|||+.++++||||++
T Consensus 224 ~~~i----~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 224 LRMI----MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHH----HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHH----HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 3333 333332 3334469999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-48 Score=337.09 Aligned_cols=196 Identities=30% Similarity=0.507 Sum_probs=170.1
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
-.|+|+|+++++|.+.+++|+|| ||+.||+|..++...+.+. .++.++.||+.||+|||++||+||||||+|||++.
T Consensus 61 l~HpnIv~~~~~~~~~~~~~ivm-E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~ 139 (316)
T d1fota_ 61 VTHPFIIRMWGTFQDAQQIFMIM-DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK 139 (316)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT
T ss_pred ccCcChhheeeeEeeCCeeeeEe-eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcC
Confidence 36999999999999999999999 7999999999999887766 88999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
++ ++||+|||+|+... ....+.+||+.|||||++.+..++.+ +||||+||++|+|++|+.||.+.+.... .
T Consensus 140 ~g--~vkL~DFG~a~~~~--~~~~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~----~ 210 (316)
T d1fota_ 140 NG--HIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKT----Y 210 (316)
T ss_dssp TS--CEEECCCSSCEECS--SCBCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHH----H
T ss_pred CC--CEEEecCccceEec--cccccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHH----H
Confidence 55 59999999998643 33456789999999999988888755 9999999999999999999998776443 3
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
.++.......| ..+|++++++|.+||.+||.+|+ |++++++||||++-
T Consensus 211 ~~i~~~~~~~p--~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 211 EKILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHHCCCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHcCCCCCC--CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 34444444443 44899999999999999999996 89999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-48 Score=343.78 Aligned_cols=201 Identities=25% Similarity=0.324 Sum_probs=168.8
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
..|+|+|+++++|.+.+.+|+|| ||+.||+|.+++.+.+.+. .++.++.||+.||.|||++||+||||||+|||++.
T Consensus 64 ~~hpnIv~l~~~~~~~~~~~ivm-E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~ 142 (364)
T d1omwa3 64 GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 142 (364)
T ss_dssp SCCTTBCCEEEEEECSSEEEEEE-CCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS
T ss_pred CCCCcEEEEEEEEEECCEEEEEE-EecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcC
Confidence 46999999999999999999999 7999999999998887765 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
++ ++||+|||+|+.... ......+||+.|+|||++.+....+.++|||||||++|+|+||+.||.+...... ..+.
T Consensus 143 ~g--~iKl~DFGla~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~ 218 (364)
T d1omwa3 143 HG--HVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEID 218 (364)
T ss_dssp SS--CEEECCCTTCEECSS-SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHH
T ss_pred CC--cEEEeeeceeeecCC-CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 55 599999999986543 3345678999999999987544334559999999999999999999987654332 2333
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCC-----HHHHHcCcccccC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~~~~~ 212 (293)
........ +.+..+|+++++||.+||++||.+||| ++++++||||+.-
T Consensus 219 ~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 219 RMTLTMAV--ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHSSSCCC--CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HhcccCCC--CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 33333333 334458999999999999999999999 7999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=332.79 Aligned_cols=204 Identities=25% Similarity=0.317 Sum_probs=170.7
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|...+++|+|| ||+.|+++..++...+.+. +++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 58 ~hpnIv~~~~~~~~~~~~~ivm-E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~ 136 (299)
T d1ua2a_ 58 SHPNIIGLLDAFGHKSNISLVF-DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN 136 (299)
T ss_dssp CCTTBCCEEEEECCTTCCEEEE-ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred CCCCEeEEEeeeccCCceeehh-hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC
Confidence 5899999999999999999999 7999999888877666666 999999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||+|+..... ......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+.+..+.
T Consensus 137 ~--~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~ 214 (299)
T d1ua2a_ 137 G--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214 (299)
T ss_dssp C--CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred C--ccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH
Confidence 4 5999999999865433 334556899999999998776655666999999999999999999999988877766666
Q ss_pred HHHhccccC----------------CCC------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQYS----------------VPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~----------------~~~------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
......... .+. ...+|+++++||.+||++||++|||+.|+|+||||+..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 215 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 543221110 000 12468999999999999999999999999999999754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=336.74 Aligned_cols=197 Identities=31% Similarity=0.528 Sum_probs=170.0
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
-.|+|+|+++++|.+.+++|+|| ||+.||+|.+++...+.++ +++.++.||+.||+|||++|++||||||+|||++.
T Consensus 60 ~~hp~Iv~~~~~~~~~~~~yivm-Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~ 138 (320)
T d1xjda_ 60 WEHPFLTHMFCTFQTKENLFFVM-EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 138 (320)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred CCCCcEEEEEEEEccCCceeEEE-eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC
Confidence 36999999999999999999999 7999999999999888776 99999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.+ ++||+|||+|+..... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+....+
T Consensus 139 ~~--~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~--- 212 (320)
T d1xjda_ 139 DG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELF--- 212 (320)
T ss_dssp TS--CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH---
T ss_pred CC--ceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHHHH---
Confidence 55 5999999999865433 33345679999999999998888754 99999999999999999999987764433
Q ss_pred HHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHH-HHHcCccccc
Q 022732 162 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP-EIMKHQWFLK 211 (293)
Q Consensus 162 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~-ell~h~~~~~ 211 (293)
.++......+| ..+|+++++||.+||++||.+|||+. ++++||||++
T Consensus 213 -~~i~~~~~~~p--~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 213 -HSIRMDNPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp -HHHHHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred -HHHHcCCCCCC--ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 33333444333 45899999999999999999999995 8999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=341.16 Aligned_cols=201 Identities=22% Similarity=0.373 Sum_probs=173.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++++|++.+++|+|| |||.||+|++++.+.+ .+. +++.++.||+.||+|||++||+||||||+|||++.
T Consensus 59 ~HpnIv~~~~~~~~~~~~~lvm-E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~ 137 (321)
T d1tkia_ 59 RHRNILHLHESFESMEELVMIF-EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCeEEEEEEECCEEEEEE-ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC
Confidence 5899999999999999999999 7999999999998765 455 99999999999999999999999999999999987
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
++..++||+|||+++............||+.|+|||.+.+..++.+ +||||+||++|+|++|..||.+.+....+..
T Consensus 138 ~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~-- 214 (321)
T d1tkia_ 138 RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIEN-- 214 (321)
T ss_dssp SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--
T ss_pred CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence 6666799999999987655555566789999999999988777654 9999999999999999999998776444433
Q ss_pred HHHhccccCCCC--CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+......++. +..+|+++++||.+||.+||.+|||+.++++||||++.
T Consensus 215 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 215 --IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp --HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred --HHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 3334433332 24589999999999999999999999999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=331.21 Aligned_cols=195 Identities=24% Similarity=0.332 Sum_probs=151.5
Q ss_pred CCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHc----CCHH--HHHHHHHHHHHHHHHHHHcC-----CeecC
Q 022732 6 SSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLL----GLLV--QARFFFQQLISGVSYCHAMQ-----VCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~----~~~~--~~~~~~~qil~~l~~LH~~~-----iiHrd 72 (293)
.|+|+|++++++.+ .+.+|+|| |||.||+|.+++.+. +.++ .++.++.||+.||+|||++| |+|||
T Consensus 61 ~HpnIv~~~~~~~~~~~~~~~ivm-Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrD 139 (269)
T d2java1 61 KHPNIVRYYDRIIDRTNTTLYIVM-EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139 (269)
T ss_dssp CCTTBCCEEEEEEC----CEEEEE-ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------
T ss_pred CCCCEeeEEEEEEeCCCCEEEEEE-ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCc
Confidence 69999999999965 56789999 799999999999653 3344 89999999999999999976 99999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCC
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 151 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 151 (293)
|||+|||++.++ .+||+|||+|+..... ....+.+||+.|||||++.+..++.+ +|||||||++|+|+||+.||.+
T Consensus 140 iKp~NIll~~~~--~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 140 LKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp CCGGGEEECTTS--CEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCC
T ss_pred CchhhcCcCCCC--cEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCC
Confidence 999999997665 5999999999865432 23356789999999999988887654 9999999999999999999988
Q ss_pred CCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 152 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
.+.... ...+...... +.+..+|+++++||.+||++||.+|||+.++++|||+
T Consensus 217 ~~~~~~----~~~i~~~~~~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 217 FSQKEL----AGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SSHHHH----HHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCHHHH----HHHHHcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 765433 3333333322 2344689999999999999999999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-47 Score=337.85 Aligned_cols=195 Identities=25% Similarity=0.440 Sum_probs=169.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|...+.+|+|| ||+.||+|..++.+.+.+. +++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 99 ~hpnIv~~~~~~~~~~~~~~v~-e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~ 177 (350)
T d1rdqe_ 99 NFPFLVKLEFSFKDNSNLYMVM-EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177 (350)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CCCcEeeccccccccccccccc-ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC
Confidence 6999999999999999999999 7999999999999888776 999999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 163 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 163 (293)
+ ++||+|||+|+... ....+..||+.|||||++.+..++.+ +|||||||++|+|+||+.||.+.+.... ..
T Consensus 178 g--~ikL~DFG~a~~~~--~~~~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~----~~ 248 (350)
T d1rdqe_ 178 G--YIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQI----YE 248 (350)
T ss_dssp S--CEEECCCTTCEECS--SCBCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH
T ss_pred C--CEEeeeceeeeecc--cccccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHHHH----HH
Confidence 4 59999999998653 33456789999999999998888655 9999999999999999999988765433 33
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCcccccC
Q 022732 164 RILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN 212 (293)
Q Consensus 164 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~~ 212 (293)
.+....... +..+|+++.+||++||.+||.+|+ |++++++||||+..
T Consensus 249 ~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 249 KIVSGKVRF--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHCCCCC--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhcCCCCC--CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 444444433 345899999999999999999995 89999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=326.24 Aligned_cols=193 Identities=33% Similarity=0.455 Sum_probs=164.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccC-chhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSL-CLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~g-g~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++++|.+.+..|+|| ||+.+ +++..++.+.+.+. +++.++.||+.||+|||++||+||||||+|||++.
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~-e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~ 145 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLIL-ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 145 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEE-ECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET
T ss_pred CCCCccEEEEEEeeCCeEEEEE-EeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec
Confidence 5899999999999999999999 68875 68889998887766 89999999999999999999999999999999975
Q ss_pred CCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+. +.+||+|||+|+.... ....+..||+.|+|||++.+..+.++++||||+||++|+|++|+.||.+.+ .
T Consensus 146 ~~-~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~-- 215 (273)
T d1xwsa_ 146 NR-GELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E-- 215 (273)
T ss_dssp TT-TEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H--
T ss_pred CC-CeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------H--
Confidence 43 3699999999975432 334567899999999999888877777999999999999999999997632 1
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 163 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 163 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
+......+ +..+|+++++||.+||.+||++|||++++++||||++..
T Consensus 216 --i~~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 216 --IIRGQVFF--RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp --HHHCCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --HhhcccCC--CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 22233333 345899999999999999999999999999999997654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=319.30 Aligned_cols=203 Identities=24% Similarity=0.308 Sum_probs=166.8
Q ss_pred CCcchhhhhceee-----eceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSV-----KMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~-----~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.|+|+++++++|. ...++|++| ||+.++.+........ .++ .++.++.||+.||+|||++||+||||||+|
T Consensus 68 ~HpnIv~~~~~~~~~~~~~~~~~~~~~-e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 68 EHPNVVRLFDVCTVSRTDRETKLTLVF-EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEE-ECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCCCcceeeeeecccccccCceEEEEE-EeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence 5899999999995 346889999 7999988765554332 233 889999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
||++..+ .+||+|||+++............||+.|+|||++.+..|+.+ +||||+||++|+|++|+.||.+.+....
T Consensus 147 ILi~~~~--~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~ 223 (305)
T d1blxa_ 147 ILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223 (305)
T ss_dssp EEECTTC--CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCC--CeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHH
Confidence 9997655 599999999987655566667889999999999998888665 9999999999999999999999887776
Q ss_pred HHHHHHHHhcccc-C--------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 158 FRKTIQRILSVQY-S--------------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 158 ~~~~~~~~~~~~~-~--------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+..+......... . ......+|+.+++||.+||++||++|||+.|+|+||||+.-
T Consensus 224 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 6666553321110 0 01123478999999999999999999999999999999753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=328.24 Aligned_cols=195 Identities=23% Similarity=0.360 Sum_probs=164.7
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC-----------------------HH--HHHHHHHHHHH
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL-----------------------LV--QARFFFQQLIS 58 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~-----------------------~~--~~~~~~~qil~ 58 (293)
+..|+|+|+++++|.+.+.+|+|| |||.||+|.++|++... +. .++.++.||+.
T Consensus 97 l~~HpnIv~l~~~~~~~~~~~lv~-Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 175 (325)
T d1rjba_ 97 LGSHENIVNLLGACTLSGPIYLIF-EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175 (325)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred hcCCCcEeEEEEEEeeCCeEEEEE-EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHH
Confidence 467999999999999999999999 79999999999976531 22 79999999999
Q ss_pred HHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCC---CCCcCCCCccchhhhccccCCCchhhhhhh
Q 022732 59 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSC 135 (293)
Q Consensus 59 ~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl 135 (293)
||+|||++||+||||||+|||++.++ ++||+|||+|+........ .+..||+.|||||++.+..++.+ +||||+
T Consensus 176 gl~yLH~~~IiHRDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~ 252 (325)
T d1rjba_ 176 GMEFLEFKSCVHRDLAARNVLVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSY 252 (325)
T ss_dssp HHHHHHHTTEEETTCSGGGEEEETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHH
T ss_pred HHHHHHhCCeeeccCchhccccccCC--eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccch
Confidence 99999999999999999999997665 5999999999865433322 24568999999999988887655 999999
Q ss_pred hhHHHHHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 136 GVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 136 G~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
||++|||+| |+.||.+.+....+..++. .....+.+..+|+++++||.+||+.||++|||++++++|
T Consensus 253 Gvil~emlt~g~~Pf~~~~~~~~~~~~~~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999997 8999998776555544443 334455556689999999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=315.95 Aligned_cols=204 Identities=25% Similarity=0.390 Sum_probs=165.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHH-cCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLL-LGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~-~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++++|.+.+++|+|| ||+.++.+...... .+.++ +++.++.||+.||+|||++|||||||||+|||++.
T Consensus 59 ~Hp~Iv~~~~~~~~~~~~~iv~-e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~ 137 (298)
T d1gz8a_ 59 NHPNIVKLLDVIHTENKLYLVF-EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137 (298)
T ss_dssp CCTTBCCEEEEEEETTEEEEEE-ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCCcEEEeccccccccceeEEE-eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc
Confidence 6999999999999999999999 79987655444333 23344 99999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCC-CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
++ .+||+|||+|+.... .......+||+.|+|||++....+.+.++|+||+||++|+|++|+.||.+.+....+..+
T Consensus 138 ~~--~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i 215 (298)
T d1gz8a_ 138 EG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215 (298)
T ss_dssp TS--CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cC--cceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH
Confidence 55 599999999976433 334455689999999999888887777799999999999999999999988776666655
Q ss_pred HHHHhccccC--------------CCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 162 IQRILSVQYS--------------VPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 162 ~~~~~~~~~~--------------~~~---------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
.......... .+. ...+|+++++||.+||++||.+|||+.++++||||+.-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 216 FRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 5433221100 000 12478999999999999999999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=314.25 Aligned_cols=197 Identities=19% Similarity=0.279 Sum_probs=155.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|++++++. .+.+|+|| ||+.||+|.+++... +.++ ++..++.||+.||+|||++||+||||||+|||++.
T Consensus 62 ~HpnIv~~~~~~~-~~~~~lv~-Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~ 139 (276)
T d1uwha_ 62 RHVNILLFMGYST-APQLAIVT-QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE 139 (276)
T ss_dssp CCTTBCCEEEEEC-SSSCEEEE-ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred CCCCEeeeeEEEe-ccEEEEEE-ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcC
Confidence 6999999999875 46789999 799999999999765 3344 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhcccc--CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
++ ++||+|||+|+..... ....+..||+.|||||++.+.. ..+.++||||+||++|||+||+.||.+.+....
T Consensus 140 ~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~ 217 (276)
T d1uwha_ 140 DL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217 (276)
T ss_dssp TS--SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred CC--CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH
Confidence 65 5999999999754322 2234567999999999986532 224559999999999999999999998877655
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+...+.+..........+..+++++.+||.+||..||++|||+.+++++
T Consensus 218 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 5544443221111112234588999999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-44 Score=312.48 Aligned_cols=203 Identities=26% Similarity=0.379 Sum_probs=165.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|...++.|+++ ||+.++.+..+.+..+.++ +++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 58 ~hpnIv~~~~~~~~~~~~~i~~-e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~ 136 (286)
T d1ob3a_ 58 KHSNIVKLYDVIHTKKRLVLVF-EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136 (286)
T ss_dssp CCTTBCCEEEEEECSSCEEEEE-ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CCCcEEeeeeecccCCceeEEE-EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC
Confidence 5899999999999999999999 7999998888887777666 999999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCCC-CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||.|...... .......|++.|+|||.+.+..+.+.++|+||+||++|+|++|+.||.+.+....+.++.
T Consensus 137 ~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~ 214 (286)
T d1ob3a_ 137 G--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214 (286)
T ss_dssp S--CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred C--CEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 5 5999999998754332 223455799999999999877776677999999999999999999999887766666555
Q ss_pred HHHhccccC-----------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 163 QRILSVQYS-----------------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 163 ~~~~~~~~~-----------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
......... ......+|+++++||++||++||++|||++|+|+||||++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 432211100 0012347899999999999999999999999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=309.94 Aligned_cols=194 Identities=20% Similarity=0.260 Sum_probs=158.3
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+|+++++|..+ ..|+|| ||+.+|+|.+++.+.+.++ ++..++.||+.||+|||++||+||||||+|||++.+
T Consensus 66 ~HpnIv~~~g~~~~~-~~~lvm-E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~ 143 (277)
T d1xbba_ 66 DNPYIVRMIGICEAE-SWMLVM-EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 143 (277)
T ss_dssp CCTTBCCEEEEEESS-SEEEEE-ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CCCCCceEEEEeccC-CEEEEE-EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc
Confidence 599999999999754 578999 7999999999999887766 899999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
+ .+||+|||+|+...... ......||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+.....
T Consensus 144 ~--~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~ 220 (277)
T d1xbba_ 144 H--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220 (277)
T ss_dssp T--EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred C--cccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHH
Confidence 5 59999999998543222 1234568999999999988877655 999999999999998 89999987653322
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHH---HcCccc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI---MKHQWF 209 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el---l~h~~~ 209 (293)
..+.. ....+.+..+|+++.+||.+||+.||.+|||++++ |+|+|+
T Consensus 221 ----~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 221 ----AMLEK-GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ----HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----HHHHc-CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 22222 23344456689999999999999999999999998 456554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=315.85 Aligned_cols=205 Identities=25% Similarity=0.354 Sum_probs=164.0
Q ss_pred CCcchhhhhceeee------ceeEEEeehhhccCchhHHHH---HHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCC
Q 022732 6 SSSSEYAMLGVSVK------MKFVFLSLSFFFSLCLFFMWL---LLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLK 74 (293)
Q Consensus 6 ~~~~~v~~~~~~~~------~~~~~lv~~ey~~gg~L~~~l---~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlk 74 (293)
.|+|+++++++|.. ..++|+|| ||+.++.+..+. .....++ +++.++.||+.||+|||++||+|||||
T Consensus 71 ~h~niv~~~~~~~~~~~~~~~~~~~lv~-Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiK 149 (350)
T d1q5ka_ 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 149 (350)
T ss_dssp CCTTBCCEEEEEEEC--CCSCCEEEEEE-ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred CCCCCCcEEEEEEecCccCCceEEEEEE-eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence 58999999999954 34689999 799987544433 3344444 899999999999999999999999999
Q ss_pred CCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 75 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 75 p~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
|+|||++.++. .+||+|||+++.........+.+||+.|+|||++.+....+.++||||+||++|+|++|+.||...+.
T Consensus 150 p~NILl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 150 PQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp GGGEEECTTTC-CEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred cceEEEecCCC-ceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 99999976542 59999999998766666667789999999999987765555669999999999999999999998877
Q ss_pred hHHHHHHHHHHhccc-------------cCCC----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 155 PKDFRKTIQRILSVQ-------------YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~-------------~~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
...+..+........ ...+ ....+++++.+||.+||.+||.+|||+.|+|+||||++
T Consensus 229 ~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 666655543221100 0011 12347899999999999999999999999999999975
Q ss_pred C
Q 022732 212 N 212 (293)
Q Consensus 212 ~ 212 (293)
.
T Consensus 309 ~ 309 (350)
T d1q5ka_ 309 L 309 (350)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-44 Score=310.78 Aligned_cols=192 Identities=20% Similarity=0.294 Sum_probs=151.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++|++...+.+|+|| ||+.||+|..++.... .++ ++..++.||+.||.|||++|++||||||+|||++.
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~-Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~ 163 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIIT-EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS 163 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCCCCccEEEEEeeCCEEEEEE-EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECC
Confidence 6999999999999999999999 7999999999988753 444 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCCC------CCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCch
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQP------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP 155 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~ 155 (293)
++ ++||+|||+|+........ ....||+.|||||++.+..++.+ +|||||||++|||+| |+.||.+....
T Consensus 164 ~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 164 NL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp TC--CEEECCC-----------------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CC--cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHH
Confidence 55 5999999999854332211 12357899999999988777655 999999999999998 89999887764
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 156 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
... ..+. .....+.+..++.++.+||.+||+.||++|||+.+++++
T Consensus 241 ~~~----~~i~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 241 DVI----NAIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHH----HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHH----HHHH-cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 332 2222 233445566789999999999999999999999998875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=309.11 Aligned_cols=201 Identities=24% Similarity=0.329 Sum_probs=162.5
Q ss_pred CCcchhhhhceeeece------eEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVKMK------FVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~------~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~N 77 (293)
.|+|+|+++++|...+ ++|+|| ||+ |.+|..+++.. .++ .++.++.||+.||+|||++||+||||||+|
T Consensus 75 ~hpniv~l~~~~~~~~~~~~~~~~~lv~-e~~-~~~l~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~N 151 (346)
T d1cm8a_ 75 RHENVIGLLDVFTPDETLDDFTDFYLVM-PFM-GTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN 151 (346)
T ss_dssp CBTTBCCCSEEECSCSSTTTCCCCEEEE-ECC-SEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CCCCeeEEEEEeccCccccccceEEEEE-ecc-cccHHHHHHhc-cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcch
Confidence 5899999999998765 579999 798 66777776554 444 999999999999999999999999999999
Q ss_pred EEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHH
Q 022732 78 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 157 (293)
Q Consensus 78 Il~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 157 (293)
||++.++ .+|++|||+|+... ......+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+....
T Consensus 152 IL~~~~~--~~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~ 227 (346)
T d1cm8a_ 152 LAVNEDC--ELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227 (346)
T ss_dssp EEECTTC--CEEECCCTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred hhccccc--ccccccccceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH
Confidence 9997655 59999999998643 3445678999999999998766666669999999999999999999998876555
Q ss_pred HHHHHHHHhccc-------------------cCC------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 158 FRKTIQRILSVQ-------------------YSV------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 158 ~~~~~~~~~~~~-------------------~~~------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
+........... ... .....+|+++++||.+||.+||.+|||+.++|+||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 444333211100 000 0123478999999999999999999999999999999864
Q ss_pred C
Q 022732 213 L 213 (293)
Q Consensus 213 ~ 213 (293)
.
T Consensus 308 ~ 308 (346)
T d1cm8a_ 308 H 308 (346)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-44 Score=307.54 Aligned_cols=192 Identities=19% Similarity=0.284 Sum_probs=158.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC--HH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL--LV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~--~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+|+++++|.+.+.+|+|| ||+.+|+|..++..... ++ .++.++.||+.||+|||++||+||||||+|||++
T Consensus 71 ~HpnIv~~~~~~~~~~~~~iv~-E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~ 149 (287)
T d1opja_ 71 KHPNLVQLLGVCTREPPFYIIT-EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 149 (287)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCCEecCCccEeeCCeeEEEe-ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC
Confidence 5899999999999999999999 79999999999977532 33 7899999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
.++ ++||+|||+|+....... .....||+.|+|||++.+..++.+ +||||+||++|||++|..||........+.
T Consensus 150 ~~~--~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~ 226 (287)
T d1opja_ 150 ENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226 (287)
T ss_dssp GGG--CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCC--cEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHH
Confidence 665 599999999986433222 123358899999999988887654 999999999999999777665555544433
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
..+. .....+.+..+|+++.+||.+||+.||++|||++++++
T Consensus 227 ~~i~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 227 ELLE----KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh----cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 3332 33444555669999999999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=310.52 Aligned_cols=201 Identities=27% Similarity=0.402 Sum_probs=169.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.++|++++++++.+....|+|| ||+.||+|..++...+.+. .++.++.||+.||+|||++|++||||||+|||++.+
T Consensus 87 h~pnIv~~~~~~~~~~~~~~v~-e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~ 165 (322)
T d1vzoa_ 87 QSPFLVTLHYAFQTETKLHLIL-DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 165 (322)
T ss_dssp TCTTBCCEEEEEEETTEEEEEE-CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred CCCeEEEeeeeeccCCceeeee-ecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC
Confidence 4589999999999999999999 7999999999998887665 899999999999999999999999999999999766
Q ss_pred CCCCEEEecCCCCcCcCC--CCCCCCCcCCCCccchhhhcccc-CCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 160 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 160 (293)
+ .+||+|||+|+.... .....+..|++.|+|||.+.+.. +...++|||||||++|+|++|+.||.+.........
T Consensus 166 ~--~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~ 243 (322)
T d1vzoa_ 166 G--HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243 (322)
T ss_dssp S--CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred C--CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 4 599999999975432 22334567999999999997644 335559999999999999999999988776555555
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCC-----CHHHHHcCccccc
Q 022732 161 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLK 211 (293)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~~~~ 211 (293)
+.......... .+..+|+++++||.+||++||.+|| |++|+++||||++
T Consensus 244 i~~~~~~~~~~--~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 244 ISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHhcccCCCC--CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 55555444433 3345899999999999999999999 5899999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.6e-44 Score=312.38 Aligned_cols=206 Identities=20% Similarity=0.340 Sum_probs=164.0
Q ss_pred CCCCcchhhhhceeee--ceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVK--MKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~--~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+.+|+|+++++++|.. .+++|+|| ||+.+++|..+.+ .-...+++.++.||+.||.|||++||+||||||+|||++
T Consensus 86 l~~hpnIv~~~~~~~~~~~~~~~~v~-e~~~~~~L~~~~~-~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~ 163 (328)
T d3bqca1 86 LRGGPNIITLADIVKDPVSRTPALVF-EHVNNTDFKQLYQ-TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163 (328)
T ss_dssp HTTSTTBCCEEEEEECTTTCSEEEEE-ECCCSCBGGGTTT-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred ccCCCCCcEEEEEEEecCCCceeEEE-eecCCCcHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc
Confidence 4579999999999984 46799999 7999999987642 222339999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 161 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 161 (293)
.++. .+||+|||+|+...........+||+.|+|||++.+....+.++|+||+||++|++++|+.||............
T Consensus 164 ~~~~-~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~ 242 (328)
T d3bqca1 164 HEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242 (328)
T ss_dssp TTTT-EEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred CCCC-eeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence 6542 589999999987666666677889999999999887665556699999999999999999999876654322222
Q ss_pred HHHHhcc------------c--------------------cCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 162 IQRILSV------------Q--------------------YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 162 ~~~~~~~------------~--------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
+..+... . ...+....+|+++++||++||++||.+|||++|+|+||||
T Consensus 243 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 2211110 0 0011123378999999999999999999999999999999
Q ss_pred ccC
Q 022732 210 LKN 212 (293)
Q Consensus 210 ~~~ 212 (293)
+..
T Consensus 323 ~~v 325 (328)
T d3bqca1 323 YTV 325 (328)
T ss_dssp TTS
T ss_pred CCC
Confidence 753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=306.00 Aligned_cols=194 Identities=21% Similarity=0.291 Sum_probs=159.0
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc-CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL-GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~-~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++|++.. +.+|+|| ||+.||+|.+++... +.++ ++..++.||+.||+|||++||+||||||+|||++.
T Consensus 67 ~HpnIv~l~g~~~~-~~~~lvm-E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~ 144 (285)
T d1u59a_ 67 DNPYIVRLIGVCQA-EALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 144 (285)
T ss_dssp CCTTBCCEEEEEES-SSEEEEE-ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE
T ss_pred CCCCEeeEeeeecc-CeEEEEE-EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc
Confidence 59999999999975 4689999 799999999998654 3444 89999999999999999999999999999999977
Q ss_pred CCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .+||+|||+|+...... ......||+.|+|||++.+..++.+ +||||+||++|||+| |+.||.+......
T Consensus 145 ~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~ 221 (285)
T d1u59a_ 145 RH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEV 221 (285)
T ss_dssp TT--EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHH
T ss_pred CC--ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHH
Confidence 65 59999999998543322 2234568999999999988877655 999999999999998 8999998776443
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHH---HcCccc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI---MKHQWF 209 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~el---l~h~~~ 209 (293)
. ..+.. ....+.+..+|+++.+||.+||..||++|||+.++ |+|+|+
T Consensus 222 ~----~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 222 M----AFIEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp H----HHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----HHHHc-CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3 22222 22334455699999999999999999999999887 567776
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-44 Score=303.01 Aligned_cols=192 Identities=20% Similarity=0.334 Sum_probs=148.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++|++...+..|+|| ||+.+|+|.+++.... .+. .+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 58 ~HpnIv~~~g~~~~~~~~~lv~-E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~ 136 (263)
T d1sm2a_ 58 SHPKLVQLYGVCLEQAPICLVF-EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136 (263)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG
T ss_pred CCCCcccccceeccCCceEEEE-EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC
Confidence 5999999999999999999999 7999999999987654 333 78899999999999999999999999999999987
Q ss_pred CCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhC-CCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g-~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||+|+....... .....||+.|+|||++.+..++.+ +||||+||++|||+|+ .+||...+.....
T Consensus 137 ~~--~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~~~~~- 212 (263)
T d1sm2a_ 137 NQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVV- 212 (263)
T ss_dssp GG--CEEECSCC------------------CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-
T ss_pred CC--CeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCHHHHH-
Confidence 65 499999999986433222 234578999999999988887655 9999999999999995 5666554443222
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..+.. ....+.+..+++++.+||.+||+.||++|||++++++|
T Consensus 213 ---~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 213 ---EDIST-GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---HHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHh-cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 22222 22334445589999999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-43 Score=308.08 Aligned_cols=207 Identities=23% Similarity=0.328 Sum_probs=160.8
Q ss_pred CCcchhhhhceeeecee----EEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVKMKF----VFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~----~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|++++++++..... .++++ +|+.||+|+++++..+.-. .++.++.||+.||+|||++||+||||||+|||+
T Consensus 64 ~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl 142 (345)
T d1pmea_ 64 RHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 142 (345)
T ss_dssp CCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE
Confidence 68999999999976542 23444 4688999999997754323 999999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCC----CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
+.++ .+||+|||+|+..... ......+||+.|+|||++......+.++|+||+||++|+|++|+.||.+.+...
T Consensus 143 ~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~ 220 (345)
T d1pmea_ 143 NTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220 (345)
T ss_dssp CTTC--CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CCCC--CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH
Confidence 7654 5999999999753222 223556799999999998665555666999999999999999999998877655
Q ss_pred HHHHHHHHHhccc----------------cCCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccccc
Q 022732 157 DFRKTIQRILSVQ----------------YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 211 (293)
Q Consensus 157 ~~~~~~~~~~~~~----------------~~~~---------~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~ 211 (293)
............. ...+ ....+|+++++||.+||++||.+|||+.++|+||||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 4433332211110 0000 12347899999999999999999999999999999986
Q ss_pred CCCC
Q 022732 212 NLPA 215 (293)
Q Consensus 212 ~~~~ 215 (293)
....
T Consensus 301 ~~~~ 304 (345)
T d1pmea_ 301 YYDP 304 (345)
T ss_dssp TCCG
T ss_pred CCCC
Confidence 6544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-43 Score=304.98 Aligned_cols=197 Identities=18% Similarity=0.296 Sum_probs=153.9
Q ss_pred CCCcchhhhhceeeece----eEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 5 GSSSSEYAMLGVSVKMK----FVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~----~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
-.|+|++++++++...+ ..|+|| ||+.|++|..++...+.+. +++.++.||+.||.|||++||+||||||+||
T Consensus 64 ~~hpniv~~~~~~~~~~~~~~~~~lvm-E~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NI 142 (277)
T d1o6ya_ 64 LNHPAIVAVYDTGEAETPAGPLPYIVM-EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 142 (277)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEE-ECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred cCCCCCCcccceeeeccCCCceEEEEE-ECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccc
Confidence 36899999999998764 489999 7999999999999888766 8999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCC----CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCc
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 154 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 154 (293)
|++.++. ++++|||.++..... ......+||+.|+|||++.+..++.+ +||||+||++|+|+||+.||.+.+.
T Consensus 143 ll~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 143 MISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp EEETTSC--EEECCCTTCEECC----------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCcccc--ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCH
Confidence 9977654 999999998643222 23345679999999999988777655 9999999999999999999998776
Q ss_pred hHHHHHHHHHHhccccCC--CCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCccc
Q 022732 155 PKDFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 209 (293)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~ 209 (293)
...+..+.. ..... .....+|+++.+||.+||++||.+||+..+.+.|+|.
T Consensus 220 ~~~~~~~~~----~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 220 VSVAYQHVR----EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHHHH----CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHh----cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 554443332 22221 2234589999999999999999999954445556664
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=304.06 Aligned_cols=204 Identities=24% Similarity=0.324 Sum_probs=160.2
Q ss_pred CCcchhhhhceeee--------ceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 022732 6 SSSSEYAMLGVSVK--------MKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKL 75 (293)
Q Consensus 6 ~~~~~v~~~~~~~~--------~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp 75 (293)
.|+|++++++++.. .+++|+|| ||+.++.+.........+. .++.++.||+.||.|||++||+||||||
T Consensus 67 ~h~nii~~~~~~~~~~~~~~~~~~~~~iv~-e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp 145 (318)
T d3blha1 67 KHENVVNLIEICRTKASPYNRCKGSIYLVF-DFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA 145 (318)
T ss_dssp CCTTBCCEEEEEEC----------CEEEEE-ECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred cCCCccceEeeeecccccccccCceEEEEE-eccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCc
Confidence 58999999999865 45789999 7999988876665555554 8999999999999999999999999999
Q ss_pred CcEEEcCCCCCCEEEecCCCCcCcCC-----CCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCC
Q 022732 76 ENTLLDGSPAPRLKICDFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 150 (293)
Q Consensus 76 ~NIl~~~~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 150 (293)
+|||++.++ .+||+|||+++.... .....+.+||+.|+|||++.+....+.++||||+||++|+|++|+.||.
T Consensus 146 ~NILl~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 146 ANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp GGEEECTTS--CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hheeecCCC--cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 999997665 599999999974332 2233446799999999998876544556999999999999999999999
Q ss_pred CCCchHHHHHHHHHHhccccCCCCC--------------------------CCCCHHHHHHHHHccccCCCCCCCHHHHH
Q 022732 151 DPDEPKDFRKTIQRILSVQYSVPDT--------------------------NPISQECRDLISRIFVADPAARITIPEIM 204 (293)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~s~~~~~li~~~L~~dp~~Rpt~~ell 204 (293)
+.+....+..+.+............ ...++++++||.+||++||++|||+.|+|
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 8776555544444332221110000 01367889999999999999999999999
Q ss_pred cCcccccC
Q 022732 205 KHQWFLKN 212 (293)
Q Consensus 205 ~h~~~~~~ 212 (293)
+||||+..
T Consensus 304 ~Hpff~~~ 311 (318)
T d3blha1 304 NHDFFWSD 311 (318)
T ss_dssp HSGGGSSS
T ss_pred cChhhccC
Confidence 99999753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=302.38 Aligned_cols=196 Identities=18% Similarity=0.242 Sum_probs=155.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----LLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+|++++++.+ +..|+|| ||+.+|+|.+++.... ...++..++.||+.||.|||++||+||||||+|||++
T Consensus 66 ~HpnIv~~~g~~~~-~~~~iv~-Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~ 143 (272)
T d1qpca_ 66 QHQRLVRLYAVVTQ-EPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143 (272)
T ss_dssp CCTTBCCEEEEECS-SSCEEEE-ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CCCCEeEEEeeecc-CCeEEEE-EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee
Confidence 58999999998765 5679999 7999999999875443 2238999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
.++ .+||+|||+|+...... ......||+.|+|||++.+..++.+ +||||+||++|||+||..|+........+
T Consensus 144 ~~~--~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~~- 219 (272)
T d1qpca_ 144 DTL--SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEV- 219 (272)
T ss_dssp TTS--CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHH-
T ss_pred ccc--ceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 654 59999999998653322 2344578999999999988777654 99999999999999965554443333222
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc--Ccccc
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK--HQWFL 210 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~--h~~~~ 210 (293)
.+.+.. ....+.+..+++++.+||.+||+.||++|||+.++++ ++||.
T Consensus 220 --~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 220 --IQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp --HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHh-cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 222222 2334445568999999999999999999999999998 78875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-43 Score=296.54 Aligned_cols=192 Identities=19% Similarity=0.319 Sum_probs=160.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CH--HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LL--VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~--~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+++++|+|.+.+.+|+|| ||+.+|+|..++.... .+ ..++.++.||++||.|||++||+||||||+||+++.
T Consensus 57 ~HpnIv~~~g~~~~~~~~~iv~-Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~ 135 (258)
T d1k2pa_ 57 SHEKLVQLYGVCTKQRPIFIIT-EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 135 (258)
T ss_dssp CCTTBCCEEEEECCSSSEEEEE-ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT
T ss_pred CCCceeeEEEEEeeCCceEEEE-EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC
Confidence 6999999999999999999999 7999999999976543 23 388999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCCC--CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||+|+....... .....||+.|+|||++.+..++.+ +||||+||++|||+| |+.||.+.+.....
T Consensus 136 ~~--~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~- 211 (258)
T d1k2pa_ 136 QG--VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETA- 211 (258)
T ss_dssp TC--CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-
T ss_pred CC--cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHH-
Confidence 55 599999999975433322 234568999999999988887655 999999999999998 89999988764433
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
..+.. ....+.+...++++.+||.+||+.||++|||++++++|
T Consensus 212 ---~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 212 ---EHIAQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---HHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHh-CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 33332 23444556689999999999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=297.94 Aligned_cols=204 Identities=25% Similarity=0.355 Sum_probs=166.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 83 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~ 83 (293)
.|+|+++++++|......++|+ +|+.|++|..+++..+.+. .++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 59 ~h~niv~~~~~~~~~~~~~iv~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~ 137 (292)
T d1unla_ 59 KHKNIVRLHDVLHSDKKLTLVF-EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137 (292)
T ss_dssp CCTTBCCEEEEEECSSEEEEEE-ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CcCCEEeeccccccccceeEEe-eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC
Confidence 6899999999999999999999 7999999999998887766 899999999999999999999999999999999765
Q ss_pred CCCCEEEecCCCCcCcCCCC-CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHHHHH
Q 022732 84 PAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 162 (293)
Q Consensus 84 ~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 162 (293)
+ .+||+|||.|+...... ......+++.|+|||++.+..+.+.++||||+||++|+|++|+.||............+
T Consensus 138 ~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~ 215 (292)
T d1unla_ 138 G--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp C--CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred C--ceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 5 59999999998654433 33345678899999999877766667999999999999999999876555444333333
Q ss_pred HHHhcccc------------------------CCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccC
Q 022732 163 QRILSVQY------------------------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 212 (293)
Q Consensus 163 ~~~~~~~~------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~ 212 (293)
........ .......+++.+.+||.+||++||.+|||++|+|+||||++-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 216 FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred HhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 32221110 001123478999999999999999999999999999999754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=305.67 Aligned_cols=204 Identities=24% Similarity=0.368 Sum_probs=152.6
Q ss_pred CCcchhhhhceee------eceeEEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 022732 6 SSSSEYAMLGVSV------KMKFVFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTL 79 (293)
Q Consensus 6 ~~~~~v~~~~~~~------~~~~~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl 79 (293)
.|+|+|+++++|. ..+++|+|| ||+.|+.+ ..+...-....++.+++||+.||.|||++||+||||||+|||
T Consensus 74 ~hpnIv~~~~~f~~~~~~~~~~~~~iv~-Ey~~~~l~-~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil 151 (355)
T d2b1pa1 74 NHKNIISLLNVFTPQKTLEEFQDVYLVM-ELMDANLC-QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151 (355)
T ss_dssp CCTTBCCCSEEECSCCSTTTCCEEEEEE-ECCSEEHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCCCeeEEEEEEecccccccCceeEEEE-eccchHHH-HhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccc
Confidence 5899999999996 447999999 79987654 455444444599999999999999999999999999999999
Q ss_pred EcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 80 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 80 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
++.++ .+|++|||+++...........+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+......
T Consensus 152 ~~~~~--~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~ 228 (355)
T d2b1pa1 152 VKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_dssp ECTTC--CEEECCCCC---------------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccccc--ceeeechhhhhccccccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHH
Confidence 97655 499999999987766666677789999999999988877665 999999999999999999999887655554
Q ss_pred HHHHHHhcc------------------ccCCCC------------------CCCCCHHHHHHHHHccccCCCCCCCHHHH
Q 022732 160 KTIQRILSV------------------QYSVPD------------------TNPISQECRDLISRIFVADPAARITIPEI 203 (293)
Q Consensus 160 ~~~~~~~~~------------------~~~~~~------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~el 203 (293)
.+....... ...... ....|+++.+||++||.+||++|||++|+
T Consensus 229 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el 308 (355)
T d2b1pa1 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308 (355)
T ss_dssp HHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 444322210 000000 00136789999999999999999999999
Q ss_pred HcCcccccCCC
Q 022732 204 MKHQWFLKNLP 214 (293)
Q Consensus 204 l~h~~~~~~~~ 214 (293)
|+||||+....
T Consensus 309 L~Hpw~~~~~~ 319 (355)
T d2b1pa1 309 LQHPYINVWYD 319 (355)
T ss_dssp HTSTTTGGGCC
T ss_pred hcCcccCCCCC
Confidence 99999987543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-43 Score=302.51 Aligned_cols=194 Identities=21% Similarity=0.348 Sum_probs=153.0
Q ss_pred CCCcchhhhhceeeec-eeEEEeehhhccCchhHHHHHHcCC----------------H--HHHHHHHHHHHHHHHHHHH
Q 022732 5 GSSSSEYAMLGVSVKM-KFVFLSLSFFFSLCLFFMWLLLLGL----------------L--VQARFFFQQLISGVSYCHA 65 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~-~~~~lv~~ey~~gg~L~~~l~~~~~----------------~--~~~~~~~~qil~~l~~LH~ 65 (293)
..|+|++++++++... +.+|+|| |||.+|+|.+++..... + .+++.++.||+.||.|||+
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~-E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~ 152 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 152 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEE-ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCeEEEeeeeeccCCCeEEEEE-EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh
Confidence 4688999999997664 5688999 79999999999976532 2 2899999999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHH
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 142 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 142 (293)
+||+||||||+|||++.++ ++||+|||+|+..... .......||+.|+|||++.+..++.+ +||||+||++|||
T Consensus 153 ~~ivHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~el 229 (299)
T d1ywna1 153 RKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEI 229 (299)
T ss_dssp TTCCCSCCCGGGEEECGGG--CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHH
T ss_pred CCCcCCcCCccceeECCCC--cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHH
Confidence 9999999999999997655 5999999999754322 22345679999999999988777555 9999999999999
Q ss_pred HhC-CCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 143 LVG-GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 143 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+|| ..||.+......+...+.. ....+.+..+++++.++|.+||+.||++|||+.++++|
T Consensus 230 lt~~~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 230 FSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHhc----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 986 5688877665544444332 22334455689999999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=297.56 Aligned_cols=191 Identities=19% Similarity=0.316 Sum_probs=149.5
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|++++++. .+.+|+|| ||+.+|+|..++.... .++ +++.++.||+.||.|||++|++||||||+||+++.
T Consensus 66 ~HpnIv~l~~~~~-~~~~~iv~-E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~ 143 (273)
T d1mp8a_ 66 DHPHIVKLIGVIT-ENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 143 (273)
T ss_dssp CCTTBCCEEEEEC-SSSCEEEE-ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE
T ss_pred CCCCEeeEEEEEe-cCeEEEEE-EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecC
Confidence 6999999999996 57789999 7999999999886643 343 89999999999999999999999999999999987
Q ss_pred CCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
++ .+||+|||+|+...... ......||+.|+|||++.+..++.+ +||||+||++|||++ |.+||.+........
T Consensus 144 ~~--~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~ 220 (273)
T d1mp8a_ 144 ND--CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220 (273)
T ss_dssp TT--EEEECC-------------------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred CC--cEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 65 49999999998643322 2334568999999999988887655 999999999999998 899999877655443
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+ .. ....+.+..+|+++.+||.+||..||.+|||+.+++++
T Consensus 221 ~i----~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 221 RI----EN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HH----HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH----Hc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 32 22 22345556799999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=301.79 Aligned_cols=195 Identities=22% Similarity=0.333 Sum_probs=161.4
Q ss_pred CCCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc----------------CCHH--HHHHHHHHHHHHHHHHH
Q 022732 3 PVGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL----------------GLLV--QARFFFQQLISGVSYCH 64 (293)
Q Consensus 3 ~~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~----------------~~~~--~~~~~~~qil~~l~~LH 64 (293)
.+..|+|+|++|+++.+.+..|+|| ||+.||+|.++|+.. ..++ ++..++.||+.||.|||
T Consensus 66 ~l~~HpnIv~~~~~~~~~~~~~iV~-ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH 144 (309)
T d1fvra_ 66 KLGHHPNIINLLGACEHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144 (309)
T ss_dssp TCCCCTTBCCEEEEEEETTEEEEEE-CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred hccCCCCEeeEEEEEecCCeeEEEE-EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh
Confidence 4567999999999999999999999 799999999999765 2233 89999999999999999
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh
Q 022732 65 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 144 (293)
Q Consensus 65 ~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 144 (293)
++|++||||||+|||++.++ .+||+|||+|+............||+.|+|||.+.+..++.+ +|||||||++|||++
T Consensus 145 ~~~iiHrDlkp~NIL~~~~~--~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~ 221 (309)
T d1fvra_ 145 QKQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVS 221 (309)
T ss_dssp HTTEECSCCSGGGEEECGGG--CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHT
T ss_pred cCCccccccccceEEEcCCC--ceEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHh
Confidence 99999999999999997665 599999999986655555556679999999999988887655 999999999999999
Q ss_pred CC-CCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 145 GG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 145 g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
|. +||.+.+... +...+.. ....+.+..+++++++||.+||+.||++|||+.+++++
T Consensus 222 ~~~~p~~~~~~~~----~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 222 LGGTPYCGMTCAE----LYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TSCCTTTTCCHHH----HHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCHHH----HHHHHHh-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 75 5777665433 3333332 23445556689999999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=295.54 Aligned_cols=192 Identities=19% Similarity=0.255 Sum_probs=151.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++|++.+.+..|+|| ||+.++++..++.... .+. ++..++.||+.||+|||+++|+||||||+|||++.
T Consensus 67 ~H~nIv~~~g~~~~~~~~~~v~-e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~ 145 (283)
T d1mqba_ 67 SHHNIIRLEGVISKYKPMMIIT-EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 145 (283)
T ss_dssp CCTTBCCEEEEECSSSSEEEEE-ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCCCEeeeeEEEecCCceEEEE-EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC
Confidence 5899999999999999999999 7999999999887653 344 89999999999999999999999999999999976
Q ss_pred CCCCCEEEecCCCCcCcCCCC----CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
++ .+||+|||+|+...... ......||+.|+|||++.+..++.+ +||||+||++|||++|..||........+
T Consensus 146 ~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~ 222 (283)
T d1mqba_ 146 NL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEV 222 (283)
T ss_dssp TC--CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CC--eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHH
Confidence 65 59999999998643322 1223468999999999988877655 99999999999999976655544443333
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
...+ ......+.+..++..+.++|.+||..||++|||+.++++
T Consensus 223 ~~~i----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 223 MKAI----NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHH----HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHH----hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 3222 223344555668999999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=294.80 Aligned_cols=198 Identities=20% Similarity=0.275 Sum_probs=153.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHc--CCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLL--GLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~--~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+|++|+++.+ +.+|+|| ||+.+|+|..++... +.++ +++.++.||+.||+|||++||+||||||+|||++
T Consensus 70 ~h~nIv~~~g~~~~-~~~~lv~-Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~ 147 (285)
T d1fmka3 70 RHEKLVQLYAVVSE-EPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 147 (285)
T ss_dssp CCTTBCCEEEEECS-SSCEEEE-CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ccCCEeEEEEEEec-CCeEEEE-EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC
Confidence 58999999999965 5678999 799999999888543 3343 9999999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCC--CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHHH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 159 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 159 (293)
.++ .+||+|||+|+...... ......||+.|+|||++.+..++.+ +||||+||++|||++|..||........+.
T Consensus 148 ~~~--~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~ 224 (285)
T d1fmka3 148 ENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVL 224 (285)
T ss_dssp GGG--CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred CCC--cEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 665 49999999998543222 2234579999999999988887654 999999999999999765554444433332
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc--CcccccC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK--HQWFLKN 212 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~--h~~~~~~ 212 (293)
..+ .. ....+.+..+|+++++||.+||+.||++|||+++++. ++||...
T Consensus 225 ~~i---~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 225 DQV---ER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHH---HT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHH---Hh-cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 222 22 2344555668999999999999999999999999987 7788643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-42 Score=301.92 Aligned_cols=202 Identities=22% Similarity=0.331 Sum_probs=158.8
Q ss_pred CCcchhhhhceeeec-----eeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 022732 6 SSSSEYAMLGVSVKM-----KFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENT 78 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~-----~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NI 78 (293)
.|+|+|+++++|... ...++|+ +|+.||+|.+++..++ ++ +++.++.||+.||+|||++||+||||||+||
T Consensus 75 ~h~~iv~~~~~~~~~~~~~~~~~~~i~-~~~~gg~L~~~~~~~~-l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NI 152 (348)
T d2gfsa1 75 KHENVIGLLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 152 (348)
T ss_dssp CCTTBCCCSEEECSCSSTTTCCCCEEE-EECCSEEHHHHHTTCC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCCCeeeEEEEEeeccccccCceEEEE-EeecCCchhhhccccc-ccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccc
Confidence 589999999999643 3345556 4789999999996654 44 9999999999999999999999999999999
Q ss_pred EEcCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchHHH
Q 022732 79 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 158 (293)
Q Consensus 79 l~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 158 (293)
|++.++ .+|++|||+|.... ....+..||+.|+|||++.+..+.+.++|+||+||++|+|++|+.||.+.+.....
T Consensus 153 Li~~~~--~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~ 228 (348)
T d2gfsa1 153 AVNEDC--ELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 228 (348)
T ss_dssp EECTTC--CEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccccc--cccccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 997665 59999999987532 33456679999999999888776666799999999999999999999988766555
Q ss_pred HHHHHHHhcccc-------------------CCCC------CCCCCHHHHHHHHHccccCCCCCCCHHHHHcCcccccCC
Q 022732 159 RKTIQRILSVQY-------------------SVPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 159 ~~~~~~~~~~~~-------------------~~~~------~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
..+......... ..+. ...+|+++++||.+||.+||.+|||+.|+|+||||++..
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 229 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 554443221110 0000 134789999999999999999999999999999998654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=293.64 Aligned_cols=192 Identities=21% Similarity=0.310 Sum_probs=160.9
Q ss_pred CCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC----------------CHH--HHHHHHHHHHHHHHHHHHc
Q 022732 5 GSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG----------------LLV--QARFFFQQLISGVSYCHAM 66 (293)
Q Consensus 5 ~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~----------------~~~--~~~~~~~qil~~l~~LH~~ 66 (293)
..|+|+|+++++|.+.+.+|+|| ||+.+|+|.++|.... .++ +++.++.||+.||+|||++
T Consensus 76 ~~HpnIv~~~~~~~~~~~~~~v~-e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~ 154 (299)
T d1fgka_ 76 GKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 154 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEE-CCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEecccccccCCeEEEEE-EccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC
Confidence 46999999999999999999999 7999999999997654 233 8999999999999999999
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHH
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 143 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 143 (293)
||+||||||+|||++.++ .+||+|||+++..... .......||+.|+|||++.+..|+.+ +|||||||++|||+
T Consensus 155 ~ivHrDiKp~NiLl~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell 231 (299)
T d1fgka_ 155 KCIHRDLAARNVLVTEDN--VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIF 231 (299)
T ss_dssp TCCCSCCSGGGEEECTTC--CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHH
T ss_pred CEEeeeecccceeecCCC--CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhc
Confidence 999999999999997765 4999999999854332 23344678999999999988887655 99999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 144 V-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 144 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
+ |..||.+.+.... ...+. .....+.+..+|+++++||.+||++||.+|||+.++++
T Consensus 232 ~~g~~p~~~~~~~~~----~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 232 TLGGSPYPGVPVEEL----FKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TTSCCSSTTCCHHHH----HHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCCCHHHH----HHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8 7888887665332 22222 23444555678999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-42 Score=292.04 Aligned_cols=191 Identities=20% Similarity=0.297 Sum_probs=156.6
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|++||+|.+ +..|+|| ||+.+|++..++.... .++ .++.++.||+.||.|||++||+||||||+||+++.
T Consensus 69 ~H~nIv~~~g~~~~-~~~~lv~-e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~ 146 (273)
T d1u46a_ 69 DHRNLIRLYGVVLT-PPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT 146 (273)
T ss_dssp CCTTBCCEEEEECS-SSCEEEE-ECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE
T ss_pred CCCCEEEEEEEEee-cchheee-eeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc
Confidence 58999999999976 5678999 7999999998886643 344 89999999999999999999999999999999987
Q ss_pred CCCCCEEEecCCCCcCcCCCCC----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 157 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~ 157 (293)
++ .+||+|||+++....... .....|++.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+...
T Consensus 147 ~~--~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~- 222 (273)
T d1u46a_ 147 RD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQ- 222 (273)
T ss_dssp TT--EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH-
T ss_pred cc--ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHH-
Confidence 65 599999999986433222 233457889999999988776544 999999999999998 899999877644
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 158 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
....+.......+.+..+|+++.+||.+||..||++|||+.++++
T Consensus 223 ---~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 223 ---ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ---HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 334444555556666779999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=285.84 Aligned_cols=190 Identities=19% Similarity=0.289 Sum_probs=149.8
Q ss_pred CCcchhhhhceeee-ceeEEEeehhhccCchhHHHHHHcCC----HHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 6 SSSSEYAMLGVSVK-MKFVFLSLSFFFSLCLFFMWLLLLGL----LVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 6 ~~~~~v~~~~~~~~-~~~~~lv~~ey~~gg~L~~~l~~~~~----~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
.|+|+++++|++.+ .+.+|+|| ||+.+|+|.+++.+.+. ...++.++.||+.||.|||+++++||||||+|||+
T Consensus 58 ~HpnIv~~~g~~~~~~~~~~lv~-ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~ 136 (262)
T d1byga_ 58 RHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 136 (262)
T ss_dssp CCTTBCCEEEEECCC--CCEEEE-CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCCEeeEEEEEEecCCcEEEEE-eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee
Confidence 69999999999854 56789999 79999999999976542 22899999999999999999999999999999999
Q ss_pred cCCCCCCEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHHH
Q 022732 81 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 159 (293)
Q Consensus 81 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~ 159 (293)
+.++ .+||+|||+++... .......+|+.|+|||++.+..++. ++|||||||++|||+| |++||...+......
T Consensus 137 ~~~~--~~kl~dfg~s~~~~--~~~~~~~~~~~y~aPE~l~~~~~t~-~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~ 211 (262)
T d1byga_ 137 SEDN--VAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211 (262)
T ss_dssp CTTS--CEEECCCCC--------------CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred cCCC--CEeecccccceecC--CCCccccccccCCChHHHhCCCCCh-HHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 7665 49999999998543 2334557899999999998877754 4999999999999998 788888776544332
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 160 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
. +. .....+.+..+++++++||.+||..||.+|||+.+++++
T Consensus 212 ~----i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 212 R----VE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp H----HT-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H----HH-cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2 22 223444555689999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=295.80 Aligned_cols=192 Identities=19% Similarity=0.321 Sum_probs=154.1
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 82 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~ 82 (293)
.|+|+|+++|+|.+.+ .++++ ||+.+|+|..++.... .++ .++.++.||+.||.|||++||+||||||+|||++.
T Consensus 69 ~HpnIv~l~g~~~~~~-~~~v~-e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~ 146 (317)
T d1xkka_ 69 DNPHVCRLLGICLTST-VQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 146 (317)
T ss_dssp CCTTBCCEEEEEESSS-EEEEE-ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE
T ss_pred CCCCEeeEEEEEecCC-eeEEE-EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC
Confidence 5999999999998754 56777 5888999998887653 344 79999999999999999999999999999999987
Q ss_pred CCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHh-CCCCCCCCCchHHH
Q 022732 83 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 158 (293)
Q Consensus 83 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~ 158 (293)
++ ++||+|||+|+....... .....||+.|+|||++.+..++.+ +||||+||++|||+| |..||.+.+.....
T Consensus 147 ~~--~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~~ 223 (317)
T d1xkka_ 147 PQ--HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS 223 (317)
T ss_dssp TT--EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGHH
T ss_pred CC--CeEeeccccceecccccccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 65 599999999985433222 233468999999999988877655 999999999999998 78999887654432
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcCc
Q 022732 159 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 207 (293)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h~ 207 (293)
..+.. ....+.+..+++++.+||.+||..||.+|||+.+++.|.
T Consensus 224 -~~i~~----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 224 -SILEK----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp -HHHHH----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHHHc----CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 22222 233444556899999999999999999999999999984
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-41 Score=291.00 Aligned_cols=194 Identities=23% Similarity=0.349 Sum_probs=160.4
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC------------------H--HHHHHHHHHHHHHHHHH
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL------------------L--VQARFFFQQLISGVSYC 63 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~------------------~--~~~~~~~~qil~~l~~L 63 (293)
+..|+|+|++++++.+.+..|+|| |||.+|+|.++++.... + ..+..++.||+.||+||
T Consensus 83 l~~HpnIv~~~g~~~~~~~~~lvm-E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L 161 (311)
T d1t46a_ 83 LGNHMNIVNLLGACTIGGPTLVIT-EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (311)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEE-ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCEEEEEEEEeeCCEEEEEE-EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 357999999999999999999999 79999999999976541 2 28999999999999999
Q ss_pred HHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHH
Q 022732 64 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 140 (293)
Q Consensus 64 H~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ 140 (293)
|++|++||||||+||+++.++ .+|++|||+++....... .....||+.|+|||++.+..++.+ +|||||||++|
T Consensus 162 H~~~ivHrDLKp~NIl~~~~~--~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ 238 (311)
T d1t46a_ 162 ASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLW 238 (311)
T ss_dssp HHTTCCCSCCSGGGEEEETTT--EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHH
T ss_pred HhCCeeecccccccccccccC--cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHH
Confidence 999999999999999997665 599999999986543222 234578999999999987776554 99999999999
Q ss_pred HHHh-CCCCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 141 VMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 141 el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
||+| |.+||.+......+.+++.. ....+.+..+|..+.+||.+||.+||++|||+.++++
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhc----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9998 56667666654444444433 3344445568999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-40 Score=289.18 Aligned_cols=191 Identities=20% Similarity=0.296 Sum_probs=156.4
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCC------------------------HH--HHHHHHHHHHHH
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGL------------------------LV--QARFFFQQLISG 59 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~------------------------~~--~~~~~~~qil~~ 59 (293)
.|+|++++++++...+..++|| ||+.+|+|.+++..... +. ++..++.||+.|
T Consensus 74 ~h~niv~~~~~~~~~~~~~~v~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~g 152 (301)
T d1lufa_ 74 DNPNIVKLLGVCAVGKPMCLLF-EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 152 (301)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHH
T ss_pred CCCCcccceeeeccCCceEEEE-EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHH
Confidence 6899999999999999999999 79999999999976432 22 789999999999
Q ss_pred HHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCcCCC---CCCCCCcCCCCccchhhhccccCCCchhhhhhhh
Q 022732 60 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 136 (293)
Q Consensus 60 l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG 136 (293)
|+|||++|++||||||+|||++.++ .+||+|||+|+..... ....+..||+.|+|||++.+..++.+ +||||+|
T Consensus 153 l~ylH~~~ivHrDlKp~NILld~~~--~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~G 229 (301)
T d1lufa_ 153 MAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYG 229 (301)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHH
T ss_pred hhhcccCCeEeeEEcccceEECCCC--cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccch
Confidence 9999999999999999999997655 5999999999743222 22345678999999999998888655 9999999
Q ss_pred hHHHHHHhCC-CCCCCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 137 VTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 137 ~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
|++|||++|. +||.+.+..+.. ..+.... ..+.+..+++++.+||.+||+.+|++|||+.++++
T Consensus 230 vvl~ell~~~~~p~~~~~~~e~~----~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 230 VVLWEIFSYGLQPYYGMAHEEVI----YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHH----HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHccCCCCCCCCCHHHHH----HHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999985 678777654333 3333332 23345568999999999999999999999999966
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-40 Score=284.75 Aligned_cols=193 Identities=18% Similarity=0.247 Sum_probs=153.4
Q ss_pred CCcchhhhhceeee-ceeEEEeehhhccCchhHHHHHHcCCH---HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 6 SSSSEYAMLGVSVK-MKFVFLSLSFFFSLCLFFMWLLLLGLL---VQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 6 ~~~~~v~~~~~~~~-~~~~~lv~~ey~~gg~L~~~l~~~~~~---~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
.|+|+|+++|++.. ++..++|| ||+.+|+|.+++...... ..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 86 ~HpnIv~~~g~~~~~~~~~~lv~-E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~ 164 (311)
T d1r0pa_ 86 SHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 164 (311)
T ss_dssp CCTTBCCCCEEEEETTTEEEEEE-ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCCEeEEeEEEEecCCceEEEE-EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC
Confidence 59999999999876 46889999 799999999999865432 27889999999999999999999999999999997
Q ss_pred CCCCCCEEEecCCCCcCcCCCCC-----CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCCchH
Q 022732 82 GSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 156 (293)
Q Consensus 82 ~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 156 (293)
.++ .+||+|||+++....... .....||+.|+|||.+.+..++.+ +|||||||++|||+||..||.......
T Consensus 165 ~~~--~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~ 241 (311)
T d1r0pa_ 165 EKF--TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTF 241 (311)
T ss_dssp TTC--CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC-----
T ss_pred CCC--CEEEecccchhhccccccccceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 655 599999999986433221 223468999999999988777555 999999999999999888776644332
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 157 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+ ...+... ...+.+..+++++.+||.+||..||++|||+.++++|
T Consensus 242 ~~---~~~i~~g-~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 242 DI---TVYLLQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -C---HHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH---HHHHHcC-CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 22 2222222 2334445689999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=283.78 Aligned_cols=192 Identities=19% Similarity=0.265 Sum_probs=157.8
Q ss_pred CCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC------------CHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 022732 6 SSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG------------LLVQARFFFQQLISGVSYCHAMQVCHRDL 73 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~------------~~~~~~~~~~qil~~l~~LH~~~iiHrdl 73 (293)
.|+|+|++++++......++|| ||+.+|+|.+++.... ....+..++.|++.||.|||+++|+||||
T Consensus 81 ~h~nIv~~~~~~~~~~~~~lv~-e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDl 159 (308)
T d1p4oa_ 81 NCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 159 (308)
T ss_dssp CCTTBCCEEEEECSSSSCEEEE-ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred CCCCEeeeeeEEecCCceeEEE-eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceE
Confidence 5999999999999999999999 7999999999996542 12278899999999999999999999999
Q ss_pred CCCcEEEcCCCCCCEEEecCCCCcCcCCCCC---CCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhC-CCCC
Q 022732 74 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPF 149 (293)
Q Consensus 74 kp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g-~~pf 149 (293)
||+|||++.+. ++||+|||+|+....... .....||+.|+|||.+.+..++.+ +||||+||++|||+|| +.||
T Consensus 160 k~~NiLld~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~ 236 (308)
T d1p4oa_ 160 AARNCMVAEDF--TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 236 (308)
T ss_dssp SGGGEEECTTC--CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTT
T ss_pred cCCceeecCCc--eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCC
Confidence 99999997655 599999999985433222 234468999999999988887655 9999999999999998 5778
Q ss_pred CCCCchHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 150 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
.+.+....+. .+... ...+.+..+++.+.++|.+||+.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~----~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 237 QGLSNEQVLR----FVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp TTSCHHHHHH----HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHH----HHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7766544333 33322 2334455689999999999999999999999999984
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-39 Score=280.54 Aligned_cols=208 Identities=15% Similarity=0.175 Sum_probs=151.4
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcCCHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLGLLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 81 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~ 81 (293)
+..+++++.+++++.+.+..++|| ||+.++.+..+....+.++ .+..++.|++.||+|||++||+||||||+|||++
T Consensus 59 l~~~~~i~~~~~~~~~~~~~~ivm-e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~ 137 (299)
T d1ckia_ 59 MQGGVGIPTIRWCGAEGDYNVMVM-ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137 (299)
T ss_dssp STTSTTCCCEEEEEEETTEEEEEE-ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred ccCCCcccEEEEEEecCCEEEEEE-EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccc
Confidence 344556667777778888999999 6886654444444444444 9999999999999999999999999999999986
Q ss_pred CCC-CCCEEEecCCCCcCcCCCC--------CCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCC
Q 022732 82 GSP-APRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 152 (293)
Q Consensus 82 ~~~-~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 152 (293)
..+ ...+||+|||+|+...... ...+.+||+.|||||++.+..++.+ +||||+||++|||++|+.||...
T Consensus 138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGL 216 (299)
T ss_dssp CGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCccccc
Confidence 432 3469999999998543222 2345579999999999988877554 99999999999999999999876
Q ss_pred CchHHHHHHHH---HHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHH---HHHcCcccccCCC
Q 022732 153 DEPKDFRKTIQ---RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP---EIMKHQWFLKNLP 214 (293)
Q Consensus 153 ~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~---ell~h~~~~~~~~ 214 (293)
..........+ ....... ......+|+++.+||.+||..+|.+||+++ ++|+|+|.+.+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 217 KAATKRQKYERISEKKMSTPI-EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp C-------HHHHHHHHHHSCH-HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred chHHHHHHHHHhhcccCCCCh-hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 54333222211 1111110 011234889999999999999999999986 4577877655443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=276.91 Aligned_cols=198 Identities=20% Similarity=0.197 Sum_probs=147.4
Q ss_pred CCcchhhhhceeeece----eEEEeehhhccCchhHHHHHHcCCHH-HHHHHHHHHHHHHHHHHH--------cCCeecC
Q 022732 6 SSSSEYAMLGVSVKMK----FVFLSLSFFFSLCLFFMWLLLLGLLV-QARFFFQQLISGVSYCHA--------MQVCHRD 72 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~~----~~~lv~~ey~~gg~L~~~l~~~~~~~-~~~~~~~qil~~l~~LH~--------~~iiHrd 72 (293)
.|+|+|++++++.+.+ ++|+|| ||+.+|+|.+++++.+... ++..++.|++.||.|||+ +||+|||
T Consensus 55 ~HpnIv~~~~~~~~~~~~~~~~~lv~-Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrD 133 (303)
T d1vjya_ 55 RHENILGFIAADNKDNGTWTQLWLVS-DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp CCTTBCCEEEEEEEECSSSEEEEEEE-ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSC
T ss_pred CCCcCcceEEEEEeCCCcceEEEEEE-ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccc
Confidence 5999999999998764 789999 7999999999998865333 888999999999999996 5999999
Q ss_pred CCCCcEEEcCCCCCCEEEecCCCCcCcCCCC-----CCCCCcCCCCccchhhhccccC-----CCchhhhhhhhhHHHHH
Q 022732 73 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVM 142 (293)
Q Consensus 73 lkp~NIl~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslG~il~el 142 (293)
|||+|||++.++ ++||+|||+++...... .....+||+.|+|||++.+... .+.++|||||||++|||
T Consensus 134 lKp~NILl~~~~--~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el 211 (303)
T d1vjya_ 134 LKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp CCGGGEEECTTS--CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred cCccceEEcCCC--CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHH
Confidence 999999997654 59999999997543322 2345679999999999875431 13458999999999999
Q ss_pred HhCCCCCCCCCch-----------HHHHHHHHHHhccccCCCCC-----CCCCHHHHHHHHHccccCCCCCCCHHHHHcC
Q 022732 143 LVGGYPFEDPDEP-----------KDFRKTIQRILSVQYSVPDT-----NPISQECRDLISRIFVADPAARITIPEIMKH 206 (293)
Q Consensus 143 ~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~L~~dp~~Rpt~~ell~h 206 (293)
+||..||...... .....+...........+.+ ......+.+|+.+||+.||++|||+.+++++
T Consensus 212 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 9998877432210 01122222222222221111 1123568899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9e-38 Score=269.87 Aligned_cols=198 Identities=16% Similarity=0.115 Sum_probs=154.1
Q ss_pred CCCCcchhhhhceeeeceeEEEeehhhccCchhHHHHHHcC-CHH--HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 022732 4 VGSSSSEYAMLGVSVKMKFVFLSLSFFFSLCLFFMWLLLLG-LLV--QARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 80 (293)
Q Consensus 4 ~~~~~~~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l~~~~-~~~--~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~ 80 (293)
+..++|++++++++....+.|+|| ||+ |++|..+++..+ .+. .+..++.|++.||+|||++||+||||||+|||+
T Consensus 57 l~~~~~i~~~~~~~~~~~~~~~vm-e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili 134 (293)
T d1csna_ 57 LAGCTGIPNVYYFGQEGLHNVLVI-DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 134 (293)
T ss_dssp TTTCTTCCCEEEEEEETTEEEEEE-ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred hcCCCCCCEEEEEeecCCccEEEE-Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Confidence 456789999999999999999999 688 689999987755 344 899999999999999999999999999999999
Q ss_pred cCC---CCCCEEEecCCCCcCcCCC--------CCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCC
Q 022732 81 DGS---PAPRLKICDFGYSKSSVLH--------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 149 (293)
Q Consensus 81 ~~~---~~~~vkl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 149 (293)
+.. ..+.+||+|||+|+..... ....+.+||+.|||||++.+..++.+ +|||||||++|+|++|+.||
T Consensus 135 ~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf 213 (293)
T d1csna_ 135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPW 213 (293)
T ss_dssp CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTT
T ss_pred cCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcC
Confidence 753 2346999999999754321 22345679999999999988777555 99999999999999999999
Q ss_pred CCCCchHHH---HHHHHHHhccccCCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHHc
Q 022732 150 EDPDEPKDF---RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 205 (293)
Q Consensus 150 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ell~ 205 (293)
.+....... ..+........ .......+|+++.+++..|+..+|.+||+.+.+.+
T Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~-~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 214 QGLKAATNKQKYERIGEKKQSTP-LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SSCCSCCHHHHHHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCccchhHHHHHHHHHhccCCCC-hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 875543221 11111111110 00112347899999999999999999999876644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-36 Score=267.57 Aligned_cols=204 Identities=22% Similarity=0.368 Sum_probs=144.5
Q ss_pred CCcchhhhhceeeec--eeEEEeehhhccCc-hhHHHHHHcC--CH--HHHHHHHHHHHHHHHHHHH-cCCeecCCCCCc
Q 022732 6 SSSSEYAMLGVSVKM--KFVFLSLSFFFSLC-LFFMWLLLLG--LL--VQARFFFQQLISGVSYCHA-MQVCHRDLKLEN 77 (293)
Q Consensus 6 ~~~~~v~~~~~~~~~--~~~~lv~~ey~~gg-~L~~~l~~~~--~~--~~~~~~~~qil~~l~~LH~-~~iiHrdlkp~N 77 (293)
+++|++++++++... ...++++. ++..+ .......... .+ ..++.++.||+.||+|||+ .||+||||||+|
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMV-FEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEE-ECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred CcCceEEEEEEeeeccccceeeeee-ecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 467899999998754 45666663 44433 3333332222 22 2899999999999999998 899999999999
Q ss_pred EEEcCCCCC----CEEEecCCCCcCcCCCCCCCCCcCCCCccchhhhccccCCCchhhhhhhhhHHHHHHhCCCCCCCCC
Q 022732 78 TLLDGSPAP----RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 153 (293)
Q Consensus 78 Il~~~~~~~----~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 153 (293)
||++..+.. .+|++|||.|+... ......+||+.|+|||++.+..++.+ +|+||+||++++|++|+.||....
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC----
T ss_pred eeeeccCcccccceeeEeecccccccc--cccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCc
Confidence 999754432 48999999997543 33456789999999999998888655 999999999999999999997643
Q ss_pred ch------HHHHHHHHHHhcc-----------------c---c----------------CCCCCCCCCHHHHHHHHHccc
Q 022732 154 EP------KDFRKTIQRILSV-----------------Q---Y----------------SVPDTNPISQECRDLISRIFV 191 (293)
Q Consensus 154 ~~------~~~~~~~~~~~~~-----------------~---~----------------~~~~~~~~s~~~~~li~~~L~ 191 (293)
.. ..+......+... . . ........++++++||.+||.
T Consensus 234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 313 (362)
T d1q8ya_ 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313 (362)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence 21 1111111110000 0 0 000111246789999999999
Q ss_pred cCCCCCCCHHHHHcCcccccCC
Q 022732 192 ADPAARITIPEIMKHQWFLKNL 213 (293)
Q Consensus 192 ~dp~~Rpt~~ell~h~~~~~~~ 213 (293)
+||.+|||++|+|+||||+...
T Consensus 314 ~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 314 LDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp SSTTTCBCHHHHHTCGGGTTCT
T ss_pred CChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.55 E-value=6.6e-16 Score=123.46 Aligned_cols=68 Identities=15% Similarity=0.109 Sum_probs=55.6
Q ss_pred EEEeehhhccCchhHHHHHHcCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEecCCCCcCc
Q 022732 23 VFLSLSFFFSLCLFFMWLLLLGLLVQARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 99 (293)
Q Consensus 23 ~~lv~~ey~~gg~L~~~l~~~~~~~~~~~~~~qil~~l~~LH~~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~~~ 99 (293)
.++|| ||+.+..+..+ ....+..++.|++.+|.|||++||+||||||+|||++.++ ++|+|||.|+..
T Consensus 85 ~~lvm-e~~~~~~~~~l-----~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~~ 152 (191)
T d1zara2 85 NAVLM-ELIDAKELYRV-----RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVEV 152 (191)
T ss_dssp TEEEE-ECCCCEEGGGC-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEET
T ss_pred CEEEE-Eeeccccccch-----hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEECCCcccC
Confidence 46888 79998765431 1226778999999999999999999999999999997543 899999998743
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.34 E-value=0.0033 Score=50.22 Aligned_cols=30 Identities=10% Similarity=-0.230 Sum_probs=24.2
Q ss_pred hhhhhceeeeceeEEEeehhhccCchhHHHH
Q 022732 10 EYAMLGVSVKMKFVFLSLSFFFSLCLFFMWL 40 (293)
Q Consensus 10 ~v~~~~~~~~~~~~~lv~~ey~~gg~L~~~l 40 (293)
..+++.++...+..|+|| +++.|.++.+..
T Consensus 72 vP~vl~~~~~~~~~~lv~-~~l~G~~~~~~~ 101 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLM-SEADGVLCSEEY 101 (263)
T ss_dssp CCCEEEEEEETTEEEEEE-ECCSSEEHHHHT
T ss_pred CCcEEEEEecCCceEEEE-Eecccccccccc
Confidence 457788888889999999 799998886554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.07 E-value=0.042 Score=46.63 Aligned_cols=28 Identities=18% Similarity=0.239 Sum_probs=24.0
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 67 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 67 ~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++|+|+.|.||+++.+. +++.||-.|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~---~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE---TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC---EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc---eEEechhhcc
Confidence 589999999999997543 8999998775
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.87 E-value=0.023 Score=46.59 Aligned_cols=30 Identities=27% Similarity=0.338 Sum_probs=24.6
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.|+||+|+.+.||+++.+. ..-+.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE--LSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred cccccCCcchhhhhccccc--ceeEecccccc
Confidence 5799999999999997543 24799999774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.38 E-value=0.28 Score=40.01 Aligned_cols=28 Identities=18% Similarity=0.183 Sum_probs=22.8
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 66 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 66 ~~iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
.++||+|+.|.|||++. . ..+.||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~--~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD--G--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESS--S--EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeC--C--ceEEechhcc
Confidence 46899999999999953 2 4689999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=87.01 E-value=0.11 Score=40.68 Aligned_cols=28 Identities=25% Similarity=0.258 Sum_probs=22.8
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEecCCCCc
Q 022732 68 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 97 (293)
Q Consensus 68 iiHrdlkp~NIl~~~~~~~~vkl~Dfg~a~ 97 (293)
++|+|+.|.||+++.+. .+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~--~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGR--FSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCc--eEEEEEchhcc
Confidence 79999999999997542 25699998764
|